,Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes,_type
0,GO_Biological_Process_2018,nervous system development (GO:0007399),98/455,2.984808524892284e-14,1.1757160779550708e-10,0,0,2.622517257442934,81.67215202344373,CNTFR;SH3GL3;PLXND1;RAPGEFL1;SOX3;DPYSL2;ADORA1;EPHB2;EPHB1;SH3GL2;MBNL1;SZT2;RBFOX3;DSCAM;MAP1S;TMOD2;PCDHA11;OLFM1;FEZ2;KCNQ2;ADGRB1;IGSF8;PCDH19;KALRN;PCDHA1;MOBP;BTBD3;DVL1;PCDHA5;PCDHA4;PCDHA3;MBP;PCDHA2;PCDHA9;ASIC2;PCDHA8;PCDHA7;GPM6B;PCDHA6;ZBTB16;CRIM1;INHBA;ARHGAP26;CHERP;PCDHGA10;PCDHGA11;RCAN1;PCDHGA12;CDK5;DLG3;NF1;TPP1;LRCH4;FGF13;SDK2;FGFR2;TENM1;PCDHGB7;DAGLA;PCDHGB6;PCDHGB5;PCDHGB4;PCDHGB2;MTR;PKD1;PCDHGA8;PCDHGA7;PCDHGA6;DBNL;PCDHGA5;PCDHGA4;PCDHGA3;PCDHGA2;PCDHGA1;NAV1;NAV2;PCDHGA9;ALDH5A1;PCDHGB1;HAP1;DAGLB;DSCAML1;SHANK3;SHANK2;SRC;CAMK2A;NRXN2;TRAK1;SPOCK1;FYN;PCDH1;CAMK2G;PCDHGC5;PCDHGC4;PCDHGC3;CABLES1;S100B;NFASC,Hypo
1,GO_Biological_Process_2018,protein phosphorylation (GO:0006468),77/470,3.792035992694152e-06,0.0074684148876111,0,0,1.8470443112178008,23.05592913855701,MAST4;LRRK2;FLT4;PRKAG1;PKD1;STK10;DSTYK;PPP4R1;TBK1;EEF2K;PIM2;EPHB2;EPHB1;STK32C;CSNK1G3;PDGFRA;CDKL4;PRKCH;KSR1;PRKCB;PRKCE;LMTK2;PRKCA;BAZ1B;PRKAB1;BCR;MELK;PRKAR1B;MAPKAPK2;KIT;TYRO3;RARA;SIK3;PRKD2;BIRC6;ULK1;ERG;FAM20A;SGK1;CAMK2B;NIM1K;RNASEL;SRC;CAMK2A;STK39;STK4;PRKCZ;CAMKK2;GRK2;ABL1;ABL2;PTK2B;FYN;CLSPN;MAP4K5;CAMK2G;MARK2;MAP4K4;SRPK2;CDK18;DAB2IP;EIF2AK4;CDC42BPB;CDC42BPA;MAPK14;MTOR;SRPK1;SMAD7;SBK1;STK24;CDK5;WNK2;ATP13A2;CDK14;MAP3K11;FGFR2;CDK16,Hypo
2,GO_Biological_Process_2018,cytoskeleton organization (GO:0007010),29/126,8.971755914985843e-06,0.0112942861226771,0,0,2.794061297541551,32.470985401396085,SPTBN4;LAMA5;CNTNAP1;RTKN;MAST4;LIMD1;SIPA1L3;SYNE3;SYNE2;FGD1;SYNE1;ZMYM1;CAPZB;DPYSL2;PACSIN2;PAK6;PTK2B;WASF3;PAK4;SUN1;DST;MICAL3;ANK3;CDC42BPB;ANK1;DIAPH1;BIN1;RHOJ;BRWD1,Hypo
3,GO_Biological_Process_2018,regulation of Ras protein signal transduction (GO:0046578),23/90,1.222366798756018e-05,0.0112942861226771,0,0,3.203564430055225,36.23915807644165,GIT2;EPO;SPRY4;AGAP2;DAB2IP;AGAP1;RASAL1;ASAP1;ARHGAP17;AGAP3;ASAP2;RASGRP1;ARFGAP1;ARHGAP44;ACAP2;RASA3;SGSM3;MADD;RASA2;NF1;ARHGEF2;EPHB2;RALGPS1,Hypo
4,GO_Biological_Process_2018,phosphorylation (GO:0016310),64/386,1.6582905733910664e-05,0.0112942861226771,0,0,1.8682808270156697,20.564425200053904,DGKG;LRRK2;PRKAG1;LIMD1;HK1;STK10;DSTYK;PPP4R1;TBK1;PIM2;EPHB2;CDKL4;PRKCH;KSR1;PRKCB;PRKCE;LMTK2;PRKCA;PRKAB1;DGKZ;BCR;MELK;PRKAR1B;MAPKAPK2;RARA;SIK3;PRKD2;BIRC6;ULK1;ERG;FAM20A;SGK1;DGKI;CAMK2B;NIM1K;RNASEL;CAMK2A;STK39;STK4;PRKCZ;CAMKK2;ABL1;PTK2B;FYN;MAP4K5;MARK2;MAP4K4;TEFM;SRPK2;CDK18;TNK2;EIF2AK4;CDC42BPB;CDC42BPA;MTOR;SRPK1;STK24;CDK5;WNK2;PI4KA;COQ8A;CDK14;MAP3K11;CDK16,Hypo
5,GO_Biological_Process_2018,vesicle-mediated transport (GO:0016192),67/410,1.720378693477099e-05,0.0112942861226771,0,0,1.836857009703206,20.151021289942506,LRRK2;AP2A1;GOLGA4;DPYSL2;KIF13A;KIF1C;KIF1B;VPS39;NSF;CSNK1G3;STX8;VPS33A;AKTIP;DENND2A;TSC2;LMTK2;BET1L;ARFGAP1;DNM1;MAPK8IP1;ACAP2;BIN1;HEATR5B;RHOJ;RIN3;TBC1D23;SFT2D2;STX1A;CHMP5;NAPA;SPTBN4;RAB5C;LRP1;MGRN1;AGAP2;AGAP1;DENND3;ASAP1;AGAP3;ASAP2;TRAK1;KALRN;CYTH3;VPS53;VPS11;VTI1A;STX3;LDLR;RAB6B;ATP9B;ATP9A;RAB11FIP4;SPTBN2;GIT2;ARFGEF2;RIC1;SORT1;CCZ1;SYT13;SYT7;MYO1E;EHD4;CDK5;SYT12;SGSM3;SPIRE1;UBE2O,Hypo
6,GO_Biological_Process_2018,neuron projection development (GO:0031175),34/167,2.6278060102532077e-05,0.0147870398205534,0,0,2.390545779898598,25.212551297160296,CNTNAP1;LRRK2;USH1C;HMGB1;FRY;PPP1R9A;PPP1R9B;BLOC1S5;MAP4;STX3;EPHB2;EPHB1;SH3GL2;GPM6B;MAP4K4;ANKRD27;DBNL;UNC5A;MAP1S;DAB2IP;SLC9A6;STK24;CDK5;CTTN;TBC1D24;RAPGEF2;ULK1;TBC1D23;MAPT;SGK1;SHANK3;SHANK2;FRYL;CDK16,Hypo
7,GO_Biological_Process_2018,positive regulation of synaptic transmission (GO:0050806),18/67,5.161124673726824e-05,0.0254120876122624,0,0,3.4226771453923184,33.78788481238157,RGS14;TSHZ3;CLSTN1;EIF2AK4;PRKCZ;GRIN2B;SLC8A2;SLC8A3;RIMS1;RIMS3;KCTD13;PTK2B;HAP1;EPHB2;CACNG2;SHANK3;SHANK2;CACNG4,Hypo
8,GO_Biological_Process_2018,positive regulation of epithelial cell migration (GO:0010634),19/74,6.361514974464178e-05,0.0278422305382382,0,0,3.219292876983193,31.10692900957505,SCARB1;SRC;FLT4;PRKCE;PRKCA;FGF1;PPM1F;MTOR;EPB41L4B;ABL1;PTK2B;ITGB1BP1;PRKD2;DOCK1;GPLD1;CLASP1;SASH1;BCAR1;CLASP2,Hypo
9,GO_Biological_Process_2018,long-term synaptic potentiation (GO:0060291),9/21,7.729181291179883e-05,0.0286258982202246,0,0,6.969860896445131,65.99010295075068,SLC8A3;RGS14;TSHZ3;PTK2B;PRKCZ;GRIN2B;SHANK3;SHANK2;SLC8A2,Hypo
10,GO_Biological_Process_2018,regulation of protein secretion (GO:0050708),24/107,7.994030983053334e-05,0.0286258982202246,0,0,2.697443981533611,25.448307821093437,RHBDF1;KCNJ11;TGFB3;UQCC2;RHBDF2;SLC2A1;P3H1;SLC2A2;PRKCA;CACNA1D;CACNA1C;CACNA1E;SYT7;PER2;MYO18A;ATP13A2;SERGEF;SLC25A5;MYH10;SLC25A4;STX1A;LLGL1;RAPGEF3;RAPGEF4,Hypo
11,GO_Biological_Process_2018,neuron projection morphogenesis (GO:0048812),32/163,9.311653604838204e-05,0.0291728615468086,0,0,2.282148230106106,21.18212114231467,SPTBN4;CNTNAP1;LRRK2;LRP4;BTBD3;DVL1;SLIT1;APBB1;EPHB2;EPHB1;MAP4K4;NTNG2;ANKRD27;DBNL;MAP1S;DAB2IP;ANK3;EIF2AK4;BAIAP2;S100B;SLC9A6;STK24;CDK5;CTTN;MAP1A;ADGRB1;SGK1;SHANK3;DSCAML1;LLGL1;FGFR2;SHANK2,Hypo
12,GO_Biological_Process_2018,vascular endothelial growth factor receptor signaling pathway (GO:0048010),18/70,9.628007111157973e-05,0.0291728615468086,0,0,3.2246774964166267,29.82262109731894,CYFIP2;SHC2;SRC;FLT4;PXN;DAB2IP;PIK3R1;BAIAP2;MAPK14;VAV2;MAPKAPK2;ELMO1;ELMO2;PTK2B;PRKD2;FYN;DOCK1;BCAR1,Hypo
13,GO_Biological_Process_2018,Golgi vesicle transport (GO:0048193),46/271,0.00013895011419998006,0.0390946071309801,0,0,1.913982259570495,16.99883358015233,ARF3;NAPA;DCTN6;SPTBN4;DYNC1I2;SPTBN5;ATP8A1;PEF1;STX18;TGFA;KLC1;GOLGA2;CYTH3;KLC2;CAPZB;VTI1A;TRAPPC12;MYO18A;TBC1D14;KIF3C;RAB6B;ATP9B;ATP9A;SPTBN2;NSF;DYNC1H1;TRAPPC3;TMED9;TRAPPC10;COG1;ANK3;F2;ANK1;AP3B2;DYNLL2;SPTB;SORL1;ARFGAP1;BET1L;DYNC1LI2;KIF26A;SGSM2;KDELR2;COPG1;CNIH3;ERGIC1,Hypo
14,GO_Biological_Process_2018,protein autophosphorylation (GO:0046777),33/175,0.00016311251817576936,0.042833347272957,0,0,2.170953734929137,18.933040139811048,CAMK2B;SRC;LRRK2;FLT4;CAMK2A;STK39;STK4;CAMKK2;STK10;EEF2K;ABL1;ABL2;PTK2B;FYN;PIM2;EPHB1;MARK2;PDGFRA;TNK2;LMTK2;EIF2AK4;MTOR;MELK;STK24;WNK2;MAPKAPK2;KIT;TYRO3;ULK1;PRKD2;ATP13A2;MAP3K11;FGFR2,Hypo
15,GO_Biological_Process_2018,regulation of lipid metabolic process (GO:0019216),22/100,0.00020963087571582409,0.0516085012152894,0,0,2.629162676880519,22.269434608790327,ABCA1;NCOA1;ALAS1;H2AFY;CHD9;MID1IP1;PRKAG2;G0S2;IRS2;RORA;NR1D1;GRHL1;NCOR2;DISP3;RBL1;RXRA;OPA3;PSAP;THRSP;RGL1;BBS4;PPARD,Hypo
16,GO_Biological_Process_2018,axonogenesis (GO:0007409),39/223,0.0002311987436385537,0.0535701088936625,0,0,1.9815882874889088,16.590318566133085,CYFIP2;SPTBN4;SPTBN5;SRC;NRXN3;IRS2;PIK3R1;NTN1;RAP1GAP;FAM129B;KIF5C;SLIT1;TNR;FYN;APBB1;EPHB2;EPHB1;SCN1B;SPTBN2;NTNG2;UNC5A;MAP1S;PRKCA;PTPN11;ANK3;BAIAP2;S100B;SPTB;ENAH;SLC9A6;CDK5;FEZ2;MAP1A;ADGRB1;ULK1;DSCAML1;SHANK3;LLGL1;FGFR2,Hypo
17,GO_Biological_Process_2018,regulation of anatomical structure morphogenesis (GO:0022603),19/82,0.00027468120188611127,0.060109403012744,0,0,2.809244326074984,23.03552086000057,EGLN1;PHLDB1;PLXND1;LRRK2;FLT4;VASH2;VASH1;MYO19;ZMYM1;INF2;CAPZB;BCL6;NF1;MAPT;CLASP1;FGFR2;HTATIP2;CLASP2;BCL9L,Hypo
18,GO_Biological_Process_2018,positive regulation of programmed cell death (GO:0043068),43/257,0.00031054202800514987,0.0629471042611427,0,0,1.879323103764292,15.179652242137148,HRK;RARG;TNFAIP8;TRIO;USP27X;LRRK2;HMGB1;FOXO3;STK4;KALRN;FGD1;PREX1;ABR;RASSF2;FRZB;MCF2L;ABL1;APBB1;CTNNBL1;BOK;ARHGEF12;PLEKHG2;TGFB3;PLEKHG5;ARHGEF16;DAB2IP;HIP1R;PAWR;VAV2;CLIP3;TIAM1;MELK;OBSCN;BCL6;BIN1;ARHGEF3;NF1;ARHGEF1;ITGA6;ARHGEF2;ARHGEF7;GPLD1;MAP3K11,Hypo
19,GO_Biological_Process_2018,peptidyl-serine phosphorylation (GO:0018105),28/145,0.00032959170614314424,0.0629471042611427,0,0,2.2329126533080745,17.90272536178007,CAMK2B;MAST4;LRRK2;CAMK2A;STK39;STK4;PRKCZ;PKD1;CAMKK2;TBK1;GRK2;CLSPN;CAMK2G;STK32C;CSNK1G3;PRKCH;PRKCB;PRKCE;LMTK2;PRKCA;MAPK14;MTOR;SBK1;CDK5;MAPKAPK2;ULK1;PRKD2;SGK1,Hypo
20,GO_Biological_Process_2018,regulation of vesicle-mediated transport (GO:0060627),27/138,0.0003355900455658789,0.0629471042611427,0,0,2.2691318463549357,18.152193057615943,TBC1D9B;RAB5C;HIP1;SRC;LRRK2;TBC1D30;ABL1;PACSIN2;AP2S1;TBC1D14;ABL2;TBC1D22A;TBC1D15;TBC1D16;NSF;ADPRHL1;HIP1R;TSC2;BET1L;ARFGAP1;SGSM1;TBC1D1;RAB15;SGSM3;SGSM2;HAP1;LLGL1,Hypo
21,GO_Biological_Process_2018,hippo signaling (GO:0035329),10/30,0.0003656938188785481,0.0654758160255727,0,0,4.646907216494846,36.77429532374777,TJP1;WWC1;DVL2;NPHP4;AMOTL2;LIMD1;STK4;TEAD1;MAP3K14;TJP2,Hypo
22,GO_Biological_Process_2018,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),60/396,0.0003840656586562659,0.06577541867161,0,0,1.6736583522297808,13.16281587855854,CYFIP2;PTPRT;ARPC1B;FLT4;IRS2;AP2A1;TCIRG1;IDE;FGF1;SOGA1;BLNK;EPHB2;ATP6V1E1;EPHB1;PDK2;PDGFRA;TSC2;DNM1;VAV2;TIAM1;MAPKAPK2;KIT;ELMO1;RAPGEF2;ELMO2;PRKD2;HAP1;ARHGEF7;DOCK1;GPLD1;SHC2;RGS14;SRC;ARHGEF28;PXN;PDGFA;MST1R;PIK3R1;KALRN;AP2S1;ABL1;ABL2;PTK2B;FYN;PAG1;ATP6V0A1;KL;SORT1;TNK2;NTRK3;PTPN11;SORBS1;BAIAP2;MAPK14;GRIN2B;SULF2;ARPC3;HNRNPF;BCAR1;FGFR2,Hypo
23,GO_Biological_Process_2018,regulation of small GTPase mediated signal transduction (GO:0051056),27/140,0.00042614721269111286,0.068762615482796,0,0,2.228721715240291,17.296497897386438,TRIO;SRC;ARHGAP17;KALRN;ARHGAP6;FGD1;ARHGAP44;INPP5B;PREX1;ABR;ARHGAP21;MCF2L;ARHGEF12;PLEKHG2;PLEKHG5;ARHGEF16;ARHGAP26;VAV2;BCR;TIAM1;ARHGAP31;OBSCN;RHOJ;ARHGEF3;ARHGEF1;ARHGEF2;ARHGEF7,Hypo
24,GO_Biological_Process_2018,peptidyl-serine modification (GO:0018209),31/170,0.0004652552682928837,0.068762615482796,0,0,2.0815735113837017,15.971756058771843,CAMK2B;GALNT13;MAST4;LRRK2;CAMK2A;STK39;STK4;PRKCZ;PKD1;CAMKK2;TBK1;GRK2;CLSPN;CAMK2G;STK32C;GALNT9;CSNK1G3;PRKCH;PRKCB;GALNT2;PRKCE;LMTK2;PRKCA;MAPK14;MTOR;SBK1;CDK5;MAPKAPK2;ULK1;PRKD2;SGK1,Hypo
25,GO_Biological_Process_2018,lysosome organization (GO:0007040),10/31,0.0004930407943174375,0.068762615482796,0,0,4.425380461462936,33.69891216619554,ABCA1;LRRK2;AKTIP;GAA;VPS33A;HPS1;VPS11;TFEB;HPS4;TPP1,Hypo
26,GO_Biological_Process_2018,positive regulation of kinase activity (GO:0033674),23/113,0.0005021843527456369,0.068762615482796,0,0,2.3818255203828635,18.09364062513577,PDGFRA;VAC14;XRCC6;FLT4;NTRK3;PRKAG1;LMTK2;PRKAG2;MST1R;F2;EREG;CAMKK2;DSTYK;RASSF2;TRAF4;KIT;TYRO3;RAPGEF2;PTK2B;MAPT;EPHB2;EPHB1;FGFR2,Hypo
27,GO_Biological_Process_2018,amino acid transport (GO:0006865),13/48,0.000509281031839965,0.068762615482796,0,0,3.454458293384468,26.19346651753478,SLC6A19;SLC6A18;SLC43A2;SLC6A17;SLC38A10;SLC16A10;SLC6A1;SLC7A1;SLC7A5;SLC25A29;SLC6A8;SLC7A8;SLC38A4,Hypo
28,GO_Biological_Process_2018,phospholipid translocation (GO:0045332),8/21,0.0005116237627438707,0.068762615482796,0,0,5.715598510655154,43.31235421832662,ABCA1;ATP8A2;ATP8B2;ATP8A1;ATP11C;ATP11A;ATP9B;ATP9A,Hypo
29,GO_Biological_Process_2018,cytoskeleton-dependent intracellular transport (GO:0030705),9/26,0.0005237061346747604,0.068762615482796,0,0,4.918538048913538,37.15748839961115,DYNC1I2;MYO10;KIF5C;KIF13A;CCDC88C;KIF1C;KIF1B;KIF3C;DYNLL2,Hypo
30,GO_Biological_Process_2018,positive regulation of multicellular organismal process (GO:0051240),35/202,0.0005617500680305499,0.0710848100648243,0,0,1.9571457606979248,14.6481664891487,PAXIP1;NUMA1;LRP1;SRC;TGFB1I1;ALOX12B;ENO1;PPM1F;FAM129B;LDLR;CLASP1;SOX5;BCL9L;CLASP2;IL33;PRKCH;SMAD3;H2AFY;TGFB3;PRKCE;NFAM1;ZBTB16;INHBA;AXIN2;MTOR;EREG;TIAM1;OLFM1;AGO2;TMEM119;HAP1;PPIB;DOCK1;CARD11;FGFR2,Hypo
31,GO_Biological_Process_2018,membrane depolarization (GO:0051899),12/43,0.0006172036699715382,0.0710848100648243,0,0,3.599121142514731,26.59862633821673,CACNA1I;CACNB3;CACNB4;P2RX4;ABL1;CACNA1D;CACNA1C;CACNG2;CACNA1E;CACNG4;SCN1B;TPCN1,Hypo
32,GO_Biological_Process_2018,positive regulation of protein phosphorylation (GO:0001934),61/412,0.0006329361720075001,0.0710848100648243,0,0,1.628318997826674,11.99279897128953,TENM1;LRRK2;FLT4;WWC1;PRKAG1;PRKAG2;HMGB1;RPTOR;TBK1;RASSF2;TRIM5;TNKS1BP1;EPHB2;TNFRSF4;EPHB1;PDE8A;PDGFRA;KSR1;AKTIP;LMTK2;GPR37L1;AXIN2;F2;EREG;CLIP3;TRAF7;TWSG1;TRAF4;KIT;TYRO3;RAPGEF2;PRKD2;TNFRSF25;ARHGEF2;FAM20A;RAPGEF3;OPRD1;SRC;PELI2;PDGFA;ALOX12B;MST1R;STK4;RASGRP1;CAMKK2;ABL1;DVL2;PTK2B;XRCC6;SEMA4D;TGFB3;TNK2;NTRK3;IL34;DAB2IP;INHBA;MTOR;PIN1;CSPG4;CALM3;FGFR2,Hypo
33,GO_Biological_Process_2018,microtubule bundle formation (GO:0001578),10/32,0.0006550515209440206,0.0710848100648243,0,0,4.223992502343018,30.96523015968989,CLIP1;NUMA1;TTLL3;MAP1S;NCKAP5L;CFAP46;NAV1;MAPRE2;CLASP1;CCDC40,Hypo
34,GO_Biological_Process_2018,regulation of potassium ion transmembrane transport (GO:1901379),10/32,0.0006550515209440206,0.0710848100648243,0,0,4.223992502343018,30.96523015968989,KCNIP3;KCNQ1;NOS1AP;STK39;NEDD4L;FLNA;AKAP6;CACNA1D;KCNAB1;KCNAB2,Hypo
35,GO_Biological_Process_2018,platelet-derived growth factor receptor signaling pathway (GO:0048008),7/17,0.0006674581761930542,0.0710848100648243,0,0,6.499227997941328,47.5225749706029,PDGFRA;RGS14;SRC;ABL1;PDGFA;ABL2;BCAR1,Hypo
36,GO_Biological_Process_2018,regulation of epithelial to mesenchymal transition (GO:0010717),16/68,0.0006786306359346582,0.0710848100648243,0,0,2.86341579826585,20.88985971331066,PHLDB1;SMAD3;TGFB3;TGFB1I1;DAB2IP;LDLRAD4;AXIN2;MTOR;OVOL2;SMAD7;OLFM1;TIAM1;SDHAF2;CLASP1;CLASP2;BCL9L,Hypo
37,GO_Biological_Process_2018,protein complex assembly (GO:0006461),33/189,0.0006926959860278248,0.0710848100648243,0,0,1.9745796717627704,14.364907857541231,NAPA;KMT2D;NUFIP1;AHNAK;TRRAP;PEF1;LRRK2;TCF7;QPRT;TGFA;RASGRP1;SLC9A1;GOLGA2;SH3PXD2A;TRAPPC12;CAMK2G;BCL9L;BOK;SH3GLB1;NSF;TLE3;TRAPPC3;DBNL;TRAPPC10;TRAPPC9;AXIN2;SMARCA4;DDIT3;ITGB1BP1;MAPT;CNIH3;PFKM;DGKH,Hypo
38,GO_Biological_Process_2018,positive regulation of apoptotic process (GO:0043065),48/307,0.0007038100006418256,0.0710848100648243,0,0,1.733529834476207,12.58369674993204,HRK;RARG;TNFAIP8;TRIO;USP27X;HMGB1;FOXO3;STK4;KALRN;GRAMD4;FGD1;PPM1F;PREX1;ABR;RASSF2;FRZB;MCF2L;ABL1;APBB1;CTNNBL1;BOK;SRPK2;ARHGEF12;PLEKHG2;TGFB3;PLEKHG5;ARHGEF16;DAB2IP;HIP1R;PAWR;VAV2;CLIP3;TIAM1;TRAF7;MELK;OBSCN;CDK5;BCL6;BIN1;DDIT3;ARHGEF3;NF1;ARHGEF1;ITGA6;ARHGEF2;ARHGEF7;GPLD1;MAP3K11,Hypo
39,GO_Biological_Process_2018,lipid translocation (GO:0034204),8/22,0.000735690127589063,0.0712401808440389,0,0,5.307047226717669,38.28876185351898,ABCA1;ATP8A2;ATP8B2;ATP8A1;ATP11C;ATP11A;ATP9B;ATP9A,Hypo
40,GO_Biological_Process_2018,negative regulation of protein kinase activity (GO:0006469),22/109,0.0007415200341725302,0.0712401808440389,0,0,2.355999904612009,16.979239851860722,CDKN1C;H2AFY;LRRC4;DAB2IP;TSC2;PRKAG2;RTN4RL2;ADARB1;SRCIN1;SORL1;PPM1F;CORO1C;PREX1;DEPTOR;DVL1;ABL1;NF1;FGFR1OP;ITGB1BP1;CEP85;EPHB2;TRIB1,Hypo
41,GO_Biological_Process_2018,regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),5/9,0.0007890266370848249,0.0737197453759085,0,0,11.597686375321336,82.86211135616232,PDGFRA;HIP1;LRP1;HIP1R;PDGFA,Hypo
42,GO_Biological_Process_2018,regulation of endocytosis (GO:0030100),16/69,0.0008047598505113139,0.0737197453759085,0,0,2.8092329905757936,20.015691362625105,SCARB1;HIP1;RAB5C;LRP1;SRC;HIP1R;TSC2;NEDD4L;ARFGAP1;SYT7;CLIP3;AP2S1;PACSIN2;ABL1;ABL2;LDLR,Hypo
43,GO_Biological_Process_2018,positive regulation of GTPase activity (GO:0043547),33/192,0.000917210203143862,0.0808489550521567,0,0,1.9369986515880748,13.547705379979922,TBC1D9B;DOCK9;RAP1GDS1;RASGRP1;RAP1GAP;CORO1C;ABR;ARHGAP21;LARS;TBC1D30;TBC1D14;TBC1D22A;TBC1D15;TBC1D16;ARHGEF10;RIC1;ADPRHL1;SEMA4D;NTRK3;ARHGEF16;MTSS1L;BCR;SGSM1;TIAM1;TBC1D1;SGSM3;SGSM2;NF1;PIN1;RAPGEF2;ITGA6;ARHGEF7;RAPGEF3,Hypo
44,GO_Biological_Process_2018,protein dephosphorylation (GO:0006470),24/125,0.000923636196330808,0.0808489550521567,0,0,2.2144906079392985,15.473071703771812,PTPRT;DUSP5;MTMR3;PTPRS;CTDP1;EYA1;DUSP1;EYA2;PTPN21;PDXP;PTPN11;PTPRF;PPM1F;SSH1;DUSP14;CTTNBP2NL;DUSP7;PTPRE;PTPRB;SDHAF2;PPP2R2C;BTRC;SBF1;PTPN5,Hypo
45,GO_Biological_Process_2018,"regulation of synaptic transmission, glutamatergic (GO:0051966)",12/45,0.0009633381131869044,0.0810905633096107,0,0,3.380617318697814,23.478745974539603,GRM2;TSHZ3;CDK5;LRRK2;GRM8;PTK2B;ATP1A2;CACNG2;SHANK3;GRM1;CACNG4;SHANK2,Hypo
46,GO_Biological_Process_2018,lytic vacuole organization (GO:0080171),9/28,0.0009675695545955076,0.0810905633096107,0,0,4.400309119010819,30.54132778569792,ABCA1;LRRK2;AKTIP;GAA;HPS1;VPS11;TFEB;HPS4;TPP1,Hypo
47,GO_Biological_Process_2018,activation of GTPase activity (GO:0090630),18/84,0.0010567903708241,0.0863126894445986,0,0,2.5386787125917563,17.39634390077992,ARHGEF10;TBC1D9B;ADPRHL1;NTRK3;ARHGEF16;MTSS1L;RASGRP1;CORO1C;SGSM1;TIAM1;TBC1D1;SGSM3;TBC1D30;SGSM2;TBC1D14;TBC1D22A;TBC1D15;TBC1D16,Hypo
48,GO_Biological_Process_2018,regulation of insulin secretion (GO:0050796),20/98,0.0010946965437098,0.0863126894445986,0,0,2.387671050883486,16.277417524967188,MIDN;KCNJ11;STXBP4;UQCC2;SLC2A1;SLC2A2;IRS2;PRKCA;CACNA1D;CACNA1C;NR1D1;CACNA1E;SYT7;PER2;SLC25A5;SLC25A4;STX1A;RAPGEF3;CDK16;RAPGEF4,Hypo
49,GO_Biological_Process_2018,regulation of axon extension (GO:0030516),10/34,0.0011111937170413,0.0863126894445986,0,0,3.8715635738831615,26.335615958859613,OLFM1;SEMA7A;GOLGA4;PTPRS;CTTN;ERCC2;TWF2;ABL1;MAPT;NTN1,Hypo
50,GO_Biological_Process_2018,actomyosin structure organization (GO:0031032),16/71,0.001117529109336,0.0863126894445986,0,0,2.7067782269436877,18.39698413034619,MYBPC1;SRC;TMOD2;LMOD1;CDC42BPB;SORBS1;CDC42BPA;EPB41L4B;OBSCN;FRMD6;EPB41L1;EPB41L2;MYO18A;KCTD13;MYH9;MYH10,Hypo
51,GO_Biological_Process_2018,positive regulation of protein localization to cell periphery (GO:1904377),12/46,0.0011892817229344,0.0889318004910886,0,0,3.281005281369514,22.095620826951503,CLIP3;PRKCH;LRP1;NUMA1;EPB41L2;PRKCE;ARHGEF16;PIK3R1;STX3;SORBS1;EPHB2;PLS1,Hypo
52,GO_Biological_Process_2018,actin filament organization (GO:0007015),23/120,0.0011965944214337,0.0889318004910886,0,0,2.2090798688201843,14.863298486969986,MYBPC1;HIP1;ACTN1;TMOD2;LMOD1;HIP1R;SHROOM3;ARHGAP17;FRY;PPP1R9A;BAIAP2;AKAP2;PPP1R9B;BIN3;COBLL1;RHOJ;FAT1;FLNA;ARHGEF2;BCAR1;FRYL;PLS1;CAP2,Hypo
53,GO_Biological_Process_2018,regulation of autophagy (GO:0010506),34/203,0.0012296267887651,0.0896944429804831,0,0,1.8775370285728403,12.58145932795631,USP10;LRRK2;PRKAG1;PRKAG2;HMGB1;SOGA1;GOLGA2;RPTOR;LARS;PSAP;ABL1;PIP4K2A;TBC1D14;ABL2;SH3BP4;PIM2;ATP6V1E1;ATP6V0A1;BOK;UBQLN2;SH3GLB1;SREBF1;KDM4A;TFEB;WBP11;PRKAB1;MTOR;TPCN1;TMEM59;RRAGC;CDK5;ULK1;ATP13A2;MAPT,Hypo
54,GO_Biological_Process_2018,regulation of calcineurin-NFAT signaling cascade (GO:0070884),6/14,0.001283335697785,0.0919101693377363,0,0,6.960648148148148,46.3460318953828,RCAN1;RCAN2;AKAP6;SPPL3;LMCD1;SLC9A1,Hypo
55,GO_Biological_Process_2018,cell morphogenesis (GO:0000902),14/59,0.0013183515670324,0.0927319075453725,0,0,2.8933654729109275,19.18698606869216,CYFIP2;TENM1;TENM2;TENM4;SHROOM3;FRY;STK4;SSH1;CAPZB;CDH22;PACSIN2;ARHGEF2;FRYL;CAP2,Hypo
56,GO_Biological_Process_2018,regulation of transmembrane transport (GO:0034762),8/24,0.0014174037030271,0.0965322225109352,0,0,4.643151390319258,30.45409779360717,KCNJ4;KCNJ6;KCNJ10;KCNJ11;KCNJ12;KCNJ9;NEDD4L;CTTNBP2NL,Hypo
57,GO_Biological_Process_2018,regulation of ion transmembrane transport (GO:0034765),10/35,0.0014213934769317,0.0965322225109352,0,0,3.716494845360825,24.365777142470897,KCNJ4;KCNJ6;AHCYL1;KCNJ10;KCNJ11;KCNJ12;KCNJ9;KCNQ1;NEDD4L;AKAP6,Hypo
58,GO_Biological_Process_2018,intracellular cholesterol transport (GO:0032367),5/10,0.0014514408114429,0.0969021246826033,0,0,9.277634961439588,60.63118657379572,ABCA1;LDLRAP1;LDLR;ABCG1;SYT7,Hypo
59,GO_Biological_Process_2018,neuron development (GO:0048666),26/144,0.0014862931560294,0.0975751456933332,0,0,2.0535959688502063,13.371928694276312,TENM1;TENM2;ATP8A2;TENM4;USH1C;HMGB1;FRY;PPP1R9A;PPP1R9B;BLOC1S5;UNK;MAP4;STX3;SH3GL2;GPM6B;UNC5A;CCSAP;CDK5;TBC1D24;RAPGEF2;ULK1;TBC1D23;MAPT;MAPRE2;FRYL;CDK16,Hypo
60,GO_Biological_Process_2018,protein localization to plasma membrane (GO:0072659),24/130,0.0016228375672616,0.1047927406138273,0,0,2.109445717980368,13.55019137860069,NSF;SPTBN4;SMURF1;STXBP1;KCNIP3;TTC7B;ANK3;ANK1;TSPAN15;GOLGA4;CACNB3;TSPAN14;RAB31;RILPL2;RILPL1;RAB15;KIF13A;MAP7;TSPAN5;RAPGEF2;FLNA;FGF13;RAMP1;CLASP2,Hypo
61,GO_Biological_Process_2018,regulation of protein localization to plasma membrane (GO:1903076),15/67,0.0016912678225666,0.1074500637595193,0,0,2.683064997018485,17.124063591844312,PRKCH;LRP1;STX8;PRKCE;ARHGEF16;PIK3R1;SORBS1;CLIP3;TMEM59;CDK5;TMBIM1;STX3;LDLRAP1;EPHB2;PLS1,Hypo
62,GO_Biological_Process_2018,endosome to lysosome transport (GO:0008333),12/48,0.0017734342589826,0.11088186581163,0,0,3.0983832129342965,19.62775371106809,MGRN1;SORT1;BIN1;AKTIP;VPS33A;KIF13A;VPS11;DENND3;TRAK1;CACNG2;CACNG4;VPS39,Hypo
63,GO_Biological_Process_2018,regulation of cellular catabolic process (GO:0031329),13/55,0.0020107480343292,0.1218513308803549,0,0,2.8775966762543943,17.86771275862318,USP10;LRRK2;HMGB1;SOGA1;RPTOR;RRAGC;PSAP;ABL1;PIP4K2A;ABL2;ULK1;MAPT;BOK,Hypo
64,GO_Biological_Process_2018,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),13/55,0.0020107480343292,0.1218513308803549,0,0,2.8775966762543943,17.86771275862318,FBN2;SMAD3;SMURF1;TGFB1I1;HTRA3;LDLRAD4;SMAD7;PEG10;ADAMTSL2;PRDM16;PMEPA1;PIN1;BCL9L,Hypo
65,GO_Biological_Process_2018,neuromuscular junction development (GO:0007528),7/20,0.0020476132701004,0.1222052828928134,0,0,4.998574765430144,30.94657837113109,CACNB1;CACNB3;CACNB4;LRRK2;DVL1;LRP4;ANK3,Hypo
66,GO_Biological_Process_2018,regulation of dendritic spine development (GO:0060998),9/31,0.0021598146991322,0.1237805523439333,0,0,3.799634677532669,23.32114257223013,CAMK2B;ARHGAP44;PTPRS;CDK5;LRRK2;CPEB3;SRCIN1;SHANK3;SHANK2,Hypo
67,GO_Biological_Process_2018,skeletal system morphogenesis (GO:0048705),9/31,0.0021598146991322,0.1237805523439333,0,0,3.799634677532669,23.32114257223013,FBN2;WWOX;PDGFRA;RARG;IFT140;ANKRD11;RARA;DSCAML1;FGFR2,Hypo
68,GO_Biological_Process_2018,positive regulation of protein modification process (GO:0031401),28/163,0.0021682808102897,0.1237805523439333,0,0,1.9332485451111885,11.858199903168243,LRRK2;FLT4;PELI2;STK4;RASGRP1;SPPL3;CAMKK2;GOLGA2;ABL1;DVL2;SYMPK;PDE8A;PPP1R16B;SEMA4D;AKTIP;NTRK3;IL34;AXIN2;F2;MTOR;CLIP3;NOS1AP;PIN1;RAB3GAP2;CALM3;FAM20A;RAMP1;RAPGEF3,Hypo
69,GO_Biological_Process_2018,negative regulation of Ras protein signal transduction (GO:0046580),10/37,0.0022522166347274,0.1253060628371542,0,0,3.4408171057655594,20.974671842297468,ARHGAP44;KANK1;RASA3;SPRY4;RASA2;DAB2IP;NF1;KCTD13;RASAL1;EPHB2,Hypo
70,GO_Biological_Process_2018,regulation of protein binding (GO:0043393),21/111,0.0022586266721091,0.1253060628371542,0,0,2.172455503715224,13.236767729221246,HDAC5;PRMT8;LRP1;LRRK2;AKTIP;HIP1R;DAB2IP;TMC8;STK4;PKD1;SPPL3;SORL1;PEX14;GOLGA2;DNAJB2;TIAM1;DVL1;PIN1;RAPGEF2;ITGB1BP1;LDLRAP1,Hypo
71,GO_Biological_Process_2018,regulation of endothelial cell migration (GO:0010594),15/69,0.0023037269794937,0.1260330635031348,0,0,2.5834051105368934,15.689605776858835,SCARB1;FLT4;DAB2IP;PRKCA;VASH1;FGF1;ADGRB1;ABL1;NF1;PTK2B;ITGB1BP1;PRKD2;GPLD1;SASH1;BCAR1,Hypo
72,GO_Biological_Process_2018,glycerophospholipid biosynthetic process (GO:0046474),28/164,0.0023770144645972,0.1266334083689206,0,0,1.9189263634694247,11.593980395053066,ARF3;AGPAT5;VAC14;MTMR3;MTMR12;SLC44A2;PIK3R1;PLA2G5;LCLAT1;PIK3R6;AGPAT4;INPP5E;PIP4K2A;PIP5K1C;SBF1;PLEKHA1;SYNJ2;DDHD1;INPP4A;FIG4;GNPAT;SYNJ1;GPAM;GPD1;PITPNM2;PI4KA;CHPT1;LPIN1,Hypo
73,GO_Biological_Process_2018,regulation of cell cycle process (GO:0010564),18/90,0.0024010220760031,0.1266334083689206,0,0,2.326345755693582,14.032193694900403,SH3GLB1;CUL9;DYNC1H1;AHCTF1;NUMA1;PDXP;MYO19;CDK5;BIN1;KIF13A;PIN1;BIRC6;E4F1;USP51;CALM3;BBS4;MAD1L1;RAB11FIP4,Hypo
74,GO_Biological_Process_2018,mitochondrion distribution (GO:0048311),5/11,0.0024480472370525,0.1266334083689206,0,0,7.730934018851757,46.481967255041226,CLUH;LRRK2;MAPT;HAP1;TRAK1,Hypo
75,GO_Biological_Process_2018,methionine metabolic process (GO:0006555),5/11,0.0024480472370525,0.1266334083689206,0,0,7.730934018851757,46.481967255041226,MSRA;AHCYL1;MTHFD1;SMS;MTR,Hypo
76,GO_Biological_Process_2018,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),4/7,0.0024754436264043,0.1266334083689206,0,0,12.365193559438165,74.20767700199245,AKAP6;LMCD1;SPPL3;SLC9A1,Hypo
77,GO_Biological_Process_2018,regulation of intracellular signal transduction (GO:1902531),59/422,0.002998049527067,0.1514015011168841,0,0,1.5202255719057796,8.832196432452053,TRIO;LRRK2;WWC1;ULK4;PRKAG1;PRKAG2;FGF1;ARHGAP6;ARHGAP44;PREX1;MCF2L;PIP4K2A;CMKLR1;PPP1R16B;PLEKHG2;ARHGEF12;PLEKHG5;ARHGEF16;PPP2R5B;PPP2R5C;PRKAB1;RNF41;VAV2;BCR;TIAM1;OBSCN;RRAGC;KAT6A;RHOJ;ARHGEF3;PRKD2;ARHGEF1;MAPT;ARHGEF2;ARHGEF7;AKAP6;ARHGAP17;KALRN;FGD1;INPP5B;ABR;ARHGAP21;SMYD2;PAK6;PIP5K1C;RBBP7;RFFL;PAK4;TGFB3;DAB2IP;INHBA;ARHGAP26;MAPK14;BOP1;ARHGAP31;CDK5;NLRP10;PIN1;TAF4,Hypo
78,GO_Biological_Process_2018,positive regulation of phosphorylation (GO:0042327),33/208,0.0035205333379847,0.1755364660547057,0,0,1.7583277442432372,9.933044488960984,VAC14;PFKFB3;LRRK2;FLT4;PELI2;MST1R;STK4;RASGRP1;CAMKK2;DSTYK;ABL1;DVL2;EPHB2;EPHB1;PDE8A;PDGFRA;DSCAM;SEMA4D;IL34;AKTIP;NTRK3;LMTK2;AXIN2;F2;MTOR;EREG;CLIP3;KIT;TYRO3;PIN1;ITGA6;FAM20A;FGFR2,Hypo
79,GO_Biological_Process_2018,regulation of microtubule depolymerization (GO:0031114),7/22,0.0037862432939708,0.1841236090734722,0,0,4.331617773202951,24.154750905844864,MAP1S;MID1IP1;MAP1A;ARHGEF2;FGF13;CLASP1;CLASP2,Hypo
80,GO_Biological_Process_2018,glucose transport (GO:0015758),7/22,0.0037862432939708,0.1841236090734722,0,0,4.331617773202951,24.154750905844864,SORT1;SLC45A1;SLC2A13;SLC2A12;SLC2A1;SLC2A5;PPARD,Hypo
81,GO_Biological_Process_2018,negative regulation of protein oligomerization (GO:0032460),5/12,0.0038617595609397,0.1855057428114831,0,0,6.62614763128902,36.81906631416492,OPRD1;SRC;TMC8;SORL1;CRYAB,Hypo
82,GO_Biological_Process_2018,cellular response to growth factor stimulus (GO:0071363),24/139,0.0040326282610338,0.1897029176237071,0,0,1.9433834484626848,10.714527758186408,WWOX;SMAD3;FLT4;NTRK3;PDE2A;TWF2;DAB2IP;MTSS1L;PTPN11;MAPK14;RUNX2;SMAD7;NR4A1;ACAP2;DSTYK;MARS;MAPKAPK2;RAPGEF2;PRKD2;ITGB1BP1;MAPT;PDE8A;BCAR1;SOX5,Hypo
83,GO_Biological_Process_2018,regulation of peptide hormone secretion (GO:0090276),15/73,0.0040831584611275,0.1897029176237071,0,0,2.40470462443197,13.228002293230746,KCNJ11;UQCC2;SLC2A1;SLC2A2;PRKCA;CACNA1D;CACNA1C;CACNA1E;SYT7;PER2;SLC25A5;SLC25A4;RAPGEF3;STX1A;RAPGEF4,Hypo
84,GO_Biological_Process_2018,positive regulation of cation transmembrane transport (GO:1904064),6/17,0.0040936146224968,0.1897029176237071,0,0,5.061447811447811,27.82949479858358,KCNQ1;NOS1AP;FLNA;AKAP6;ANK3;PDZK1,Hypo
85,GO_Biological_Process_2018,regulation of cellular localization (GO:0060341),10/40,0.0041858482390057,0.1914831873804909,0,0,3.0962199312714778,16.955042491203848,RIMS1;DYNC1H1;NUMA1;STXBP4;WWC1;CAMK2A;DVL1;NR1D1;MAD1L1;CDK16,Hypo
86,GO_Biological_Process_2018,negative regulation of cellular response to transforming growth factor beta stimulus (GO:1903845),12/53,0.0043051915057859,0.1914831873804909,0,0,2.719776485690553,14.817161857511923,SMAD3;SMURF1;TGFB1I1;PEG10;HTRA3;ADAMTSL2;PRDM16;PMEPA1;PIN1;LDLRAD4;BCL9L;SMAD7,Hypo
87,GO_Biological_Process_2018,regulation of cellular component organization (GO:0051128),24/140,0.0044280872446245,0.1914831873804909,0,0,1.926522719948437,10.441343874308767,ABCA1;RAB5C;HIP1;SEMA4D;HIP1R;DAB2IP;TSC2;TMC8;PTPN11;ARFGAP1;MTOR;RPTOR;ZMYM1;CAPZB;ABL1;PACSIN2;AP2S1;ABL2;RAPGEF2;SPOCK1;CHPT1;SGK1;BCAR1;BCL9L,Hypo
88,GO_Biological_Process_2018,regulation of MAPK cascade (GO:0043408),32/203,0.0044314501348538,0.1914831873804909,0,0,1.7444096860155254,9.453005637218808,WWC1;FLT4;ULK4;PELI2;PDGFA;ALOX12B;MST1R;HMGB1;RASGRP1;TRIM5;PAK6;EPHB2;EPHB1;TNFRSF4;PAK4;PDGFRA;KSR1;DUSP1;TGFB3;NTRK3;DAB2IP;LMTK2;GPR37L1;INHBA;RNF41;TRAF7;KIT;TYRO3;NF1;TNFRSF25;TRIB1;FGFR2,Hypo
89,GO_Biological_Process_2018,cytoskeletal anchoring at nuclear membrane (GO:0090286),4/8,0.004569540394457,0.1914831873804909,0,0,9.273381294964029,49.96815593463664,SUN1;SYNE3;SYNE2;SYNE1,Hypo
90,GO_Biological_Process_2018,negative regulation of hippo signaling (GO:0035331),4/8,0.004569540394457,0.1914831873804909,0,0,9.273381294964029,49.96815593463664,WWC1;WWC2;LIMD1;MARK3,Hypo
91,GO_Biological_Process_2018,inositol phosphate catabolic process (GO:0071545),4/8,0.004569540394457,0.1914831873804909,0,0,9.273381294964029,49.96815593463664,SYNJ1;INPP1;IMPA2;NUDT3,Hypo
92,GO_Biological_Process_2018,regulation of nitrogen compound metabolic process (GO:0051171),4/8,0.004569540394457,0.1914831873804909,0,0,9.273381294964029,49.96815593463664,SCARB1;LRP1;NOS1AP;LDLR,Hypo
93,GO_Biological_Process_2018,positive regulation of extracellular matrix assembly (GO:1901203),4/8,0.004569540394457,0.1914831873804909,0,0,9.273381294964029,49.96815593463664,PHLDB1;SMAD3;CLASP1;CLASP2,Hypo
94,GO_Biological_Process_2018,positive regulation of protein kinase activity (GO:0045860),28/172,0.00475271823611,0.1931838210592834,0,0,1.811510001156203,9.689836855945208,SRC;STK39;PRKAG1;PRKAG2;STK4;CAMKK2;RPTOR;STK10;RASSF2;PAK6;PTK2B;CLSPN;MAP4K5;MAP3K4;MARK2;PAK4;MAP4K4;XRCC6;DAB2IP;SRCIN1;EREG;DLG3;STK24;TRAF4;DOK7;RAPGEF2;CALM3;MAP3K14,Hypo
95,GO_Biological_Process_2018,regulation of GTPase activity (GO:0043087),30/188,0.0047948052668352,0.1931838210592834,0,0,1.7693829113924051,9.448897873965482,GPSM1;PLXND1;DOCK9;LRRK2;RAP1GDS1;RASGRP1;RAP1GAP;FGD1;ABR;ARHGAP21;LARS;TBC1D30;SH3BP4;TBC1D15;RIC1;SEMA4D;DAB2IP;VAV2;BCR;LRCH1;SGSM3;SGSM2;NF1;PIN1;RAPGEF2;RAB3GAP2;ITGB1BP1;ITGA6;ARHGEF7;RAPGEF3,Hypo
96,GO_Biological_Process_2018,plasma membrane bounded cell projection organization (GO:0120036),21/118,0.0047988613916335,0.1931838210592834,0,0,2.014894742749034,10.758281839453314,UNC5A;PLEKHA1;HMGB1;FRY;PPP1R9A;PPP1R9B;TTC17;BLOC1S5;CDK5;CTTN;TBC1D24;RAPGEF2;ULK1;TBC1D23;MAP4;MAPT;STX3;SH3GL2;GPM6B;FRYL;CDK16,Hypo
97,GO_Biological_Process_2018,MAPK cascade (GO:0000165),41/278,0.0048336048965614,0.1931838210592834,0,0,1.6142345938514653,8.607361545763302,CAMK2B;SPTBN4;SPTBN5;SHC2;LRRK2;CAMK2A;PDGFA;IRS2;RASAL1;FGF1;RASGRP1;CAMKK2;MBP;FYN;BTRC;MAP4K5;MARK3;CAMK2G;SPTBN2;MAP4K4;DUSP5;PDGFRA;KL;KSR1;DAB2IP;NRG2;GRIN2B;SPTB;EREG;DUSP7;STK24;RASA3;KIT;MAPKAPK2;RASA2;NF1;RAPGEF2;CCM2;FGF13;SHANK3;FGFR2,Hypo
98,GO_Biological_Process_2018,histone H3-K4 methylation (GO:0051568),7/23,0.0049910635544099,0.1931838210592834,0,0,4.060666495110653,21.52196388928272,KMT2D;PAXIP1;KMT2A;SETD1B;TET3;SETMAR;WDR61,Hypo
99,GO_Biological_Process_2018,regulation of cell size (GO:0008361),7/23,0.0049910635544099,0.1931838210592834,0,0,4.060666495110653,21.52196388928272,RAP1GAP2;RPTOR;RARG;DEPTOR;LARS;MTOR;VAV2,Hypo
100,GO_Biological_Process_2018,negative regulation of supramolecular fiber organization (GO:1902904),12/54,0.0050543328818132,0.1931838210592834,0,0,2.654872475305912,14.037663188002655,CLIP3;KANK1;MID1IP1;TWF2;HIP1R;ARHGEF2;FGF13;SHANK3;CRYAB;LDLR;CLASP1;CLASP2,Hypo
101,GO_Biological_Process_2018,modulation of chemical synaptic transmission (GO:0050804),16/82,0.0052449507971292,0.1931838210592834,0,0,2.25426968756855,11.836019140093974,USP46;GRID1;LRRK2;GRIK5;CLSTN1;CAMK2A;GRIK4;ATP1A2;SYN3;GRM1;GRM2;RIMS1;RIMS3;CDK5;GRM8;KCTD13,Hypo
102,GO_Biological_Process_2018,ephrin receptor signaling pathway (GO:0048013),16/82,0.0052449507971292,0.1931838210592834,0,0,2.25426968756855,11.836019140093974,SRC;ARPC1B;ARHGEF28;AP2A1;PTPN11;KALRN;GRIN2B;DNM1;VAV2;TIAM1;ARPC3;AP2S1;FYN;EPHB2;ARHGEF7;EPHB1,Hypo
103,GO_Biological_Process_2018,regulation of vesicle fusion (GO:0031338),13/61,0.005251960058752,0.1931838210592834,0,0,2.5170581655480984,13.212425755508578,TBC1D9B;ADPRHL1;STXBP1;SGSM1;TBC1D1;SGSM3;TBC1D30;SGSM2;VPS11;TBC1D14;TBC1D22A;TBC1D15;TBC1D16,Hypo
104,GO_Biological_Process_2018,negative regulation of protein complex assembly (GO:0031333),9/35,0.0052992175798806,0.1931838210592834,0,0,3.214362144810367,16.843887961592515,OPRD1;ANKRD27;THRA;PMEPA1;TMC8;ULK1;LDLRAD4;PRKCZ;SORL1,Hypo
105,GO_Biological_Process_2018,regulation of actin cytoskeleton organization (GO:0032956),15/75,0.0053231499551208,0.1931838210592834,0,0,2.3242894056847545,12.16925892401125,PDGFRA;LRP1;TWF2;HIP1R;PDGFA;ARHGAP17;BAIAP2;MTOR;ARHGAP44;RHOJ;ABL1;ABL2;PTK2B;RAPGEF3;GPM6B,Hypo
106,GO_Biological_Process_2018,axon guidance (GO:0007411),26/158,0.0055027201152617,0.1931838210592834,0,0,1.8343570843570844,9.543266105828222,CYFIP2;SPTBN4;SPTBN5;PLXND1;SRC;NRXN3;IRS2;PIK3R1;NTN1;RAP1GAP;FAM129B;KIF5C;SLIT1;TNR;FYN;EPHB2;EPHB1;SCN1B;SPTBN2;UNC5A;PRKCA;PTPN11;SPTB;ENAH;FEZ2;SHANK3,Hypo
107,GO_Biological_Process_2018,cell morphogenesis involved in neuron differentiation (GO:0048667),18/97,0.005537589632688,0.1931838210592834,0,0,2.119388316691564,11.012757003039688,SPTBN4;NTNG2;MAP1S;LRP4;ANK3;BAIAP2;S100B;UNK;CDK5;BTBD3;MAP1A;ADGRB1;DVL1;SLIT1;APBB1;DSCAML1;LLGL1;FGFR2,Hypo
108,GO_Biological_Process_2018,antigen processing and presentation of exogenous peptide antigen (GO:0002478),18/97,0.005537589632688,0.1931838210592834,0,0,2.119388316691564,11.012757003039688,DCTN6;DYNC1I2;DYNC1H1;AP2A1;KLC1;DYNLL2;DYNC1LI2;KLC2;CAPZB;KIF26A;AP1S2;AP2S1;AP1S1;KIF3C;CTSF;CTSD;SH3GL2;SPTBN2,Hypo
109,GO_Biological_Process_2018,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),18/97,0.005537589632688,0.1931838210592834,0,0,2.119388316691564,11.012757003039688,DCTN6;DYNC1I2;DYNC1H1;AP2A1;KLC1;DYNLL2;DYNC1LI2;KLC2;CAPZB;KIF26A;AP1S2;AP2S1;AP1S1;KIF3C;CTSF;CTSD;SH3GL2;SPTBN2,Hypo
110,GO_Biological_Process_2018,phosphatidylinositol metabolic process (GO:0046488),20/112,0.0056038190604482,0.1931838210592834,0,0,2.022752872268529,10.48657175077548,ARF3;VAC14;MTMR3;MTMR12;PLEKHA1;TTC7B;PIK3R1;PLA2G5;SYNJ2;PIK3R6;INPP4A;INPP5B;FIG4;SYNJ1;INPP5E;PITPNM2;PI4KA;PIP4K2A;PIP5K1C;SBF1,Hypo
111,GO_Biological_Process_2018,regulation of cardiac muscle cell membrane repolarization (GO:0099623),6/18,0.0056400455500933,0.1931838210592834,0,0,4.63940329218107,24.022195285407204,KCNQ1;NOS1AP;FLNA;CACNA1D;SCN1B;SNTA1,Hypo
112,GO_Biological_Process_2018,regulation of microtubule polymerization or depolymerization (GO:0031110),6/18,0.0056400455500933,0.1931838210592834,0,0,4.63940329218107,24.022195285407204,MAP1S;MAP1A;ABL1;MAPT;CLASP1;CLASP2,Hypo
113,GO_Biological_Process_2018,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",6/18,0.0056400455500933,0.1931838210592834,0,0,4.63940329218107,24.022195285407204,TSHZ3;PTK2B;CACNG2;SHANK3;CACNG4;SHANK2,Hypo
114,GO_Biological_Process_2018,actin filament polymerization (GO:0030041),6/18,0.0056400455500933,0.1931838210592834,0,0,4.63940329218107,24.022195285407204,PREX1;COBLL1;CORO7;ARHGAP6;WASF3;TTC17,Hypo
115,GO_Biological_Process_2018,regulation of cellular carbohydrate metabolic process (GO:0010675),5/13,0.0057759823726574,0.1961344359129115,0,0,5.797557840616967,29.880885185415917,SIK3;RORA;MLYCD;PDK2;PDK1,Hypo
116,GO_Biological_Process_2018,phosphatidylinositol biosynthetic process (GO:0006661),18/98,0.0061806576822808,0.2063187339873228,0,0,2.0927795031055902,10.644568409152871,ARF3;VAC14;MTMR3;MTMR12;PLEKHA1;PIK3R1;SYNJ2;PIK3R6;INPP4A;FIG4;DPM3;SYNJ1;INPP5E;PITPNM2;PI4KA;PIP4K2A;PIP5K1C;SBF1,Hypo
117,GO_Biological_Process_2018,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),18/98,0.0061806576822808,0.2063187339873228,0,0,2.0927795031055902,10.644568409152871,DCTN6;DYNC1I2;DYNC1H1;AP2A1;KLC1;DYNLL2;DYNC1LI2;KLC2;CAPZB;KIF26A;AP1S2;AP2S1;AP1S1;KIF3C;CTSF;CTSD;SH3GL2;SPTBN2,Hypo
118,GO_Biological_Process_2018,actin polymerization or depolymerization (GO:0008154),9/36,0.0064661611606275,0.2140353681656453,0,0,3.0951399622187874,15.603135004922338,PREX1;COBLL1;TWF2;MICAL3;CORO7;ARHGAP6;WASF3;CAP2;TTC17,Hypo
119,GO_Biological_Process_2018,regulation of actin cytoskeleton reorganization (GO:2000249),8/30,0.0066520103317794,0.2165476751808189,0,0,3.3757138844677463,16.92190064095919,PDGFRA;CDK5;NTRK3;ABL1;ABL2;PTK2B;BAIAP2;RAPGEF3,Hypo
120,GO_Biological_Process_2018,regulation of ARF protein signal transduction (GO:0032012),8/30,0.0066520103317794,0.2165476751808189,0,0,3.3757138844677463,16.92190064095919,GIT2;ACAP2;AGAP2;AGAP1;ASAP1;AGAP3;ASAP2;ARFGAP1,Hypo
121,GO_Biological_Process_2018,protein transport (GO:0015031),46/326,0.0068262495775646,0.2196386776508996,0,0,1.5332758103241295,7.646415595696781,NAPA;UNC119B;TBC1D9B;RAB5C;LRP1;AP2A1;TCIRG1;RPGR;GOLGA4;RAB23;KIF13A;TBC1D30;LAMP2;TBC1D14;STX3;ATP6V1E1;TBC1D22A;RAB6B;TBC1D15;ATP6V0A1;TBC1D16;NSF;TMED9;RIC1;ADPRHL1;PRKCB;STX8;LMTK2;ANK3;SGSM1;CLIP3;TBC1D1;RAB31;CTTN;RAB15;SGSM3;SGSM2;SCG5;RAB3GAP2;MYH9;KDELR2;ITGB1BP1;ARHGEF2;RAMP1;STX1A;ABCG1,Hypo
122,GO_Biological_Process_2018,regulation of apoptotic process (GO:0042981),101/815,0.0068584811756945,0.2196386776508996,0,0,1.3262797817883238,6.607882993220307,RTKN;TRIO;FAIM2;PREX1;STK10;RASSF2;DIP2A;PIM2;EPHB2;TNFRSF4;EPHB1;MAP3K4;PDGFRA;AREL1;ACTN1;LMTK2;FBXO10;CLIP3;TIAM1;MELK;OBSCN;BIN1;MADD;TYRO3;GPLD1;ANP32A;STK39;MST1R;PIK3R1;FOXO3;STK4;KALRN;ABR;BAG3;ABL1;ABL2;BCL2L14;TGFB3;TNFRSF9;INHBA;SON;STK24;CDK5;BCL6;NF1;MAP3K14;MAP3K11;FGFR2;HRK;AVEN;TNFAIP8;RARG;HIP1;FLT4;HMGB1;BABAM2;DSTYK;MCF2L;MYO18A;CTNNBL1;BOK;HTATIP2;ARHGEF12;PLEKHG2;DUSP1;PLEKHG5;ARHGEF16;PAWR;VAV2;RNF144B;PAX7;KIT;NOS1AP;ARHGEF3;BIRC6;ITGA6;TNFRSF25;ARHGEF1;ARHGEF2;ARHGEF7;SGK1;CRYAB;USP27X;SRC;FGD1;FAM129B;FRZB;FLNA;PAK6;PTK2B;FYN;HS1BP3;APBB1;MAP4K5;PAK4;MAP4K4;SEMA4D;NTRK3;DAB2IP;HIP1R;BCAR1,Hypo
123,GO_Biological_Process_2018,cellular protein localization (GO:0034613),46/327,0.0072139204312331,0.225983146063065,0,0,1.5277333353270133,7.534387764274628,NAPA;CNTNAP1;TBC1D9B;RAB5C;LRRK2;AP2A1;RPGR;SEPT8;SEPT9;NACC2;RAB23;KIF13A;TBC1D30;FLNA;TBC1D14;STX3;TBC1D22A;RAB6B;BBS4;TBC1D15;TBC1D16;CEP68;NSF;TMED9;SEPT11;RIC1;ADPRHL1;USP4;SMURF1;STX8;AXIN2;SMAD7;SGSM1;TBC1D1;RAB31;RRAGC;CTTN;RAB15;SGSM3;CROCC;SGSM2;SCG5;RAB3GAP2;KDELR2;ARHGEF2;STX1A,Hypo
124,GO_Biological_Process_2018,positive regulation of protein localization to plasma membrane (GO:1903078),10/43,0.007238316148199,0.225983146063065,0,0,2.8142767885035926,13.869787941079691,CLIP3;PRKCH;LRP1;PRKCE;ARHGEF16;PIK3R1;STX3;SORBS1;EPHB2;PLS1,Hypo
125,GO_Biological_Process_2018,regulation of transcription factor import into nucleus (GO:0042990),6/19,0.0075729466565791,0.225983146063065,0,0,4.282288698955366,20.911156693277977,SMAD3;BAG3;RAB23;NF1;FLNA;PIK3R1,Hypo
126,GO_Biological_Process_2018,hexose transmembrane transport (GO:0035428),6/19,0.0075729466565791,0.225983146063065,0,0,4.282288698955366,20.911156693277977,SLC45A1;SLC2A13;SLC2A12;SLC2A1;SLC2A5;PPARD,Hypo
127,GO_Biological_Process_2018,positive regulation of axon extension (GO:0045773),6/19,0.0075729466565791,0.225983146063065,0,0,4.282288698955366,20.911156693277977,SEMA7A;GOLGA4;DSCAM;TWF2;MAPT;NTN1,Hypo
128,GO_Biological_Process_2018,myelin assembly (GO:0032288),4/9,0.0075939623648166,0.225983146063065,0,0,7.4182939362795475,36.20425487995991,CNTNAP1;TENM4;AHNAK2;CD9,Hypo
129,GO_Biological_Process_2018,response to leucine (GO:0043201),4/9,0.0075939623648166,0.225983146063065,0,0,7.4182939362795475,36.20425487995991,RPTOR;LARS;UBR2;MTOR,Hypo
130,GO_Biological_Process_2018,cellular response to leucine (GO:0071233),4/9,0.0075939623648166,0.225983146063065,0,0,7.4182939362795475,36.20425487995991,RPTOR;LARS;UBR2;MTOR,Hypo
131,GO_Biological_Process_2018,positive regulation of triglyceride biosynthetic process (GO:0010867),4/9,0.0075939623648166,0.225983146063065,0,0,7.4182939362795475,36.20425487995991,SREBF1;SCARB1;LDLR;GPLD1,Hypo
132,GO_Biological_Process_2018,negative regulation of protein phosphorylation (GO:0001933),28/178,0.0076303017076383,0.225983146063065,0,0,1.738466874783212,8.476117584327575,LRRK2;LRRC4;PRKAG2;LDLRAD4;PRKCZ;PPM1F;CORO1C;PREX1;RASSF2;DEPTOR;DVL1;PMEPA1;EPHB2;H2AFY;SEMA4D;DUSP1;NTRK3;DAB2IP;TSC2;RTN4RL2;SMAD7;FKBP8;NF1;FGFR1OP;CALM3;ITGB1BP1;CEP85;TRIB1,Hypo
133,GO_Biological_Process_2018,epidermal growth factor receptor signaling pathway (GO:0007173),12/57,0.0079392159804688,0.2294579702722537,0,0,2.477468180254558,11.980889333716297,SRC;PXN;REPS2;ABL1;TGFA;ABL2;PTK2B;PTPN11;PIK3R1;PAG1;BCAR1;EREG,Hypo
134,GO_Biological_Process_2018,organelle transport along microtubule (GO:0072384),8/31,0.0082145165570503,0.2294579702722537,0,0,3.2287646084269914,15.504051013079373,ARHGAP21;TMEM201;MAP1S;MAPT;HAP1;COPG1;TRAK1;PEX14,Hypo
135,GO_Biological_Process_2018,regulation of glucose metabolic process (GO:0010906),7/25,0.0082337517740556,0.2294579702722537,0,0,3.609081031623492,17.321833143066645,SIK3;IRS2;RORA;MLYCD;PDK2;GPLD1;PDK1,Hypo
136,GO_Biological_Process_2018,cellular response to vascular endothelial growth factor stimulus (GO:0035924),7/25,0.0082337517740556,0.2294579702722537,0,0,3.609081031623492,17.321833143066645,NR4A1;FLT4;MAPKAPK2;DAB2IP;ITGB1BP1;PRKD2;MAPK14,Hypo
137,GO_Biological_Process_2018,peptidyl-tyrosine dephosphorylation (GO:0035335),7/25,0.0082337517740556,0.2294579702722537,0,0,3.609081031623492,17.321833143066645,DUSP5;PTPRS;DUSP1;PTPN11;PTPRF;DUSP14;DUSP7,Hypo
138,GO_Biological_Process_2018,regulation of fibroblast migration (GO:0010762),5/14,0.0082719044881086,0.2294579702722537,0,0,5.153099114538703,24.708546029493814,PRKCE;ITGB1BP1;ARHGEF7;RFFL;CORO1C,Hypo
139,GO_Biological_Process_2018,negative regulation of focal adhesion assembly (GO:0051895),5/14,0.0082719044881086,0.2294579702722537,0,0,5.153099114538703,24.708546029493814,SRC;ITGB1BP1;ARHGAP6;CORO1C;CLASP2,Hypo
140,GO_Biological_Process_2018,positive regulation of transporter activity (GO:0032411),5/14,0.0082719044881086,0.2294579702722537,0,0,5.153099114538703,24.708546029493814,KMT2A;WNK2;STK39;PDZK1;SGK1,Hypo
141,GO_Biological_Process_2018,response to ATP (GO:0033198),5/14,0.0082719044881086,0.2294579702722537,0,0,5.153099114538703,24.708546029493814,P2RX4;KCNJ11;PDXP;RYR3;SSH1,Hypo
142,GO_Biological_Process_2018,positive regulation of intracellular transport (GO:0032388),10/44,0.0085671713998193,0.232731642371644,0,0,2.7313523347483324,13.000739076480976,TENM1;DYNC1H1;RIPOR1;NUMA1;STX18;HIP1R;PCNT;OAZ1;SORL1;BOK,Hypo
143,GO_Biological_Process_2018,protein N-linked glycosylation via asparagine (GO:0018279),10/44,0.0085671713998193,0.232731642371644,0,0,2.7313523347483324,13.000739076480976,ST6GAL1;DPM3;RPN1;ST3GAL6;UGGT2;ST6GALNAC3;UGGT1;ST3GAL2;DDOST;ST3GAL3,Hypo
144,GO_Biological_Process_2018,regulation of focal adhesion assembly (GO:0051893),10/44,0.0085671713998193,0.232731642371644,0,0,2.7313523347483324,13.000739076480976,SRC;ABL1;ITGB1BP1;ARHGAP6;PPM1F;GPM6B;CLASP1;SLC9A1;CORO1C;CLASP2,Hypo
145,GO_Biological_Process_2018,ER to Golgi vesicle-mediated transport (GO:0006888),28/180,0.0088616346219686,0.237432863302468,0,0,1.7154006243496358,8.107024583423815,NAPA;DCTN6;SPTBN4;DYNC1I2;SPTBN5;PEF1;TGFA;GOLGA2;CAPZB;TRAPPC12;VTI1A;SPTBN2;NSF;TRAPPC3;DYNC1H1;TMED9;COG1;ANK3;F2;ANK1;SPTB;DYNLL2;BET1L;ARFGAP1;DYNC1LI2;COPG1;CNIH3;ERGIC1,Hypo
146,GO_Biological_Process_2018,axon development (GO:0061564),17/94,0.0089409655091059,0.237432863302468,0,0,2.0528013114665984,9.683293077621414,SPTBN4;NTNG2;MAP1S;MTR;RTN4RL2;ANK3;BAIAP2;S100B;CDK5;MAP1A;ADGRB1;SLIT1;APBB1;EPHB2;DSCAML1;LLGL1;FGFR2,Hypo
147,GO_Biological_Process_2018,lysosomal transport (GO:0007041),14/72,0.0089637170028729,0.237432863302468,0,0,2.243231689940154,10.57587348783612,SPTBN5;MGRN1;SORT1;AKTIP;VPS33A;DENND3;TRAK1;SORL1;BIN1;LARS;VPS53;KIF13A;VPS11;VPS39,Hypo
148,GO_Biological_Process_2018,positive regulation of developmental growth (GO:0048639),11/51,0.0089813395867143,0.237432863302468,0,0,2.554280556988138,12.037318474526623,RIMS1;GOLGA4;SEMA7A;SEMA4D;SMURF1;TWF2;NEDD4L;RASAL1;MAPT;PPIB;NTN1,Hypo
149,GO_Biological_Process_2018,regulation of cell division (GO:0051302),13/65,0.0091210208824399,0.2385318216162159,0,0,2.3229220443985543,10.911167967766303,SH3GLB1;AHCTF1;KDF1;PDXP;FGF1;MYO19;KIF13A;PIN1;BIRC6;CALM3;BBS4;RAB11FIP4;FGFR2,Hypo
150,GO_Biological_Process_2018,receptor metabolic process (GO:0043112),12/58,0.0091440226108272,0.2385318216162159,0,0,2.4234755687171896,11.377381404614995,SH3GLB1;ARFGEF2;RAB31;GRK2;LRP1;SMURF1;LMTK2;CD9;ACKR3;LDLRAP1;RAMP1;DNM1,Hypo
151,GO_Biological_Process_2018,regulation of MAP kinase activity (GO:0043405),16/87,0.0093796664762907,0.2430691200665091,0,0,2.0949356948308258,9.78169694456362,TENM1;RGS14;DUSP1;LRRK2;SPRY4;DAB2IP;PDGFA;MST1R;FGF1;RASGRP1;SORL1;PIK3R6;DUSP7;NF1;EPHB2;TRIB1,Hypo
152,GO_Biological_Process_2018,"retrograde vesicle-mediated transport, Golgi to ER (GO:0006890)",15/80,0.0097810110293345,0.2507537017538336,0,0,2.144901610017889,9.925129866246918,ARF3;NSF;NAPA;TMED9;STX18;KLC1;ARFGAP1;KLC2;KIF26A;KDELR2;KIF3C;COPG1;RAB6B;ATP9B;ATP9A,Hypo
153,GO_Biological_Process_2018,entrainment of circadian clock by photoperiod (GO:0043153),6/20,0.0099409523436163,0.2507537017538336,0,0,3.976190476190476,18.334581899180566,PER2;PER1;CRTC1;USP2;BHLHE40;CRY2,Hypo
154,GO_Biological_Process_2018,regulation of calcium ion transmembrane transport (GO:1903169),6/20,0.0099409523436163,0.2507537017538336,0,0,3.976190476190476,18.334581899180566,CACNB1;DIAPH1;NOS1AP;PTK2B;ATP1A2;FYN,Hypo
155,GO_Biological_Process_2018,cellular response to amino acid stimulus (GO:0071230),8/32,0.0100364801225643,0.2507537017538336,0,0,3.0940611053896325,14.23741132127023,RPTOR;RRAGC;LARS;SH3BP4;UBR2;FYN;CPEB3;MTOR,Hypo
156,GO_Biological_Process_2018,peptidyl-asparagine modification (GO:0018196),10/45,0.0100753315595746,0.2507537017538336,0,0,2.653166421207658,12.198371090555757,ST6GAL1;DPM3;RPN1;ST3GAL6;UGGT2;ST6GALNAC3;UGGT1;ST3GAL2;DDOST;ST3GAL3,Hypo
157,GO_Biological_Process_2018,protein polymerization (GO:0051258),10/45,0.0100753315595746,0.2507537017538336,0,0,2.653166421207658,12.198371090555757,PREX1;GPX4;COBLL1;MID1IP1;MAPT;CORO7;FGF13;ARHGAP6;WASF3;TTC17,Hypo
158,GO_Biological_Process_2018,protein N-linked glycosylation (GO:0006487),14/73,0.0101218173594464,0.2507537017538336,0,0,2.205088247653733,10.128107147800428,ST6GAL1;B4GALT1;PMM1;RPN1;DDOST;DPM3;B3GALT1;MAN1C1;ST3GAL6;ST6GALNAC3;UGGT2;UGGT1;ST3GAL2;ST3GAL3,Hypo
159,GO_Biological_Process_2018,apoptotic cell clearance (GO:0043277),7/26,0.0103375591101325,0.2544977833425753,0,0,3.4189397838394235,15.631295254046076,SCARB1;LRP1;MEGF10;ADGRB1;TYRO3;RARA;HMGB1,Hypo
160,GO_Biological_Process_2018,plasma membrane bounded cell projection morphogenesis (GO:0120039),11/52,0.0104123325433046,0.2547464465097956,0,0,2.491842664687606,11.37467457127862,CNTNAP1;DBNL;ANKRD27;SLC9A6;CTTN;STK24;MAP1S;LRRK2;DAB2IP;SGK1;MAP4K4,Hypo
161,GO_Biological_Process_2018,activation of protein kinase activity (GO:0032147),34/233,0.0112330855110443,0.2675887769898298,0,0,1.5918160741074894,7.145490109222507,LRRK2;STK39;TGFA;ADCY3;FGF1;STK4;INAVA;STK10;ABL1;PAK6;PTK2B;CLSPN;MAP4K5;MAP3K4;MARK2;MAP4K4;PAK4;DUSP5;NTRK3;DAB2IP;MAPK14;MTOR;DUSP7;TRAF7;ADCY9;PRKAR1B;STK24;PRKAR1A;KIT;MADD;MAPKAPK2;ITGB1BP1;MAP3K14;MAP3K11,Hypo
162,GO_Biological_Process_2018,G-protein coupled glutamate receptor signaling pathway (GO:0007216),5/15,0.0114261414120394,0.2675887769898298,0,0,4.637532133676093,20.738354761240785,GRM2;DAGLA;GRM8;DAGLB;GRM1,Hypo
163,GO_Biological_Process_2018,negative regulation of adherens junction organization (GO:1903392),5/15,0.0114261414120394,0.2675887769898298,0,0,4.637532133676093,20.738354761240785,SRC;ITGB1BP1;ARHGAP6;CORO1C;CLASP2,Hypo
164,GO_Biological_Process_2018,peptidyl-threonine modification (GO:0018210),16/89,0.0116249643749462,0.2675887769898298,0,0,2.0373135385530734,9.07541768753504,CAMK2B;GALNT13;GALNT2;LRRK2;CAMK2A;STK39;LMTK2;CAMKK2;TBK1;SBK1;CDK5;ULK1;PRKD2;CAMK2G;GALNT9;MARK2,Hypo
165,GO_Biological_Process_2018,regulation of phospholipase C activity (GO:1900274),4/10,0.0116889888836302,0.2675887769898298,0,0,6.181569030489894,27.502468234562105,PDGFRA;KIT;ABL1;ABL2,Hypo
166,GO_Biological_Process_2018,establishment of spindle localization (GO:0051293),4/10,0.0116889888836302,0.2675887769898298,0,0,6.181569030489894,27.502468234562105,DYNC1H1;MAP4;CLASP1;LLGL1,Hypo
167,GO_Biological_Process_2018,negative regulation of cell activation (GO:0050866),4/10,0.0116889888836302,0.2675887769898298,0,0,6.181569030489894,27.502468234562105,PDGFRA;PDGFA;F2;LDLR,Hypo
168,GO_Biological_Process_2018,cellular response to ATP (GO:0071318),4/10,0.0116889888836302,0.2675887769898298,0,0,6.181569030489894,27.502468234562105,P2RX4;PDXP;RYR3;SSH1,Hypo
169,GO_Biological_Process_2018,actin filament-based transport (GO:0099515),4/10,0.0116889888836302,0.2675887769898298,0,0,6.181569030489894,27.502468234562105,MLPH;MOBP;MYO19;SYNE2,Hypo
170,GO_Biological_Process_2018,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),4/10,0.0116889888836302,0.2675887769898298,0,0,6.181569030489894,27.502468234562105,PRKCE;STK39;NEDD4L;ATP1A2,Hypo
171,GO_Biological_Process_2018,protein oligomerization (GO:0051259),32/217,0.0117524393041991,0.2675887769898298,0,0,1.611137727926049,7.159403795206203,SPTBN5;TOR2A;B4GALT1;NUFIP1;AHNAK;QPRT;IDE;RASGRP1;SLC9A1;PANX1;ALAD;PANX2;SEPT9;SCUBE1;NACC2;TRPS1;TRAPPC12;CAMK2G;BOK;SH3GLB1;SEPT11;TRAPPC10;PEX14;EHD4;RAD51;DDIT3;CCDC88C;VWA2;MAPT;CRYAB;PFKM;DGKH,Hypo
172,GO_Biological_Process_2018,central nervous system development (GO:0007417),32/217,0.0117524393041991,0.2675887769898298,0,0,1.611137727926049,7.159403795206203,SH3GL3;RARG;THRA;SRC;PKD1;SOX3;ATXN1;SPOCK1;MBP;FYN;ASIC2;SH3GL2;EIF2B5;SZT2;SLC6A17;MAP1S;ZBTB16;PTPN11;S100B;GRIN2B;SLC8A3;RCAN1;ALDH5A1;CDK5;COL4A1;RARA;NF1;TPP1;HAP1;TBC1D23;DSCAML1;FGFR2,Hypo
173,GO_Biological_Process_2018,regulation of stress fiber assembly (GO:0051492),12/60,0.0119758741460702,0.2697662809212674,0,0,2.3222394220846234,10.275586978335282,ARHGEF10;TGFB3;PXN;ABL1;ARHGEF10L;ITGB1BP1;ARHGAP6;RAPGEF3;PPM1F;CLASP1;SLC9A1;CLASP2,Hypo
174,GO_Biological_Process_2018,intra-Golgi vesicle-mediated transport (GO:0006891),8/33,0.0121417838667367,0.2697662809212674,0,0,2.970133882595263,13.101565181668354,NAPA;NSF;TRAPPC3;TRAPPC10;VTI1A;COG1;COPG1;RAB6B,Hypo
175,GO_Biological_Process_2018,regulation of autophagosome assembly (GO:2000785),8/33,0.0121417838667367,0.2697662809212674,0,0,2.970133882595263,13.101565181668354,SH3GLB1;MTMR3;LRRK2;FEZ2;PIP4K2A;TBC1D14;RAB3GAP2;UBQLN2,Hypo
176,GO_Biological_Process_2018,negative regulation of cell proliferation (GO:0008285),49/363,0.0121436377538102,0.2697662809212674,0,0,1.4559283246832877,6.422026880705725,CDKN1C;TENM1;RARG;ATP8A2;TGFB1I1;CHD5;ADARB1;SPEG;PIM2;TNS2;P3H1;TSC2;AXIN2;PPP2R5C;CGRRF1;CBFA2T3;FOXP3;EREG;RNF41;ADGRB1;RAPGEF2;ITGB1BP1;TRIB1;GPLD1;CTBP2;TOB1;FAM129B;DNAJB2;MNT;FRZB;NACC2;LMNA;MXI1;SMYD2;SH3BP4;PTK2B;IGFBP6;ZBTB7C;TGFB3;KDF1;DAB2IP;INHBA;MYO16;CHERP;PER2;DLG3;WNK2;BHLHE40;NF1,Hypo
177,GO_Biological_Process_2018,protein localization to membrane (GO:0072657),25/160,0.0121905046976353,0.2697662809212674,0,0,1.7234247234247235,7.595301537580199,SPTBN4;STXBP1;NRXN2;SYNE3;DVL1;MAP7;TSPAN5;FLNA;CLASP2;SH3GLB1;SMURF1;KCNIP3;TTC7B;ANK3;ANK1;TSPAN15;CACNB3;TSPAN14;DLG3;RAB15;RAPGEF2;ITGB1BP1;FGF13;SHANK3;RAMP1,Hypo
178,GO_Biological_Process_2018,establishment of endothelial barrier (GO:0061028),6/21,0.0127910951158726,0.2786997961775195,0,0,3.710905349794239,16.1758588493424,PPP1R16B;TJP1;PDE2A;RAPGEF2;RAPGEF3;TJP2,Hypo
179,GO_Biological_Process_2018,photoperiodism (GO:0009648),6/21,0.0127910951158726,0.2786997961775195,0,0,3.710905349794239,16.1758588493424,PER2;PER1;CRTC1;USP2;BHLHE40;CRY2,Hypo
180,GO_Biological_Process_2018,negative regulation of small GTPase mediated signal transduction (GO:0051058),7/27,0.0128064643584998,0.2786997961775195,0,0,3.247812660833762,14.15333492647131,RASA3;SPRY4;RASA2;DAB2IP;NF1;RASAL1;EPHB2,Hypo
181,GO_Biological_Process_2018,negative regulation of intracellular signal transduction (GO:1902532),25/161,0.0131350512149769,0.2842800370098589,0,0,1.7106569900687547,7.411371726399204,SRC;USP10;MGRN1;WWC1;WWC2;RORA;UBR2;LIMD1;HDAC7;PREX1;DEPTOR;SH3BP4;RFFL;MARK3;PLEKHA1;DUSP1;PDE2A;PPP2R5B;DAB2IP;TSC2;PPP2R5C;PER1;TNIP1;DDIT3;NF1,Hypo
182,GO_Biological_Process_2018,peptidyl-threonine phosphorylation (GO:0018107),13/68,0.0132668404184002,0.2855633027763848,0,0,2.1958511287370346,9.491539184462496,CAMK2B;LRRK2;CAMK2A;STK39;LMTK2;CAMKK2;TBK1;SBK1;CDK5;ULK1;PRKD2;CAMK2G;MARK2,Hypo
183,GO_Biological_Process_2018,cellular response to nutrient levels (GO:0031669),11/54,0.0137916503959435,0.2952462549435956,0,0,2.3756791441284766,10.176677539258474,RPTOR;SREBF1;RIPOR1;RRAGC;STK24;LRRK2;MARS;LAMP2;ULK1;PDK2;MTOR,Hypo
184,GO_Biological_Process_2018,negative regulation of kinase activity (GO:0033673),16/91,0.0142723096345891,0.2998406910235634,0,0,1.982764563943468,8.425627168138687,CDKN1C;LRRC4;PRKAG2;TSC2;IRS2;RTN4RL2;PPM1F;PREX1;DEPTOR;DVL1;NF1;FGFR1OP;ITGB1BP1;MAPT;CEP85;TRIB1,Hypo
185,GO_Biological_Process_2018,bone development (GO:0060348),8/34,0.0145540103929782,0.2998406910235634,0,0,2.855739523092767,12.079460324479925,RARG;GNAS;RARA;DYM;P3H1;PPIB;FGFR2;SULF2,Hypo
186,GO_Biological_Process_2018,endosomal transport (GO:0016197),33/229,0.0147071061960897,0.2998406910235634,0,0,1.568091086199738,6.616441927435409,AP5Z1;MGRN1;AP2A1;DENND3;TRAK1;BLOC1S5;VPS53;KIF13A;MVB12B;VPS11;VTI1A;RAB6B;VPS39;RAB11FIP4;ABCA1;MON2;RIC1;ANKRD27;SORT1;STX8;VPS33A;AKTIP;DENND2A;LMTK2;VPS37B;BET1L;EHD4;BIN1;HEATR5B;UBE2O;CORO7;TBC1D23;CHMP5,Hypo
187,GO_Biological_Process_2018,regulation of extent of cell growth (GO:0061387),3/6,0.01476319482203,0.2998406910235634,0,0,9.269131997945555,39.07511999036861,OLFM1;CTTN;ABL1,Hypo
188,GO_Biological_Process_2018,establishment of endothelial intestinal barrier (GO:0090557),3/6,0.01476319482203,0.2998406910235634,0,0,9.269131997945555,39.07511999036861,TJP1;RAPGEF2;TJP2,Hypo
189,GO_Biological_Process_2018,"regulation of wound healing, spreading of epidermal cells (GO:1903689)",3/6,0.01476319482203,0.2998406910235634,0,0,9.269131997945555,39.07511999036861,CLASP1;MTOR;CLASP2,Hypo
190,GO_Biological_Process_2018,SREBP signaling pathway (GO:0032933),3/6,0.01476319482203,0.2998406910235634,0,0,9.269131997945555,39.07511999036861,SCAP;ARHGEF10L;ERLIN2,Hypo
191,GO_Biological_Process_2018,regulation of lysosomal protein catabolic process (GO:1905165),3/6,0.01476319482203,0.2998406910235634,0,0,9.269131997945555,39.07511999036861,LRP1;ATP13A2;LDLR,Hypo
192,GO_Biological_Process_2018,regulation of non-motile cilium assembly (GO:1902855),3/6,0.01476319482203,0.2998406910235634,0,0,9.269131997945555,39.07511999036861,SEPT9;MAP4;HAP1,Hypo
193,GO_Biological_Process_2018,glycosaminoglycan biosynthetic process (GO:0006024),17/99,0.0147674775472382,0.2998406910235634,0,0,1.9270942424892432,8.123334278922627,B4GALT1;CHPF;B3GAT2;SDC3;XYLT2;XYLT1;NDST1;CHST11;CHST15;CHST1;ST3GAL6;CSPG4;GPC4;GPC6;ST3GAL2;CHST2;ST3GAL3,Hypo
194,GO_Biological_Process_2018,positive regulation of MAPK cascade (GO:0043410),40/289,0.0149360472095063,0.3017081536320283,0,0,1.4971719338085323,6.294077440705017,TENM1;SEMA7A;WWC1;LRRK2;FLT4;PELI2;PDGFA;ALOX12B;MST1R;PLA2G5;HMGB1;FGF1;PRKCZ;RASGRP1;PIK3R6;INAVA;DSTYK;TRIM5;PTK2B;EPHB2;EPHB1;PDE8A;TNFRSF4;PDGFRA;KSR1;NTRK3;SEMA4C;DAB2IP;LMTK2;PRKCA;PTPN11;GPR37L1;TRAF7;KIT;TYRO3;RAPGEF2;ACKR3;PRKD2;TNFRSF25;FGFR2,Hypo
195,GO_Biological_Process_2018,sialylation (GO:0097503),5/16,0.0153087686912765,0.3071238754093247,0,0,4.215704603879411,17.61881860448056,ST6GAL1;ST3GAL6;ST6GALNAC3;ST3GAL2;ST3GAL3,Hypo
196,GO_Biological_Process_2018,phosphatidic acid metabolic process (GO:0046473),9/41,0.0154772673381234,0.3071238754093247,0,0,2.6107998454404946,10.882813574516463,AGPAT5;GNPAT;GPAM;GPD1;PLA2G5;DDHD1;LCLAT1;AGPAT4;DGKH,Hypo
197,GO_Biological_Process_2018,cardiac muscle cell action potential involved in contraction (GO:0086002),7/28,0.0156719723171551,0.3071238754093247,0,0,3.0929833590667357,12.85407190336615,RYR2;KCNQ1;NEDD4L;CACNA1D;CACNA1C;SCN1B;SNTA1,Hypo
198,GO_Biological_Process_2018,positive regulation of calcium-mediated signaling (GO:0050850),7/28,0.0156719723171551,0.3071238754093247,0,0,3.0929833590667357,12.85407190336615,P2RX4;AKAP6;CALM3;HAP1;SPPL3;LMCD1;SLC9A1,Hypo
199,GO_Biological_Process_2018,regulation of defense response to virus by virus (GO:0050690),7/28,0.0156719723171551,0.3071238754093247,0,0,3.0929833590667357,12.85407190336615,AP2S1;AP1S2;ELMO1;AP1S1;AP2A1;FYN;DOCK2,Hypo
200,GO_Biological_Process_2018,positive regulation of lipid biosynthetic process (GO:0046889),7/28,0.0156719723171551,0.3071238754093247,0,0,3.0929833590667357,12.85407190336615,SCARB1;SREBF1;MID1IP1;SORBS1;LDLR;MTOR;GPLD1,Hypo
201,GO_Biological_Process_2018,regulation of RNA splicing (GO:0043484),11/55,0.0157636389677645,0.3073909598714088,0,0,2.321557503867973,9.634578145458338,SRPK2;CLK1;MBNL1;MBNL2;SON;AHNAK;HNRNPF;AHNAK2;PIK3R1;MBNL3;SRPK1,Hypo
202,GO_Biological_Process_2018,histone lysine methylation (GO:0034968),6/22,0.0161679210320612,0.3080323405503424,0,0,3.478780864197531,14.349018515839113,KMT2D;PAXIP1;KMT2A;SETD1B;DOT1L;SETMAR,Hypo
203,GO_Biological_Process_2018,negative regulation of protein import into nucleus (GO:0042308),6/22,0.0161679210320612,0.3080323405503424,0,0,3.478780864197531,14.349018515839113,RAB23;PDE2A;DAB2IP;NF1;AXIN2;CABP1,Hypo
204,GO_Biological_Process_2018,positive regulation of endothelial cell migration (GO:0010595),13/70,0.0167469828399744,0.3080323405503424,0,0,2.1185682326621924,8.663963525952239,SCARB1;FLT4;PRKCA;HMGB1;FGF1;P2RX4;ABL1;PTK2B;ITGB1BP1;PRKD2;GPLD1;SASH1;BCAR1,Hypo
205,GO_Biological_Process_2018,stress-activated protein kinase signaling cascade (GO:0031098),13/70,0.0167469828399744,0.3080323405503424,0,0,2.1185682326621924,8.663963525952239,STK39;STK4;STK10;STK24;CCDC88C;PAK6;CCM2;BTRC;MAP4K5;MAP3K14;MAP3K4;PAK4;MAP4K4,Hypo
206,GO_Biological_Process_2018,regulation of macroautophagy (GO:0016241),19/116,0.0167532199393229,0.3080323405503424,0,0,1.8211118644791704,7.446826540379445,SH3GLB1;GPSM1;MTMR3;LRRK2;PRKAG1;TSC2;PRKAG2;PRKAB1;MTOR;RPTOR;TBK1;RRAGC;CDK5;TBC1D14;ULK1;ATP13A2;ATP6V1E1;ATP6V0A1;UBQLN2,Hypo
207,GO_Biological_Process_2018,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),4/11,0.0169695399592344,0.3080323405503424,0,0,5.298194097782998,21.597215675599703,TNRC6C;AGO2;CPEB3;TOB1,Hypo
208,GO_Biological_Process_2018,calcium ion regulated exocytosis (GO:0017156),4/11,0.0169695399592344,0.3080323405503424,0,0,5.298194097782998,21.597215675599703,RIMS1;RIMS3;ARHGAP17;SYT7,Hypo
209,GO_Biological_Process_2018,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),4/11,0.0169695399592344,0.3080323405503424,0,0,5.298194097782998,21.597215675599703,TNRC6C;AGO2;CPEB3;TOB1,Hypo
210,GO_Biological_Process_2018,cytoplasmic mRNA processing body assembly (GO:0033962),4/11,0.0169695399592344,0.3080323405503424,0,0,5.298194097782998,21.597215675599703,DYNC1H1;ATXN2;LIMD1;LSM14A,Hypo
211,GO_Biological_Process_2018,fatty acid transmembrane transport (GO:1902001),4/11,0.0169695399592344,0.3080323405503424,0,0,5.298194097782998,21.597215675599703,MID1IP1;PRKAG2;THRSP;ACACB,Hypo
212,GO_Biological_Process_2018,regulation of synaptic vesicle cycle (GO:0098693),4/11,0.0169695399592344,0.3080323405503424,0,0,5.298194097782998,21.597215675599703,RIMS1;RIMS3;CDK5;LRRK2,Hypo
213,GO_Biological_Process_2018,"regulation of synaptic transmission, GABAergic (GO:0032228)",4/11,0.0169695399592344,0.3080323405503424,0,0,5.298194097782998,21.597215675599703,USP46;STXBP1;HAP1;SYN3,Hypo
214,GO_Biological_Process_2018,regulation of hippo signaling (GO:0035330),4/11,0.0169695399592344,0.3080323405503424,0,0,5.298194097782998,21.597215675599703,WWC1;WWC2;LIMD1;MARK3,Hypo
215,GO_Biological_Process_2018,regulation of lamellipodium morphogenesis (GO:2000392),4/11,0.0169695399592344,0.3080323405503424,0,0,5.298194097782998,21.597215675599703,KANK1;SRC;ARHGEF7;CORO1C,Hypo
216,GO_Biological_Process_2018,carnitine shuttle (GO:0006853),4/11,0.0169695399592344,0.3080323405503424,0,0,5.298194097782998,21.597215675599703,MID1IP1;PRKAG2;THRSP;ACACB,Hypo
217,GO_Biological_Process_2018,carbohydrate catabolic process (GO:0016052),8/35,0.0172961755463521,0.312521263656335,0,0,2.749818819849716,11.15675704189122,HK3;NEU4;PKM;HKDC1;NEU1;PFKM;HK1;DERA,Hypo
218,GO_Biological_Process_2018,oligosaccharide metabolic process (GO:0009311),12/63,0.0174267850634689,0.3134434080593796,0,0,2.1852728707582103,8.84980200104373,ST6GAL1;NEU4;GALNT13;B4GALT1;GALNT2;B3GALT1;NEU1;ST3GAL6;ST6GALNAC3;GALNT9;ST3GAL2;ST3GAL3,Hypo
219,GO_Biological_Process_2018,regulation of kinase activity (GO:0043549),17/101,0.0177926110849728,0.3185686139259454,0,0,1.88100165053088,7.578503011005864,CDKN1C;PDGFRA;VAC14;FLT4;NTRK3;LMTK2;IRS2;MST1R;CAMKK2;DSTYK;RBL1;KIT;TYRO3;MAPT;EPHB2;EPHB1;FGFR2,Hypo
220,GO_Biological_Process_2018,regulation of cation channel activity (GO:2001257),13/71,0.0187271047635528,0.3337831025503838,0,0,2.081925480212913,8.28144851522817,AHNAK;EPO;KCNAB1;ANK3;CACNB1;CACNB3;CACNB4;PTK2B;CACNG2;SHANK3;CNIH3;SHANK2;CACNG4,Hypo
221,GO_Biological_Process_2018,regulation of striated muscle contraction (GO:0006942),7/29,0.0189641807383663,0.3364860717496623,0,0,2.952229448369438,11.706189961022307,SLC8A3;RYR2;GRK2;P2RX4;ATP1A2;CALM3;SMAD7,Hypo
222,GO_Biological_Process_2018,phosphate-containing compound metabolic process (GO:0006796),27/183,0.0192923569792569,0.3407739647591623,0,0,1.610524420976839,6.358424937719676,INPP1;LRRK2;PDXP;PLA2G5;LIMD1;NUDT3;INPP5B;IMPA2;PIP4K2A;EPHB2;DUSP5;GPX4;TNK2;ITPK1;MOCOS;HDHD2;MTOR;INPP4A;ITPKB;PTPRB;SYNJ1;CDK5;PI4KA;PLCH2;FAM20A;COQ8A;PFKM,Hypo
223,GO_Biological_Process_2018,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),14/79,0.0197167125789146,0.342960733604282,0,0,2.000874125874126,7.856009367752353,CDKN1C;SMAD3;SMURF1;TGFB1I1;HTRA3;LDLRAD4;DKK3;SMAD7;PEG10;ADAMTSL2;PRDM16;PMEPA1;PIN1;BCL9L,Hypo
224,GO_Biological_Process_2018,intracellular protein transport (GO:0006886),46/347,0.0197728796664715,0.342960733604282,0,0,1.4246175214271757,5.589407058207205,OPRD1;NAPA;TBC1D9B;RAB5C;NUP188;AP2A1;AKAP6;TRAK1;PKD1;RPGR;IPO9;RAB23;KIF13A;TBC1D30;LAMP2;TBC1D14;STX3;TNPO1;TBC1D22A;RAB6B;TBC1D15;TBC1D16;NSF;TMED9;RIC1;ADPRHL1;NUP133;SMURF1;STX8;HPS4;TSC2;SORL1;SGSM1;TBC1D1;RAB31;CTTN;BCL6;RAB15;SGSM3;SGSM2;SCG5;RAB3GAP2;KDELR2;HAP1;ARHGEF2;STX1A,Hypo
225,GO_Biological_Process_2018,calcium ion transport (GO:0006816),19/118,0.0198082741611591,0.342960733604282,0,0,1.784122948804461,6.996715649154747,RYR1;RYR2;CAMK2A;CACNA1D;CACNA1C;TRPC4AP;CACNA1E;PKD1;RYR3;SLC8A2;PANX1;SLC8A3;CACNA1I;CACNB3;P2RX4;FYN;CACNG2;RAMP1;CACNG4,Hypo
226,GO_Biological_Process_2018,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),5/17,0.0199817585937091,0.342960733604282,0,0,3.864181662382177,15.120293574007633,RYR2;AKAP6;CALM3;HAP1;SLC9A1,Hypo
227,GO_Biological_Process_2018,long-term memory (GO:0007616),5/17,0.0199817585937091,0.342960733604282,0,0,3.864181662382177,15.120293574007633,RGS14;EIF2AK4;CPEB3;SGK1;LDLR,Hypo
228,GO_Biological_Process_2018,regulation of synaptic vesicle exocytosis (GO:2000300),5/17,0.0199817585937091,0.342960733604282,0,0,3.864181662382177,15.120293574007633,NAPA;RIMS1;RIMS3;STXBP1;LRRK2,Hypo
229,GO_Biological_Process_2018,regulation of dendritic spine morphogenesis (GO:0061001),6/23,0.0201127010567629,0.342960733604282,0,0,3.2739651416122006,12.78942977239074,CAMK2B;ARHGAP44;CDK5;LRRK2;SRCIN1;SHANK3,Hypo
230,GO_Biological_Process_2018,negative regulation of axon extension (GO:0030517),6/23,0.0201127010567629,0.342960733604282,0,0,3.2739651416122006,12.78942977239074,SEMA4A;SEMA7A;PTPRS;SEMA4D;SEMA4C;ERCC2,Hypo
231,GO_Biological_Process_2018,glutamate receptor signaling pathway (GO:0007215),8/36,0.0203904698670585,0.3461985379583778,0,0,2.651463881124025,10.32132070623912,GRM2;DAGLA;GRM8;GRIK4;PTK2B;DAGLB;GRIN2B;GRM1,Hypo
232,GO_Biological_Process_2018,receptor internalization (GO:0031623),10/50,0.0208109758092394,0.351171300666996,0,0,2.320876288659794,8.987070646538356,RAB31;GRK2;LRP1;CD9;ACKR3;LDLRAP1;CACNG2;RAMP1;DNM1;CACNG4,Hypo
233,GO_Biological_Process_2018,positive regulation of protein localization to membrane (GO:1905477),16/95,0.0209508138250175,0.351171300666996,0,0,1.8819525349181208,7.274833915742935,PRKCH;LRP1;PRKCE;ARHGEF16;ANK3;PDZK1;PIK3R1;SORBS1;DYNLL2;CLIP3;NMT1;ITGB1BP1;FYN;STX3;EPHB2;PLS1,Hypo
234,GO_Biological_Process_2018,regulation of cytoskeleton organization (GO:0051493),16/95,0.0209508138250175,0.351171300666996,0,0,1.8819525349181208,7.274833915742935,PHLDB1;LRP1;TWF2;HIP1R;PDGFA;ARHGAP17;BAIAP2;MTOR;ARHGAP44;DIAPH1;RHOJ;ABL1;MAPT;CLASP1;GPM6B;MARK2,Hypo
235,GO_Biological_Process_2018,ERBB signaling pathway (GO:0038127),14/80,0.0218242878574534,0.3525046315432682,0,0,1.9704482844978712,7.536436228671587,SRC;PXN;TGFA;PRKCA;PTPN11;NRG2;PIK3R1;EREG;REPS2;ABL1;ABL2;PTK2B;PAG1;BCAR1,Hypo
236,GO_Biological_Process_2018,beta-catenin-TCF complex assembly (GO:1904837),7/30,0.0227113685806427,0.3525046315432682,0,0,2.823715008167558,10.687449740961414,KMT2D;TLE3;TRRAP;TCF7;AXIN2;BCL9L;SMARCA4,Hypo
237,GO_Biological_Process_2018,aminoglycan metabolic process (GO:0006022),7/30,0.0227113685806427,0.3525046315432682,0,0,2.823715008167558,10.687449740961414,B3GAT2;SDC3;XYLT2;XYLT1;CSPG4;GPC4;GPC6,Hypo
238,GO_Biological_Process_2018,phospholipid transport (GO:0015914),11/58,0.0229491299917434,0.3525046315432682,0,0,2.173010874216804,8.201975767168243,ABCA1;SCARB1;ATP8A2;ATP8A1;ATP8B2;ATP11C;ATP11A;LDLR;ATP9B;ABCG1;ATP9A,Hypo
239,GO_Biological_Process_2018,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),11/58,0.0229491299917434,0.3525046315432682,0,0,2.173010874216804,8.201975767168243,ZFYVE28;RHBDF1;AFAP1L2;HIP1;RHBDF2;MVB12B;HIP1R;DAB2IP;HAP1;ARHGEF7;SH3GL2,Hypo
240,GO_Biological_Process_2018,integrin-mediated signaling pathway (GO:0007229),11/58,0.0229491299917434,0.3525046315432682,0,0,2.173010874216804,8.201975767168243,LAMA5;SEMA7A;DST;SRC;ABL1;MYH9;PTK2B;ITGB1BP1;CCM2;DOCK1;BCAR1,Hypo
241,GO_Biological_Process_2018,monovalent inorganic cation transport (GO:0015672),17/104,0.0231984715668496,0.3525046315432682,0,0,1.8158362619000896,6.834206435934701,KCNJ4;KCNK6;KCNJ6;KCNJ10;KCND3;KCNJ12;TRAPPC10;NEDD4L;KCNAB1;ATP1A2;KCNA6;ASIC2;FGF13;SGK1;KCNK3;KCNH1;ASIC1,Hypo
242,GO_Biological_Process_2018,microtubule anchoring (GO:0034453),4/12,0.0235234436525698,0.3525046315432682,0,0,4.635662898252827,17.382612892412695,BCCIP;PEX14;CLASP1;CLASP2,Hypo
243,GO_Biological_Process_2018,regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter (GO:1901836),4/12,0.0235234436525698,0.3525046315432682,0,0,4.635662898252827,17.382612892412695,H2AFY;MARS;MTOR;SMARCA4,Hypo
244,GO_Biological_Process_2018,peptidyl-tyrosine modification (GO:0018212),10/51,0.0236962563886782,0.3525046315432682,0,0,2.2641438270052805,8.47341835210454,PDGFRA;SRC;FLT4;KIT;ABL1;ABL2;PTK2B;FYN;EPHB2;FGFR2,Hypo
245,GO_Biological_Process_2018,positive regulation of receptor activity (GO:2000273),8/37,0.0238580120922247,0.3525046315432682,0,0,2.559892041620796,9.5628227709599,BUD31;TGFA;AKAP6;CALM3;HAP1;EPHB2;SHANK3;EREG,Hypo
246,GO_Biological_Process_2018,positive regulation of stress fiber assembly (GO:0051496),8/37,0.0238580120922247,0.3525046315432682,0,0,2.559892041620796,9.5628227709599,ARHGEF10;TGFB3;PXN;ABL1;ARHGEF10L;ITGB1BP1;PPM1F;RAPGEF3,Hypo
247,GO_Biological_Process_2018,angiotensin-activated signaling pathway (GO:0038166),3/7,0.0239790318596076,0.3525046315432682,0,0,6.951463790446842,25.932960526804987,AHCYL1;SRC;CAMK2A,Hypo
248,GO_Biological_Process_2018,positive regulation of lamellipodium morphogenesis (GO:2000394),3/7,0.0239790318596076,0.3525046315432682,0,0,6.951463790446842,25.932960526804987,SRC;ARHGEF7;CORO1C,Hypo
249,GO_Biological_Process_2018,protein C-linked glycosylation via tryptophan (GO:0018317),3/7,0.0239790318596076,0.3525046315432682,0,0,6.951463790446842,25.932960526804987,DPM3;DPY19L3;DPY19L4,Hypo
250,GO_Biological_Process_2018,postsynaptic density assembly (GO:0097107),3/7,0.0239790318596076,0.3525046315432682,0,0,6.951463790446842,25.932960526804987,NRXN2;SHANK3;SHANK2,Hypo
251,GO_Biological_Process_2018,cellular ion homeostasis (GO:0006873),3/7,0.0239790318596076,0.3525046315432682,0,0,6.951463790446842,25.932960526804987,ATP13A2;SLC4A1;RHCG,Hypo
252,GO_Biological_Process_2018,cellular response to sterol depletion (GO:0071501),3/7,0.0239790318596076,0.3525046315432682,0,0,6.951463790446842,25.932960526804987,SCAP;ARHGEF10L;ERLIN2,Hypo
253,GO_Biological_Process_2018,regulation of T-helper 17 type immune response (GO:2000316),3/7,0.0239790318596076,0.3525046315432682,0,0,6.951463790446842,25.932960526804987,NLRP10;IL12RB1;SMAD7,Hypo
254,GO_Biological_Process_2018,negative regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000587),3/7,0.0239790318596076,0.3525046315432682,0,0,6.951463790446842,25.932960526804987,PDGFRA;LRP1;PDGFA,Hypo
255,GO_Biological_Process_2018,retinoic acid receptor signaling pathway (GO:0048384),3/7,0.0239790318596076,0.3525046315432682,0,0,6.951463790446842,25.932960526804987,RARG;RXRA;RARA,Hypo
256,GO_Biological_Process_2018,phosphorylated carbohydrate dephosphorylation (GO:0046838),3/7,0.0239790318596076,0.3525046315432682,0,0,6.951463790446842,25.932960526804987,SYNJ1;INPP1;IMPA2,Hypo
257,GO_Biological_Process_2018,negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),3/7,0.0239790318596076,0.3525046315432682,0,0,6.951463790446842,25.932960526804987,ADARB1;PPM1F;CORO1C,Hypo
258,GO_Biological_Process_2018,protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan (GO:0018406),3/7,0.0239790318596076,0.3525046315432682,0,0,6.951463790446842,25.932960526804987,DPM3;DPY19L3;DPY19L4,Hypo
259,GO_Biological_Process_2018,regulation of atrial cardiac muscle cell membrane repolarization (GO:0060372),3/7,0.0239790318596076,0.3525046315432682,0,0,6.951463790446842,25.932960526804987,KCNQ1;FLNA;CACNA1D,Hypo
260,GO_Biological_Process_2018,inositol phosphate dephosphorylation (GO:0046855),3/7,0.0239790318596076,0.3525046315432682,0,0,6.951463790446842,25.932960526804987,SYNJ1;INPP1;IMPA2,Hypo
261,GO_Biological_Process_2018,regulation of collateral sprouting (GO:0048670),3/7,0.0239790318596076,0.3525046315432682,0,0,6.951463790446842,25.932960526804987,PTPRS;SEMA4D;FGF13,Hypo
262,GO_Biological_Process_2018,ion homeostasis (GO:0050801),3/7,0.0239790318596076,0.3525046315432682,0,0,6.951463790446842,25.932960526804987,SLC4A1;KLHL3;RHCG,Hypo
263,GO_Biological_Process_2018,forebrain neuron differentiation (GO:0021879),3/7,0.0239790318596076,0.3525046315432682,0,0,6.951463790446842,25.932960526804987,RAPGEF2;INHBA;SHANK3,Hypo
264,GO_Biological_Process_2018,response to caffeine (GO:0031000),3/7,0.0239790318596076,0.3525046315432682,0,0,6.951463790446842,25.932960526804987,RYR1;RYR2;RYR3,Hypo
265,GO_Biological_Process_2018,regulation of cellular response to insulin stimulus (GO:1900076),3/7,0.0239790318596076,0.3525046315432682,0,0,6.951463790446842,25.932960526804987,TSC2;VWA2;GPLD1,Hypo
266,GO_Biological_Process_2018,cellular response to caffeine (GO:0071313),3/7,0.0239790318596076,0.3525046315432682,0,0,6.951463790446842,25.932960526804987,RYR1;RYR2;RYR3,Hypo
267,GO_Biological_Process_2018,regulation of dendrite morphogenesis (GO:0048814),9/44,0.0240730504912767,0.3525046315432682,0,0,2.386619562817399,8.894125151712823,ARHGAP44;FBXW8;SEMA4D;CDK5;LRRK2;NEDD4L;RAPGEF2;SRCIN1;SHANK3,Hypo
268,GO_Biological_Process_2018,positive regulation of transport (GO:0051050),9/44,0.0240730504912767,0.3525046315432682,0,0,2.386619562817399,8.894125151712823,CLIP3;DYNC1H1;LRP1;KMT2A;NUMA1;NEDD4L;SGK1;LDLR;GPLD1,Hypo
269,GO_Biological_Process_2018,receptor clustering (GO:0043113),6/24,0.0246627503234448,0.3558482546668478,0,0,3.091906721536352,11.447664848980525,DLG3;DVL1;NRXN2;LRP4;FLNA;ITGB1BP1,Hypo
270,GO_Biological_Process_2018,macromolecule modification (GO:0043412),6/24,0.0246627503234448,0.3558482546668478,0,0,3.091906721536352,11.447664848980525,ST6GAL1;ST3GAL6;ST6GALNAC3;PRDM10;ST3GAL2;ST3GAL3,Hypo
271,GO_Biological_Process_2018,regulation of neuronal synaptic plasticity (GO:0048168),6/24,0.0246627503234448,0.3558482546668478,0,0,3.091906721536352,11.447664848980525,CAMK2B;SYNGR1;CAMK2A;EPHB2;PPFIA3;SLC8A2,Hypo
272,GO_Biological_Process_2018,regulation of cardiac muscle cell action potential (GO:0098901),6/24,0.0246627503234448,0.3558482546668478,0,0,3.091906721536352,11.447664848980525,RYR2;NOS1AP;FLNA;CTNNA3;CACNA1C;FGF13,Hypo
273,GO_Biological_Process_2018,cellular response to organonitrogen compound (GO:0071417),16/97,0.0250711387186495,0.3561555999507116,0,0,1.835280299258238,6.764912825122058,PDE2A;PDXP;AKAP6;RYR3;MTOR;SSH1;RPTOR;DIAPH1;P2RX4;RRAGC;LARS;KCNQ1;RAPGEF2;SH3BP4;CPEB3;RAPGEF3,Hypo
274,GO_Biological_Process_2018,regulation of organelle organization (GO:0033043),18/113,0.0252765722877383,0.3561555999507116,0,0,1.7608695652173914,6.476262217635031,TMED9;TBC1D9B;ADPRHL1;STX18;SGSM1;DIAPH1;TBC1D1;SGSM3;TBC1D30;SGSM2;VPS11;TBC1D14;ATP13A2;MAPT;TBC1D22A;TBC1D15;MARK2;TBC1D16,Hypo
275,GO_Biological_Process_2018,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),5/18,0.0254978114206907,0.3561555999507116,0,0,3.566739173422978,13.086946182884311,TRIM5;NFKBIL1;PRKCA;TRIB1;SASH1,Hypo
276,GO_Biological_Process_2018,positive regulation of metabolic process (GO:0009893),5/18,0.0254978114206907,0.3561555999507116,0,0,3.566739173422978,13.086946182884311,DISP3;FASN;ABL1;ABL2;ACACB,Hypo
277,GO_Biological_Process_2018,negative regulation of microtubule depolymerization (GO:0007026),5/18,0.0254978114206907,0.3561555999507116,0,0,3.566739173422978,13.086946182884311,MID1IP1;ARHGEF2;FGF13;CLASP1;CLASP2,Hypo
278,GO_Biological_Process_2018,DNA conformation change (GO:0071103),5/18,0.0254978114206907,0.3561555999507116,0,0,3.566739173422978,13.086946182884311,TOP1MT;KAT6A;HMGB3;ASH1L;HMGB1,Hypo
279,GO_Biological_Process_2018,establishment of epithelial cell polarity (GO:0090162),5/18,0.0254978114206907,0.3561555999507116,0,0,3.566739173422978,13.086946182884311,CYTH3;FBF1;MYO18A;SIPA1L3;CLASP1,Hypo
280,GO_Biological_Process_2018,cell-substrate adherens junction assembly (GO:0007045),5/18,0.0254978114206907,0.3561555999507116,0,0,3.566739173422978,13.086946182884311,LAMA5;CTTN;ACTN1;SORBS1;ARHGEF7,Hypo
281,GO_Biological_Process_2018,focal adhesion assembly (GO:0048041),5/18,0.0254978114206907,0.3561555999507116,0,0,3.566739173422978,13.086946182884311,LAMA5;CTTN;ACTN1;SORBS1;ARHGEF7,Hypo
282,GO_Biological_Process_2018,negative regulation of cellular process (GO:0048523),66/534,0.0263317291415014,0.3665041734571529,0,0,1.3160896074908814,4.78659241731141,TENM1;RARG;ATP8A2;PLXND1;EPO;TGFB1I1;JADE1;CHD5;ADARB1;ENO1;PPP1R9B;SPEG;PIM2;PDE8A;TNS2;DSCAM;ACTN1;P3H1;TSC2;AXIN2;PPP2R5C;CGRRF1;FOXP3;CBFA2T3;RNF41;EREG;ADGRB1;RAPGEF2;MYH9;ITGB1BP1;GPLD1;CTBP2;STK39;NEDD4L;UBR2;TOB1;FAM129B;DNAJB2;MNT;FRZB;NACC2;LMNA;MXI1;SMYD2;SH3BP4;PTK2B;APBB2;IGFBP6;RBBP7;APBB1;ZBTB7C;SMAD3;SEMA4D;TGFB3;DAB2IP;INHBA;MYO16;DCBLD2;CHERP;SMARCA4;NR4A1;BCL6;DLG3;WNK2;BHLHE40;CD9,Hypo
283,GO_Biological_Process_2018,positive regulation of protein dephosphorylation (GO:0035307),7/31,0.0269396227904171,0.3736449794769483,0,0,2.705910104649168,9.779584243572046,PPP1R16B;SYMPK;PIN1;AKAP6;CALM3;SPPL3;MTOR,Hypo
284,GO_Biological_Process_2018,negative regulation of protein serine/threonine kinase activity (GO:0071901),12/67,0.027350946499248,0.3753845932422925,0,0,2.02589361103293,7.291199500992218,H2AFY;PRKAR1B;RGS14;DUSP1;PRKAR1A;SPRY4;ABL1;DAB2IP;NF1;PKIG;SORL1;DUSP7,Hypo
285,GO_Biological_Process_2018,insulin receptor signaling pathway (GO:0008286),12/67,0.027350946499248,0.3753845932422925,0,0,2.02589361103293,7.291199500992218,IRS2;IDE;TCIRG1;PIK3R1;SORBS1;ATP6V1E1;BAIAP2;SOGA1;PDK2;GPLD1;BCAR1;ATP6V0A1,Hypo
286,GO_Biological_Process_2018,positive regulation of autophagy (GO:0010508),12/67,0.027350946499248,0.3753845932422925,0,0,2.02589361103293,7.291199500992218,GPSM1;SH3GLB1;TMEM59;TBK1;LRRK2;TFEB;TSC2;SH3BP4;PIM2;EIF2AK4;CAMKK2;TPCN1,Hypo
287,GO_Biological_Process_2018,homotypic cell-cell adhesion (GO:0034109),8/38,0.0277186182621831,0.3777980530613815,0,0,2.4744249914177825,8.872424326487046,PDGFRA;MEGF10;CSRP1;STXBP1;TYRO3;GNAS;FLNA;MYH9,Hypo
288,GO_Biological_Process_2018,positive regulation of neuron death (GO:1901216),8/38,0.0277186182621831,0.3777980530613815,0,0,2.4744249914177825,8.872424326487046,SRPK2;CDK5;DDIT3;NF1;FYN;MAPT;FOXO3;GRIN2B,Hypo
289,GO_Biological_Process_2018,positive regulation of protein binding (GO:0032092),11/60,0.0289097386651603,0.3913246068799545,0,0,2.0840850006841314,7.385115179696791,TIAM1;TRAF4;LRP1;LRRK2;AKTIP;ABL1;HIP1R;RAPGEF2;STK4;PKD1;SPPL3,Hypo
290,GO_Biological_Process_2018,"regulation of mRNA splicing, via spliceosome (GO:0048024)",11/60,0.0289097386651603,0.3913246068799545,0,0,2.0840850006841314,7.385115179696791,SRPK2;MBNL1;MBNL2;SON;RBFOX3;SFSWAP;CELF4;CELF5;SRSF4;MBNL3;SRPK1,Hypo
291,GO_Biological_Process_2018,regulation of protein catabolic process (GO:0042176),15/91,0.0295849545276281,0.3919418223080702,0,0,1.8333333333333333,6.454230456414271,NSF;LRP1;SMURF1;AGAP2;DAB2IP;NEDD4L;FURIN;IDE;OAZ1;SORL1;RNF41;ADGRB1;FLNA;PIN1;ATP13A2,Hypo
292,GO_Biological_Process_2018,small GTPase mediated signal transduction (GO:0007264),16/99,0.0297705169819767,0.3919418223080702,0,0,1.790857327967506,6.293496614879584,SHC2;KSR1;TNK2;RAP1GDS1;MAPK14;NTN1;CNKSR2;ABR;ARHGAP31;RRAGC;MAPKAPK2;NF1;RAPGEF2;RGL1;RIN2;RALGDS,Hypo
293,GO_Biological_Process_2018,canonical glycolysis (GO:0061621),6/25,0.0298508623235392,0.3919418223080702,0,0,2.9290123456790123,10.285348555243868,HK3;PKM;ENO1;PFKM;PFKP;HK1,Hypo
294,GO_Biological_Process_2018,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),6/25,0.0298508623235392,0.3919418223080702,0,0,2.9290123456790123,10.285348555243868,CHPF;CHST11;B3GAT2;XYLT2;CHST15;CSPG4,Hypo
295,GO_Biological_Process_2018,monocarboxylic acid catabolic process (GO:0072329),6/25,0.0298508623235392,0.3919418223080702,0,0,2.9290123456790123,10.285348555243868,ALDH5A1;ASPG;ABAT;HOGA1;LPIN1;PPARD,Hypo
296,GO_Biological_Process_2018,modulation of excitatory postsynaptic potential (GO:0098815),6/25,0.0298508623235392,0.3919418223080702,0,0,2.9290123456790123,10.285348555243868,RIMS1;LRRK2;PTK2B;PRKCZ;SHANK3;SHANK2,Hypo
297,GO_Biological_Process_2018,regulation of cellular protein localization (GO:1903827),6/25,0.0298508623235392,0.3919418223080702,0,0,2.9290123456790123,10.285348555243868,DVL1;PIN1;ATP13A2;KCNAB2;MAPT;RAB11FIP5,Hypo
298,GO_Biological_Process_2018,glycolytic process through glucose-6-phosphate (GO:0061620),6/25,0.0298508623235392,0.3919418223080702,0,0,2.9290123456790123,10.285348555243868,HK3;PKM;ENO1;PFKM;PFKP;HK1,Hypo
299,GO_Biological_Process_2018,glucose catabolic process to pyruvate (GO:0061718),6/25,0.0298508623235392,0.3919418223080702,0,0,2.9290123456790123,10.285348555243868,HK3;PKM;ENO1;PFKM;PFKP;HK1,Hypo
300,GO_Biological_Process_2018,regulation of programmed cell death (GO:0043067),36/268,0.0301177448395625,0.3941322156911527,0,0,1.4445465355096747,5.059727562538114,RARG;HIP1;RTKN;ANP32A;LRRK2;STK39;STK4;STK10;ABL1;PAK6;ABL2;DIP2A;HS1BP3;FYN;MAP4K5;DCPS;TNFRSF4;MAP3K4;BCL2L14;MAP4K4;PAK4;DUSP1;TGFB3;ACTN1;TNFRSF9;INHBA;FBXO10;STK24;CDK5;BCL6;MADD;NOS1AP;TNFRSF25;SGK1;MAP3K14;BCAR1,Hypo
301,GO_Biological_Process_2018,regulation of mitotic cell cycle (GO:0007346),24/165,0.0304637339297502,0.3962607919640274,0,0,1.582731269746581,5.525660458919146,CUL9;DYNC1H1;AFAP1L2;PARP3;SMAD3;NUMA1;USP2;STK39;PDXP;PRKCA;STK4;STK10;RBL1;STK24;ERCC2;PIN1;PAK6;PIM2;MAP4K5;MAP3K14;MAP3K4;MAP9;PAK4;MAP4K4,Hypo
302,GO_Biological_Process_2018,regulation of triglyceride biosynthetic process (GO:0010866),4/13,0.0314112178837128,0.3962607919640274,0,0,4.120360854173804,14.258880361210256,SREBF1;SCARB1;LDLR;GPLD1,Hypo
303,GO_Biological_Process_2018,myelination in peripheral nervous system (GO:0022011),4/13,0.0314112178837128,0.3962607919640274,0,0,4.120360854173804,14.258880361210256,ARHGEF10;CNTNAP1;AHNAK2;NF1,Hypo
304,GO_Biological_Process_2018,cardiolipin metabolic process (GO:0032048),4/13,0.0314112178837128,0.3962607919640274,0,0,4.120360854173804,14.258880361210256,HADHA;TAMM41;PDXP;LCLAT1,Hypo
305,GO_Biological_Process_2018,regulation of cAMP-dependent protein kinase activity (GO:2000479),4/13,0.0314112178837128,0.3962607919640274,0,0,4.120360854173804,14.258880361210256,PRKAR1B;PRKAR1A;RAPGEF2;PKIG,Hypo
306,GO_Biological_Process_2018,regulation of synaptic vesicle transport (GO:1902803),4/13,0.0314112178837128,0.3962607919640274,0,0,4.120360854173804,14.258880361210256,RIMS1;RIMS3;CDK5;LRRK2,Hypo
307,GO_Biological_Process_2018,intestinal absorption (GO:0050892),4/13,0.0314112178837128,0.3962607919640274,0,0,4.120360854173804,14.258880361210256,KCNQ1;SLC2A2;SLC2A5;TJP2,Hypo
308,GO_Biological_Process_2018,glycerolipid catabolic process (GO:0046503),4/13,0.0314112178837128,0.3962607919640274,0,0,4.120360854173804,14.258880361210256,SMPD4;ABHD2;ENPP6;MGLL,Hypo
309,GO_Biological_Process_2018,regulation of cellular component movement (GO:0051270),9/46,0.0314145710073508,0.3962607919640274,0,0,2.257362462926605,7.811565441088048,DIAPH1;ACTN1;ABL1;ZSWIM8;ABL2;CD9;MEMO1;NRG2;EREG,Hypo
310,GO_Biological_Process_2018,dendrite morphogenesis (GO:0048813),7/32,0.0316725085484392,0.3962607919640274,0,0,2.5975295934122493,8.967467552715975,BTBD3;DVL1;LRP4;EPHB2;EPHB1;SHANK3;SHANK2,Hypo
311,GO_Biological_Process_2018,regulation of mitochondrial fission (GO:0090140),5/19,0.0318995583422903,0.3962607919640274,0,0,3.311788468600808,11.40965147457454,INF2;LRRK2;DDHD1;MAPT;MYO19,Hypo
312,GO_Biological_Process_2018,positive regulation of excitatory postsynaptic potential (GO:2000463),5/19,0.0318995583422903,0.3962607919640274,0,0,3.311788468600808,11.40965147457454,RIMS1;PTK2B;PRKCZ;SHANK3;SHANK2,Hypo
313,GO_Biological_Process_2018,positive regulation of phospholipase activity (GO:0010518),5/19,0.0318995583422903,0.3962607919640274,0,0,3.311788468600808,11.40965147457454,PDGFRA;KIT;ABL2;PLA2G5;FGFR2,Hypo
314,GO_Biological_Process_2018,positive regulation of neuron apoptotic process (GO:0043525),5/19,0.0318995583422903,0.3962607919640274,0,0,3.311788468600808,11.40965147457454,SRPK2;CDK5;DDIT3;NF1;FOXO3,Hypo
315,GO_Biological_Process_2018,negative regulation of cell junction assembly (GO:1901889),5/19,0.0318995583422903,0.3962607919640274,0,0,3.311788468600808,11.40965147457454,SRC;ITGB1BP1;ARHGAP6;CORO1C;CLASP2,Hypo
316,GO_Biological_Process_2018,negative regulation of protein catabolic process (GO:0042177),8/39,0.0319905894502565,0.3962607919640274,0,0,2.394471944453673,8.242523097637358,RIC1;ADGRB1;AGAP2;TIMP2;DAB2IP;FLNA;TIMP3;PIN1,Hypo
317,GO_Biological_Process_2018,regulation of RNA metabolic process (GO:0051252),8/39,0.0319905894502565,0.3962607919640274,0,0,2.394471944453673,8.242523097637358,CLK1;MBNL1;MBNL2;SON;AHNAK;HNRNPF;AHNAK2;MBNL3,Hypo
318,GO_Biological_Process_2018,potassium ion transport (GO:0006813),11/61,0.032272923551178,0.398504845981474,0,0,2.0422898401237752,7.012256655289401,KCNJ4;KCNK6;KCNJ6;KCNJ10;KCND3;KCNJ12;KCNAB1;ATP1A2;KCNA6;KCNK3;KCNH1,Hypo
319,GO_Biological_Process_2018,regulation of protein phosphorylation (GO:0001932),35/261,0.0328305136749835,0.404123104268001,0,0,1.4414381108620808,4.924524695046676,SPTBN4;LRRK2;FLT4;ULK4;PELI2;PDGFA;STK4;RASGRP1;CAMKK2;CORO1C;ABL1;DVL2;PAK6;FYN;EPHB2;PDE8A;BRD4;PAK4;SEMA4D;TGFB3;IL34;AKTIP;NTRK3;DAB2IP;EIF2AK4;INHBA;AXIN2;F2;MTOR;RNF41;CLIP3;CCDC88C;FKBP8;PIN1;FAM20A,Hypo
320,GO_Biological_Process_2018,protein localization to cell periphery (GO:1990778),18/117,0.0344615049186892,0.4041420855996194,0,0,1.689346884999059,5.689572283661084,SPTBN4;SMURF1;STXBP1;KCNIP3;TTC7B;ANK3;ANK1;TSPAN15;CACNB3;TSPAN14;RAB15;MAP7;TSPAN5;RAPGEF2;FLNA;FGF13;RAMP1;CLASP2,Hypo
321,GO_Biological_Process_2018,positive regulation of cytoskeleton organization (GO:0051495),13/77,0.0344820620498785,0.4041420855996194,0,0,1.8861157718120805,6.351147874261968,TENM1;DYNC1H1;NUMA1;PRKCE;NTRK3;LMOD1;PDXP;BAIAP2;CTTN;CDK5;ABL1;CDC42EP1;PTK2B,Hypo
322,GO_Biological_Process_2018,regulation of cytokinesis (GO:0032465),13/77,0.0344820620498785,0.4041420855996194,0,0,1.8861157718120805,6.351147874261968,SH3GLB1;AHCTF1;PRKCE;PDXP;MYO19;CIT;KIF13A;PIN1;BIRC6;CALM3;BBS4;RAB11FIP4;MAP9,Hypo
323,GO_Biological_Process_2018,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),13/77,0.0344820620498785,0.4041420855996194,0,0,1.8861157718120805,6.351147874261968,SMAD3;SMURF1;TGFB1I1;HTRA3;LDLRAD4;LEMD2;SMAD7;PEG10;ADAMTSL2;PRDM16;PMEPA1;PIN1;BCL9L,Hypo
324,GO_Biological_Process_2018,metal ion transport (GO:0030001),16/101,0.0350908401281453,0.4041420855996194,0,0,1.7485248494433967,5.857235026581534,KCNJ4;KCNK6;KCNJ6;KCNJ10;KCND3;KCNJ12;TRAPPC10;NEDD4L;KCNAB1;ATP1A2;KCNA6;FGF13;SGK1;KCNK3;KCNH1;ASIC1,Hypo
325,GO_Biological_Process_2018,polyol metabolic process (GO:0019751),9/47,0.0356131045773531,0.4041420855996194,0,0,2.1978361669242656,7.329875052727957,INPP5B;INPP4A;ITPKB;SYNJ1;INPP1;IMPA2;ITPK1;PLCH2;NUDT3,Hypo
326,GO_Biological_Process_2018,regulation of organelle assembly (GO:1902115),9/47,0.0356131045773531,0.4041420855996194,0,0,2.1978361669242656,7.329875052727957,ATXN2;MTMR3;SRC;IFT140;STX18;VPS11;TRAPPC12;TBC1D14;UBQLN2,Hypo
327,GO_Biological_Process_2018,positive regulation of organelle assembly (GO:1902117),9/47,0.0356131045773531,0.4041420855996194,0,0,2.1978361669242656,7.329875052727957,SH3GLB1;DYNC1H1;NUMA1;CROCC;STX18;PIP4K2A;RAB3GAP2;ASAP1;BBS4,Hypo
328,GO_Biological_Process_2018,inositol phosphate metabolic process (GO:0043647),9/47,0.0356131045773531,0.4041420855996194,0,0,2.1978361669242656,7.329875052727957,INPP5B;INPP4A;ITPKB;SYNJ1;INPP1;IMPA2;ITPK1;PLCH2;NUDT3,Hypo
329,GO_Biological_Process_2018,lipoprotein transport (GO:0042953),3/8,0.0356247497586754,0.4041420855996194,0,0,5.560862865947612,18.543890947660675,UNC119B;LRP1;PRKCB,Hypo
330,GO_Biological_Process_2018,negative regulation of protein homooligomerization (GO:0032463),3/8,0.0356247497586754,0.4041420855996194,0,0,5.560862865947612,18.543890947660675,SRC;CRYAB;PEX14,Hypo
331,GO_Biological_Process_2018,positive regulation of steroid biosynthetic process (GO:0010893),3/8,0.0356247497586754,0.4041420855996194,0,0,5.560862865947612,18.543890947660675,NR1D1;FGF1;ABCG1,Hypo
332,GO_Biological_Process_2018,negative regulation of potassium ion transmembrane transporter activity (GO:1901017),3/8,0.0356247497586754,0.4041420855996194,0,0,5.560862865947612,18.543890947660675,STK39;NEDD4L;KCNAB1,Hypo
333,GO_Biological_Process_2018,regulation of microvillus organization (GO:0032530),3/8,0.0356247497586754,0.4041420855996194,0,0,5.560862865947612,18.543890947660675,CDHR2;TWF2;USH1C,Hypo
334,GO_Biological_Process_2018,plasma membrane to endosome transport (GO:0048227),3/8,0.0356247497586754,0.4041420855996194,0,0,5.560862865947612,18.543890947660675,RAB5C;SORT1;SGSM3,Hypo
335,GO_Biological_Process_2018,TORC1 signaling (GO:0038202),3/8,0.0356247497586754,0.4041420855996194,0,0,5.560862865947612,18.543890947660675,RPTOR;CARD11;MTOR,Hypo
336,GO_Biological_Process_2018,cellular response to epinephrine stimulus (GO:0071872),3/8,0.0356247497586754,0.4041420855996194,0,0,5.560862865947612,18.543890947660675,RYR2;KCNQ1;SLC9A1,Hypo
337,GO_Biological_Process_2018,cellular response to purine-containing compound (GO:0071415),3/8,0.0356247497586754,0.4041420855996194,0,0,5.560862865947612,18.543890947660675,RYR1;RYR2;RYR3,Hypo
338,GO_Biological_Process_2018,peripheral nervous system axon ensheathment (GO:0032292),3/8,0.0356247497586754,0.4041420855996194,0,0,5.560862865947612,18.543890947660675,ARHGEF10;CNTNAP1;NF1,Hypo
339,GO_Biological_Process_2018,actin filament network formation (GO:0051639),3/8,0.0356247497586754,0.4041420855996194,0,0,5.560862865947612,18.543890947660675,COBLL1;ACTN1;PLS1,Hypo
340,GO_Biological_Process_2018,negative regulation of cAMP-dependent protein kinase activity (GO:2000480),3/8,0.0356247497586754,0.4041420855996194,0,0,5.560862865947612,18.543890947660675,PRKAR1B;PRKAR1A;PKIG,Hypo
341,GO_Biological_Process_2018,bone resorption (GO:0045453),3/8,0.0356247497586754,0.4041420855996194,0,0,5.560862865947612,18.543890947660675,SRC;PTK2B;TPP1,Hypo
342,GO_Biological_Process_2018,lipoprotein localization (GO:0044872),3/8,0.0356247497586754,0.4041420855996194,0,0,5.560862865947612,18.543890947660675,UNC119B;LRP1;PRKCB,Hypo
343,GO_Biological_Process_2018,response to epinephrine (GO:0071871),3/8,0.0356247497586754,0.4041420855996194,0,0,5.560862865947612,18.543890947660675,RYR2;KCNQ1;SLC9A1,Hypo
344,GO_Biological_Process_2018,establishment of Golgi localization (GO:0051683),3/8,0.0356247497586754,0.4041420855996194,0,0,5.560862865947612,18.543890947660675,ARHGAP21;RIPOR1;COPG1,Hypo
345,GO_Biological_Process_2018,Schwann cell development (GO:0014044),3/8,0.0356247497586754,0.4041420855996194,0,0,5.560862865947612,18.543890947660675,ARHGEF10;CNTNAP1;NF1,Hypo
346,GO_Biological_Process_2018,negative chemotaxis (GO:0050919),6/26,0.0357048605708727,0.4041420855996194,0,0,2.7824074074074074,9.2722848975035,SEMA4A;SEMA7A;SEMA4D;SEMA4C;SLIT1;PDGFA,Hypo
347,GO_Biological_Process_2018,regulation of microtubule-based process (GO:0032886),6/26,0.0357048605708727,0.4041420855996194,0,0,2.7824074074074074,9.2722848975035,DIAPH1;PHLDB1;MEMO1;MAPT;CLASP1;CLASP2,Hypo
348,GO_Biological_Process_2018,regulation of actin filament-based process (GO:0032970),11/62,0.0359043701729871,0.4052358570527116,0,0,2.0021337054677466,6.660891134855661,ARHGAP44;LRP1;RHOJ;TWF2;ABL1;HIP1R;PDGFA;ARHGAP17;BAIAP2;GPM6B;MTOR,Hypo
349,GO_Biological_Process_2018,negative regulation of ERK1 and ERK2 cascade (GO:0070373),8/40,0.0366905206004959,0.4094163191086505,0,0,2.31951596292482,7.666549638416987,RGS14;TNIP1;WNK2;DAB2IP;TIMP3;PIN1;ITGB1BP1;EPHB2,Hypo
350,GO_Biological_Process_2018,phosphatidic acid biosynthetic process (GO:0006654),8/40,0.0366905206004959,0.4094163191086505,0,0,2.31951596292482,7.666549638416987,AGPAT5;GNPAT;GPAM;GPD1;PLA2G5;DDHD1;LCLAT1;AGPAT4,Hypo
351,GO_Biological_Process_2018,regulation of cholesterol biosynthetic process (GO:0045540),8/40,0.0366905206004959,0.4094163191086505,0,0,2.31951596292482,7.666549638416987,SREBF1;GPAM;FASN;SCAP;ERLIN2;FGF1;ACACB;ABCG1,Hypo
352,GO_Biological_Process_2018,positive regulation of epithelial to mesenchymal transition (GO:0010718),8/40,0.0366905206004959,0.4094163191086505,0,0,2.31951596292482,7.666549638416987,TIAM1;OLFM1;SMAD3;TGFB3;TGFB1I1;AXIN2;MTOR;BCL9L,Hypo
353,GO_Biological_Process_2018,neural tube closure (GO:0001843),7/33,0.0369307864556367,0.4097756840809948,0,0,2.4974860445781704,8.23848157697071,MTHFD1;DVL1;SEMA4C;DVL2;IFT122;TSC2;BBS4,Hypo
354,GO_Biological_Process_2018,platelet aggregation (GO:0070527),7/33,0.0369307864556367,0.4097756840809948,0,0,2.4974860445781704,8.23848157697071,PDGFRA;CSRP1;STXBP1;TYRO3;GNAS;FLNA;MYH9,Hypo
355,GO_Biological_Process_2018,cytosolic transport (GO:0016482),18/118,0.0370990882930195,0.4104868224331575,0,0,1.6723602484472049,5.509027059083107,MON2;ANKRD27;RIC1;SORT1;STX8;AKTIP;DENND2A;LMTK2;AP2A1;SYT7;BET1L;HEATR5B;VPS53;VTI1A;UBE2O;TBC1D23;CORO7;RAB6B,Hypo
356,GO_Biological_Process_2018,cellular response to insulin stimulus (GO:0032869),17/110,0.0376180797566373,0.4150633505921411,0,0,1.6981181405025338,5.570286841064233,HDAC5;IRS2;PIK3R1;IDE;TCIRG1;SORBS1;BAIAP2;SOGA1;RAB31;PKM;MARS;ATP6V1E1;PDK2;GPLD1;BCAR1;ATP6V0A1;PCK2,Hypo
357,GO_Biological_Process_2018,positive regulation of MAP kinase activity (GO:0043406),25/177,0.0377508147070699,0.4153644109808613,0,0,1.5292207792207793,5.010871469167133,TENM1;LRRK2;STK39;PDGFA;TGFA;MST1R;FGF1;STK4;RASGRP1;PIK3R6;INAVA;DVL2;MAP3K4;SASH1;DUSP5;NTRK3;DAB2IP;MAPK14;DUSP7;TRAF7;MADD;MAPKAPK2;KIT;MAP3K14;MAP3K11,Hypo
358,GO_Biological_Process_2018,negative regulation of protein depolymerization (GO:1901880),5/20,0.0392191032038194,0.4279336496394593,0,0,3.0908311910882604,10.009939080219082,MID1IP1;ARHGEF2;FGF13;CLASP1;CLASP2,Hypo
359,GO_Biological_Process_2018,eye morphogenesis (GO:0048592),5/20,0.0392191032038194,0.4279336496394593,0,0,3.0908311910882604,10.009939080219082,FBN2;RARG;COL5A1;NF1;IFT122,Hypo
360,GO_Biological_Process_2018,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),5/20,0.0392191032038194,0.4279336496394593,0,0,3.0908311910882604,10.009939080219082,DSTYK;SPRY4;PRKD2;FGFR2;SULF2,Hypo
361,GO_Biological_Process_2018,cellular response to oxygen-containing compound (GO:1901701),36/274,0.0400279792976324,0.4355530675507575,0,0,1.407655225099444,4.530083087914568,RARG;PXN;TWF2;PDXP;AKAP6;RORA;RYR3;CAMKK2;RPTOR;SBNO2;LARS;ABL2;SH3BP4;PTK2B;PDK2;UPF1;PDGFRA;WNT5B;NFKBIL1;PDE2A;WNT9B;DAB2IP;NR1D1;MAPK14;MTOR;SSH1;P2RX4;RRAGC;TNIP1;KCNQ1;RARA;RAPGEF2;MAPT;CPEB3;GPLD1;RAPGEF3,Hypo
362,GO_Biological_Process_2018,cytoplasmic microtubule organization (GO:0031122),9/48,0.0401806697799853,0.4360100778605018,0,0,2.141362501486149,6.883129778409804,DYNC1H1;NUMA1;KATNAL1;CCDC13;CCDC88C;TUBGCP6;FIGN;MAPT;CLASP1,Hypo
363,GO_Biological_Process_2018,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),4/14,0.040666956770098,0.4364772281128511,0,0,3.7081192189105856,11.874656234757868,KCNQ1;NOS1AP;SCN1B;SNTA1,Hypo
364,GO_Biological_Process_2018,regulation of gastrulation (GO:0010470),4/14,0.040666956770098,0.4364772281128511,0,0,3.7081192189105856,11.874656234757868,PHLDB1;TENM4;CLASP1;CLASP2,Hypo
365,GO_Biological_Process_2018,negative regulation of cation transmembrane transport (GO:1904063),4/14,0.040666956770098,0.4364772281128511,0,0,3.7081192189105856,11.874656234757868,EPO;STK39;NEDD4L;ATP1A2,Hypo
366,GO_Biological_Process_2018,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",4/14,0.040666956770098,0.4364772281128511,0,0,3.7081192189105856,11.874656234757868,TNRC6C;AGO2;CPEB3;TOB1,Hypo
367,GO_Biological_Process_2018,regulation of stress-activated MAPK cascade (GO:0032872),8/41,0.0418331323896907,0.4466719064298486,0,0,2.2491027681552915,7.138802004536191,PER1;ULK4;SEMA4C;DAB2IP;EPHB1;INAVA;MAP4K4;MAPK8IP1,Hypo
368,GO_Biological_Process_2018,negative regulation of cell-matrix adhesion (GO:0001953),6/27,0.0422472667767735,0.4466719064298486,0,0,2.6497648442092885,8.384427306579854,SRC;ITGB1BP1;ARHGAP6;CORO1C;CLASP2;AJAP1,Hypo
369,GO_Biological_Process_2018,microtubule polymerization (GO:0046785),6/27,0.0422472667767735,0.4466719064298486,0,0,2.6497648442092885,8.384427306579854,GOLGA2;TUBGCP6;MAPT;FGF13;CLASP1;CLASP2,Hypo
370,GO_Biological_Process_2018,telomere maintenance via telomere lengthening (GO:0010833),6/27,0.0422472667767735,0.4466719064298486,0,0,2.6497648442092885,8.384427306579854,STN1;RAD51;TNKS1BP1;SMG5;SMG6;WRAP53,Hypo
371,GO_Biological_Process_2018,negative regulation of microtubule polymerization or depolymerization (GO:0031111),6/27,0.0422472667767735,0.4466719064298486,0,0,2.6497648442092885,8.384427306579854,CLIP3;MID1IP1;ARHGEF2;FGF13;CLASP1;CLASP2,Hypo
372,GO_Biological_Process_2018,phosphatidylinositol-mediated signaling (GO:0048015),10/56,0.042523981952575,0.4466719064298486,0,0,2.0174809502465263,6.370573532679379,PDGFRA;PLEKHA1;PITPNM2;TYRO3;PI4KA;NF1;IRS2;PIK3R1;PIK3R6;KCNH1,Hypo
373,GO_Biological_Process_2018,negative regulation of cellular catabolic process (GO:0031330),10/56,0.042523981952575,0.4466719064298486,0,0,2.0174809502465263,6.370573532679379,GOLGA2;KDM4A;RIC1;LARS;TIMP2;DAB2IP;TIMP3;TBC1D14;GPLD1;MTOR,Hypo
374,GO_Biological_Process_2018,regulation of secretion by cell (GO:1903530),10/56,0.042523981952575,0.4466719064298486,0,0,2.0174809502465263,6.370573532679379,NSF;RHBDF1;RIMS1;RAB15;RHBDF2;CAMK2A;SCG5;P3H1;HAP1;LLGL1,Hypo
375,GO_Biological_Process_2018,keratan sulfate metabolic process (GO:0042339),7/34,0.0427321787344198,0.4476650320076586,0,0,2.40485312899106,7.58202826118495,B4GALT1;CHST1;ST3GAL6;GNS;ST3GAL2;CHST2;ST3GAL3,Hypo
376,GO_Biological_Process_2018,cellular protein modification process (GO:0006464),114/1001,0.043266854982115,0.4520640365372713,0,0,1.2014390874726442,3.772961357982755,FBXO21;GOLGA2;STK10;PPP4R1;TBK1;FNTB;MACROD1;PIM2;SBF1;BTRC;CSNK1G3;CDKL4;PRKCH;FBXW8;WSB2;PRKCB;PRKCE;LMTK2;P3H1;PRKCA;FBXO10;PRKAB1;BCR;MELK;PRKAR1B;MAPKAPK2;SIK3;SPARCL1;ULK1;PRKD2;ERG;CUL9;MTMR3;EPAS1;RPN1;STK39;KLHL11;STK4;FBXO44;PRKCZ;FBXO41;ABL1;ARSI;ABL2;ST3GAL6;ST3GAL2;MARK2;SRPK2;CDK18;ZBTB16;TMEM132A;EIF2AK4;FBXO31;SSH1;SRPK1;COPS4;PTPRE;MSRA;PTPRB;STK24;CDK5;WNK2;CDK14;MAP3K11;CDK16;PTPRT;PTPRS;LRRK2;PRKAG1;PTPN21;DSTYK;B3GALT1;DUSP5;KSR1;DUSP1;POMGNT1;DDOST;DUSP7;CTTNBP2NL;SDHAF2;GAN;RARA;VWA1;BIRC6;FAM20A;SGK1;CAMK2B;NIM1K;RNASEL;CTDP1;CAMK2A;PDXP;ALOX12B;CAMKK2;PTK2B;FYN;RBBP7;MAP4K5;MAP4K4;UBL4A;SERPIND1;KLHL2;FBXL18;KLHL3;CDC42BPB;FBXL16;CDC42BPA;SGPP2;MTOR;SPSB1;MGAT4A;ASB2;PTPN5;ENGASE,Hypo
377,GO_Biological_Process_2018,positive regulation of protein polymerization (GO:0032273),11/64,0.0440074384269991,0.4585854496400779,0,0,1.9263674136639195,6.016809438265973,TENM1;CLIP1;NUMA1;CTTN;PRKCE;LMOD1;CDC42EP1;PTK2B;MAPT;BAIAP2;CLASP1,Hypo
378,GO_Biological_Process_2018,positive regulation of stress-activated MAPK cascade (GO:0032874),13/80,0.0451887451340623,0.4672256584937735,0,0,1.801362315937093,5.578651970363552,FLT4;SEMA4C;DAB2IP;HMGB1;RASGRP1;INAVA;RASSF2;TRAF4;PTK2B;MAP3K4;SASH1;MAP3K11;ANKRD6,Hypo
379,GO_Biological_Process_2018,negative regulation of MAPK cascade (GO:0043409),13/80,0.0451887451340623,0.4672256584937735,0,0,1.801362315937093,5.578651970363552,RGS14;DUSP1;SPRY4;DAB2IP;SORL1;DUSP7;TNIP1;WNK2;NF1;TIMP3;PIN1;ITGB1BP1;EPHB2,Hypo
380,GO_Biological_Process_2018,regulation of cell cycle (GO:0051726),29/215,0.0454507118623741,0.4672256584937735,0,0,1.449894488197791,4.481807703757992,SRC;STK39;ADARB1;STK4;STK10;CCNB2;PAK6;USP51;E4F1;PIM2;MAP4K5;MAP3K4;MAP4K4;PAK4;SRPK2;AFAP1L2;ESX1;TSC2;INHBA;PER2;BOP1;NR4A1;SON;RBL1;STK24;MADD;RARA;MAP3K14;FGFR2,Hypo
381,GO_Biological_Process_2018,Golgi organization (GO:0007030),18/121,0.0458937566130373,0.4672256584937735,0,0,1.6233793644093348,5.002323694130667,SPTBN5;TMED9;FBXW8;ATP8B2;LRRK2;COG1;SYNE1;GOLGA2;ARHGAP21;NPLOC4;GORASP2;TRAPPC12;VTI1A;MYO18A;DYM;ARHGEF7;CLASP1;CLASP2,Hypo
382,GO_Biological_Process_2018,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),5/21,0.0474778651458389,0.4672256584937735,0,0,2.8974935732647813,8.83008753849075,RYR2;ATP1A2;CALM3;CACNA1C;SLC9A1,Hypo
383,GO_Biological_Process_2018,regulation of protein kinase activity (GO:0045859),21/147,0.0481912773311778,0.4672256584937735,0,0,1.5486435113184724,4.696381069224099,XRCC6;LRRC4;PRKAG1;TSC2;PRKAG2;RTN4RL2;PPM1F;EREG;CAMKK2;PREX1;RASSF2;DEPTOR;TRAF4;DVL1;NF1;FGFR1OP;RAPGEF2;PTK2B;ITGB1BP1;CEP85;TRIB1,Hypo
384,GO_Biological_Process_2018,protein localization to organelle (GO:0033365),15/97,0.0484676629693704,0.4672256584937735,0,0,1.6986197768954434,5.141481618765476,CEP68;TUB;RIPOR1;IFT140;LRRK2;IFT122;SORL1;ACAP2;OBSCN;CROCC;DVL1;LMNA;PACSIN2;DCP1A;BBS4,Hypo
385,GO_Biological_Process_2018,regulation of heart rate by cardiac conduction (GO:0086091),7/35,0.0490911853905116,0.4672256584937735,0,0,2.318836850231601,6.989149997127673,KCNH6;KCND3;KCNQ1;CACNA1D;CTNNA3;CACNA1C;SCN1B,Hypo
386,GO_Biological_Process_2018,regulation of mitotic spindle organization (GO:0060236),7/35,0.0490911853905116,0.4672256584937735,0,0,2.318836850231601,6.989149997127673,DYNC1H1;PARP3;NUMA1;PMEPA1;CCSAP;MAP9;CHMP5,Hypo
387,GO_Biological_Process_2018,regulation of sodium ion transport (GO:0002028),7/35,0.0490911853905116,0.4672256584937735,0,0,2.318836850231601,6.989149997127673,SPTBN4;PER1;AHCYL1;P2RX4;ANK3;SCN1B;SNTA1,Hypo
388,GO_Biological_Process_2018,neural crest cell development (GO:0014032),7/35,0.0490911853905116,0.4672256584937735,0,0,2.318836850231601,6.989149997127673,SEMA4A;SEMA7A;TCOF1;SEMA4D;PEF1;SEMA4C;CORO1C,Hypo
389,GO_Biological_Process_2018,positive regulation of protein catabolic process (GO:0045732),13/81,0.0492211423350657,0.4672256584937735,0,0,1.774772996446901,5.344608239547118,NSF;LRP1;SMURF1;UQCC2;DAB2IP;NEDD4L;FURIN;IDE;OAZ1;SORL1;RNF41;VPS11;GPLD1,Hypo
390,GO_Biological_Process_2018,primary neural tube formation (GO:0014020),6/28,0.0494950815737183,0.4672256584937735,0,0,2.5291806958473626,7.602418668937419,MTHFD1;SEMA4C;DVL2;IFT122;TSC2;BBS4,Hypo
391,GO_Biological_Process_2018,regulation of vasculature development (GO:1901342),6/28,0.0494950815737183,0.4672256584937735,0,0,2.5291806958473626,7.602418668937419,EGLN1;PLXND1;VASH2;NF1;VASH1;HTATIP2,Hypo
392,GO_Biological_Process_2018,negative regulation of circadian rhythm (GO:0042754),3/9,0.0496401651486708,0.4672256584937735,0,0,4.633795582948125,13.91507957644256,PER2;CIPC;CRY2,Hypo
393,GO_Biological_Process_2018,regulation of SNARE complex assembly (GO:0035542),3/9,0.0496401651486708,0.4672256584937735,0,0,4.633795582948125,13.91507957644256,ANKRD27;STXBP1;VPS11,Hypo
394,GO_Biological_Process_2018,positive regulation of long-term synaptic potentiation (GO:1900273),3/9,0.0496401651486708,0.4672256584937735,0,0,4.633795582948125,13.91507957644256,EIF2AK4;EPHB2;SHANK3,Hypo
395,GO_Biological_Process_2018,heterochromatin organization (GO:0070828),3/9,0.0496401651486708,0.4672256584937735,0,0,4.633795582948125,13.91507957644256,HP1BP3;TNRC18;BAHCC1,Hypo
396,GO_Biological_Process_2018,positive regulation of autophagosome assembly (GO:2000786),3/9,0.0496401651486708,0.4672256584937735,0,0,4.633795582948125,13.91507957644256,SH3GLB1;PIP4K2A;RAB3GAP2,Hypo
397,GO_Biological_Process_2018,protein localization to vacuole (GO:0072665),3/9,0.0496401651486708,0.4672256584937735,0,0,4.633795582948125,13.91507957644256,SH3GLB1;SZT2;SH3BP4,Hypo
398,GO_Biological_Process_2018,regulation of sequestering of calcium ion (GO:0051282),3/9,0.0496401651486708,0.4672256584937735,0,0,4.633795582948125,13.91507957644256,RYR2;DIAPH1;PTK2B,Hypo
399,GO_Biological_Process_2018,postsynaptic density organization (GO:0097106),3/9,0.0496401651486708,0.4672256584937735,0,0,4.633795582948125,13.91507957644256,NRXN2;SHANK3;SHANK2,Hypo
400,GO_Biological_Process_2018,glucose import (GO:0046323),3/9,0.0496401651486708,0.4672256584937735,0,0,4.633795582948125,13.91507957644256,SORT1;SLC2A13;SLC2A12,Hypo
401,GO_Biological_Process_2018,negative regulation of amyloid-beta formation (GO:1902430),3/9,0.0496401651486708,0.4672256584937735,0,0,4.633795582948125,13.91507957644256,BIN1;HAP1;SORL1,Hypo
402,GO_Biological_Process_2018,axonal transport of mitochondrion (GO:0019896),3/9,0.0496401651486708,0.4672256584937735,0,0,4.633795582948125,13.91507957644256,MAPT;HAP1;TRAK1,Hypo
403,GO_Biological_Process_2018,proton-transporting V-type ATPase complex assembly (GO:0070070),3/9,0.0496401651486708,0.4672256584937735,0,0,4.633795582948125,13.91507957644256,VMA21;TCIRG1;ATP6V0A1,Hypo
404,GO_Biological_Process_2018,histone H3-K4 trimethylation (GO:0080182),3/9,0.0496401651486708,0.4672256584937735,0,0,4.633795582948125,13.91507957644256,KMT2A;TET3;WDR61,Hypo
405,GO_Biological_Process_2018,positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter (GO:1901838),3/9,0.0496401651486708,0.4672256584937735,0,0,4.633795582948125,13.91507957644256,MARS;MTOR;SMARCA4,Hypo
406,GO_Biological_Process_2018,vacuolar proton-transporting V-type ATPase complex assembly (GO:0070072),3/9,0.0496401651486708,0.4672256584937735,0,0,4.633795582948125,13.91507957644256,VMA21;TCIRG1;ATP6V0A1,Hypo
407,GO_Biological_Process_2018,negative regulation of response to reactive oxygen species (GO:1901032),3/9,0.0496401651486708,0.4672256584937735,0,0,4.633795582948125,13.91507957644256,LRRK2;GPR37L1;PDE8A,Hypo
408,GO_Biological_Process_2018,actin filament reorganization (GO:0090527),3/9,0.0496401651486708,0.4672256584937735,0,0,4.633795582948125,13.91507957644256,FRY;FRYL;BCAR1,Hypo
409,GO_Biological_Process_2018,actin crosslink formation (GO:0051764),3/9,0.0496401651486708,0.4672256584937735,0,0,4.633795582948125,13.91507957644256,FLNA;BAIAP2;PLS1,Hypo
410,GO_Biological_Process_2018,long-chain fatty acid biosynthetic process (GO:0042759),3/9,0.0496401651486708,0.4672256584937735,0,0,4.633795582948125,13.91507957644256,ACOT7;ALOX12B;ALOXE3,Hypo
411,GO_Biological_Process_2018,regulation of morphogenesis of an epithelium (GO:1905330),3/9,0.0496401651486708,0.4672256584937735,0,0,4.633795582948125,13.91507957644256,FGF1;FGFR2;AJAP1,Hypo
412,GO_Biological_Process_2018,neurotrophin TRK receptor signaling pathway (GO:0048011),3/9,0.0496401651486708,0.4672256584937735,0,0,4.633795582948125,13.91507957644256,SORT1;HAP1;BCAR1,Hypo
413,GO_Biological_Process_2018,positive regulation of ion transmembrane transport (GO:0034767),3/9,0.0496401651486708,0.4672256584937735,0,0,4.633795582948125,13.91507957644256,WNK2;STK39;PDZK1,Hypo
414,GO_Biological_Process_2018,wound healing (GO:0042060),9/50,0.0504665353236412,0.4672256584937735,0,0,2.036679609454518,6.082431288433542,SCARB1;EPB41L4B;PDGFRA;SMAD3;NF1;PDGFA;SYT7;EREG;DCBLD2,Hypo
415,GO_Biological_Process_2018,neurogenesis (GO:0022008),9/50,0.0504665353236412,0.4672256584937735,0,0,2.036679609454518,6.082431288433542,DAGLA;BTBD3;SPOCK1;MAPT;HAP1;DAGLB;TRAK1;EPHB1;CIT,Hypo
416,GO_Biological_Process_2018,positive regulation of CREB transcription factor activity (GO:0032793),4/15,0.0512999936646151,0.4672256584937735,0,0,3.3708306082406803,10.011584831692312,OPRD1;CRTC3;CRTC1;PRKD2,Hypo
417,GO_Biological_Process_2018,positive regulation of potassium ion transmembrane transport (GO:1901381),4/15,0.0512999936646151,0.4672256584937735,0,0,3.3708306082406803,10.011584831692312,KCNQ1;NOS1AP;FLNA;AKAP6,Hypo
418,GO_Biological_Process_2018,ventricular cardiac muscle cell action potential (GO:0086005),4/15,0.0512999936646151,0.4672256584937735,0,0,3.3708306082406803,10.011584831692312,RYR2;KCNQ1;NEDD4L;SNTA1,Hypo
419,GO_Biological_Process_2018,intracellular lipid transport (GO:0032365),4/15,0.0512999936646151,0.4672256584937735,0,0,3.3708306082406803,10.011584831692312,MID1IP1;PRKAG2;THRSP;ACACB,Hypo
420,GO_Biological_Process_2018,mitochondrion localization (GO:0051646),4/15,0.0512999936646151,0.4672256584937735,0,0,3.3708306082406803,10.011584831692312,LRRK2;HAP1;TRAK1;MARK2,Hypo
421,GO_Biological_Process_2018,regulation of cell-substrate junction assembly (GO:0090109),4/15,0.0512999936646151,0.4672256584937735,0,0,3.3708306082406803,10.011584831692312,GPM6B;CLASP1;SLC9A1;CORO1C,Hypo
422,GO_Biological_Process_2018,ganglioside metabolic process (GO:0001573),4/15,0.0512999936646151,0.4672256584937735,0,0,3.3708306082406803,10.011584831692312,NEU4;NEU1;B4GALNT1;ST6GALNAC3,Hypo
423,GO_Biological_Process_2018,regulation of delayed rectifier potassium channel activity (GO:1902259),4/15,0.0512999936646151,0.4672256584937735,0,0,3.3708306082406803,10.011584831692312,NOS1AP;KCNAB1;AKAP6;ANK3,Hypo
424,GO_Biological_Process_2018,negative regulation of axon extension involved in axon guidance (GO:0048843),4/15,0.0512999936646151,0.4672256584937735,0,0,3.3708306082406803,10.011584831692312,SEMA4A;SEMA7A;SEMA4D;SEMA4C,Hypo
425,GO_Biological_Process_2018,positive regulation of cellular response to insulin stimulus (GO:1900078),4/15,0.0512999936646151,0.4672256584937735,0,0,3.3708306082406803,10.011584831692312,PTPN11;SORBS1;PIK3R1;PRKCZ,Hypo
426,GO_Biological_Process_2018,negative regulation of platelet activation (GO:0010544),4/15,0.0512999936646151,0.4672256584937735,0,0,3.3708306082406803,10.011584831692312,PDGFRA;PDGFA;CD9;F2,Hypo
427,GO_Biological_Process_2018,positive regulation of potassium ion transport (GO:0043268),4/15,0.0512999936646151,0.4672256584937735,0,0,3.3708306082406803,10.011584831692312,KCNQ1;NOS1AP;FLNA;AKAP6,Hypo
428,GO_Biological_Process_2018,cytoplasmic sequestering of protein (GO:0051220),4/15,0.0512999936646151,0.4672256584937735,0,0,3.3708306082406803,10.011584831692312,NFKBIL1;MXI1;FLNA;PKD1,Hypo
429,GO_Biological_Process_2018,regulation of peptide secretion (GO:0002791),4/15,0.0512999936646151,0.4672256584937735,0,0,3.3708306082406803,10.011584831692312,RHBDF1;RHBDF2;P3H1;LLGL1,Hypo
430,GO_Biological_Process_2018,establishment of protein localization to endoplasmic reticulum (GO:0072599),4/15,0.0512999936646151,0.4672256584937735,0,0,3.3708306082406803,10.011584831692312,RYR2;PMM1;RAB3GAP2;SRP68,Hypo
431,GO_Biological_Process_2018,transport along microtubule (GO:0010970),4/15,0.0512999936646151,0.4672256584937735,0,0,3.3708306082406803,10.011584831692312,DYNC1I2;ARHGAP21;COPG1;DYNLL2,Hypo
432,GO_Biological_Process_2018,positive regulation of cellular component organization (GO:0051130),16/106,0.0513604239979192,0.4672256584937735,0,0,1.6509249684017009,4.901410277968571,SH3GLB1;CAMK2B;TMED9;LRP1;TGFB3;CLSTN1;DAB2IP;NEDD4L;LRP4;ASAP1;CLIP3;EPHB2;EPHB1;SHANK3;LDLR;RAPGEF3,Hypo
433,GO_Biological_Process_2018,regulation of JNK cascade (GO:0046328),14/90,0.0530186281245638,0.4799933713496766,0,0,1.7102272727272727,5.023128965303334,FLT4;ULK4;DAB2IP;HMGB1;RASGRP1;MAPK8IP1;PER1;RASSF2;TRAF4;PTK2B;EPHB1;MAP3K11;ANKRD6;MAP4K4,Hypo
434,GO_Biological_Process_2018,positive regulation of cellular protein localization (GO:1903829),11/66,0.0532826797723017,0.4799933713496766,0,0,1.856111397627643,5.442385819906783,TENM1;RIPOR1;NUMA1;CROCC;TRAPPC12;FYN;MAPT;STX3;F2;PCNT;OAZ1,Hypo
435,GO_Biological_Process_2018,positive regulation of transcription from RNA polymerase II promoter (GO:0045944),97/848,0.0534030979059429,0.4799933713496766,0,0,1.2058058224939152,3.5328742268455606,CRTC3;PLXND1;CRTC1;WWC1;RORA;FGF1;TBK1;ZMIZ1;ZMIZ2;ZBTB38;EBF3;FOXP3;RUNX2;DDIT3;PRKD2;MAML3;ERG;KMT2D;PAXIP1;AKNA;KMT2A;CTBP2;EPAS1;WDR61;PIK3R1;FOXO3;GLIS1;SLC9A1;RAI1;SBNO2;PRDM16;CAMTA1;SCAP;BCL9L;XRCC6;SMAD3;TGFB3;NFATC2;ERLIN2;INHBA;NR1D1;SMARCA4;SMAD7;NR4A1;AGO2;PIN1;TCF4;LHX4;FGFR2;RARG;ELL;THRA;ARHGEF10L;TCF20;HMGB1;LITAF;PKD1;ZIC3;TEAD1;DLGAP5;NCOA1;SREBF1;TFEB;TET1;KLF15;ETV5;RBL1;ELF4;IRF2;TET3;RARA;ITGA6;ITGB1BP1;ARHGEF2;PPARD;HDAC5;RNASEL;NFIX;NUFIP1;HLF;DOT1L;RXRA;PLAGL1;MEF2D;BRD4;IL33;WWOX;DAB2IP;GRHL1;PER1;TNIP1;NFIC;ERCC2;TAF4;LPIN1;PFKM;SSBP3,Hypo
436,GO_Biological_Process_2018,positive regulation of DNA metabolic process (GO:0051054),13/82,0.0534945053464108,0.4799933713496766,0,0,1.748954381869468,5.121246830515569,PDGFRA;PARP3;STN1;EYA1;EPO;TGFB3;EYA2;PDGFA;HMGB1;EREG;BABAM2;RAD51;PRKD2,Hypo
437,GO_Biological_Process_2018,regulation of multicellular organismal development (GO:2000026),8/43,0.0534950723591033,0.4799933713496766,0,0,2.1203472120052966,6.208728051986669,TIAM1;PHLDB1;HMGB1;FGF1;CCSAP;CLASP1;CLASP2;SMAD7,Hypo
438,GO_Biological_Process_2018,negative regulation of protein metabolic process (GO:0051248),8/43,0.0534950723591033,0.4799933713496766,0,0,2.1203472120052966,6.208728051986669,ADGRB1;AGAP2;FLNA;PIN1;APBB1;LDLR;FOXP3;CRYAB,Hypo
439,GO_Biological_Process_2018,negative regulation of cell growth (GO:0030308),17/115,0.0538856694981141,0.4823992094387992,0,0,1.61103075477475,4.705644762628721,SMAD3;PTPRS;JADE1;ENO1;INHBA;SMARCA4;PPP1R9B;DCBLD2;DNAJB2;BCL6;FRZB;ERCC2;SH3BP4;APBB2;APBB1;RBBP7;FGF13,Hypo
440,GO_Biological_Process_2018,axonal transport (GO:0098930),7/36,0.0560189500902319,0.4961974180452827,0,0,2.238752728627966,6.452231444807228,BLOC1S5;DST;KIF1B;MAPT;HAP1;TRAK1;AP3B2,Hypo
441,GO_Biological_Process_2018,dephosphorylation (GO:0016311),18/124,0.0560850862501682,0.4961974180452827,0,0,1.5771709832415328,4.543648770663781,PTPRT;DUSP5;MTMR3;PTPRS;CTDP1;DUSP1;PTPN21;PDXP;HDHD2;SSH1;CTTNBP2NL;DUSP7;PTPRE;PTPRB;SDHAF2;BTRC;SBF1;PTPN5,Hypo
442,GO_Biological_Process_2018,carboxylic acid transport (GO:0046942),9/51,0.0562030278608258,0.4961974180452827,0,0,1.9880768381541176,5.723245078747557,SLC6A19;SLC25A29;SLC6A18;SLC7A8;SLC43A2;PSAP;SLC16A10;SLC7A1;SLC38A4,Hypo
443,GO_Biological_Process_2018,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),5/22,0.0566866814217763,0.4961974180452827,0,0,2.7269015575381825,7.826796457420239,PRKCB;TMEM204;DAB2IP;PRKD2;FAM129B,Hypo
444,GO_Biological_Process_2018,cellular response to nerve growth factor stimulus (GO:1990090),5/22,0.0566866814217763,0.4961974180452827,0,0,2.7269015575381825,7.826796457420239,ACAP2;NTRK3;RAPGEF2;MAPT;SH3GL2,Hypo
445,GO_Biological_Process_2018,regulation of transcription from RNA polymerase III promoter (GO:0006359),5/22,0.0566866814217763,0.4961974180452827,0,0,2.7269015575381825,7.826796457420239,RPTOR;TENM1;ELL;POLR3G;MTOR,Hypo
446,GO_Biological_Process_2018,regulation of ERBB signaling pathway (GO:1901184),5/22,0.0566866814217763,0.4961974180452827,0,0,2.7269015575381825,7.826796457420239,RHBDF1;RHBDF2;MVB12B;NRG2;EREG,Hypo
447,GO_Biological_Process_2018,negative regulation of GTPase activity (GO:0034260),5/22,0.0566866814217763,0.4961974180452827,0,0,2.7269015575381825,7.826796457420239,GPSM1;LRCH1;LRRK2;DAB2IP;SH3BP4,Hypo
448,GO_Biological_Process_2018,digestive system development (GO:0055123),5/22,0.0566866814217763,0.4961974180452827,0,0,2.7269015575381825,7.826796457420239,CLMP;KIT;ITGA6;PKD1;FGFR2,Hypo
449,GO_Biological_Process_2018,regulation of calcium ion transport into cytosol (GO:0010522),5/22,0.0566866814217763,0.4961974180452827,0,0,2.7269015575381825,7.826796457420239,DIAPH1;P2RX4;EPO;PTK2B;FYN,Hypo
450,GO_Biological_Process_2018,keratan sulfate biosynthetic process (GO:0018146),6/29,0.0574596714803828,0.4974365845301711,0,0,2.4190821256038646,6.910524035563994,B4GALT1;CHST1;ST3GAL6;ST3GAL2;CHST2;ST3GAL3,Hypo
451,GO_Biological_Process_2018,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),6/29,0.0574596714803828,0.4974365845301711,0,0,2.4190821256038646,6.910524035563994,AFAP1L2;HIP1;HIP1R;TGFA;HAP1;EREG,Hypo
452,GO_Biological_Process_2018,semaphorin-plexin signaling pathway (GO:0071526),6/29,0.0574596714803828,0.4974365845301711,0,0,2.4190821256038646,6.910524035563994,SEMA4A;SEMA7A;PLXND1;SEMA4D;SEMA4C;FLNA,Hypo
453,GO_Biological_Process_2018,tube closure (GO:0060606),6/29,0.0574596714803828,0.4974365845301711,0,0,2.4190821256038646,6.910524035563994,MTHFD1;SEMA4C;DVL2;IFT122;TSC2;BBS4,Hypo
454,GO_Biological_Process_2018,cardiac muscle cell action potential (GO:0086001),6/29,0.0574596714803828,0.4974365845301711,0,0,2.4190821256038646,6.910524035563994,KCND3;KCNQ1;ATP1A2;CACNA1D;CACNA1C;SCN1B,Hypo
455,GO_Biological_Process_2018,positive regulation of actin filament bundle assembly (GO:0032233),8/44,0.0600333042594842,0.5083144847129543,0,0,2.061334248769882,5.798235996903607,ARHGEF10;TGFB3;PXN;ABL1;ARHGEF10L;ITGB1BP1;PPM1F;RAPGEF3,Hypo
456,GO_Biological_Process_2018,positive regulation of cell migration (GO:0030335),29/221,0.0608892230979975,0.5083144847129543,0,0,1.40411352594135,3.929691234039422,RIPOR1;SEMA7A;SRC;PDGFA;FGF1;SYNE2;PPM1F;PTK2B;CLASP1;CLASP2;PDGFRA;SEMA4A;WNT5B;SEMA4D;PRKCE;NTRK3;SEMA4C;DAB2IP;PRKCA;MTOR;TIAM1;AGO2;RAPGEF2;FGFR1OP;ITGA6;ARHGEF2;ARHGEF7;DOCK1;BCAR1,Hypo
457,GO_Biological_Process_2018,regulation of cell proliferation (GO:0042127),85/740,0.0618777016422336,0.5083144847129543,0,0,1.2103841352352496,3.3680093222685503,TENM1;RARG;ATP8A2;EPO;TGFB1I1;FLT4;HP1BP3;CHD5;IRS2;ADARB1;TCIRG1;FGF1;PPP1R9B;SPEG;PIM2;TNFRSF4;TNS2;KCNH1;BOK;PDGFRA;GLP2R;TET1;P3H1;TSC2;LIFR;AXIN2;PPP2R5C;CGRRF1;FOXP3;CBFA2T3;RNF41;EREG;TIAM1;ADGRB1;KIT;RARA;RAPGEF2;BIRC6;TNFRSF25;ITGB1BP1;ARHGEF2;SLC25A5;SGK1;GPLD1;KMT2D;CTBP2;SRC;DOT1L;PDGFA;TGFA;MST1R;TOB1;FAM129B;DNAJB2;MNT;FRZB;NACC2;LMNA;MXI1;ABL1;SMYD2;ABL2;SH3BP4;PTK2B;FYN;STX3;IGFBP6;ZBTB7C;SRPK2;XRCC6;TGFB3;TNK2;TNFRSF9;NTRK3;IL34;DAB2IP;INHBA;MYO16;CHERP;BCL6;DLG3;WNK2;BHLHE40;FGFR1OP;FGFR2,Hypo
458,GO_Biological_Process_2018,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",4/16,0.0632970811540337,0.5083144847129543,0,0,3.0897567660157588,8.527469326836092,TNRC6C;AGO2;CPEB3;TOB1,Hypo
459,GO_Biological_Process_2018,glucose transmembrane transport (GO:1904659),4/16,0.0632970811540337,0.5083144847129543,0,0,3.0897567660157588,8.527469326836092,SLC45A1;SLC2A1;SLC2A5;PPARD,Hypo
460,GO_Biological_Process_2018,regulation of membrane depolarization (GO:0003254),4/16,0.0632970811540337,0.5083144847129543,0,0,3.0897567660157588,8.527469326836092,LRRK2;NEDD4L;SCN1B;SMAD7,Hypo
461,GO_Biological_Process_2018,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),4/16,0.0632970811540337,0.5083144847129543,0,0,3.0897567660157588,8.527469326836092,PRKCH;PRKCB;NFAM1;PRKD2,Hypo
462,GO_Biological_Process_2018,cellular response to pH (GO:0071467),4/16,0.0632970811540337,0.5083144847129543,0,0,3.0897567660157588,8.527469326836092,GPLD1;SLC9A1;RAB11FIP5;ASIC1,Hypo
463,GO_Biological_Process_2018,hexose transport (GO:0008645),4/16,0.0632970811540337,0.5083144847129543,0,0,3.0897567660157588,8.527469326836092,SLC2A13;SLC2A12;SLC2A2;SLC2A5,Hypo
464,GO_Biological_Process_2018,dendritic spine morphogenesis (GO:0060997),4/16,0.0632970811540337,0.5083144847129543,0,0,3.0897567660157588,8.527469326836092,EPHB2;EPHB1;SHANK3;SHANK2,Hypo
465,GO_Biological_Process_2018,positive regulation of cilium assembly (GO:0045724),4/16,0.0632970811540337,0.5083144847129543,0,0,3.0897567660157588,8.527469326836092,SEPT9;CROCC;HAP1;BBS4,Hypo
466,GO_Biological_Process_2018,positive regulation of triglyceride metabolic process (GO:0090208),4/16,0.0632970811540337,0.5083144847129543,0,0,3.0897567660157588,8.527469326836092,SREBF1;SCARB1;LDLR;GPLD1,Hypo
467,GO_Biological_Process_2018,activation of protein kinase A activity (GO:0034199),4/16,0.0632970811540337,0.5083144847129543,0,0,3.0897567660157588,8.527469326836092,ADCY9;PRKAR1B;PRKAR1A;ADCY3,Hypo
468,GO_Biological_Process_2018,regulation of membrane repolarization (GO:0060306),4/16,0.0632970811540337,0.5083144847129543,0,0,3.0897567660157588,8.527469326836092,CACNB3;KCNQ1;NEDD4L;AKAP6,Hypo
469,GO_Biological_Process_2018,regulation of glucose transport (GO:0010827),4/16,0.0632970811540337,0.5083144847129543,0,0,3.0897567660157588,8.527469326836092,CLIP3;PRKCB;SLC2A1;PRKAG2,Hypo
470,GO_Biological_Process_2018,epithelial cell development (GO:0002064),4/16,0.0632970811540337,0.5083144847129543,0,0,3.0897567660157588,8.527469326836092,WNT5B;RILPL2;RILPL1;SIPA1L3,Hypo
471,GO_Biological_Process_2018,regulation of histone H3-K4 methylation (GO:0051569),4/16,0.0632970811540337,0.5083144847129543,0,0,3.0897567660157588,8.527469326836092,PAXIP1;KMT2A;H2AFY;WDR61,Hypo
472,GO_Biological_Process_2018,positive regulation of JNK cascade (GO:0046330),12/76,0.0634940553936639,0.5083144847129543,0,0,1.7401315789473684,4.797210386390996,RASSF2;TRAF4;FLT4;DVL2;DAB2IP;PTK2B;HMGB1;RASGRP1;MAP3K4;SASH1;MAP3K11;ANKRD6,Hypo
473,GO_Biological_Process_2018,positive regulation of axonogenesis (GO:0050772),7/37,0.0635231746074414,0.5083144847129543,0,0,2.164007548464573,5.964763256219835,SEMA7A;GOLGA4;PLXND1;SEMA4D;TWF2;MAPT;NTN1,Hypo
474,GO_Biological_Process_2018,positive regulation of multi-organism process (GO:0043902),7/37,0.0635231746074414,0.5083144847129543,0,0,2.164007548464573,5.964763256219835,NLRP10;MVB12B;AGO2;PRKCA;INHBA;LHFPL2;SASH1,Hypo
475,GO_Biological_Process_2018,myelination (GO:0042552),7/37,0.0635231746074414,0.5083144847129543,0,0,2.164007548464573,5.964763256219835,EIF2B5;SLC8A3;ARHGEF10;CNTNAP1;NFASC;NF1;MBP,Hypo
476,GO_Biological_Process_2018,protein peptidyl-prolyl isomerization (GO:0000413),7/37,0.0635231746074414,0.5083144847129543,0,0,2.164007548464573,5.964763256219835,FKBP8;PIN1;CWC27;PPIB;FKBP6;NKTR;FKBP5,Hypo
477,GO_Biological_Process_2018,regulation of actin filament polymerization (GO:0030833),11/68,0.0637813649713124,0.5083144847129543,0,0,1.7907856283307546,4.928768927641362,TENM1;KANK1;PLEKHG2;CTTN;PRKCE;LMOD1;TWF2;HIP1R;CDC42EP1;PTK2B;BAIAP2,Hypo
478,GO_Biological_Process_2018,negative regulation of cellular protein catabolic process (GO:1903363),3/10,0.0659049748255424,0.5083144847129543,0,0,3.9716046665199207,10.800943115654707,RIC1;DAB2IP;FURIN,Hypo
479,GO_Biological_Process_2018,3'-UTR-mediated mRNA destabilization (GO:0061158),3/10,0.0659049748255424,0.5083144847129543,0,0,3.9716046665199207,10.800943115654707,ZC3H12D;UPF1;CPEB3,Hypo
480,GO_Biological_Process_2018,hair cell differentiation (GO:0035315),3/10,0.0659049748255424,0.5083144847129543,0,0,3.9716046665199207,10.800943115654707,ERCC2;USH1C;USH2A,Hypo
481,GO_Biological_Process_2018,positive regulation of glucose import in response to insulin stimulus (GO:2001275),3/10,0.0659049748255424,0.5083144847129543,0,0,3.9716046665199207,10.800943115654707,PTPN11;PIK3R1;SORBS1,Hypo
482,GO_Biological_Process_2018,epithelial cell morphogenesis (GO:0003382),3/10,0.0659049748255424,0.5083144847129543,0,0,3.9716046665199207,10.800943115654707,RILPL2;RILPL1;SIPA1L3,Hypo
483,GO_Biological_Process_2018,peptidyl-lysine dimethylation (GO:0018027),3/10,0.0659049748255424,0.5083144847129543,0,0,3.9716046665199207,10.800943115654707,SMYD2;SETMAR;ASH1L,Hypo
484,GO_Biological_Process_2018,neurotransmitter receptor transport (GO:0099637),3/10,0.0659049748255424,0.5083144847129543,0,0,3.9716046665199207,10.800943115654707,HIP1;CACNG2;CACNG4,Hypo
485,GO_Biological_Process_2018,glycerolipid metabolic process (GO:0046486),3/10,0.0659049748255424,0.5083144847129543,0,0,3.9716046665199207,10.800943115654707,DGKG;ALDH5A1;DGKZ,Hypo
486,GO_Biological_Process_2018,Rap protein signal transduction (GO:0032486),3/10,0.0659049748255424,0.5083144847129543,0,0,3.9716046665199207,10.800943115654707,SGSM3;RAPGEF2;RAPGEF3,Hypo
487,GO_Biological_Process_2018,endosomal vesicle fusion (GO:0034058),3/10,0.0659049748255424,0.5083144847129543,0,0,3.9716046665199207,10.800943115654707,VPS8;VPS11;VPS39,Hypo
488,GO_Biological_Process_2018,central nervous system projection neuron axonogenesis (GO:0021952),3/10,0.0659049748255424,0.5083144847129543,0,0,3.9716046665199207,10.800943115654707,SPTBN4;SZT2;EPHB1,Hypo
489,GO_Biological_Process_2018,positive regulation of reproductive process (GO:2000243),3/10,0.0659049748255424,0.5083144847129543,0,0,3.9716046665199207,10.800943115654707,AGO2;INHBA;LHFPL2,Hypo
490,GO_Biological_Process_2018,protein-cofactor linkage (GO:0018065),3/10,0.0659049748255424,0.5083144847129543,0,0,3.9716046665199207,10.800943115654707,POP5;SDHAF2;GAD1,Hypo
491,GO_Biological_Process_2018,ectoderm development (GO:0007398),3/10,0.0659049748255424,0.5083144847129543,0,0,3.9716046665199207,10.800943115654707,AMER2;SMURF1;ITGA6,Hypo
492,GO_Biological_Process_2018,telomere maintenance via recombination (GO:0000722),3/10,0.0659049748255424,0.5083144847129543,0,0,3.9716046665199207,10.800943115654707,RAD51;ERCC1;NSMCE2,Hypo
493,GO_Biological_Process_2018,regulation of phospholipase activity (GO:0010517),3/10,0.0659049748255424,0.5083144847129543,0,0,3.9716046665199207,10.800943115654707,LRP1;PLA2G5;FGFR2,Hypo
494,GO_Biological_Process_2018,stress fiber assembly (GO:0043149),3/10,0.0659049748255424,0.5083144847129543,0,0,3.9716046665199207,10.800943115654707,SRC;KCTD13;SORBS1,Hypo
495,GO_Biological_Process_2018,negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),3/10,0.0659049748255424,0.5083144847129543,0,0,3.9716046665199207,10.800943115654707,PMEPA1;LDLRAD4;SMAD7,Hypo
496,GO_Biological_Process_2018,cellular response to leucine starvation (GO:1990253),3/10,0.0659049748255424,0.5083144847129543,0,0,3.9716046665199207,10.800943115654707,LARS;EIF2AK4;MTOR,Hypo
497,GO_Biological_Process_2018,neurotransmitter receptor internalization (GO:0099590),3/10,0.0659049748255424,0.5083144847129543,0,0,3.9716046665199207,10.800943115654707,CACNG2;DNM1;CACNG4,Hypo
498,GO_Biological_Process_2018,positive regulation of vacuole organization (GO:0044090),3/10,0.0659049748255424,0.5083144847129543,0,0,3.9716046665199207,10.800943115654707,SH3GLB1;PIP4K2A;RAB3GAP2,Hypo
499,GO_Biological_Process_2018,negative regulation of sodium ion transmembrane transport (GO:1902306),3/10,0.0659049748255424,0.5083144847129543,0,0,3.9716046665199207,10.800943115654707,PRKCE;STK39;NEDD4L,Hypo
500,GO_Biological_Process_2018,positive regulation of transcription from RNA polymerase III promoter (GO:0045945),3/10,0.0659049748255424,0.5083144847129543,0,0,3.9716046665199207,10.800943115654707,RPTOR;ELL;MTOR,Hypo
501,GO_Biological_Process_2018,contractile actin filament bundle assembly (GO:0030038),3/10,0.0659049748255424,0.5083144847129543,0,0,3.9716046665199207,10.800943115654707,SRC;KCTD13;SORBS1,Hypo
502,GO_Biological_Process_2018,aspartate family amino acid metabolic process (GO:0009066),3/10,0.0659049748255424,0.5083144847129543,0,0,3.9716046665199207,10.800943115654707,MSRA;MTHFD1;SMS,Hypo
503,GO_Biological_Process_2018,astrocyte development (GO:0014002),3/10,0.0659049748255424,0.5083144847129543,0,0,3.9716046665199207,10.800943115654707,EIF2B5;NF1;MAPT,Hypo
504,GO_Biological_Process_2018,regulation of cation transmembrane transport (GO:1904062),6/30,0.0661467540805172,0.5083144847129543,0,0,2.318158436213992,6.295838878931935,KCNIP3;CACNA1D;KCNAB1;KCNAB2;PDZK1;SNTA1,Hypo
505,GO_Biological_Process_2018,positive regulation of cation channel activity (GO:2001259),6/30,0.0661467540805172,0.5083144847129543,0,0,2.318158436213992,6.295838878931935,AKAP6;CALM3;ANK3;HAP1;EPHB2;SHANK3,Hypo
506,GO_Biological_Process_2018,protein localization to lysosome (GO:0061462),6/30,0.0661467540805172,0.5083144847129543,0,0,2.318158436213992,6.295838878931935,SZT2;LARS;SH3BP4;CACNG2;SORL1;CACNG4,Hypo
507,GO_Biological_Process_2018,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),6/30,0.0661467540805172,0.5083144847129543,0,0,2.318158436213992,6.295838878931935,KANK1;ERCC2;LRP4;RAPGEF2;ITGB1BP1;CORO1C,Hypo
508,GO_Biological_Process_2018,acylglycerol catabolic process (GO:0046464),6/30,0.0661467540805172,0.5083144847129543,0,0,2.318158436213992,6.295838878931935,DAGLA;ABHD16A;ABHD2;FABP12;DAGLB;MGLL,Hypo
509,GO_Biological_Process_2018,negative regulation of transferase activity (GO:0051348),6/30,0.0661467540805172,0.5083144847129543,0,0,2.318158436213992,6.295838878931935,CDKN1C;SRC;ABL1;IRS2;MAPT;SMAD7,Hypo
510,GO_Biological_Process_2018,positive regulation of intracellular signal transduction (GO:1902533),57/479,0.0662939117798818,0.5083144847129543,0,0,1.25780939004514,3.4132635255914594,HIP1;SLC44A2;FLT4;WWC1;CHD5;IRS2;HMGB1;FGF1;LITAF;RPTOR;TBK1;TRIM5;PIM2;EPHB2;TNFRSF4;EPHB1;BOK;PDGFRA;KSR1;PRKCB;UNC5B;PLEKHG5;LMTK2;NRG2;GPR37L1;EREG;TRAF7;RRAGC;NOS1AP;KIT;TYRO3;RAPGEF2;PRKD2;TNFRSF25;ITGB1BP1;RBCK1;SRC;PELI2;PDGFA;ALOX12B;MST1R;PIK3R1;CXXC5;INAVA;FLNA;FYN;SASH1;BRD4;KL;SEMA4D;NTRK3;DAB2IP;PTPN11;S100B;P2RX4;MAP3K14;FGFR2,Hypo
511,GO_Biological_Process_2018,regulation of protein oligomerization (GO:0032459),5/23,0.0668461292412567,0.5083144847129543,0,0,2.57526421022565,6.967021623369182,SH3GLB1;OPRD1;TMC8;IDE;SORL1,Hypo
512,GO_Biological_Process_2018,glycolytic process (GO:0006096),5/23,0.0668461292412567,0.5083144847129543,0,0,2.57526421022565,6.967021623369182,HK3;PKM;HKDC1;PFKM;HK1,Hypo
513,GO_Biological_Process_2018,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),5/23,0.0668461292412567,0.5083144847129543,0,0,2.57526421022565,6.967021623369182,RYR2;ATP1A2;AKAP6;CALM3;CACNA1C,Hypo
514,GO_Biological_Process_2018,negative regulation of transcription factor import into nucleus (GO:0042992),5/23,0.0668461292412567,0.5083144847129543,0,0,2.57526421022565,6.967021623369182,NFKBIL1;RAB23;MXI1;NF1;PKD1,Hypo
515,GO_Biological_Process_2018,regulation of axon extension involved in axon guidance (GO:0048841),5/23,0.0668461292412567,0.5083144847129543,0,0,2.57526421022565,6.967021623369182,SEMA4A;SEMA7A;SEMA4D;DSCAM;SEMA4C,Hypo
516,GO_Biological_Process_2018,cellular response to catecholamine stimulus (GO:0071870),5/23,0.0668461292412567,0.5083144847129543,0,0,2.57526421022565,6.967021623369182,RYR2;LRRK2;KCNQ1;ABL1;SLC9A1,Hypo
517,GO_Biological_Process_2018,positive regulation of mRNA catabolic process (GO:0061014),5/23,0.0668461292412567,0.5083144847129543,0,0,2.57526421022565,6.967021623369182,TNRC6C;UPF1;AGO2;CPEB3;TOB1,Hypo
518,GO_Biological_Process_2018,hexose metabolic process (GO:0019318),8/45,0.0670518646391535,0.5088965217988934,0,0,2.005511175439085,5.419470507913317,ALDH5A1;KCNJ11;PMM1;GAA;CHST15;CHST1;IRS2;PPARD,Hypo
519,GO_Biological_Process_2018,cellular response to peptide hormone stimulus (GO:0071375),16/110,0.0676997072513367,0.5128252824288762,0,0,1.5803207991374948,4.255287816091032,HDAC5;SRC;ADCY3;IRS2;PIK3R1;SORBS1;NR4A1;RAB31;ADCY9;PKM;PRKAR1B;PRKAR1A;GNB2;MARS;GPLD1;PCK2,Hypo
520,GO_Biological_Process_2018,embryonic organ development (GO:0048568),9/53,0.0688969578521068,0.5208927389240863,0,0,1.8974989461851903,5.076081507308506,RARG;KMT2A;KIT;RARA;PDGFA;IFT122;TBC1D23;TEAD1;FGFR2,Hypo
521,GO_Biological_Process_2018,actin cytoskeleton reorganization (GO:0031532),10/61,0.0695963819999652,0.5251726986549103,0,0,1.819183343440469,4.848201281669785,CTTN;KIT;MYH9;FLNA;CDC42BPB;FRY;CDC42BPA;ANTXR1;BCAR1;FRYL,Hypo
522,GO_Biological_Process_2018,regulation of neuron projection development (GO:0010975),17/119,0.0700200529432566,0.5263530315715419,0,0,1.547508191067425,4.114783437190283,CAMK2B;KANK1;PTPRS;ULK4;TWF2;DAB2IP;P3H1;RTN4RL2;SSH1;NCS1;ERCC2;ABL2;RAPGEF2;SPOCK1;PTK2B;SCN1B;MARK2,Hypo
523,GO_Biological_Process_2018,brain development (GO:0007420),17/119,0.0700200529432566,0.5263530315715419,0,0,1.547508191067425,4.114783437190283,RARG;SLC6A17;THRA;MAP1S;PTPN11;GRIN2B;ATXN1;COL4A1;NF1;RARA;RAPGEF2;TBC1D23;HAP1;SHANK3;DSCAML1;BBS4;SHANK2,Hypo
524,GO_Biological_Process_2018,potassium ion import (GO:0010107),7/38,0.0716080799120771,0.536243777136258,0,0,2.094084637989142,5.5211533311279615,KCNJ4;KCNJ6;KCNJ10;KCNJ11;KCNJ12;KCNJ9;ATP1A2,Hypo
525,GO_Biological_Process_2018,membrane depolarization during action potential (GO:0086010),7/38,0.0716080799120771,0.536243777136258,0,0,2.094084637989142,5.5211533311279615,CACNA1I;ATP1A2;CACNA1D;CACNA1C;CACNA1E;SCN1B;TPCN1,Hypo
526,GO_Biological_Process_2018,"negative regulation of transcription, DNA-templated (GO:0045892)",92/813,0.0720662207038198,0.5386505566458188,0,0,1.1900915036973228,3.1301427925547736,CDKN1C;RARG;TENM2;THRA;TCF25;EPO;WWC1;WWC2;BHLHE41;UBE2D1;HMGB1;ENO1;LIMD1;BCL7A;TRPS1;BTRC;TNFRSF4;PIAS4;ZHX2;SMARCC2;H2AFY;ZBTB38;ESX1;USP2;FOXP3;CBFA2T3;RUNX2;EREG;DKK3;NCOR2;NFX1;DDIT3;KAT6A;IRF2;CRY2;RARA;ERF;PPARD;MCPH1;HDAC5;NFIX;CTBP2;TSHZ3;CIPC;NEDD4L;FOXO3;CXXC5;GLIS1;PPM1F;FAM129B;SBNO2;MNT;ATXN1;RXRA;NACC2;MXI1;PRDM16;SMYD2;HIVEP1;FLNA;E4F1;APBB1;E2F6;MTA3;ATF7IP;SPEN;WWOX;KDM4A;XRCC6;SMAD3;SEMA4D;ZBTB16;PDE2A;DAB2IP;FOXN3;NR1D1;PEX14;GATAD2A;SMARCA4;SMAD7;PER2;PER1;NR6A1;SP2;CDK5;BCL6;NFIC;BHLHE40;FOSB;MAFK;CPEB3;FGFR2,Hypo
527,GO_Biological_Process_2018,calcium ion transmembrane transport (GO:0070588),13/86,0.0730852721017716,0.5438295849074215,0,0,1.6527535165946492,4.32381542711299,CACNA1D;CACNA1C;PKD1;TRPC4AP;GRIN2B;RYR3;SLC8A2;SLC8A3;CACNB3;P2RX4;CACNG2;SLC25A23;CACNG4,Hypo
528,GO_Biological_Process_2018,regulation of peptidyl-serine phosphorylation (GO:0033135),13/86,0.0730852721017716,0.5438295849074215,0,0,1.6527535165946492,4.32381542711299,OPRD1;TENM1;SPTBN4;NTRK3;STK4;PPM1F;SMAD7;RPTOR;RASSF2;TBK1;TNKS1BP1;PRKD2;RAPGEF3,Hypo
529,GO_Biological_Process_2018,regulation of protein kinase B signaling (GO:0051896),22/163,0.0732255485294868,0.5438295849074215,0,0,1.4493319796356787,3.788859452045061,PDGFRA;KL;HIP1;PLEKHA1;SRC;PPP2R5B;TSC2;PDGFA;IRS2;PTPN11;MST1R;PIK3R1;PPP2R5C;NRG2;FGF1;EREG;RNF41;DDIT3;KIT;ITGB1BP1;FYN;FGFR2,Hypo
530,GO_Biological_Process_2018,enzyme linked receptor protein signaling pathway (GO:0007167),17/120,0.0745107812713064,0.5438295849074215,0,0,1.532398455039955,3.9793498525017914,PTPRT;SHC2;TRIO;SRC;TNK2;FLT4;NTRK3;LIFR;PTPRF;AKAP2;ABL1;BLNK;ABL2;PTK2B;FYN;PAG1;BCAR1,Hypo
531,GO_Biological_Process_2018,pyruvate metabolic process (GO:0006090),8/46,0.0745544573429056,0.5438295849074215,0,0,1.952626158599382,5.069457726471593,HK3;PDHA1;PKM;HKDC1;HOGA1;PFKM;HK1;PCK2,Hypo
532,GO_Biological_Process_2018,cytoskeleton-dependent cytokinesis (GO:0061640),11/70,0.075540858015991,0.5438295849074215,0,0,1.7298887247489096,4.468443740706613,SEPT8;SEPT9;SEPT11;RTKN;BIN3;SON;SPIRE1;ANK3;MYH10;BBS4;CIT,Hypo
533,GO_Biological_Process_2018,protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787),11/70,0.075540858015991,0.5438295849074215,0,0,1.7298887247489096,4.468443740706613,RMND5B;RNF144B;SPSB1;AREL1;SMURF1;BTBD3;UBR4;RNF19B;KLHL11;NEDD4L;UBE3B,Hypo
534,GO_Biological_Process_2018,secondary alcohol metabolic process (GO:1902652),6/31,0.0755564722000848,0.5438295849074215,0,0,2.2253086419753085,5.747693894329304,ABCA1;RXRA;SOAT1;LDLRAP1;ABCG1;PPARD,Hypo
535,GO_Biological_Process_2018,liver development (GO:0001889),6/31,0.0755564722000848,0.5438295849074215,0,0,2.2253086419753085,5.747693894329304,RARG;ZIC3;NF1;RARA;PCK2;CCDC40,Hypo
536,GO_Biological_Process_2018,cell morphogenesis involved in differentiation (GO:0000904),9/54,0.0758630381746498,0.5438295849074215,0,0,1.8552292632663576,4.784312891936458,LAMA5;UNK;RILPL2;RILPL1;ACTN1;TYRO3;ANTXR1;SIPA1L3;SRCIN1,Hypo
537,GO_Biological_Process_2018,glycosphingolipid metabolic process (GO:0006687),9/54,0.0758630381746498,0.5438295849074215,0,0,1.8552292632663576,4.784312891936458,NEU4;SMPD4;CERK;ST8SIA1;PSAP;NEU1;ARSI;B4GALNT1;ST6GALNAC3,Hypo
538,GO_Biological_Process_2018,sensory perception (GO:0007600),9/54,0.0758630381746498,0.5438295849074215,0,0,1.8552292632663576,4.784312891936458,OPRD1;P2RX4;USH1G;USH1C;GNAS;ALOXE3;USH2A;RETREG1;BBS4,Hypo
539,GO_Biological_Process_2018,regulation of heart contraction (GO:0008016),14/95,0.0766219779122753,0.5438295849074215,0,0,1.6042113049688806,4.121012421335533,RYR1;RYR2;AHCYL1;KCNJ11;KCNJ12;ATP1A2;ATP2B1;RYR3;SLC8A2;SMAD7;SLC8A3;P2RX4;KCNQ1;CALM3,Hypo
540,GO_Biological_Process_2018,positive regulation of epidermal cell differentiation (GO:0045606),4/17,0.0766248843928964,0.5438295849074215,0,0,2.8519250533639022,7.326120312742382,PRKCH;H2AFY;NUMA1;KDF1,Hypo
541,GO_Biological_Process_2018,"mRNA cis splicing, via spliceosome (GO:0045292)",4/17,0.0766248843928964,0.5438295849074215,0,0,2.8519250533639022,7.326120312742382,SFSWAP;WBP11;SNRNP200;DCPS,Hypo
542,GO_Biological_Process_2018,positive regulation of dendrite extension (GO:1903861),4/17,0.0766248843928964,0.5438295849074215,0,0,2.8519250533639022,7.326120312742382,RIMS1;SMURF1;NEDD4L;RASAL1,Hypo
543,GO_Biological_Process_2018,peptidyl-lysine trimethylation (GO:0018023),4/17,0.0766248843928964,0.5438295849074215,0,0,2.8519250533639022,7.326120312742382,SETD4;KMT2A;TET3;WDR61,Hypo
544,GO_Biological_Process_2018,regulation of protein localization to membrane (GO:1905475),4/17,0.0766248843928964,0.5438295849074215,0,0,2.8519250533639022,7.326120312742382,CDK5;STX8;FYN;LDLRAP1,Hypo
545,GO_Biological_Process_2018,response to purine-containing compound (GO:0014074),4/17,0.0766248843928964,0.5438295849074215,0,0,2.8519250533639022,7.326120312742382,RYR1;RYR2;P2RX4;KCNJ11,Hypo
546,GO_Biological_Process_2018,neurotrophin signaling pathway (GO:0038179),4/17,0.0766248843928964,0.5438295849074215,0,0,2.8519250533639022,7.326120312742382,SORT1;RAPGEF2;HAP1;BCAR1,Hypo
547,GO_Biological_Process_2018,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),4/17,0.0766248843928964,0.5438295849074215,0,0,2.8519250533639022,7.326120312742382,RYR2;ATP1A2;CALM3;CACNA1C,Hypo
548,GO_Biological_Process_2018,synaptic vesicle transport (GO:0048489),4/17,0.0766248843928964,0.5438295849074215,0,0,2.8519250533639022,7.326120312742382,CDK5;SYNJ1;KIF5C;SYT7,Hypo
549,GO_Biological_Process_2018,septin ring organization (GO:0031106),4/17,0.0766248843928964,0.5438295849074215,0,0,2.8519250533639022,7.326120312742382,SEPT8;SEPT9;SEPT11;RTKN,Hypo
550,GO_Biological_Process_2018,positive regulation of transcription of Notch receptor target (GO:0007221),4/17,0.0766248843928964,0.5438295849074215,0,0,2.8519250533639022,7.326120312742382,PLXND1;WWC1;MAML3;DLGAP5,Hypo
551,GO_Biological_Process_2018,membrane depolarization during cardiac muscle cell action potential (GO:0086012),4/17,0.0766248843928964,0.5438295849074215,0,0,2.8519250533639022,7.326120312742382,ATP1A2;CACNA1D;CACNA1C;SCN1B,Hypo
552,GO_Biological_Process_2018,regulation of cellular protein catabolic process (GO:1903362),4/17,0.0766248843928964,0.5438295849074215,0,0,2.8519250533639022,7.326120312742382,RIC1;UQCC2;DAB2IP;VPS11,Hypo
553,GO_Biological_Process_2018,negative regulation of axon guidance (GO:1902668),4/17,0.0766248843928964,0.5438295849074215,0,0,2.8519250533639022,7.326120312742382,SEMA4A;SEMA7A;SEMA4D;SEMA4C,Hypo
554,GO_Biological_Process_2018,microtubule nucleation (GO:0007020),4/17,0.0766248843928964,0.5438295849074215,0,0,2.8519250533639022,7.326120312742382,GOLGA2;TUBGCP6;CLASP1;CLASP2,Hypo
555,GO_Biological_Process_2018,dendritic spine organization (GO:0097061),5/24,0.0779470268020286,0.5443853520801253,0,0,2.4395886889460154,6.225161463812914,FYN;EPHB2;SHANK3;EPHB1;SHANK2,Hypo
556,GO_Biological_Process_2018,negative regulation of cytoskeleton organization (GO:0051494),5/24,0.0779470268020286,0.5443853520801253,0,0,2.4395886889460154,6.225161463812914,KANK1;HIP1R;TWF2;SHANK3;CLASP1,Hypo
557,GO_Biological_Process_2018,regulation of chromosome organization (GO:0033044),5/24,0.0779470268020286,0.5443853520801253,0,0,2.4395886889460154,6.225161463812914,UPF1;SETMAR;MAPT;SMG5;SMG6,Hypo
558,GO_Biological_Process_2018,sensory perception of pain (GO:0019233),5/24,0.0779470268020286,0.5443853520801253,0,0,2.4395886889460154,6.225161463812914,OPRD1;P2RX4;RETREG1;EPHB1;ALOXE3,Hypo
559,GO_Biological_Process_2018,regulation of AMPA receptor activity (GO:2000311),5/24,0.0779470268020286,0.5443853520801253,0,0,2.4395886889460154,6.225161463812914,CACNG2;CNIH3;SHANK3;SHANK2;CACNG4,Hypo
560,GO_Biological_Process_2018,positive regulation of dephosphorylation (GO:0035306),5/24,0.0779470268020286,0.5443853520801253,0,0,2.4395886889460154,6.225161463812914,PPP1R16B;PIN1;SYMPK;CALM3;SPPL3,Hypo
561,GO_Biological_Process_2018,Golgi to plasma membrane protein transport (GO:0043001),5/24,0.0779470268020286,0.5443853520801253,0,0,2.4395886889460154,6.225161463812914,NSF;GOLGA4;RAB31;KIF13A;ANK3,Hypo
562,GO_Biological_Process_2018,negative regulation of developmental growth (GO:0048640),5/24,0.0779470268020286,0.5443853520801253,0,0,2.4395886889460154,6.225161463812914,PTPRS;WWC1;WWC2;ERCC2;FGF13,Hypo
563,GO_Biological_Process_2018,ATP generation from ADP (GO:0006757),5/24,0.0779470268020286,0.5443853520801253,0,0,2.4395886889460154,6.225161463812914,HK3;PKM;HKDC1;PFKM;HK1,Hypo
564,GO_Biological_Process_2018,regulation of cellular response to stress (GO:0080135),15/104,0.0795712351443111,0.5547453012981264,0,0,1.5644107656127515,3.9596841859944334,CAMK2B;NUP188;NUP133;CAMK2A;VASH1;EIF2AK4;MTOR;RPTOR;BAG3;MAPKAPK2;ABL1;USP51;MAPT;CRYAB;CAMK2G,Hypo
565,GO_Biological_Process_2018,Golgi to plasma membrane transport (GO:0006893),7/39,0.0802744112306399,0.5576735552689431,0,0,2.028531909418425,5.116574906785523,NSF;ARFGEF2;GOLGA4;RAB31;KIF13A;ANK3;LLGL1,Hypo
566,GO_Biological_Process_2018,cellular response to amino acid starvation (GO:0034198),7/39,0.0802744112306399,0.5576735552689431,0,0,2.028531909418425,5.116574906785523,SH3GLB1;SZT2;RRAGC;LARS;EIF2AK4;ITFG2;MTOR,Hypo
567,GO_Biological_Process_2018,regulation of transcription from RNA polymerase II promoter (GO:0006357),160/1478,0.0817542363680029,0.5606140534844097,0,0,1.134747925161706,2.8414515273333567,CRTC3;CRTC1;EPO;WWC1;WWC2;UBE2D1;RORA;ENO1;FGF1;TBK1;ZMIZ1;ZMIZ2;GTF2I;SMARCC2;PRKCB;ZBTB38;ESX1;USP2;EBF3;RFX1;FOXP3;RUNX2;PRKAR1A;DDIT3;ERF;PRKD2;MAML3;ERG;KMT2D;AKNA;KMT2A;CTBP2;TSHZ3;EPAS1;TSHZ1;TCF7;TGFA;NEDD4L;WDR61;PIK3R1;FOXO3;GTF2E1;GLIS1;SLC9A1;RAI1;SBNO2;PRDM16;SMYD2;HIVEP1;CAMTA1;E4F1;BCL9L;XRCC6;SMAD3;TGFB3;SMURF1;ZBTB16;PDE2A;NFATC2;INHBA;NR1D1;MED13L;SMARCA4;SMAD7;NR4A1;SP2;BCL6;AGO2;BHLHE40;PIN1;TCF4;MAFK;LHX4;CPEB3;BRWD1;FGFR2;RARG;TENM2;THRA;TCF25;BHLHE41;CHD5;TCF20;HMGB1;MED16;CHD2;LITAF;PKD1;ZMYM1;ZIC3;TRPS1;TEAD1;HTATIP2;NCOA1;BRD3;SREBF1;ZHX2;KLF13;H2AFY;BUD31;TFEB;TET1;KLF15;ETV5;NCOR2;RBL1;ELF4;NFX1;KIT;IRF2;CRY2;TET3;RARA;ITGA6;ITGB1BP1;ARHGEF2;PPARD;MCPH1;HDAC5;RNASEL;CTDP1;NFIX;NUFIP1;HLF;DOT1L;FOXK1;CXXC5;TRAK1;TOB1;MNT;RXRA;PLAGL1;MXI1;UBN1;APBB1;MEF2D;E2F6;BRD4;SPEN;IL33;WWOX;SEMA4D;KCNIP3;DAB2IP;MAPK14;GRHL1;GATAD2A;TARBP1;PER2;PER1;NR6A1;TNIP1;TEF;NFIC;ERCC2;FOSB;TAF4;LPIN1;PFKM;SSBP3,Hypo
568,GO_Biological_Process_2018,regulation of primary metabolic process (GO:0080090),19/139,0.0824407953432702,0.5606140534844097,0,0,1.4701795270153637,3.6690901079960456,ABCA1;NCOA1;ALAS1;H2AFY;LRP1;CHD9;G0S2;IRS2;NR1D1;GRHL1;OAZ1;NCOR2;RXRA;OPA3;PSAP;RGL1;LDLR;BBS4;PPARD,Hypo
569,GO_Biological_Process_2018,negative regulation of protein modification process (GO:0031400),10/63,0.082917607737127,0.5606140534844097,0,0,1.7503404007002528,4.358186290017314,PPP1R16B;LRRK2;NTRK3;FKBP8;DAB2IP;P3H1;MAPT;EPHB2;SNTA1;CORO1C,Hypo
570,GO_Biological_Process_2018,regulation of axonogenesis (GO:0050770),9/55,0.083244830087956,0.5606140534844097,0,0,1.814797392648344,4.511530518721675,OLFM1;PLXND1;CTTN;ERCC2;ABL1;ZSWIM8;LRP4;MARK2;SSH1,Hypo
571,GO_Biological_Process_2018,regulated exocytosis (GO:0045055),20/148,0.0836438087027834,0.5606140534844097,0,0,1.4509391191709844,3.6000525405652475,ABCC4;TEX264;TGFB3;BRPF3;ACTN1;STXBP1;PDGFA;ARHGAP17;LHFPL2;SGPP2;RIMS1;SYNGR1;RIMS3;RAB31;LAMP2;PSAP;TIMP3;FLNA;CD9;RAB11FIP5,Hypo
572,GO_Biological_Process_2018,positive regulation of extracellular matrix organization (GO:1903055),3/11,0.0842557805693756,0.5606140534844097,0,0,3.4749614791987677,8.596700600976762,SMAD3;CLASP1;CLASP2,Hypo
573,GO_Biological_Process_2018,regulation of long-term neuronal synaptic plasticity (GO:0048169),3/11,0.0842557805693756,0.5606140534844097,0,0,3.4749614791987677,8.596700600976762,CAMK2B;SYNGR1;SHANK3,Hypo
574,GO_Biological_Process_2018,brain morphogenesis (GO:0048854),3/11,0.0842557805693756,0.5606140534844097,0,0,3.4749614791987677,8.596700600976762,SHANK3;SHANK2;BBS4,Hypo
575,GO_Biological_Process_2018,phosphatidylinositol dephosphorylation (GO:0046856),3/11,0.0842557805693756,0.5606140534844097,0,0,3.4749614791987677,8.596700600976762,INPP5B;MTMR3;SYNJ1,Hypo
576,GO_Biological_Process_2018,negative regulation of peptide secretion (GO:0002792),3/11,0.0842557805693756,0.5606140534844097,0,0,3.4749614791987677,8.596700600976762,RHBDF1;RHBDF2;SERGEF,Hypo
577,GO_Biological_Process_2018,negative regulation of amyloid precursor protein catabolic process (GO:1902992),3/11,0.0842557805693756,0.5606140534844097,0,0,3.4749614791987677,8.596700600976762,BIN1;HAP1;SORL1,Hypo
578,GO_Biological_Process_2018,stress granule assembly (GO:0034063),3/11,0.0842557805693756,0.5606140534844097,0,0,3.4749614791987677,8.596700600976762,DYNC1H1;ATXN2;MAPT,Hypo
579,GO_Biological_Process_2018,regulation of short-term neuronal synaptic plasticity (GO:0048172),3/11,0.0842557805693756,0.5606140534844097,0,0,3.4749614791987677,8.596700600976762,SYNGR1;PPFIA3;SLC8A2,Hypo
580,GO_Biological_Process_2018,positive regulation of glycoprotein biosynthetic process (GO:0010560),3/11,0.0842557805693756,0.5606140534844097,0,0,3.4749614791987677,8.596700600976762,GOLGA2;SOAT1;RAMP1,Hypo
581,GO_Biological_Process_2018,regulation of RNA polymerase II transcriptional preinitiation complex assembly (GO:0045898),3/11,0.0842557805693756,0.5606140534844097,0,0,3.4749614791987677,8.596700600976762,ATF7IP;THRA;HMGB1,Hypo
582,GO_Biological_Process_2018,negative regulation of potassium ion transport (GO:0043267),3/11,0.0842557805693756,0.5606140534844097,0,0,3.4749614791987677,8.596700600976762,STK39;PTK2B;NEDD4L,Hypo
583,GO_Biological_Process_2018,negative regulation of heart contraction (GO:0045822),3/11,0.0842557805693756,0.5606140534844097,0,0,3.4749614791987677,8.596700600976762,SPTBN4;GRK2;RNLS,Hypo
584,GO_Biological_Process_2018,establishment of synaptic vesicle localization (GO:0097480),3/11,0.0842557805693756,0.5606140534844097,0,0,3.4749614791987677,8.596700600976762,CDK5;SYNJ1;KIF5C,Hypo
585,GO_Biological_Process_2018,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),3/11,0.0842557805693756,0.5606140534844097,0,0,3.4749614791987677,8.596700600976762,WNK2;ANK3;SLC9A1,Hypo
586,GO_Biological_Process_2018,hemidesmosome assembly (GO:0031581),3/11,0.0842557805693756,0.5606140534844097,0,0,3.4749614791987677,8.596700600976762,LAMB3;ITGA6;PLEC,Hypo
587,GO_Biological_Process_2018,regulation of lipid kinase activity (GO:0043550),3/11,0.0842557805693756,0.5606140534844097,0,0,3.4749614791987677,8.596700600976762,RBL1;PIK3R1;F2,Hypo
588,GO_Biological_Process_2018,regulation of hydrogen peroxide-induced cell death (GO:1903205),3/11,0.0842557805693756,0.5606140534844097,0,0,3.4749614791987677,8.596700600976762,LRRK2;GPR37L1;PDE8A,Hypo
589,GO_Biological_Process_2018,Golgi ribbon formation (GO:0090161),3/11,0.0842557805693756,0.5606140534844097,0,0,3.4749614791987677,8.596700600976762,GOLGA2;MYO18A;VTI1A,Hypo
590,GO_Biological_Process_2018,cell-substrate junction assembly (GO:0007044),3/11,0.0842557805693756,0.5606140534844097,0,0,3.4749614791987677,8.596700600976762,LAMB3;ITGA6;PLEC,Hypo
591,GO_Biological_Process_2018,regulation of ventricular cardiac muscle cell action potential (GO:0098911),3/11,0.0842557805693756,0.5606140534844097,0,0,3.4749614791987677,8.596700600976762,RYR2;CTNNA3;CACNA1C,Hypo
592,GO_Biological_Process_2018,divalent metal ion transport (GO:0070838),13/88,0.0844245366205659,0.5607896285807913,0,0,1.6085011185682327,3.976049413401293,RYR1;MRS2;RYR2;CAMK2A;CACNA1D;CACNA1C;CACNA1E;RYR3;PANX1;CACNA1I;CACNB3;FYN;RAMP1,Hypo
593,GO_Biological_Process_2018,regulation of glutamate receptor signaling pathway (GO:1900449),6/32,0.0856835470010617,0.5662877376462792,0,0,2.1396011396011394,5.257202097012377,PTK2B;CACNG2;CNIH3;SHANK3;CACNG4;SHANK2,Hypo
594,GO_Biological_Process_2018,cyclic-nucleotide-mediated signaling (GO:0019935),6/32,0.0856835470010617,0.5662877376462792,0,0,2.1396011396011394,5.257202097012377,KSR1;PDE2A;ADCY3;RAPGEF2;AKAP6;RAPGEF3,Hypo
595,GO_Biological_Process_2018,positive regulation of transcription factor import into nucleus (GO:0042993),6/32,0.0856835470010617,0.5662877376462792,0,0,2.1396011396011394,5.257202097012377,SMAD3;BAG3;FLNA;PIK3R1;SPPL3;CHERP,Hypo
596,GO_Biological_Process_2018,regulation of ERK1 and ERK2 cascade (GO:0070372),31/247,0.0863914464840825,0.5700098956462328,0,0,1.3337724123289525,3.266230722023153,SEMA7A;RGS14;FLT4;PDGFA;MST1R;PLA2G5;HMGB1;PRKCZ;RASGRP1;DSTYK;TIMP3;PTK2B;EPHB2;EPHB1;PDE8A;PDGFRA;NTRK3;DAB2IP;LMTK2;PRKCA;PTPN11;TNIP1;WNK2;KIT;TYRO3;RAPGEF2;PIN1;ACKR3;PRKD2;ITGB1BP1;FGFR2,Hypo
597,GO_Biological_Process_2018,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),12/80,0.086636339819657,0.5706698035946977,0,0,1.6374066654525588,4.005155524306733,PPP1R16B;PDGFRA;SEMA4D;UNC5B;KIT;PPP2R5B;DAB2IP;PIP4K2A;TSC2;PDGFA;PPP2R5C;PIP5K1C,Hypo
598,GO_Biological_Process_2018,positive regulation of neuron projection development (GO:0010976),14/97,0.0877104321280893,0.576780287399906,0,0,1.565381360151349,3.80969121130393,CAMK2B;PLXND1;SMURF1;TWF2;DAB2IP;P3H1;NEDD4L;RASAL1;RIMS1;ABL2;RAPGEF2;PTK2B;SCN1B;MARK2,Hypo
599,GO_Biological_Process_2018,regulation of neuron death (GO:1901214),11/72,0.0885835573897754,0.5786881328424193,0,0,1.6729850607462018,4.054996282405261,TBK1;CDK5;RILPL1;LRRK2;FAIM2;FYN;ATP13A2;MAPT;EPHB1;SORL1;GRIN2B,Hypo
600,GO_Biological_Process_2018,negative regulation of TOR signaling (GO:0032007),7/40,0.0895194839657056,0.5786881328424193,0,0,1.9669520734883577,4.746843431582889,PREX1;SZT2;DEPTOR;SH3BP4;TSC2;UBR2;ITFG2,Hypo
601,GO_Biological_Process_2018,peptidyl-proline modification (GO:0018208),7/40,0.0895194839657056,0.5786881328424193,0,0,1.9669520734883577,4.746843431582889,FKBP8;PIN1;CWC27;PPIB;FKBP6;NKTR;FKBP5,Hypo
602,GO_Biological_Process_2018,neuron migration (GO:0001764),7/40,0.0895194839657056,0.5786881328424193,0,0,1.9669520734883577,4.746843431582889,NHSL1;CDK5;SPOCK1;RAPGEF2;NAV1;FGF13;MARK2,Hypo
603,GO_Biological_Process_2018,regulation of intracellular transport (GO:0032386),7/40,0.0895194839657056,0.5786881328424193,0,0,1.9669520734883577,4.746843431582889,DYNC1H1;NUMA1;WWC1;LRRK2;ATP13A2;HAP1;CRYAB,Hypo
604,GO_Biological_Process_2018,regulation of spindle assembly (GO:0090169),5/25,0.0899710757530414,0.5786881328424193,0,0,2.3174807197943443,5.581112435233727,DYNC1H1;NUMA1;PMEPA1;CCSAP;CHMP5,Hypo
605,GO_Biological_Process_2018,lamellipodium organization (GO:0097581),5/25,0.0899710757530414,0.5786881328424193,0,0,2.3174807197943443,5.581112435233727,ABLIM1;ABLIM2;CTTN;KIT;ARHGEF7,Hypo
606,GO_Biological_Process_2018,negative regulation of insulin receptor signaling pathway (GO:0046627),5/25,0.0899710757530414,0.5786881328424193,0,0,2.3174807197943443,5.581112435233727,KANK1;PTPRE;PRKCB;TSC2;PRKCZ,Hypo
607,GO_Biological_Process_2018,negative regulation of epithelial to mesenchymal transition (GO:0010719),5/25,0.0899710757530414,0.5786881328424193,0,0,2.3174807197943443,5.581112435233727,SDHAF2;DAB2IP;LDLRAD4;OVOL2;SMAD7,Hypo
608,GO_Biological_Process_2018,positive regulation of embryonic development (GO:0040019),5/25,0.0899710757530414,0.5786881328424193,0,0,2.3174807197943443,5.581112435233727,PHLDB1;TENM4;CLASP1;FAM129B;CLASP2,Hypo
609,GO_Biological_Process_2018,regulation of voltage-gated calcium channel activity (GO:1901385),5/25,0.0899710757530414,0.5786881328424193,0,0,2.3174807197943443,5.581112435233727,CACNB1;CACNB3;CACNB4;AHNAK;NOS1AP,Hypo
610,GO_Biological_Process_2018,neutral amino acid transport (GO:0015804),5/25,0.0899710757530414,0.5786881328424193,0,0,2.3174807197943443,5.581112435233727,SLC7A5;SLC6A19;SLC43A2;SLC6A17;SLC7A8,Hypo
611,GO_Biological_Process_2018,regulation of neuron apoptotic process (GO:0043523),13/89,0.090487291015261,0.5786881328424193,0,0,1.587248322147651,3.8134368993072743,SRPK2;UNC5B;TGFB3;AGAP2;FAIM2;FOXO3;CDK5;DDIT3;ERCC2;TYRO3;NF1;PTK2B;RETREG1,Hypo
612,GO_Biological_Process_2018,regulation of epithelial cell migration (GO:0010632),8/48,0.0910147881128973,0.5786881328424193,0,0,1.854788877445932,4.445434227969336,SRC;PRKCE;DAB2IP;DOCK1;PPM1F;CLASP1;CORO1C;CLASP2,Hypo
613,GO_Biological_Process_2018,regulation of adherens junction organization (GO:1903391),4/18,0.0912326302348673,0.5786881328424193,0,0,2.648069299662311,6.340385286129587,GPM6B;CLASP1;SLC9A1;CORO1C,Hypo
614,GO_Biological_Process_2018,regulation of spindle organization (GO:0090224),4/18,0.0912326302348673,0.5786881328424193,0,0,2.648069299662311,6.340385286129587,DYNC1H1;PARP3;NUMA1;MAP9,Hypo
615,GO_Biological_Process_2018,regulation of dephosphorylation (GO:0035303),4/18,0.0912326302348673,0.5786881328424193,0,0,2.648069299662311,6.340385286129587,PPP1R16B;MTMR3;SMG5;SMG6,Hypo
616,GO_Biological_Process_2018,positive regulation of actin cytoskeleton reorganization (GO:2000251),4/18,0.0912326302348673,0.5786881328424193,0,0,2.648069299662311,6.340385286129587,CDK5;NTRK3;ABL1;BAIAP2,Hypo
617,GO_Biological_Process_2018,regulation of dendrite extension (GO:1903859),4/18,0.0912326302348673,0.5786881328424193,0,0,2.648069299662311,6.340385286129587,RIMS1;SMURF1;NEDD4L;RASAL1,Hypo
618,GO_Biological_Process_2018,regulation of smooth muscle cell migration (GO:0014910),4/18,0.0912326302348673,0.5786881328424193,0,0,2.648069299662311,6.340385286129587,LRP1;PDGFA;TRIB1;SORL1,Hypo
619,GO_Biological_Process_2018,membrane lipid metabolic process (GO:0006643),4/18,0.0912326302348673,0.5786881328424193,0,0,2.648069299662311,6.340385286129587,ALOX12B;ST3GAL6;TEX2;ALOXE3,Hypo
620,GO_Biological_Process_2018,receptor localization to synapse (GO:0097120),4/18,0.0912326302348673,0.5786881328424193,0,0,2.648069299662311,6.340385286129587,DLG3;KIF5C;CACNG2;CACNG4,Hypo
621,GO_Biological_Process_2018,positive regulation of binding (GO:0051099),12/81,0.0931433332671866,0.5840286064384842,0,0,1.6135863956566607,3.830034089750954,GPSM1;TIAM1;LRP1;LRRK2;AKTIP;RARA;HIP1R;RAPGEF2;HMGB1;STK4;PKD1;SPPL3,Hypo
622,GO_Biological_Process_2018,positive regulation of cell growth (GO:0030307),14/98,0.0936146941936995,0.5840286064384842,0,0,1.546659779614325,3.6633687349388726,SEMA7A;SEMA4D;SMURF1;TWF2;NEDD4L;RASAL1;AKAP6;NTN1;RPTOR;RIMS1;GOLGA4;FGFR1OP;MAPT;HDGFL2,Hypo
623,GO_Biological_Process_2018,cellular response to starvation (GO:0009267),15/107,0.0961451227730145,0.5840286064384842,0,0,1.51314459049545,3.5436280710499224,SH3GLB1;SREBF1;RIPOR1;SZT2;MTMR3;LRRK2;EIF2AK4;ITFG2;MTOR;RPTOR;RRAGC;STK24;LARS;MARS;LAMP2,Hypo
624,GO_Biological_Process_2018,glycogen metabolic process (GO:0005977),6/33,0.0965174996761127,0.5840286064384842,0,0,2.0602423411065387,4.816910344171122,PER2;AGL;GAA;PRKAG2;PGM2;NR1D1,Hypo
625,GO_Biological_Process_2018,negative regulation of neurogenesis (GO:0050768),6/33,0.0965174996761127,0.5840286064384842,0,0,2.0602423411065387,4.816910344171122,SOX3;DISP3;NF1;DTX1;EIF2AK4;SORL1,Hypo
626,GO_Biological_Process_2018,oligosaccharide biosynthetic process (GO:0009312),6/33,0.0965174996761127,0.5840286064384842,0,0,2.0602423411065387,4.816910344171122,GALNT13;B4GALT1;GALNT2;B3GALT1;ST3GAL2;GALNT9,Hypo
627,GO_Biological_Process_2018,embryonic organ morphogenesis (GO:0048562),6/33,0.0965174996761127,0.5840286064384842,0,0,2.0602423411065387,4.816910344171122,FBN2;RYR2;PDGFRA;RARG;DSCAML1;FGFR2,Hypo
628,GO_Biological_Process_2018,regulation of neurotransmitter receptor activity (GO:0099601),6/33,0.0965174996761127,0.5840286064384842,0,0,2.0602423411065387,4.816910344171122,PTK2B;CACNG2;CNIH3;SHANK3;CACNG4;SHANK2,Hypo
629,GO_Biological_Process_2018,glycolipid metabolic process (GO:0006664),10/65,0.0976919602094897,0.5840286064384842,0,0,1.6865042174320526,3.922700896933104,NEU4;SMPD4;CERK;PSAP;NEU1;ARSI;ST3GAL6;B4GALNT1;ST6GALNAC3;ST3GAL2,Hypo
630,GO_Biological_Process_2018,fatty acid catabolic process (GO:0009062),10/65,0.0976919602094897,0.5840286064384842,0,0,1.6865042174320526,3.922700896933104,HADHA;SLC25A17;BDH2;ACADL;ABHD16A;ABHD2;HSD17B4;AIG1;LPIN1;PPARD,Hypo
631,GO_Biological_Process_2018,transcription initiation from RNA polymerase II promoter (GO:0006367),21/160,0.0983646106979886,0.5840286064384842,0,0,1.4027881893552032,3.2531698797491058,RARG;THRA;RORA;ESRRG;NR1D1;MED16;GTF2E1;RUNX2;NR4A1;MED24;RXRA;NR6A1;ERCC2;RARA;TCF4;MAML3;TAF4;TEAD1;RXRG;GTF2I;PPARD,Hypo
632,GO_Biological_Process_2018,Ras protein signal transduction (GO:0007265),28/223,0.0985828317617467,0.5840286064384842,0,0,1.333920328717415,3.090504188504648,RIPOR1;SHC2;RTKN;RAB5C;ARHGAP6;NTN1;RAB23;PAK6;RALGDS;RAB6B;PAK4;DBNL;KSR1;MAPK14;CNKSR2;TIAM1;RAB31;RAB15;SGSM3;RHOJ;MAPKAPK2;ARHGEF3;ELMO1;NF1;RAPGEF2;CDC42EP1;ARHGEF1;RAPGEF3,Hypo
633,GO_Biological_Process_2018,regulation of cholesterol metabolic process (GO:0090181),7/41,0.099337266978852,0.5840286064384842,0,0,1.908994580848294,4.408316111035544,SREBF1;ACADL;GPAM;FASN;SCAP;LDLRAP1;ACACB,Hypo
634,GO_Biological_Process_2018,negative regulation of cell projection organization (GO:0031345),7/41,0.099337266978852,0.5840286064384842,0,0,1.908994580848294,4.408316111035544,KANK1;PTPRS;ERCC2;SPOCK1;FYN;RTN4RL2;GRIN2B,Hypo
635,GO_Biological_Process_2018,regulation of substrate adhesion-dependent cell spreading (GO:1900024),7/41,0.099337266978852,0.5840286064384842,0,0,1.908994580848294,4.408316111035544,KANK1;ABL1;FLNA;ITGB1BP1;ARHGEF7;DOCK1;CORO1C,Hypo
636,GO_Biological_Process_2018,regulation of cellular metabolic process (GO:0031323),7/41,0.099337266978852,0.5840286064384842,0,0,1.908994580848294,4.408316111035544,FASN;ACACB;PDK2;ABCG1;TBC1D16;SSH1;RNF41,Hypo
637,GO_Biological_Process_2018,"retrograde transport, endosome to Golgi (GO:0042147)",12/82,0.0999402776752935,0.5840286064384842,0,0,1.5904467049977886,3.663089009624602,RIC1;HEATR5B;VPS53;TRAPPC10;DENND2A;SGSM2;VTI1A;TBC1D14;UBE2O;TBC1D23;RAB6B;BET1L,Hypo
638,GO_Biological_Process_2018,cilium assembly (GO:0060271),35/288,0.1019792843625478,0.5840286064384842,0,0,1.2856582627271695,2.9351392756542936,UNC119B;DYNC1I2;FBF1;CEP164;ASAP1;RPGR;SEPT8;SEPT9;ABLIM1;RAB23;FLNA;CFAP46;NPHP4;KIF3C;PCNT;TNPO1;NINL;BBS4;CLASP1;DYNC1H1;ABCC4;SEPT11;IFT140;CCDC13;ODF2;RAB3IP;IFT122;DYNLL2;RILPL2;TTLL3;RILPL1;FGFR1OP;DZIP1;MAPRE2;CCDC40,Hypo
639,GO_Biological_Process_2018,regulation of signal transduction (GO:0009966),29/233,0.1022224091014866,0.5840286064384842,0,0,1.3206305947678394,3.0118358898812323,SRC;FLT4;PXN;DTX1;RORA;MST1R;RGS3;TRIM5;TMEM204;IGFBP6;EPHB2;EPHB1;SASH1;GIT2;PDGFRA;NTRK3;TSC2;LMTK2;LIFR;FOXP3;KIF26A;KIT;TYRO3;VWA2;BIRC6;ITGB1BP1;LLGL1;MGLL;FGFR2,Hypo
640,GO_Biological_Process_2018,protein stabilization (GO:0050821),20/152,0.1027496595992023,0.5840286064384842,0,0,1.4066572460354845,3.20079192924332,HIP1;USP27X;STXBP4;USP2;HPS4;HIP1R;P3H1;PIK3R1;STK4;CPN2;SMAD7;RASSF2;LAMP2;DVL1;PIN1;FLNA;PIM2;PPIB;CRYAB;CCT5,Hypo
641,GO_Biological_Process_2018,regulation of p38MAPK cascade (GO:1900744),5/26,0.1028916104005052,0.5840286064384842,0,0,2.2070020810380706,5.018897462942009,PER1;ULK4;DAB2IP;MAP3K4;SASH1,Hypo
642,GO_Biological_Process_2018,regulation of supramolecular fiber organization (GO:1902903),5/26,0.1028916104005052,0.5840286064384842,0,0,2.2070020810380706,5.018897462942009,MAP1S;MAP1A;ABL1;MAPT;SSH1,Hypo
643,GO_Biological_Process_2018,negative regulation of cellular response to insulin stimulus (GO:1900077),5/26,0.1028916104005052,0.5840286064384842,0,0,2.2070020810380706,5.018897462942009,KANK1;PTPRE;PRKCB;TSC2;PRKCZ,Hypo
644,GO_Biological_Process_2018,mitotic spindle organization (GO:0007052),11/74,0.1029162382833442,0.5840286064384842,0,0,1.619694327791285,3.682925494629329,GOLGA2;ARHGEF10;DYNC1H1;BCCIP;FLNA;TUBGCP6;MAP4;PCNT;CLASP1;MAP9;CLASP2,Hypo
645,GO_Biological_Process_2018,positive regulation of signal transduction (GO:0009967),26/206,0.103386901760408,0.5840286064384842,0,0,1.3415915915915917,3.0444429426792907,KANK1;CTBP2;PIK3R1;FGF1;PRKCZ;RIMS1;DSTYK;ZMIZ1;DVL1;TSPAN5;FLNA;PTK2B;SASH1;PRKCB;DAB2IP;PRKCA;SMARCA4;SULF2;TRAF7;TSPAN14;PRKD2;ITGB1BP1;MAML3;SHANK3;FGFR2;SHANK2,Hypo
646,GO_Biological_Process_2018,cellular response to acid chemical (GO:0071229),13/91,0.103402152508915,0.5840286064384842,0,0,1.5463775598003786,3.5089309388082195,RARG;WNT5B;WNT9B;TWF2;MTOR;RPTOR;RRAGC;LARS;RARA;SH3BP4;ABL2;PTK2B;CPEB3,Hypo
647,GO_Biological_Process_2018,activation of MAPK activity (GO:0000187),16/117,0.1039750519250876,0.5840286064384842,0,0,1.4702202381561835,3.3279968441477483,DUSP5;DBNL;LRRK2;NTRK3;STK39;DAB2IP;TGFA;FGF1;MAPK14;INAVA;DUSP7;MADD;MAPKAPK2;KIT;MAP4K5;MAP3K11,Hypo
648,GO_Biological_Process_2018,positive regulation of keratinocyte differentiation (GO:0045618),3/12,0.1044999081723734,0.5840286064384842,0,0,3.088683444615648,6.976004945409247,PRKCH;H2AFY;NUMA1,Hypo
649,GO_Biological_Process_2018,regulation of bone remodeling (GO:0046850),3/12,0.1044999081723734,0.5840286064384842,0,0,3.088683444615648,6.976004945409247,SRC;NF1;SYT7,Hypo
650,GO_Biological_Process_2018,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),3/12,0.1044999081723734,0.5840286064384842,0,0,3.088683444615648,6.976004945409247,KANK1;ITGB1BP1;CORO1C,Hypo
651,GO_Biological_Process_2018,exit from mitosis (GO:0010458),3/12,0.1044999081723734,0.5840286064384842,0,0,3.088683444615648,6.976004945409247,CTDP1;CLASP1;CLASP2,Hypo
652,GO_Biological_Process_2018,polyamine metabolic process (GO:0006595),3/12,0.1044999081723734,0.5840286064384842,0,0,3.088683444615648,6.976004945409247,SMOX;SMS;OAZ1,Hypo
653,GO_Biological_Process_2018,eye photoreceptor cell development (GO:0042462),3/12,0.1044999081723734,0.5840286064384842,0,0,3.088683444615648,6.976004945409247,USH1C;MAPRE2;BBS4,Hypo
654,GO_Biological_Process_2018,regulation of protein localization to cell periphery (GO:1904375),3/12,0.1044999081723734,0.5840286064384842,0,0,3.088683444615648,6.976004945409247,CDK5;STX8;LDLRAP1,Hypo
655,GO_Biological_Process_2018,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),3/12,0.1044999081723734,0.5840286064384842,0,0,3.088683444615648,6.976004945409247,DAB2IP;PIK3R1;BOK,Hypo
656,GO_Biological_Process_2018,positive regulation of neuron migration (GO:2001224),3/12,0.1044999081723734,0.5840286064384842,0,0,3.088683444615648,6.976004945409247,DAB2IP;RAPGEF2;ARHGEF2,Hypo
657,GO_Biological_Process_2018,histone H3-K9 demethylation (GO:0033169),3/12,0.1044999081723734,0.5840286064384842,0,0,3.088683444615648,6.976004945409247,KDM4A;KDM4B;KDM3A,Hypo
658,GO_Biological_Process_2018,Golgi localization (GO:0051645),3/12,0.1044999081723734,0.5840286064384842,0,0,3.088683444615648,6.976004945409247,ARHGAP21;RIPOR1;COPG1,Hypo
659,GO_Biological_Process_2018,regulation of cholesterol storage (GO:0010885),3/12,0.1044999081723734,0.5840286064384842,0,0,3.088683444615648,6.976004945409247,ABCA1;SCARB1;ABCG1,Hypo
660,GO_Biological_Process_2018,intracellular steroid hormone receptor signaling pathway (GO:0030518),10/66,0.1056221918132665,0.5840286064384842,0,0,1.656296023564065,3.723165935204965,NCOA1;KDM3A;MED24;NR6A1;SRC;TGFB1I1;PMEPA1;DDX54;PADI2;MED16,Hypo
661,GO_Biological_Process_2018,vesicle transport along microtubule (GO:0047496),4/19,0.1070547923493893,0.5840286064384842,0,0,2.471394313120932,5.522119282414287,DYNC1H1;KIF13A;HAP1;TRAK1,Hypo
662,GO_Biological_Process_2018,endothelial cell development (GO:0001885),4/19,0.1070547923493893,0.5840286064384842,0,0,2.471394313120932,5.522119282414287,PPP1R16B;PDE2A;RAPGEF2;RAPGEF3,Hypo
663,GO_Biological_Process_2018,purine ribonucleotide catabolic process (GO:0009154),4/19,0.1070547923493893,0.5840286064384842,0,0,2.471394313120932,5.522119282414287,PDE2A;PDE4A;AMPD3;NUDT3,Hypo
664,GO_Biological_Process_2018,regulation of neuron migration (GO:2001222),4/19,0.1070547923493893,0.5840286064384842,0,0,2.471394313120932,5.522119282414287,ULK4;DAB2IP;RAPGEF2;ARHGEF2,Hypo
665,GO_Biological_Process_2018,regulation of platelet activation (GO:0010543),4/19,0.1070547923493893,0.5840286064384842,0,0,2.471394313120932,5.522119282414287,PDGFRA;PDGFA;PRKCA;F2,Hypo
666,GO_Biological_Process_2018,calcium ion transport into cytosol (GO:0060402),4/19,0.1070547923493893,0.5840286064384842,0,0,2.471394313120932,5.522119282414287,RYR2;CACNB3;CACNA1C;GRIN2B,Hypo
667,GO_Biological_Process_2018,triglyceride biosynthetic process (GO:0019432),4/19,0.1070547923493893,0.5840286064384842,0,0,2.471394313120932,5.522119282414287,GNPAT;GPAM;LPIN1;PCK2,Hypo
668,GO_Biological_Process_2018,regulation of long-term synaptic potentiation (GO:1900271),4/19,0.1070547923493893,0.5840286064384842,0,0,2.471394313120932,5.522119282414287,ABL1;EIF2AK4;EPHB2;SHANK3,Hypo
669,GO_Biological_Process_2018,sodium ion transport (GO:0006814),9/58,0.1078771341381384,0.5840286064384842,0,0,1.7034034633946311,3.79307469290962,SLC8A3;TRAPPC10;NEDD4L;ATP1A2;SGK1;FGF13;SCN1B;SLC8A2;ASIC1,Hypo
670,GO_Biological_Process_2018,post-Golgi vesicle-mediated transport (GO:0006892),9/58,0.1078771341381384,0.5840286064384842,0,0,1.7034034633946311,3.79307469290962,ARFGEF2;MON2;SORT1;VTI1A;AP2A1;CORO7;AP3B2;SORL1;LLGL1,Hypo
671,GO_Biological_Process_2018,regulation of insulin receptor signaling pathway (GO:0046626),6/34,0.10804293104658,0.5840286064384842,0,0,1.9865520282186948,4.420528457498535,KANK1;PTPRE;PRKCB;TSC2;VWA2;PRKCZ,Hypo
672,GO_Biological_Process_2018,ncRNA metabolic process (GO:0034660),6/34,0.10804293104658,0.5840286064384842,0,0,1.9865520282186948,4.420528457498535,MEPCE;AGO2;DROSHA;BCDIN3D;MAPT;FKBP6,Hypo
673,GO_Biological_Process_2018,response to amino acid (GO:0043200),6/34,0.10804293104658,0.5840286064384842,0,0,1.9865520282186948,4.420528457498535,RPTOR;RRAGC;LARS;SH3BP4;CPEB3;MTOR,Hypo
674,GO_Biological_Process_2018,regulation of Wnt signaling pathway (GO:0030111),15/109,0.10830268119242,0.5840286064384842,0,0,1.4807850898894936,3.291526662652148,AMER2;KANK1;WWOX;LRP1;LRRK2;TSC2;FOXP3;SMARCA4;SULF2;TIAM1;FRZB;DVL1;BTRC;CDK14;FGFR2,Hypo
675,GO_Biological_Process_2018,macropinocytosis (GO:0044351),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,MAPKAPK2;DOCK2,Hypo
676,GO_Biological_Process_2018,negative regulation of cholesterol storage (GO:0010887),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,ABCA1;ABCG1,Hypo
677,GO_Biological_Process_2018,protein repair (GO:0030091),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,MSRA;MSRB3,Hypo
678,GO_Biological_Process_2018,protein localization to non-motile cilium (GO:0097499),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,TUB;SPATA7,Hypo
679,GO_Biological_Process_2018,negative regulation of chromosome organization (GO:2001251),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,ERCC1;SETMAR,Hypo
680,GO_Biological_Process_2018,galactosylceramide metabolic process (GO:0006681),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,ALDH5A1;B3GALT1,Hypo
681,GO_Biological_Process_2018,determination of liver left/right asymmetry (GO:0071910),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,ZIC3;CCDC40,Hypo
682,GO_Biological_Process_2018,positive regulation of T-helper 17 type immune response (GO:2000318),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,NLRP10;IL12RB1,Hypo
683,GO_Biological_Process_2018,cellular hyperosmotic response (GO:0071474),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,EPO;ARHGEF2,Hypo
684,GO_Biological_Process_2018,negative regulation of necroptotic process (GO:0060546),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,ARHGEF2;SLC25A4,Hypo
685,GO_Biological_Process_2018,astral microtubule organization (GO:0030953),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,NUMA1;CLASP1,Hypo
686,GO_Biological_Process_2018,regulation of digestive system process (GO:0044058),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,KCNQ1;SGK1,Hypo
687,GO_Biological_Process_2018,cardiolipin acyl-chain remodeling (GO:0035965),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,HADHA;LCLAT1,Hypo
688,GO_Biological_Process_2018,regulation of mesenchymal stem cell differentiation (GO:2000739),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,PDGFRA;SOX5,Hypo
689,GO_Biological_Process_2018,dendrite extension (GO:0097484),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,SLC9A6;SH3GL2,Hypo
690,GO_Biological_Process_2018,azole transport (GO:0045117),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,SLC35F3;SLC15A4,Hypo
691,GO_Biological_Process_2018,regulation of glial cell apoptotic process (GO:0034350),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,PRKCH;PRKCA,Hypo
692,GO_Biological_Process_2018,positive regulation of T-helper 2 cell differentiation (GO:0045630),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,RARA;PRKCZ,Hypo
693,GO_Biological_Process_2018,negative regulation of cAMP-mediated signaling (GO:0043951),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,MGRN1;PDE2A,Hypo
694,GO_Biological_Process_2018,regulation of blood vessel remodeling (GO:0060312),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,FLT4;TMBIM1,Hypo
695,GO_Biological_Process_2018,deadenylation-independent decapping of nuclear-transcribed mRNA (GO:0031087),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,EDC4;DCP1A,Hypo
696,GO_Biological_Process_2018,signal complex assembly (GO:0007172),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,SRC;PXN,Hypo
697,GO_Biological_Process_2018,regulation of protein localization to cell cortex (GO:1904776),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,NUMA1;EPB41L2,Hypo
698,GO_Biological_Process_2018,acetyl-CoA biosynthetic process (GO:0006085),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,PDHA1;MLYCD,Hypo
699,GO_Biological_Process_2018,negative regulation of amino acid transport (GO:0051956),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,HRH3;STK39,Hypo
700,GO_Biological_Process_2018,adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway (GO:0007196),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,GRM8;GRM1,Hypo
701,GO_Biological_Process_2018,positive regulation of microtubule motor activity (GO:2000576),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,DYNC1I2;DYNLL2,Hypo
702,GO_Biological_Process_2018,positive regulation of catecholamine secretion (GO:0033605),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,GRK2;STX1A,Hypo
703,GO_Biological_Process_2018,purine ribonucleoside monophosphate catabolic process (GO:0009169),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,AMPD3;NUDT3,Hypo
704,GO_Biological_Process_2018,white fat cell differentiation (GO:0050872),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,PER2;CTBP2,Hypo
705,GO_Biological_Process_2018,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0014808),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,RYR1;RYR2,Hypo
706,GO_Biological_Process_2018,gland morphogenesis (GO:0022612),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,TGFB3;FGFR2,Hypo
707,GO_Biological_Process_2018,negative regulation of cytoplasmic translation (GO:2000766),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,UNK;CPEB3,Hypo
708,GO_Biological_Process_2018,plus-end-directed organelle transport along microtubule (GO:0072386),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,KIF13A;MAPT,Hypo
709,GO_Biological_Process_2018,telencephalon cell migration (GO:0022029),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,LRRK2;FGF13,Hypo
710,GO_Biological_Process_2018,plasma membrane fusion (GO:0045026),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,NSF;VASH2,Hypo
711,GO_Biological_Process_2018,positive regulation of sodium ion transmembrane transport (GO:1902307),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,WNK2;ANK3,Hypo
712,GO_Biological_Process_2018,positive regulation of keratinocyte migration (GO:0051549),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,EPB41L4B;MTOR,Hypo
713,GO_Biological_Process_2018,imitative learning (GO:0098596),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,NRXN2;SHANK3,Hypo
714,GO_Biological_Process_2018,cellular response to magnesium ion (GO:0071286),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,ANK3;RYR3,Hypo
715,GO_Biological_Process_2018,regulation of biosynthetic process (GO:0009889),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,MID1IP1;THRSP,Hypo
716,GO_Biological_Process_2018,morphogenesis of an endothelium (GO:0003159),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,PRKD2;CCM2,Hypo
717,GO_Biological_Process_2018,equilibrioception (GO:0050957),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,USH1G;USH1C,Hypo
718,GO_Biological_Process_2018,sterol import (GO:0035376),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,SCARB1;LDLR,Hypo
719,GO_Biological_Process_2018,astrocyte activation (GO:0048143),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,LRP1;MAPT,Hypo
720,GO_Biological_Process_2018,regulation of NFAT protein import into nucleus (GO:0051532),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,SPPL3;CHERP,Hypo
721,GO_Biological_Process_2018,glutamate catabolic process (GO:0006538),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,ALDH5A1;GAD1,Hypo
722,GO_Biological_Process_2018,inner ear receptor cell differentiation (GO:0060113),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,USH1C;USH2A,Hypo
723,GO_Biological_Process_2018,response to manganese ion (GO:0010042),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,LRRK2;ATP13A2,Hypo
724,GO_Biological_Process_2018,cholesterol import (GO:0070508),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,SCARB1;LDLR,Hypo
725,GO_Biological_Process_2018,positive regulation of protein glycosylation (GO:0060050),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,GOLGA2;RAMP1,Hypo
726,GO_Biological_Process_2018,polyamine biosynthetic process (GO:0006596),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,SMOX;SMS,Hypo
727,GO_Biological_Process_2018,vocal learning (GO:0042297),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,NRXN2;SHANK3,Hypo
728,GO_Biological_Process_2018,transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,TRIO;PTPRF,Hypo
729,GO_Biological_Process_2018,regulation of protein depolymerization (GO:1901879),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,MAP1S;MAP1A,Hypo
730,GO_Biological_Process_2018,aldehyde catabolic process (GO:0046185),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,PDXP;HOGA1,Hypo
731,GO_Biological_Process_2018,positive regulation of amyloid-beta clearance (GO:1900223),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,LRP1;LDLR,Hypo
732,GO_Biological_Process_2018,negative regulation of lymphocyte migration (GO:2000402),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,LRCH1;PADI2,Hypo
733,GO_Biological_Process_2018,nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070431),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,OTULIN;INAVA,Hypo
734,GO_Biological_Process_2018,negative regulation of glucocorticoid receptor signaling pathway (GO:2000323),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,PER1;CRY2,Hypo
735,GO_Biological_Process_2018,positive regulation of fibroblast migration (GO:0010763),2/6,0.1093535348118027,0.5840286064384842,0,0,4.631930184804928,10.251245252658242,PRKCE;ARHGEF7,Hypo
736,GO_Biological_Process_2018,regulation of ion transport (GO:0043269),8/50,0.1093971019355524,0.5840286064384842,0,0,1.7662694325928106,3.908349566462468,KCNJ4;KCNJ6;KCNJ10;KCNJ11;KCNJ12;KCNJ9;NEDD4L;PDZK1,Hypo
737,GO_Biological_Process_2018,negative regulation of protein secretion (GO:0050709),7/42,0.1097184993055288,0.5840286064384842,0,0,1.85434894493052,4.097809448104416,RHBDF1;MIDN;KCNJ11;RHBDF2;SERGEF;FOXP3;RAB11FIP5,Hypo
738,GO_Biological_Process_2018,regulation of ion transmembrane transporter activity (GO:0032412),7/42,0.1097184993055288,0.5840286064384842,0,0,1.85434894493052,4.097809448104416,AHCYL1;WNK2;STK39;NEDD4L;CACNA1D;PDZK1;SCN1B,Hypo
739,GO_Biological_Process_2018,cellular response to retinoic acid (GO:0071300),7/42,0.1097184993055288,0.5840286064384842,0,0,1.85434894493052,4.097809448104416,RARG;WNT5B;TWF2;WNT9B;RARA;ABL2;PTK2B,Hypo
740,GO_Biological_Process_2018,negative regulation of phosphorylation (GO:0042326),11/75,0.1105640962806066,0.5869433628696897,0,0,1.5942979628674574,3.510898993619866,CDKN1C;LRRK2;NTRK3;FKBP8;DAB2IP;IRS2;MAPT;INHBA;EPHB2;CBFA2T3;CORO1C,Hypo
741,GO_Biological_Process_2018,cAMP-mediated signaling (GO:0019933),11/75,0.1105640962806066,0.5869433628696897,0,0,1.5942979628674574,3.510898993619866,ABCA1;ADGRD1;ADCY9;KSR1;PDE2A;GNAS;RAPGEF2;ADCY3;AKAP6;RAMP1;RAPGEF3,Hypo
742,GO_Biological_Process_2018,negative regulation of protein binding (GO:0032091),10/67,0.1139109271341386,0.6030848682545322,0,0,1.627147766323024,3.534715700421465,GOLGA2;DNAJB2;LRRK2;DVL1;TMC8;PIN1;ITGB1BP1;SORL1;PTPRF;PEX14,Hypo
743,GO_Biological_Process_2018,regulation of cardiac conduction (GO:1903779),10/67,0.1139109271341386,0.6030848682545322,0,0,1.627147766323024,3.534715700421465,RYR1;SLC8A3;RYR2;AHCYL1;KCNJ11;ATP1A2;CALM3;ATP2B1;RYR3;SLC8A2,Hypo
744,GO_Biological_Process_2018,positive regulation of supramolecular fiber organization (GO:1902905),12/84,0.1144004301623012,0.6045653942249914,0,0,1.54609563123495,3.3520133134009416,TENM1;CLIP1;NUMA1;CTTN;PRKCE;LMOD1;CDC42EP1;PDXP;PTK2B;MAPT;BAIAP2;CLASP1,Hypo
745,GO_Biological_Process_2018,negative regulation of transcription from RNA polymerase II promoter (GO:0000122),64/565,0.1144975334074241,0.6045653942249914,0,0,1.1886470960517987,2.576038362090276,RARG;TENM2;TCF25;EPO;ZMYND8;WWC1;WWC2;BHLHE41;UBE2D1;ENO1;HMGB1;TRPS1;ZHX2;H2AFY;ESX1;USP2;NCOR2;NFX1;DDIT3;IRF2;CRY2;RARA;ERF;PPARD;MCPH1;HDAC5;NFIX;NEDD4L;FOXO3;CXXC5;GLIS1;MNT;RXRA;BAG3;NACC2;PRDM16;MXI1;SMYD2;HIVEP1;E4F1;APBB1;E2F6;SPEN;WWOX;SMAD3;SEMA4D;ZBTB16;PDE2A;DAB2IP;NR1D1;GATAD2A;SMARCA4;SMAD7;PER2;PER1;NR6A1;SP2;BCL6;NFIC;BHLHE40;FOSB;MAFK;CPEB3;FGFR2,Hypo
746,GO_Biological_Process_2018,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),5/27,0.1166744222975604,0.6119581217444615,0,0,2.1065669548960035,4.5256809062865,PPP2R1B;EYA1;EYA2;UNC5B;INHBA,Hypo
747,GO_Biological_Process_2018,regulation of protein transport (GO:0051223),5/27,0.1166744222975604,0.6119581217444615,0,0,2.1065669548960035,4.5256809062865,RHBDF1;RHBDF2;P3H1;ATP13A2;LLGL1,Hypo
748,GO_Biological_Process_2018,regulation of neurotransmitter secretion (GO:0046928),5/27,0.1166744222975604,0.6119581217444615,0,0,2.1065669548960035,4.5256809062865,RIMS1;PNKD;RIMS3;LRRK2;CAMK2A,Hypo
749,GO_Biological_Process_2018,protein targeting to vacuole (GO:0006623),5/27,0.1166744222975604,0.6119581217444615,0,0,2.1065669548960035,4.5256809062865,LARS;SMURF1;VPS13D;VTI1A;SORL1,Hypo
750,GO_Biological_Process_2018,regulation of protein localization to cell surface (GO:2000008),5/27,0.1166744222975604,0.6119581217444615,0,0,2.1065669548960035,4.5256809062865,NEDD4L;STX3;KCNAB2;GPM6B;RAB11FIP5,Hypo
751,GO_Biological_Process_2018,mitotic cytokinesis (GO:0000281),9/59,0.1169060628572774,0.6123576882909785,0,0,1.669242658423493,3.58283664928344,SEPT8;SEPT9;SEPT11;RTKN;SON;ANK3;MYH10;BBS4;CIT,Hypo
752,GO_Biological_Process_2018,negative regulation of signal transduction (GO:0009968),34/283,0.1183468520881633,0.6190813417998345,0,0,1.2686109783602049,2.707387777511228,KANK1;LRP1;MGRN1;LRRK2;FLT4;MST1R;PRKCZ;FAM129B;FRZB;BTRC;EPHB2;EPHB1;WWOX;PDGFRA;PRKCB;NFKBIL1;NTRK3;SPRY4;DAB2IP;TSC2;LMTK2;IFT122;NRG2;EREG;DKK3;SULF2;DLK2;PTPRE;KIF26A;KIT;TMBIM1;TYRO3;TRIB1;FGFR2,Hypo
753,GO_Biological_Process_2018,regulation of microtubule polymerization (GO:0031113),6/35,0.1202398489286115,0.624834782229289,0,0,1.9179438058748404,4.062716668981914,CLIP3;CLIP1;NUMA1;ABL1;MAPT;CLASP1,Hypo
754,GO_Biological_Process_2018,regulation of cardiac muscle contraction (GO:0055117),6/35,0.1202398489286115,0.624834782229289,0,0,1.9179438058748404,4.062716668981914,RYR2;P2RX4;KCNQ1;CALM3;SLC9A1;SMAD7,Hypo
755,GO_Biological_Process_2018,lipid phosphorylation (GO:0046834),6/35,0.1202398489286115,0.624834782229289,0,0,1.9179438058748404,4.062716668981914,DGKG;TTC7B;PI4KA;PIK3R1;DGKZ;DGKI,Hypo
756,GO_Biological_Process_2018,positive regulation of DNA replication (GO:0045740),6/35,0.1202398489286115,0.624834782229289,0,0,1.9179438058748404,4.062716668981914,PDGFRA;STN1;EPO;TGFB3;PDGFA;EREG,Hypo
757,GO_Biological_Process_2018,endothelial cell migration (GO:0043542),6/35,0.1202398489286115,0.624834782229289,0,0,1.9179438058748404,4.062716668981914,NR4A1;PLXND1;PLEKHG5;PXN;ABL1;MYH9,Hypo
758,GO_Biological_Process_2018,digestive tract development (GO:0048565),7/43,0.1206508363973854,0.626144459248091,0,0,1.8027391776748445,3.812531160494864,CLMP;ZIC3;KIT;ITGA6;PKD1;FGFR2;CCDC40,Hypo
759,GO_Biological_Process_2018,regulation of cell growth (GO:0001558),25/201,0.1224828400404837,0.6303722709652627,0,0,1.3189197166469897,2.769446966880081,JADE1;AKAP6;ENO1;PPP1R9B;RPTOR;DNAJB2;FRZB;SPOCK1;SH3BP4;APBB2;APBB1;RBBP7;SMAD3;TMC8;INHBA;MTOR;SMARCA4;DCBLD2;BCL6;KIF26A;FGFR1OP;CHPT1;SGK1;HDGFL2;BCAR1,Hypo
760,GO_Biological_Process_2018,negative regulation of phosphatase activity (GO:0010923),10/68,0.1225539576929674,0.6303722709652627,0,0,1.59900462140064,3.3566366974082604,PPP1R26;SH3RF2;ELL;SEMA4D;DLG3;CRY2;PPP1R1B;GPATCH2;ELFN2;PPP1R12B,Hypo
761,GO_Biological_Process_2018,Golgi to endosome transport (GO:0006895),4/20,0.1240137230748912,0.6303722709652627,0,0,2.316803699897225,4.836010436207122,MON2;SORT1;AP2A1;CORO7,Hypo
762,GO_Biological_Process_2018,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),4/20,0.1240137230748912,0.6303722709652627,0,0,2.316803699897225,4.836010436207122,LRRK2;CREB3L1;DDIT3;BOK,Hypo
763,GO_Biological_Process_2018,positive regulation of dendritic spine development (GO:0060999),4/20,0.1240137230748912,0.6303722709652627,0,0,2.316803699897225,4.836010436207122,CAMK2B;CPEB3;SHANK3;SHANK2,Hypo
764,GO_Biological_Process_2018,negative regulation of actin filament bundle assembly (GO:0032232),4/20,0.1240137230748912,0.6303722709652627,0,0,2.316803699897225,4.836010436207122,ARHGAP6;SHANK3;CLASP1;CLASP2,Hypo
765,GO_Biological_Process_2018,steroid hormone mediated signaling pathway (GO:0043401),4/20,0.1240137230748912,0.6303722709652627,0,0,2.316803699897225,4.836010436207122,NR6A1;MED24;ABHD2;MED16,Hypo
766,GO_Biological_Process_2018,melanosome localization (GO:0032400),4/20,0.1240137230748912,0.6303722709652627,0,0,2.316803699897225,4.836010436207122,BLOC1S5;MLPH;VPS33A;BBS4,Hypo
767,GO_Biological_Process_2018,telomere maintenance via telomerase (GO:0007004),4/20,0.1240137230748912,0.6303722709652627,0,0,2.316803699897225,4.836010436207122,TNKS1BP1;SMG5;SMG6;WRAP53,Hypo
768,GO_Biological_Process_2018,vesicle cytoskeletal trafficking (GO:0099518),4/20,0.1240137230748912,0.6303722709652627,0,0,2.316803699897225,4.836010436207122,MLPH;MOBP;HAP1;TRAK1,Hypo
769,GO_Biological_Process_2018,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),4/20,0.1240137230748912,0.6303722709652627,0,0,2.316803699897225,4.836010436207122,KANK1;CAPZB;TBC1D30;RAP1GAP,Hypo
770,GO_Biological_Process_2018,negative regulation of interferon-gamma production (GO:0032689),4/20,0.1240137230748912,0.6303722709652627,0,0,2.316803699897225,4.836010436207122,RARA;INHBA;HMGB1;FOXP3,Hypo
771,GO_Biological_Process_2018,chondroitin sulfate biosynthetic process (GO:0030206),4/20,0.1240137230748912,0.6303722709652627,0,0,2.316803699897225,4.836010436207122,CHPF;CHST11;CHST15;CSPG4,Hypo
772,GO_Biological_Process_2018,negative regulation of macromolecule biosynthetic process (GO:0010558),4/20,0.1240137230748912,0.6303722709652627,0,0,2.316803699897225,4.836010436207122,AP2A1;NR1D1;APBB1;FOXP3,Hypo
773,GO_Biological_Process_2018,axon extension (GO:0048675),4/20,0.1240137230748912,0.6303722709652627,0,0,2.316803699897225,4.836010436207122,SLC9A6;CDK5;SLIT1;ULK1,Hypo
774,GO_Biological_Process_2018,positive regulation of histone H3-K4 methylation (GO:0051571),3/13,0.1264265280686868,0.6303722709652627,0,0,2.7796610169491527,5.748600119218783,PAXIP1;KMT2A;WDR61,Hypo
775,GO_Biological_Process_2018,regulation of acyl-CoA biosynthetic process (GO:0050812),3/13,0.1264265280686868,0.6303722709652627,0,0,2.7796610169491527,5.748600119218783,PDHA1;PDK2;PDK1,Hypo
776,GO_Biological_Process_2018,regulation of glucose import in response to insulin stimulus (GO:2001273),3/13,0.1264265280686868,0.6303722709652627,0,0,2.7796610169491527,5.748600119218783,PTPN11;SORBS1;PIK3R1,Hypo
777,GO_Biological_Process_2018,regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),3/13,0.1264265280686868,0.6303722709652627,0,0,2.7796610169491527,5.748600119218783,PDHA1;PDK2;PDK1,Hypo
778,GO_Biological_Process_2018,regulation of macrophage differentiation (GO:0045649),3/13,0.1264265280686868,0.6303722709652627,0,0,2.7796610169491527,5.748600119218783,IL34;PRKCA;INHBA,Hypo
779,GO_Biological_Process_2018,synaptic vesicle localization (GO:0097479),3/13,0.1264265280686868,0.6303722709652627,0,0,2.7796610169491527,5.748600119218783,CDK5;SYNJ1;KIF5C,Hypo
780,GO_Biological_Process_2018,membrane repolarization (GO:0086009),3/13,0.1264265280686868,0.6303722709652627,0,0,2.7796610169491527,5.748600119218783,KCND3;KCNQ1;ATP1A2,Hypo
781,GO_Biological_Process_2018,regulation of endothelial cell chemotaxis (GO:2001026),3/13,0.1264265280686868,0.6303722709652627,0,0,2.7796610169491527,5.748600119218783,P2RX4;PRKD2;FGF1,Hypo
782,GO_Biological_Process_2018,cellular response to low-density lipoprotein particle stimulus (GO:0071404),3/13,0.1264265280686868,0.6303722709652627,0,0,2.7796610169491527,5.748600119218783,ABCA1;CD9;LDLR,Hypo
783,GO_Biological_Process_2018,regulation of oxidoreductase activity (GO:0051341),3/13,0.1264265280686868,0.6303722709652627,0,0,2.7796610169491527,5.748600119218783,SZT2;ABL1;ABL2,Hypo
784,GO_Biological_Process_2018,diacylglycerol metabolic process (GO:0046339),3/13,0.1264265280686868,0.6303722709652627,0,0,2.7796610169491527,5.748600119218783,DAGLA;DAGLB;DGKZ,Hypo
785,GO_Biological_Process_2018,regulation of fatty acid oxidation (GO:0046320),3/13,0.1264265280686868,0.6303722709652627,0,0,2.7796610169491527,5.748600119218783,ACADL;PRKAG2;MLYCD,Hypo
786,GO_Biological_Process_2018,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",3/13,0.1264265280686868,0.6303722709652627,0,0,2.7796610169491527,5.748600119218783,RTCB;CSTF2;TSEN54,Hypo
787,GO_Biological_Process_2018,positive regulation of sodium ion transport (GO:0010765),3/13,0.1264265280686868,0.6303722709652627,0,0,2.7796610169491527,5.748600119218783,AHCYL1;ANK3;SCN1B,Hypo
788,GO_Biological_Process_2018,positive regulation of cellular carbohydrate metabolic process (GO:0010676),3/13,0.1264265280686868,0.6303722709652627,0,0,2.7796610169491527,5.748600119218783,PRKCE;IRS2;GPLD1,Hypo
789,GO_Biological_Process_2018,renal absorption (GO:0070293),3/13,0.1264265280686868,0.6303722709652627,0,0,2.7796610169491527,5.748600119218783,KCNQ1;KLHL3;SGK1,Hypo
790,GO_Biological_Process_2018,positive regulation of nervous system development (GO:0051962),8/52,0.1296480247084692,0.6408840452270809,0,0,1.6857972099990637,3.443969070340132,CAMK2B;SPEN;TENM4;RGS14;CLSTN1;DAB2IP;EPHB2;EPHB1,Hypo
791,GO_Biological_Process_2018,positive regulation of secretion by cell (GO:1903532),8/52,0.1296480247084692,0.6408840452270809,0,0,1.6857972099990637,3.443969070340132,GRK2;TGFB3;MYO18A;ATP13A2;MYH10;STX1A;CLASP1;CLASP2,Hypo
792,GO_Biological_Process_2018,regulation of mRNA processing (GO:0050684),5/28,0.1312786325899917,0.6408840452270809,0,0,2.014865317983681,4.0910495323511045,SRPK2;AHCYL1;PTCD2;SON;SRPK1,Hypo
793,GO_Biological_Process_2018,chondrocyte differentiation (GO:0002062),5/28,0.1312786325899917,0.6408840452270809,0,0,2.014865317983681,4.0910495323511045,WNT5B;CREB3L2;RUNX2;GPLD1;SULF2,Hypo
794,GO_Biological_Process_2018,positive regulation of protein tyrosine kinase activity (GO:0061098),5/28,0.1312786325899917,0.6408840452270809,0,0,2.014865317983681,4.0910495323511045,DLG3;DOK7;TGFA;SRCIN1;EREG,Hypo
795,GO_Biological_Process_2018,positive regulation of cell communication (GO:0010647),5/28,0.1312786325899917,0.6408840452270809,0,0,2.014865317983681,4.0910495323511045,RIMS1;RIMS3;CLSTN1;KCTD13;ANK3,Hypo
796,GO_Biological_Process_2018,neural crest cell migration (GO:0001755),5/28,0.1312786325899917,0.6408840452270809,0,0,2.014865317983681,4.0910495323511045,SEMA4A;SEMA7A;SEMA4D;SEMA4C;CORO1C,Hypo
797,GO_Biological_Process_2018,regulation of lipid biosynthetic process (GO:0046890),5/28,0.1312786325899917,0.6408840452270809,0,0,2.014865317983681,4.0910495323511045,MID1IP1;PRKAG2;THRSP;SORBS1;MTOR,Hypo
798,GO_Biological_Process_2018,calcium ion import (GO:0070509),5/28,0.1312786325899917,0.6408840452270809,0,0,2.014865317983681,4.0910495323511045,CACNA1I;CACNA1D;CACNA1C;SLC25A23;CACNA1E,Hypo
799,GO_Biological_Process_2018,regulation of adenylate cyclase activity (GO:0045761),5/28,0.1312786325899917,0.6408840452270809,0,0,2.014865317983681,4.0910495323511045,GRM2;GABBR2;HRH3;NF1;CAP2,Hypo
800,GO_Biological_Process_2018,neuron projection extension (GO:1990138),5/28,0.1312786325899917,0.6408840452270809,0,0,2.014865317983681,4.0910495323511045,SLC9A6;CDK5;ULK1;EIF2AK4;SH3GL2,Hypo
801,GO_Biological_Process_2018,mitotic nuclear envelope disassembly (GO:0007077),7/44,0.1321190218754629,0.6408840452270809,0,0,1.753919127568124,3.5500236614474,CCNB2;NUP188;NUP133;PRKCB;LMNA;PRKCA;LPIN1,Hypo
802,GO_Biological_Process_2018,regulation of potassium ion transport (GO:0043266),6/36,0.1330840331807431,0.6408840452270809,0,0,1.853909465020576,3.738917374876154,KCNIP3;PTK2B;CACNA1D;KCNAB1;KCNAB2;ANK3,Hypo
803,GO_Biological_Process_2018,muscle cell differentiation (GO:0042692),6/36,0.1330840331807431,0.6408840452270809,0,0,1.853909465020576,3.738917374876154,MBNL1;MEGF10;TMEM204;SEMA4C;RORA;SYNE1,Hypo
804,GO_Biological_Process_2018,carbohydrate biosynthetic process (GO:0016051),6/36,0.1330840331807431,0.6408840452270809,0,0,1.853909465020576,3.738917374876154,GALNT13;B4GALT1;GALNT2;B3GALT1;ST3GAL2;GALNT9,Hypo
805,GO_Biological_Process_2018,calcium ion transmembrane import into cytosol (GO:0097553),6/36,0.1330840331807431,0.6408840452270809,0,0,1.853909465020576,3.738917374876154,RYR1;RYR2;FAM155A;GRIN2B;RYR3;CHERP,Hypo
806,GO_Biological_Process_2018,cardiac muscle contraction (GO:0060048),6/36,0.1330840331807431,0.6408840452270809,0,0,1.853909465020576,3.738917374876154,RYR2;GRK2;GAA;KCNQ1;ATP1A2;SCN1B,Hypo
807,GO_Biological_Process_2018,positive regulation of signaling (GO:0023056),6/36,0.1330840331807431,0.6408840452270809,0,0,1.853909465020576,3.738917374876154,NSF;RIMS1;RIMS3;CLSTN1;KCTD13;ECE1,Hypo
808,GO_Biological_Process_2018,regulation of filopodium assembly (GO:0051489),6/36,0.1330840331807431,0.6408840452270809,0,0,1.853909465020576,3.738917374876154,PPP1R16B;TENM1;TENM2;CAPZB;MYO10;TGFB3,Hypo
809,GO_Biological_Process_2018,negative regulation of cell communication (GO:0010648),11/78,0.1353993910473477,0.6408840452270809,0,0,1.5226574707688991,3.0445938352440955,PDGFRA;KIF26A;FLT4;NTRK3;KIT;TYRO3;LMTK2;MST1R;EPHB2;EPHB1;FGFR2,Hypo
810,GO_Biological_Process_2018,regulation of cellular response to heat (GO:1900034),11/78,0.1353993910473477,0.6408840452270809,0,0,1.5226574707688991,3.0445938352440955,RPTOR;CAMK2B;NUP188;NUP133;BAG3;MAPKAPK2;CAMK2A;MAPT;CRYAB;CAMK2G;MTOR,Hypo
811,GO_Biological_Process_2018,glycosaminoglycan metabolic process (GO:0030203),9/61,0.1361546628173371,0.6408840452270809,0,0,1.60486267982404,3.2000381080829308,NDST1;B3GAT2;SDC3;XYLT2;XYLT1;CSPG4;GPC4;GNS;GPC6,Hypo
812,GO_Biological_Process_2018,regulation of calcium ion-dependent exocytosis (GO:0017158),8/53,0.14044821729123,0.6408840452270809,0,0,1.648243506121982,3.235364239602492,RIMS1;CACNA1I;RIMS3;SYT12;LRRK2;SYT13;STX1A;SYT7,Hypo
813,GO_Biological_Process_2018,GTP metabolic process (GO:0046039),4/21,0.1420221674171334,0.6408840452270809,0,0,2.1804002176410133,4.255644366120813,IMPDH1;LRRK2;RAB23;MOCOS,Hypo
814,GO_Biological_Process_2018,establishment of protein localization to vacuole (GO:0072666),4/21,0.1420221674171334,0.6408840452270809,0,0,2.1804002176410133,4.255644366120813,VPS13D;VTI1A;CACNG2;CACNG4,Hypo
815,GO_Biological_Process_2018,regulation of cardiac muscle hypertrophy (GO:0010611),4/21,0.1420221674171334,0.6408840452270809,0,0,2.1804002176410133,4.255644366120813,P2RX4;PRKCA;LMCD1;SLC9A1,Hypo
816,GO_Biological_Process_2018,positive regulation of lamellipodium organization (GO:1902745),4/21,0.1420221674171334,0.6408840452270809,0,0,2.1804002176410133,4.255644366120813,SRC;TWF2;ARHGEF7;CORO1C,Hypo
817,GO_Biological_Process_2018,vesicle docking (GO:0048278),4/21,0.1420221674171334,0.6408840452270809,0,0,2.1804002176410133,4.255644366120813,NSF;STX8;STX3;STX1A,Hypo
818,GO_Biological_Process_2018,cellular response to alkaloid (GO:0071312),4/21,0.1420221674171334,0.6408840452270809,0,0,2.1804002176410133,4.255644366120813,RYR1;RYR2;RAD51;RYR3,Hypo
819,GO_Biological_Process_2018,positive regulation of lipid metabolic process (GO:0045834),4/21,0.1420221674171334,0.6408840452270809,0,0,2.1804002176410133,4.255644366120813,DISP3;SORBS1;F2;MTOR,Hypo
820,GO_Biological_Process_2018,"synaptic transmission, glutamatergic (GO:0035249)",4/21,0.1420221674171334,0.6408840452270809,0,0,2.1804002176410133,4.255644366120813,NAPA;GRID1;GRIK5;GRIK4,Hypo
821,GO_Biological_Process_2018,RNA-dependent DNA biosynthetic process (GO:0006278),4/21,0.1420221674171334,0.6408840452270809,0,0,2.1804002176410133,4.255644366120813,TNKS1BP1;SMG5;SMG6;WRAP53,Hypo
822,GO_Biological_Process_2018,establishment of spindle orientation (GO:0051294),4/21,0.1420221674171334,0.6408840452270809,0,0,2.1804002176410133,4.255644366120813,NUMA1;MAP4;CLASP1;LLGL1,Hypo
823,GO_Biological_Process_2018,negative regulation of ion transmembrane transporter activity (GO:0032413),4/21,0.1420221674171334,0.6408840452270809,0,0,2.1804002176410133,4.255644366120813,EPO;PRKCE;STK39;NEDD4L,Hypo
824,GO_Biological_Process_2018,negative regulation of macroautophagy (GO:0016242),4/21,0.1420221674171334,0.6408840452270809,0,0,2.1804002176410133,4.255644366120813,LRRK2;FEZ2;TSC2;MTOR,Hypo
825,GO_Biological_Process_2018,positive regulation of cellular biosynthetic process (GO:0031328),20/159,0.1422889301272782,0.6408840452270809,0,0,1.3352965296156858,2.603688786949012,SCARB1;PDGFRA;SREBF1;STN1;SMAD3;EPO;TGFB3;MID1IP1;PDGFA;IRS2;NR1D1;SORBS1;MTOR;EREG;P2RX4;NOS1AP;PRKD2;CPEB3;LDLR;GPLD1,Hypo
826,GO_Biological_Process_2018,negative regulation of cell differentiation (GO:0045596),19/150,0.1427912328348869,0.6408840452270809,0,0,1.345903123406375,2.61962765030561,ABCA1;TRIO;SMAD3;SEMA4D;ZBTB16;DAB2IP;RORA;WDR61;LDLRAD4;AXIN2;LIMD1;USH2A;OVOL2;SMAD7;HDAC7;COL5A1;SDHAF2;PTK2B;ABCG1,Hypo
827,GO_Biological_Process_2018,"positive regulation of transcription, DNA-templated (GO:0045893)",120/1120,0.1431104381916574,0.6408840452270809,0,0,1.118032786885246,2.173610754898478,CRTC3;CRTC1;EPO;RORA;MYRFL;FGF1;TBK1;ZMIZ1;ZMIZ2;CREB3L2;PIM2;BTRC;SMARCC2;ZBTB38;EBF3;FOXP3;RUNX2;DDIT3;KAT6A;PADI2;PRKD2;MAML3;ERG;KMT2D;AKNA;KMT2A;CTBP2;EPAS1;WDR61;PIK3R1;FOXO3;GLIS1;SLC9A1;RAI1;SBNO2;PRDM16;DVL1;DVL2;CAMTA1;HIVEP3;BCL9L;XRCC6;AFAP1L2;SMAD3;TGFB3;ZBTB16;NFATC2;ESRRG;FOXN3;INHBA;NR1D1;SMARCA4;SMAD7;NR4A1;AGO2;PIN1;TCF4;LHX4;FGFR2;CDKN1C;RARG;ELL;THRA;TGFB1I1;TCF20;HMGB1;MED16;LITAF;PKD1;RPTOR;ZIC3;TEAD1;NCOA1;SREBF1;ATMIN;TFEB;TET1;KLF15;ARID1B;ETV5;MED24;RBL1;ELF4;IRF2;TET3;RARA;ITGA6;ITGB1BP1;ARHGEF2;PPARD;HDAC5;RNASEL;KDM3A;NFIX;NUFIP1;HLF;DOT1L;CAMKK2;FAM129B;RXRA;PLAGL1;PCBD2;APBB1;MEF2D;BRD4;ATF7IP;IL33;WWOX;DAB2IP;GRHL1;MTOR;PER1;TNIP1;NFIC;ERCC2;ERCC6;TAF4;LPIN1;PFKM;SSBP3,Hypo
828,GO_Biological_Process_2018,adherens junction assembly (GO:0034333),2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,PIP5K1C;SMAD7,Hypo
829,GO_Biological_Process_2018,regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051342),2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,EGLN1;CALM3,Hypo
830,GO_Biological_Process_2018,intracellular sterol transport (GO:0032366),2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,ABCA1;ABCG1,Hypo
831,GO_Biological_Process_2018,"neurotransmitter receptor transport, postsynaptic endosome to lysosome (GO:0098943)",2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,CACNG2;CACNG4,Hypo
832,GO_Biological_Process_2018,ornithine transport (GO:0015822),2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,SLC25A29;SLC7A1,Hypo
833,GO_Biological_Process_2018,regulation of ER to Golgi vesicle-mediated transport (GO:0060628),2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,STX18;SORL1,Hypo
834,GO_Biological_Process_2018,sulfur amino acid biosynthetic process (GO:0000097),2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,MTHFD1;MTR,Hypo
835,GO_Biological_Process_2018,release of sequestered calcium ion into cytosol by endoplasmic reticulum (GO:1903514),2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,RYR1;RYR2,Hypo
836,GO_Biological_Process_2018,regulation of toll-like receptor 9 signaling pathway (GO:0034163),2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,PTPRS;HMGB1,Hypo
837,GO_Biological_Process_2018,central nervous system neuron axonogenesis (GO:0021955),2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,SPTBN4;EPHB1,Hypo
838,GO_Biological_Process_2018,activation of MAPKKK activity (GO:0000185),2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,TRAF7;DAB2IP,Hypo
839,GO_Biological_Process_2018,glycosphingolipid catabolic process (GO:0046479),2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,NEU4;NEU1,Hypo
840,GO_Biological_Process_2018,positive regulation of protein deubiquitination (GO:1903003),2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,SART3;TNIP1,Hypo
841,GO_Biological_Process_2018,regulation of smooth muscle cell differentiation (GO:0051150),2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,FGFR2;EREG,Hypo
842,GO_Biological_Process_2018,chromatin-mediated maintenance of transcription (GO:0048096),2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,PADI2;ARID1B,Hypo
843,GO_Biological_Process_2018,determination of digestive tract left/right asymmetry (GO:0071907),2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,ZIC3;CCDC40,Hypo
844,GO_Biological_Process_2018,adenine nucleotide transport (GO:0051503),2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,SLC25A17;SLC25A4,Hypo
845,GO_Biological_Process_2018,negative regulation of nitrogen compound metabolic process (GO:0051172),2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,AP2A1;LDLR,Hypo
846,GO_Biological_Process_2018,glycosylceramide metabolic process (GO:0006677),2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,ALDH5A1;ST6GALNAC3,Hypo
847,GO_Biological_Process_2018,peroxisome proliferator activated receptor signaling pathway (GO:0035357),2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,RXRA;ALOXE3,Hypo
848,GO_Biological_Process_2018,positive regulation of mitotic sister chromatid separation (GO:1901970),2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,NSMCE2;DLGAP5,Hypo
849,GO_Biological_Process_2018,negative regulation of membrane protein ectodomain proteolysis (GO:0051045),2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,TIMP2;TIMP3,Hypo
850,GO_Biological_Process_2018,negative regulation of T cell mediated immunity (GO:0002710),2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,FOXP3;SMAD7,Hypo
851,GO_Biological_Process_2018,negative regulation of receptor internalization (GO:0002091),2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,ATXN2;UBQLN2,Hypo
852,GO_Biological_Process_2018,regulation of glucocorticoid receptor signaling pathway (GO:2000322),2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,PER1;CRY2,Hypo
853,GO_Biological_Process_2018,purine ribonucleotide transport (GO:0015868),2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,SLC25A17;SLC25A4,Hypo
854,GO_Biological_Process_2018,negative regulation of B cell apoptotic process (GO:0002903),2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,BCL6;IRS2,Hypo
855,GO_Biological_Process_2018,regulation of norepinephrine secretion (GO:0014061),2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,HRH3;STX1A,Hypo
856,GO_Biological_Process_2018,positive regulation of interleukin-5 production (GO:0032754),2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,RARA;PRKCZ,Hypo
857,GO_Biological_Process_2018,negative regulation of T cell cytokine production (GO:0002725),2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,FOXP3;SMAD7,Hypo
858,GO_Biological_Process_2018,cellular response to platelet-derived growth factor stimulus (GO:0036120),2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,MARS;MTSS1L,Hypo
859,GO_Biological_Process_2018,negative regulation of RIG-I signaling pathway (GO:0039536),2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,NPLOC4;SEC14L1,Hypo
860,GO_Biological_Process_2018,negative regulation of necrotic cell death (GO:0060547),2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,ARHGEF2;SLC25A4,Hypo
861,GO_Biological_Process_2018,negative regulation of dendrite development (GO:2000171),2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,PTPRS;RAPGEF2,Hypo
862,GO_Biological_Process_2018,regulation of transcription involved in cell fate commitment (GO:0060850),2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,CHD5;RORA,Hypo
863,GO_Biological_Process_2018,long-chain fatty acid catabolic process (GO:0042758),2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,ACADL;AIG1,Hypo
864,GO_Biological_Process_2018,negative regulation of heart rate (GO:0010459),2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,SPTBN4;RNLS,Hypo
865,GO_Biological_Process_2018,hyperosmotic response (GO:0006972),2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,EPO;ARHGEF2,Hypo
866,GO_Biological_Process_2018,cAMP catabolic process (GO:0006198),2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,PDE2A;PDE4A,Hypo
867,GO_Biological_Process_2018,chondroitin sulfate proteoglycan metabolic process (GO:0050654),2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,B3GAT2;XYLT2,Hypo
868,GO_Biological_Process_2018,regulation of Cdc42 protein signal transduction (GO:0032489),2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,ABCA1;ABL1,Hypo
869,GO_Biological_Process_2018,axon regeneration (GO:0031103),2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,RTN4RL2;MTR,Hypo
870,GO_Biological_Process_2018,purine nucleotide biosynthetic process (GO:0006164),2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,MTHFD1;PPAT,Hypo
871,GO_Biological_Process_2018,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,NCOR2;BCDIN3D,Hypo
872,GO_Biological_Process_2018,regulation of chromatin assembly or disassembly (GO:0001672),2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,MAP1S;PADI2,Hypo
873,GO_Biological_Process_2018,positive regulation of glutamate receptor signaling pathway (GO:1900451),2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,EPHB2;SHANK3,Hypo
874,GO_Biological_Process_2018,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,NSMCE2;DLGAP5,Hypo
875,GO_Biological_Process_2018,negative regulation of glial cell apoptotic process (GO:0034351),2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,PRKCH;PRKCA,Hypo
876,GO_Biological_Process_2018,regulation of dendritic spine maintenance (GO:1902950),2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,FYN;GRIN2B,Hypo
877,GO_Biological_Process_2018,bone cell development (GO:0098751),2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,SRC;KIT,Hypo
878,GO_Biological_Process_2018,positive regulation of extracellular matrix disassembly (GO:0090091),2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,CLASP1;CLASP2,Hypo
879,GO_Biological_Process_2018,vesicle transport along actin filament (GO:0030050),2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,MLPH;MOBP,Hypo
880,GO_Biological_Process_2018,retrograde axonal transport (GO:0008090),2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,DST;HAP1,Hypo
881,GO_Biological_Process_2018,negative regulation of telomere capping (GO:1904354),2/7,0.1435033581848909,0.6408840452270809,0,0,3.705338809034908,7.193533062663419,ERCC1;SMG6,Hypo
882,GO_Biological_Process_2018,nucleus organization (GO:0006997),7/45,0.1441050804653877,0.6421152850148896,0,0,1.70766855378281,3.308116902521679,SUN1;NUMA1;NUP133;BIN1;LEMD2;SYNE1;CHMP5,Hypo
883,GO_Biological_Process_2018,nicotinamide nucleotide metabolic process (GO:0046496),7/45,0.1441050804653877,0.6421152850148896,0,0,1.70766855378281,3.308116902521679,HK3;PKM;HKDC1;QPRT;NMNAT3;PFKM;HK1,Hypo
884,GO_Biological_Process_2018,peptidyl-tyrosine phosphorylation (GO:0018108),11/79,0.1442932476575613,0.6422272344894171,0,0,1.5001820222673907,2.9042137904078844,PDGFRA;SRC;FLT4;TNK2;KIT;ABL1;ABL2;PTK2B;FYN;EPHB2;FGFR2,Hypo
885,GO_Biological_Process_2018,positive regulation of catabolic process (GO:0009896),9/62,0.146356767063271,0.6490834141235227,0,0,1.5744947653903356,3.025719230712656,NSF;LRP1;SMURF1;DAB2IP;NEDD4L;IDE;OAZ1;SORL1;RNF41,Hypo
886,GO_Biological_Process_2018,regulation of sodium ion transmembrane transporter activity (GO:2000649),6/37,0.1465474291096676,0.6490834141235227,0,0,1.7940063719633612,3.445220878345597,PRKCE;WNK2;STK39;NEDD4L;ANK3;SCN1B,Hypo
887,GO_Biological_Process_2018,actin filament bundle assembly (GO:0051017),6/37,0.1465474291096676,0.6490834141235227,0,0,1.7940063719633612,3.445220878345597,USH1C;PDXP;PAWR;ESPN;BAIAP2;PLS1,Hypo
888,GO_Biological_Process_2018,regulation of metal ion transport (GO:0010959),6/37,0.1465474291096676,0.6490834141235227,0,0,1.7940063719633612,3.445220878345597,CAMK2B;SPTBN4;PER1;P2RX4;ANK3;CAMK2G,Hypo
889,GO_Biological_Process_2018,regulation of embryonic development (GO:0045995),5/29,0.1466575878573077,0.6490834141235227,0,0,1.9308054841473865,3.706479906664144,PHLDB1;CCSAP;CLASP1;FAM129B;CLASP2,Hypo
890,GO_Biological_Process_2018,"transcription, DNA-templated (GO:0006351)",41/356,0.148540363993541,0.6520699483492373,0,0,1.2092011940099945,2.3058239990045104,GTF3C1;CTDP1;NFIX;HLF;ELL;KMT2A;THRA;EPAS1;TGFB1I1;DTX1;WDR61;MLLT1;MED16;FOXO3;GTF2E1;GLIS1;MNT;TRPS1;DVL1;HIVEP1;DVL2;HIVEP3;NFRKB;SOX5;TEFM;GTF2I;NCOA1;KLF13;NFATC2;ASH1L;BAZ1B;POU2F2;EREG;RRAGC;NFX1;NFIC;ERCC2;POLR3G;TCF4;ERCC6;TAF4,Hypo
891,GO_Biological_Process_2018,positive regulation of cellular catabolic process (GO:0031331),14/106,0.1494433571045315,0.6520699483492373,0,0,1.4115388070427597,2.683106377322603,SH3GLB1;UPF1;PFKFB3;UQCC2;LRRK2;TFEB;IRS2;FURIN;TPCN1;TMEM59;VPS11;SH3BP4;PIM2;GPLD1,Hypo
892,GO_Biological_Process_2018,mitotic cell cycle arrest (GO:0071850),3/14,0.149815512377776,0.6520699483492373,0,0,2.52682448522202,4.796798927549129,DUSP1;E4F1;MCPH1,Hypo
893,GO_Biological_Process_2018,regulation of extracellular matrix disassembly (GO:0010715),3/14,0.149815512377776,0.6520699483492373,0,0,2.52682448522202,4.796798927549129,LRP1;CLASP1;CLASP2,Hypo
894,GO_Biological_Process_2018,regulation of secretion (GO:0051046),3/14,0.149815512377776,0.6520699483492373,0,0,2.52682448522202,4.796798927549129,KCNQ1;SGK1;GPLD1,Hypo
895,GO_Biological_Process_2018,negative regulation of hemopoiesis (GO:1903707),3/14,0.149815512377776,0.6520699483492373,0,0,2.52682448522202,4.796798927549129,ZBTB16;PTK2B;WDR61,Hypo
896,GO_Biological_Process_2018,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),3/14,0.149815512377776,0.6520699483492373,0,0,2.52682448522202,4.796798927549129,RYR2;ATP1A2;CACNA1C,Hypo
897,GO_Biological_Process_2018,oligodendrocyte differentiation (GO:0048709),3/14,0.149815512377776,0.6520699483492373,0,0,2.52682448522202,4.796798927549129,EIF2B5;SLC8A3;CDK5,Hypo
898,GO_Biological_Process_2018,cellular protein complex disassembly (GO:0043624),3/14,0.149815512377776,0.6520699483492373,0,0,2.52682448522202,4.796798927549129,NSF;NAPA;PEX14,Hypo
899,GO_Biological_Process_2018,neuromuscular process controlling balance (GO:0050885),3/14,0.149815512377776,0.6520699483492373,0,0,2.52682448522202,4.796798927549129,USH1G;USH1C;TPP1,Hypo
900,GO_Biological_Process_2018,cellular response to osmotic stress (GO:0071470),3/14,0.149815512377776,0.6520699483492373,0,0,2.52682448522202,4.796798927549129,EPO;STK39;ARHGEF2,Hypo
901,GO_Biological_Process_2018,regulation of transferase activity (GO:0051338),3/14,0.149815512377776,0.6520699483492373,0,0,2.52682448522202,4.796798927549129,PPP1R3F;ZER1;SMG6,Hypo
902,GO_Biological_Process_2018,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",3/14,0.149815512377776,0.6520699483492373,0,0,2.52682448522202,4.796798927549129,RTCB;CSTF2;TSEN54,Hypo
903,GO_Biological_Process_2018,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),3/14,0.149815512377776,0.6520699483492373,0,0,2.52682448522202,4.796798927549129,LRRK2;GPR37L1;PDE8A,Hypo
904,GO_Biological_Process_2018,clathrin coat assembly (GO:0048268),3/14,0.149815512377776,0.6520699483492373,0,0,2.52682448522202,4.796798927549129,HIP1;HIP1R;AP2S1,Hypo
905,GO_Biological_Process_2018,response to insulin (GO:0032868),10/71,0.1505487220773238,0.6545379870447886,0,0,1.5201115430116614,2.878283342105793,HDAC5;RAB31;PKM;SORT1;MARS;IRS2;PIK3R1;SORBS1;GPLD1;PCK2,Hypo
906,GO_Biological_Process_2018,action potential (GO:0001508),8/54,0.1516804249376326,0.6587311949606778,0,0,1.6123225719786862,3.0408072196891296,CACNA1I;KCNQ1;AKAP6;CACNA1D;ANK3;CACNA1C;CACNA1E;TPCN1,Hypo
907,GO_Biological_Process_2018,cartilage development (GO:0051216),7/46,0.1565885285378033,0.6740971884904913,0,0,1.663789804294179,3.0848888313426284,WNT5B;ZBTB16;CREB3L2;PKD1;RUNX2;GPLD1;SULF2,Hypo
908,GO_Biological_Process_2018,mitotic spindle assembly (GO:0090307),7/46,0.1565885285378033,0.6740971884904913,0,0,1.663789804294179,3.0848888313426284,GOLGA2;ARHGEF10;BCCIP;FLNA;TUBGCP6;CLASP1;MAP9,Hypo
909,GO_Biological_Process_2018,icosanoid metabolic process (GO:0006690),7/46,0.1565885285378033,0.6740971884904913,0,0,1.663789804294179,3.0848888313426284,DAGLA;GPX4;MAPKAPK2;ALOX12B;DAGLB;ALOXE3;MGLL,Hypo
910,GO_Biological_Process_2018,nuclear envelope disassembly (GO:0051081),7/46,0.1565885285378033,0.6740971884904913,0,0,1.663789804294179,3.0848888313426284,CCNB2;NUP188;NUP133;PRKCB;LMNA;PRKCA;LPIN1,Hypo
911,GO_Biological_Process_2018,COPII vesicle coating (GO:0048208),9/63,0.1569299623878599,0.6740971884904913,0,0,1.54525158852825,2.8617374449785857,GOLGA2;NSF;NAPA;TRAPPC3;PEF1;TRAPPC10;TGFA;TRAPPC9;CNIH3,Hypo
912,GO_Biological_Process_2018,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway (GO:0007193),9/63,0.1569299623878599,0.6740971884904913,0,0,1.54525158852825,2.8617374449785857,ADCY9;CHRM4;GRM8;PSAP;ADCY3;FLNA;GPR37L1;HTR5A;GRM1,Hypo
913,GO_Biological_Process_2018,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",9/63,0.1569299623878599,0.6740971884904913,0,0,1.54525158852825,2.8617374449785857,GOLGA2;NSF;NAPA;TRAPPC3;PEF1;TRAPPC10;TGFA;TRAPPC9;CNIH3,Hypo
914,GO_Biological_Process_2018,positive regulation of cell projection organization (GO:0031346),9/63,0.1569299623878599,0.6740971884904913,0,0,1.54525158852825,2.8617374449785857,CAMK2B;TWF2;DAB2IP;P3H1;RAPGEF2;ABL2;PTK2B;SCN1B;MARK2,Hypo
915,GO_Biological_Process_2018,synapse assembly (GO:0007416),9/63,0.1569299623878599,0.6740971884904913,0,0,1.54525158852825,2.8617374449785857,DBNL;PLXND1;DSCAM;CDK5;DVL1;NRXN2;SHANK3;SHANK2;SDK2,Hypo
916,GO_Biological_Process_2018,vesicle coating (GO:0006901),9/63,0.1569299623878599,0.6740971884904913,0,0,1.54525158852825,2.8617374449785857,GOLGA2;NSF;NAPA;TRAPPC3;PEF1;TRAPPC10;TGFA;TRAPPC9;CNIH3,Hypo
917,GO_Biological_Process_2018,negative regulation of nucleic acid-templated transcription (GO:1903507),50/444,0.1574022758015882,0.6753895036845927,0,0,1.1792679668714934,2.1804080785718694,CDKN1C;THRA;BHLHE41;ENO1;LIMD1;BCL7A;BTRC;TNFRSF4;PIAS4;ZHX2;SMARCC2;ZBTB38;ESX1;FOXP3;CBFA2T3;RUNX2;DKK3;EREG;DDIT3;KAT6A;CRY2;RARA;PPARD;HDAC5;CTBP2;TSHZ3;CIPC;PPM1F;FAM129B;SBNO2;ATXN1;NACC2;PRDM16;MTA3;ATF7IP;SPEN;KDM4A;XRCC6;ZBTB16;DAB2IP;NR1D1;FOXN3;PEX14;GATAD2A;SMARCA4;PER2;PER1;CDK5;BCL6;BHLHE40,Hypo
918,GO_Biological_Process_2018,Rho protein signal transduction (GO:0007266),10/72,0.1605431052602843,0.678931837519231,0,0,1.4955104755570336,2.7355770000015083,RIPOR1;RTKN;RHOJ;ARHGEF3;CDC42EP1;PAK6;ARHGEF1;ARHGAP6;NTN1;PAK4,Hypo
919,GO_Biological_Process_2018,regulation of fat cell differentiation (GO:0045598),10/72,0.1605431052602843,0.678931837519231,0,0,1.4955104755570336,2.7355770000015083,FTO;TRIO;SMAD3;FRZB;ZBTB16;RORA;NR1D1;MEDAG;CMKLR1;PPARD,Hypo
920,GO_Biological_Process_2018,positive regulation of protein autophosphorylation (GO:0031954),4/22,0.1609856146846818,0.678931837519231,0,0,2.0591526778577136,3.76091936833438,RASSF2;PDGFA;TNKS1BP1;CALM3,Hypo
921,GO_Biological_Process_2018,protein localization to cilium (GO:0061512),4/22,0.1609856146846818,0.678931837519231,0,0,2.0591526778577136,3.76091936833438,TUB;IFT140;IFT122;BBS4,Hypo
922,GO_Biological_Process_2018,positive regulation of protein targeting to membrane (GO:0090314),4/22,0.1609856146846818,0.678931837519231,0,0,2.0591526778577136,3.76091936833438,ITGB1BP1;FYN;ANK3;PDZK1,Hypo
923,GO_Biological_Process_2018,early endosome to late endosome transport (GO:0045022),4/22,0.1609856146846818,0.678931837519231,0,0,2.0591526778577136,3.76091936833438,ANKRD27;AKTIP;STX8;LMTK2,Hypo
924,GO_Biological_Process_2018,regulation of DNA biosynthetic process (GO:2000278),4/22,0.1609856146846818,0.678931837519231,0,0,2.0591526778577136,3.76091936833438,PRKD2;SMG5;FAM129B;SMG6,Hypo
925,GO_Biological_Process_2018,peripheral nervous system development (GO:0007422),4/22,0.1609856146846818,0.678931837519231,0,0,2.0591526778577136,3.76091936833438,NFASC;ADGRB1;NF1;ASIC2,Hypo
926,GO_Biological_Process_2018,sulfur amino acid metabolic process (GO:0000096),4/22,0.1609856146846818,0.678931837519231,0,0,2.0591526778577136,3.76091936833438,MSRA;MTHFD1;SMS;MTR,Hypo
927,GO_Biological_Process_2018,cytosolic calcium ion transport (GO:0060401),4/22,0.1609856146846818,0.678931837519231,0,0,2.0591526778577136,3.76091936833438,RYR2;CACNB3;CACNA1C;SLC25A23,Hypo
928,GO_Biological_Process_2018,purine-containing compound biosynthetic process (GO:0072522),4/22,0.1609856146846818,0.678931837519231,0,0,2.0591526778577136,3.76091936833438,DGUOK;MTHFD1;PPAT;AMPD3,Hypo
929,GO_Biological_Process_2018,regulation of membrane protein ectodomain proteolysis (GO:0051043),4/22,0.1609856146846818,0.678931837519231,0,0,2.0591526778577136,3.76091936833438,TIMP2;TIMP3;FURIN;GPLD1,Hypo
930,GO_Biological_Process_2018,regulation of bone resorption (GO:0045124),4/22,0.1609856146846818,0.678931837519231,0,0,2.0591526778577136,3.76091936833438,SRC;NF1;PLEKHM1;PRKCA,Hypo
931,GO_Biological_Process_2018,positive regulation of phosphatase activity (GO:0010922),4/22,0.1609856146846818,0.678931837519231,0,0,2.0591526778577136,3.76091936833438,AKAP6;CALM3;MTOR;GPLD1,Hypo
932,GO_Biological_Process_2018,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),4/22,0.1609856146846818,0.678931837519231,0,0,2.0591526778577136,3.76091936833438,STXBP4;NR1D1;GPLD1;CDK16,Hypo
933,GO_Biological_Process_2018,negative regulation of protein polymerization (GO:0032272),4/22,0.1609856146846818,0.678931837519231,0,0,2.0591526778577136,3.76091936833438,CLIP3;KANK1;TWF2;HIP1R,Hypo
934,GO_Biological_Process_2018,negative regulation of secretion by cell (GO:1903531),5/30,0.1627597588325891,0.6829650583151802,0,0,1.8534704370179949,3.364938578662175,RHBDF1;PNKD;HRH3;RHBDF2;SERGEF,Hypo
935,GO_Biological_Process_2018,phosphatidylinositol 3-kinase signaling (GO:0014065),5/30,0.1627597588325891,0.6829650583151802,0,0,1.8534704370179949,3.364938578662175,PLEKHA1;TYRO3;NF1;PIK3R1;PIK3R6,Hypo
936,GO_Biological_Process_2018,chondroitin sulfate metabolic process (GO:0030204),5/30,0.1627597588325891,0.6829650583151802,0,0,1.8534704370179949,3.364938578662175,CHPF;CHST11;B3GAT2;CHST15;CSPG4,Hypo
937,GO_Biological_Process_2018,cellular response to cAMP (GO:0071320),5/30,0.1627597588325891,0.6829650583151802,0,0,1.8534704370179949,3.364938578662175,KCNQ1;PDE2A;RAPGEF2;AKAP6;RAPGEF3,Hypo
938,GO_Biological_Process_2018,protein catabolic process (GO:0030163),11/81,0.1629671828608418,0.6829650583151802,0,0,1.4571575922787887,2.6435846742915565,NEU4;LAMP2;DAB2IP;DENND3;TPP1;IDE;NR1D1;CTSD;FBXO44;MTOR;RNF41,Hypo
939,GO_Biological_Process_2018,long-chain fatty acid metabolic process (GO:0001676),8/55,0.1633290390791824,0.6829650583151802,0,0,1.577930188224467,2.859191304755465,DAGLA;ACADL;HSD17B4;ALOX12B;DAGLB;AIG1;ALOXE3;MGLL,Hypo
940,GO_Biological_Process_2018,negative regulation of cellular response to growth factor stimulus (GO:0090288),8/55,0.1633290390791824,0.6829650583151802,0,0,1.577930188224467,2.859191304755465,SMURF1;HTRA3;SPRY4;DAB2IP;LEMD2;FAM129B;SULF2;SMAD7,Hypo
941,GO_Biological_Process_2018,fat cell differentiation (GO:0045444),8/55,0.1633290390791824,0.6829650583151802,0,0,1.577930188224467,2.859191304755465,CLIP3;PER2;NR4A1;WNT5B;CTBP2;PRDM16;ALOXE3;BBS4,Hypo
942,GO_Biological_Process_2018,positive regulation of hydrolase activity (GO:0051345),21/172,0.166810075826031,0.6834824966453518,0,0,1.2904431833396846,2.3110539024539625,RIC1;SEMA4D;DOCK9;RAP1GDS1;RASGRP1;RAP1GAP;BCR;DNAJB2;ABR;ARHGAP21;LARS;SGSM3;TBC1D30;SGSM2;NF1;PIN1;RAPGEF2;CALM3;ITGA6;ARHGEF7;RAPGEF3,Hypo
943,GO_Biological_Process_2018,transcription from RNA polymerase II promoter (GO:0006366),54/485,0.167357327656942,0.6834824966453518,0,0,1.164285294722312,2.0813044123795605,RARG;ELL;THRA;TGFB1I1;RORA;MED16;TRPS1;NFRKB;TEAD1;GTF2I;SOX5;KLF13;ASH1L;RUNX2;MED24;NFX1;ZC3H11A;DDIT3;RARA;SRSF4;MAML3;PPARD;CTDP1;NFIX;HLF;KMT2A;EPAS1;CSTF2;DTX1;WDR61;MLLT1;GTF2E1;GLIS1;MNT;RXRA;DVL1;DVL2;HIVEP1;SYMPK;HIVEP3;RXRG;INTS1;NFATC2;ESRRG;NR1D1;POU2F2;NR4A1;NR6A1;NFIC;ERCC2;INTS7;TCF4;ERCC6;TAF4,Hypo
944,GO_Biological_Process_2018,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),9/64,0.1678619802236595,0.6834824966453518,0,0,1.5170717999156949,2.70738633447705,PTPRT;CADM3;DSCAM;CADM1;CDH22;PKD1;DSCAML1;PCDHA7;SDK2,Hypo
945,GO_Biological_Process_2018,positive regulation of endocytosis (GO:0045807),9/64,0.1678619802236595,0.6834824966453518,0,0,1.5170717999156949,2.70738633447705,CLIP3;TUB;HIP1;LRP1;HIP1R;NEDD4L;LDLRAP1;DOCK2;LDLR,Hypo
946,GO_Biological_Process_2018,negative regulation of neuron differentiation (GO:0045665),9/64,0.1678619802236595,0.6834824966453518,0,0,1.5170717999156949,2.70738633447705,SOX3;DISP3;KANK1;PTPRS;ERCC2;DTX1;SPOCK1;RTN4RL2;EIF2AK4,Hypo
947,GO_Biological_Process_2018,ion transmembrane transport (GO:0034220),26/219,0.1700411640900377,0.6834824966453518,0,0,1.2503150819212996,2.2152016472026554,RYR1;RYR2;ATP8A1;NEDD4L;ATP1A2;TCIRG1;RYR3;CALHM2;LRRC8D;ATP6V1E1;ASIC2;ATP6V0A1;ASIC1;SLC13A3;ATP8B2;KCND3;TSC22D3;ATP11C;ATP2B1;TPCN1;CLCN6;CLCN5;P2RX4;ATP13A2;SGK1;KCNK3,Hypo
948,GO_Biological_Process_2018,positive regulation of protein kinase B signaling (GO:0051897),16/127,0.1730399600824425,0.6834824966453518,0,0,1.3370226482946237,2.3454488877442063,PDGFRA;KL;HIP1;SRC;PDGFA;IRS2;PTPN11;MST1R;PIK3R1;NRG2;FGF1;EREG;KIT;ITGB1BP1;FYN;FGFR2,Hypo
949,GO_Biological_Process_2018,Wnt signaling pathway (GO:0016055),14/109,0.1741710915121871,0.6834824966453518,0,0,1.366735537190083,2.388667176570804,CSNK1G3;RARG;WNT5B;LRRK2;TCF7;WNT9B;LRP4;AXIN2;TNKS2;FRZB;DVL1;OTULIN;DVL2;BTRC,Hypo
950,GO_Biological_Process_2018,regulation of cell motility (GO:2000145),14/109,0.1741710915121871,0.6834824966453518,0,0,1.366735537190083,2.388667176570804,PLXND1;MEMO1;NRG2;SRCIN1;NTN1;EREG;DIAPH1;LMNA;ABL1;ABL2;PIN1;FLNA;AMOTL2;SGK1,Hypo
951,GO_Biological_Process_2018,positive regulation of ERK1 and ERK2 cascade (GO:0070374),24/201,0.1741763934096362,0.6834824966453518,0,0,1.2582853723357446,2.199088657904213,PDGFRA;SEMA7A;FLT4;NTRK3;PDGFA;LMTK2;PRKCA;PTPN11;MST1R;PLA2G5;HMGB1;PRKCZ;RASGRP1;DSTYK;KIT;TYRO3;RAPGEF2;PTK2B;ACKR3;PRKD2;EPHB2;EPHB1;PDE8A;FGFR2,Hypo
952,GO_Biological_Process_2018,regulation of mRNA metabolic process (GO:1903311),3/15,0.1744443999262634,0.6834824966453518,0,0,2.316127375449409,4.044303994255914,SRPK2;PTCD2;SRPK1,Hypo
953,GO_Biological_Process_2018,maintenance of protein location in nucleus (GO:0051457),3/15,0.1744443999262634,0.6834824966453518,0,0,2.316127375449409,4.044303994255914,SUN1;BBS4;SYNE1,Hypo
954,GO_Biological_Process_2018,regulation of protein homooligomerization (GO:0032462),3/15,0.1744443999262634,0.6834824966453518,0,0,2.316127375449409,4.044303994255914,HRK;SRC;CRYAB,Hypo
955,GO_Biological_Process_2018,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),3/15,0.1744443999262634,0.6834824966453518,0,0,2.316127375449409,4.044303994255914,PDGFRA;LRP1;PDGFA,Hypo
956,GO_Biological_Process_2018,positive regulation of small GTPase mediated signal transduction (GO:0051057),3/15,0.1744443999262634,0.6834824966453518,0,0,2.316127375449409,4.044303994255914,EPO;SRC;RASGRP1,Hypo
957,GO_Biological_Process_2018,L-alpha-amino acid transmembrane transport (GO:1902475),3/15,0.1744443999262634,0.6834824966453518,0,0,2.316127375449409,4.044303994255914,SLC7A5;SLC25A29;SLC7A1,Hypo
958,GO_Biological_Process_2018,lipoxygenase pathway (GO:0019372),3/15,0.1744443999262634,0.6834824966453518,0,0,2.316127375449409,4.044303994255914,GPX4;ALOX12B;ALOXE3,Hypo
959,GO_Biological_Process_2018,regulation of interleukin-4 production (GO:0032673),3/15,0.1744443999262634,0.6834824966453518,0,0,2.316127375449409,4.044303994255914,RARA;FOXP3;PRKCZ,Hypo
960,GO_Biological_Process_2018,positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),3/15,0.1744443999262634,0.6834824966453518,0,0,2.316127375449409,4.044303994255914,ELL;WDR61;BRD4,Hypo
961,GO_Biological_Process_2018,sodium ion import (GO:0097369),3/15,0.1744443999262634,0.6834824966453518,0,0,2.316127375449409,4.044303994255914,SLC9A6;SLC9A8;SLC9A1,Hypo
962,GO_Biological_Process_2018,regulation of clathrin-dependent endocytosis (GO:2000369),3/15,0.1744443999262634,0.6834824966453518,0,0,2.316127375449409,4.044303994255914,TNK2;HIP1R;UBQLN2,Hypo
963,GO_Biological_Process_2018,positive regulation of phosphoprotein phosphatase activity (GO:0032516),3/15,0.1744443999262634,0.6834824966453518,0,0,2.316127375449409,4.044303994255914,AKAP6;CALM3;MTOR,Hypo
964,GO_Biological_Process_2018,negative regulation of cellular component movement (GO:0051271),3/15,0.1744443999262634,0.6834824966453518,0,0,2.316127375449409,4.044303994255914,ACTN1;CD9;PIN1,Hypo
965,GO_Biological_Process_2018,sodium ion import across plasma membrane (GO:0098719),3/15,0.1744443999262634,0.6834824966453518,0,0,2.316127375449409,4.044303994255914,SLC9A6;SLC9A8;SLC9A1,Hypo
966,GO_Biological_Process_2018,negative regulation of cytokine production involved in immune response (GO:0002719),3/15,0.1744443999262634,0.6834824966453518,0,0,2.316127375449409,4.044303994255914,TGFB3;FOXP3;SMAD7,Hypo
967,GO_Biological_Process_2018,positive regulation of collagen metabolic process (GO:0010714),3/15,0.1744443999262634,0.6834824966453518,0,0,2.316127375449409,4.044303994255914,TGFB3;CREB3L1;F2,Hypo
968,GO_Biological_Process_2018,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),3/15,0.1744443999262634,0.6834824966453518,0,0,2.316127375449409,4.044303994255914,ADGRB1;MAPK14;RAPGEF3,Hypo
969,GO_Biological_Process_2018,positive regulation of collagen biosynthetic process (GO:0032967),3/15,0.1744443999262634,0.6834824966453518,0,0,2.316127375449409,4.044303994255914,TGFB3;CREB3L1;F2,Hypo
970,GO_Biological_Process_2018,embryonic cranial skeleton morphogenesis (GO:0048701),3/15,0.1744443999262634,0.6834824966453518,0,0,2.316127375449409,4.044303994255914,PDGFRA;MTHFD1;FGFR2,Hypo
971,GO_Biological_Process_2018,regulation of cell junction assembly (GO:1901888),3/15,0.1744443999262634,0.6834824966453518,0,0,2.316127375449409,4.044303994255914,TJP1;PRKCH;RAPGEF2,Hypo
972,GO_Biological_Process_2018,cellular sodium ion homeostasis (GO:0006883),3/15,0.1744443999262634,0.6834824966453518,0,0,2.316127375449409,4.044303994255914,NEDD4L;ATP1A2;SLC9A1,Hypo
973,GO_Biological_Process_2018,regulation of cartilage development (GO:0061035),3/15,0.1744443999262634,0.6834824966453518,0,0,2.316127375449409,4.044303994255914,ZBTB16;TRPS1;SOX5,Hypo
974,GO_Biological_Process_2018,septin ring assembly (GO:0000921),3/15,0.1744443999262634,0.6834824966453518,0,0,2.316127375449409,4.044303994255914,SEPT8;SEPT9;SEPT11,Hypo
975,GO_Biological_Process_2018,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",6/39,0.1752029540315568,0.6834824966453518,0,0,1.6850916573138794,2.935109903561361,MBNL1;MBNL2;RBFOX3;CELF4;CELF5;MBNL3,Hypo
976,GO_Biological_Process_2018,inositol lipid-mediated signaling (GO:0048017),6/39,0.1752029540315568,0.6834824966453518,0,0,1.6850916573138794,2.935109903561361,PDGFRA;PITPNM2;PI4KA;IRS2;PIK3R1;KCNH1,Hypo
977,GO_Biological_Process_2018,regulation of plasma membrane bounded cell projection assembly (GO:0120032),6/39,0.1752029540315568,0.6834824966453518,0,0,1.6850916573138794,2.935109903561361,PPP1R16B;CAPZB;MYO10;IFT140;TWF2;SSH1,Hypo
978,GO_Biological_Process_2018,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),6/39,0.1752029540315568,0.6834824966453518,0,0,1.6850916573138794,2.935109903561361,TMBIM1;MADD;TMC8;FAIM2;ARHGEF2;RFFL,Hypo
979,GO_Biological_Process_2018,positive regulation of protein transport (GO:0051222),8/56,0.1753768070009492,0.6834824966453518,0,0,1.5449708204600068,2.6895136888407136,TENM1;RIPOR1;TGFB3;MYO18A;ATP13A2;PCNT;OAZ1;MYH10,Hypo
980,GO_Biological_Process_2018,skeletal system development (GO:0001501),18/146,0.178346820910111,0.6834824966453518,0,0,1.304493400621118,2.248979485915332,WWOX;IFT140;ANKRD11;ZBTB16;P3H1;PKD1;SGPP2;PAPSS1;SULF2;TCOF1;FRZB;TRPS1;CREB3L2;GNAS;DYM;PPIB;FGFR2;CMKLR1,Hypo
981,GO_Biological_Process_2018,positive regulation of macrophage differentiation (GO:0045651),2/8,0.1794629092694294,0.6834824966453518,0,0,3.087611225188227,5.303857577682986,IL34;PRKCA,Hypo
982,GO_Biological_Process_2018,regulation of establishment of protein localization to mitochondrion (GO:1903747),2/8,0.1794629092694294,0.6834824966453518,0,0,3.087611225188227,5.303857577682986,SREBF1;MAPT,Hypo
983,GO_Biological_Process_2018,neurotransmitter receptor diffusion trapping (GO:0099628),2/8,0.1794629092694294,0.6834824966453518,0,0,3.087611225188227,5.303857577682986,CACNG2;CACNG4,Hypo
984,GO_Biological_Process_2018,response to magnesium ion (GO:0032026),2/8,0.1794629092694294,0.6834824966453518,0,0,3.087611225188227,5.303857577682986,ANK3;RYR3,Hypo
985,GO_Biological_Process_2018,ventricular cardiac muscle cell membrane repolarization (GO:0099625),2/8,0.1794629092694294,0.6834824966453518,0,0,3.087611225188227,5.303857577682986,KCND3;KCNQ1,Hypo
986,GO_Biological_Process_2018,negative regulation of toll-like receptor 4 signaling pathway (GO:0034144),2/8,0.1794629092694294,0.6834824966453518,0,0,3.087611225188227,5.303857577682986,DAB2IP;NR1D1,Hypo
987,GO_Biological_Process_2018,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),2/8,0.1794629092694294,0.6834824966453518,0,0,3.087611225188227,5.303857577682986,NSMCE2;DLGAP5,Hypo
988,GO_Biological_Process_2018,cardiolipin biosynthetic process (GO:0032049),2/8,0.1794629092694294,0.6834824966453518,0,0,3.087611225188227,5.303857577682986,TAMM41;PDXP,Hypo
989,GO_Biological_Process_2018,negative regulation of activated T cell proliferation (GO:0046007),2/8,0.1794629092694294,0.6834824966453518,0,0,3.087611225188227,5.303857577682986,PRKAR1A;FOXP3,Hypo
990,GO_Biological_Process_2018,transepithelial transport (GO:0070633),2/8,0.1794629092694294,0.6834824966453518,0,0,3.087611225188227,5.303857577682986,RHCG;GPLD1,Hypo
991,GO_Biological_Process_2018,regulation of cytoplasmic transport (GO:1903649),2/8,0.1794629092694294,0.6834824966453518,0,0,3.087611225188227,5.303857577682986,SRC;LRRK2,Hypo
992,GO_Biological_Process_2018,positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316),2/8,0.1794629092694294,0.6834824966453518,0,0,3.087611225188227,5.303857577682986,AKAP6;CALM3,Hypo
993,GO_Biological_Process_2018,negative regulation of voltage-gated potassium channel activity (GO:1903817),2/8,0.1794629092694294,0.6834824966453518,0,0,3.087611225188227,5.303857577682986,KCNAB1;ANK3,Hypo
994,GO_Biological_Process_2018,central nervous system myelination (GO:0022010),2/8,0.1794629092694294,0.6834824966453518,0,0,3.087611225188227,5.303857577682986,CNTNAP1;TENM4,Hypo
995,GO_Biological_Process_2018,deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),2/8,0.1794629092694294,0.6834824966453518,0,0,3.087611225188227,5.303857577682986,DCP1A;DCPS,Hypo
996,GO_Biological_Process_2018,dimeric G-protein coupled receptor signaling pathway (GO:0038042),2/8,0.1794629092694294,0.6834824966453518,0,0,3.087611225188227,5.303857577682986,RAMP1;GRM1,Hypo
997,GO_Biological_Process_2018,protein localization to endosome (GO:0036010),2/8,0.1794629092694294,0.6834824966453518,0,0,3.087611225188227,5.303857577682986,ACAP2;PACSIN2,Hypo
998,GO_Biological_Process_2018,regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),2/8,0.1794629092694294,0.6834824966453518,0,0,3.087611225188227,5.303857577682986,BIN1;SORL1,Hypo
999,GO_Biological_Process_2018,positive regulation of regulatory T cell differentiation (GO:0045591),2/8,0.1794629092694294,0.6834824966453518,0,0,3.087611225188227,5.303857577682986,BCL6;FOXP3,Hypo
1000,GO_Biological_Process_2018,heterochromatin assembly (GO:0031507),2/8,0.1794629092694294,0.6834824966453518,0,0,3.087611225188227,5.303857577682986,TNRC18;BAHCC1,Hypo
1001,GO_Biological_Process_2018,positive regulation of monocyte differentiation (GO:0045657),2/8,0.1794629092694294,0.6834824966453518,0,0,3.087611225188227,5.303857577682986,IL34;ACIN1,Hypo
1002,GO_Biological_Process_2018,phospholipid homeostasis (GO:0055091),2/8,0.1794629092694294,0.6834824966453518,0,0,3.087611225188227,5.303857577682986,ABCA1;ABCG1,Hypo
1003,GO_Biological_Process_2018,ketone body biosynthetic process (GO:0046951),2/8,0.1794629092694294,0.6834824966453518,0,0,3.087611225188227,5.303857577682986,BDH2;AACS,Hypo
1004,GO_Biological_Process_2018,regulation of lipid transport (GO:0032368),2/8,0.1794629092694294,0.6834824966453518,0,0,3.087611225188227,5.303857577682986,DISP3;LRP1,Hypo
1005,GO_Biological_Process_2018,cellular biogenic amine catabolic process (GO:0042402),2/8,0.1794629092694294,0.6834824966453518,0,0,3.087611225188227,5.303857577682986,DMGDH;SMOX,Hypo
1006,GO_Biological_Process_2018,negative regulation of cilium assembly (GO:1902018),2/8,0.1794629092694294,0.6834824966453518,0,0,3.087611225188227,5.303857577682986,TBC1D30;MAP4,Hypo
1007,GO_Biological_Process_2018,regulation of T-helper 2 cell differentiation (GO:0045628),2/8,0.1794629092694294,0.6834824966453518,0,0,3.087611225188227,5.303857577682986,RARA;PRKCZ,Hypo
1008,GO_Biological_Process_2018,regulation of amyloid fibril formation (GO:1905906),2/8,0.1794629092694294,0.6834824966453518,0,0,3.087611225188227,5.303857577682986,CRYAB;LDLR,Hypo
1009,GO_Biological_Process_2018,regulation of long term synaptic depression (GO:1900452),2/8,0.1794629092694294,0.6834824966453518,0,0,3.087611225188227,5.303857577682986,MAPT;SHANK3,Hypo
1010,GO_Biological_Process_2018,positive regulation of chemokine secretion (GO:0090197),2/8,0.1794629092694294,0.6834824966453518,0,0,3.087611225188227,5.303857577682986,IL33;MBP,Hypo
1011,GO_Biological_Process_2018,peptidyl-lysine monomethylation (GO:0018026),2/8,0.1794629092694294,0.6834824966453518,0,0,3.087611225188227,5.303857577682986,SETD4;SMYD2,Hypo
1012,GO_Biological_Process_2018,glycerol-3-phosphate metabolic process (GO:0006072),2/8,0.1794629092694294,0.6834824966453518,0,0,3.087611225188227,5.303857577682986,GNPAT;GPAM,Hypo
1013,GO_Biological_Process_2018,histone H3-K36 demethylation (GO:0070544),2/8,0.1794629092694294,0.6834824966453518,0,0,3.087611225188227,5.303857577682986,KDM4A;KDM4B,Hypo
1014,GO_Biological_Process_2018,postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),2/8,0.1794629092694294,0.6834824966453518,0,0,3.087611225188227,5.303857577682986,CACNG2;CACNG4,Hypo
1015,GO_Biological_Process_2018,regulation of keratinocyte migration (GO:0051547),2/8,0.1794629092694294,0.6834824966453518,0,0,3.087611225188227,5.303857577682986,EPB41L4B;MTOR,Hypo
1016,GO_Biological_Process_2018,succinate metabolic process (GO:0006105),2/8,0.1794629092694294,0.6834824966453518,0,0,3.087611225188227,5.303857577682986,ALDH5A1;GAD1,Hypo
1017,GO_Biological_Process_2018,barbed-end actin filament capping (GO:0051016),2/8,0.1794629092694294,0.6834824966453518,0,0,3.087611225188227,5.303857577682986,CAPZB;TWF2,Hypo
1018,GO_Biological_Process_2018,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),2/8,0.1794629092694294,0.6834824966453518,0,0,3.087611225188227,5.303857577682986,CACNB1;NOS1AP,Hypo
1019,GO_Biological_Process_2018,4-hydroxyproline metabolic process (GO:0019471),2/8,0.1794629092694294,0.6834824966453518,0,0,3.087611225188227,5.303857577682986,EGLN1;HOGA1,Hypo
1020,GO_Biological_Process_2018,negative regulation of glial cell differentiation (GO:0045686),2/8,0.1794629092694294,0.6834824966453518,0,0,3.087611225188227,5.303857577682986,NF1;F2,Hypo
1021,GO_Biological_Process_2018,cellular response to angiotensin (GO:1904385),2/8,0.1794629092694294,0.6834824966453518,0,0,3.087611225188227,5.303857577682986,AHCYL1;CAMK2A,Hypo
1022,GO_Biological_Process_2018,negative regulation of anion transmembrane transport (GO:1903960),2/8,0.1794629092694294,0.6834824966453518,0,0,3.087611225188227,5.303857577682986,STK39;IRS2,Hypo
1023,GO_Biological_Process_2018,"nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",2/8,0.1794629092694294,0.6834824966453518,0,0,3.087611225188227,5.303857577682986,EDC4;DCP1A,Hypo
1024,GO_Biological_Process_2018,cellular cation homeostasis (GO:0030003),2/8,0.1794629092694294,0.6834824966453518,0,0,3.087611225188227,5.303857577682986,ATP13A2;LETMD1,Hypo
1025,GO_Biological_Process_2018,negative regulation of T-helper cell differentiation (GO:0045623),2/8,0.1794629092694294,0.6834824966453518,0,0,3.087611225188227,5.303857577682986,FOXP3;SMAD7,Hypo
1026,GO_Biological_Process_2018,excitatory synapse assembly (GO:1904861),2/8,0.1794629092694294,0.6834824966453518,0,0,3.087611225188227,5.303857577682986,SHANK3;SHANK2,Hypo
1027,GO_Biological_Process_2018,anterograde axonal transport (GO:0008089),5/31,0.1795296250710375,0.6834824966453518,0,0,1.7820842396677872,3.060578280195664,BLOC1S5;KIF1B;HAP1;TRAK1;AP3B2,Hypo
1028,GO_Biological_Process_2018,positive regulation of viral genome replication (GO:0045070),5/31,0.1795296250710375,0.6834824966453518,0,0,1.7820842396677872,3.060578280195664,SRPK2;ADARB1;PPIB;FKBP6;SRPK1,Hypo
1029,GO_Biological_Process_2018,positive regulation of bone mineralization (GO:0030501),5/31,0.1795296250710375,0.6834824966453518,0,0,1.7820842396677872,3.060578280195664,FBN2;KL;TGFB3;TMEM119;GPM6B,Hypo
1030,GO_Biological_Process_2018,negative regulation of toll-like receptor signaling pathway (GO:0034122),5/31,0.1795296250710375,0.6834824966453518,0,0,1.7820842396677872,3.060578280195664,PTPRS;NFKBIL1;DAB2IP;TYRO3;NR1D1,Hypo
1031,GO_Biological_Process_2018,positive regulation of transferase activity (GO:0051347),17/137,0.1797576219787332,0.6834824966453518,0,0,1.3140627694430074,2.2551234079202658,PDGFRA;VAC14;FLT4;NTRK3;LMTK2;MST1R;SORL1;DSTYK;KIT;TYRO3;PIN1;EPHB2;EPHB1;MAP3K4;FGFR2;SERINC5;WRAP53,Hypo
1032,GO_Biological_Process_2018,positive regulation of ERBB signaling pathway (GO:1901186),4/23,0.1808044583661986,0.6834824966453518,0,0,1.950668036998972,3.3363039556827068,AFAP1L2;HIP1;HIP1R;HAP1,Hypo
1033,GO_Biological_Process_2018,lamellipodium assembly (GO:0030032),4/23,0.1808044583661986,0.6834824966453518,0,0,1.950668036998972,3.3363039556827068,ABLIM1;ABLIM2;KIT;ARHGEF7,Hypo
1034,GO_Biological_Process_2018,vesicle-mediated transport between endosomal compartments (GO:0098927),4/23,0.1808044583661986,0.6834824966453518,0,0,1.950668036998972,3.3363039556827068,ANKRD27;AKTIP;STX8;LMTK2,Hypo
1035,GO_Biological_Process_2018,cellular response to ammonium ion (GO:0071242),4/23,0.1808044583661986,0.6834824966453518,0,0,1.950668036998972,3.3363039556827068,DIAPH1;LRRK2;ABL1;PPP1R9B,Hypo
1036,GO_Biological_Process_2018,negative regulation of axonogenesis (GO:0050771),4/23,0.1808044583661986,0.6834824966453518,0,0,1.950668036998972,3.3363039556827068,PTPRS;ERCC2;LRP4;FGF13,Hypo
1037,GO_Biological_Process_2018,divalent inorganic cation homeostasis (GO:0072507),4/23,0.1808044583661986,0.6834824966453518,0,0,1.950668036998972,3.3363039556827068,TMC8;ATP13A2;ANK3;FAM20A,Hypo
1038,GO_Biological_Process_2018,positive regulation of ion transmembrane transporter activity (GO:0032414),4/23,0.1808044583661986,0.6834824966453518,0,0,1.950668036998972,3.3363039556827068,WNK2;STK39;ANK3;PDZK1,Hypo
1039,GO_Biological_Process_2018,regulation of microtubule cytoskeleton organization (GO:0070507),4/23,0.1808044583661986,0.6834824966453518,0,0,1.950668036998972,3.3363039556827068,PHLDB1;MAPT;CLASP1;CLASP2,Hypo
1040,GO_Biological_Process_2018,cholesterol efflux (GO:0033344),4/23,0.1808044583661986,0.6834824966453518,0,0,1.950668036998972,3.3363039556827068,ABCA1;SCARB1;SOAT1;ABCG1,Hypo
1041,GO_Biological_Process_2018,melanosome organization (GO:0032438),4/23,0.1808044583661986,0.6834824966453518,0,0,1.950668036998972,3.3363039556827068,BLOC1S5;HPS1;KIF13A;HPS4,Hypo
1042,GO_Biological_Process_2018,negative regulation of signaling (GO:0023057),11/83,0.1827702483730241,0.6876504362109805,0,0,1.4165234084006648,2.407417495668596,PDGFRA;KIF26A;FLT4;NTRK3;KIT;TYRO3;LMTK2;MST1R;EPHB2;EPHB1;FGFR2,Hypo
1043,GO_Biological_Process_2018,establishment of protein localization to membrane (GO:0090150),11/83,0.1827702483730241,0.6876504362109805,0,0,1.4165234084006648,2.407417495668596,NSF;GOLGA4;RAB31;RILPL2;RILPL1;KIF13A;RAB3IP;RAB3GAP2;ZDHHC7;ANK3;SYNE3,Hypo
1044,GO_Biological_Process_2018,negative regulation of neuron death (GO:1901215),11/83,0.1827702483730241,0.6876504362109805,0,0,1.4165234084006648,2.407417495668596,CDK5;UNC5B;TGFB3;LRRK2;ERCC2;TYRO3;AGAP2;PTK2B;ATP13A2;SORL1;RETREG1,Hypo
1045,GO_Biological_Process_2018,protein maturation (GO:0051604),11/83,0.1827702483730241,0.6876504362109805,0,0,1.4165234084006648,2.407417495668596,RHBDF1;POP5;TSPAN15;TSPAN14;RHBDF2;TSPAN5;ECE1;CPXM1;FURIN;PCSK7;SORL1,Hypo
1046,GO_Biological_Process_2018,glycoprotein metabolic process (GO:0009100),7/48,0.1829544699540765,0.6876504362109805,0,0,1.5824535857298871,2.687825828571507,NEU4;TNIP1;MGAT4A;MAN1C1;ST6GALNAC3;ST3GAL2;ENGASE,Hypo
1047,GO_Biological_Process_2018,regulation of mitochondrion organization (GO:0010821),7/48,0.1829544699540765,0.6876504362109805,0,0,1.5824535857298871,2.687825828571507,SREBF1;INF2;LRRK2;ATP13A2;MAPT;WBP11;MYO19,Hypo
1048,GO_Biological_Process_2018,regulation of cell migration (GO:0030334),36/316,0.1835436591741835,0.689207315049675,0,0,1.1936856247201075,2.023658480602206,KANK1;RIPOR1;SEMA7A;PLXND1;SRC;ZMYND8;ULK4;PDGFA;ADARB1;LDLRAD4;FGF1;SYNE2;CORO1C;LMNA;FLNA;PTK2B;RFFL;PDGFRA;SEMA4A;WNT5B;SEMA4D;NTRK3;SEMA4C;PRKCA;SRCIN1;SORL1;RNF41;SMAD7;TIAM1;STK24;NF1;FGFR1OP;AMOTL2;ITGA6;SGK1;BCAR1,Hypo
1049,GO_Biological_Process_2018,response to retinoic acid (GO:0032526),8/57,0.1878049736750997,0.7045369441011599,0,0,1.5133567330124635,2.530863991862898,RARG;RXRA;WNT5B;WNT9B;RARA;TWF2;ABL2;PTK2B,Hypo
1050,GO_Biological_Process_2018,cognition (GO:0050890),6/40,0.1903235685937134,0.7119511269616688,0,0,1.635439360929557,2.7132424112815507,HRH3;GNAS;NF1;JAKMIP1;SOBP;BBS4,Hypo
1051,GO_Biological_Process_2018,ameboidal-type cell migration (GO:0001667),6/40,0.1903235685937134,0.7119511269616688,0,0,1.635439360929557,2.7132424112815507,SEMA4A;SEMA7A;SEMA4D;SEMA4C;AMOTL2;CORO1C,Hypo
1052,GO_Biological_Process_2018,androgen receptor signaling pathway (GO:0030521),6/40,0.1903235685937134,0.7119511269616688,0,0,1.635439360929557,2.7132424112815507,NCOA1;KDM3A;MED24;TGFB1I1;PMEPA1;MED16,Hypo
1053,GO_Biological_Process_2018,regulation of canonical Wnt signaling pathway (GO:0060828),25/213,0.190771134208745,0.7129482899888487,0,0,1.2339043934788616,2.044185741930277,AMER2;LRRK2;JADE1;LRP4;LIMD1;STK4;SCEL;TNKS2;FRZB;DVL1;DVL2;NPHP4;IGFBP6;BTRC;ANKRD6;DAB2IP;AXIN2;BICC1;DKK3;SDHAF2;DDIT3;WNK2;PIN1;CDK14;FGFR2,Hypo
1054,GO_Biological_Process_2018,regulation of mitotic nuclear division (GO:0007088),11/84,0.1930725506533129,0.7201825539994315,0,0,1.3970412654454,2.2976987519128453,CUL9;PMEPA1;TGFA;PDXP;PIN1;CEP85;CCSAP;MAP9;PPP1R9B;EREG;CHMP5,Hypo
1055,GO_Biological_Process_2018,regulation of neuron differentiation (GO:0045664),11/84,0.1930725506533129,0.7201825539994315,0,0,1.3970412654454,2.2976987519128453,SOX3;DISP3;TIAM1;BIN1;LRRK2;ULK4;NCS1;DTX1;TCF4;ARHGEF2;EIF2AK4,Hypo
1056,GO_Biological_Process_2018,cellular response to glucagon stimulus (GO:0071377),5/32,0.1969085309617945,0.7250638566917932,0,0,1.7159859087879654,2.7885045024854715,ADCY9;PRKAR1B;PRKAR1A;GNB2;ADCY3,Hypo
1057,GO_Biological_Process_2018,central nervous system neuron differentiation (GO:0021953),5/32,0.1969085309617945,0.7250638566917932,0,0,1.7159859087879654,2.7885045024854715,WNT9B;CHD5;SPOCK1;FAIM2;MAPT,Hypo
1058,GO_Biological_Process_2018,mitochondrial transmembrane transport (GO:1990542),5/32,0.1969085309617945,0.7250638566917932,0,0,1.7159859087879654,2.7885045024854715,MID1IP1;PRKAG2;THRSP;SLC25A23;ACACB,Hypo
1059,GO_Biological_Process_2018,G2 DNA damage checkpoint (GO:0031572),5/32,0.1969085309617945,0.7250638566917932,0,0,1.7159859087879654,2.7885045024854715,BABAM2;CLSPN;FOXN3;STK4;MAP3K14,Hypo
1060,GO_Biological_Process_2018,positive regulation of dendrite development (GO:1900006),5/32,0.1969085309617945,0.7250638566917932,0,0,1.7159859087879654,2.7885045024854715,FBXW8;DAB2IP;CPEB3;SHANK3;SHANK2,Hypo
1061,GO_Biological_Process_2018,ceramide biosynthetic process (GO:0046513),5/32,0.1969085309617945,0.7250638566917932,0,0,1.7159859087879654,2.7885045024854715,SMPD4;ALOX12B;B4GALNT1;ST6GALNAC3;ALOXE3,Hypo
1062,GO_Biological_Process_2018,protein glycosylation (GO:0006486),16/130,0.1974777838011726,0.7250638566917932,0,0,1.301620130989314,2.1113960062322423,PARP3;B4GALT1;PMM1;GALNT2;TET1;TRAK1;POMGNT1;DDOST;GOLGA2;DPM3;TNKS2;B3GALT1;TET3;MAN1C1;ST3GAL2;GALNT9,Hypo
1063,GO_Biological_Process_2018,"DNA-templated transcription, initiation (GO:0006352)",22/186,0.1987245796530328,0.7250638566917932,0,0,1.244471713389333,2.010861492031757,GTF3C1;RARG;THRA;RORA;ESRRG;NR1D1;MED16;GTF2E1;RUNX2;NR4A1;MED24;RXRA;NR6A1;ERCC2;RARA;TCF4;MAML3;TAF4;TEAD1;RXRG;GTF2I;PPARD,Hypo
1064,GO_Biological_Process_2018,negative regulation of cell migration (GO:0030336),15/121,0.1992294991536268,0.7250638566917932,0,0,1.3122714640924382,2.1170847403960766,KANK1;LRP1;ZMYND8;DAB2IP;ADARB1;LDLRAD4;RNF41;CORO1C;SMAD7;STK24;NF1;ITGB1BP1;TRIB1;CLASP1;CLASP2,Hypo
1065,GO_Biological_Process_2018,peptidyl-threonine dephosphorylation (GO:0035970),3/16,0.2000937866677156,0.7250638566917932,0,0,2.137845205641816,3.439726852966764,DUSP5;DUSP1;PPM1F,Hypo
1066,GO_Biological_Process_2018,positive regulation of regulated secretory pathway (GO:1903307),3/16,0.2000937866677156,0.7250638566917932,0,0,2.137845205641816,3.439726852966764,CACNA1I;RAB15;STX1A,Hypo
1067,GO_Biological_Process_2018,cytoplasmic sequestering of transcription factor (GO:0042994),3/16,0.2000937866677156,0.7250638566917932,0,0,2.137845205641816,3.439726852966764,NFKBIL1;MXI1;PKD1,Hypo
1068,GO_Biological_Process_2018,regulation of water loss via skin (GO:0033561),3/16,0.2000937866677156,0.7250638566917932,0,0,2.137845205641816,3.439726852966764,KDF1;ALOX12B;ALOXE3,Hypo
1069,GO_Biological_Process_2018,stabilization of membrane potential (GO:0030322),3/16,0.2000937866677156,0.7250638566917932,0,0,2.137845205641816,3.439726852966764,KCNK6;KCNK13;KCNK3,Hypo
1070,GO_Biological_Process_2018,regulation of bicellular tight junction assembly (GO:2000810),3/16,0.2000937866677156,0.7250638566917932,0,0,2.137845205641816,3.439726852966764,TJP1;PRKCH;NPHP4,Hypo
1071,GO_Biological_Process_2018,positive regulation of cardiac muscle hypertrophy (GO:0010613),3/16,0.2000937866677156,0.7250638566917932,0,0,2.137845205641816,3.439726852966764,PRKCA;AKAP6;SLC9A1,Hypo
1072,GO_Biological_Process_2018,DNA methylation or demethylation (GO:0044728),3/16,0.2000937866677156,0.7250638566917932,0,0,2.137845205641816,3.439726852966764,ATF7IP;DNMT3A;GATAD2A,Hypo
1073,GO_Biological_Process_2018,positive regulation of myotube differentiation (GO:0010831),3/16,0.2000937866677156,0.7250638566917932,0,0,2.137845205641816,3.439726852966764,ADGRB1;MAPK14;FAM129B,Hypo
1074,GO_Biological_Process_2018,miRNA metabolic process (GO:0010586),3/16,0.2000937866677156,0.7250638566917932,0,0,2.137845205641816,3.439726852966764,AGO2;BCDIN3D;DROSHA,Hypo
1075,GO_Biological_Process_2018,regulation of steroid metabolic process (GO:0019218),3/16,0.2000937866677156,0.7250638566917932,0,0,2.137845205641816,3.439726852966764,ACADL;RORA;ABCG1,Hypo
1076,GO_Biological_Process_2018,bone morphogenesis (GO:0060349),3/16,0.2000937866677156,0.7250638566917932,0,0,2.137845205641816,3.439726852966764,RARG;RARA;FGFR2,Hypo
1077,GO_Biological_Process_2018,positive regulation of response to endoplasmic reticulum stress (GO:1905898),3/16,0.2000937866677156,0.7250638566917932,0,0,2.137845205641816,3.439726852966764,DDIT3;PIK3R1;BOK,Hypo
1078,GO_Biological_Process_2018,postsynaptic membrane organization (GO:0001941),3/16,0.2000937866677156,0.7250638566917932,0,0,2.137845205641816,3.439726852966764,NRXN2;LRP4;SHANK3,Hypo
1079,GO_Biological_Process_2018,DNA alkylation (GO:0006305),3/16,0.2000937866677156,0.7250638566917932,0,0,2.137845205641816,3.439726852966764,ATF7IP;DNMT3A;GATAD2A,Hypo
1080,GO_Biological_Process_2018,establishment of skin barrier (GO:0061436),3/16,0.2000937866677156,0.7250638566917932,0,0,2.137845205641816,3.439726852966764,KDF1;ALOX12B;ALOXE3,Hypo
1081,GO_Biological_Process_2018,guanosine-containing compound metabolic process (GO:1901068),3/16,0.2000937866677156,0.7250638566917932,0,0,2.137845205641816,3.439726852966764,DGUOK;LRRK2;RAB23,Hypo
1082,GO_Biological_Process_2018,positive regulation of histone methylation (GO:0031062),4/24,0.2013759480123944,0.7250638566917932,0,0,1.8530318602261049,2.969635003934776,PAXIP1;KMT2A;TET1;WDR61,Hypo
1083,GO_Biological_Process_2018,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),4/24,0.2013759480123944,0.7250638566917932,0,0,1.8530318602261049,2.969635003934776,RBL1;NACC2;JADE1;MYO16,Hypo
1084,GO_Biological_Process_2018,negative regulation of sequestering of calcium ion (GO:0051283),4/24,0.2013759480123944,0.7250638566917932,0,0,1.8530318602261049,2.969635003934776,RYR1;RYR2;RYR3;CHERP,Hypo
1085,GO_Biological_Process_2018,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",4/24,0.2013759480123944,0.7250638566917932,0,0,1.8530318602261049,2.969635003934776,ELL;WDR61;ERCC6;BRD4,Hypo
1086,GO_Biological_Process_2018,receptor catabolic process (GO:0032801),4/24,0.2013759480123944,0.7250638566917932,0,0,1.8530318602261049,2.969635003934776,SH3GLB1;SMURF1;AP2S1;AP2A1,Hypo
1087,GO_Biological_Process_2018,positive regulation of microtubule polymerization or depolymerization (GO:0031112),4/24,0.2013759480123944,0.7250638566917932,0,0,1.8530318602261049,2.969635003934776,CLIP1;NUMA1;MAPT;CLASP1,Hypo
1088,GO_Biological_Process_2018,axoneme assembly (GO:0035082),4/24,0.2013759480123944,0.7250638566917932,0,0,1.8530318602261049,2.969635003934776,TTLL3;CFAP46;MAPRE2;CCDC40,Hypo
1089,GO_Biological_Process_2018,regulation of chemotaxis (GO:0050920),4/24,0.2013759480123944,0.7250638566917932,0,0,1.8530318602261049,2.969635003934776,PDGFRA;ZSWIM8;STX3;PPM1F,Hypo
1090,GO_Biological_Process_2018,transition metal ion homeostasis (GO:0055076),4/24,0.2013759480123944,0.7250638566917932,0,0,1.8530318602261049,2.969635003934776,BDH2;SLC25A28;TMC8;ATP13A2,Hypo
1091,GO_Biological_Process_2018,cAMP metabolic process (GO:0046058),4/24,0.2013759480123944,0.7250638566917932,0,0,1.8530318602261049,2.969635003934776,ADCY9;PDE2A;ADCY3;PDE4A,Hypo
1092,GO_Biological_Process_2018,positive regulation of microtubule polymerization (GO:0031116),4/24,0.2013759480123944,0.7250638566917932,0,0,1.8530318602261049,2.969635003934776,CLIP1;NUMA1;MAPT;CLASP1,Hypo
1093,GO_Biological_Process_2018,camera-type eye development (GO:0043010),4/24,0.2013759480123944,0.7250638566917932,0,0,1.8530318602261049,2.969635003934776,FBN2;NF1;IFT122;CACNA1C,Hypo
1094,GO_Biological_Process_2018,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),10/76,0.203565788557426,0.7322328969553124,0,0,1.4045610746641677,2.235732621231735,EYA1;UNC5B;SRC;EYA2;TMBIM1;FAIM2;ITGA6;BIRC6;ARHGEF2;RFFL,Hypo
1095,GO_Biological_Process_2018,negative regulation of sequence-specific DNA binding transcription factor activity (GO:0043433),17/140,0.2037388309375532,0.7322328969553124,0,0,1.281797955072153,2.039233318798956,EGLN1;NFKBIL1;DAB2IP;EIF2AK4;FOXP3;PEX14;SMAD7;NLRP10;DDIT3;BHLHE40;OTULIN;FLNA;RBCK1;BTRC;TRIB1;TNFRSF4;CMKLR1,Hypo
1096,GO_Biological_Process_2018,regulation of calcium-mediated signaling (GO:0050848),6/41,0.2059212219000364,0.7387283179091472,0,0,1.5886243386243386,2.510442041209024,RCAN1;P2RX4;LRRK2;RCAN2;MAPT;CMKLR1,Hypo
1097,GO_Biological_Process_2018,negative regulation of proteolysis (GO:0045861),6/41,0.2059212219000364,0.7387283179091472,0,0,1.5886243386243386,2.510442041209024,TMEM59;CDK5;LRRK2;TIMP2;TIMP3;F2,Hypo
1098,GO_Biological_Process_2018,positive regulation of JUN kinase activity (GO:0043507),7/50,0.2110115370091371,0.7398184385318772,0,0,1.5086835270320411,2.347273903987812,DBNL;DVL2;DAB2IP;MAP4K5;MAP3K4;SASH1;MAP3K11,Hypo
1099,GO_Biological_Process_2018,regulation of extrinsic apoptotic signaling pathway (GO:2001236),8/59,0.213720860002617,0.7398184385318772,0,0,1.45384786252297,2.2434101135490123,WWOX;DEPTOR;SRC;MADD;TMC8;G0S2;ITGA6;BIRC6,Hypo
1100,GO_Biological_Process_2018,positive regulation of biomineral tissue development (GO:0070169),5/33,0.2148355025497868,0.7398184385318772,0,0,1.6546088872567022,2.5445942971303337,FBN2;KL;TGFB3;TMEM119;GPM6B,Hypo
1101,GO_Biological_Process_2018,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),5/33,0.2148355025497868,0.7398184385318772,0,0,1.6546088872567022,2.5445942971303337,PDGFRA;KIT;DAB2IP;PTK2B;PIK3R1,Hypo
1102,GO_Biological_Process_2018,positive regulation of Notch signaling pathway (GO:0045747),5/33,0.2148355025497868,0.7398184385318772,0,0,1.6546088872567022,2.5445942971303337,TSPAN14;ZMIZ1;TSPAN5;ITGB1BP1;MAML3,Hypo
1103,GO_Biological_Process_2018,cellular glucose homeostasis (GO:0001678),5/33,0.2148355025497868,0.7398184385318772,0,0,1.6546088872567022,2.5445942971303337,HK3;HKDC1;PIK3R1;HK1;PCK2,Hypo
1104,GO_Biological_Process_2018,regulation of intracellular protein transport (GO:0033157),5/33,0.2148355025497868,0.7398184385318772,0,0,1.6546088872567022,2.5445942971303337,TENM1;RIPOR1;ATP13A2;PCNT;OAZ1,Hypo
1105,GO_Biological_Process_2018,COPII-coated vesicle budding (GO:0090114),9/68,0.2148912708583468,0.7398184385318772,0,0,1.4139051161815943,2.1740531617838244,GOLGA2;NSF;NAPA;TRAPPC3;PEF1;TRAPPC10;TGFA;TRAPPC9;CNIH3,Hypo
1106,GO_Biological_Process_2018,inositol metabolic process (GO:0006020),2/9,0.2165551306492141,0.7398184385318772,0,0,2.6463772367263125,4.048719312960691,IMPA2;ITPK1,Hypo
1107,GO_Biological_Process_2018,adult heart development (GO:0007512),2/9,0.2165551306492141,0.7398184385318772,0,0,2.6463772367263125,4.048719312960691,SCUBE1;MEF2D,Hypo
1108,GO_Biological_Process_2018,regulation of macrophage cytokine production (GO:0010935),2/9,0.2165551306492141,0.7398184385318772,0,0,2.6463772367263125,4.048719312960691,SEMA7A;TGFB3,Hypo
1109,GO_Biological_Process_2018,positive regulation of voltage-gated potassium channel activity (GO:1903818),2/9,0.2165551306492141,0.7398184385318772,0,0,2.6463772367263125,4.048719312960691,NOS1AP;AKAP6,Hypo
1110,GO_Biological_Process_2018,epithelial cell apoptotic process (GO:1904019),2/9,0.2165551306492141,0.7398184385318772,0,0,2.6463772367263125,4.048719312960691,RYR2;DAB2IP,Hypo
1111,GO_Biological_Process_2018,anoikis (GO:0043276),2/9,0.2165551306492141,0.7398184385318772,0,0,2.6463772367263125,4.048719312960691,TSC2;MTOR,Hypo
1112,GO_Biological_Process_2018,postsynaptic membrane assembly (GO:0097104),2/9,0.2165551306492141,0.7398184385318772,0,0,2.6463772367263125,4.048719312960691,NRXN2;LRP4,Hypo
1113,GO_Biological_Process_2018,sarcoplasmic reticulum calcium ion transport (GO:0070296),2/9,0.2165551306492141,0.7398184385318772,0,0,2.6463772367263125,4.048719312960691,RYR1;RYR2,Hypo
1114,GO_Biological_Process_2018,regulation of T-helper 1 type immune response (GO:0002825),2/9,0.2165551306492141,0.7398184385318772,0,0,2.6463772367263125,4.048719312960691,NLRP10;IL12RB1,Hypo
1115,GO_Biological_Process_2018,negative regulation of catenin import into nucleus (GO:0035414),2/9,0.2165551306492141,0.7398184385318772,0,0,2.6463772367263125,4.048719312960691,DAB2IP;AXIN2,Hypo
1116,GO_Biological_Process_2018,potassium ion export (GO:0071435),2/9,0.2165551306492141,0.7398184385318772,0,0,2.6463772367263125,4.048719312960691,KCND3;KCNQ1,Hypo
1117,GO_Biological_Process_2018,embryonic digestive tract morphogenesis (GO:0048557),2/9,0.2165551306492141,0.7398184385318772,0,0,2.6463772367263125,4.048719312960691,PDGFRA;FGFR2,Hypo
1118,GO_Biological_Process_2018,nuclear migration (GO:0007097),2/9,0.2165551306492141,0.7398184385318772,0,0,2.6463772367263125,4.048719312960691,TMEM201;SYNE2,Hypo
1119,GO_Biological_Process_2018,Cdc42 protein signal transduction (GO:0032488),2/9,0.2165551306492141,0.7398184385318772,0,0,2.6463772367263125,4.048719312960691,RHOJ;NTN1,Hypo
1120,GO_Biological_Process_2018,central nervous system neuron development (GO:0021954),2/9,0.2165551306492141,0.7398184385318772,0,0,2.6463772367263125,4.048719312960691,RAPGEF2;MAPT,Hypo
1121,GO_Biological_Process_2018,response to dopamine (GO:1903350),2/9,0.2165551306492141,0.7398184385318772,0,0,2.6463772367263125,4.048719312960691,LRRK2;ABL1,Hypo
1122,GO_Biological_Process_2018,response to muscle stretch (GO:0035994),2/9,0.2165551306492141,0.7398184385318772,0,0,2.6463772367263125,4.048719312960691,RYR2;SLC9A1,Hypo
1123,GO_Biological_Process_2018,nicotinamide nucleotide biosynthetic process (GO:0019359),2/9,0.2165551306492141,0.7398184385318772,0,0,2.6463772367263125,4.048719312960691,QPRT;NMNAT3,Hypo
1124,GO_Biological_Process_2018,negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),2/9,0.2165551306492141,0.7398184385318772,0,0,2.6463772367263125,4.048719312960691,DAB2IP;TSC2,Hypo
1125,GO_Biological_Process_2018,response to muramyl dipeptide (GO:0032495),2/9,0.2165551306492141,0.7398184385318772,0,0,2.6463772367263125,4.048719312960691,ARHGEF2;INAVA,Hypo
1126,GO_Biological_Process_2018,receptor recycling (GO:0001881),2/9,0.2165551306492141,0.7398184385318772,0,0,2.6463772367263125,4.048719312960691,ARFGEF2;LMTK2,Hypo
1127,GO_Biological_Process_2018,Golgi vesicle budding (GO:0048194),2/9,0.2165551306492141,0.7398184385318772,0,0,2.6463772367263125,4.048719312960691,ATP8A1;MYO18A,Hypo
1128,GO_Biological_Process_2018,positive regulation of epidermis development (GO:0045684),2/9,0.2165551306492141,0.7398184385318772,0,0,2.6463772367263125,4.048719312960691,NUMA1;KDF1,Hypo
1129,GO_Biological_Process_2018,podosome assembly (GO:0071800),2/9,0.2165551306492141,0.7398184385318772,0,0,2.6463772367263125,4.048719312960691,DBNL;SH3PXD2A,Hypo
1130,GO_Biological_Process_2018,positive regulation of establishment of protein localization to telomere (GO:1904851),2/9,0.2165551306492141,0.7398184385318772,0,0,2.6463772367263125,4.048719312960691,CCT5;WRAP53,Hypo
1131,GO_Biological_Process_2018,production of siRNA involved in RNA interference (GO:0030422),2/9,0.2165551306492141,0.7398184385318772,0,0,2.6463772367263125,4.048719312960691,AGO2;DROSHA,Hypo
1132,GO_Biological_Process_2018,regulation of Rac protein signal transduction (GO:0035020),2/9,0.2165551306492141,0.7398184385318772,0,0,2.6463772367263125,4.048719312960691,ARHGAP44;ARHGAP17,Hypo
1133,GO_Biological_Process_2018,pinocytosis (GO:0006907),2/9,0.2165551306492141,0.7398184385318772,0,0,2.6463772367263125,4.048719312960691,MAPKAPK2;DOCK2,Hypo
1134,GO_Biological_Process_2018,negative regulation of alcohol biosynthetic process (GO:1902931),2/9,0.2165551306492141,0.7398184385318772,0,0,2.6463772367263125,4.048719312960691,SCAP;ERLIN2,Hypo
1135,GO_Biological_Process_2018,engulfment of apoptotic cell (GO:0043652),2/9,0.2165551306492141,0.7398184385318772,0,0,2.6463772367263125,4.048719312960691,MEGF10;ADGRB1,Hypo
1136,GO_Biological_Process_2018,regulation of organ morphogenesis (GO:2000027),2/9,0.2165551306492141,0.7398184385318772,0,0,2.6463772367263125,4.048719312960691,FGFR2;AJAP1,Hypo
1137,GO_Biological_Process_2018,negative regulation of lymphocyte apoptotic process (GO:0070229),2/9,0.2165551306492141,0.7398184385318772,0,0,2.6463772367263125,4.048719312960691,BCL6;IRS2,Hypo
1138,GO_Biological_Process_2018,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),2/9,0.2165551306492141,0.7398184385318772,0,0,2.6463772367263125,4.048719312960691,DAB2IP;FAM129B,Hypo
1139,GO_Biological_Process_2018,endothelial cell chemotaxis (GO:0035767),2/9,0.2165551306492141,0.7398184385318772,0,0,2.6463772367263125,4.048719312960691,NR4A1;PLEKHG5,Hypo
1140,GO_Biological_Process_2018,protein hexamerization (GO:0034214),2/9,0.2165551306492141,0.7398184385318772,0,0,2.6463772367263125,4.048719312960691,PANX1;PANX2,Hypo
1141,GO_Biological_Process_2018,ether lipid metabolic process (GO:0046485),2/9,0.2165551306492141,0.7398184385318772,0,0,2.6463772367263125,4.048719312960691,GNPAT;TMEM86A,Hypo
1142,GO_Biological_Process_2018,regulation of homotypic cell-cell adhesion (GO:0034110),2/9,0.2165551306492141,0.7398184385318772,0,0,2.6463772367263125,4.048719312960691,PRKCA;ANK3,Hypo
1143,GO_Biological_Process_2018,negative regulation of transcription by competitive promoter binding (GO:0010944),2/9,0.2165551306492141,0.7398184385318772,0,0,2.6463772367263125,4.048719312960691,BHLHE41;SMAD7,Hypo
1144,GO_Biological_Process_2018,negative regulation of potassium ion transmembrane transport (GO:1901380),2/9,0.2165551306492141,0.7398184385318772,0,0,2.6463772367263125,4.048719312960691,STK39;NEDD4L,Hypo
1145,GO_Biological_Process_2018,cellular response to acidic pH (GO:0071468),2/9,0.2165551306492141,0.7398184385318772,0,0,2.6463772367263125,4.048719312960691,SLC9A1;RAB11FIP5,Hypo
1146,GO_Biological_Process_2018,cytoskeletal anchoring at plasma membrane (GO:0007016),2/9,0.2165551306492141,0.7398184385318772,0,0,2.6463772367263125,4.048719312960691,SPTBN4;ANK3,Hypo
1147,GO_Biological_Process_2018,DNA topological change (GO:0006265),2/9,0.2165551306492141,0.7398184385318772,0,0,2.6463772367263125,4.048719312960691,TOP1MT;HMGB1,Hypo
1148,GO_Biological_Process_2018,cyclic nucleotide catabolic process (GO:0009214),2/9,0.2165551306492141,0.7398184385318772,0,0,2.6463772367263125,4.048719312960691,PDE2A;PDE4A,Hypo
1149,GO_Biological_Process_2018,regulation of organ growth (GO:0046620),2/9,0.2165551306492141,0.7398184385318772,0,0,2.6463772367263125,4.048719312960691,WWC1;WWC2,Hypo
1150,GO_Biological_Process_2018,oligosaccharide catabolic process (GO:0009313),2/9,0.2165551306492141,0.7398184385318772,0,0,2.6463772367263125,4.048719312960691,NEU4;NEU1,Hypo
1151,GO_Biological_Process_2018,cellular response to dopamine (GO:1903351),2/9,0.2165551306492141,0.7398184385318772,0,0,2.6463772367263125,4.048719312960691,LRRK2;ABL1,Hypo
1152,GO_Biological_Process_2018,positive regulation of synapse maturation (GO:0090129),2/9,0.2165551306492141,0.7398184385318772,0,0,2.6463772367263125,4.048719312960691,CAMK2B;DAB2IP,Hypo
1153,GO_Biological_Process_2018,regulation of telomere maintenance (GO:0032204),4/25,0.2225959257493098,0.7492745686414383,0,0,1.7646943669554152,2.651271775748792,UPF1;ERCC1;SMG5;SMG6,Hypo
1154,GO_Biological_Process_2018,in utero embryonic development (GO:0001701),4/25,0.2225959257493098,0.7492745686414383,0,0,1.7646943669554152,2.651271775748792,MBNL1;TGFB3;PKD1;FGFR2,Hypo
1155,GO_Biological_Process_2018,response to amyloid-beta (GO:1904645),4/25,0.2225959257493098,0.7492745686414383,0,0,1.7646943669554152,2.651271775748792,CACNB1;LRP1;CDK5;FYN,Hypo
1156,GO_Biological_Process_2018,positive regulation of glucose transport (GO:0010828),4/25,0.2225959257493098,0.7492745686414383,0,0,1.7646943669554152,2.651271775748792,CLIP3;IRS2;PIK3R1;SORBS1,Hypo
1157,GO_Biological_Process_2018,negative regulation of cellular protein localization (GO:1903828),4/25,0.2225959257493098,0.7492745686414383,0,0,1.7646943669554152,2.651271775748792,H2AFY;NEDD4L;MAPT;GPM6B,Hypo
1158,GO_Biological_Process_2018,cellular response to epidermal growth factor stimulus (GO:0071364),4/25,0.2225959257493098,0.7492745686414383,0,0,1.7646943669554152,2.651271775748792,MARS;DAB2IP;PTPN11;PDE8A,Hypo
1159,GO_Biological_Process_2018,regulation of apoptotic signaling pathway (GO:2001233),4/25,0.2225959257493098,0.7492745686414383,0,0,1.7646943669554152,2.651271775748792,TRAF7;DEPTOR;MADD;DAB2IP,Hypo
1160,GO_Biological_Process_2018,regulation of potassium ion transmembrane transporter activity (GO:1901016),4/25,0.2225959257493098,0.7492745686414383,0,0,1.7646943669554152,2.651271775748792,STK39;NEDD4L;CACNA1D;KCNAB1,Hypo
1161,GO_Biological_Process_2018,long-chain fatty acid transport (GO:0015909),4/25,0.2225959257493098,0.7492745686414383,0,0,1.7646943669554152,2.651271775748792,MID1IP1;PRKAG2;THRSP;ACACB,Hypo
1162,GO_Biological_Process_2018,long-chain fatty-acyl-CoA metabolic process (GO:0035336),4/25,0.2225959257493098,0.7492745686414383,0,0,1.7646943669554152,2.651271775748792,ACOT7;TECR;ACSL6;ACSL4,Hypo
1163,GO_Biological_Process_2018,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),4/25,0.2225959257493098,0.7492745686414383,0,0,1.7646943669554152,2.651271775748792,RPTOR;PRKAG2;TNKS1BP1;CALM3,Hypo
1164,GO_Biological_Process_2018,signal transduction in response to DNA damage (GO:0042770),4/25,0.2225959257493098,0.7492745686414383,0,0,1.7646943669554152,2.651271775748792,PAXIP1;USP10;ABL1;MAPK14,Hypo
1165,GO_Biological_Process_2018,signal peptide processing (GO:0006465),4/25,0.2225959257493098,0.7492745686414383,0,0,1.7646943669554152,2.651271775748792,FURIN;F2;SPPL3;SEC11C,Hypo
1166,GO_Biological_Process_2018,inorganic cation import across plasma membrane (GO:0098659),4/25,0.2225959257493098,0.7492745686414383,0,0,1.7646943669554152,2.651271775748792,FAM155A;SLC9A6;SLC9A8;SLC9A1,Hypo
1167,GO_Biological_Process_2018,positive regulation of protein metabolic process (GO:0051247),12/96,0.2237522739434535,0.7492745686414383,0,0,1.324340262420758,1.9828231111785852,NSF;LRP1;SMURF1;DAB2IP;NEDD4L;SCAP;IDE;INHBA;OAZ1;SORL1;EREG;RNF41,Hypo
1168,GO_Biological_Process_2018,positive regulation of actin filament polymerization (GO:0030838),7/51,0.2256030153113237,0.7492745686414383,0,0,1.4743133860478173,2.195220777376542,TENM1;CTTN;PRKCE;LMOD1;CDC42EP1;PTK2B;BAIAP2,Hypo
1169,GO_Biological_Process_2018,regulation of telomere maintenance via telomerase (GO:0032210),7/51,0.2256030153113237,0.7492745686414383,0,0,1.4743133860478173,2.195220777376542,STN1;TNKS2;SRC;SMG5;MAP3K4;CCT5;SMG6,Hypo
1170,GO_Biological_Process_2018,reverse cholesterol transport (GO:0043691),3/17,0.2265514118436032,0.7492745686414383,0,0,1.985031917235307,2.947342391459043,ABCA1;SCARB1;ABCG1,Hypo
1171,GO_Biological_Process_2018,negative regulation of telomere maintenance (GO:0032205),3/17,0.2265514118436032,0.7492745686414383,0,0,1.985031917235307,2.947342391459043,TNKS2;ERCC1;SMG6,Hypo
1172,GO_Biological_Process_2018,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),3/17,0.2265514118436032,0.7492745686414383,0,0,1.985031917235307,2.947342391459043,HIP1R;SLC25A5;BOK,Hypo
1173,GO_Biological_Process_2018,positive regulation of response to biotic stimulus (GO:0002833),3/17,0.2265514118436032,0.7492745686414383,0,0,1.985031917235307,2.947342391459043,NLRP10;PRKCA;SASH1,Hypo
1174,GO_Biological_Process_2018,protein mannosylation (GO:0035268),3/17,0.2265514118436032,0.7492745686414383,0,0,1.985031917235307,2.947342391459043,DPM3;DPY19L3;DPY19L4,Hypo
1175,GO_Biological_Process_2018,pigment granule transport (GO:0051904),3/17,0.2265514118436032,0.7492745686414383,0,0,1.985031917235307,2.947342391459043,BLOC1S5;MLPH;BBS4,Hypo
1176,GO_Biological_Process_2018,negative regulation of stress fiber assembly (GO:0051497),3/17,0.2265514118436032,0.7492745686414383,0,0,1.985031917235307,2.947342391459043,ARHGAP6;CLASP1;CLASP2,Hypo
1177,GO_Biological_Process_2018,regulation of collagen biosynthetic process (GO:0032965),3/17,0.2265514118436032,0.7492745686414383,0,0,1.985031917235307,2.947342391459043,TGFB3;CREB3L1;F2,Hypo
1178,GO_Biological_Process_2018,regulation of receptor recycling (GO:0001919),3/17,0.2265514118436032,0.7492745686414383,0,0,1.985031917235307,2.947342391459043,NSF;ECE1;TBC1D16,Hypo
1179,GO_Biological_Process_2018,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),3/17,0.2265514118436032,0.7492745686414383,0,0,1.985031917235307,2.947342391459043,CADM3;CADM1;RASGRP1,Hypo
1180,GO_Biological_Process_2018,macrophage activation (GO:0042116),3/17,0.2265514118436032,0.7492745686414383,0,0,1.985031917235307,2.947342391459043,SBNO2;CRTC3;MAPT,Hypo
1181,GO_Biological_Process_2018,regulation of lamellipodium organization (GO:1902743),3/17,0.2265514118436032,0.7492745686414383,0,0,1.985031917235307,2.947342391459043,CAPZB;TWF2;SSH1,Hypo
1182,GO_Biological_Process_2018,regulation of establishment or maintenance of cell polarity (GO:0032878),3/17,0.2265514118436032,0.7492745686414383,0,0,1.985031917235307,2.947342391459043,KANK1;PTK2B;LLGL1,Hypo
1183,GO_Biological_Process_2018,regulation of B cell receptor signaling pathway (GO:0050855),3/17,0.2265514118436032,0.7492745686414383,0,0,1.985031917235307,2.947342391459043,PRKCH;PRKCB;NFAM1,Hypo
1184,GO_Biological_Process_2018,melanosome transport (GO:0032402),3/17,0.2265514118436032,0.7492745686414383,0,0,1.985031917235307,2.947342391459043,BLOC1S5;MLPH;BBS4,Hypo
1185,GO_Biological_Process_2018,cellular monovalent inorganic cation homeostasis (GO:0030004),3/17,0.2265514118436032,0.7492745686414383,0,0,1.985031917235307,2.947342391459043,NEDD4L;ATP1A2;SLC9A1,Hypo
1186,GO_Biological_Process_2018,positive regulation of G-protein coupled receptor protein signaling pathway (GO:0045745),3/17,0.2265514118436032,0.7492745686414383,0,0,1.985031917235307,2.947342391459043,LRRK2;F2;UBQLN2,Hypo
1187,GO_Biological_Process_2018,regulation of telomere maintenance via telomere lengthening (GO:1904356),3/17,0.2265514118436032,0.7492745686414383,0,0,1.985031917235307,2.947342391459043,TNKS2;SMG5;SMG6,Hypo
1188,GO_Biological_Process_2018,glycosphingolipid biosynthetic process (GO:0006688),3/17,0.2265514118436032,0.7492745686414383,0,0,1.985031917235307,2.947342391459043,ST8SIA1;B4GALNT1;ST6GALNAC3,Hypo
1189,GO_Biological_Process_2018,cardiac muscle cell contraction (GO:0086003),3/17,0.2265514118436032,0.7492745686414383,0,0,1.985031917235307,2.947342391459043,CACNA1D;CACNA1C;SCN1B,Hypo
1190,GO_Biological_Process_2018,positive regulation of interleukin-6 secretion (GO:2000778),3/17,0.2265514118436032,0.7492745686414383,0,0,1.985031917235307,2.947342391459043,NLRP10;MBP;HMGB1,Hypo
1191,GO_Biological_Process_2018,cell chemotaxis (GO:0060326),8/60,0.2271649025249262,0.7506732810785942,0,0,1.425810029311574,2.113163219906744,PDGFRA;NR4A1;PLEKHG5;ARHGEF16;KIT;ELMO2;EPHB1;BCAR1,Hypo
1192,GO_Biological_Process_2018,protein homooligomerization (GO:0051260),22/190,0.2277181612331095,0.7518707771141813,0,0,1.2145697490614502,1.7971339384657714,RYR1;TOR2A;SPTBN5;B4GALT1;KCNJ12;IDE;ACACB;CLYBL;RYR3;PEX14;GOLGA2;ALAD;SCUBE1;EHD4;ALDH5A1;RXRA;RAD51;NACC2;CCDC88C;VWA2;CRYAB;ASIC1,Hypo
1193,GO_Biological_Process_2018,protein O-linked glycosylation (GO:0006493),14/115,0.2291418236768882,0.7559377248436037,0,0,1.2851137386465918,1.8935047665721296,ST6GAL1;GALNT13;GALNT2;TET1;TRAK1;POMGNT1;DPM3;MUC2;B3GALT1;TET3;XXYLT1;ST3GAL2;GALNT9;ST3GAL3,Hypo
1194,GO_Biological_Process_2018,epithelial tube morphogenesis (GO:0060562),5/34,0.2332480157580569,0.7625796161569036,0,0,1.5974647637620778,2.3253542898578567,RYR2;COL4A1;PRKD2;CCM2;PKD1,Hypo
1195,GO_Biological_Process_2018,regulation of JUN kinase activity (GO:0043506),5/34,0.2332480157580569,0.7625796161569036,0,0,1.5974647637620778,2.3253542898578567,DVL2;DAB2IP;MAP3K4;SASH1;MAP3K11,Hypo
1196,GO_Biological_Process_2018,regulation of alcohol biosynthetic process (GO:1902930),5/34,0.2332480157580569,0.7625796161569036,0,0,1.5974647637620778,2.3253542898578567,SREBF1;GPAM;FASN;SCAP;ACACB,Hypo
1197,GO_Biological_Process_2018,response to glucagon (GO:0033762),5/34,0.2332480157580569,0.7625796161569036,0,0,1.5974647637620778,2.3253542898578567,ADCY9;PRKAR1B;PRKAR1A;GNB2;ADCY3,Hypo
1198,GO_Biological_Process_2018,macromolecule catabolic process (GO:0009057),5/34,0.2332480157580569,0.7625796161569036,0,0,1.5974647637620778,2.3253542898578567,SH3GLB1;SMURF1;TPP1;CTSD;MTOR,Hypo
1199,GO_Biological_Process_2018,positive regulation of interleukin-6 production (GO:0032755),6/43,0.2383827141888662,0.7625796161569036,0,0,1.502585919252586,2.1545246733737327,NLRP10;MBP;HMGB1;ARHGEF2;INAVA;EREG,Hypo
1200,GO_Biological_Process_2018,negative regulation of ERBB signaling pathway (GO:1901185),6/43,0.2383827141888662,0.7625796161569036,0,0,1.502585919252586,2.1545246733737327,ZFYVE28;DAB2IP;NRG2;ARHGEF7;SH3GL2;EREG,Hypo
1201,GO_Biological_Process_2018,regulation of Notch signaling pathway (GO:0008593),9/70,0.2401573039162722,0.7625796161569036,0,0,1.3673955456457294,1.9505366052601607,TSPAN14;ZMIZ1;DTX1;TSPAN5;ITGB1BP1;MAML3;LLGL1;FAM129B;DLK2,Hypo
1202,GO_Biological_Process_2018,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),9/70,0.2401573039162722,0.7625796161569036,0,0,1.3673955456457294,1.9505366052601607,RNF144B;RNF114;LRRK2;DVL1;RNF19B;TRIB1;CBFA2T3;UBQLN2;SMAD7,Hypo
1203,GO_Biological_Process_2018,positive regulation of ossification (GO:0045778),7/52,0.2405293473228288,0.7625796161569036,0,0,1.4414708068851148,2.0539707377524232,FBN2;KL;TGFB3;ZBTB16;TMEM119;RUNX2;GPM6B,Hypo
1204,GO_Biological_Process_2018,regulation of cell-matrix adhesion (GO:0001952),7/52,0.2405293473228288,0.7625796161569036,0,0,1.4414708068851148,2.0539707377524232,NF1;PTK2B;CLASP1;GPM6B;AJAP1;SLC9A1;CORO1C,Hypo
1205,GO_Biological_Process_2018,negative regulation of MAP kinase activity (GO:0043407),8/61,0.2409022972425433,0.7625796161569036,0,0,1.3988302275421176,1.99104435484266,RGS3;RGS14;DUSP1;SPRY4;DAB2IP;NF1;SORL1;DUSP7,Hypo
1206,GO_Biological_Process_2018,nucleotide biosynthetic process (GO:0009165),4/26,0.2443603475598385,0.7625796161569036,0,0,1.684387554891152,2.373489552124641,ADCY9;MTHFD1;PPAT;ADCY3,Hypo
1207,GO_Biological_Process_2018,regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902893),4/26,0.2443603475598385,0.7625796161569036,0,0,1.684387554891152,2.373489552124641,SMAD3;TEAD1;SMARCA4;PPARD,Hypo
1208,GO_Biological_Process_2018,positive regulation of wound healing (GO:0090303),4/26,0.2443603475598385,0.7625796161569036,0,0,1.684387554891152,2.373489552124641,KANK1;PRKCE;F2;MTOR,Hypo
1209,GO_Biological_Process_2018,regulation of cardiac muscle cell contraction (GO:0086004),4/26,0.2443603475598385,0.7625796161569036,0,0,1.684387554891152,2.373489552124641,RYR2;CTNNA3;CACNA1C;FGF13,Hypo
1210,GO_Biological_Process_2018,endocrine system development (GO:0035270),4/26,0.2443603475598385,0.7625796161569036,0,0,1.684387554891152,2.373489552124641,SOX3;THRA;NF1;DKK3,Hypo
1211,GO_Biological_Process_2018,positive regulation of glucose import (GO:0046326),4/26,0.2443603475598385,0.7625796161569036,0,0,1.684387554891152,2.373489552124641,IRS2;PTPN11;PIK3R1;SORBS1,Hypo
1212,GO_Biological_Process_2018,apoptotic process (GO:0006915),26/231,0.2480433828547202,0.7625796161569036,0,0,1.1763348714568227,1.639989163469062,CYFIP2;HIP1;JADE1;STK4;PLAGL1;PAK6;PTK2B;BCL2L14;PAK4;BOK;YARS;PRKCE;ZBTB16;TNFRSF9;PAWR;TSC2;MTOR;CIT;TRAF7;MELK;RRAGC;CDK5;ERCC2;ELMO1;TNFRSF25;PPARD,Hypo
1213,GO_Biological_Process_2018,ion transport (GO:0006811),32/289,0.2488025758114065,0.7625796161569036,0,0,1.1550942737855174,1.6068465216867178,RYR1;RYR2;ATP8A1;NEDD4L;SLC4A1;ATP1A2;TCIRG1;RYR3;SLC8A2;SLC9A1;PANX1;PANX2;CALHM2;ATP6V1E1;ASIC2;SLC15A4;ATP6V0A1;ASIC1;ATP8B2;TSC22D3;ATP11C;ATP2B1;TPCN1;SLC8A3;CLCN6;CLCN5;P2RX4;SLC9A6;SLC9A8;ATP13A2;SGK1;KCNK3,Hypo
1214,GO_Biological_Process_2018,plasma membrane bounded cell projection assembly (GO:0120031),27/241,0.2506970498902058,0.7625796161569036,0,0,1.1702217621415136,1.6190135585610583,UNC119B;FBF1;CEP164;ASAP1;NTN1;FGD1;PPP1R9B;RPGR;SEPT8;SEPT9;ABLIM1;ABLIM2;RAB23;FLNA;PCNT;BBS4;ABCC4;SEPT11;IFT122;DYNLL2;RILPL2;TTLL3;RILPL1;KIT;RAPGEF2;DZIP1;ARHGEF7,Hypo
1215,GO_Biological_Process_2018,regulation of hydrolase activity (GO:0051336),10/80,0.2508491535172901,0.7625796161569036,0,0,1.3240058910162005,1.8309723840371304,PLXND1;VMA21;DAB2IP;NF1;RAB3GAP2;ITGB1BP1;RAP1GAP;FGD1;TBC1D15;VAV2,Hypo
1216,GO_Biological_Process_2018,negative regulation of Wnt signaling pathway (GO:0030178),20/174,0.2513440204666026,0.7625796161569036,0,0,1.204225825987484,1.6629547957561095,AMER2;WWOX;LRP1;JADE1;DAB2IP;TSC2;LRP4;AXIN2;STK4;LIMD1;BICC1;DKK3;SDHAF2;FRZB;DDIT3;DVL1;DVL2;NPHP4;IGFBP6;ANKRD6,Hypo
1217,GO_Biological_Process_2018,negative regulation of cell-substrate adhesion (GO:0010812),5/35,0.2520827102700714,0.7625796161569036,0,0,1.5441302485004285,2.127808440441667,KANK1;SPOCK1;ITGB1BP1;CORO1C;AJAP1,Hypo
1218,GO_Biological_Process_2018,negative regulation of protein kinase B signaling (GO:0051898),5/35,0.2520827102700714,0.7625796161569036,0,0,1.5441302485004285,2.127808440441667,PLEKHA1;DDIT3;PPP2R5B;TSC2;PPP2R5C,Hypo
1219,GO_Biological_Process_2018,regulation of mitochondrial membrane potential (GO:0051881),5/35,0.2520827102700714,0.7625796161569036,0,0,1.5441302485004285,2.127808440441667,OPRD1;SLC25A27;LRRK2;ABL1;MAPT,Hypo
1220,GO_Biological_Process_2018,positive regulation of ATPase activity (GO:0032781),5/35,0.2520827102700714,0.7625796161569036,0,0,1.5441302485004285,2.127808440441667,DNAJB2;RYR2;DYNC1I2;SETMAR;DYNLL2,Hypo
1221,GO_Biological_Process_2018,regulation of phosphoprotein phosphatase activity (GO:0043666),5/35,0.2520827102700714,0.7625796161569036,0,0,1.5441302485004285,2.127808440441667,PPP1R1B;CRY2;AKAP6;CALM3;MTOR,Hypo
1222,GO_Biological_Process_2018,actin filament bundle organization (GO:0061572),5/35,0.2520827102700714,0.7625796161569036,0,0,1.5441302485004285,2.127808440441667,USH1C;PAWR;ESPN;BAIAP2;PLS1,Hypo
1223,GO_Biological_Process_2018,negative regulation of hydrolase activity (GO:0051346),13/108,0.2525925350167755,0.7625796161569036,0,0,1.2684563758389262,1.7453675877497614,PPP1R26;GPSM1;EGLN1;ELL;LRRK2;GPATCH2;DAB2IP;ELFN2;SH3RF2;LRCH1;DLG3;SH3BP4;PPP1R12B,Hypo
1224,GO_Biological_Process_2018,glucan catabolic process (GO:0009251),3/18,0.2536151692777526,0.7625796161569036,0,0,1.852593733949666,2.541642338723844,AGL;GAA;PGM2,Hypo
1225,GO_Biological_Process_2018,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),3/18,0.2536151692777526,0.7625796161569036,0,0,1.852593733949666,2.541642338723844,TECR;ACSL6;ACSL4,Hypo
1226,GO_Biological_Process_2018,establishment of melanosome localization (GO:0032401),3/18,0.2536151692777526,0.7625796161569036,0,0,1.852593733949666,2.541642338723844,BLOC1S5;MLPH;BBS4,Hypo
1227,GO_Biological_Process_2018,mitotic recombination (GO:0006312),3/18,0.2536151692777526,0.7625796161569036,0,0,1.852593733949666,2.541642338723844,RAD51;ERCC1;NSMCE2,Hypo
1228,GO_Biological_Process_2018,regulation of amyloid-beta formation (GO:1902003),3/18,0.2536151692777526,0.7625796161569036,0,0,1.852593733949666,2.541642338723844,BIN1;HAP1;SORL1,Hypo
1229,GO_Biological_Process_2018,response to nutrient levels (GO:0031667),3/18,0.2536151692777526,0.7625796161569036,0,0,1.852593733949666,2.541642338723844,RPTOR;ULK1;MTOR,Hypo
1230,GO_Biological_Process_2018,posttranscriptional gene silencing by RNA (GO:0035194),3/18,0.2536151692777526,0.7625796161569036,0,0,1.852593733949666,2.541642338723844,TNRC6C;AGO2;LIMD1,Hypo
1231,GO_Biological_Process_2018,negative regulation of protein dephosphorylation (GO:0035308),3/18,0.2536151692777526,0.7625796161569036,0,0,1.852593733949666,2.541642338723844,PPP1R16B;PPP1R1B;CRY2,Hypo
1232,GO_Biological_Process_2018,negative regulation of peptidyl-serine phosphorylation (GO:0033137),3/18,0.2536151692777526,0.7625796161569036,0,0,1.852593733949666,2.541642338723844,RASSF2;PPM1F;SMAD7,Hypo
1233,GO_Biological_Process_2018,glycogen catabolic process (GO:0005980),3/18,0.2536151692777526,0.7625796161569036,0,0,1.852593733949666,2.541642338723844,AGL;GAA;PGM2,Hypo
1234,GO_Biological_Process_2018,glycogen biosynthetic process (GO:0005978),3/18,0.2536151692777526,0.7625796161569036,0,0,1.852593733949666,2.541642338723844,PER2;PGM2;NR1D1,Hypo
1235,GO_Biological_Process_2018,regulation of cAMP-mediated signaling (GO:0043949),3/18,0.2536151692777526,0.7625796161569036,0,0,1.852593733949666,2.541642338723844,MGRN1;PDE2A;RAPGEF2,Hypo
1236,GO_Biological_Process_2018,blood vessel endothelial cell migration (GO:0043534),3/18,0.2536151692777526,0.7625796161569036,0,0,1.852593733949666,2.541642338723844,NR4A1;MYH9;GPLD1,Hypo
1237,GO_Biological_Process_2018,negative regulation of protein transport (GO:0051224),3/18,0.2536151692777526,0.7625796161569036,0,0,1.852593733949666,2.541642338723844,RHBDF1;RHBDF2;SERGEF,Hypo
1238,GO_Biological_Process_2018,regulation of cellular response to growth factor stimulus (GO:0090287),3/18,0.2536151692777526,0.7625796161569036,0,0,1.852593733949666,2.541642338723844,FBN2;TMEM204;FGFR2,Hypo
1239,GO_Biological_Process_2018,DNA methylation (GO:0006306),3/18,0.2536151692777526,0.7625796161569036,0,0,1.852593733949666,2.541642338723844,ATF7IP;DNMT3A;GATAD2A,Hypo
1240,GO_Biological_Process_2018,snRNA metabolic process (GO:0016073),3/18,0.2536151692777526,0.7625796161569036,0,0,1.852593733949666,2.541642338723844,INTS1;MEPCE;INTS7,Hypo
1241,GO_Biological_Process_2018,mRNA destabilization (GO:0061157),3/18,0.2536151692777526,0.7625796161569036,0,0,1.852593733949666,2.541642338723844,ZC3H12D;UPF1;CPEB3,Hypo
1242,GO_Biological_Process_2018,DNA ligation (GO:0006266),3/18,0.2536151692777526,0.7625796161569036,0,0,1.852593733949666,2.541642338723844,PARP3;XRCC6;HMGB1,Hypo
1243,GO_Biological_Process_2018,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),3/18,0.2536151692777526,0.7625796161569036,0,0,1.852593733949666,2.541642338723844,SMAD3;SMAD7;DKK3,Hypo
1244,GO_Biological_Process_2018,glucan biosynthetic process (GO:0009250),3/18,0.2536151692777526,0.7625796161569036,0,0,1.852593733949666,2.541642338723844,PER2;PGM2;NR1D1,Hypo
1245,GO_Biological_Process_2018,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,NPLOC4;SEC14L1,Hypo
1246,GO_Biological_Process_2018,glomerular filtration (GO:0003094),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,MYO1E;SULF2,Hypo
1247,GO_Biological_Process_2018,cellular response to growth hormone stimulus (GO:0071378),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,PXN;PIK3R1,Hypo
1248,GO_Biological_Process_2018,positive regulation of cytoplasmic transport (GO:1903651),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,VPS11;SORL1,Hypo
1249,GO_Biological_Process_2018,positive regulation of receptor recycling (GO:0001921),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,NSF;ECE1,Hypo
1250,GO_Biological_Process_2018,response to laminar fluid shear stress (GO:0034616),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,ABCA1;SMAD7,Hypo
1251,GO_Biological_Process_2018,galactose metabolic process (GO:0006012),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,CHST1;PGM2,Hypo
1252,GO_Biological_Process_2018,positive regulation of bone remodeling (GO:0046852),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,PLEKHM1;PRKCA,Hypo
1253,GO_Biological_Process_2018,regulation of amyloid-beta clearance (GO:1900221),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,LRP1;LDLR,Hypo
1254,GO_Biological_Process_2018,neuroepithelial cell differentiation (GO:0060563),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,BCCIP;USH1C,Hypo
1255,GO_Biological_Process_2018,positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,KMT2D;BUD31,Hypo
1256,GO_Biological_Process_2018,positive regulation of lipase activity (GO:0060193),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,PLA2G5;FGFR2,Hypo
1257,GO_Biological_Process_2018,DNA dealkylation involved in DNA repair (GO:0006307),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,FTO;ASCC2,Hypo
1258,GO_Biological_Process_2018,regulation of pH (GO:0006885),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,PDK2;SLC9A1,Hypo
1259,GO_Biological_Process_2018,primary miRNA processing (GO:0031053),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,SMAD3;DROSHA,Hypo
1260,GO_Biological_Process_2018,actin filament depolymerization (GO:0030042),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,MICAL3;TWF2,Hypo
1261,GO_Biological_Process_2018,negative regulation of autophagosome assembly (GO:1902902),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,LRRK2;FEZ2,Hypo
1262,GO_Biological_Process_2018,protein localization to synapse (GO:0035418),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,KIF5C;NRXN2,Hypo
1263,GO_Biological_Process_2018,regulation of establishment of protein localization to telomere (GO:0070203),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,CCT5;WRAP53,Hypo
1264,GO_Biological_Process_2018,regulation of cytoplasmic translation (GO:2000765),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,UNK;CPEB3,Hypo
1265,GO_Biological_Process_2018,negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,NFKBIL1;TRIB1,Hypo
1266,GO_Biological_Process_2018,insulin-like growth factor receptor signaling pathway (GO:0048009),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,TSC2;PIK3R1,Hypo
1267,GO_Biological_Process_2018,positive regulation of circadian rhythm (GO:0042753),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,RORA;BTRC,Hypo
1268,GO_Biological_Process_2018,DNA dealkylation (GO:0035510),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,FTO;ASCC2,Hypo
1269,GO_Biological_Process_2018,actin filament capping (GO:0051693),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,CAPZB;TWF2,Hypo
1270,GO_Biological_Process_2018,negative regulation of protein maturation (GO:1903318),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,TMEM59;LRRK2,Hypo
1271,GO_Biological_Process_2018,intraciliary retrograde transport (GO:0035721),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,IFT140;IFT122,Hypo
1272,GO_Biological_Process_2018,maintenance of apical/basal cell polarity (GO:0035090),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,LRCH4;ANK1,Hypo
1273,GO_Biological_Process_2018,protein localization to mitochondrion (GO:0070585),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,LRRK2;HK1,Hypo
1274,GO_Biological_Process_2018,regulation of podosome assembly (GO:0071801),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,SRC;ASAP1,Hypo
1275,GO_Biological_Process_2018,positive regulation of bone resorption (GO:0045780),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,PLEKHM1;PRKCA,Hypo
1276,GO_Biological_Process_2018,ceramide catabolic process (GO:0046514),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,NEU4;NEU1,Hypo
1277,GO_Biological_Process_2018,ganglioside biosynthetic process (GO:0001574),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,B4GALNT1;ST6GALNAC3,Hypo
1278,GO_Biological_Process_2018,regulation of mitochondrial depolarization (GO:0051900),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,SRC;LRRK2,Hypo
1279,GO_Biological_Process_2018,regulation of astrocyte differentiation (GO:0048710),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,BIN1;F2,Hypo
1280,GO_Biological_Process_2018,positive regulation of interleukin-13 production (GO:0032736),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,RARA;PRKCZ,Hypo
1281,GO_Biological_Process_2018,regulation of neuroblast proliferation (GO:1902692),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,LRRK2;NF1,Hypo
1282,GO_Biological_Process_2018,endothelial tube morphogenesis (GO:0061154),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,PRKD2;CCM2,Hypo
1283,GO_Biological_Process_2018,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,NLRP10;IL12RB1,Hypo
1284,GO_Biological_Process_2018,medium-chain fatty acid metabolic process (GO:0051791),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,ACOT7;ABHD2,Hypo
1285,GO_Biological_Process_2018,regulation of lysosomal lumen pH (GO:0035751),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,LRRK2;VPS33A,Hypo
1286,GO_Biological_Process_2018,regulation of phospholipid metabolic process (GO:1903725),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,MTMR3;PIK3R1,Hypo
1287,GO_Biological_Process_2018,maintenance of epithelial cell apical/basal polarity (GO:0045199),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,LRCH4;ANK1,Hypo
1288,GO_Biological_Process_2018,ketone body metabolic process (GO:1902224),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,BDH2;AACS,Hypo
1289,GO_Biological_Process_2018,regulation of axon regeneration (GO:0048679),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,PTPRS;STK24,Hypo
1290,GO_Biological_Process_2018,positive regulation of type 2 immune response (GO:0002830),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,RARA;PRKCZ,Hypo
1291,GO_Biological_Process_2018,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,TGFA;EREG,Hypo
1292,GO_Biological_Process_2018,regulation of B cell apoptotic process (GO:0002902),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,BCL6;IRS2,Hypo
1293,GO_Biological_Process_2018,low-density lipoprotein particle receptor catabolic process (GO:0032802),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,AP2S1;AP2A1,Hypo
1294,GO_Biological_Process_2018,regulation of synapse maturation (GO:0090128),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,CAMK2B;DAB2IP,Hypo
1295,GO_Biological_Process_2018,adrenal gland development (GO:0030325),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,NF1;DKK3,Hypo
1296,GO_Biological_Process_2018,endothelium development (GO:0003158),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,LAMA5;SCUBE1,Hypo
1297,GO_Biological_Process_2018,regulation of cellular respiration (GO:0043457),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,PRDM16;CBFA2T3,Hypo
1298,GO_Biological_Process_2018,neuron projection regeneration (GO:0031102),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,RTN4RL2;MTR,Hypo
1299,GO_Biological_Process_2018,phosphatidylglycerol biosynthetic process (GO:0006655),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,TAMM41;PDXP,Hypo
1300,GO_Biological_Process_2018,positive regulation of alcohol biosynthetic process (GO:1902932),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,FGF1;ABCG1,Hypo
1301,GO_Biological_Process_2018,cellular biogenic amine metabolic process (GO:0006576),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,SMS;OAZ1,Hypo
1302,GO_Biological_Process_2018,response to acidic pH (GO:0010447),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,SLC9A1;RAB11FIP5,Hypo
1303,GO_Biological_Process_2018,muscle cell migration (GO:0014812),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,MEGF10;ITGB1BP1,Hypo
1304,GO_Biological_Process_2018,negative regulation of inclusion body assembly (GO:0090084),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,DNAJB2;SORL1,Hypo
1305,GO_Biological_Process_2018,positive regulation of glial cell differentiation (GO:0045687),2/10,0.2542176731607968,0.7625796161569036,0,0,2.315451745379877,3.1711602757918778,TENM4;BIN1,Hypo
1306,GO_Biological_Process_2018,negative regulation of response to stimulus (GO:0048585),15/127,0.2548753704547044,0.7625796161569036,0,0,1.2415559246954595,1.697182858668032,PDGFRA;FLT4;NTRK3;LMTK2;MST1R;FOXP3;NCOR2;RBL1;NLRP10;KIF26A;KIT;TYRO3;EPHB2;EPHB1;FGFR2,Hypo
1307,GO_Biological_Process_2018,unsaturated fatty acid metabolic process (GO:0033559),6/44,0.2551611916970802,0.7625796161569036,0,0,1.462962962962963,1.9982023134999989,DAGLA;HSD17B4;ALOX12B;DAGLB;ALOXE3;MGLL,Hypo
1308,GO_Biological_Process_2018,positive regulation of macroautophagy (GO:0016239),6/44,0.2551611916970802,0.7625796161569036,0,0,1.462962962962963,1.9982023134999989,GPSM1;SH3GLB1;TBK1;PIP4K2A;TSC2;RAB3GAP2,Hypo
1309,GO_Biological_Process_2018,heart contraction (GO:0060047),6/44,0.2551611916970802,0.7625796161569036,0,0,1.462962962962963,1.9982023134999989,RYR2;GRK2;GAA;KCNQ1;ATP1A2;SCN1B,Hypo
1310,GO_Biological_Process_2018,microtubule cytoskeleton organization involved in mitosis (GO:1902850),6/44,0.2551611916970802,0.7625796161569036,0,0,1.462962962962963,1.9982023134999989,DYNC1H1;BCCIP;MAP4;PCNT;CLASP1;CLASP2,Hypo
1311,GO_Biological_Process_2018,regulation of intracellular pH (GO:0051453),6/44,0.2551611916970802,0.7625796161569036,0,0,1.462962962962963,1.9982023134999989,SLC9A6;LRRK2;VPS33A;SLC9A8;SLC4A1;SLC9A1,Hypo
1312,GO_Biological_Process_2018,posttranscriptional regulation of gene expression (GO:0010608),6/44,0.2551611916970802,0.7625796161569036,0,0,1.462962962962963,1.9982023134999989,CYFIP2;PER1;ATXN2;TCOF1;NACC2;FOXO3,Hypo
1313,GO_Biological_Process_2018,myeloid cell differentiation (GO:0030099),6/44,0.2551611916970802,0.7625796161569036,0,0,1.462962962962963,1.9982023134999989,EPO;ZBTB16;KAT6A;KIT;ACIN1;INHBA,Hypo
1314,GO_Biological_Process_2018,sprouting angiogenesis (GO:0002040),6/44,0.2551611916970802,0.7625796161569036,0,0,1.462962962962963,1.9982023134999989,NR4A1;FLT4;OTULIN;PTK2B;ITGB1BP1;GPLD1,Hypo
1315,GO_Biological_Process_2018,cholesterol transport (GO:0030301),6/44,0.2551611916970802,0.7625796161569036,0,0,1.462962962962963,1.9982023134999989,ABCA1;SCARB1;SOAT1;LDLRAP1;LDLR;ABCG1,Hypo
1316,GO_Biological_Process_2018,adherens junction organization (GO:0034332),6/44,0.2551611916970802,0.7625796161569036,0,0,1.462962962962963,1.9982023134999989,CADM3;CADM1;CDH22;PIP5K1C;INAVA;SMAD7,Hypo
1317,GO_Biological_Process_2018,positive regulation of viral life cycle (GO:1903902),6/44,0.2551611916970802,0.7625796161569036,0,0,1.462962962962963,1.9982023134999989,SRPK2;ADARB1;VPS37B;TRIM11;FKBP6;SRPK1,Hypo
1318,GO_Biological_Process_2018,monocarboxylic acid transport (GO:0015718),7/53,0.2557590841811808,0.7632083580224782,0,0,1.410056165946877,1.9226388739214524,NCOA1;SLC25A17;RXRA;SLCO2B1;SLC10A3;SLC6A1;PPARD,Hypo
1319,GO_Biological_Process_2018,positive regulation of protein import into nucleus (GO:0042307),7/53,0.2557590841811808,0.7632083580224782,0,0,1.410056165946877,1.9226388739214524,KANK1;SMAD3;BAG3;TGFB3;FLNA;PIK3R1;F2,Hypo
1320,GO_Biological_Process_2018,positive regulation of cell differentiation (GO:0045597),22/194,0.2584713919325533,0.7707182534612624,0,0,1.1860585737720737,1.6047019777198133,FBN2;PRKCH;SMAD3;TGFB3;TGFB1I1;ZBTB16;AXIN2;MAPK14;RUNX2;MTOR;MEDAG;TIAM1;BLOC1S5;OLFM1;FRZB;ABL1;TMEM119;RAPGEF2;CMKLR1;SOX5;PPARD;BCL9L,Hypo
1321,GO_Biological_Process_2018,cell-matrix adhesion (GO:0007160),11/90,0.2598085487571616,0.7741194202378664,0,0,1.2905060027026851,1.739357244120142,SGCE;TIAM1;LAMA5;CTTN;COL13A1;ACTN1;ITGB1BP1;SORBS1;ARHGEF7;PKD1;PPFIA2,Hypo
1322,GO_Biological_Process_2018,circulatory system development (GO:0072359),13/109,0.2632121049536258,0.783667786403879,0,0,1.2551733780760626,1.6753992610543649,RARG;TCF25;NTRK3;TSC2;ECE1;PTPN11;CACNA1C;PKD1;MTHFD1;DVL2;NF1;RARA;MEF2D,Hypo
1323,GO_Biological_Process_2018,positive regulation of lipid kinase activity (GO:0090218),4/27,0.2665665950323643,0.787110807970377,0,0,1.611063943875955,2.130037871628523,PDGFRA;KIT;PTK2B;F2,Hypo
1324,GO_Biological_Process_2018,negative regulation of synaptic transmission (GO:0050805),4/27,0.2665665950323643,0.787110807970377,0,0,1.611063943875955,2.130037871628523,PNKD;STXBP1;LRRK2;SHANK2,Hypo
1325,GO_Biological_Process_2018,release of sequestered calcium ion into cytosol (GO:0051209),4/27,0.2665665950323643,0.787110807970377,0,0,1.611063943875955,2.130037871628523,RYR1;RYR2;RYR3;CHERP,Hypo
1326,GO_Biological_Process_2018,negative regulation of osteoblast differentiation (GO:0045668),4/27,0.2665665950323643,0.787110807970377,0,0,1.611063943875955,2.130037871628523,SEMA4D;AXIN2;LIMD1;HDAC7,Hypo
1327,GO_Biological_Process_2018,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),4/27,0.2665665950323643,0.787110807970377,0,0,1.611063943875955,2.130037871628523,ABL1;FLNA;ARHGEF7;DOCK1,Hypo
1328,GO_Biological_Process_2018,regulation of protein targeting to membrane (GO:0090313),4/27,0.2665665950323643,0.787110807970377,0,0,1.611063943875955,2.130037871628523,FYN;ITGB1BP1;ANK3;PDZK1,Hypo
1329,GO_Biological_Process_2018,regulation of autophagy of mitochondrion (GO:1903146),4/27,0.2665665950323643,0.787110807970377,0,0,1.611063943875955,2.130037871628523,SREBF1;ATP13A2;WBP11;CAMKK2,Hypo
1330,GO_Biological_Process_2018,regulation of calcium ion transmembrane transporter activity (GO:1901019),4/27,0.2665665950323643,0.787110807970377,0,0,1.611063943875955,2.130037871628523,CACNB1;CACNB3;CACNB4;AHNAK,Hypo
1331,GO_Biological_Process_2018,regulation of cilium assembly (GO:1902017),4/27,0.2665665950323643,0.787110807970377,0,0,1.611063943875955,2.130037871628523,IFT140;CROCC;TBC1D30;BBS4,Hypo
1332,GO_Biological_Process_2018,response to hexose (GO:0009746),4/27,0.2665665950323643,0.787110807970377,0,0,1.611063943875955,2.130037871628523,EIF2B5;IRS2;SLC2A5;GPLD1,Hypo
1333,GO_Biological_Process_2018,endocytic recycling (GO:0032456),4/27,0.2665665950323643,0.787110807970377,0,0,1.611063943875955,2.130037871628523,EHD4;VPS53;LMTK2;RAB11FIP4,Hypo
1334,GO_Biological_Process_2018,cellular response to transforming growth factor beta stimulus (GO:0071560),12/100,0.2674268824340258,0.7890595430019685,0,0,1.2638615254714325,1.6669184502805965,WWOX;TWSG1;SMAD3;TGFB3;SMURF1;SRC;PXN;PDE2A;FURIN;PRKCZ;SOX5;SMAD7,Hypo
1335,GO_Biological_Process_2018,endocytosis (GO:0006897),29/263,0.2691289417234693,0.792986822974481,0,0,1.1493835564632024,1.5086402564965546,SCARB1;LRP1;LRRK2;AP2A1;CORO1C;DPYSL2;ADORA1;PACSIN2;AP1S1;PIP5K1C;LDLRAP1;LDLR;ATP9B;ATP9A;CSNK1G3;SORT1;HIP1R;TSC2;SORL1;IGF2R;SYT7;DNM1;MYO1E;CTTN;BIN1;HEATR5B;RHOJ;TYRO3;RIN3,Hypo
1336,GO_Biological_Process_2018,negative regulation of dephosphorylation (GO:0035305),8/63,0.2691605438732879,0.792986822974481,0,0,1.3478138751053272,1.7689346274152875,PPP1R16B;PPP1R26;SH3RF2;ELL;DLG3;GPATCH2;ELFN2;PPP1R12B,Hypo
1337,GO_Biological_Process_2018,regulation of smoothened signaling pathway (GO:0008589),5/36,0.2712760445017062,0.796241683526245,0,0,1.4942366697072726,1.949408596683948,MGRN1;IFT122;RORA;BTRC;FGFR2,Hypo
1338,GO_Biological_Process_2018,endoderm formation (GO:0001706),5/36,0.2712760445017062,0.796241683526245,0,0,1.4942366697072726,1.949408596683948,DUSP5;LAMB3;COL4A2;DUSP1;INHBA,Hypo
1339,GO_Biological_Process_2018,organophosphate biosynthetic process (GO:0090407),5/36,0.2712760445017062,0.796241683526245,0,0,1.4942366697072726,1.949408596683948,AGPAT5;GNPAT;GPAM;MOCOS;AGPAT4,Hypo
1340,GO_Biological_Process_2018,epithelial cell migration (GO:0010631),5/36,0.2712760445017062,0.796241683526245,0,0,1.4942366697072726,1.949408596683948,PLXND1;NUP188;PXN;KIT;ABL1,Hypo
1341,GO_Biological_Process_2018,regulation of cell morphogenesis involved in differentiation (GO:0010769),5/36,0.2712760445017062,0.796241683526245,0,0,1.4942366697072726,1.949408596683948,SEMA4D;NEDD4L;MARK2;CORO1C;SSH1,Hypo
1342,GO_Biological_Process_2018,positive regulation of blood vessel endothelial cell migration (GO:0043536),6/45,0.2722467464083867,0.7973085011915505,0,0,1.4253719531497309,1.8544751452177572,P2RX4;RHOJ;PRKCA;PRKD2;HMGB1;HDAC7,Hypo
1343,GO_Biological_Process_2018,peptidyl-tyrosine autophosphorylation (GO:0038083),6/45,0.2722467464083867,0.7973085011915505,0,0,1.4253719531497309,1.8544751452177572,SRC;TNK2;ABL1;ABL2;PTK2B;FYN,Hypo
1344,GO_Biological_Process_2018,negative regulation of ossification (GO:0030279),6/45,0.2722467464083867,0.7973085011915505,0,0,1.4253719531497309,1.8544751452177572,SEMA4D;LRP4;PTK2B;AXIN2;LIMD1;HDAC7,Hypo
1345,GO_Biological_Process_2018,protein polyubiquitination (GO:0000209),31/283,0.2729235810860036,0.7986968691662468,0,0,1.1409257467100091,1.4815644689866607,PELI2;NEDD4L;UBE2D1;RNF19B;UBR2;UBE3B;FBXO21;FBXO44;FBXO41;RNF114;TNKS2;TRIM5;BTRC;RFFL;UNKL;SASH1;NHLRC3;FBXW8;ANAPC7;SMURF1;FBXL18;KLHL3;UBE4B;FBXL16;FBXO10;RNF41;FBXO31;RNF144B;SPSB1;UBE2O;RBCK1,Hypo
1346,GO_Biological_Process_2018,macroautophagy (GO:0016236),13/110,0.2739833601393814,0.8011610340901669,0,0,1.2421642565557325,1.608215037565595,MTMR3;SRC;VPS33A;LIX1L;PRKAG1;PRKAG2;TCIRG1;VPS37B;PRKAB1;DYNLL2;LAMP2;ULK1;ATP13A2,Hypo
1347,GO_Biological_Process_2018,negative regulation of canonical Wnt signaling pathway (GO:0090090),17/148,0.2741723975510396,0.8011610340901669,0,0,1.2029831413418213,1.5566579982428324,AMER2;JADE1;DAB2IP;LRP4;AXIN2;STK4;LIMD1;BICC1;DKK3;SDHAF2;FRZB;DDIT3;DVL1;DVL2;NPHP4;IGFBP6;ANKRD6,Hypo
1348,GO_Biological_Process_2018,regulation of angiogenesis (GO:0045765),20/177,0.276495290412182,0.8031681013338882,0,0,1.181017128147586,1.5182701401959096,EGLN1;PLXND1;PRKCB;VASH2;DAB2IP;PRKCA;VASH1;FGF1;PIK3R6;FAM129B;COL4A2;ADGRB1;AGO2;NF1;PRKD2;RAPGEF3;SASH1;GTF2I;HTATIP2;PAK4,Hypo
1349,GO_Biological_Process_2018,regulation of protein ubiquitination (GO:0031396),12/101,0.2787704618350828,0.8031681013338882,0,0,1.2495912616968727,1.596186082881915,DNAJB2;PER2;PAXIP1;ZER1;USP4;LRRK2;ADGRB1;UBE2D1;PTK2B;INAVA;SASH1;SMAD7,Hypo
1350,GO_Biological_Process_2018,negative regulation of growth (GO:0045926),14/120,0.2796830039451777,0.8031681013338882,0,0,1.2241540620614375,1.55969278804156,SMAD3;JADE1;ENO1;INHBA;SMARCA4;PPP1R9B;DCBLD2;DNAJB2;BCL6;FRZB;SH3BP4;APBB2;APBB1;RBBP7,Hypo
1351,GO_Biological_Process_2018,positive regulation of proteasomal protein catabolic process (GO:1901800),9/73,0.2798324883530915,0.8031681013338882,0,0,1.3030815301391037,1.6595578701287754,RNF144B;RNF114;LRRK2;DVL1;DAB2IP;RNF19B;TRIB1;CBFA2T3;SMAD7,Hypo
1352,GO_Biological_Process_2018,regulation of protein complex assembly (GO:0043254),9/73,0.2798324883530915,0.8031681013338882,0,0,1.3030815301391037,1.6595578701287754,NAPA;SRC;STXBP1;TRAPPC12;VPS11;DAB2IP;ULK1;PTPN11;PRKCZ,Hypo
1353,GO_Biological_Process_2018,regulation of mitotic spindle assembly (GO:1901673),3/19,0.281095239074885,0.8031681013338882,0,0,1.7367103235747303,2.2039926216031454,PMEPA1;CCSAP;CHMP5,Hypo
1354,GO_Biological_Process_2018,negative regulation of smoothened signaling pathway (GO:0045879),3/19,0.281095239074885,0.8031681013338882,0,0,1.7367103235747303,2.2039926216031454,MGRN1;IFT122;BTRC,Hypo
1355,GO_Biological_Process_2018,cellular polysaccharide catabolic process (GO:0044247),3/19,0.281095239074885,0.8031681013338882,0,0,1.7367103235747303,2.2039926216031454,AGL;GAA;PGM2,Hypo
1356,GO_Biological_Process_2018,protein targeting to lysosome (GO:0006622),3/19,0.281095239074885,0.8031681013338882,0,0,1.7367103235747303,2.2039926216031454,LARS;LAMP2;SORL1,Hypo
1357,GO_Biological_Process_2018,Rac protein signal transduction (GO:0016601),3/19,0.281095239074885,0.8031681013338882,0,0,1.7367103235747303,2.2039926216031454,TIAM1;DBNL;ELMO1,Hypo
1358,GO_Biological_Process_2018,positive regulation of oxidoreductase activity (GO:0051353),3/19,0.281095239074885,0.8031681013338882,0,0,1.7367103235747303,2.2039926216031454,POR;ABL1;ABL2,Hypo
1359,GO_Biological_Process_2018,osteoclast differentiation (GO:0030316),3/19,0.281095239074885,0.8031681013338882,0,0,1.7367103235747303,2.2039926216031454,SBNO2;SRC;MAPK14,Hypo
1360,GO_Biological_Process_2018,intracellular estrogen receptor signaling pathway (GO:0030520),3/19,0.281095239074885,0.8031681013338882,0,0,1.7367103235747303,2.2039926216031454,SRC;DDX54;PADI2,Hypo
1361,GO_Biological_Process_2018,cellular response to interleukin-7 (GO:0098761),3/19,0.281095239074885,0.8031681013338882,0,0,1.7367103235747303,2.2039926216031454,IRS2;BRWD1;SMARCA4,Hypo
1362,GO_Biological_Process_2018,positive regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902895),3/19,0.281095239074885,0.8031681013338882,0,0,1.7367103235747303,2.2039926216031454,SMAD3;TEAD1;SMARCA4,Hypo
1363,GO_Biological_Process_2018,interleukin-7-mediated signaling pathway (GO:0038111),3/19,0.281095239074885,0.8031681013338882,0,0,1.7367103235747303,2.2039926216031454,IRS2;BRWD1;SMARCA4,Hypo
1364,GO_Biological_Process_2018,protein heterotetramerization (GO:0051290),3/19,0.281095239074885,0.8031681013338882,0,0,1.7367103235747303,2.2039926216031454,XRCC6;LRP4;GRIN2B,Hypo
1365,GO_Biological_Process_2018,regulation of cAMP biosynthetic process (GO:0030817),3/19,0.281095239074885,0.8031681013338882,0,0,1.7367103235747303,2.2039926216031454,CALM3;RAMP1;CAP2,Hypo
1366,GO_Biological_Process_2018,regulation of catenin import into nucleus (GO:0035412),3/19,0.281095239074885,0.8031681013338882,0,0,1.7367103235747303,2.2039926216031454,KANK1;DAB2IP;AXIN2,Hypo
1367,GO_Biological_Process_2018,regulation of gluconeogenesis (GO:0006111),3/19,0.281095239074885,0.8031681013338882,0,0,1.7367103235747303,2.2039926216031454,NR1D1;SOGA1;PDK2,Hypo
1368,GO_Biological_Process_2018,acylglycerol biosynthetic process (GO:0046463),3/19,0.281095239074885,0.8031681013338882,0,0,1.7367103235747303,2.2039926216031454,GNPAT;GPAM;LPIN1,Hypo
1369,GO_Biological_Process_2018,regulation of myotube differentiation (GO:0010830),3/19,0.281095239074885,0.8031681013338882,0,0,1.7367103235747303,2.2039926216031454,HDAC5;BHLHE41;MAPK14,Hypo
1370,GO_Biological_Process_2018,glycerophospholipid metabolic process (GO:0006650),8/64,0.2836317661187126,0.8031681013338882,0,0,1.3236722083272032,1.6679308646911657,SMPD4;ALDH5A1;SYNJ1;PIGQ;ENPP6;GPLD1;SERINC5;DGKH,Hypo
1371,GO_Biological_Process_2018,glucose metabolic process (GO:0006006),8/64,0.2836317661187126,0.8031681013338882,0,0,1.3236722083272032,1.6679308646911657,PER2;ALDH5A1;KCNJ11;GAA;IRS2;ENO1;PPARD;PCK2,Hypo
1372,GO_Biological_Process_2018,regulation of TORC1 signaling (GO:1903432),4/28,0.289114587200445,0.8031681013338882,0,0,1.5438506337786913,1.9158139232290852,SZT2;RRAGC;LARS;ITFG2,Hypo
1373,GO_Biological_Process_2018,cellular response to ketone (GO:1901655),4/28,0.289114587200445,0.8031681013338882,0,0,1.5438506337786913,1.9158139232290852,SRC;ADCY3;DCPS;PCK2,Hypo
1374,GO_Biological_Process_2018,positive regulation of sprouting angiogenesis (GO:1903672),4/28,0.289114587200445,0.8031681013338882,0,0,1.5438506337786913,1.9158139232290852,PPP1R16B;RHOJ;FGF1;HDAC7,Hypo
1375,GO_Biological_Process_2018,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),4/28,0.289114587200445,0.8031681013338882,0,0,1.5438506337786913,1.9158139232290852,WWOX;PPP2R1B;G0S2;INHBA,Hypo
1376,GO_Biological_Process_2018,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),4/28,0.289114587200445,0.8031681013338882,0,0,1.5438506337786913,1.9158139232290852,SMAD3;PIN1;SMAD7;DKK3,Hypo
1377,GO_Biological_Process_2018,regulation of fatty acid biosynthetic process (GO:0042304),4/28,0.289114587200445,0.8031681013338882,0,0,1.5438506337786913,1.9158139232290852,ACADL;MID1IP1;PRKAG2;ERLIN2,Hypo
1378,GO_Biological_Process_2018,intraciliary transport (GO:0042073),6/46,0.289595477642924,0.8031681013338882,0,0,1.3896604938271604,1.7221648860138588,IFT140;IFT122;KIF3C;TNPO1;DYNLL2;RPGR,Hypo
1379,GO_Biological_Process_2018,regulation of generation of precursor metabolites and energy (GO:0043467),6/46,0.289595477642924,0.8031681013338882,0,0,1.3896604938271604,1.7221648860138588,NUP188;NUP133;UQCC2;PRDM16;PRKAG1;PRKAG2,Hypo
1380,GO_Biological_Process_2018,positive regulation of ion transport (GO:0043270),6/46,0.289595477642924,0.8031681013338882,0,0,1.3896604938271604,1.7221648860138588,AHCYL1;P2RX4;CAMK2A;CACNA1D;ANK3;SCN1B,Hypo
1381,GO_Biological_Process_2018,aminoglycan biosynthetic process (GO:0006023),6/46,0.289595477642924,0.8031681013338882,0,0,1.3896604938271604,1.7221648860138588,NDST1;SDC3;XYLT2;XYLT1;GPC4;GPC6,Hypo
1382,GO_Biological_Process_2018,negative regulation of autophagy (GO:0010507),6/46,0.289595477642924,0.8031681013338882,0,0,1.3896604938271604,1.7221648860138588,GOLGA2;KDM4A;LARS;LRRK2;TBC1D14;MTOR,Hypo
1383,GO_Biological_Process_2018,cellular response to ionizing radiation (GO:0071479),6/46,0.289595477642924,0.8031681013338882,0,0,1.3896604938271604,1.7221648860138588,XRCC6;RAD51;TNKS1BP1;INTS7;MAPK14;CRYAB,Hypo
1384,GO_Biological_Process_2018,tRNA aminoacylation for protein translation (GO:0006418),6/46,0.289595477642924,0.8031681013338882,0,0,1.3896604938271604,1.7221648860138588,YARS;LRRC47;LARS;MARS;NARS2;CARS2,Hypo
1385,GO_Biological_Process_2018,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),54/512,0.2898388587751826,0.8031681013338882,0,0,1.0939693770383063,1.354804681398125,CDKN1C;THRA;BHLHE41;ENO1;LIMD1;BCL7A;BTRC;TNFRSF4;PIAS4;ZHX2;SMARCC2;ZBTB38;ESX1;FOXP3;CBFA2T3;RUNX2;DKK3;EREG;DDIT3;KAT6A;CRY2;RARA;PPARD;HDAC5;CTBP2;TSHZ3;CIPC;TOB1;PPM1F;FAM129B;SBNO2;ATXN1;NACC2;PRDM16;MTA3;ATF7IP;SPEN;KDM4A;XRCC6;TGFB3;ZBTB16;DAB2IP;SAMD4B;NR1D1;FOXN3;PEX14;GATAD2A;SMARCA4;PER2;PER1;CDK5;BCL6;BHLHE40;CPEB3,Hypo
1386,GO_Biological_Process_2018,regulation of cell differentiation (GO:0045595),14/121,0.2902096297996021,0.8031681013338882,0,0,1.2126457866687264,1.5002268640947616,PHLDB1;MEGF10;PRKCB;UQCC2;PLEKHB1;NR1D1;RUNX2;SMAD7;TIAM1;BCL6;TRPS1;FGFR2;CLASP1;CLASP2,Hypo
1387,GO_Biological_Process_2018,regulation of dendrite development (GO:0050773),5/37,0.2907648890887825,0.8031681013338882,0,0,1.447461439588689,1.7879626734154408,CAMK2B;SEMA4D;DAB2IP;NEDD4L;CPEB3,Hypo
1388,GO_Biological_Process_2018,regulation of peptidyl-threonine phosphorylation (GO:0010799),5/37,0.2907648890887825,0.8031681013338882,0,0,1.447461439588689,1.7879626734154408,RPTOR;PRKAG2;TNKS1BP1;CALM3;SMAD7,Hypo
1389,GO_Biological_Process_2018,regulation of feeding behavior (GO:0060259),2/11,0.2919869817492074,0.8031681013338882,0,0,2.058065252110427,2.53357312139422,AGRP;EIF2AK4,Hypo
1390,GO_Biological_Process_2018,T-helper cell differentiation (GO:0042093),2/11,0.2919869817492074,0.8031681013338882,0,0,2.058065252110427,2.53357312139422,RORA;HMGB1,Hypo
1391,GO_Biological_Process_2018,negative regulation of fatty acid biosynthetic process (GO:0045717),2/11,0.2919869817492074,0.8031681013338882,0,0,2.058065252110427,2.53357312139422,ACADL;ERLIN2,Hypo
1392,GO_Biological_Process_2018,calcineurin-NFAT signaling cascade (GO:0033173),2/11,0.2919869817492074,0.8031681013338882,0,0,2.058065252110427,2.53357312139422,ADGRB2;NFATC2,Hypo
1393,GO_Biological_Process_2018,regulation of mitotic centrosome separation (GO:0046602),2/11,0.2919869817492074,0.8031681013338882,0,0,2.058065252110427,2.53357312139422,CEP85;MAP9,Hypo
1394,GO_Biological_Process_2018,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),2/11,0.2919869817492074,0.8031681013338882,0,0,2.058065252110427,2.53357312139422,CREB3L1;DDIT3,Hypo
1395,GO_Biological_Process_2018,relaxation of cardiac muscle (GO:0055119),2/11,0.2919869817492074,0.8031681013338882,0,0,2.058065252110427,2.53357312139422,P2RX4;ATP1A2,Hypo
1396,GO_Biological_Process_2018,regulation of integrin-mediated signaling pathway (GO:2001044),2/11,0.2919869817492074,0.8031681013338882,0,0,2.058065252110427,2.53357312139422,FLNA;ITGB1BP1,Hypo
1397,GO_Biological_Process_2018,response to axon injury (GO:0048678),2/11,0.2919869817492074,0.8031681013338882,0,0,2.058065252110427,2.53357312139422,RTN4RL2;MTR,Hypo
1398,GO_Biological_Process_2018,negative regulation of myotube differentiation (GO:0010832),2/11,0.2919869817492074,0.8031681013338882,0,0,2.058065252110427,2.53357312139422,HDAC5;BHLHE41,Hypo
1399,GO_Biological_Process_2018,positive regulation of mesenchymal cell proliferation (GO:0002053),2/11,0.2919869817492074,0.8031681013338882,0,0,2.058065252110427,2.53357312139422,PDGFA;FGFR2,Hypo
1400,GO_Biological_Process_2018,renal filtration (GO:0097205),2/11,0.2919869817492074,0.8031681013338882,0,0,2.058065252110427,2.53357312139422,MYO1E;SULF2,Hypo
1401,GO_Biological_Process_2018,negative regulation of protein localization to cell surface (GO:2000009),2/11,0.2919869817492074,0.8031681013338882,0,0,2.058065252110427,2.53357312139422,NEDD4L;GPM6B,Hypo
1402,GO_Biological_Process_2018,relaxation of muscle (GO:0090075),2/11,0.2919869817492074,0.8031681013338882,0,0,2.058065252110427,2.53357312139422,P2RX4;ATP1A2,Hypo
1403,GO_Biological_Process_2018,positive regulation of chondrocyte differentiation (GO:0032332),2/11,0.2919869817492074,0.8031681013338882,0,0,2.058065252110427,2.53357312139422,ZBTB16;SOX5,Hypo
1404,GO_Biological_Process_2018,camera-type eye morphogenesis (GO:0048593),2/11,0.2919869817492074,0.8031681013338882,0,0,2.058065252110427,2.53357312139422,NF1;IFT122,Hypo
1405,GO_Biological_Process_2018,response to nitric oxide (GO:0071731),2/11,0.2919869817492074,0.8031681013338882,0,0,2.058065252110427,2.53357312139422,EGLN1;MTR,Hypo
1406,GO_Biological_Process_2018,negative regulation of cardiac muscle hypertrophy (GO:0010614),2/11,0.2919869817492074,0.8031681013338882,0,0,2.058065252110427,2.53357312139422,P2RX4;LMNA,Hypo
1407,GO_Biological_Process_2018,modulation by host of viral genome replication (GO:0044827),2/11,0.2919869817492074,0.8031681013338882,0,0,2.058065252110427,2.53357312139422,EIF2AK4;PPIB,Hypo
1408,GO_Biological_Process_2018,carbohydrate phosphorylation (GO:0046835),2/11,0.2919869817492074,0.8031681013338882,0,0,2.058065252110427,2.53357312139422,ITPK1;HK1,Hypo
1409,GO_Biological_Process_2018,positive regulation of fatty acid oxidation (GO:0046321),2/11,0.2919869817492074,0.8031681013338882,0,0,2.058065252110427,2.53357312139422,IRS2;MLYCD,Hypo
1410,GO_Biological_Process_2018,low-density lipoprotein receptor particle metabolic process (GO:0032799),2/11,0.2919869817492074,0.8031681013338882,0,0,2.058065252110427,2.53357312139422,AP2S1;AP2A1,Hypo
1411,GO_Biological_Process_2018,positive regulation of glucose metabolic process (GO:0010907),2/11,0.2919869817492074,0.8031681013338882,0,0,2.058065252110427,2.53357312139422,IRS2;GPLD1,Hypo
1412,GO_Biological_Process_2018,"negative regulation of translation, ncRNA-mediated (GO:0040033)",2/11,0.2919869817492074,0.8031681013338882,0,0,2.058065252110427,2.53357312139422,TNRC6C;AGO2,Hypo
1413,GO_Biological_Process_2018,embryonic hemopoiesis (GO:0035162),2/11,0.2919869817492074,0.8031681013338882,0,0,2.058065252110427,2.53357312139422,KMT2A;KIT,Hypo
1414,GO_Biological_Process_2018,aspartate family amino acid biosynthetic process (GO:0009067),2/11,0.2919869817492074,0.8031681013338882,0,0,2.058065252110427,2.53357312139422,MTHFD1;MTR,Hypo
1415,GO_Biological_Process_2018,carbohydrate derivative catabolic process (GO:1901136),2/11,0.2919869817492074,0.8031681013338882,0,0,2.058065252110427,2.53357312139422,NEU4;DERA,Hypo
1416,GO_Biological_Process_2018,miRNA mediated inhibition of translation (GO:0035278),2/11,0.2919869817492074,0.8031681013338882,0,0,2.058065252110427,2.53357312139422,TNRC6C;AGO2,Hypo
1417,GO_Biological_Process_2018,positive regulation of T-helper cell differentiation (GO:0045624),2/11,0.2919869817492074,0.8031681013338882,0,0,2.058065252110427,2.53357312139422,RARA;PRKCZ,Hypo
1418,GO_Biological_Process_2018,cardiac muscle cell membrane repolarization (GO:0099622),2/11,0.2919869817492074,0.8031681013338882,0,0,2.058065252110427,2.53357312139422,KCND3;KCNQ1,Hypo
1419,GO_Biological_Process_2018,membrane repolarization during action potential (GO:0086011),2/11,0.2919869817492074,0.8031681013338882,0,0,2.058065252110427,2.53357312139422,KCND3;KCNQ1,Hypo
1420,GO_Biological_Process_2018,spinal cord development (GO:0021510),2/11,0.2919869817492074,0.8031681013338882,0,0,2.058065252110427,2.53357312139422,NF1;PKD1,Hypo
1421,GO_Biological_Process_2018,hepatocyte growth factor receptor signaling pathway (GO:0048012),2/11,0.2919869817492074,0.8031681013338882,0,0,2.058065252110427,2.53357312139422,MST1R;BCAR1,Hypo
1422,GO_Biological_Process_2018,negative regulation of morphogenesis of an epithelium (GO:1905331),2/11,0.2919869817492074,0.8031681013338882,0,0,2.058065252110427,2.53357312139422,CLASP1;CLASP2,Hypo
1423,GO_Biological_Process_2018,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",2/11,0.2919869817492074,0.8031681013338882,0,0,2.058065252110427,2.53357312139422,CCT5;WRAP53,Hypo
1424,GO_Biological_Process_2018,postsynapse assembly (GO:0099068),2/11,0.2919869817492074,0.8031681013338882,0,0,2.058065252110427,2.53357312139422,NRXN2;LRP4,Hypo
1425,GO_Biological_Process_2018,embryonic eye morphogenesis (GO:0048048),2/11,0.2919869817492074,0.8031681013338882,0,0,2.058065252110427,2.53357312139422,FBN2;RARG,Hypo
1426,GO_Biological_Process_2018,mesonephros development (GO:0001823),2/11,0.2919869817492074,0.8031681013338882,0,0,2.058065252110427,2.53357312139422,ZBTB16;FGF1,Hypo
1427,GO_Biological_Process_2018,cellular response to sterol (GO:0036315),2/11,0.2919869817492074,0.8031681013338882,0,0,2.058065252110427,2.53357312139422,RORA;GPLD1,Hypo
1428,GO_Biological_Process_2018,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),2/11,0.2919869817492074,0.8031681013338882,0,0,2.058065252110427,2.53357312139422,STK24;PDK1,Hypo
1429,GO_Biological_Process_2018,myeloid cell activation involved in immune response (GO:0002275),2/11,0.2919869817492074,0.8031681013338882,0,0,2.058065252110427,2.53357312139422,SBNO2;DOCK2,Hypo
1430,GO_Biological_Process_2018,regulation of protein kinase C signaling (GO:0090036),2/11,0.2919869817492074,0.8031681013338882,0,0,2.058065252110427,2.53357312139422,FLT4;ULK4,Hypo
1431,GO_Biological_Process_2018,positive regulation of myoblast fusion (GO:1901741),2/11,0.2919869817492074,0.8031681013338882,0,0,2.058065252110427,2.53357312139422,ADGRB1;MAPK14,Hypo
1432,GO_Biological_Process_2018,mitotic nuclear division (GO:0140014),9/74,0.2934521196971783,0.8060724543146341,0,0,1.2829627868267746,1.5729647069522927,GOLGA2;ARHGEF10;CTDP1;BCCIP;FLNA;TUBGCP6;CLASP1;MAP9;CLASP2,Hypo
1433,GO_Biological_Process_2018,nitrogen compound transport (GO:0071705),9/74,0.2934521196971783,0.8060724543146341,0,0,1.2829627868267746,1.5729647069522927,SLC6A19;SLC25A29;SLC6A18;SLC7A8;SLC43A2;SLC16A10;RHCG;SLC7A1;SLC38A4,Hypo
1434,GO_Biological_Process_2018,cellular response to reactive oxygen species (GO:0034614),8/65,0.2982973729812028,0.8182404959421713,0,0,1.3003776175763817,1.57302050291068,PDGFRA;PLEKHA1;PXN;ABL1;MTR;MAPT;PDK2;CAMKK2,Hypo
1435,GO_Biological_Process_2018,O-glycan processing (GO:0016266),8/65,0.2982973729812028,0.8182404959421713,0,0,1.3003776175763817,1.57302050291068,ST6GAL1;GALNT13;MUC2;GALNT2;XXYLT1;GALNT9;ST3GAL2;ST3GAL3,Hypo
1436,GO_Biological_Process_2018,sulfur compound biosynthetic process (GO:0044272),14/122,0.3008547688622997,0.8246812348981201,0,0,1.2013506274869912,1.4429754273621511,B4GALT1;CHPF;B3GAT2;XYLT2;PAPSS1;NDST1;CHST11;CHST15;CHST1;ST3GAL6;CSPG4;ST3GAL2;CHST2;ST3GAL3,Hypo
1437,GO_Biological_Process_2018,positive regulation of developmental process (GO:0051094),13/113,0.3071045238959143,0.8354562292271969,0,0,1.2046979865771812,1.4222268332360706,PAXIP1;SRC;ZBTB16;DDHD1;CORO1C;FAM129B;AGO2;LMNA;TMEM119;ARHGEF7;FGFR2;RAPGEF3;SOX5,Hypo
1438,GO_Biological_Process_2018,negative regulation of cellular biosynthetic process (GO:0031327),6/47,0.3071636043212891,0.8354562292271969,0,0,1.3556910569105691,1.600223506265796,ACADL;RAPGEF2;AP2A1;ERLIN2;SOGA1;FOXP3,Hypo
1439,GO_Biological_Process_2018,histone H4 acetylation (GO:0043967),6/47,0.3071636043212891,0.8354562292271969,0,0,1.3556910569105691,1.600223506265796,PER1;KMT2A;TRRAP;JADE1;CHD5;APBB1,Hypo
1440,GO_Biological_Process_2018,regulation of vacuole organization (GO:0044088),3/20,0.3088155038727592,0.8354562292271969,0,0,1.634460255596846,1.9205091965850865,MTMR3;TBC1D14;UBQLN2,Hypo
1441,GO_Biological_Process_2018,regulation of regulatory T cell differentiation (GO:0045589),3/20,0.3088155038727592,0.8354562292271969,0,0,1.634460255596846,1.9205091965850865,BCL6;NFATC2;FOXP3,Hypo
1442,GO_Biological_Process_2018,negative regulation of ion transport (GO:0043271),3/20,0.3088155038727592,0.8354562292271969,0,0,1.634460255596846,1.9205091965850865,HRH3;PTK2B;GPM6B,Hypo
1443,GO_Biological_Process_2018,response to progesterone (GO:0032570),3/20,0.3088155038727592,0.8354562292271969,0,0,1.634460255596846,1.9205091965850865,SRC;TGFB3;ABHD2,Hypo
1444,GO_Biological_Process_2018,regulation of glycogen biosynthetic process (GO:0005979),3/20,0.3088155038727592,0.8354562292271969,0,0,1.634460255596846,1.9205091965850865,PPP1R3F;IRS2;SORBS1,Hypo
1445,GO_Biological_Process_2018,organelle disassembly (GO:1903008),3/20,0.3088155038727592,0.8354562292271969,0,0,1.634460255596846,1.9205091965850865,GOLGA2;KLC1;RETREG1,Hypo
1446,GO_Biological_Process_2018,adrenergic receptor signaling pathway (GO:0071875),3/20,0.3088155038727592,0.8354562292271969,0,0,1.634460255596846,1.9205091965850865,ADCY9;RAPGEF2;GPR101,Hypo
1447,GO_Biological_Process_2018,heparan sulfate proteoglycan metabolic process (GO:0030201),3/20,0.3088155038727592,0.8354562292271969,0,0,1.634460255596846,1.9205091965850865,NDST1;XYLT2;SULF2,Hypo
1448,GO_Biological_Process_2018,negative regulation of adenylate cyclase activity (GO:0007194),3/20,0.3088155038727592,0.8354562292271969,0,0,1.634460255596846,1.9205091965850865,GABBR2;GRM2;HRH3,Hypo
1449,GO_Biological_Process_2018,cellular response to steroid hormone stimulus (GO:0071383),3/20,0.3088155038727592,0.8354562292271969,0,0,1.634460255596846,1.9205091965850865,SRC;ABHD2;ATP1A2,Hypo
1450,GO_Biological_Process_2018,regulation of transport (GO:0051049),3/20,0.3088155038727592,0.8354562292271969,0,0,1.634460255596846,1.9205091965850865,DISP3;WWC1;SLC2A1,Hypo
1451,GO_Biological_Process_2018,positive regulation of cAMP biosynthetic process (GO:0030819),3/20,0.3088155038727592,0.8354562292271969,0,0,1.634460255596846,1.9205091965850865,NF1;CALM3;RAMP1,Hypo
1452,GO_Biological_Process_2018,cell projection assembly (GO:0030031),3/20,0.3088155038727592,0.8354562292271969,0,0,1.634460255596846,1.9205091965850865,CYFIP2;RHOJ;PDGFA,Hypo
1453,GO_Biological_Process_2018,negative regulation of intracellular protein transport (GO:0090317),3/20,0.3088155038727592,0.8354562292271969,0,0,1.634460255596846,1.9205091965850865,LRRK2;ITGB1BP1;CABP1,Hypo
1454,GO_Biological_Process_2018,negative regulation of cyclase activity (GO:0031280),3/20,0.3088155038727592,0.8354562292271969,0,0,1.634460255596846,1.9205091965850865,GABBR2;GRM2;HRH3,Hypo
1455,GO_Biological_Process_2018,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),3/20,0.3088155038727592,0.8354562292271969,0,0,1.634460255596846,1.9205091965850865,ADCY9;RAPGEF2;GPR101,Hypo
1456,GO_Biological_Process_2018,regulation of cellular amide metabolic process (GO:0034248),5/38,0.3104870577078771,0.8386378482760353,0,0,1.4035210719015343,1.6415765764918528,CYFIP2;ATXN2;TCOF1;ATP13A2;FOXO3,Hypo
1457,GO_Biological_Process_2018,DNA damage checkpoint (GO:0000077),5/38,0.3104870577078771,0.8386378482760353,0,0,1.4035210719015343,1.6415765764918528,DOT1L;INTS7;CLSPN;STK4;MAP3K14,Hypo
1458,GO_Biological_Process_2018,synaptic vesicle endocytosis (GO:0048488),4/29,0.3119077044235571,0.8386378482760353,0,0,1.4820143884892083,1.7266178312428324,CDK5;SYNJ1;PIP5K1C;DNM1,Hypo
1459,GO_Biological_Process_2018,vacuolar transport (GO:0007034),4/29,0.3119077044235571,0.8386378482760353,0,0,1.4820143884892083,1.7266178312428324,SPTBN5;VPS53;VPS13D;VTI1A,Hypo
1460,GO_Biological_Process_2018,positive regulation of histone modification (GO:0031058),4/29,0.3119077044235571,0.8386378482760353,0,0,1.4820143884892083,1.7266178312428324,PAXIP1;SART3;TET1;FOXP3,Hypo
1461,GO_Biological_Process_2018,synaptic vesicle recycling (GO:0036465),4/29,0.3119077044235571,0.8386378482760353,0,0,1.4820143884892083,1.7266178312428324,CDK5;SYNJ1;PIP5K1C;SYT7,Hypo
1462,GO_Biological_Process_2018,regulation of activated T cell proliferation (GO:0046006),4/29,0.3119077044235571,0.8386378482760353,0,0,1.4820143884892083,1.7266178312428324,PRKAR1A;HMGB1;IL12RB1;FOXP3,Hypo
1463,GO_Biological_Process_2018,amino acid transmembrane transport (GO:0003333),4/29,0.3119077044235571,0.8386378482760353,0,0,1.4820143884892083,1.7266178312428324,SLC7A5;SLC7A8;SLC38A10;SLC38A4,Hypo
1464,GO_Biological_Process_2018,lung development (GO:0030324),4/29,0.3119077044235571,0.8386378482760353,0,0,1.4820143884892083,1.7266178312428324,ZIC3;PKD1;FGFR2;CCDC40,Hypo
1465,GO_Biological_Process_2018,positive regulation of vasculature development (GO:1904018),12/104,0.3136324639494957,0.8427000514986792,0,0,1.2086418091263966,1.4014606377118888,PRKCB;AGO2;KIT;VASH2;RAPGEF2;PRKCA;PRKD2;FGF1;PIK3R6;RAPGEF3;SASH1;PAK4,Hypo
1466,GO_Biological_Process_2018,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),10/85,0.3144811861000581,0.8444044935570069,0,0,1.2353951890034365,1.429143484322201,SEMA4D;SRC;TNK2;ABL1;PDGFA;PTK2B;FYN;CSPG4;ARHGEF2;PRKCZ,Hypo
1467,GO_Biological_Process_2018,regulation of neurogenesis (GO:0050767),7/57,0.3190660824157856,0.8549668698202582,0,0,1.296963458569223,1.4815953410762082,SPEN;PER2;RGS14;BIN1;LRRK2;ULK4;SORL1,Hypo
1468,GO_Biological_Process_2018,protein homotetramerization (GO:0051289),7/57,0.3190660824157856,0.8549668698202582,0,0,1.296963458569223,1.4815953410762082,RYR1;GOLGA2;ALDH5A1;RXRA;KCNJ12;ACACB;RYR3,Hypo
1469,GO_Biological_Process_2018,positive regulation of cell death (GO:0010942),7/57,0.3190660824157856,0.8549668698202582,0,0,1.296963458569223,1.4815953410762082,RARG;LRP1;LRRK2;FYN;AXIN2;MAPT;GRIN2B,Hypo
1470,GO_Biological_Process_2018,cilium organization (GO:0044782),21/192,0.3223845223069483,0.8560943401178281,0,0,1.1382408847416623,1.2885003794964642,UNC119B;ABCC4;SEPT11;FBF1;CEP164;IFT122;ASAP1;DYNLL2;RPGR;TTC17;SEPT8;SEPT9;ABLIM1;RILPL2;TTLL3;RILPL1;RAB23;FLNA;DZIP1;PCNT;BBS4,Hypo
1471,GO_Biological_Process_2018,platelet degranulation (GO:0002576),14/124,0.3224631181871982,0.8560943401178281,0,0,1.1793764087152516,1.3347787238328177,ABCC4;TEX264;TGFB3;BRPF3;ACTN1;STXBP1;PDGFA;LHFPL2;SGPP2;LAMP2;PSAP;TIMP3;FLNA;CD9,Hypo
1472,GO_Biological_Process_2018,interstrand cross-link repair (GO:0036297),6/48,0.3249077636880599,0.8560943401178281,0,0,1.3233392122281011,1.4877163910179312,RAD51;FANCD2;ERCC1;FANCC;FANCE;FAN1,Hypo
1473,GO_Biological_Process_2018,neutrophil degranulation (GO:0043312),50/479,0.3255689130784719,0.8560943401178281,0,0,1.080910317752423,1.212977156631999,B4GALT1;ATP8A1;SLC44A2;TCIRG1;HMGB1;SLC2A5;ALAD;STK10;HK3;LAMP2;TIMP2;PGM2;CTSD;DBNL;NHLRC3;NFAM1;GAA;ATP11A;KCNAB2;AMPD3;DDOST;RAB31;PKM;TMBIM1;PADI2;DOCK2;GRN;RAB5C;UBR4;GNS;SYNGR1;PGRMC1;PSAP;NEU1;SLC15A4;ATP6V0A1;DYNC1H1;XRCC6;AGL;CMTM6;PDAP1;NBEAL2;MAPK14;IGF2R;DERA;DIAPH1;PTPRB;NFASC;TSPAN14;IMPDH1,Hypo
1474,GO_Biological_Process_2018,regulation of TOR signaling (GO:0032006),8/67,0.3281097245964543,0.8560943401178281,0,0,1.2561573775070258,1.3998708262423687,RPTOR;PREX1;DEPTOR;RRAGC;TSC2;SH3BP4;UBR2;RFFL,Hypo
1475,GO_Biological_Process_2018,extrinsic apoptotic signaling pathway (GO:0097191),8/67,0.3281097245964543,0.8560943401178281,0,0,1.2561573775070258,1.3998708262423687,SMAD3;BAG3;SORT1;DAB2IP;G0S2;INHBA;BOK;RNF41,Hypo
1476,GO_Biological_Process_2018,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),2/12,0.3294843918808396,0.8560943401178281,0,0,1.8521560574948663,2.0563123579627134,SETMAR;USP51,Hypo
1477,GO_Biological_Process_2018,regulation of myoblast fusion (GO:1901739),2/12,0.3294843918808396,0.8560943401178281,0,0,1.8521560574948663,2.0563123579627134,ADGRB1;MAPK14,Hypo
1478,GO_Biological_Process_2018,peptidyl-arginine modification (GO:0018195),2/12,0.3294843918808396,0.8560943401178281,0,0,1.8521560574948663,2.0563123579627134,PRMT8;PADI2,Hypo
1479,GO_Biological_Process_2018,regulation of oligodendrocyte differentiation (GO:0048713),2/12,0.3294843918808396,0.8560943401178281,0,0,1.8521560574948663,2.0563123579627134,TENM4;NF1,Hypo
1480,GO_Biological_Process_2018,ribose phosphate metabolic process (GO:0019693),2/12,0.3294843918808396,0.8560943401178281,0,0,1.8521560574948663,2.0563123579627134,PGM2;DERA,Hypo
1481,GO_Biological_Process_2018,positive regulation of establishment of protein localization (GO:1904951),2/12,0.3294843918808396,0.8560943401178281,0,0,1.8521560574948663,2.0563123579627134,CCT5;WRAP53,Hypo
1482,GO_Biological_Process_2018,vesicle budding from membrane (GO:0006900),2/12,0.3294843918808396,0.8560943401178281,0,0,1.8521560574948663,2.0563123579627134,ATP8A1;MYO18A,Hypo
1483,GO_Biological_Process_2018,regulation of cytokine biosynthetic process (GO:0042035),2/12,0.3294843918808396,0.8560943401178281,0,0,1.8521560574948663,2.0563123579627134,FOXP3;EREG,Hypo
1484,GO_Biological_Process_2018,oligodendrocyte development (GO:0014003),2/12,0.3294843918808396,0.8560943401178281,0,0,1.8521560574948663,2.0563123579627134,EIF2B5;CNTNAP1,Hypo
1485,GO_Biological_Process_2018,phospholipid efflux (GO:0033700),2/12,0.3294843918808396,0.8560943401178281,0,0,1.8521560574948663,2.0563123579627134,ABCA1;ABCG1,Hypo
1486,GO_Biological_Process_2018,serine family amino acid biosynthetic process (GO:0009070),2/12,0.3294843918808396,0.8560943401178281,0,0,1.8521560574948663,2.0563123579627134,MTHFD1;SERINC5,Hypo
1487,GO_Biological_Process_2018,positive regulation of T-helper 1 type immune response (GO:0002827),2/12,0.3294843918808396,0.8560943401178281,0,0,1.8521560574948663,2.0563123579627134,NLRP10;IL12RB1,Hypo
1488,GO_Biological_Process_2018,mitochondrion transport along microtubule (GO:0047497),2/12,0.3294843918808396,0.8560943401178281,0,0,1.8521560574948663,2.0563123579627134,MAP1S;MAPT,Hypo
1489,GO_Biological_Process_2018,protein import into peroxisome matrix (GO:0016558),2/12,0.3294843918808396,0.8560943401178281,0,0,1.8521560574948663,2.0563123579627134,PEX1;PEX14,Hypo
1490,GO_Biological_Process_2018,DNA ligation involved in DNA repair (GO:0051103),2/12,0.3294843918808396,0.8560943401178281,0,0,1.8521560574948663,2.0563123579627134,PARP3;HMGB1,Hypo
1491,GO_Biological_Process_2018,regulation of cell communication by electrical coupling (GO:0010649),2/12,0.3294843918808396,0.8560943401178281,0,0,1.8521560574948663,2.0563123579627134,CALM3;ANK3,Hypo
1492,GO_Biological_Process_2018,histone H3 deacetylation (GO:0070932),2/12,0.3294843918808396,0.8560943401178281,0,0,1.8521560574948663,2.0563123579627134,PER2;PER1,Hypo
1493,GO_Biological_Process_2018,spliceosomal tri-snRNP complex assembly (GO:0000244),2/12,0.3294843918808396,0.8560943401178281,0,0,1.8521560574948663,2.0563123579627134,SART3;USP4,Hypo
1494,GO_Biological_Process_2018,regulation of skeletal muscle tissue development (GO:0048641),2/12,0.3294843918808396,0.8560943401178281,0,0,1.8521560574948663,2.0563123579627134,MEGF10;UQCC2,Hypo
1495,GO_Biological_Process_2018,negative regulation of histone modification (GO:0031057),2/12,0.3294843918808396,0.8560943401178281,0,0,1.8521560574948663,2.0563123579627134,H2AFY;FOXP3,Hypo
1496,GO_Biological_Process_2018,response to interleukin-6 (GO:0070741),2/12,0.3294843918808396,0.8560943401178281,0,0,1.8521560574948663,2.0563123579627134,SBNO2;ST3GAL6,Hypo
1497,GO_Biological_Process_2018,purine nucleoside monophosphate biosynthetic process (GO:0009127),2/12,0.3294843918808396,0.8560943401178281,0,0,1.8521560574948663,2.0563123579627134,IMPDH1;PPAT,Hypo
1498,GO_Biological_Process_2018,collagen metabolic process (GO:0032963),2/12,0.3294843918808396,0.8560943401178281,0,0,1.8521560574948663,2.0563123579627134,COL5A1;P3H1,Hypo
1499,GO_Biological_Process_2018,skeletal muscle cell differentiation (GO:0035914),2/12,0.3294843918808396,0.8560943401178281,0,0,1.8521560574948663,2.0563123579627134,MEGF10;LEMD2,Hypo
1500,GO_Biological_Process_2018,positive regulation of cyclase activity (GO:0031281),2/12,0.3294843918808396,0.8560943401178281,0,0,1.8521560574948663,2.0563123579627134,NF1;MAPK14,Hypo
1501,GO_Biological_Process_2018,transcription from mitochondrial promoter (GO:0006390),2/12,0.3294843918808396,0.8560943401178281,0,0,1.8521560574948663,2.0563123579627134,FOXO3;TEFM,Hypo
1502,GO_Biological_Process_2018,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),2/12,0.3294843918808396,0.8560943401178281,0,0,1.8521560574948663,2.0563123579627134,SPRY4;SULF2,Hypo
1503,GO_Biological_Process_2018,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),2/12,0.3294843918808396,0.8560943401178281,0,0,1.8521560574948663,2.0563123579627134,PRKCB;PRKD2,Hypo
1504,GO_Biological_Process_2018,negative regulation of fatty acid metabolic process (GO:0045922),2/12,0.3294843918808396,0.8560943401178281,0,0,1.8521560574948663,2.0563123579627134,ACADL;ERLIN2,Hypo
1505,GO_Biological_Process_2018,calcineurin-mediated signaling (GO:0097720),2/12,0.3294843918808396,0.8560943401178281,0,0,1.8521560574948663,2.0563123579627134,ADGRB2;NFATC2,Hypo
1506,GO_Biological_Process_2018,regulation of catabolic process (GO:0009894),2/12,0.3294843918808396,0.8560943401178281,0,0,1.8521560574948663,2.0563123579627134,NEDD4L;FURIN,Hypo
1507,GO_Biological_Process_2018,positive regulation of SMAD protein import into nucleus (GO:0060391),2/12,0.3294843918808396,0.8560943401178281,0,0,1.8521560574948663,2.0563123579627134,SMAD3;TGFB3,Hypo
1508,GO_Biological_Process_2018,eye photoreceptor cell differentiation (GO:0001754),2/12,0.3294843918808396,0.8560943401178281,0,0,1.8521560574948663,2.0563123579627134,DSCAM;SDK2,Hypo
1509,GO_Biological_Process_2018,regulation of mesenchymal cell proliferation (GO:0010464),2/12,0.3294843918808396,0.8560943401178281,0,0,1.8521560574948663,2.0563123579627134,PDGFA;FGFR2,Hypo
1510,GO_Biological_Process_2018,positive regulation of interleukin-1 production (GO:0032732),2/12,0.3294843918808396,0.8560943401178281,0,0,1.8521560574948663,2.0563123579627134,HMGB1;INAVA,Hypo
1511,GO_Biological_Process_2018,regulation of protein glycosylation (GO:0060049),2/12,0.3294843918808396,0.8560943401178281,0,0,1.8521560574948663,2.0563123579627134,GOLGA2;RAMP1,Hypo
1512,GO_Biological_Process_2018,pentose-phosphate shunt (GO:0006098),2/12,0.3294843918808396,0.8560943401178281,0,0,1.8521560574948663,2.0563123579627134,PGM2;DERA,Hypo
1513,GO_Biological_Process_2018,carbohydrate derivative transport (GO:1901264),2/12,0.3294843918808396,0.8560943401178281,0,0,1.8521560574948663,2.0563123579627134,SCARB1;ABCG1,Hypo
1514,GO_Biological_Process_2018,regulation of cholesterol homeostasis (GO:2000188),2/12,0.3294843918808396,0.8560943401178281,0,0,1.8521560574948663,2.0563123579627134,RORA;NR1D1,Hypo
1515,GO_Biological_Process_2018,regulation of histone methylation (GO:0031060),2/12,0.3294843918808396,0.8560943401178281,0,0,1.8521560574948663,2.0563123579627134,TET1;PRDM10,Hypo
1516,GO_Biological_Process_2018,ERBB2 signaling pathway (GO:0038128),5/39,0.3303817757032654,0.8561669832205018,0,0,1.3621654317253893,1.5086069295984068,SRC;PRKCA;PIK3R1;NRG2;EREG,Hypo
1517,GO_Biological_Process_2018,positive regulation of fat cell differentiation (GO:0045600),5/39,0.3303817757032654,0.8561669832205018,0,0,1.3621654317253893,1.5086069295984068,FRZB;ZBTB16;MEDAG;CMKLR1;PPARD,Hypo
1518,GO_Biological_Process_2018,positive regulation of reactive oxygen species metabolic process (GO:2000379),5/39,0.3303817757032654,0.8561669832205018,0,0,1.3621654317253893,1.5086069295984068,ADGRB1;MAPT;F2;MAPK14;RNF41,Hypo
1519,GO_Biological_Process_2018,clathrin-dependent endocytosis (GO:0072583),5/39,0.3303817757032654,0.8561669832205018,0,0,1.3621654317253893,1.5086069295984068,CDK5;SYNJ1;AP2S1;AP2A1;PIP5K1C,Hypo
1520,GO_Biological_Process_2018,ciliary basal body-plasma membrane docking (GO:0097711),11/96,0.3329842054633413,0.8576481743315124,0,0,1.199011012347177,1.318504715020082,DYNC1I2;DYNC1H1;ODF2;CEP164;FBF1;RAB3IP;FGFR1OP;NPHP4;PCNT;NINL;CLASP1,Hypo
1521,GO_Biological_Process_2018,cellular metal ion homeostasis (GO:0006875),11/96,0.3329842054633413,0.8576481743315124,0,0,1.199011012347177,1.318504715020082,SLC8A3;RYR2;NEDD4L;RMDN3;ATP1A2;ATP13A2;ATP2B1;LETMD1;SLC8A2;SLC9A1;CHERP,Hypo
1522,GO_Biological_Process_2018,negative regulation of cation channel activity (GO:2001258),4/30,0.3348535384321258,0.8576481743315124,0,0,1.424934777452763,1.5589670515763885,EPO;KCNAB1;CALM3;EPHB2,Hypo
1523,GO_Biological_Process_2018,connective tissue development (GO:0061448),4/30,0.3348535384321258,0.8576481743315124,0,0,1.424934777452763,1.5589670515763885,ZBTB16;CREB3L2;PKD1;SULF2,Hypo
1524,GO_Biological_Process_2018,bile acid and bile salt transport (GO:0015721),4/30,0.3348535384321258,0.8576481743315124,0,0,1.424934777452763,1.5589670515763885,NCOA1;RXRA;SLCO2B1;SLC10A3,Hypo
1525,GO_Biological_Process_2018,cellular response to drug (GO:0035690),4/30,0.3348535384321258,0.8576481743315124,0,0,1.424934777452763,1.5589670515763885,KCNQ1;PDE2A;PPM1F;GPLD1,Hypo
1526,GO_Biological_Process_2018,activation of protein kinase B activity (GO:0032148),4/30,0.3348535384321258,0.8576481743315124,0,0,1.424934777452763,1.5589670515763885,NTRK3;ITGB1BP1;FGF1;MTOR,Hypo
1527,GO_Biological_Process_2018,activation of JUN kinase activity (GO:0007257),4/30,0.3348535384321258,0.8576481743315124,0,0,1.424934777452763,1.5589670515763885,DBNL;DAB2IP;MAP4K5;MAP3K11,Hypo
1528,GO_Biological_Process_2018,fatty-acyl-CoA biosynthetic process (GO:0046949),4/30,0.3348535384321258,0.8576481743315124,0,0,1.424934777452763,1.5589670515763885,FASN;TECR;ACSL6;ACSL4,Hypo
1529,GO_Biological_Process_2018,regulation of developmental growth (GO:0048638),4/30,0.3348535384321258,0.8576481743315124,0,0,1.424934777452763,1.5589670515763885,OLFM1;CTTN;ABL1;FGFR2,Hypo
1530,GO_Biological_Process_2018,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),4/30,0.3348535384321258,0.8576481743315124,0,0,1.424934777452763,1.5589670515763885,SMAD3;P2RX4;NOS1AP;ADGRB1,Hypo
1531,GO_Biological_Process_2018,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),4/30,0.3348535384321258,0.8576481743315124,0,0,1.424934777452763,1.5589670515763885,HDAC5;RHOJ;ITGB1BP1;HDAC7,Hypo
1532,GO_Biological_Process_2018,response to ionizing radiation (GO:0010212),9/77,0.3352086348140002,0.8576481743315124,0,0,1.2261569233566687,1.340192154105091,IKBIP;BABAM2;PAXIP1;RAD51;EYA1;FANCD2;TNKS1BP1;INTS7;MAPK14,Hypo
1533,GO_Biological_Process_2018,cholesterol homeostasis (GO:0042632),7/58,0.3353270321321819,0.8576481743315124,0,0,1.271462161807595,1.389261869840921,ABCA1;SCARB1;DISP3;SOAT1;LDLRAP1;LDLR;ABCG1,Hypo
1534,GO_Biological_Process_2018,sterol homeostasis (GO:0055092),7/58,0.3353270321321819,0.8576481743315124,0,0,1.271462161807595,1.389261869840921,ABCA1;SCARB1;DISP3;SOAT1;LDLRAP1;LDLR;ABCG1,Hypo
1535,GO_Biological_Process_2018,positive regulation of transcription from RNA polymerase I promoter (GO:0045943),3/21,0.3366143888084585,0.8576481743315124,0,0,1.5435713062831706,1.6806670658728051,MARS;MTOR;SMARCA4,Hypo
1536,GO_Biological_Process_2018,sterol transport (GO:0015918),3/21,0.3366143888084585,0.8576481743315124,0,0,1.5435713062831706,1.6806670658728051,LDLRAP1;LDLR;ABCG1,Hypo
1537,GO_Biological_Process_2018,histone lysine demethylation (GO:0070076),3/21,0.3366143888084585,0.8576481743315124,0,0,1.5435713062831706,1.6806670658728051,KDM4A;KDM4B;KDM3A,Hypo
1538,GO_Biological_Process_2018,protein O-linked glycosylation via threonine (GO:0018243),3/21,0.3366143888084585,0.8576481743315124,0,0,1.5435713062831706,1.6806670658728051,GALNT13;GALNT2;GALNT9,Hypo
1539,GO_Biological_Process_2018,embryonic skeletal system morphogenesis (GO:0048704),3/21,0.3366143888084585,0.8576481743315124,0,0,1.5435713062831706,1.6806670658728051,PDGFRA;DSCAML1;FGFR2,Hypo
1540,GO_Biological_Process_2018,regulation of nuclear division (GO:0051783),3/21,0.3366143888084585,0.8576481743315124,0,0,1.5435713062831706,1.6806670658728051,CUL9;PDXP;PIN1,Hypo
1541,GO_Biological_Process_2018,regulation of interleukin-2 production (GO:0032663),3/21,0.3366143888084585,0.8576481743315124,0,0,1.5435713062831706,1.6806670658728051,PRKD2;FOXP3;HDAC7,Hypo
1542,GO_Biological_Process_2018,negative regulation of cAMP biosynthetic process (GO:0030818),3/21,0.3366143888084585,0.8576481743315124,0,0,1.5435713062831706,1.6806670658728051,GABBR2;GRM2;HRH3,Hypo
1543,GO_Biological_Process_2018,embryonic skeletal system development (GO:0048706),3/21,0.3366143888084585,0.8576481743315124,0,0,1.5435713062831706,1.6806670658728051,PDGFRA;DSCAML1;SULF2,Hypo
1544,GO_Biological_Process_2018,hepaticobiliary system development (GO:0061008),3/21,0.3366143888084585,0.8576481743315124,0,0,1.5435713062831706,1.6806670658728051,RARG;NF1;RARA,Hypo
1545,GO_Biological_Process_2018,cellular protein complex localization (GO:0034629),3/21,0.3366143888084585,0.8576481743315124,0,0,1.5435713062831706,1.6806670658728051,EXOC3L4;NACC2;SMAD7,Hypo
1546,GO_Biological_Process_2018,fatty acid metabolic process (GO:0006631),12/106,0.3374435817917785,0.859205086410999,0,0,1.1827942823265924,1.2849367863107528,PER2;GNPAT;ACOT7;ALDH5A1;GPX4;GPAM;FASN;ALOX12B;MLYCD;LPIN1;ALOXE3;PPARD,Hypo
1547,GO_Biological_Process_2018,sphingolipid metabolic process (GO:0006665),13/116,0.3412136415305739,0.868243239010937,0,0,1.1694142177624292,1.2574085249650002,CERK;ALOX12B;TEX2;SGPP2;NEU4;SMPD4;PSAP;NEU1;ARSI;PRKD2;B4GALNT1;ST6GALNAC3;ALOXE3,Hypo
1548,GO_Biological_Process_2018,RNA methylation (GO:0001510),6/49,0.342785283549516,0.8705552752427749,0,0,1.2924921045076083,1.3838079943184531,MEPCE;BCDIN3D;TRMT13;BUD23;TRMT61A;TARBP1,Hypo
1549,GO_Biological_Process_2018,non-recombinational repair (GO:0000726),6/49,0.342785283549516,0.8705552752427749,0,0,1.2924921045076083,1.3838079943184531,PIAS4;BABAM2;XRCC6;PAXIP1;ERCC1;SETMAR,Hypo
1550,GO_Biological_Process_2018,protein heterooligomerization (GO:0051291),6/49,0.342785283549516,0.8705552752427749,0,0,1.2924921045076083,1.3838079943184531,SEPT9;SEPT11;XRCC6;TRPS1;LRP4;GRIN2B,Hypo
1551,GO_Biological_Process_2018,G2/M transition of mitotic cell cycle (GO:0000086),14/126,0.3444319882723586,0.8741737125031062,0,0,1.1581869834710743,1.2344635909990254,DYNC1I2;DYNC1H1;ODF2;CEP164;USH1C;CCNB2;MELK;FGFR1OP;BTRC;PPP1R12B;PCNT;CDK14;NINL;CLASP1,Hypo
1552,GO_Biological_Process_2018,neutrophil activation involved in immune response (GO:0002283),50/483,0.3479766181362963,0.8816526202026923,0,0,1.0706819010574935,1.1302332184674615,B4GALT1;ATP8A1;SLC44A2;TCIRG1;HMGB1;SLC2A5;ALAD;STK10;HK3;LAMP2;TIMP2;PGM2;CTSD;DBNL;NHLRC3;NFAM1;GAA;ATP11A;KCNAB2;AMPD3;DDOST;RAB31;PKM;TMBIM1;PADI2;DOCK2;GRN;RAB5C;UBR4;GNS;SYNGR1;PGRMC1;PSAP;NEU1;SLC15A4;ATP6V0A1;DYNC1H1;XRCC6;AGL;CMTM6;PDAP1;NBEAL2;MAPK14;IGF2R;DERA;DIAPH1;PTPRB;NFASC;TSPAN14;IMPDH1,Hypo
1553,GO_Biological_Process_2018,regulation of response to external stimulus (GO:0032101),12/107,0.3494826134924356,0.8816526202026923,0,0,1.1702786377708978,1.2303156467545264,PDGFRA;SEMA7A;SBNO2;STK24;BCL6;NLRP10;TRIM5;FNTB;NMT1;F2;MGLL;BRD4,Hypo
1554,GO_Biological_Process_2018,positive regulation of mitotic nuclear division (GO:0045840),5/40,0.3503900870905325,0.8816526202026923,0,0,1.323172970987881,1.387622358701551,NUMA1;H2AFY;NSMCE2;TGFA;EREG,Hypo
1555,GO_Biological_Process_2018,response to cAMP (GO:0051591),5/40,0.3503900870905325,0.8816526202026923,0,0,1.323172970987881,1.387622358701551,KCNQ1;PDE2A;RAPGEF2;AKAP6;RAPGEF3,Hypo
1556,GO_Biological_Process_2018,negative regulation of catabolic process (GO:0009895),5/40,0.3503900870905325,0.8816526202026923,0,0,1.323172970987881,1.387622358701551,ADGRB1;AGAP2;FLNA;PIN1;CBFA2T3,Hypo
1557,GO_Biological_Process_2018,intraciliary transport involved in cilium assembly (GO:0035735),5/40,0.3503900870905325,0.8816526202026923,0,0,1.323172970987881,1.387622358701551,IFT140;IFT122;KIF3C;TNPO1;DYNLL2,Hypo
1558,GO_Biological_Process_2018,regulation of protein dephosphorylation (GO:0035304),5/40,0.3503900870905325,0.8816526202026923,0,0,1.323172970987881,1.387622358701551,PPP1R16B;SYMPK;PIN1;CALM3;SPPL3,Hypo
1559,GO_Biological_Process_2018,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),7/59,0.3516970905850586,0.8816526202026923,0,0,1.2469416841521834,1.3030353707398397,TWSG1;TGFB3;PMEPA1;PIN1;LDLRAD4;INHBA;SMAD7,Hypo
1560,GO_Biological_Process_2018,sterol metabolic process (GO:0016125),7/59,0.3516970905850586,0.8816526202026923,0,0,1.2469416841521834,1.3030353707398397,ABCA1;RXRA;SOAT1;PRKAG2;LDLRAP1;ABCG1;PPARD,Hypo
1561,GO_Biological_Process_2018,regulation of protein metabolic process (GO:0051246),7/59,0.3516970905850586,0.8816526202026923,0,0,1.2469416841521834,1.3030353707398397,LRP1;BTBD3;KLHL11;NEDD4L;FURIN;LDLR;SSH1,Hypo
1562,GO_Biological_Process_2018,cell cycle G2/M phase transition (GO:0044839),14/127,0.3555274964342146,0.8816526202026923,0,0,1.1478735464053245,1.1870765122633162,DYNC1I2;DYNC1H1;ODF2;CEP164;USH1C;CCNB2;MELK;FGFR1OP;BTRC;PPP1R12B;PCNT;CDK14;NINL;CLASP1,Hypo
1563,GO_Biological_Process_2018,regulation of ubiquitin-protein transferase activity (GO:0051438),4/31,0.3578644838276814,0.8816526202026923,0,0,1.3720832857523504,1.4099540207393382,ZER1;ABL1;PIN1;SMAD7,Hypo
1564,GO_Biological_Process_2018,renal water homeostasis (GO:0003091),4/31,0.3578644838276814,0.8816526202026923,0,0,1.3720832857523504,1.4099540207393382,ADCY9;PRKAR1B;PRKAR1A;ADCY3,Hypo
1565,GO_Biological_Process_2018,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),4/31,0.3578644838276814,0.8816526202026923,0,0,1.3720832857523504,1.4099540207393382,TMBIM1;FAIM2;ARHGEF2;RFFL,Hypo
1566,GO_Biological_Process_2018,regulation of protein autophosphorylation (GO:0031952),4/31,0.3578644838276814,0.8816526202026923,0,0,1.3720832857523504,1.4099540207393382,RASSF2;PDGFA;TNKS1BP1;CALM3,Hypo
1567,GO_Biological_Process_2018,vesicle-mediated transport to the plasma membrane (GO:0098876),4/31,0.3578644838276814,0.8816526202026923,0,0,1.3720832857523504,1.4099540207393382,ARFGEF2;ANKRD27;VPS39;LLGL1,Hypo
1568,GO_Biological_Process_2018,negative regulation of blood vessel endothelial cell migration (GO:0043537),4/31,0.3578644838276814,0.8816526202026923,0,0,1.3720832857523504,1.4099540207393382,HDAC5;ITGB1BP1;HMGB1;VASH1,Hypo
1569,GO_Biological_Process_2018,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),4/31,0.3578644838276814,0.8816526202026923,0,0,1.3720832857523504,1.4099540207393382,AKAP6;CALM3;HAP1;F2,Hypo
1570,GO_Biological_Process_2018,regulation of glucose import (GO:0046324),4/31,0.3578644838276814,0.8816526202026923,0,0,1.3720832857523504,1.4099540207393382,PRKAG2;IRS2;PIK3R1;SORBS1,Hypo
1571,GO_Biological_Process_2018,positive regulation of neuron differentiation (GO:0045666),11/98,0.3582848336000142,0.8816526202026923,0,0,1.1713171263775024,1.2022715057356177,CAMK2B;TWF2;DAB2IP;P3H1;ABL2;RAPGEF2;PTK2B;TCF4;ARHGEF2;SCN1B;MARK2,Hypo
1572,GO_Biological_Process_2018,regulation of osteoblast differentiation (GO:0045667),8/69,0.3583940284900556,0.8816526202026923,0,0,1.2148368253110702,1.2465711082325786,FBN2;SEMA4D;TMEM119;AXIN2;LIMD1;RUNX2;FGFR2;HDAC7,Hypo
1573,GO_Biological_Process_2018,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),8/69,0.3583940284900556,0.8816526202026923,0,0,1.2148368253110702,1.2465711082325786,TENM1;TENM2;TGFB3;CROCC;TWF2;PLEKHM1;CDC42EP1;BBS4,Hypo
1574,GO_Biological_Process_2018,regulation of blood vessel endothelial cell migration (GO:0043535),6/50,0.3607544270046143,0.8816526202026923,0,0,1.263047138047138,1.2877495736586306,P2RX4;NF1;PRKCA;PRKD2;HMGB1;VASH1,Hypo
1575,GO_Biological_Process_2018,fatty acid beta-oxidation (GO:0006635),6/50,0.3607544270046143,0.8816526202026923,0,0,1.263047138047138,1.2877495736586306,HADHA;SLC25A17;BDH2;ACADL;HSD17B4;PPARD,Hypo
1576,GO_Biological_Process_2018,double-strand break repair via nonhomologous end joining (GO:0006303),6/50,0.3607544270046143,0.8816526202026923,0,0,1.263047138047138,1.2877495736586306,PIAS4;BABAM2;XRCC6;PAXIP1;ERCC1;SETMAR,Hypo
1577,GO_Biological_Process_2018,regulation of bone mineralization (GO:0030500),6/50,0.3607544270046143,0.8816526202026923,0,0,1.263047138047138,1.2877495736586306,FBN2;KL;TGFB3;TMEM119;PTK2B;GPM6B,Hypo
1578,GO_Biological_Process_2018,regulation of cellular protein metabolic process (GO:0032268),6/50,0.3607544270046143,0.8816526202026923,0,0,1.263047138047138,1.2877495736586306,CYFIP2;ATXN2;TCOF1;INHBA;FOXO3;SSH1,Hypo
1579,GO_Biological_Process_2018,fatty acid oxidation (GO:0019395),6/50,0.3607544270046143,0.8816526202026923,0,0,1.263047138047138,1.2877495736586306,HADHA;SLC25A17;BDH2;ACADL;HSD17B4;PPARD,Hypo
1580,GO_Biological_Process_2018,regulation of cytokine production (GO:0001817),12/108,0.3615938709513581,0.8816526202026923,0,0,1.1580237358101135,1.177980654138853,IL33;PER1;TWSG1;AFAP1L2;TBK1;NLRP10;NFAM1;MAPKAPK2;DTX4;MAPK14;CARD11;EREG,Hypo
1581,GO_Biological_Process_2018,response to calcium ion (GO:0051592),9/79,0.3635880607914192,0.8816526202026923,0,0,1.1909913888275558,1.204966187996422,RYR1;ITPKB;RYR2;AHCYL1;PEF1;CALM3;RYR3;GPLD1;KCNH1,Hypo
1582,GO_Biological_Process_2018,NAD biosynthetic process (GO:0009435),3/22,0.3643452418386853,0.8816526202026923,0,0,1.4622496147919877,1.4763652868386326,RNLS;QPRT;NMNAT3,Hypo
1583,GO_Biological_Process_2018,regulation of catecholamine secretion (GO:0050433),3/22,0.3643452418386853,0.8816526202026923,0,0,1.4622496147919877,1.4763652868386326,GRK2;HRH3;STX1A,Hypo
1584,GO_Biological_Process_2018,negative regulation of cell cycle G1/S phase transition (GO:1902807),3/22,0.3643452418386853,0.8816526202026923,0,0,1.4622496147919877,1.4763652868386326,RBL1;JADE1;MYO16,Hypo
1585,GO_Biological_Process_2018,negative regulation of myeloid cell differentiation (GO:0045638),3/22,0.3643452418386853,0.8816526202026923,0,0,1.4622496147919877,1.4763652868386326,ZBTB16;PTK2B;WDR61,Hypo
1586,GO_Biological_Process_2018,negative regulation of actin filament polymerization (GO:0030837),3/22,0.3643452418386853,0.8816526202026923,0,0,1.4622496147919877,1.4763652868386326,KANK1;TWF2;HIP1R,Hypo
1587,GO_Biological_Process_2018,positive regulation of interleukin-10 production (GO:0032733),3/22,0.3643452418386853,0.8816526202026923,0,0,1.4622496147919877,1.4763652868386326,HMGB1;PRKCZ;INAVA,Hypo
1588,GO_Biological_Process_2018,positive regulation of erythrocyte differentiation (GO:0045648),3/22,0.3643452418386853,0.8816526202026923,0,0,1.4622496147919877,1.4763652868386326,INHBA;FOXO3;MAPK14,Hypo
1589,GO_Biological_Process_2018,protein localization to cell surface (GO:0034394),3/22,0.3643452418386853,0.8816526202026923,0,0,1.4622496147919877,1.4763652868386326,SMURF1;USP4;FLNA,Hypo
1590,GO_Biological_Process_2018,regulation of cytokine production involved in inflammatory response (GO:1900015),3/22,0.3643452418386853,0.8816526202026923,0,0,1.4622496147919877,1.4763652868386326,PER1;F2;MAPK14,Hypo
1591,GO_Biological_Process_2018,protein O-linked glycosylation via serine (GO:0018242),3/22,0.3643452418386853,0.8816526202026923,0,0,1.4622496147919877,1.4763652868386326,GALNT13;GALNT2;GALNT9,Hypo
1592,GO_Biological_Process_2018,positive regulation of biosynthetic process (GO:0009891),3/22,0.3643452418386853,0.8816526202026923,0,0,1.4622496147919877,1.4763652868386326,ADGRB1;SORBS1;MTOR,Hypo
1593,GO_Biological_Process_2018,urogenital system development (GO:0001655),3/22,0.3643452418386853,0.8816526202026923,0,0,1.4622496147919877,1.4763652868386326,IFT140;ITGA6;EPHB2,Hypo
1594,GO_Biological_Process_2018,protein complex localization (GO:0031503),3/22,0.3643452418386853,0.8816526202026923,0,0,1.4622496147919877,1.4763652868386326,NACC2;SMAD7;RPGR,Hypo
1595,GO_Biological_Process_2018,viral genome replication (GO:0019079),3/22,0.3643452418386853,0.8816526202026923,0,0,1.4622496147919877,1.4763652868386326,GRK2;CTBP2;PI4KA,Hypo
1596,GO_Biological_Process_2018,inner ear morphogenesis (GO:0042472),3/22,0.3643452418386853,0.8816526202026923,0,0,1.4622496147919877,1.4763652868386326,USH1C;EPHB2;FGFR2,Hypo
1597,GO_Biological_Process_2018,negative regulation of lyase activity (GO:0051350),3/22,0.3643452418386853,0.8816526202026923,0,0,1.4622496147919877,1.4763652868386326,GABBR2;GRM2;HRH3,Hypo
1598,GO_Biological_Process_2018,NLS-bearing protein import into nucleus (GO:0006607),3/22,0.3643452418386853,0.8816526202026923,0,0,1.4622496147919877,1.4763652868386326,RERE;TRPS1;TNPO1,Hypo
1599,GO_Biological_Process_2018,regulation of natural killer cell mediated cytotoxicity (GO:0042269),3/22,0.3643452418386853,0.8816526202026923,0,0,1.4622496147919877,1.4763652868386326,CADM1;RASGRP1;PIK3R6,Hypo
1600,GO_Biological_Process_2018,regulation of granulocyte chemotaxis (GO:0071622),2/13,0.3664039957531879,0.8816526202026923,0,0,1.6836848982639536,1.690451191461817,CMKLR1;JAM3,Hypo
1601,GO_Biological_Process_2018,regulation of plasma membrane bounded cell projection organization (GO:0120035),2/13,0.3664039957531879,0.8816526202026923,0,0,1.6836848982639536,1.690451191461817,ULK4;NCS1,Hypo
1602,GO_Biological_Process_2018,atrial cardiac muscle cell action potential (GO:0086014),2/13,0.3664039957531879,0.8816526202026923,0,0,1.6836848982639536,1.690451191461817,KCNQ1;CACNA1C,Hypo
1603,GO_Biological_Process_2018,regulation of cell aging (GO:0090342),2/13,0.3664039957531879,0.8816526202026923,0,0,1.6836848982639536,1.690451191461817,LMNA;VASH1,Hypo
1604,GO_Biological_Process_2018,maintenance of gastrointestinal epithelium (GO:0030277),2/13,0.3664039957531879,0.8816526202026923,0,0,1.6836848982639536,1.690451191461817,MUC2;INAVA,Hypo
1605,GO_Biological_Process_2018,positive regulation of glycogen biosynthetic process (GO:0045725),2/13,0.3664039957531879,0.8816526202026923,0,0,1.6836848982639536,1.690451191461817,IRS2;SORBS1,Hypo
1606,GO_Biological_Process_2018,multivesicular body sorting pathway (GO:0071985),2/13,0.3664039957531879,0.8816526202026923,0,0,1.6836848982639536,1.690451191461817,SORT1;CHMP5,Hypo
1607,GO_Biological_Process_2018,positive regulation of cholesterol efflux (GO:0010875),2/13,0.3664039957531879,0.8816526202026923,0,0,1.6836848982639536,1.690451191461817,ABCA1;LRP1,Hypo
1608,GO_Biological_Process_2018,positive regulation of endothelial cell chemotaxis (GO:2001028),2/13,0.3664039957531879,0.8816526202026923,0,0,1.6836848982639536,1.690451191461817,P2RX4;PRKD2,Hypo
1609,GO_Biological_Process_2018,poly(A)+ mRNA export from nucleus (GO:0016973),2/13,0.3664039957531879,0.8816526202026923,0,0,1.6836848982639536,1.690451191461817,ZC3H3;ZC3H11A,Hypo
1610,GO_Biological_Process_2018,negative regulation of viral release from host cell (GO:1902187),2/13,0.3664039957531879,0.8816526202026923,0,0,1.6836848982639536,1.690451191461817,TRIM5;TRIM11,Hypo
1611,GO_Biological_Process_2018,ER-associated misfolded protein catabolic process (GO:0071712),2/13,0.3664039957531879,0.8816526202026923,0,0,1.6836848982639536,1.690451191461817,UGGT2;UGGT1,Hypo
1612,GO_Biological_Process_2018,sensory perception of taste (GO:0050909),2/13,0.3664039957531879,0.8816526202026923,0,0,1.6836848982639536,1.690451191461817,ASIC2;ASIC1,Hypo
1613,GO_Biological_Process_2018,positive regulation of muscle contraction (GO:0045933),2/13,0.3664039957531879,0.8816526202026923,0,0,1.6836848982639536,1.690451191461817,CTTN;ENO1,Hypo
1614,GO_Biological_Process_2018,dicarboxylic acid catabolic process (GO:0043649),2/13,0.3664039957531879,0.8816526202026923,0,0,1.6836848982639536,1.690451191461817,GAD1;QPRT,Hypo
1615,GO_Biological_Process_2018,regulation of neurotransmitter transport (GO:0051588),2/13,0.3664039957531879,0.8816526202026923,0,0,1.6836848982639536,1.690451191461817,RIMS1;CAMK2A,Hypo
1616,GO_Biological_Process_2018,RNA interference (GO:0016246),2/13,0.3664039957531879,0.8816526202026923,0,0,1.6836848982639536,1.690451191461817,AGO2;DROSHA,Hypo
1617,GO_Biological_Process_2018,secretion (GO:0046903),2/13,0.3664039957531879,0.8816526202026923,0,0,1.6836848982639536,1.690451191461817,TPD52;RIMS1,Hypo
1618,GO_Biological_Process_2018,regulation of T cell cytokine production (GO:0002724),2/13,0.3664039957531879,0.8816526202026923,0,0,1.6836848982639536,1.690451191461817,FOXP3;SMAD7,Hypo
1619,GO_Biological_Process_2018,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),2/13,0.3664039957531879,0.8816526202026923,0,0,1.6836848982639536,1.690451191461817,ATF7IP;PAXIP1,Hypo
1620,GO_Biological_Process_2018,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",2/13,0.3664039957531879,0.8816526202026923,0,0,1.6836848982639536,1.690451191461817,TCIRG1;ATP6V0A1,Hypo
1621,GO_Biological_Process_2018,glomerular visceral epithelial cell differentiation (GO:0072112),2/13,0.3664039957531879,0.8816526202026923,0,0,1.6836848982639536,1.690451191461817,MYO1E;KLF15,Hypo
1622,GO_Biological_Process_2018,negative regulation of ubiquitin-protein transferase activity (GO:0051444),2/13,0.3664039957531879,0.8816526202026923,0,0,1.6836848982639536,1.690451191461817,ABL1;SMAD7,Hypo
1623,GO_Biological_Process_2018,amyloid precursor protein metabolic process (GO:0042982),2/13,0.3664039957531879,0.8816526202026923,0,0,1.6836848982639536,1.690451191461817,LDLRAP1;ABCG1,Hypo
1624,GO_Biological_Process_2018,endothelial cell differentiation (GO:0045446),2/13,0.3664039957531879,0.8816526202026923,0,0,1.6836848982639536,1.690451191461817,LAMA5;SCUBE1,Hypo
1625,GO_Biological_Process_2018,mitotic DNA integrity checkpoint (GO:0044774),2/13,0.3664039957531879,0.8816526202026923,0,0,1.6836848982639536,1.690451191461817,SETMAR;CLSPN,Hypo
1626,GO_Biological_Process_2018,detection of calcium ion (GO:0005513),2/13,0.3664039957531879,0.8816526202026923,0,0,1.6836848982639536,1.690451191461817,RYR2;CALM3,Hypo
1627,GO_Biological_Process_2018,pre-miRNA processing (GO:0031054),2/13,0.3664039957531879,0.8816526202026923,0,0,1.6836848982639536,1.690451191461817,AGO2;DROSHA,Hypo
1628,GO_Biological_Process_2018,negative regulation of macrophage derived foam cell differentiation (GO:0010745),2/13,0.3664039957531879,0.8816526202026923,0,0,1.6836848982639536,1.690451191461817,ABCA1;ABCG1,Hypo
1629,GO_Biological_Process_2018,sodium ion export from cell (GO:0036376),2/13,0.3664039957531879,0.8816526202026923,0,0,1.6836848982639536,1.690451191461817,ATP1A2;SLC9A1,Hypo
1630,GO_Biological_Process_2018,glucosamine-containing compound metabolic process (GO:1901071),2/13,0.3664039957531879,0.8816526202026923,0,0,1.6836848982639536,1.690451191461817,MGAT3;CHST2,Hypo
1631,GO_Biological_Process_2018,regulation of NMDA receptor activity (GO:2000310),2/13,0.3664039957531879,0.8816526202026923,0,0,1.6836848982639536,1.690451191461817,PTK2B;EPHB2,Hypo
1632,GO_Biological_Process_2018,DNA replication-independent nucleosome organization (GO:0034724),2/13,0.3664039957531879,0.8816526202026923,0,0,1.6836848982639536,1.690451191461817,UBN1;CABIN1,Hypo
1633,GO_Biological_Process_2018,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",2/13,0.3664039957531879,0.8816526202026923,0,0,1.6836848982639536,1.690451191461817,SFSWAP;SRSF4,Hypo
1634,GO_Biological_Process_2018,viral translation (GO:0019081),2/13,0.3664039957531879,0.8816526202026923,0,0,1.6836848982639536,1.690451191461817,EIF2AK4;EIF3F,Hypo
1635,GO_Biological_Process_2018,regulation of DNA-templated transcription in response to stress (GO:0043620),2/13,0.3664039957531879,0.8816526202026923,0,0,1.6836848982639536,1.690451191461817,RGS14;DDIT3,Hypo
1636,GO_Biological_Process_2018,sodium ion export (GO:0071436),2/13,0.3664039957531879,0.8816526202026923,0,0,1.6836848982639536,1.690451191461817,ATP1A2;SLC9A1,Hypo
1637,GO_Biological_Process_2018,response to reactive oxygen species (GO:0000302),7/60,0.3681447344586929,0.8853004328649521,0,0,1.2233465075403722,1.2224646190339008,EGLN1;PDGFRA;STK24;PXN;MAPT;PDK2;CAMKK2,Hypo
1638,GO_Biological_Process_2018,odontogenesis (GO:0042476),5/41,0.3704552026482859,0.8867591020728175,0,0,1.286346758069123,1.277371597836255,TGFB3;ANKRD11;AXIN2;INHBA;FGFR2,Hypo
1639,GO_Biological_Process_2018,cellular response to peptide (GO:1901653),5/41,0.3704552026482859,0.8867591020728175,0,0,1.286346758069123,1.277371597836255,CACNB1;LRP1;CDK5;SRC;ARHGEF2,Hypo
1640,GO_Biological_Process_2018,neutrophil mediated immunity (GO:0002446),50/487,0.3707959240920553,0.8867591020728175,0,0,1.0606407322654463,1.05226531648753,B4GALT1;ATP8A1;SLC44A2;TCIRG1;HMGB1;SLC2A5;ALAD;STK10;HK3;LAMP2;TIMP2;PGM2;CTSD;DBNL;NHLRC3;NFAM1;GAA;ATP11A;KCNAB2;AMPD3;DDOST;RAB31;PKM;TMBIM1;PADI2;DOCK2;GRN;RAB5C;UBR4;GNS;SYNGR1;PGRMC1;PSAP;NEU1;SLC15A4;ATP6V0A1;DYNC1H1;XRCC6;AGL;CMTM6;PDAP1;NBEAL2;MAPK14;IGF2R;DERA;DIAPH1;PTPRB;NFASC;TSPAN14;IMPDH1,Hypo
1641,GO_Biological_Process_2018,phospholipid metabolic process (GO:0006644),8/70,0.3736503765990393,0.8867591020728175,0,0,1.195176239992027,1.1765730119238789,AGPAT5;GNPAT;ALDH5A1;GPX4;GPAM;PIP4K2A;PLA2G5;AGPAT4,Hypo
1642,GO_Biological_Process_2018,negative regulation of neuron projection development (GO:0010977),6/51,0.3787746109163269,0.8867591020728175,0,0,1.2349108367626886,1.1988686611022867,KANK1;PTPRS;ERCC2;LRP4;SPOCK1;RTN4RL2,Hypo
1643,GO_Biological_Process_2018,regulation of exocytosis (GO:0017157),6/51,0.3787746109163269,0.8867591020728175,0,0,1.2349108367626886,1.1988686611022867,NSF;RAB15;HAP1;LLGL1;CLASP1;CLASP2,Hypo
1644,GO_Biological_Process_2018,neuron differentiation (GO:0030182),15/139,0.3794621654533933,0.8867591020728175,0,0,1.1206551637909477,1.0859152828026428,UNC119B;TENM1;TENM2;ATP8A2;WNT5B;TENM4;WNT9B;INHBA;CCSAP;USH2A;RUNX2;CDK5;ERCC2;PIN1;SPOCK1,Hypo
1645,GO_Biological_Process_2018,negative regulation of BMP signaling pathway (GO:0030514),4/32,0.3808581855826539,0.8867591020728175,0,0,1.3230069006019674,1.27713585600597,SMURF1;HTRA3;LEMD2;SMAD7,Hypo
1646,GO_Biological_Process_2018,phagosome maturation (GO:0090382),4/32,0.3808581855826539,0.8867591020728175,0,0,1.3230069006019674,1.27713585600597,RAB31;TCIRG1;ATP6V1E1;ATP6V0A1,Hypo
1647,GO_Biological_Process_2018,substrate adhesion-dependent cell spreading (GO:0034446),4/32,0.3808581855826539,0.8867591020728175,0,0,1.3230069006019674,1.27713585600597,LAMA5;TYRO3;ANTXR1;SRCIN1,Hypo
1648,GO_Biological_Process_2018,aminoglycan catabolic process (GO:0006026),4/32,0.3808581855826539,0.8867591020728175,0,0,1.3230069006019674,1.27713585600597,SDC3;GPC4;GNS;GPC6,Hypo
1649,GO_Biological_Process_2018,oxoacid metabolic process (GO:0043436),4/32,0.3808581855826539,0.8867591020728175,0,0,1.3230069006019674,1.27713585600597,B3GAT2;CHST1;SULT4A1;SULF2,Hypo
1650,GO_Biological_Process_2018,protein tetramerization (GO:0051262),10/90,0.3811984692995482,0.8867591020728175,0,0,1.157860824742268,1.1166816465668377,RYR1;GOLGA2;XRCC6;ALDH5A1;RXRA;KCNJ12;LRP4;ACACB;GRIN2B;RYR3,Hypo
1651,GO_Biological_Process_2018,striated muscle contraction (GO:0006941),7/61,0.3846391204296124,0.8867591020728175,0,0,1.2006252263586283,1.1471370529354694,RYR2;MYBPC1;GRK2;GAA;KCNQ1;ATP1A2;SCN1B,Hypo
1652,GO_Biological_Process_2018,regulation of DNA replication (GO:0006275),7/61,0.3846391204296124,0.8867591020728175,0,0,1.2006252263586283,1.1471370529354694,PDGFRA;STN1;EPO;TGFB3;ZBTB38;PDGFA;EREG,Hypo
1653,GO_Biological_Process_2018,chemical synaptic transmission (GO:0007268),30/289,0.38656787811374,0.8867591020728175,0,0,1.0732987451737452,1.020114435203067,OPRD1;NAPA;GRIK5;CHRM4;GRIK4;NRXN2;SLC6A1;CACNA1E;GRM1;GRM2;DLGAP1;KIF1B;MBP;BSN;ASIC2;TSPOAP1;SCN1B;GABBR2;GRID1;GAD1;HTR5A;GRIN2B;CACNB1;CACNB3;CACNB4;DLG3;CDK5;KCNQ2;HAP1;KCNK3,Hypo
1654,GO_Biological_Process_2018,histone acetylation (GO:0016573),8/71,0.3889501030559102,0.8867591020728175,0,0,1.1761398002386674,1.1106337688776573,PER1;BRD1;TRRAP;BRPF3;KAT6A;JADE1;CHD5;APBB1,Hypo
1655,GO_Biological_Process_2018,regulation of cell communication (GO:0010646),8/71,0.3889501030559102,0.8867591020728175,0,0,1.1761398002386674,1.1106337688776573,RYR2;GRID1;GRIK5;SCG5;GRIK4;BIRC6;MGLL;SASH1,Hypo
1656,GO_Biological_Process_2018,generation of neurons (GO:0048699),14/130,0.3891418509938999,0.8867591020728175,0,0,1.1180001424907382,1.0551812196735366,UNC119B;WNT5B;WNT9B;NAV1;RUNX2;CIT;PER2;CDK5;PIN1;RAPGEF2;SPOCK1;MAPT;FGF13;MARK2,Hypo
1657,GO_Biological_Process_2018,inorganic cation transmembrane transport (GO:0098662),15/140,0.3903064509374878,0.8867591020728175,0,0,1.1116279069767443,1.0458451876772232,CACNA1D;CACNA1C;TCIRG1;TRPC4AP;PKD1;RYR3;SLC8A2;SLC9A1;SLC8A3;P2RX4;ATP6V1E1;CACNG2;SCN1B;CACNG4;ASIC1,Hypo
1658,GO_Biological_Process_2018,ceramide metabolic process (GO:0006672),5/42,0.3905227909558448,0.8867591020728175,0,0,1.2515111512540815,1.176757073452504,SMPD4;CERK;ALOX12B;ST6GALNAC3;ALOXE3,Hypo
1659,GO_Biological_Process_2018,cellular response to calcium ion (GO:0071277),5/42,0.3905227909558448,0.8867591020728175,0,0,1.2515111512540815,1.176757073452504,RYR1;ITPKB;RYR3;GPLD1;KCNH1,Hypo
1660,GO_Biological_Process_2018,chromosome condensation (GO:0030261),3/23,0.3918763518962719,0.8867591020728175,0,0,1.389060092449923,1.3012838819475316,ACIN1;NCAPD2;NCAPH,Hypo
1661,GO_Biological_Process_2018,regulation of telomere capping (GO:1904353),3/23,0.3918763518962719,0.8867591020728175,0,0,1.389060092449923,1.3012838819475316,TNKS2;MAP3K4;SMG6,Hypo
1662,GO_Biological_Process_2018,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),3/23,0.3918763518962719,0.8867591020728175,0,0,1.389060092449923,1.3012838819475316,RHBDF1;PTK2B;PKD1,Hypo
1663,GO_Biological_Process_2018,membrane assembly (GO:0071709),3/23,0.3918763518962719,0.8867591020728175,0,0,1.389060092449923,1.3012838819475316,NRXN2;LRP4;ANK3,Hypo
1664,GO_Biological_Process_2018,phospholipid dephosphorylation (GO:0046839),3/23,0.3918763518962719,0.8867591020728175,0,0,1.389060092449923,1.3012838819475316,INPP5B;MTMR3;SYNJ1,Hypo
1665,GO_Biological_Process_2018,negative regulation of signal transduction in absence of ligand (GO:1901099),3/23,0.3918763518962719,0.8867591020728175,0,0,1.389060092449923,1.3012838819475316,EYA1;EYA2;UNC5B,Hypo
1666,GO_Biological_Process_2018,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),3/23,0.3918763518962719,0.8867591020728175,0,0,1.389060092449923,1.3012838819475316,EYA1;EYA2;UNC5B,Hypo
1667,GO_Biological_Process_2018,cellular response to interleukin-6 (GO:0071354),3/23,0.3918763518962719,0.8867591020728175,0,0,1.389060092449923,1.3012838819475316,SBNO2;PTPN11;ST3GAL6,Hypo
1668,GO_Biological_Process_2018,protein localization to Golgi apparatus (GO:0034067),3/23,0.3918763518962719,0.8867591020728175,0,0,1.389060092449923,1.3012838819475316,RIPOR1;VPS13D;SORL1,Hypo
1669,GO_Biological_Process_2018,autophagosome maturation (GO:0097352),3/23,0.3918763518962719,0.8867591020728175,0,0,1.389060092449923,1.3012838819475316,VPS33A;LIX1L;LAMP2,Hypo
1670,GO_Biological_Process_2018,cellular response to amyloid-beta (GO:1904646),3/23,0.3918763518962719,0.8867591020728175,0,0,1.389060092449923,1.3012838819475316,CACNB1;LRP1;CDK5,Hypo
1671,GO_Biological_Process_2018,positive regulation of monooxygenase activity (GO:0032770),3/23,0.3918763518962719,0.8867591020728175,0,0,1.389060092449923,1.3012838819475316,SCARB1;POR;NOS1AP,Hypo
1672,GO_Biological_Process_2018,positive regulation of cell junction assembly (GO:1901890),3/23,0.3918763518962719,0.8867591020728175,0,0,1.389060092449923,1.3012838819475316,ABL1;NPHP4;PPM1F,Hypo
1673,GO_Biological_Process_2018,regulation of chondrocyte differentiation (GO:0032330),3/23,0.3918763518962719,0.8867591020728175,0,0,1.389060092449923,1.3012838819475316,ZBTB16;TRPS1;SOX5,Hypo
1674,GO_Biological_Process_2018,ammonium transport (GO:0015696),3/23,0.3918763518962719,0.8867591020728175,0,0,1.389060092449923,1.3012838819475316,SEC14L1;SLC44A2;RHCG,Hypo
1675,GO_Biological_Process_2018,microtubule polymerization or depolymerization (GO:0031109),3/23,0.3918763518962719,0.8867591020728175,0,0,1.389060092449923,1.3012838819475316,NCKAP5L;MAPT;FGF13,Hypo
1676,GO_Biological_Process_2018,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),3/23,0.3918763518962719,0.8867591020728175,0,0,1.389060092449923,1.3012838819475316,ELL;WDR61;BRD4,Hypo
1677,GO_Biological_Process_2018,positive regulation of protein oligomerization (GO:0032461),3/23,0.3918763518962719,0.8867591020728175,0,0,1.389060092449923,1.3012838819475316,HRK;SH3GLB1;IDE,Hypo
1678,GO_Biological_Process_2018,TOR signaling (GO:0031929),3/23,0.3918763518962719,0.8867591020728175,0,0,1.389060092449923,1.3012838819475316,RPTOR;MTOR;CARD11,Hypo
1679,GO_Biological_Process_2018,sensory perception of sound (GO:0007605),9/81,0.3922104026496862,0.8867591020728175,0,0,1.1577794951056155,1.0836316396617751,SPTBN4;LOXHD1;EYA1;USH1G;KCNQ1;KIT;USH1C;CACNA1D;USH2A,Hypo
1680,GO_Biological_Process_2018,lipid transport (GO:0006869),10/91,0.3947246237348768,0.8867591020728175,0,0,1.143502609138348,1.0629621895931216,NCOA1;ABCA1;SCARB1;SLC25A17;RXRA;SLCO2B1;PSAP;SLC10A3;LDLR;PPARD,Hypo
1681,GO_Biological_Process_2018,regulation of calcium ion transport (GO:0051924),6/52,0.3968065969420387,0.8867591020728175,0,0,1.2079978529253892,1.1165599996942608,CAMK2B;P2RX4;CAMK2A;SARAF;CACNA1D;CAMK2G,Hypo
1682,GO_Biological_Process_2018,positive regulation of cell-substrate adhesion (GO:0010811),6/52,0.3968065969420387,0.8867591020728175,0,0,1.2079978529253892,1.1165599996942608,ABL1;FLNA;PTK2B;ARHGEF7;DOCK1;PPM1F,Hypo
1683,GO_Biological_Process_2018,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),7/62,0.4011502168431203,0.8867591020728175,0,0,1.1787301735834932,1.076674909173018,EPO;SRC;LRRK2;CREB3L1;ACKR3;ENO1;ARHGEF2,Hypo
1684,GO_Biological_Process_2018,cellular protein catabolic process (GO:0044257),7/62,0.4011502168431203,0.8867591020728175,0,0,1.1787301735834932,1.076674909173018,AP2S1;DAB2IP;AP2A1;DENND3;IDE;TCIRG1;CTSF,Hypo
1685,GO_Biological_Process_2018,tRNA processing (GO:0008033),7/62,0.4011502168431203,0.8867591020728175,0,0,1.1787301735834932,1.076674909173018,POP5;WDR4;RTCB;CSTF2;ADAT1;TRMT61A;TSEN54,Hypo
1686,GO_Biological_Process_2018,modification-dependent protein catabolic process (GO:0019941),15/141,0.4011816786182242,0.8867591020728175,0,0,1.1027439399532424,1.0071811319914696,UBL4A;AREL1;SMURF1;UBR4;UBE2D1;NEDD4L;UBE4B;KLHL3;FBXO21;FBXO10;TRPC4AP;RNF144B;NPLOC4;BTRC;RFFL,Hypo
1687,GO_Biological_Process_2018,double-strand break repair (GO:0006302),15/141,0.4011816786182242,0.8867591020728175,0,0,1.1027439399532424,1.0071811319914696,PIAS4;XRCC6;PARP3;PAXIP1;AP5Z1;EYA1;NSMCE2;RECQL;SETMAR;PALB2;BABAM2;RAD51;ERCC1;TNKS1BP1;FAN1,Hypo
1688,GO_Biological_Process_2018,negative regulation of receptor-mediated endocytosis (GO:0048261),2/14,0.4025020658147796,0.8867591020728175,0,0,1.5432922655715264,1.404480919411767,ATXN2;UBQLN2,Hypo
1689,GO_Biological_Process_2018,myeloid dendritic cell activation (GO:0001773),2/14,0.4025020658147796,0.8867591020728175,0,0,1.5432922655715264,1.404480919411767,HMGB1;DOCK2,Hypo
1690,GO_Biological_Process_2018,"retrograde transport, endosome to plasma membrane (GO:1990126)",2/14,0.4025020658147796,0.8867591020728175,0,0,1.5432922655715264,1.404480919411767,ANKRD27;VPS39,Hypo
1691,GO_Biological_Process_2018,regulation of platelet aggregation (GO:0090330),2/14,0.4025020658147796,0.8867591020728175,0,0,1.5432922655715264,1.404480919411767,CD9;PRKCA,Hypo
1692,GO_Biological_Process_2018,regulation of monocyte differentiation (GO:0045655),2/14,0.4025020658147796,0.8867591020728175,0,0,1.5432922655715264,1.404480919411767,IL34;ACIN1,Hypo
1693,GO_Biological_Process_2018,pyrimidine-containing compound catabolic process (GO:0072529),2/14,0.4025020658147796,0.8867591020728175,0,0,1.5432922655715264,1.404480919411767,TET3;TET1,Hypo
1694,GO_Biological_Process_2018,pancreas development (GO:0031016),2/14,0.4025020658147796,0.8867591020728175,0,0,1.5432922655715264,1.404480919411767,ZIC3;CCDC40,Hypo
1695,GO_Biological_Process_2018,N-acetylglucosamine metabolic process (GO:0006044),2/14,0.4025020658147796,0.8867591020728175,0,0,1.5432922655715264,1.404480919411767,MGAT3;CHST2,Hypo
1696,GO_Biological_Process_2018,regulation of neural precursor cell proliferation (GO:2000177),2/14,0.4025020658147796,0.8867591020728175,0,0,1.5432922655715264,1.404480919411767,DISP3;LRRK2,Hypo
1697,GO_Biological_Process_2018,purine-containing compound salvage (GO:0043101),2/14,0.4025020658147796,0.8867591020728175,0,0,1.5432922655715264,1.404480919411767,DGUOK;AMPD3,Hypo
1698,GO_Biological_Process_2018,positive regulation of glycogen metabolic process (GO:0070875),2/14,0.4025020658147796,0.8867591020728175,0,0,1.5432922655715264,1.404480919411767,IRS2;SORBS1,Hypo
1699,GO_Biological_Process_2018,cell migration involved in sprouting angiogenesis (GO:0002042),2/14,0.4025020658147796,0.8867591020728175,0,0,1.5432922655715264,1.404480919411767,NR4A1;GPLD1,Hypo
1700,GO_Biological_Process_2018,monosaccharide transport (GO:0015749),2/14,0.4025020658147796,0.8867591020728175,0,0,1.5432922655715264,1.404480919411767,SLC2A12;SLC2A2,Hypo
1701,GO_Biological_Process_2018,cAMP biosynthetic process (GO:0006171),2/14,0.4025020658147796,0.8867591020728175,0,0,1.5432922655715264,1.404480919411767,ADCY9;ADCY3,Hypo
1702,GO_Biological_Process_2018,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),2/14,0.4025020658147796,0.8867591020728175,0,0,1.5432922655715264,1.404480919411767,LRRK2;CREB3L1,Hypo
1703,GO_Biological_Process_2018,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),2/14,0.4025020658147796,0.8867591020728175,0,0,1.5432922655715264,1.404480919411767,HDAC5;ITGB1BP1,Hypo
1704,GO_Biological_Process_2018,fatty acid transport (GO:0015908),2/14,0.4025020658147796,0.8867591020728175,0,0,1.5432922655715264,1.404480919411767,SLC25A17;PPARD,Hypo
1705,GO_Biological_Process_2018,regulation of synapse organization (GO:0050807),2/14,0.4025020658147796,0.8867591020728175,0,0,1.5432922655715264,1.404480919411767,CAMK2B;ABL1,Hypo
1706,GO_Biological_Process_2018,negative regulation of smooth muscle cell migration (GO:0014912),2/14,0.4025020658147796,0.8867591020728175,0,0,1.5432922655715264,1.404480919411767,LRP1;TRIB1,Hypo
1707,GO_Biological_Process_2018,positive regulation of heart rate (GO:0010460),2/14,0.4025020658147796,0.8867591020728175,0,0,1.5432922655715264,1.404480919411767,RYR2;KCNQ1,Hypo
1708,GO_Biological_Process_2018,positive regulation of muscle hypertrophy (GO:0014742),2/14,0.4025020658147796,0.8867591020728175,0,0,1.5432922655715264,1.404480919411767,PRKCA;SLC9A1,Hypo
1709,GO_Biological_Process_2018,positive regulation of calcium ion-dependent exocytosis (GO:0045956),2/14,0.4025020658147796,0.8867591020728175,0,0,1.5432922655715264,1.404480919411767,CACNA1I;STX1A,Hypo
1710,GO_Biological_Process_2018,establishment of protein localization to chromosome (GO:0070199),2/14,0.4025020658147796,0.8867591020728175,0,0,1.5432922655715264,1.404480919411767,H2AFY;WRAP53,Hypo
1711,GO_Biological_Process_2018,neuron cell-cell adhesion (GO:0007158),2/14,0.4025020658147796,0.8867591020728175,0,0,1.5432922655715264,1.404480919411767,NRXN3;NRXN2,Hypo
1712,GO_Biological_Process_2018,ribonucleoside monophosphate biosynthetic process (GO:0009156),2/14,0.4025020658147796,0.8867591020728175,0,0,1.5432922655715264,1.404480919411767,IMPDH1;PPAT,Hypo
1713,GO_Biological_Process_2018,ncRNA transcription (GO:0098781),2/14,0.4025020658147796,0.8867591020728175,0,0,1.5432922655715264,1.404480919411767,GTF3C1;MARS,Hypo
1714,GO_Biological_Process_2018,acetyl-CoA metabolic process (GO:0006084),2/14,0.4025020658147796,0.8867591020728175,0,0,1.5432922655715264,1.404480919411767,MLYCD;ACACB,Hypo
1715,GO_Biological_Process_2018,stem cell development (GO:0048864),2/14,0.4025020658147796,0.8867591020728175,0,0,1.5432922655715264,1.404480919411767,TCOF1;PEF1,Hypo
1716,GO_Biological_Process_2018,regulation of phosphate metabolic process (GO:0019220),2/14,0.4025020658147796,0.8867591020728175,0,0,1.5432922655715264,1.404480919411767,SMG5;SMG6,Hypo
1717,GO_Biological_Process_2018,neurotransmitter biosynthetic process (GO:0042136),2/14,0.4025020658147796,0.8867591020728175,0,0,1.5432922655715264,1.404480919411767,DAGLA;DAGLB,Hypo
1718,GO_Biological_Process_2018,negative regulation of Rho protein signal transduction (GO:0035024),2/14,0.4025020658147796,0.8867591020728175,0,0,1.5432922655715264,1.404480919411767,KANK1;KCTD13,Hypo
1719,GO_Biological_Process_2018,acyl-CoA biosynthetic process (GO:0071616),2/14,0.4025020658147796,0.8867591020728175,0,0,1.5432922655715264,1.404480919411767,FASN;MLYCD,Hypo
1720,GO_Biological_Process_2018,regulation of T cell differentiation (GO:0045580),4/33,0.4037578593194345,0.8867591020728175,0,0,1.2773150937378177,1.1584480729787574,ZMIZ1;ABL1;NFATC2;FOXP3,Hypo
1721,GO_Biological_Process_2018,regulation of cell-substrate adhesion (GO:0010810),4/33,0.4037578593194345,0.8867591020728175,0,0,1.2773150937378177,1.1584480729787574,NF1;SPOCK1;PPM1F;CORO1C,Hypo
1722,GO_Biological_Process_2018,cellular response to glucose starvation (GO:0042149),4/33,0.4037578593194345,0.8867591020728175,0,0,1.2773150937378177,1.1584480729787574,SH3GLB1;SZT2;MTMR3;ITFG2,Hypo
1723,GO_Biological_Process_2018,positive regulation of catalytic activity (GO:0043085),4/33,0.4037578593194345,0.8867591020728175,0,0,1.2773150937378177,1.1584480729787574,MID1IP1;ABL1;ABL2;MAPK14,Hypo
1724,GO_Biological_Process_2018,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),4/33,0.4037578593194345,0.8867591020728175,0,0,1.2773150937378177,1.1584480729787574,DLG3;LRCH4;ANK1;MARK2,Hypo
1725,GO_Biological_Process_2018,exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay (GO:0043928),4/33,0.4037578593194345,0.8867591020728175,0,0,1.2773150937378177,1.1584480729787574,EDC4;WDR61;DCP1A;DCPS,Hypo
1726,GO_Biological_Process_2018,positive regulation of locomotion (GO:0040017),4/33,0.4037578593194345,0.8867591020728175,0,0,1.2773150937378177,1.1584480729787574,STX3;VPS37B;NTN1;PPM1F,Hypo
1727,GO_Biological_Process_2018,positive regulation of organelle organization (GO:0010638),4/33,0.4037578593194345,0.8867591020728175,0,0,1.2773150937378177,1.1584480729787574,TMED9;SYNJ1;STX18;RAB3GAP2,Hypo
1728,GO_Biological_Process_2018,positive regulation of adenylate cyclase activity (GO:0045762),4/33,0.4037578593194345,0.8867591020728175,0,0,1.2773150937378177,1.1584480729787574,ADCY9;NF1;ADCY3;CAP2,Hypo
1729,GO_Biological_Process_2018,activation of MAPKK activity (GO:0000186),4/33,0.4037578593194345,0.8867591020728175,0,0,1.2773150937378177,1.1584480729787574,LRRK2;STK4;MAP3K14;MAP3K4,Hypo
1730,GO_Biological_Process_2018,negative regulation of binding (GO:0051100),9/82,0.406562903554415,0.8867591020728175,0,0,1.1418559844170142,1.027689360966537,GOLGA2;DNAJB2;LRRK2;DVL1;TMC8;PIN1;ITGB1BP1;SORL1;PEX14,Hypo
1731,GO_Biological_Process_2018,negative regulation of DNA metabolic process (GO:0051053),5/43,0.4105412161008536,0.8867591020728175,0,0,1.218508997429306,1.0848129114052931,KMT2A;TGFB3;ERCC1;TET1;FAM129B,Hypo
1732,GO_Biological_Process_2018,regulation of ATP metabolic process (GO:1903578),5/43,0.4105412161008536,0.8867591020728175,0,0,1.218508997429306,1.0848129114052931,NUP188;NUP133;UQCC2;PRKAG1;PRKAG2,Hypo
1733,GO_Biological_Process_2018,histone H3 acetylation (GO:0043966),5/43,0.4105412161008536,0.8867591020728175,0,0,1.218508997429306,1.0848129114052931,PER1;BRD1;BRPF3;KAT6A;JADE1,Hypo
1734,GO_Biological_Process_2018,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),15/142,0.4120792898728984,0.8867591020728175,0,0,1.0939998779222364,0.969874101492494,PTPRT;TENM1;CADM3;TENM2;DSCAM;CADM1;TENM4;PCDHGB4;PCDHGC3;PKD1;CDH22;ERCC2;DSCAML1;PCDHA7;SDK2,Hypo
1735,GO_Biological_Process_2018,positive regulation of intracellular protein transport (GO:0090316),16/152,0.4123019988267363,0.8867591020728175,0,0,1.0897256524119472,0.9654960467648658,SH3GLB1;TENM1;RIPOR1;MYBPC1;HPS4;ANK3;PDZK1;WBP11;OAZ1;SORL1;BAG3;VPS11;ITGB1BP1;FYN;PCNT;RAPGEF3,Hypo
1736,GO_Biological_Process_2018,negative regulation of neuron apoptotic process (GO:0043524),7/63,0.4176489210332264,0.8867591020728175,0,0,1.1576170869788986,1.0107318024393728,UNC5B;TGFB3;ERCC2;TYRO3;AGAP2;PTK2B;RETREG1,Hypo
1737,GO_Biological_Process_2018,cellular lipid catabolic process (GO:0044242),3/24,0.4190906864479796,0.8867591020728175,0,0,1.3228410008071023,1.150432417434982,ACADL;LPIN1;PPARD,Hypo
1738,GO_Biological_Process_2018,negative regulation of protein localization to membrane (GO:1905476),3/24,0.4190906864479796,0.8867591020728175,0,0,1.3228410008071023,1.150432417434982,TMEM59;TMBIM1;ITGB1BP1,Hypo
1739,GO_Biological_Process_2018,positive regulation of purine nucleotide biosynthetic process (GO:1900373),3/24,0.4190906864479796,0.8867591020728175,0,0,1.3228410008071023,1.150432417434982,CALM3;ENO1;RAMP1,Hypo
1740,GO_Biological_Process_2018,regulation of epidermal growth factor-activated receptor activity (GO:0007176),3/24,0.4190906864479796,0.8867591020728175,0,0,1.3228410008071023,1.150432417434982,ZFYVE28;TGFA;EREG,Hypo
1741,GO_Biological_Process_2018,positive regulation of endopeptidase activity (GO:0010950),3/24,0.4190906864479796,0.8867591020728175,0,0,1.3228410008071023,1.150432417434982,MBP;FYN;GRIN2B,Hypo
1742,GO_Biological_Process_2018,DNA geometric change (GO:0032392),3/24,0.4190906864479796,0.8867591020728175,0,0,1.3228410008071023,1.150432417434982,RECQL;HMGB3;HMGB1,Hypo
1743,GO_Biological_Process_2018,negative regulation of oxidative stress-induced cell death (GO:1903202),3/24,0.4190906864479796,0.8867591020728175,0,0,1.3228410008071023,1.150432417434982,LRRK2;GPR37L1;PDE8A,Hypo
1744,GO_Biological_Process_2018,cellular senescence (GO:0090398),3/24,0.4190906864479796,0.8867591020728175,0,0,1.3228410008071023,1.150432417434982,KAT6A;NSMCE2;MAPK14,Hypo
1745,GO_Biological_Process_2018,cilium-dependent cell motility (GO:0060285),3/24,0.4190906864479796,0.8867591020728175,0,0,1.3228410008071023,1.150432417434982,DNAH2;DNAH17;CFAP46,Hypo
1746,GO_Biological_Process_2018,limb development (GO:0060173),3/24,0.4190906864479796,0.8867591020728175,0,0,1.3228410008071023,1.150432417434982,KDF1;IFT122;LRP4,Hypo
1747,GO_Biological_Process_2018,positive regulation of vascular endothelial growth factor production (GO:0010575),3/24,0.4190906864479796,0.8867591020728175,0,0,1.3228410008071023,1.150432417434982,FLT4;RORA;SULF2,Hypo
1748,GO_Biological_Process_2018,fatty acid derivative biosynthetic process (GO:1901570),3/24,0.4190906864479796,0.8867591020728175,0,0,1.3228410008071023,1.150432417434982,BDH2;FASN;AACS,Hypo
1749,GO_Biological_Process_2018,"protein alpha-1,2-demannosylation (GO:0036508)",3/24,0.4190906864479796,0.8867591020728175,0,0,1.3228410008071023,1.150432417434982,MAN1C1;UGGT2;UGGT1,Hypo
1750,GO_Biological_Process_2018,actin nucleation (GO:0045010),3/24,0.4190906864479796,0.8867591020728175,0,0,1.3228410008071023,1.150432417434982,ARPC3;ARPC1B;LMOD1,Hypo
1751,GO_Biological_Process_2018,proteoglycan biosynthetic process (GO:0030166),3/24,0.4190906864479796,0.8867591020728175,0,0,1.3228410008071023,1.150432417434982,NDST1;B3GAT2;XYLT2,Hypo
1752,GO_Biological_Process_2018,organic cation transport (GO:0015695),3/24,0.4190906864479796,0.8867591020728175,0,0,1.3228410008071023,1.150432417434982,SEC14L1;SLC44A2;RHCG,Hypo
1753,GO_Biological_Process_2018,ear morphogenesis (GO:0042471),3/24,0.4190906864479796,0.8867591020728175,0,0,1.3228410008071023,1.150432417434982,USH1C;EPHB2;FGFR2,Hypo
1754,GO_Biological_Process_2018,positive regulation of cytokine secretion (GO:0050715),8/73,0.4195845665365773,0.8867591020728175,0,0,1.1398241305553356,0.9899260694524532,IL33;CADM1;NLRP10;MBP;HMGB1;MAPK14;PRKCZ;RASGRP1,Hypo
1755,GO_Biological_Process_2018,canonical Wnt signaling pathway (GO:0060070),8/73,0.4195845665365773,0.8867591020728175,0,0,1.1398241305553356,0.9899260694524532,RARG;FRZB;LRRK2;TCF7;DVL1;OTULIN;WNT9B;DVL2,Hypo
1756,GO_Biological_Process_2018,positive regulation of peptidyl-serine phosphorylation (GO:0033138),9/83,0.4209171768061266,0.8867591020728175,0,0,1.1263628388821587,0.9746633842650269,RPTOR;OPRD1;TENM1;TBK1;NTRK3;TNKS1BP1;PRKD2;STK4;RAPGEF3,Hypo
1757,GO_Biological_Process_2018,positive regulation of homeostatic process (GO:0032846),9/83,0.4209171768061266,0.8867591020728175,0,0,1.1263628388821587,0.9746633842650269,RYR2;P2RX4;PLEKHM1;PRKCA;INHBA;FOXO3;MAPK14;GPLD1;SMARCA4,Hypo
1758,GO_Biological_Process_2018,protein ubiquitination (GO:0016567),51/506,0.4224857220992117,0.8867591020728175,0,0,1.03853965939274,0.8948053827461815,UBE2D1;RNF19B;KLHDC7A;UBE3B;FBXO21;RNF114;BTRC;UNKL;AREL1;NHLRC3;FBXW8;UBE4B;FBXO10;TRPC4AP;RNF41;PJA1;TRAF7;RNF144B;GAN;KCTD13;BIRC6;RBCK1;PDZRN4;CUL9;MGRN1;EPAS1;PELI2;UBR4;NEDD4L;KLHL11;WDR61;UBR2;FBXO44;FBXO41;RMND5B;PDZD4;TNKS2;BTBD3;HLTF;SASH1;UBL4A;SMURF1;FBXL18;KLHL2;KLHL3;FBXL16;FBXO31;SPSB1;OTULIN;UBE2O;ASB2,Hypo
1759,GO_Biological_Process_2018,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),14/133,0.423045392877841,0.8867591020728175,0,0,1.0896329606222654,0.9373848602866136,CYFIP2;MYO10;SRC;PRKCE;ARPC1B;PIK3R1;BAIAP2;VAV2;ARPC3;ELMO1;ABL1;ELMO2;FYN;DOCK1,Hypo
1760,GO_Biological_Process_2018,protein targeting (GO:0006605),14/133,0.423045392877841,0.8867591020728175,0,0,1.0896329606222654,0.9373848602866136,PMM1;RAB3IP;VPS13D;HPS4;ZDHHC7;AKAP6;PEX1;SRP68;TRAK1;SORL1;PITRM1;LAMP2;VTI1A;HAP1,Hypo
1761,GO_Biological_Process_2018,negative regulation of gene expression (GO:0010629),62/618,0.4253207425940116,0.8867591020728175,0,0,1.033246707718571,0.8833347058577495,CDKN1C;THRA;BHLHE41;ENO1;LIMD1;BCL7A;DIP2A;BTRC;TNFRSF4;PIAS4;ZHX2;SMARCC2;H2AFY;ZBTB38;ESX1;DNMT3A;FOXP3;CBFA2T3;RUNX2;DKK3;EREG;NCOR2;OLFM1;RBL1;DDIT3;KAT6A;CRY2;RARA;MAPT;PPARD;OPRD1;HDAC5;CTBP2;TSHZ3;CIPC;TOB1;PPM1F;FAM129B;SBNO2;ATXN1;NACC2;PRDM16;RBBP7;MTA3;ATF7IP;SPEN;KDM4A;XRCC6;ZBTB16;DAB2IP;SAMD4B;NR1D1;FOXN3;PEX14;GATAD2A;SMARCA4;PER2;PER1;CDK5;BCL6;BHLHE40;CPEB3,Hypo
1762,GO_Biological_Process_2018,regulation of wound healing (GO:0061041),4/34,0.4264924975366813,0.8867591020728175,0,0,1.2346694073312778,1.0521365031591683,KANK1;PRKCE;F2;AJAP1,Hypo
1763,GO_Biological_Process_2018,response to peptide (GO:1901652),4/34,0.4264924975366813,0.8867591020728175,0,0,1.2346694073312778,1.0521365031591683,EIF2B5;FYN;QRFPR;INAVA,Hypo
1764,GO_Biological_Process_2018,negative regulation of endothelial cell migration (GO:0010596),4/34,0.4264924975366813,0.8867591020728175,0,0,1.2346694073312778,1.0521365031591683,ADGRB1;DAB2IP;HMGB1;VASH1,Hypo
1765,GO_Biological_Process_2018,positive regulation of cell development (GO:0010720),4/34,0.4264924975366813,0.8867591020728175,0,0,1.2346694073312778,1.0521365031591683,SPEN;RGS14;AKAP6;FAM129B,Hypo
1766,GO_Biological_Process_2018,regulation of interferon-beta production (GO:0032648),4/34,0.4264924975366813,0.8867591020728175,0,0,1.2346694073312778,1.0521365031591683,PTPRS;TBK1;POLR3B;POLR3G,Hypo
1767,GO_Biological_Process_2018,cellular macromolecular complex assembly (GO:0034622),4/34,0.4264924975366813,0.8867591020728175,0,0,1.2346694073312778,1.0521365031591683,BIN1;KIF13A;USH1C;TCF4,Hypo
1768,GO_Biological_Process_2018,embryonic limb morphogenesis (GO:0030326),4/34,0.4264924975366813,0.8867591020728175,0,0,1.2346694073312778,1.0521365031591683,RARG;MBNL1;ECE1;CACNA1C,Hypo
1769,GO_Biological_Process_2018,positive regulation of exocytosis (GO:0045921),4/34,0.4264924975366813,0.8867591020728175,0,0,1.2346694073312778,1.0521365031591683,RAB15;ATP13A2;CLASP1;CLASP2,Hypo
1770,GO_Biological_Process_2018,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),21/204,0.4304417237726297,0.8867591020728175,0,0,1.0628882713373955,0.8959545820288486,PRKCB;SLC44A2;USP10;PLEKHG5;PELI2;DAB2IP;RORA;CXXC5;S100B;LITAF;INAVA;PER1;TBK1;NLRP10;TNIP1;TRIM5;FLNA;RBCK1;PIM2;MAP3K14;BRD4,Hypo
1771,GO_Biological_Process_2018,regulation of steroid biosynthetic process (GO:0050810),5/44,0.4304617254560204,0.8867591020728175,0,0,1.1871992617493905,1.0006865373473552,SREBF1;GPAM;FASN;SCAP;ACACB,Hypo
1772,GO_Biological_Process_2018,negative regulation of immune system process (GO:0002683),5/44,0.4304617254560204,0.8867591020728175,0,0,1.1871992617493905,1.0006865373473552,NLRP10;TSC22D3;NFKBIL1;TYRO3;FOXP3,Hypo
1773,GO_Biological_Process_2018,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),15/144,0.4339078193790495,0.8867591020728175,0,0,1.0769184544198065,0.8991441646108109,SMAD3;TGFB3;SMURF1;SRC;TGFB1I1;PXN;UBE2D1;FURIN;INHBA;PRKCZ;TOB1;RUNX2;AKAP2;SMAD7;TWSG1,Hypo
1774,GO_Biological_Process_2018,cellular response to decreased oxygen levels (GO:0036294),7/64,0.4341071627963012,0.8867591020728175,0,0,1.1372448104306057,0.9489896902688952,OPRD1;SLC8A3;EPAS1;HP1BP3;LMNA;RORA;MTOR,Hypo
1775,GO_Biological_Process_2018,Fc-gamma receptor signaling pathway (GO:0038094),14/134,0.434366507169134,0.8867591020728175,0,0,1.0804924242424243,0.9009865600066918,CYFIP2;MYO10;SRC;PRKCE;ARPC1B;PIK3R1;BAIAP2;VAV2;ARPC3;ELMO1;ABL1;ELMO2;FYN;DOCK1,Hypo
1776,GO_Biological_Process_2018,regulation of G-protein coupled receptor protein signaling pathway (GO:0008277),8/74,0.4348733431066308,0.8867591020728175,0,0,1.1224916518428365,0.9346993098545248,GIT2;RGS3;MGRN1;LRRK2;FNTB;NMT1;MGLL;PPP1R9B,Hypo
1777,GO_Biological_Process_2018,regulation of cell cycle G2/M phase transition (GO:1902749),9/84,0.4352544702487261,0.8867591020728175,0,0,1.1112828438948996,0.9243922180308858,DYNC1I2;DYNC1H1;H2AFY;ODF2;CEP164;FGFR1OP;PCNT;NINL;CLASP1,Hypo
1778,GO_Biological_Process_2018,peptide metabolic process (GO:0006518),11/104,0.4352955066708152,0.8867591020728175,0,0,1.0953822777509743,0.911062469303724,MIPEP;ALDH5A1;LAMP2;GDAP1L1;TPP1;CPXM1;FURIN;IDE;F2;SPPL3;SEC11C,Hypo
1779,GO_Biological_Process_2018,vesicle fusion (GO:0006906),10/94,0.4353698915888189,0.8867591020728175,0,0,1.1024791359842907,0.916776760639556,SYT12;STX8;VPS8;VPS11;VTI1A;STX3;SYT13;VPS39;STX1A;SYT7,Hypo
1780,GO_Biological_Process_2018,skin development (GO:0043588),10/94,0.4353698915888189,0.8867591020728175,0,0,1.1024791359842907,0.916776760639556,RYR1;SCEL;COL5A1;KDF1;PDGFA;ITGA6;ALOX12B;PKD1;ALOXE3;EREG,Hypo
1781,GO_Biological_Process_2018,positive regulation of peptidyl-lysine acetylation (GO:2000758),2/15,0.4375878478519471,0.8867591020728175,0,0,1.4244984994471648,1.177316383434859,PAXIP1;FOXP3,Hypo
1782,GO_Biological_Process_2018,myotube differentiation (GO:0014902),2/15,0.4375878478519471,0.8867591020728175,0,0,1.4244984994471648,1.177316383434859,SORT1;KCNH1,Hypo
1783,GO_Biological_Process_2018,nuclear pore organization (GO:0006999),2/15,0.4375878478519471,0.8867591020728175,0,0,1.4244984994471648,1.177316383434859,AHCTF1;NUP133,Hypo
1784,GO_Biological_Process_2018,autonomic nervous system development (GO:0048483),2/15,0.4375878478519471,0.8867591020728175,0,0,1.4244984994471648,1.177316383434859,KIF26A;NF1,Hypo
1785,GO_Biological_Process_2018,substrate-dependent cell migration (GO:0006929),2/15,0.4375878478519471,0.8867591020728175,0,0,1.4244984994471648,1.177316383434859,ITGB1BP1;NTN1,Hypo
1786,GO_Biological_Process_2018,negative regulation of TORC1 signaling (GO:1904262),2/15,0.4375878478519471,0.8867591020728175,0,0,1.4244984994471648,1.177316383434859,SZT2;ITFG2,Hypo
1787,GO_Biological_Process_2018,regulation of mitotic metaphase/anaphase transition (GO:0030071),2/15,0.4375878478519471,0.8867591020728175,0,0,1.4244984994471648,1.177316383434859,NSMCE2;DLGAP5,Hypo
1788,GO_Biological_Process_2018,negative regulation of insulin secretion (GO:0046676),2/15,0.4375878478519471,0.8867591020728175,0,0,1.4244984994471648,1.177316383434859,MIDN;KCNJ11,Hypo
1789,GO_Biological_Process_2018,anterograde synaptic vesicle transport (GO:0048490),2/15,0.4375878478519471,0.8867591020728175,0,0,1.4244984994471648,1.177316383434859,BLOC1S5;AP3B2,Hypo
1790,GO_Biological_Process_2018,regulation of establishment of cell polarity (GO:2000114),2/15,0.4375878478519471,0.8867591020728175,0,0,1.4244984994471648,1.177316383434859,KANK1;PTK2B,Hypo
1791,GO_Biological_Process_2018,unsaturated fatty acid biosynthetic process (GO:0006636),2/15,0.4375878478519471,0.8867591020728175,0,0,1.4244984994471648,1.177316383434859,ALOX12B;ALOXE3,Hypo
1792,GO_Biological_Process_2018,glycerophospholipid catabolic process (GO:0046475),2/15,0.4375878478519471,0.8867591020728175,0,0,1.4244984994471648,1.177316383434859,SMPD4;ENPP6,Hypo
1793,GO_Biological_Process_2018,presynapse assembly (GO:0099054),2/15,0.4375878478519471,0.8867591020728175,0,0,1.4244984994471648,1.177316383434859,DVL1;LRP4,Hypo
1794,GO_Biological_Process_2018,negative regulation of interleukin-2 production (GO:0032703),2/15,0.4375878478519471,0.8867591020728175,0,0,1.4244984994471648,1.177316383434859,FOXP3;HDAC7,Hypo
1795,GO_Biological_Process_2018,mitotic chromosome condensation (GO:0007076),2/15,0.4375878478519471,0.8867591020728175,0,0,1.4244984994471648,1.177316383434859,NCAPD2;NCAPH,Hypo
1796,GO_Biological_Process_2018,cellular biogenic amine biosynthetic process (GO:0042401),2/15,0.4375878478519471,0.8867591020728175,0,0,1.4244984994471648,1.177316383434859,SMOX;SMS,Hypo
1797,GO_Biological_Process_2018,neural crest cell differentiation (GO:0014033),2/15,0.4375878478519471,0.8867591020728175,0,0,1.4244984994471648,1.177316383434859,TCOF1;PEF1,Hypo
1798,GO_Biological_Process_2018,mesenchymal cell development (GO:0014031),2/15,0.4375878478519471,0.8867591020728175,0,0,1.4244984994471648,1.177316383434859,TCOF1;PEF1,Hypo
1799,GO_Biological_Process_2018,vasculature development (GO:0001944),2/15,0.4375878478519471,0.8867591020728175,0,0,1.4244984994471648,1.177316383434859,PDGFRA;FLT4,Hypo
1800,GO_Biological_Process_2018,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),2/15,0.4375878478519471,0.8867591020728175,0,0,1.4244984994471648,1.177316383434859,FURIN;GPLD1,Hypo
1801,GO_Biological_Process_2018,regulation of macrophage chemotaxis (GO:0010758),2/15,0.4375878478519471,0.8867591020728175,0,0,1.4244984994471648,1.177316383434859,PTK2B;CMKLR1,Hypo
1802,GO_Biological_Process_2018,negative regulation of viral entry into host cell (GO:0046597),2/15,0.4375878478519471,0.8867591020728175,0,0,1.4244984994471648,1.177316383434859,TRIM5;TRIM11,Hypo
1803,GO_Biological_Process_2018,positive regulation of interleukin-4 production (GO:0032753),2/15,0.4375878478519471,0.8867591020728175,0,0,1.4244984994471648,1.177316383434859,RARA;PRKCZ,Hypo
1804,GO_Biological_Process_2018,filopodium assembly (GO:0046847),2/15,0.4375878478519471,0.8867591020728175,0,0,1.4244984994471648,1.177316383434859,FGD1;PPP1R9B,Hypo
1805,GO_Biological_Process_2018,microtubule depolymerization (GO:0007019),2/15,0.4375878478519471,0.8867591020728175,0,0,1.4244984994471648,1.177316383434859,NCKAP5L;CCSAP,Hypo
1806,GO_Biological_Process_2018,negative regulation of mRNA processing (GO:0050686),2/15,0.4375878478519471,0.8867591020728175,0,0,1.4244984994471648,1.177316383434859,SFSWAP;SRSF4,Hypo
1807,GO_Biological_Process_2018,negative regulation of protein processing (GO:0010955),2/15,0.4375878478519471,0.8867591020728175,0,0,1.4244984994471648,1.177316383434859,TMEM59;LRRK2,Hypo
1808,GO_Biological_Process_2018,protein targeting to peroxisome (GO:0006625),2/15,0.4375878478519471,0.8867591020728175,0,0,1.4244984994471648,1.177316383434859,PEX1;PEX14,Hypo
1809,GO_Biological_Process_2018,synaptic vesicle transport along microtubule (GO:0099517),2/15,0.4375878478519471,0.8867591020728175,0,0,1.4244984994471648,1.177316383434859,BLOC1S5;AP3B2,Hypo
1810,GO_Biological_Process_2018,positive regulation of protein export from nucleus (GO:0046827),2/15,0.4375878478519471,0.8867591020728175,0,0,1.4244984994471648,1.177316383434859,BAG3;RAPGEF3,Hypo
1811,GO_Biological_Process_2018,endoderm development (GO:0007492),2/15,0.4375878478519471,0.8867591020728175,0,0,1.4244984994471648,1.177316383434859,DUSP5;DUSP1,Hypo
1812,GO_Biological_Process_2018,myeloid cell development (GO:0061515),2/15,0.4375878478519471,0.8867591020728175,0,0,1.4244984994471648,1.177316383434859,SRC;KIT,Hypo
1813,GO_Biological_Process_2018,membrane repolarization during cardiac muscle cell action potential (GO:0086013),2/15,0.4375878478519471,0.8867591020728175,0,0,1.4244984994471648,1.177316383434859,KCND3;KCNQ1,Hypo
1814,GO_Biological_Process_2018,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),2/15,0.4375878478519471,0.8867591020728175,0,0,1.4244984994471648,1.177316383434859,CALM3;SMAD7,Hypo
1815,GO_Biological_Process_2018,heparan sulfate proteoglycan biosynthetic process (GO:0015012),2/15,0.4375878478519471,0.8867591020728175,0,0,1.4244984994471648,1.177316383434859,NDST1;XYLT2,Hypo
1816,GO_Biological_Process_2018,selective autophagy (GO:0061912),2/15,0.4375878478519471,0.8867591020728175,0,0,1.4244984994471648,1.177316383434859,WDFY3;RETREG1,Hypo
1817,GO_Biological_Process_2018,digestive tract morphogenesis (GO:0048546),2/15,0.4375878478519471,0.8867591020728175,0,0,1.4244984994471648,1.177316383434859,PDGFRA;FGFR2,Hypo
1818,GO_Biological_Process_2018,positive regulation of response to wounding (GO:1903036),2/15,0.4375878478519471,0.8867591020728175,0,0,1.4244984994471648,1.177316383434859,KANK1;PRKCE,Hypo
1819,GO_Biological_Process_2018,response to X-ray (GO:0010165),2/15,0.4375878478519471,0.8867591020728175,0,0,1.4244984994471648,1.177316383434859,IKBIP;XRCC6,Hypo
1820,GO_Biological_Process_2018,"protein localization to chromosome, telomeric region (GO:0070198)",2/15,0.4375878478519471,0.8867591020728175,0,0,1.4244984994471648,1.177316383434859,TNKS2;WRAP53,Hypo
1821,GO_Biological_Process_2018,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),2/15,0.4375878478519471,0.8867591020728175,0,0,1.4244984994471648,1.177316383434859,SEMA4C;INAVA,Hypo
1822,GO_Biological_Process_2018,cellular response to organic cyclic compound (GO:0071407),14/135,0.4456821299914255,0.8867591020728175,0,0,1.0715029711085309,0.865934369712894,PDE2A;ADCY3;PDXP;RORA;ATP1A2;AKAP6;RYR3;SSH1;DIAPH1;RAD51;P2RX4;KCNQ1;RAPGEF2;RAPGEF3,Hypo
1823,GO_Biological_Process_2018,Fc receptor mediated stimulatory signaling pathway (GO:0002431),14/135,0.4456821299914255,0.8867591020728175,0,0,1.0715029711085309,0.865934369712894,CYFIP2;MYO10;SRC;PRKCE;ARPC1B;PIK3R1;BAIAP2;VAV2;ARPC3;ELMO1;ABL1;ELMO2;FYN;DOCK1,Hypo
1824,GO_Biological_Process_2018,negative regulation of wound healing (GO:0061045),3/25,0.4458854164257624,0.8867591020728175,0,0,1.2626418265863566,1.0198273105696067,CLASP1;CLASP2;AJAP1,Hypo
1825,GO_Biological_Process_2018,"protein import into nucleus, translocation (GO:0000060)",3/25,0.4458854164257624,0.8867591020728175,0,0,1.2626418265863566,1.0198273105696067,OPRD1;BCL6;TNPO1,Hypo
1826,GO_Biological_Process_2018,glial cell differentiation (GO:0010001),3/25,0.4458854164257624,0.8867591020728175,0,0,1.2626418265863566,1.0198273105696067,EIF2B5;SLC8A3;CDK5,Hypo
1827,GO_Biological_Process_2018,"negative regulation of gene expression, epigenetic (GO:0045814)",3/25,0.4458854164257624,0.8867591020728175,0,0,1.2626418265863566,1.0198273105696067,H2AFY;DNMT3A;RBBP7,Hypo
1828,GO_Biological_Process_2018,regulation of interleukin-10 production (GO:0032653),3/25,0.4458854164257624,0.8867591020728175,0,0,1.2626418265863566,1.0198273105696067,HMGB1;FOXP3;INAVA,Hypo
1829,GO_Biological_Process_2018,positive regulation of filopodium assembly (GO:0051491),3/25,0.4458854164257624,0.8867591020728175,0,0,1.2626418265863566,1.0198273105696067,TENM1;TENM2;TGFB3,Hypo
1830,GO_Biological_Process_2018,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),3/25,0.4458854164257624,0.8867591020728175,0,0,1.2626418265863566,1.0198273105696067,CADM1;IL12RB1;RASGRP1,Hypo
1831,GO_Biological_Process_2018,regulation of lamellipodium assembly (GO:0010591),3/25,0.4458854164257624,0.8867591020728175,0,0,1.2626418265863566,1.0198273105696067,CAPZB;TWF2;SSH1,Hypo
1832,GO_Biological_Process_2018,regulation of viral release from host cell (GO:1902186),3/25,0.4458854164257624,0.8867591020728175,0,0,1.2626418265863566,1.0198273105696067,TRIM5;VPS37B;TRIM11,Hypo
1833,GO_Biological_Process_2018,respiratory tube development (GO:0030323),3/25,0.4458854164257624,0.8867591020728175,0,0,1.2626418265863566,1.0198273105696067,ZIC3;FGFR2;CCDC40,Hypo
1834,GO_Biological_Process_2018,protein depolymerization (GO:0051261),3/25,0.4458854164257624,0.8867591020728175,0,0,1.2626418265863566,1.0198273105696067,NCKAP5L;TWF2;MICAL3,Hypo
1835,GO_Biological_Process_2018,negative regulation of locomotion (GO:0040013),3/25,0.4458854164257624,0.8867591020728175,0,0,1.2626418265863566,1.0198273105696067,TRIM5;PIN1;TRIM11,Hypo
1836,GO_Biological_Process_2018,regulation of nervous system development (GO:0051960),3/25,0.4458854164257624,0.8867591020728175,0,0,1.2626418265863566,1.0198273105696067,PER2;TENM4;LRRK2,Hypo
1837,GO_Biological_Process_2018,positive regulation of nitric oxide biosynthetic process (GO:0045429),3/25,0.4458854164257624,0.8867591020728175,0,0,1.2626418265863566,1.0198273105696067,SMAD3;P2RX4;NOS1AP,Hypo
1838,GO_Biological_Process_2018,positive regulation of nitric oxide metabolic process (GO:1904407),3/25,0.4458854164257624,0.8867591020728175,0,0,1.2626418265863566,1.0198273105696067,SMAD3;P2RX4;NOS1AP,Hypo
1839,GO_Biological_Process_2018,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),3/25,0.4458854164257624,0.8867591020728175,0,0,1.2626418265863566,1.0198273105696067,PDGFRA;KIT;PTK2B,Hypo
1840,GO_Biological_Process_2018,cyclic nucleotide metabolic process (GO:0009187),3/25,0.4458854164257624,0.8867591020728175,0,0,1.2626418265863566,1.0198273105696067,ADCY9;ADCY3;PDE8A,Hypo
1841,GO_Biological_Process_2018,peptide catabolic process (GO:0043171),3/25,0.4458854164257624,0.8867591020728175,0,0,1.2626418265863566,1.0198273105696067,ECE1;TPP1;IDE,Hypo
1842,GO_Biological_Process_2018,negative regulation of multicellular organismal process (GO:0051241),13/125,0.4465285128252234,0.8867591020728175,0,0,1.0749041227229146,0.8666436226092785,WWC1;WWC2;WNT9B;DAB2IP;LRP4;LDLRAD4;OVOL2;CORO1C;SMAD7;TWSG1;SDHAF2;DDIT3;RAB11FIP5,Hypo
1843,GO_Biological_Process_2018,cellular response to oxidative stress (GO:0034599),12/115,0.4473532821890775,0.8867591020728175,0,0,1.078902281403108,0.8678761763940156,PDGFRA;PYROXD1;LRRK2;PXN;ABL1;FANCC;ATP13A2;MAPT;FOXO3;PDK2;ETV5;CAMKK2,Hypo
1844,GO_Biological_Process_2018,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",4/35,0.4489969778048774,0.8867591020728175,0,0,1.1947750555316117,0.956703129204018,EDC4;WDR61;DCP1A;DCPS,Hypo
1845,GO_Biological_Process_2018,positive regulation of peptide secretion (GO:0002793),4/35,0.4489969778048774,0.8867591020728175,0,0,1.1947750555316117,0.956703129204018,TGFB3;MYO18A;ATP13A2;MYH10,Hypo
1846,GO_Biological_Process_2018,negative regulation of epithelial cell migration (GO:0010633),4/35,0.4489969778048774,0.8867591020728175,0,0,1.1947750555316117,0.956703129204018,ADGRB1;DAB2IP;VASH1;CORO1C,Hypo
1847,GO_Biological_Process_2018,regulation of synapse assembly (GO:0051963),4/35,0.4489969778048774,0.8867591020728175,0,0,1.1947750555316117,0.956703129204018,CLSTN1;SLIT1;EPHB2;EPHB1,Hypo
1848,GO_Biological_Process_2018,carboxylic acid transmembrane transport (GO:1905039),4/35,0.4489969778048774,0.8867591020728175,0,0,1.1947750555316117,0.956703129204018,SLC7A5;SLC7A8;SLC38A10;SLC38A4,Hypo
1849,GO_Biological_Process_2018,protein kinase B signaling (GO:0043491),4/35,0.4489969778048774,0.8867591020728175,0,0,1.1947750555316117,0.956703129204018,NR4A1;TYRO3;TSC2;FOXO3,Hypo
1850,GO_Biological_Process_2018,erythrocyte differentiation (GO:0030218),4/35,0.4489969778048774,0.8867591020728175,0,0,1.1947750555316117,0.956703129204018,EPO;KIT;ACIN1;INHBA,Hypo
1851,GO_Biological_Process_2018,gland development (GO:0048732),8/75,0.4501137239198491,0.8867591020728175,0,0,1.1056765605545906,0.8826118520493329,SOX3;RARG;THRA;TGFB3;RARA;NF1;FGFR2;DKK3,Hypo
1852,GO_Biological_Process_2018,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),7/65,0.4504979937950107,0.8867591020728175,0,0,1.1175750261770814,0.8911561757160581,PIAS4;PAXIP1;TNIP1;LRRK2;UBE2D1;INAVA;SMAD7,Hypo
1853,GO_Biological_Process_2018,regulation of myeloid cell differentiation (GO:0045637),7/65,0.4504979937950107,0.8867591020728175,0,0,1.1175750261770814,0.8911561757160581,TNRC6C;KMT2D;KMT2A;PRKCB;ZBTB16;PTK2B;WDR61,Hypo
1854,GO_Biological_Process_2018,DNA recombination (GO:0006310),6/55,0.4506044536301581,0.8867591020728175,0,0,1.1338498362307887,0.9038658211112788,RAD51;ERCC1;RECQL;HMGB3;HMGB1;PALB2,Hypo
1855,GO_Biological_Process_2018,positive regulation of cysteine-type endopeptidase activity (GO:2001056),6/55,0.4506044536301581,0.8867591020728175,0,0,1.1338498362307887,0.9038658211112788,CYFIP2;FYN;HMGB1;GRAMD4;GRIN2B;PPM1F,Hypo
1856,GO_Biological_Process_2018,positive regulation of nucleic acid-templated transcription (GO:1903508),50/502,0.4586385246352855,0.8867591020728175,0,0,1.024569166278528,0.7986443980626288,CDKN1C;EPO;TGFB1I1;RORA;MYRFL;MED16;ZIC3;CREB3L2;PIM2;BTRC;TEAD1;NCOA1;SMARCC2;ATMIN;EBF3;FOXP3;RUNX2;MED24;ELF4;DDIT3;KAT6A;RARA;PPARD;KDM3A;KMT2A;FOXO3;FAM129B;CAMKK2;RAI1;PRDM16;DVL1;DVL2;HIVEP3;PCBD2;APBB1;ATF7IP;AFAP1L2;XRCC6;SMAD3;TGFB3;ZBTB16;NFATC2;ESRRG;NR1D1;FOXN3;INHBA;SMARCA4;ERCC2;TCF4;TAF4,Hypo
1857,GO_Biological_Process_2018,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),12/116,0.4596001597729912,0.8867591020728175,0,0,1.0684686830197667,0.8306258290008789,DLG3;SEMA4D;EPO;SRC;TNK2;DOK7;KIT;ABL1;PTK2B;CSPG4;ARHGEF2;SRCIN1,Hypo
1858,GO_Biological_Process_2018,chromatin remodeling (GO:0006338),12/116,0.4596001597729912,0.8867591020728175,0,0,1.0684686830197667,0.8306258290008789,HDAC5;SMARCC2;ANP32A;TOP1MT;PADI2;HMGB3;TNRC18;HMGB1;BAHCC1;FOXP3;ARID1B;SMARCA4,Hypo
1859,GO_Biological_Process_2018,regulation of protein localization to early endosome (GO:1902965),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,SORL1,Hypo
1860,GO_Biological_Process_2018,negative regulation of membrane potential (GO:0045837),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,MAPT,Hypo
1861,GO_Biological_Process_2018,quaternary ammonium group transport (GO:0015697),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,SLC25A29,Hypo
1862,GO_Biological_Process_2018,positive regulation of skeletal muscle fiber development (GO:0048743),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,FAM129B,Hypo
1863,GO_Biological_Process_2018,hindlimb morphogenesis (GO:0035137),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,RARG,Hypo
1864,GO_Biological_Process_2018,smooth muscle tissue development (GO:0048745),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,NF1,Hypo
1865,GO_Biological_Process_2018,response to chemokine (GO:1990868),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,LRCH1,Hypo
1866,GO_Biological_Process_2018,regulation of histone H3-K27 methylation (GO:0061085),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,H2AFY,Hypo
1867,GO_Biological_Process_2018,negative regulation of transforming growth factor beta production (GO:0071635),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,FURIN,Hypo
1868,GO_Biological_Process_2018,tRNA transcription from RNA polymerase III promoter (GO:0042797),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,GTF3C1,Hypo
1869,GO_Biological_Process_2018,amylin receptor signaling pathway (GO:0097647),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,RAMP1,Hypo
1870,GO_Biological_Process_2018,purine ribonucleoside bisphosphate biosynthetic process (GO:0034036),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,PAPSS1,Hypo
1871,GO_Biological_Process_2018,positive regulation of myelination (GO:0031643),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,TENM4,Hypo
1872,GO_Biological_Process_2018,positive regulation of icosanoid secretion (GO:0032305),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,P2RX4,Hypo
1873,GO_Biological_Process_2018,regulation of skeletal muscle satellite cell proliferation (GO:0014842),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,EPHB1,Hypo
1874,GO_Biological_Process_2018,positive regulation of ATP biosynthetic process (GO:2001171),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,ENO1,Hypo
1875,GO_Biological_Process_2018,negative regulation of oligodendrocyte differentiation (GO:0048715),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,NF1,Hypo
1876,GO_Biological_Process_2018,purine nucleobase biosynthetic process (GO:0009113),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,MTHFD1,Hypo
1877,GO_Biological_Process_2018,chromatin silencing at telomere (GO:0006348),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,DOT1L,Hypo
1878,GO_Biological_Process_2018,negative regulation of receptor biosynthetic process (GO:0010871),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,NR1D1,Hypo
1879,GO_Biological_Process_2018,negative regulation of lymphocyte differentiation (GO:0045620),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,INHBA,Hypo
1880,GO_Biological_Process_2018,adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway (GO:0007197),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,CHRM4,Hypo
1881,GO_Biological_Process_2018,negative regulation of meiotic cell cycle (GO:0051447),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,DUSP1,Hypo
1882,GO_Biological_Process_2018,response to lipoteichoic acid (GO:0070391),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,MAPK14,Hypo
1883,GO_Biological_Process_2018,bundle of His cell-Purkinje myocyte adhesion involved in cell communication (GO:0086073),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,CTNNA3,Hypo
1884,GO_Biological_Process_2018,negative regulation of protein targeting to membrane (GO:0090315),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,ITGB1BP1,Hypo
1885,GO_Biological_Process_2018,negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,RAP1GDS1,Hypo
1886,GO_Biological_Process_2018,muscle tissue development (GO:0060537),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,NF1,Hypo
1887,GO_Biological_Process_2018,Golgi transport vesicle coating (GO:0048200),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,TMED9,Hypo
1888,GO_Biological_Process_2018,histone H4-K12 acetylation (GO:0043983),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,JADE1,Hypo
1889,GO_Biological_Process_2018,negative regulation of neural precursor cell proliferation (GO:2000178),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,NF1,Hypo
1890,GO_Biological_Process_2018,choline catabolic process (GO:0042426),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,DMGDH,Hypo
1891,GO_Biological_Process_2018,glomerular epithelial cell differentiation (GO:0072311),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,KLF15,Hypo
1892,GO_Biological_Process_2018,negative regulation of phospholipid metabolic process (GO:1903726),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,DAB2IP,Hypo
1893,GO_Biological_Process_2018,renal filtration cell differentiation (GO:0061318),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,KLF15,Hypo
1894,GO_Biological_Process_2018,negative regulation of coenzyme metabolic process (GO:0051198),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,CBFA2T3,Hypo
1895,GO_Biological_Process_2018,3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,PAPSS1,Hypo
1896,GO_Biological_Process_2018,oxygen homeostasis (GO:0032364),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,EGLN1,Hypo
1897,GO_Biological_Process_2018,transcription initiation from RNA polymerase III promoter (GO:0006384),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,GTF3C1,Hypo
1898,GO_Biological_Process_2018,platelet dense granule organization (GO:0060155),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,ABCA1,Hypo
1899,GO_Biological_Process_2018,spermine metabolic process (GO:0008215),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,SMS,Hypo
1900,GO_Biological_Process_2018,regulation of histone deacetylase activity (GO:1901725),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,PRKD2,Hypo
1901,GO_Biological_Process_2018,regulation of ribonucleoprotein complex localization (GO:2000197),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,ZC3H3,Hypo
1902,GO_Biological_Process_2018,positive regulation of osteoblast proliferation (GO:0033690),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,TMEM119,Hypo
1903,GO_Biological_Process_2018,COPI-coated vesicle budding (GO:0035964),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,TMED9,Hypo
1904,GO_Biological_Process_2018,negative regulation of dendritic spine development (GO:0061000),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,PTPRS,Hypo
1905,GO_Biological_Process_2018,nucleus localization (GO:0051647),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,SYNE2,Hypo
1906,GO_Biological_Process_2018,positive regulation of memory T cell differentiation (GO:0043382),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,IL12RB1,Hypo
1907,GO_Biological_Process_2018,regulation of glucokinase activity (GO:0033131),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,MIDN,Hypo
1908,GO_Biological_Process_2018,regulation of interleukin-5 secretion (GO:2000662),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,PRKCZ,Hypo
1909,GO_Biological_Process_2018,ammonium transmembrane transport (GO:0072488),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,RHCG,Hypo
1910,GO_Biological_Process_2018,regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,SCN1B,Hypo
1911,GO_Biological_Process_2018,negative regulation of cell size (GO:0045792),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,DEPTOR,Hypo
1912,GO_Biological_Process_2018,blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:0002043),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,ITGB1BP1,Hypo
1913,GO_Biological_Process_2018,regulation of phosphatidylinositol biosynthetic process (GO:0010511),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,PDGFA,Hypo
1914,GO_Biological_Process_2018,aromatic compound catabolic process (GO:0019439),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,PDXP,Hypo
1915,GO_Biological_Process_2018,regulation of protein K63-linked ubiquitination (GO:1900044),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,SASH1,Hypo
1916,GO_Biological_Process_2018,photoreceptor cell differentiation (GO:0046530),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,MAPRE2,Hypo
1917,GO_Biological_Process_2018,negative regulation of vasculature development (GO:1901343),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,VASH1,Hypo
1918,GO_Biological_Process_2018,lens fiber cell development (GO:0070307),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,WNT5B,Hypo
1919,GO_Biological_Process_2018,regulation of chemokine-mediated signaling pathway (GO:0070099),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,PADI2,Hypo
1920,GO_Biological_Process_2018,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,SEMA7A,Hypo
1921,GO_Biological_Process_2018,interphase microtubule nucleation by interphase microtubule organizing center (GO:0051415),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,TUBGCP6,Hypo
1922,GO_Biological_Process_2018,regulation of interleukin-12 secretion (GO:2001182),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,MAPK14,Hypo
1923,GO_Biological_Process_2018,Golgi disassembly (GO:0090166),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,GOLGA2,Hypo
1924,GO_Biological_Process_2018,growth hormone secretion (GO:0030252),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,CDK16,Hypo
1925,GO_Biological_Process_2018,positive regulation of action potential (GO:0045760),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,ANK3,Hypo
1926,GO_Biological_Process_2018,response to lead ion (GO:0010288),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,MAPT,Hypo
1927,GO_Biological_Process_2018,regulation of hyaluronan biosynthetic process (GO:1900125),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,AP2A1,Hypo
1928,GO_Biological_Process_2018,macrophage derived foam cell differentiation (GO:0010742),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,SOAT1,Hypo
1929,GO_Biological_Process_2018,regulation of response to wounding (GO:1903034),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,STK24,Hypo
1930,GO_Biological_Process_2018,regulation of glial cell differentiation (GO:0045685),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,NF1,Hypo
1931,GO_Biological_Process_2018,mRNA 5'-splice site recognition (GO:0000395),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,SFSWAP,Hypo
1932,GO_Biological_Process_2018,cerebral cortex cell migration (GO:0021795),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,FGF13,Hypo
1933,GO_Biological_Process_2018,positive regulation of axon guidance (GO:1902669),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,DSCAM,Hypo
1934,GO_Biological_Process_2018,regulation of mitotic spindle checkpoint (GO:1903504),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,DUSP1,Hypo
1935,GO_Biological_Process_2018,regulation of keratinocyte apoptotic process (GO:1902172),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,PIAS4,Hypo
1936,GO_Biological_Process_2018,regulation of transforming growth factor beta2 production (GO:0032909),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,SMAD3,Hypo
1937,GO_Biological_Process_2018,positive regulation of protein localization to endosome (GO:1905668),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,SORL1,Hypo
1938,GO_Biological_Process_2018,vesicle fusion with Golgi apparatus (GO:0048280),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,VTI1A,Hypo
1939,GO_Biological_Process_2018,positive regulation of cholesterol storage (GO:0010886),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,SCARB1,Hypo
1940,GO_Biological_Process_2018,regulation of aldosterone biosynthetic process (GO:0032347),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,DKK3,Hypo
1941,GO_Biological_Process_2018,positive regulation of cardiac muscle contraction (GO:0060452),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,KCNQ1,Hypo
1942,GO_Biological_Process_2018,regulation of respiratory system process (GO:0044065),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,TSHZ3,Hypo
1943,GO_Biological_Process_2018,regulation of interleukin-10 secretion (GO:2001179),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,PRKCZ,Hypo
1944,GO_Biological_Process_2018,regulation of cortisol biosynthetic process (GO:2000064),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,DKK3,Hypo
1945,GO_Biological_Process_2018,aggrephagy (GO:0035973),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,WDFY3,Hypo
1946,GO_Biological_Process_2018,GDP-mannose metabolic process (GO:0019673),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,PMM1,Hypo
1947,GO_Biological_Process_2018,regulation of T-helper 17 cell lineage commitment (GO:2000328),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,IL12RB1,Hypo
1948,GO_Biological_Process_2018,negative regulation of phospholipase activity (GO:0010519),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,ABL1,Hypo
1949,GO_Biological_Process_2018,regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,LMNA,Hypo
1950,GO_Biological_Process_2018,regulation of inositol phosphate biosynthetic process (GO:0010919),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,PTK2B,Hypo
1951,GO_Biological_Process_2018,negative regulation of delayed rectifier potassium channel activity (GO:1902260),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,ANK3,Hypo
1952,GO_Biological_Process_2018,enteric nervous system development (GO:0048484),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,KIF26A,Hypo
1953,GO_Biological_Process_2018,epithelial tube formation (GO:0072175),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,FGFR2,Hypo
1954,GO_Biological_Process_2018,maintenance of protein location in extracellular region (GO:0071694),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,FBN2,Hypo
1955,GO_Biological_Process_2018,positive regulation of intracellular estrogen receptor signaling pathway (GO:0033148),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,KMT2D,Hypo
1956,GO_Biological_Process_2018,positive regulation of trophoblast cell migration (GO:1901165),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,AGO2,Hypo
1957,GO_Biological_Process_2018,cellular response to cold (GO:0070417),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,EIF2AK4,Hypo
1958,GO_Biological_Process_2018,collecting duct development (GO:0072044),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,PKD1,Hypo
1959,GO_Biological_Process_2018,astrocyte differentiation (GO:0048708),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,EIF2B5,Hypo
1960,GO_Biological_Process_2018,negative regulation of cell cycle phase transition (GO:1901988),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,H2AFY,Hypo
1961,GO_Biological_Process_2018,insulin secretion involved in cellular response to glucose stimulus (GO:0035773),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,RAB11FIP5,Hypo
1962,GO_Biological_Process_2018,negative regulation of myeloid cell apoptotic process (GO:0033033),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,EPO,Hypo
1963,GO_Biological_Process_2018,organic hydroxy compound catabolic process (GO:1901616),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,PDXP,Hypo
1964,GO_Biological_Process_2018,negative regulation of smooth muscle cell differentiation (GO:0051151),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,EREG,Hypo
1965,GO_Biological_Process_2018,chondrocyte development (GO:0002063),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,SULF2,Hypo
1966,GO_Biological_Process_2018,long term synaptic depression (GO:0060292),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,SHANK2,Hypo
1967,GO_Biological_Process_2018,regulation of mRNA export from nucleus (GO:0010793),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,ZC3H3,Hypo
1968,GO_Biological_Process_2018,regulation of interleukin-13 secretion (GO:2000665),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,PRKCZ,Hypo
1969,GO_Biological_Process_2018,peptidyl-proline hydroxylation (GO:0019511),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,EGLN1,Hypo
1970,GO_Biological_Process_2018,snRNA transcription from RNA polymerase III promoter (GO:0042796),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,ELL,Hypo
1971,GO_Biological_Process_2018,establishment of protein localization to telomere (GO:0070200),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,WRAP53,Hypo
1972,GO_Biological_Process_2018,regulation of t-circle formation (GO:1904429),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,ERCC1,Hypo
1973,GO_Biological_Process_2018,endoplasmic reticulum membrane organization (GO:0090158),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,STX18,Hypo
1974,GO_Biological_Process_2018,foam cell differentiation (GO:0090077),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,SOAT1,Hypo
1975,GO_Biological_Process_2018,phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway (GO:0007207),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,CHRM4,Hypo
1976,GO_Biological_Process_2018,dendritic spine maintenance (GO:0097062),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,FYN,Hypo
1977,GO_Biological_Process_2018,fructose 6-phosphate metabolic process (GO:0006002),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,PFKM,Hypo
1978,GO_Biological_Process_2018,cellular response to lipoteichoic acid (GO:0071223),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,MAPK14,Hypo
1979,GO_Biological_Process_2018,positive regulation of interferon-gamma secretion (GO:1902715),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,RASGRP1,Hypo
1980,GO_Biological_Process_2018,regulation of fat cell proliferation (GO:0070344),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,PER2,Hypo
1981,GO_Biological_Process_2018,granzyme-mediated apoptotic signaling pathway (GO:0008626),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,UBE4B,Hypo
1982,GO_Biological_Process_2018,positive regulation of adaptive immune response (GO:0002821),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,EIF2AK4,Hypo
1983,GO_Biological_Process_2018,negative regulation of mRNA catabolic process (GO:1902373),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,DHX34,Hypo
1984,GO_Biological_Process_2018,cellular response to chemokine (GO:1990869),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,LRCH1,Hypo
1985,GO_Biological_Process_2018,mesodermal cell fate commitment (GO:0001710),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,EYA2,Hypo
1986,GO_Biological_Process_2018,positive regulation of deacetylase activity (GO:0090045),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,PRKD2,Hypo
1987,GO_Biological_Process_2018,negative regulation of translation in response to stress (GO:0032055),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,EIF2AK4,Hypo
1988,GO_Biological_Process_2018,COPI coating of Golgi vesicle (GO:0048205),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,TMED9,Hypo
1989,GO_Biological_Process_2018,regulation of translational initiation in response to stress (GO:0043558),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,EIF2AK4,Hypo
1990,GO_Biological_Process_2018,mitochondrial ribosome assembly (GO:0061668),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,DHX30,Hypo
1991,GO_Biological_Process_2018,striated muscle hypertrophy (GO:0014897),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,RYR2,Hypo
1992,GO_Biological_Process_2018,positive regulation of protein localization to early endosome (GO:1902966),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,SORL1,Hypo
1993,GO_Biological_Process_2018,"establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,MAP1S,Hypo
1994,GO_Biological_Process_2018,negative regulation of cellular response to hypoxia (GO:1900038),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,ENO1,Hypo
1995,GO_Biological_Process_2018,regulation of T cell tolerance induction (GO:0002664),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,FOXP3,Hypo
1996,GO_Biological_Process_2018,negative regulation of glycolytic process (GO:0045820),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,CBFA2T3,Hypo
1997,GO_Biological_Process_2018,"heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,NDST1,Hypo
1998,GO_Biological_Process_2018,snRNA modification (GO:0040031),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,MEPCE,Hypo
1999,GO_Biological_Process_2018,positive regulation of podosome assembly (GO:0071803),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,ASAP1,Hypo
2000,GO_Biological_Process_2018,5S class rRNA transcription from RNA polymerase III type 1 promoter (GO:0042791),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,GTF3C1,Hypo
2001,GO_Biological_Process_2018,regulation of adiponectin secretion (GO:0070163),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,RAB11FIP5,Hypo
2002,GO_Biological_Process_2018,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,TIMP3,Hypo
2003,GO_Biological_Process_2018,ceramide transport (GO:0035627),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,PSAP,Hypo
2004,GO_Biological_Process_2018,regulation of cardiac muscle cell apoptotic process (GO:0010665),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,CAMK2A,Hypo
2005,GO_Biological_Process_2018,inner ear receptor cell development (GO:0060119),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,USH1C,Hypo
2006,GO_Biological_Process_2018,collagen biosynthetic process (GO:0032964),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,COL5A1,Hypo
2007,GO_Biological_Process_2018,phagosome-lysosome fusion (GO:0090385),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,SYT7,Hypo
2008,GO_Biological_Process_2018,regulation of protein targeting (GO:1903533),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,SREBF1,Hypo
2009,GO_Biological_Process_2018,regulation of skeletal muscle contraction (GO:0014819),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,SLC8A3,Hypo
2010,GO_Biological_Process_2018,positive regulation of protein acetylation (GO:1901985),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,RAPGEF3,Hypo
2011,GO_Biological_Process_2018,retinal ganglion cell axon guidance (GO:0031290),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,EPHB1,Hypo
2012,GO_Biological_Process_2018,ear development (GO:0043583),1/6,0.4596831205219083,0.8867591020728175,0,0,1.8517188301693177,1.439189011887332,ECE1,Hypo
2013,GO_Biological_Process_2018,epithelial cell differentiation (GO:0030855),10/96,0.462364902954937,0.8867591020728175,0,0,1.0767202109805802,0.8305829036409761,LAMA5;RARG;BDH2;SCUBE1;CDHR2;RARA;TPP1;RHCG;FGFR2;PCK2,Hypo
2014,GO_Biological_Process_2018,transforming growth factor beta receptor signaling pathway (GO:0007179),8/76,0.4652846461038873,0.8867591020728175,0,0,1.089356030774823,0.833472746519605,TWSG1;SMAD3;SRC;TGFB3;SMURF1;PXN;FURIN;PRKCZ,Hypo
2015,GO_Biological_Process_2018,hemopoiesis (GO:0030097),8/76,0.4652846461038873,0.8867591020728175,0,0,1.089356030774823,0.833472746519605,MELK;KMT2A;KAT6A;ZBTB16;KIT;INHBA;RUNX2;FGFR2,Hypo
2016,GO_Biological_Process_2018,chordate embryonic development (GO:0043009),6/56,0.4683234253028115,0.8867591020728175,0,0,1.1111111111111112,0.8428846022702755,MBNL1;TGFB3;DVL1;PKD1;FGFR2;SULF2,Hypo
2017,GO_Biological_Process_2018,regulation of BMP signaling pathway (GO:0030510),6/56,0.4683234253028115,0.8867591020728175,0,0,1.1111111111111112,0.8428846022702755,NUMA1;SMURF1;HTRA3;UBE2O;LEMD2;SMAD7,Hypo
2018,GO_Biological_Process_2018,glycosaminoglycan catabolic process (GO:0006027),6/56,0.4683234253028115,0.8867591020728175,0,0,1.1111111111111112,0.8428846022702755,SDC3;CSPG4;GPC4;GNS;GPC6;SLC9A1,Hypo
2019,GO_Biological_Process_2018,anion transport (GO:0006820),6/56,0.4683234253028115,0.8867591020728175,0,0,1.1111111111111112,0.8428846022702755,SLC22A23;SLC13A3;SLC22A15;SLC22A17;LRRC8D;SLC4A1,Hypo
2020,GO_Biological_Process_2018,protein complex disassembly (GO:0043241),5/46,0.4698292062735358,0.8867591020728175,0,0,1.1291617029280832,0.8529529886809752,VPS33A;LAMP2;DVL1;LIX1L;DVL2,Hypo
2021,GO_Biological_Process_2018,regulation of fibroblast proliferation (GO:0048145),5/46,0.4698292062735358,0.8867591020728175,0,0,1.1291617029280832,0.8529529886809752,PDGFRA;DAB2IP;NF1;PDGFA;EREG,Hypo
2022,GO_Biological_Process_2018,non-canonical Wnt signaling pathway (GO:0035567),13/127,0.4699908440342223,0.8867591020728175,0,0,1.0559284116331096,0.7972703686714295,SMURF1;CAMK2A;WNT9B;PRICKLE2;AP2A1;TNRC6C;TIAM1;DAAM1;FRZB;DVL1;AGO2;DVL2;AP2S1,Hypo
2023,GO_Biological_Process_2018,regulation of receptor-mediated endocytosis (GO:0048259),4/36,0.4712120852457685,0.8867591020728175,0,0,1.1573741007194245,0.8708626690017277,HIP1;TNK2;HIP1R;LDLRAP1,Hypo
2024,GO_Biological_Process_2018,sodium ion transmembrane transport (GO:0035725),4/36,0.4712120852457685,0.8867591020728175,0,0,1.1573741007194245,0.8708626690017277,SLC8A3;SCN1B;SLC8A2;ASIC1,Hypo
2025,GO_Biological_Process_2018,regulation of response to DNA damage stimulus (GO:2001020),4/36,0.4712120852457685,0.8867591020728175,0,0,1.1573741007194245,0.8708626690017277,SMYD2;ABL1;USP51;MAPT,Hypo
2026,GO_Biological_Process_2018,regulation of blood circulation (GO:1903522),4/36,0.4712120852457685,0.8867591020728175,0,0,1.1573741007194245,0.8708626690017277,PER2;KCNJ12;KCNQ1;ECE1,Hypo
2027,GO_Biological_Process_2018,plasma membrane organization (GO:0007009),4/36,0.4712120852457685,0.8867591020728175,0,0,1.1573741007194245,0.8708626690017277,COL5A1;PACSIN2;ANK3;SYT7,Hypo
2028,GO_Biological_Process_2018,vesicle-mediated transport in synapse (GO:0099003),4/36,0.4712120852457685,0.8867591020728175,0,0,1.1573741007194245,0.8708626690017277,CDK5;SYNJ1;KIF5C;PIP5K1C,Hypo
2029,GO_Biological_Process_2018,endosome organization (GO:0007032),4/36,0.4712120852457685,0.8867591020728175,0,0,1.1573741007194245,0.8708626690017277,ARFGEF2;AKTIP;VPS11;DNM1,Hypo
2030,GO_Biological_Process_2018,ferric iron transport (GO:0015682),4/36,0.4712120852457685,0.8867591020728175,0,0,1.1573741007194245,0.8708626690017277,LMTK2;TCIRG1;ATP6V1E1;ATP6V0A1,Hypo
2031,GO_Biological_Process_2018,organic hydroxy compound transport (GO:0015850),4/36,0.4712120852457685,0.8867591020728175,0,0,1.1573741007194245,0.8708626690017277,NCOA1;RXRA;SLCO2B1;SLC10A3,Hypo
2032,GO_Biological_Process_2018,regulation of muscle cell differentiation (GO:0051147),4/36,0.4712120852457685,0.8867591020728175,0,0,1.1573741007194245,0.8708626690017277,MEGF10;ABL1;MAPK14;FGFR2,Hypo
2033,GO_Biological_Process_2018,transferrin transport (GO:0033572),4/36,0.4712120852457685,0.8867591020728175,0,0,1.1573741007194245,0.8708626690017277,LMTK2;TCIRG1;ATP6V1E1;ATP6V0A1,Hypo
2034,GO_Biological_Process_2018,positive regulation of secretion (GO:0051047),2/16,0.47151555614137,0.8867591020728175,0,0,1.3226752713405692,0.9943914811539832,ALOX12B;GPLD1,Hypo
2035,GO_Biological_Process_2018,positive regulation of dendrite morphogenesis (GO:0050775),2/16,0.47151555614137,0.8867591020728175,0,0,1.3226752713405692,0.9943914811539832,CAMK2B;FBXW8,Hypo
2036,GO_Biological_Process_2018,regulation of toll-like receptor 4 signaling pathway (GO:0034143),2/16,0.47151555614137,0.8867591020728175,0,0,1.3226752713405692,0.9943914811539832,DAB2IP;NR1D1,Hypo
2037,GO_Biological_Process_2018,glucose 6-phosphate metabolic process (GO:0051156),2/16,0.47151555614137,0.8867591020728175,0,0,1.3226752713405692,0.9943914811539832,PGM2;DERA,Hypo
2038,GO_Biological_Process_2018,negative regulation of response to wounding (GO:1903035),2/16,0.47151555614137,0.8867591020728175,0,0,1.3226752713405692,0.9943914811539832,PTPRS;AJAP1,Hypo
2039,GO_Biological_Process_2018,regulation of RIG-I signaling pathway (GO:0039535),2/16,0.47151555614137,0.8867591020728175,0,0,1.3226752713405692,0.9943914811539832,NPLOC4;SEC14L1,Hypo
2040,GO_Biological_Process_2018,negative regulation of striated muscle cell differentiation (GO:0051154),2/16,0.47151555614137,0.8867591020728175,0,0,1.3226752713405692,0.9943914811539832,HDAC5;BHLHE41,Hypo
2041,GO_Biological_Process_2018,extracellular matrix assembly (GO:0085029),2/16,0.47151555614137,0.8867591020728175,0,0,1.3226752713405692,0.9943914811539832,FAM234B;GPM6B,Hypo
2042,GO_Biological_Process_2018,heme biosynthetic process (GO:0006783),2/16,0.47151555614137,0.8867591020728175,0,0,1.3226752713405692,0.9943914811539832,ALAD;ALAS1,Hypo
2043,GO_Biological_Process_2018,negative regulation of transcription regulatory region DNA binding (GO:2000678),2/16,0.47151555614137,0.8867591020728175,0,0,1.3226752713405692,0.9943914811539832,PER2;DDIT3,Hypo
2044,GO_Biological_Process_2018,negative regulation of translational initiation (GO:0045947),2/16,0.47151555614137,0.8867591020728175,0,0,1.3226752713405692,0.9943914811539832,AGO2;EIF2AK4,Hypo
2045,GO_Biological_Process_2018,glutamine family amino acid catabolic process (GO:0009065),2/16,0.47151555614137,0.8867591020728175,0,0,1.3226752713405692,0.9943914811539832,GAD1;ASPG,Hypo
2046,GO_Biological_Process_2018,neuron apoptotic process (GO:0051402),2/16,0.47151555614137,0.8867591020728175,0,0,1.3226752713405692,0.9943914811539832,CDK5;CIT,Hypo
2047,GO_Biological_Process_2018,peptidyl-lysine methylation (GO:0018022),2/16,0.47151555614137,0.8867591020728175,0,0,1.3226752713405692,0.9943914811539832,SETD4;SMYD2,Hypo
2048,GO_Biological_Process_2018,rRNA transcription (GO:0009303),2/16,0.47151555614137,0.8867591020728175,0,0,1.3226752713405692,0.9943914811539832,GTF3C1;MARS,Hypo
2049,GO_Biological_Process_2018,regulation of osteoblast proliferation (GO:0033688),2/16,0.47151555614137,0.8867591020728175,0,0,1.3226752713405692,0.9943914811539832,TMEM119;FGFR2,Hypo
2050,GO_Biological_Process_2018,regulation of SMAD protein import into nucleus (GO:0060390),2/16,0.47151555614137,0.8867591020728175,0,0,1.3226752713405692,0.9943914811539832,SMAD3;TGFB3,Hypo
2051,GO_Biological_Process_2018,positive regulation of cyclic nucleotide metabolic process (GO:0030801),2/16,0.47151555614137,0.8867591020728175,0,0,1.3226752713405692,0.9943914811539832,CALM3;RAMP1,Hypo
2052,GO_Biological_Process_2018,genitalia development (GO:0048806),2/16,0.47151555614137,0.8867591020728175,0,0,1.3226752713405692,0.9943914811539832,PTPN11;PKD1,Hypo
2053,GO_Biological_Process_2018,positive regulation of nitric-oxide synthase activity (GO:0051000),2/16,0.47151555614137,0.8867591020728175,0,0,1.3226752713405692,0.9943914811539832,SCARB1;NOS1AP,Hypo
2054,GO_Biological_Process_2018,negative regulation of peptide hormone secretion (GO:0090278),2/16,0.47151555614137,0.8867591020728175,0,0,1.3226752713405692,0.9943914811539832,MIDN;KCNJ11,Hypo
2055,GO_Biological_Process_2018,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),2/16,0.47151555614137,0.8867591020728175,0,0,1.3226752713405692,0.9943914811539832,RHOJ;HDAC7,Hypo
2056,GO_Biological_Process_2018,G-protein coupled acetylcholine receptor signaling pathway (GO:0007213),2/16,0.47151555614137,0.8867591020728175,0,0,1.3226752713405692,0.9943914811539832,GRK2;CHRM4,Hypo
2057,GO_Biological_Process_2018,regulation of stem cell proliferation (GO:0072091),2/16,0.47151555614137,0.8867591020728175,0,0,1.3226752713405692,0.9943914811539832,LRRK2;KDF1,Hypo
2058,GO_Biological_Process_2018,artery development (GO:0060840),2/16,0.47151555614137,0.8867591020728175,0,0,1.3226752713405692,0.9943914811539832,NF1;SMAD7,Hypo
2059,GO_Biological_Process_2018,regulation of necroptotic process (GO:0060544),2/16,0.47151555614137,0.8867591020728175,0,0,1.3226752713405692,0.9943914811539832,ARHGEF2;SLC25A4,Hypo
2060,GO_Biological_Process_2018,protein localization to chromatin (GO:0071168),2/16,0.47151555614137,0.8867591020728175,0,0,1.3226752713405692,0.9943914811539832,H2AFY;LEMD2,Hypo
2061,GO_Biological_Process_2018,embryonic heart tube development (GO:0035050),2/16,0.47151555614137,0.8867591020728175,0,0,1.3226752713405692,0.9943914811539832,RYR2;IFT122,Hypo
2062,GO_Biological_Process_2018,myoblast differentiation (GO:0045445),2/16,0.47151555614137,0.8867591020728175,0,0,1.3226752713405692,0.9943914811539832,MBNL1;EPAS1,Hypo
2063,GO_Biological_Process_2018,linoleic acid metabolic process (GO:0043651),2/16,0.47151555614137,0.8867591020728175,0,0,1.3226752713405692,0.9943914811539832,ALOX12B;ALOXE3,Hypo
2064,GO_Biological_Process_2018,inner dynein arm assembly (GO:0036159),2/16,0.47151555614137,0.8867591020728175,0,0,1.3226752713405692,0.9943914811539832,DNAAF5;CCDC40,Hypo
2065,GO_Biological_Process_2018,negative regulation of lipid storage (GO:0010888),2/16,0.47151555614137,0.8867591020728175,0,0,1.3226752713405692,0.9943914811539832,ABCA1;ABCG1,Hypo
2066,GO_Biological_Process_2018,regulation of interferon-alpha production (GO:0032647),2/16,0.47151555614137,0.8867591020728175,0,0,1.3226752713405692,0.9943914811539832,PTPRS;TBK1,Hypo
2067,GO_Biological_Process_2018,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),2/16,0.47151555614137,0.8867591020728175,0,0,1.3226752713405692,0.9943914811539832,NACC2;ACKR3,Hypo
2068,GO_Biological_Process_2018,neural tube development (GO:0021915),2/16,0.47151555614137,0.8867591020728175,0,0,1.3226752713405692,0.9943914811539832,DVL1;PKD1,Hypo
2069,GO_Biological_Process_2018,positive regulation of cardiac muscle tissue growth (GO:0055023),2/16,0.47151555614137,0.8867591020728175,0,0,1.3226752713405692,0.9943914811539832,AKAP6;FGFR2,Hypo
2070,GO_Biological_Process_2018,regulation of reactive oxygen species biosynthetic process (GO:1903426),2/16,0.47151555614137,0.8867591020728175,0,0,1.3226752713405692,0.9943914811539832,NOS1AP;ADGRB1,Hypo
2071,GO_Biological_Process_2018,negative regulation of steroid biosynthetic process (GO:0010894),2/16,0.47151555614137,0.8867591020728175,0,0,1.3226752713405692,0.9943914811539832,SCAP;ERLIN2,Hypo
2072,GO_Biological_Process_2018,cellular response to lipid (GO:0071396),18/178,0.4719398723992827,0.8867591020728175,0,0,1.0417313664596273,0.7822399275797854,UPF1;RARG;WNT5B;NFKBIL1;TWF2;WNT9B;DAB2IP;ADCY3;RORA;ATP1A2;NR1D1;MAPK14;SBNO2;TNIP1;RARA;ABL2;PTK2B;GPLD1,Hypo
2073,GO_Biological_Process_2018,positive regulation of synapse assembly (GO:0051965),3/26,0.4721712837686765,0.8867591020728175,0,0,1.2076773631674147,0.906257360595516,CLSTN1;EPHB2;EPHB1,Hypo
2074,GO_Biological_Process_2018,response to gamma radiation (GO:0010332),3/26,0.4721712837686765,0.8867591020728175,0,0,1.2076773631674147,0.906257360595516,XRCC6;FANCD2;CRYAB,Hypo
2075,GO_Biological_Process_2018,regulation of transcription regulatory region DNA binding (GO:2000677),3/26,0.4721712837686765,0.8867591020728175,0,0,1.2076773631674147,0.906257360595516,PER2;DOT1L;FAM129B,Hypo
2076,GO_Biological_Process_2018,positive regulation of interferon-beta production (GO:0032728),3/26,0.4721712837686765,0.8867591020728175,0,0,1.2076773631674147,0.906257360595516,TBK1;POLR3B;POLR3G,Hypo
2077,GO_Biological_Process_2018,tRNA methylation (GO:0030488),3/26,0.4721712837686765,0.8867591020728175,0,0,1.2076773631674147,0.906257360595516,TRMT13;TRMT61A;TARBP1,Hypo
2078,GO_Biological_Process_2018,positive regulation of cAMP metabolic process (GO:0030816),3/26,0.4721712837686765,0.8867591020728175,0,0,1.2076773631674147,0.906257360595516,CALM3;RAMP1;RAPGEF3,Hypo
2079,GO_Biological_Process_2018,regulation of muscle contraction (GO:0006937),3/26,0.4721712837686765,0.8867591020728175,0,0,1.2076773631674147,0.906257360595516,ATP1A2;ENO1;PPP1R12B,Hypo
2080,GO_Biological_Process_2018,regulation of histone acetylation (GO:0035065),3/26,0.4721712837686765,0.8867591020728175,0,0,1.2076773631674147,0.906257360595516,PAXIP1;KMT2A;FOXP3,Hypo
2081,GO_Biological_Process_2018,cation transmembrane transport (GO:0098655),3/26,0.4721712837686765,0.8867591020728175,0,0,1.2076773631674147,0.906257360595516,SLC25A29;RHCG;SLC7A1,Hypo
2082,GO_Biological_Process_2018,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),3/26,0.4721712837686765,0.8867591020728175,0,0,1.2076773631674147,0.906257360595516,STN1;TNKS2;SRC,Hypo
2083,GO_Biological_Process_2018,sodium ion homeostasis (GO:0055078),3/26,0.4721712837686765,0.8867591020728175,0,0,1.2076773631674147,0.906257360595516,NEDD4L;ATP1A2;SLC9A1,Hypo
2084,GO_Biological_Process_2018,lipid modification (GO:0030258),3/26,0.4721712837686765,0.8867591020728175,0,0,1.2076773631674147,0.906257360595516,DGKG;DGKZ;DGKI,Hypo
2085,GO_Biological_Process_2018,regulation of centrosome cycle (GO:0046605),3/26,0.4721712837686765,0.8867591020728175,0,0,1.2076773631674147,0.906257360595516,CEP85;MAP9;CHMP5,Hypo
2086,GO_Biological_Process_2018,extracellular matrix organization (GO:0030198),23/229,0.4728515083538879,0.8867591020728175,0,0,1.0338823363445369,0.7743508603717754,FBN2;LAMA5;COL13A1;LAMB3;HTRA1;PDGFA;FURIN;FAM234B;SCUBE1;SH3PXD2A;COL4A2;COL5A1;OPTC;COL4A1;PXDN;TIMP2;COL4A6;NF1;TNR;COL6A3;ITGA6;GPM6B;JAM3,Hypo
2087,GO_Biological_Process_2018,anterograde trans-synaptic signaling (GO:0098916),24/240,0.4797892670961956,0.8867591020728175,0,0,1.0288450444213684,0.755592338353365,OPRD1;GABBR2;GAD1;GRIK4;NRXN2;SLC6A1;HTR5A;GRIN2B;CACNA1E;GRM1;CACNB1;GRM2;CACNB3;CACNB4;DLG3;CDK5;KCNQ2;DLGAP1;MBP;HAP1;BSN;ASIC2;SCN1B;KCNK3,Hypo
2088,GO_Biological_Process_2018,positive regulation of cell motility (GO:2000147),18/179,0.4818151110782147,0.8867591020728175,0,0,1.0352031171636895,0.7558999594887004,PDGFRA;SEMA4A;RIPOR1;SEMA7A;WNT5B;SEMA4D;NTRK3;SEMA4C;PDGFA;PRKCA;FGF1;NTN1;SYNE2;TIAM1;FGFR1OP;PTK2B;ITGA6;BCAR1,Hypo
2089,GO_Biological_Process_2018,positive regulation of endothelial cell proliferation (GO:0001938),7/67,0.4829756833709215,0.8867591020728175,0,0,1.0802024360953852,0.7861594200691003,PPP1R16B;NR4A1;FLT4;VASH2;PRKCA;PRKD2;HMGB1,Hypo
2090,GO_Biological_Process_2018,positive regulation of cytokine production (GO:0001819),22/220,0.4834161584963337,0.8867591020728175,0,0,1.028815122176118,0.7478224451519997,IL33;AFAP1L2;XRCC6;CADM1;NFAM1;FLT4;RORA;HMGB1;PRKCZ;RASGRP1;INAVA;EREG;SULF2;TBK1;POLR3B;DDIT3;RARA;POLR3G;PRKD2;ARHGEF2;IL12RB1;CARD11,Hypo
2091,GO_Biological_Process_2018,positive regulation of protein serine/threonine kinase activity (GO:0071902),12/118,0.4839759966304673,0.8867591020728175,0,0,1.0481920672936502,0.7606939127313067,RPTOR;TENM1;SRC;LRRK2;DAB2IP;PDGFA;RAPGEF2;CALM3;MST1R;FGF1;RASGRP1;PIK3R6,Hypo
2092,GO_Biological_Process_2018,I-kappaB kinase/NF-kappaB signaling (GO:0007249),6/57,0.4858831053893578,0.8867591020728175,0,0,1.0892641007020092,0.7862168939139821,TBK1;NFKBIL1;DAB2IP;RBCK1;MAP3K14;CARD11,Hypo
2093,GO_Biological_Process_2018,regulation of glycolytic process (GO:0006110),6/57,0.4858831053893578,0.8867591020728175,0,0,1.0892641007020092,0.7862168939139821,PFKFB3;NUP188;NUP133;PRKAG1;PRKAG2;CBFA2T3,Hypo
2094,GO_Biological_Process_2018,heart development (GO:0007507),15/149,0.4882903668982261,0.8867591020728175,0,0,1.036445678583825,0.7429709397184285,RARG;TCF25;NTRK3;TSC2;IFT122;ECE1;PTPN11;CACNA1C;PKD1;SCUBE1;MTHFD1;DVL2;NF1;RARA;MEF2D,Hypo
2095,GO_Biological_Process_2018,histone modification (GO:0016570),10/98,0.4891392524943971,0.8867591020728175,0,0,1.0521321462043112,0.7523881780613546,HDAC5;KDM4A;PRMT8;EYA1;TRRAP;EYA2;KAT6A;PADI2;USP51;BAZ1B,Hypo
2096,GO_Biological_Process_2018,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),5/47,0.4891941504791496,0.8867591020728175,0,0,1.1022156934753335,0.7880796274175543,PER1;TNIP1;USP10;DAB2IP;RORA,Hypo
2097,GO_Biological_Process_2018,"positive regulation of gene expression, epigenetic (GO:0045815)",5/47,0.4891941504791496,0.8867591020728175,0,0,1.1022156934753335,0.7880796274175543,H2AFY;PADI2;ERCC6;BAZ1B;ARID1B,Hypo
2098,GO_Biological_Process_2018,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),5/47,0.4891941504791496,0.8867591020728175,0,0,1.1022156934753335,0.7880796274175543,TENM1;TENM2;CADM3;TENM4;CADM1,Hypo
2099,GO_Biological_Process_2018,myofibril assembly (GO:0030239),5/47,0.4891941504791496,0.8867591020728175,0,0,1.1022156934753335,0.7880796274175543,PDGFRA;MYBPC1;OBSCN;TMOD2;LMOD1,Hypo
2100,GO_Biological_Process_2018,regulation of DNA repair (GO:0006282),4/37,0.4930844627796626,0.8867591020728175,0,0,1.1222398704413092,0.7935075269133864,BABAM2;EYA1;EYA2;AXIN2,Hypo
2101,GO_Biological_Process_2018,phospholipid biosynthetic process (GO:0008654),4/37,0.4930844627796626,0.8867591020728175,0,0,1.1222398704413092,0.7935075269133864,AGPAT5;GNPAT;GPAM;AGPAT4,Hypo
2102,GO_Biological_Process_2018,negative regulation of G0 to G1 transition (GO:0070317),4/37,0.4930844627796626,0.8867591020728175,0,0,1.1222398704413092,0.7935075269133864,RAD51;DAB2IP;RBBP7;E2F6,Hypo
2103,GO_Biological_Process_2018,regulation of carbohydrate catabolic process (GO:0043470),4/37,0.4930844627796626,0.8867591020728175,0,0,1.1222398704413092,0.7935075269133864,NUP188;NUP133;PRKAG1;PRKAG2,Hypo
2104,GO_Biological_Process_2018,regulation of regulated secretory pathway (GO:1903305),4/37,0.4930844627796626,0.8867591020728175,0,0,1.1222398704413092,0.7935075269133864,SYT12;RAB15;SYT13;SYT7,Hypo
2105,GO_Biological_Process_2018,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),4/37,0.4930844627796626,0.8867591020728175,0,0,1.1222398704413092,0.7935075269133864,HIP1R;NMT1;DYNLL2;BOK,Hypo
2106,GO_Biological_Process_2018,regulation of macromolecule metabolic process (GO:0060255),13/129,0.4932991543175817,0.8867591020728175,0,0,1.0376070354084703,0.733214101217325,SRPK2;MTMR3;LRP1;SORT1;TOB2;MAPK14;PRDM10;TOB1;SRPK1;SART3;NLRP10;LDLR;TBC1D16,Hypo
2107,GO_Biological_Process_2018,adenylate cyclase-activating G-protein coupled receptor signaling pathway (GO:0007189),8/78,0.4953382584718994,0.8867591020728175,0,0,1.0581138737678388,0.7433402324662646,ABCA1;ADGRD1;ADCY9;GNAS;RAPGEF2;ADCY3;GPR101;RAMP1,Hypo
2108,GO_Biological_Process_2018,sensory perception of mechanical stimulus (GO:0050954),8/78,0.4953382584718994,0.8867591020728175,0,0,1.0581138737678388,0.7433402324662646,SPTBN4;LOXHD1;EYA1;USH1G;KCNQ1;USH1C;CACNA1D;USH2A,Hypo
2109,GO_Biological_Process_2018,regulation of phosphorylation (GO:0042325),12/119,0.4960835651807702,0.8867591020728175,0,0,1.038338011052921,0.727886251443398,CDKN1C;NUP188;DSCAM;NUP133;UQCC2;CCDC88C;PRKAG1;PRKAG2;ITGA6;INHBA;EREG;CORO1C,Hypo
2110,GO_Biological_Process_2018,mRNA polyadenylation (GO:0006378),3/27,0.4978718575851876,0.8867591020728175,0,0,1.1572932717000513,0.8071108507355711,AHCYL1;ZC3H3;SYMPK,Hypo
2111,GO_Biological_Process_2018,phosphatidylinositol phosphorylation (GO:0046854),3/27,0.4978718575851876,0.8867591020728175,0,0,1.1572932717000513,0.8071108507355711,TTC7B;PI4KA;PIK3R1,Hypo
2112,GO_Biological_Process_2018,regulation of double-strand break repair via homologous recombination (GO:0010569),3/27,0.4978718575851876,0.8867591020728175,0,0,1.1572932717000513,0.8071108507355711,RAD51;FIGN;USP51,Hypo
2113,GO_Biological_Process_2018,phagosome acidification (GO:0090383),3/27,0.4978718575851876,0.8867591020728175,0,0,1.1572932717000513,0.8071108507355711,TCIRG1;ATP6V1E1;ATP6V0A1,Hypo
2114,GO_Biological_Process_2018,transcription from RNA polymerase III promoter (GO:0006383),3/27,0.4978718575851876,0.8867591020728175,0,0,1.1572932717000513,0.8071108507355711,GTF3C1;ELL;POLR3G,Hypo
2115,GO_Biological_Process_2018,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),3/27,0.4978718575851876,0.8867591020728175,0,0,1.1572932717000513,0.8071108507355711,BAG3;SORT1;DAB2IP,Hypo
2116,GO_Biological_Process_2018,regulation of vascular endothelial growth factor production (GO:0010574),3/27,0.4978718575851876,0.8867591020728175,0,0,1.1572932717000513,0.8071108507355711,FLT4;RORA;SULF2,Hypo
2117,GO_Biological_Process_2018,negative regulation of organelle assembly (GO:1902116),3/27,0.4978718575851876,0.8867591020728175,0,0,1.1572932717000513,0.8071108507355711,LRRK2;TBC1D30;FEZ2,Hypo
2118,GO_Biological_Process_2018,protein localization to chromosome (GO:0034502),3/27,0.4978718575851876,0.8867591020728175,0,0,1.1572932717000513,0.8071108507355711,PARP3;TNKS2;LEMD2,Hypo
2119,GO_Biological_Process_2018,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),3/27,0.4978718575851876,0.8867591020728175,0,0,1.1572932717000513,0.8071108507355711,SEMA4D;PRKCZ;SRCIN1,Hypo
2120,GO_Biological_Process_2018,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),6/58,0.5032549522455582,0.8867591020728175,0,0,1.0682573599240266,0.7335278617607698,PLXND1;FBXW8;ABL1;FLNA;ARHGEF7;DOCK1,Hypo
2121,GO_Biological_Process_2018,response to light stimulus (GO:0009416),6/58,0.5032549522455582,0.8867591020728175,0,0,1.0682573599240266,0.7335278617607698,PER2;PER1;CRY2;REV1;UBE4B;ERCC6,Hypo
2122,GO_Biological_Process_2018,regulation of multicellular organism growth (GO:0040014),2/17,0.5041774256696413,0.8867591020728175,0,0,1.234428473648186,0.8453699949866341,PPIB;FGFR2,Hypo
2123,GO_Biological_Process_2018,high-density lipoprotein particle remodeling (GO:0034375),2/17,0.5041774256696413,0.8867591020728175,0,0,1.234428473648186,0.8453699949866341,SCARB1;ABCG1,Hypo
2124,GO_Biological_Process_2018,positive regulation of cholesterol transport (GO:0032376),2/17,0.5041774256696413,0.8867591020728175,0,0,1.234428473648186,0.8453699949866341,ABCA1;LRP1,Hypo
2125,GO_Biological_Process_2018,regulation of tissue remodeling (GO:0034103),2/17,0.5041774256696413,0.8867591020728175,0,0,1.234428473648186,0.8453699949866341,FLT4;SYT7,Hypo
2126,GO_Biological_Process_2018,cellular response to gamma radiation (GO:0071480),2/17,0.5041774256696413,0.8867591020728175,0,0,1.234428473648186,0.8453699949866341,XRCC6;CRYAB,Hypo
2127,GO_Biological_Process_2018,positive regulation of fatty acid metabolic process (GO:0045923),2/17,0.5041774256696413,0.8867591020728175,0,0,1.234428473648186,0.8453699949866341,MID1IP1;MLYCD,Hypo
2128,GO_Biological_Process_2018,DNA packaging (GO:0006323),2/17,0.5041774256696413,0.8867591020728175,0,0,1.234428473648186,0.8453699949866341,KAT6A;ASH1L,Hypo
2129,GO_Biological_Process_2018,negative regulation of lipid biosynthetic process (GO:0051055),2/17,0.5041774256696413,0.8867591020728175,0,0,1.234428473648186,0.8453699949866341,ACADL;ERLIN2,Hypo
2130,GO_Biological_Process_2018,N-glycan processing (GO:0006491),2/17,0.5041774256696413,0.8867591020728175,0,0,1.234428473648186,0.8453699949866341,MGAT4A;MAN1C1,Hypo
2131,GO_Biological_Process_2018,negative regulation of intracellular transport (GO:0032387),2/17,0.5041774256696413,0.8867591020728175,0,0,1.234428473648186,0.8453699949866341,SLC25A5;CRYAB,Hypo
2132,GO_Biological_Process_2018,positive regulation of cellular protein catabolic process (GO:1903364),2/17,0.5041774256696413,0.8867591020728175,0,0,1.234428473648186,0.8453699949866341,UQCC2;VPS11,Hypo
2133,GO_Biological_Process_2018,negative regulation of cellular carbohydrate metabolic process (GO:0010677),2/17,0.5041774256696413,0.8867591020728175,0,0,1.234428473648186,0.8453699949866341,CBFA2T3;SOGA1,Hypo
2134,GO_Biological_Process_2018,negative regulation of phosphoprotein phosphatase activity (GO:0032515),2/17,0.5041774256696413,0.8867591020728175,0,0,1.234428473648186,0.8453699949866341,PPP1R1B;CRY2,Hypo
2135,GO_Biological_Process_2018,3'-UTR-mediated mRNA stabilization (GO:0070935),2/17,0.5041774256696413,0.8867591020728175,0,0,1.234428473648186,0.8453699949866341,MAPKAPK2;MAPK14,Hypo
2136,GO_Biological_Process_2018,embryo development ending in birth or egg hatching (GO:0009792),2/17,0.5041774256696413,0.8867591020728175,0,0,1.234428473648186,0.8453699949866341,SCEL;CELF4,Hypo
2137,GO_Biological_Process_2018,phospholipid catabolic process (GO:0009395),2/17,0.5041774256696413,0.8867591020728175,0,0,1.234428473648186,0.8453699949866341,SMPD4;ENPP6,Hypo
2138,GO_Biological_Process_2018,nucleotide catabolic process (GO:0009166),2/17,0.5041774256696413,0.8867591020728175,0,0,1.234428473648186,0.8453699949866341,NUDT3;DERA,Hypo
2139,GO_Biological_Process_2018,positive regulation by host of viral transcription (GO:0043923),2/17,0.5041774256696413,0.8867591020728175,0,0,1.234428473648186,0.8453699949866341,CTDP1;SMARCA4,Hypo
2140,GO_Biological_Process_2018,positive regulation of telomere capping (GO:1904355),2/17,0.5041774256696413,0.8867591020728175,0,0,1.234428473648186,0.8453699949866341,TNKS2;MAP3K4,Hypo
2141,GO_Biological_Process_2018,detection of mechanical stimulus (GO:0050982),2/17,0.5041774256696413,0.8867591020728175,0,0,1.234428473648186,0.8453699949866341,LOXHD1;PKD1,Hypo
2142,GO_Biological_Process_2018,mesonephric tubule development (GO:0072164),2/17,0.5041774256696413,0.8867591020728175,0,0,1.234428473648186,0.8453699949866341,PKD1;FGFR2,Hypo
2143,GO_Biological_Process_2018,positive regulation of cartilage development (GO:0061036),2/17,0.5041774256696413,0.8867591020728175,0,0,1.234428473648186,0.8453699949866341,ZBTB16;SOX5,Hypo
2144,GO_Biological_Process_2018,regulation of early endosome to late endosome transport (GO:2000641),2/17,0.5041774256696413,0.8867591020728175,0,0,1.234428473648186,0.8453699949866341,SRC;VPS11,Hypo
2145,GO_Biological_Process_2018,nucleobase-containing compound biosynthetic process (GO:0034654),2/17,0.5041774256696413,0.8867591020728175,0,0,1.234428473648186,0.8453699949866341,DGUOK;AMPD3,Hypo
2146,GO_Biological_Process_2018,positive regulation of natural killer cell mediated immunity (GO:0002717),2/17,0.5041774256696413,0.8867591020728175,0,0,1.234428473648186,0.8453699949866341,CADM1;RASGRP1,Hypo
2147,GO_Biological_Process_2018,mitotic G2 DNA damage checkpoint (GO:0007095),2/17,0.5041774256696413,0.8867591020728175,0,0,1.234428473648186,0.8453699949866341,FOXN3;CLSPN,Hypo
2148,GO_Biological_Process_2018,positive regulation of protein processing (GO:0010954),2/17,0.5041774256696413,0.8867591020728175,0,0,1.234428473648186,0.8453699949866341,MYH9;ENO1,Hypo
2149,GO_Biological_Process_2018,positive regulation of focal adhesion assembly (GO:0051894),2/17,0.5041774256696413,0.8867591020728175,0,0,1.234428473648186,0.8453699949866341,ABL1;PPM1F,Hypo
2150,GO_Biological_Process_2018,2-oxoglutarate metabolic process (GO:0006103),2/17,0.5041774256696413,0.8867591020728175,0,0,1.234428473648186,0.8453699949866341,GPT2;IDH2,Hypo
2151,GO_Biological_Process_2018,positive regulation of chemotaxis (GO:0050921),5/48,0.5082972096897277,0.8867591020728175,0,0,1.076522986787828,0.7284712031634633,P2RX4;NTRK3;PRKD2;STX3;PPM1F,Hypo
2152,GO_Biological_Process_2018,cellular macromolecule catabolic process (GO:0044265),5/48,0.5082972096897277,0.8867591020728175,0,0,1.076522986787828,0.7284712031634633,NEU4;PABPC4;DAB2IP;DENND3;SND1,Hypo
2153,GO_Biological_Process_2018,negative regulation of mitotic cell cycle (GO:0045930),5/48,0.5082972096897277,0.8867591020728175,0,0,1.076522986787828,0.7284712031634633,SMAD3;BCL6;DUSP1;E4F1;MCPH1,Hypo
2154,GO_Biological_Process_2018,cation transport (GO:0006812),8/79,0.5101833446749439,0.8867591020728175,0,0,1.0431528408349169,0.7020263382086809,PANX1;PANX2;SLC25A29;P2RX4;SLC6A17;RHCG;ASIC2;SLC15A4,Hypo
2155,GO_Biological_Process_2018,regulation of endothelial cell proliferation (GO:0001936),8/79,0.5101833446749439,0.8867591020728175,0,0,1.0431528408349169,0.7020263382086809,PPP1R16B;NR4A1;FLT4;VASH2;NF1;PRKCA;PRKD2;VASH1,Hypo
2156,GO_Biological_Process_2018,ATP hydrolysis coupled proton transport (GO:0015991),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,ATP1A2,Hypo
2157,GO_Biological_Process_2018,phosphate ion transmembrane transport (GO:0035435),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,SLC37A1,Hypo
2158,GO_Biological_Process_2018,AV node cell action potential (GO:0086016),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,CACNA1C,Hypo
2159,GO_Biological_Process_2018,hemostasis (GO:0007599),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,HPS4,Hypo
2160,GO_Biological_Process_2018,regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,CAMK2A,Hypo
2161,GO_Biological_Process_2018,ribonucleoside bisphosphate biosynthetic process (GO:0034030),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,ACOT7,Hypo
2162,GO_Biological_Process_2018,positive regulation of protein kinase C signaling (GO:0090037),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,FLT4,Hypo
2163,GO_Biological_Process_2018,transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,NUP133,Hypo
2164,GO_Biological_Process_2018,sequestering of extracellular ligand from receptor (GO:0035581),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,FBN2,Hypo
2165,GO_Biological_Process_2018,miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,AGO2,Hypo
2166,GO_Biological_Process_2018,positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903589),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,PPP1R16B,Hypo
2167,GO_Biological_Process_2018,negative regulation of synapse organization (GO:1905809),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,SLIT1,Hypo
2168,GO_Biological_Process_2018,regulation of sterol transport (GO:0032371),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,LRP1,Hypo
2169,GO_Biological_Process_2018,molybdopterin cofactor metabolic process (GO:0043545),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,MOCOS,Hypo
2170,GO_Biological_Process_2018,AMP metabolic process (GO:0046033),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,AMPD3,Hypo
2171,GO_Biological_Process_2018,negative regulation of dendrite morphogenesis (GO:0050774),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,RAPGEF2,Hypo
2172,GO_Biological_Process_2018,gas homeostasis (GO:0033483),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,EGLN1,Hypo
2173,GO_Biological_Process_2018,strand invasion (GO:0042148),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,RAD51,Hypo
2174,GO_Biological_Process_2018,positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle (GO:0031659),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,PKD1,Hypo
2175,GO_Biological_Process_2018,regulation of isotype switching (GO:0045191),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,PAXIP1,Hypo
2176,GO_Biological_Process_2018,box C/D snoRNP assembly (GO:0000492),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,NUFIP1,Hypo
2177,GO_Biological_Process_2018,carnitine transport (GO:0015879),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,PDZK1,Hypo
2178,GO_Biological_Process_2018,amino-acid betaine transport (GO:0015838),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,PDZK1,Hypo
2179,GO_Biological_Process_2018,regulation of response to biotic stimulus (GO:0002831),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,TRIM5,Hypo
2180,GO_Biological_Process_2018,L-cysteine metabolic process (GO:0046439),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,AHCYL1,Hypo
2181,GO_Biological_Process_2018,regulation of memory T cell differentiation (GO:0043380),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,IL12RB1,Hypo
2182,GO_Biological_Process_2018,positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,UBQLN2,Hypo
2183,GO_Biological_Process_2018,establishment of protein localization to peroxisome (GO:0072663),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,PEX1,Hypo
2184,GO_Biological_Process_2018,pituitary gland development (GO:0021983),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,SOX3,Hypo
2185,GO_Biological_Process_2018,vascular endothelial growth factor signaling pathway (GO:0038084),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,FLT4,Hypo
2186,GO_Biological_Process_2018,positive regulation of macrophage migration (GO:1905523),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,CMKLR1,Hypo
2187,GO_Biological_Process_2018,regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,SCAP,Hypo
2188,GO_Biological_Process_2018,regulation of histone H3-K9 acetylation (GO:2000615),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,KMT2A,Hypo
2189,GO_Biological_Process_2018,protein localization to cytoplasmic stress granule (GO:1903608),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,DCP1A,Hypo
2190,GO_Biological_Process_2018,cellular lipid biosynthetic process (GO:0097384),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,GNPAT,Hypo
2191,GO_Biological_Process_2018,regulation of high voltage-gated calcium channel activity (GO:1901841),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,NOS1AP,Hypo
2192,GO_Biological_Process_2018,modification by symbiont of host morphology or physiology (GO:0044003),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,RXRA,Hypo
2193,GO_Biological_Process_2018,negative regulation of macrophage activation (GO:0043031),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,LDLR,Hypo
2194,GO_Biological_Process_2018,tRNA transcription (GO:0009304),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,GTF3C1,Hypo
2195,GO_Biological_Process_2018,regulation of dendritic cell differentiation (GO:2001198),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,HMGB1,Hypo
2196,GO_Biological_Process_2018,negative regulation of alpha-beta T cell activation (GO:0046636),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,TWSG1,Hypo
2197,GO_Biological_Process_2018,positive regulation of fatty acid beta-oxidation (GO:0032000),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,IRS2,Hypo
2198,GO_Biological_Process_2018,positive regulation of striated muscle contraction (GO:0045989),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,KCNQ1,Hypo
2199,GO_Biological_Process_2018,auditory receptor cell differentiation (GO:0042491),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,USH1C,Hypo
2200,GO_Biological_Process_2018,negative regulation of axon regeneration (GO:0048681),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,PTPRS,Hypo
2201,GO_Biological_Process_2018,V(D)J recombination (GO:0033151),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,HMGB1,Hypo
2202,GO_Biological_Process_2018,activation of signaling protein activity involved in unfolded protein response (GO:0006987),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,DAB2IP,Hypo
2203,GO_Biological_Process_2018,positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,PRKD2,Hypo
2204,GO_Biological_Process_2018,cellular response to histamine (GO:0071420),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,DIAPH1,Hypo
2205,GO_Biological_Process_2018,negative regulation of transporter activity (GO:0032410),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,CTTNBP2NL,Hypo
2206,GO_Biological_Process_2018,"wound healing, spreading of epidermal cells (GO:0035313)",1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,COL5A1,Hypo
2207,GO_Biological_Process_2018,mannose metabolic process (GO:0006013),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,PMM1,Hypo
2208,GO_Biological_Process_2018,positive regulation of insulin receptor signaling pathway (GO:0046628),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,PRKCZ,Hypo
2209,GO_Biological_Process_2018,activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,BOK,Hypo
2210,GO_Biological_Process_2018,regulation of anion transport (GO:0044070),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,PDZK1,Hypo
2211,GO_Biological_Process_2018,adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,GNAS,Hypo
2212,GO_Biological_Process_2018,tetrahydrofolate interconversion (GO:0035999),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,MTHFD1,Hypo
2213,GO_Biological_Process_2018,molybdopterin cofactor biosynthetic process (GO:0032324),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,MOCOS,Hypo
2214,GO_Biological_Process_2018,purine nucleoside bisphosphate biosynthetic process (GO:0034033),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,ACOT7,Hypo
2215,GO_Biological_Process_2018,positive regulation of isomerase activity (GO:0010912),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,SETMAR,Hypo
2216,GO_Biological_Process_2018,SA node cell action potential (GO:0086015),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,CACNA1D,Hypo
2217,GO_Biological_Process_2018,positive regulation of membrane depolarization (GO:1904181),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,ANK3,Hypo
2218,GO_Biological_Process_2018,lens fiber cell differentiation (GO:0070306),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,WNT5B,Hypo
2219,GO_Biological_Process_2018,regulation of protein deubiquitination (GO:0090085),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,TNIP1,Hypo
2220,GO_Biological_Process_2018,regulation of microtubule binding (GO:1904526),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,ABL1,Hypo
2221,GO_Biological_Process_2018,tooth mineralization (GO:0034505),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,FAM20A,Hypo
2222,GO_Biological_Process_2018,regulation of cell projection organization (GO:0031344),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,SEMA4D,Hypo
2223,GO_Biological_Process_2018,regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,DDIT3,Hypo
2224,GO_Biological_Process_2018,positive regulation of macrophage chemotaxis (GO:0010759),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,CMKLR1,Hypo
2225,GO_Biological_Process_2018,regulation of microglial cell activation (GO:1903978),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,LDLR,Hypo
2226,GO_Biological_Process_2018,cleavage furrow formation (GO:0036089),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,SPIRE1,Hypo
2227,GO_Biological_Process_2018,outer mitochondrial membrane organization (GO:0007008),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,SAMM50,Hypo
2228,GO_Biological_Process_2018,regulation of skeletal muscle fiber development (GO:0048742),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,FAM129B,Hypo
2229,GO_Biological_Process_2018,kidney epithelium development (GO:0072073),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,FGF1,Hypo
2230,GO_Biological_Process_2018,regulation of glycogen (starch) synthase activity (GO:2000465),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,PPP1R3F,Hypo
2231,GO_Biological_Process_2018,sensory organ morphogenesis (GO:0090596),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,COL5A1,Hypo
2232,GO_Biological_Process_2018,amino acid import across plasma membrane (GO:0089718),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,SLC7A1,Hypo
2233,GO_Biological_Process_2018,excitatory chemical synaptic transmission (GO:0098976),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,GRIN2B,Hypo
2234,GO_Biological_Process_2018,glyoxylate metabolic process (GO:0046487),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,HOGA1,Hypo
2235,GO_Biological_Process_2018,myoblast fusion (GO:0007520),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,KCNH1,Hypo
2236,GO_Biological_Process_2018,chylomicron remnant clearance (GO:0034382),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,LDLR,Hypo
2237,GO_Biological_Process_2018,regulation of protein heterodimerization activity (GO:0043497),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,DAB2IP,Hypo
2238,GO_Biological_Process_2018,T-helper 1 type immune response (GO:0042088),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,HMGB1,Hypo
2239,GO_Biological_Process_2018,detection of molecule of bacterial origin (GO:0032490),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,SCARB1,Hypo
2240,GO_Biological_Process_2018,metanephric nephron tubule development (GO:0072234),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,PKD1,Hypo
2241,GO_Biological_Process_2018,cellular response to cholesterol (GO:0071397),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,GPLD1,Hypo
2242,GO_Biological_Process_2018,calcitonin family receptor signaling pathway (GO:0097646),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,RAMP1,Hypo
2243,GO_Biological_Process_2018,marginal zone B cell differentiation (GO:0002315),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,PTK2B,Hypo
2244,GO_Biological_Process_2018,membrane invagination (GO:0010324),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,SMURF1,Hypo
2245,GO_Biological_Process_2018,microglial cell activation (GO:0001774),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,MAPT,Hypo
2246,GO_Biological_Process_2018,positive regulation of neurological system process (GO:0031646),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,TENM4,Hypo
2247,GO_Biological_Process_2018,positive regulation of gastrulation (GO:2000543),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,TENM4,Hypo
2248,GO_Biological_Process_2018,positive regulation of multicellular organism growth (GO:0040018),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,PPIB,Hypo
2249,GO_Biological_Process_2018,regulation of cyclic nucleotide metabolic process (GO:0030799),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,CALM3,Hypo
2250,GO_Biological_Process_2018,"substrate-dependent cell migration, cell extension (GO:0006930)",1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,NTN1,Hypo
2251,GO_Biological_Process_2018,inner ear receptor stereocilium organization (GO:0060122),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,USH1C,Hypo
2252,GO_Biological_Process_2018,positive regulation of keratinocyte proliferation (GO:0010838),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,STXBP4,Hypo
2253,GO_Biological_Process_2018,cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,CTNNA3,Hypo
2254,GO_Biological_Process_2018,negative regulation of muscle hypertrophy (GO:0014741),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,P2RX4,Hypo
2255,GO_Biological_Process_2018,negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901029),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,SLC25A5,Hypo
2256,GO_Biological_Process_2018,positive regulation of dendritic spine morphogenesis (GO:0061003),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,CAMK2B,Hypo
2257,GO_Biological_Process_2018,coenzyme A biosynthetic process (GO:0015937),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,ACOT7,Hypo
2258,GO_Biological_Process_2018,regulation of interleukin-13 production (GO:0032656),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,RARA,Hypo
2259,GO_Biological_Process_2018,ATP hydrolysis coupled cation transmembrane transport (GO:0099132),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,ATP1A2,Hypo
2260,GO_Biological_Process_2018,progesterone receptor signaling pathway (GO:0050847),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,SRC,Hypo
2261,GO_Biological_Process_2018,positive regulation of lipid transport (GO:0032370),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,LRP1,Hypo
2262,GO_Biological_Process_2018,brown fat cell differentiation (GO:0050873),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,PRDM16,Hypo
2263,GO_Biological_Process_2018,regulation of endocytic recycling (GO:2001135),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,SORL1,Hypo
2264,GO_Biological_Process_2018,tachykinin receptor signaling pathway (GO:0007217),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,GRK2,Hypo
2265,GO_Biological_Process_2018,regulation of extracellular matrix organization (GO:1903053),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,LRP1,Hypo
2266,GO_Biological_Process_2018,regulation of cardiac muscle cell membrane potential (GO:0086036),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,SLC9A1,Hypo
2267,GO_Biological_Process_2018,regulation of lymphocyte migration (GO:2000401),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,STK10,Hypo
2268,GO_Biological_Process_2018,regulation of endothelial cell chemotaxis to fibroblast growth factor (GO:2000544),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,FGF1,Hypo
2269,GO_Biological_Process_2018,protein localization to ciliary membrane (GO:1903441),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,TUB,Hypo
2270,GO_Biological_Process_2018,melanocyte differentiation (GO:0030318),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,KIT,Hypo
2271,GO_Biological_Process_2018,ribosomal protein import into nucleus (GO:0006610),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,TNPO1,Hypo
2272,GO_Biological_Process_2018,leukocyte aggregation (GO:0070486),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,SEMA4D,Hypo
2273,GO_Biological_Process_2018,nucleic acid transport (GO:0050657),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,ATXN2,Hypo
2274,GO_Biological_Process_2018,nuclear body organization (GO:0030575),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,SRPK2,Hypo
2275,GO_Biological_Process_2018,positive regulation of autophagy of mitochondrion (GO:1903599),1/7,0.512379719806482,0.8867591020728175,0,0,1.543013511202326,1.0317966070672226,CAMKK2,Hypo
2276,GO_Biological_Process_2018,regulation of cellular pH (GO:0030641),4/38,0.5145664997754792,0.8895426703066236,0,0,1.0891723595913183,0.7236793145529342,SLC9A6;SLC9A8;SLC4A1;SLC9A1,Hypo
2277,GO_Biological_Process_2018,positive regulation of DNA repair (GO:0045739),4/38,0.5145664997754792,0.8895426703066236,0,0,1.0891723595913183,0.7236793145529342,BABAM2;EYA1;EYA2;HMGB1,Hypo
2278,GO_Biological_Process_2018,positive regulation of neurogenesis (GO:0050769),7/69,0.5148914161713891,0.8895426703066236,0,0,1.0452409808576697,0.693830171777366,SPEN;RGS14;DAB2IP;RAPGEF2;TCF4;ARHGEF2;SHANK3,Hypo
2279,GO_Biological_Process_2018,regulation of innate immune response (GO:0045088),7/69,0.5148914161713891,0.8895426703066236,0,0,1.0452409808576697,0.693830171777366,RNASEL;POLR3B;TYRO3;TRAFD1;POLR3G;PTPN11;EREG,Hypo
2280,GO_Biological_Process_2018,positive regulation of response to external stimulus (GO:0032103),9/90,0.5199444027157927,0.8919577146220279,0,0,1.0286221306314045,0.6727532201308749,IL33;TNIP1;NLRP10;PDE2A;PRKCA;STX3;F2;PPM1F;SASH1,Hypo
2281,GO_Biological_Process_2018,cell junction assembly (GO:0034329),6/59,0.52041243781038,0.8919577146220279,0,0,1.0480433263452131,0.6845123443846025,TJP1;CDH22;FLNA;ITGA6;PIP5K1C;SMAD7,Hypo
2282,GO_Biological_Process_2018,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),3/28,0.5229227167826643,0.8919577146220279,0,0,1.110939907550077,0.7202463326944146,PER1;CRY2;SMARCA4,Hypo
2283,GO_Biological_Process_2018,hydrogen ion transmembrane transport (GO:1902600),3/28,0.5229227167826643,0.8919577146220279,0,0,1.110939907550077,0.7202463326944146,TCIRG1;ATP6V1E1;SLC9A1,Hypo
2284,GO_Biological_Process_2018,negative regulation of homeostatic process (GO:0032845),3/28,0.5229227167826643,0.8919577146220279,0,0,1.110939907550077,0.7202463326944146,EPO;TSC22D3;ERCC1,Hypo
2285,GO_Biological_Process_2018,cellular amino acid biosynthetic process (GO:0008652),3/28,0.5229227167826643,0.8919577146220279,0,0,1.110939907550077,0.7202463326944146,GPT2;ASPG;NAT8L,Hypo
2286,GO_Biological_Process_2018,positive regulation of phospholipid metabolic process (GO:1903727),3/28,0.5229227167826643,0.8919577146220279,0,0,1.110939907550077,0.7202463326944146,PDGFRA;KIT;PTK2B,Hypo
2287,GO_Biological_Process_2018,production of miRNAs involved in gene silencing by miRNA (GO:0035196),3/28,0.5229227167826643,0.8919577146220279,0,0,1.110939907550077,0.7202463326944146,SMAD3;AGO2;DROSHA,Hypo
2288,GO_Biological_Process_2018,cGMP metabolic process (GO:0046068),3/28,0.5229227167826643,0.8919577146220279,0,0,1.110939907550077,0.7202463326944146,ADCY9;PDE2A;ADCY3,Hypo
2289,GO_Biological_Process_2018,protein K63-linked deubiquitination (GO:0070536),3/28,0.5229227167826643,0.8919577146220279,0,0,1.110939907550077,0.7202463326944146,BABAM2;USP27X;STAMBPL1,Hypo
2290,GO_Biological_Process_2018,regulation of cell morphogenesis (GO:0022604),3/28,0.5229227167826643,0.8919577146220279,0,0,1.110939907550077,0.7202463326944146,ZMYM1;CAPZB;BCL9L,Hypo
2291,GO_Biological_Process_2018,positive regulation of fibroblast proliferation (GO:0048146),3/28,0.5229227167826643,0.8919577146220279,0,0,1.110939907550077,0.7202463326944146,PDGFRA;PDGFA;EREG,Hypo
2292,GO_Biological_Process_2018,RNA polyadenylation (GO:0043631),3/28,0.5229227167826643,0.8919577146220279,0,0,1.110939907550077,0.7202463326944146,AHCYL1;ZC3H3;SYMPK,Hypo
2293,GO_Biological_Process_2018,positive regulation of phosphate metabolic process (GO:0045937),3/28,0.5229227167826643,0.8919577146220279,0,0,1.110939907550077,0.7202463326944146,DSCAM;ITGA6;EREG,Hypo
2294,GO_Biological_Process_2018,positive regulation of macromolecule biosynthetic process (GO:0010557),14/142,0.5240012250273868,0.8919577146220279,0,0,1.0125096849173554,0.6543457815224818,PDGFRA;STN1;EPO;TGFB3;PDGFA;IRS2;SORBS1;F2;MTOR;EREG;CREB3L1;RAB3GAP2;PRKD2;CPEB3,Hypo
2295,GO_Biological_Process_2018,regulation of protein serine/threonine kinase activity (GO:0071900),8/80,0.5248838312369841,0.8919577146220279,0,0,1.0286073921501315,0.6630180193298616,RPTOR;H2AFY;SRC;BCCIP;ABL1;DAB2IP;CALM3;TRIB1,Hypo
2296,GO_Biological_Process_2018,spindle assembly (GO:0051225),8/80,0.5248838312369841,0.8919577146220279,0,0,1.0286073921501315,0.6630180193298616,GOLGA2;ARHGEF10;NUMA1;BCCIP;FLNA;TUBGCP6;CLASP1;MAP9,Hypo
2297,GO_Biological_Process_2018,cilium movement (GO:0003341),5/49,0.5271053736892358,0.8919577146220279,0,0,1.0519981304043,0.6736520527674852,DNAH17;CFAP46;DNAAF5;WDR78;CCDC40,Hypo
2298,GO_Biological_Process_2018,regulation of release of sequestered calcium ion into cytosol (GO:0051279),5/49,0.5271053736892358,0.8919577146220279,0,0,1.0519981304043,0.6736520527674852,DIAPH1;PTK2B;AKAP6;CALM3;F2,Hypo
2299,GO_Biological_Process_2018,calcium-mediated signaling (GO:0019722),7/70,0.5305848573999832,0.8919577146220279,0,0,1.0285926688397096,0.6518967057751874,RYR2;LRRK2;CACNA1C;PPP1R9A;PPP1R9B;SLC9A1;CAMKK2,Hypo
2300,GO_Biological_Process_2018,anion transmembrane transport (GO:0098656),2/18,0.5354976898191676,0.8919577146220279,0,0,1.157212525667351,0.7227471543191993,SLC13A3;LRRC8D,Hypo
2301,GO_Biological_Process_2018,positive regulation of cyclic nucleotide biosynthetic process (GO:0030804),2/18,0.5354976898191676,0.8919577146220279,0,0,1.157212525667351,0.7227471543191993,CALM3;RAMP1,Hypo
2302,GO_Biological_Process_2018,negative regulation of fibroblast proliferation (GO:0048147),2/18,0.5354976898191676,0.8919577146220279,0,0,1.157212525667351,0.7227471543191993,DAB2IP;NF1,Hypo
2303,GO_Biological_Process_2018,regulation of mitochondrial membrane permeability (GO:0046902),2/18,0.5354976898191676,0.8919577146220279,0,0,1.157212525667351,0.7227471543191993,CAMK2A;SLC25A4,Hypo
2304,GO_Biological_Process_2018,establishment of mitotic spindle localization (GO:0040001),2/18,0.5354976898191676,0.8919577146220279,0,0,1.157212525667351,0.7227471543191993,NUMA1;CLASP1,Hypo
2305,GO_Biological_Process_2018,establishment or maintenance of apical/basal cell polarity (GO:0035088),2/18,0.5354976898191676,0.8919577146220279,0,0,1.157212525667351,0.7227471543191993,DLG3;MARK2,Hypo
2306,GO_Biological_Process_2018,negative regulation of RNA splicing (GO:0033119),2/18,0.5354976898191676,0.8919577146220279,0,0,1.157212525667351,0.7227471543191993,SFSWAP;SRSF4,Hypo
2307,GO_Biological_Process_2018,anion homeostasis (GO:0055081),2/18,0.5354976898191676,0.8919577146220279,0,0,1.157212525667351,0.7227471543191993,ABCA1;ABCG1,Hypo
2308,GO_Biological_Process_2018,modulation by virus of host morphology or physiology (GO:0019048),2/18,0.5354976898191676,0.8919577146220279,0,0,1.157212525667351,0.7227471543191993,SMAD3;RXRA,Hypo
2309,GO_Biological_Process_2018,insulin secretion (GO:0030073),2/18,0.5354976898191676,0.8919577146220279,0,0,1.157212525667351,0.7227471543191993,CAMK2G;RAB11FIP5,Hypo
2310,GO_Biological_Process_2018,regulation of cholesterol efflux (GO:0010874),2/18,0.5354976898191676,0.8919577146220279,0,0,1.157212525667351,0.7227471543191993,ABCA1;LRP1,Hypo
2311,GO_Biological_Process_2018,tRNA metabolic process (GO:0006399),2/18,0.5354976898191676,0.8919577146220279,0,0,1.157212525667351,0.7227471543191993,GTF3C1;ADAT1,Hypo
2312,GO_Biological_Process_2018,positive regulation of p38MAPK cascade (GO:1900745),2/18,0.5354976898191676,0.8919577146220279,0,0,1.157212525667351,0.7227471543191993,MAP3K4;SASH1,Hypo
2313,GO_Biological_Process_2018,regulation of peptidase activity (GO:0052547),2/18,0.5354976898191676,0.8919577146220279,0,0,1.157212525667351,0.7227471543191993,FURIN;ATP13A2,Hypo
2314,GO_Biological_Process_2018,glyceraldehyde-3-phosphate metabolic process (GO:0019682),2/18,0.5354976898191676,0.8919577146220279,0,0,1.157212525667351,0.7227471543191993,PGM2;DERA,Hypo
2315,GO_Biological_Process_2018,response to organophosphorus (GO:0046683),2/18,0.5354976898191676,0.8919577146220279,0,0,1.157212525667351,0.7227471543191993,P2RX4;KCNJ11,Hypo
2316,GO_Biological_Process_2018,porphyrin-containing compound biosynthetic process (GO:0006779),2/18,0.5354976898191676,0.8919577146220279,0,0,1.157212525667351,0.7227471543191993,ALAD;ALAS1,Hypo
2317,GO_Biological_Process_2018,maintenance of protein localization in organelle (GO:0072595),2/18,0.5354976898191676,0.8919577146220279,0,0,1.157212525667351,0.7227471543191993,BBS4;HK1,Hypo
2318,GO_Biological_Process_2018,signal transduction by p53 class mediator (GO:0072331),4/39,0.5356161712298375,0.8919577146220279,0,0,1.0579944207898988,0.6605455630014396,PAXIP1;USP10;PDK2;BOK,Hypo
2319,GO_Biological_Process_2018,regulation of proteasomal protein catabolic process (GO:0061136),4/39,0.5356161712298375,0.8919577146220279,0,0,1.0579944207898988,0.6605455630014396,ALAD;RHBDF1;DAB2IP;PKD1,Hypo
2320,GO_Biological_Process_2018,regulation of G0 to G1 transition (GO:0070316),4/39,0.5356161712298375,0.8919577146220279,0,0,1.0579944207898988,0.6605455630014396,RAD51;DAB2IP;RBBP7;E2F6,Hypo
2321,GO_Biological_Process_2018,DNA replication-independent nucleosome assembly (GO:0006336),4/39,0.5356161712298375,0.8919577146220279,0,0,1.0579944207898988,0.6605455630014396,CENPI;UBN1;RBBP7;CABIN1,Hypo
2322,GO_Biological_Process_2018,acyl-CoA metabolic process (GO:0006637),4/39,0.5356161712298375,0.8919577146220279,0,0,1.0579944207898988,0.6605455630014396,ACOT7;ACSL6;MLYCD;ACACB,Hypo
2323,GO_Biological_Process_2018,regulation of coenzyme metabolic process (GO:0051196),4/39,0.5356161712298375,0.8919577146220279,0,0,1.0579944207898988,0.6605455630014396,NUP188;NUP133;PRKAG1;PRKAG2,Hypo
2324,GO_Biological_Process_2018,myeloid leukocyte differentiation (GO:0002573),5/50,0.5455888022037334,0.8919577146220279,0,0,1.0285632676378178,0.6231958860432962,SBNO2;KIT;MYH9;MAPK14;CBFA2T3,Hypo
2325,GO_Biological_Process_2018,negative regulation of protein ubiquitination (GO:0031397),5/50,0.5455888022037334,0.8919577146220279,0,0,1.0285632676378178,0.6231958860432962,PER2;USP4;ADGRB1;ABL1;SMAD7,Hypo
2326,GO_Biological_Process_2018,negative regulation of viral genome replication (GO:0045071),5/50,0.5455888022037334,0.8919577146220279,0,0,1.0285632676378178,0.6231958860432962,SRPK2;RNASEL;TNIP1;EIF2AK4;SRPK1,Hypo
2327,GO_Biological_Process_2018,cellular protein complex assembly (GO:0043623),14/144,0.5458465166492897,0.8919577146220279,0,0,0.996821360457724,0.6034930439534527,AHCTF1;SEPT11;SMAD3;HIP1;GPX4;SRC;MID1IP1;PXN;HIP1R;SEPT8;SEPT9;SAMM50;AP2S1;CCDC40,Hypo
2328,GO_Biological_Process_2018,cortical cytoskeleton organization (GO:0030865),3/29,0.547270588724001,0.8919577146220279,0,0,1.068152186796255,0.6438948717844778,RTKN;RHOJ;LLGL1,Hypo
2329,GO_Biological_Process_2018,positive regulation of myeloid cell differentiation (GO:0045639),3/29,0.547270588724001,0.8919577146220279,0,0,1.068152186796255,0.6438948717844778,INHBA;FOXO3;MAPK14,Hypo
2330,GO_Biological_Process_2018,positive regulation of interleukin-1 secretion (GO:0050716),3/29,0.547270588724001,0.8919577146220279,0,0,1.068152186796255,0.6438948717844778,PANX1;NLRP10;HMGB1,Hypo
2331,GO_Biological_Process_2018,lysosome localization (GO:0032418),3/29,0.547270588724001,0.8919577146220279,0,0,1.068152186796255,0.6438948717844778,VPS33A;KIT;PLEKHM1,Hypo
2332,GO_Biological_Process_2018,regulation of chromosome segregation (GO:0051983),3/29,0.547270588724001,0.8919577146220279,0,0,1.068152186796255,0.6438948717844778,DYNC1H1;NUMA1;MAD1L1,Hypo
2333,GO_Biological_Process_2018,regulation of keratinocyte differentiation (GO:0045616),3/29,0.547270588724001,0.8919577146220279,0,0,1.068152186796255,0.6438948717844778,PRKCH;NUMA1;H2AFY,Hypo
2334,GO_Biological_Process_2018,respiratory system development (GO:0060541),3/29,0.547270588724001,0.8919577146220279,0,0,1.068152186796255,0.6438948717844778,ZIC3;FGFR2;CCDC40,Hypo
2335,GO_Biological_Process_2018,regulation of macrophage derived foam cell differentiation (GO:0010743),3/29,0.547270588724001,0.8919577146220279,0,0,1.068152186796255,0.6438948717844778,ABCA1;PRKCH;ABCG1,Hypo
2336,GO_Biological_Process_2018,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),8/82,0.5537866652007416,0.8919577146220279,0,0,1.000695855484733,0.5913869809776934,CDKN1C;TWSG1;SMAD3;NUMA1;TGFB3;TGFB1I1;UBE2O;INHBA,Hypo
2337,GO_Biological_Process_2018,negative regulation of viral life cycle (GO:1903901),6/61,0.5539883567848178,0.8919577146220279,0,0,1.0098204264870931,0.596411666979097,SRPK2;RNASEL;TNIP1;TRIM5;TRIM11;SRPK1,Hypo
2338,GO_Biological_Process_2018,regulation of tumor necrosis factor production (GO:0032680),6/61,0.5539883567848178,0.8919577146220279,0,0,1.0098204264870931,0.596411666979097,ARFGEF2;NFKBIL1;MAPKAPK2;RARA;ARHGEF2;RASGRP1,Hypo
2339,GO_Biological_Process_2018,positive regulation of angiogenesis (GO:0045766),10/103,0.5544060379836899,0.8919577146220279,0,0,0.99528877064627,0.5870789840996519,PRKCB;AGO2;VASH2;PRKCA;PRKD2;FGF1;PIK3R6;RAPGEF3;SASH1;PAK4,Hypo
2340,GO_Biological_Process_2018,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),4/40,0.5561968352747146,0.8919577146220279,0,0,1.028548589699669,0.6033805726987415,ZFYVE28;DAB2IP;ARHGEF7;SH3GL2,Hypo
2341,GO_Biological_Process_2018,positive regulation of mitotic cell cycle phase transition (GO:1901992),4/40,0.5561968352747146,0.8919577146220279,0,0,1.028548589699669,0.6033805726987415,RPTOR;NSMCE2;DLGAP5;BRD4,Hypo
2342,GO_Biological_Process_2018,embryonic heart tube morphogenesis (GO:0003143),4/40,0.5561968352747146,0.8919577146220279,0,0,1.028548589699669,0.6033805726987415,RYR2;ZIC3;BBS4;CCDC40,Hypo
2343,GO_Biological_Process_2018,regulation of DNA methylation (GO:0044030),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,KMT2A,Hypo
2344,GO_Biological_Process_2018,biomineral tissue development (GO:0031214),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,FAM20A,Hypo
2345,GO_Biological_Process_2018,cellular response to nitric oxide (GO:0071732),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,MTR,Hypo
2346,GO_Biological_Process_2018,regulation of brown fat cell differentiation (GO:0090335),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,FTO,Hypo
2347,GO_Biological_Process_2018,positive regulation of tissue remodeling (GO:0034105),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,TMBIM1,Hypo
2348,GO_Biological_Process_2018,positive regulation of mitochondrial calcium ion concentration (GO:0051561),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,RAP1GDS1,Hypo
2349,GO_Biological_Process_2018,mast cell activation involved in immune response (GO:0002279),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,KIT,Hypo
2350,GO_Biological_Process_2018,stress-induced premature senescence (GO:0090400),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,MAPK14,Hypo
2351,GO_Biological_Process_2018,positive regulation of isotype switching (GO:0045830),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,PAXIP1,Hypo
2352,GO_Biological_Process_2018,DNA recombinase assembly (GO:0000730),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,RAD51,Hypo
2353,GO_Biological_Process_2018,integrin activation (GO:0033622),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,ITGB1BP1,Hypo
2354,GO_Biological_Process_2018,cellular response to forskolin (GO:1904322),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,ADCY3,Hypo
2355,GO_Biological_Process_2018,galactose catabolic process (GO:0019388),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,PGM2,Hypo
2356,GO_Biological_Process_2018,T-helper 17 cell differentiation (GO:0072539),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,RORA,Hypo
2357,GO_Biological_Process_2018,negative regulation of lipase activity (GO:0060192),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,SORT1,Hypo
2358,GO_Biological_Process_2018,organophosphate catabolic process (GO:0046434),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,PDXP,Hypo
2359,GO_Biological_Process_2018,lagging strand elongation (GO:0006273),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,PARP3,Hypo
2360,GO_Biological_Process_2018,intestinal cholesterol absorption (GO:0030299),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,LDLR,Hypo
2361,GO_Biological_Process_2018,cellular response to reactive nitrogen species (GO:1902170),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,MTR,Hypo
2362,GO_Biological_Process_2018,DNA repair complex assembly (GO:0090735),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,RAD51,Hypo
2363,GO_Biological_Process_2018,regulation of T cell mediated immunity (GO:0002709),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,HMGB1,Hypo
2364,GO_Biological_Process_2018,microvillus assembly (GO:0030033),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,RAPGEF2,Hypo
2365,GO_Biological_Process_2018,protein localization to microtubule (GO:0035372),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,DIAPH1,Hypo
2366,GO_Biological_Process_2018,regulation of ATP biosynthetic process (GO:2001169),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,ENO1,Hypo
2367,GO_Biological_Process_2018,phagolysosome assembly (GO:0001845),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,SYT7,Hypo
2368,GO_Biological_Process_2018,benzene-containing compound metabolic process (GO:0042537),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,KYAT3,Hypo
2369,GO_Biological_Process_2018,positive regulation of early endosome to late endosome transport (GO:2000643),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,VPS11,Hypo
2370,GO_Biological_Process_2018,response to forskolin (GO:1904321),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,ADCY3,Hypo
2371,GO_Biological_Process_2018,positive regulation of cAMP-mediated signaling (GO:0043950),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,RAPGEF2,Hypo
2372,GO_Biological_Process_2018,desensitization of G-protein coupled receptor protein signaling pathway (GO:0002029),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,GRK2,Hypo
2373,GO_Biological_Process_2018,bundle of His cell to Purkinje myocyte communication (GO:0086069),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,CTNNA3,Hypo
2374,GO_Biological_Process_2018,atrial cardiac muscle cell to AV node cell signaling (GO:0086026),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,KCNQ1,Hypo
2375,GO_Biological_Process_2018,insulin metabolic process (GO:1901142),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,IDE,Hypo
2376,GO_Biological_Process_2018,nodal signaling pathway (GO:0038092),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,SMAD3,Hypo
2377,GO_Biological_Process_2018,regulation of striated muscle cell differentiation (GO:0051153),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,HDAC5,Hypo
2378,GO_Biological_Process_2018,positive regulation of catenin import into nucleus (GO:0035413),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,KANK1,Hypo
2379,GO_Biological_Process_2018,negative regulation of calcium ion transmembrane transport (GO:1903170),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,ATP1A2,Hypo
2380,GO_Biological_Process_2018,glycosyl compound metabolic process (GO:1901657),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,KL,Hypo
2381,GO_Biological_Process_2018,regulation of positive chemotaxis (GO:0050926),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,NTRK3,Hypo
2382,GO_Biological_Process_2018,positive regulation of IRE1-mediated unfolded protein response (GO:1903896),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,DAB2IP,Hypo
2383,GO_Biological_Process_2018,regulation of store-operated calcium entry (GO:2001256),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,SARAF,Hypo
2384,GO_Biological_Process_2018,positive regulation of protein localization to cell surface (GO:2000010),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,STX3,Hypo
2385,GO_Biological_Process_2018,genetic imprinting (GO:0071514),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,DNMT3A,Hypo
2386,GO_Biological_Process_2018,lung epithelium development (GO:0060428),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,PKD1,Hypo
2387,GO_Biological_Process_2018,cell junction maintenance (GO:0034331),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,INAVA,Hypo
2388,GO_Biological_Process_2018,regulation of chemokine secretion (GO:0090196),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,IL33,Hypo
2389,GO_Biological_Process_2018,kynurenine metabolic process (GO:0070189),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,KYAT3,Hypo
2390,GO_Biological_Process_2018,protein localization to microtubule cytoskeleton (GO:0072698),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,DIAPH1,Hypo
2391,GO_Biological_Process_2018,negative regulation of establishment of protein localization (GO:1904950),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,MAPT,Hypo
2392,GO_Biological_Process_2018,early endosome to Golgi transport (GO:0034498),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,TRAPPC10,Hypo
2393,GO_Biological_Process_2018,amyloid precursor protein catabolic process (GO:0042987),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,ABCG1,Hypo
2394,GO_Biological_Process_2018,double-strand break repair via synthesis-dependent strand annealing (GO:0045003),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,RAD51,Hypo
2395,GO_Biological_Process_2018,positive regulation of immunoglobulin mediated immune response (GO:0002891),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,PAXIP1,Hypo
2396,GO_Biological_Process_2018,positive regulation of mRNA 3'-end processing (GO:0031442),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,CPEB3,Hypo
2397,GO_Biological_Process_2018,exocrine system development (GO:0035272),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,FGFR2,Hypo
2398,GO_Biological_Process_2018,positive regulation of vasculogenesis (GO:2001214),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,RAPGEF2,Hypo
2399,GO_Biological_Process_2018,establishment of protein localization to chromatin (GO:0071169),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,H2AFY,Hypo
2400,GO_Biological_Process_2018,fatty acid alpha-oxidation (GO:0001561),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,SLC25A17,Hypo
2401,GO_Biological_Process_2018,alpha-amino acid biosynthetic process (GO:1901607),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,MTHFD1,Hypo
2402,GO_Biological_Process_2018,cardiac muscle hypertrophy (GO:0003300),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,RYR2,Hypo
2403,GO_Biological_Process_2018,cGMP-mediated signaling (GO:0019934),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,PDE2A,Hypo
2404,GO_Biological_Process_2018,polyol transport (GO:0015791),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,SLC2A13,Hypo
2405,GO_Biological_Process_2018,regulation of cytoplasmic mRNA processing body assembly (GO:0010603),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,ATXN2,Hypo
2406,GO_Biological_Process_2018,basement membrane organization (GO:0071711),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,COL4A1,Hypo
2407,GO_Biological_Process_2018,leptin-mediated signaling pathway (GO:0033210),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,BBS4,Hypo
2408,GO_Biological_Process_2018,regulation of sensory perception (GO:0051931),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,MGLL,Hypo
2409,GO_Biological_Process_2018,negative regulation of neuron projection regeneration (GO:0070571),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,PTPRS,Hypo
2410,GO_Biological_Process_2018,glomerular epithelial cell development (GO:0072310),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,MYO1E,Hypo
2411,GO_Biological_Process_2018,granulocyte differentiation (GO:0030851),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,CBFA2T3,Hypo
2412,GO_Biological_Process_2018,short-chain fatty acid catabolic process (GO:0019626),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,PCK2,Hypo
2413,GO_Biological_Process_2018,peroxisomal transport (GO:0043574),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,PEX1,Hypo
2414,GO_Biological_Process_2018,asymmetric protein localization (GO:0008105),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,SHROOM3,Hypo
2415,GO_Biological_Process_2018,regulation of response to oxidative stress (GO:1902882),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,H2AFY,Hypo
2416,GO_Biological_Process_2018,mast cell degranulation (GO:0043303),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,KIT,Hypo
2417,GO_Biological_Process_2018,negative regulation of vascular permeability (GO:0043116),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,PDE2A,Hypo
2418,GO_Biological_Process_2018,calcium ion import into cytosol (GO:1902656),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,FAM155A,Hypo
2419,GO_Biological_Process_2018,regulation of protein localization to Cajal body (GO:1904869),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,CCT5,Hypo
2420,GO_Biological_Process_2018,regulation of cilium movement (GO:0003352),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,CCDC40,Hypo
2421,GO_Biological_Process_2018,acylglycerol acyl-chain remodeling (GO:0036155),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,MGLL,Hypo
2422,GO_Biological_Process_2018,positive regulation of TORC1 signaling (GO:1904263),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,LARS,Hypo
2423,GO_Biological_Process_2018,osteoblast development (GO:0002076),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,LIMD1,Hypo
2424,GO_Biological_Process_2018,positive regulation of viral entry into host cell (GO:0046598),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,TRIM11,Hypo
2425,GO_Biological_Process_2018,positive regulation of protein homodimerization activity (GO:0090073),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,TRAF4,Hypo
2426,GO_Biological_Process_2018,calcium ion import across plasma membrane (GO:0098703),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,FAM155A,Hypo
2427,GO_Biological_Process_2018,regulation of dopamine receptor signaling pathway (GO:0060159),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,LRRK2,Hypo
2428,GO_Biological_Process_2018,aldehyde biosynthetic process (GO:0046184),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,KDM3A,Hypo
2429,GO_Biological_Process_2018,negative regulation of telomerase activity (GO:0051974),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,SRC,Hypo
2430,GO_Biological_Process_2018,response to leptin (GO:0044321),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,NR1D1,Hypo
2431,GO_Biological_Process_2018,interleukin-1 beta secretion (GO:0050702),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,ABCA1,Hypo
2432,GO_Biological_Process_2018,regulation of T-helper 2 cell cytokine production (GO:2000551),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,PRKCZ,Hypo
2433,GO_Biological_Process_2018,pantothenate metabolic process (GO:0015939),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,FASN,Hypo
2434,GO_Biological_Process_2018,regulation of receptor binding (GO:1900120),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,PTPRF,Hypo
2435,GO_Biological_Process_2018,endochondral ossification (GO:0001958),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,COL13A1,Hypo
2436,GO_Biological_Process_2018,regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,FGF13,Hypo
2437,GO_Biological_Process_2018,regulation of apoptotic cell clearance (GO:2000425),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,HMGB1,Hypo
2438,GO_Biological_Process_2018,exocyst localization (GO:0051601),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,EXOC3L4,Hypo
2439,GO_Biological_Process_2018,neuron projection extension involved in neuron projection guidance (GO:1902284),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,SLIT1,Hypo
2440,GO_Biological_Process_2018,negative regulation of appetite (GO:0032099),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,BBS4,Hypo
2441,GO_Biological_Process_2018,positive regulation of cell aging (GO:0090343),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,LMNA,Hypo
2442,GO_Biological_Process_2018,microtubule nucleation by microtubule organizing center (GO:0051418),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,TUBGCP6,Hypo
2443,GO_Biological_Process_2018,regulation of chaperone-mediated autophagy (GO:1904714),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,ATP13A2,Hypo
2444,GO_Biological_Process_2018,positive regulation of membrane potential (GO:0045838),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,ANK3,Hypo
2445,GO_Biological_Process_2018,myelin maintenance (GO:0043217),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,AHNAK2,Hypo
2446,GO_Biological_Process_2018,protein lipoylation (GO:0009249),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,POP5,Hypo
2447,GO_Biological_Process_2018,positive regulation of protein localization to Cajal body (GO:1904871),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,CCT5,Hypo
2448,GO_Biological_Process_2018,aorta development (GO:0035904),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,LRP1,Hypo
2449,GO_Biological_Process_2018,glomerular visceral epithelial cell development (GO:0072015),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,MYO1E,Hypo
2450,GO_Biological_Process_2018,establishment of integrated proviral latency (GO:0075713),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,XRCC6,Hypo
2451,GO_Biological_Process_2018,development of primary female sexual characteristics (GO:0046545),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,LHFPL2,Hypo
2452,GO_Biological_Process_2018,negative regulation of platelet aggregation (GO:0090331),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,CD9,Hypo
2453,GO_Biological_Process_2018,amyloid fibril formation (GO:1990000),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,MAPT,Hypo
2454,GO_Biological_Process_2018,"peptidyl-arginine methylation, to asymmetrical-dimethyl arginine (GO:0019919)",1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,PRMT8,Hypo
2455,GO_Biological_Process_2018,microvillus organization (GO:0032528),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,RAPGEF2,Hypo
2456,GO_Biological_Process_2018,SMAD protein complex assembly (GO:0007183),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,SMAD3,Hypo
2457,GO_Biological_Process_2018,positive regulation of DNA recombination (GO:0045911),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,PAXIP1,Hypo
2458,GO_Biological_Process_2018,regulation of PERK-mediated unfolded protein response (GO:1903897),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,BOK,Hypo
2459,GO_Biological_Process_2018,desmosome organization (GO:0002934),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,PRKCA,Hypo
2460,GO_Biological_Process_2018,negative regulation of execution phase of apoptosis (GO:1900118),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,RFFL,Hypo
2461,GO_Biological_Process_2018,DNA damage induced protein phosphorylation (GO:0006975),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,ABL1,Hypo
2462,GO_Biological_Process_2018,regulation of endodeoxyribonuclease activity (GO:0032071),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,HMGB1,Hypo
2463,GO_Biological_Process_2018,axon extension involved in axon guidance (GO:0048846),1/8,0.5599392338305909,0.8919577146220279,0,0,1.3225097119401892,0.7669591057947374,SLIT1,Hypo
2464,GO_Biological_Process_2018,regulation of phosphatase activity (GO:0010921),7/72,0.5613476523185811,0.8919577146220279,0,0,0.996832812066986,0.5755860829017088,PPP1R26;SH3RF2;ELL;DLG3;GPATCH2;ELFN2;PPP1R12B,Hypo
2465,GO_Biological_Process_2018,regulation of epithelial cell proliferation (GO:0050678),7/72,0.5613476523185811,0.8919577146220279,0,0,0.996832812066986,0.5755860829017088,CDKN1C;NR4A1;DAB2IP;TGFA;NR1D1;FGFR2;EREG,Hypo
2466,GO_Biological_Process_2018,cell-cell junction organization (GO:0045216),7/72,0.5613476523185811,0.8919577146220279,0,0,0.996832812066986,0.5755860829017088,TJP1;CADM3;SMAD3;CADM1;TGFB3;CDH22;SDK2,Hypo
2467,GO_Biological_Process_2018,telomere maintenance (GO:0000723),5/51,0.563720769105885,0.8919577146220279,0,0,1.006147311948139,0.5767198564162532,PARP3;XRCC6;STN1;RAD51;NSMCE2,Hypo
2468,GO_Biological_Process_2018,arachidonic acid metabolic process (GO:0019369),5/51,0.563720769105885,0.8919577146220279,0,0,1.006147311948139,0.5767198564162532,DAGLA;ALOX12B;DAGLB;ALOXE3;MGLL,Hypo
2469,GO_Biological_Process_2018,coenzyme metabolic process (GO:0006732),5/51,0.563720769105885,0.8919577146220279,0,0,1.006147311948139,0.5767198564162532,ACOT7;FASN;MOCOS;ACSL6;MLYCD,Hypo
2470,GO_Biological_Process_2018,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),2/19,0.5654273707568428,0.8919577146220279,0,0,1.089080806860732,0.6209649341298267,CDKN1C;TGFB1I1,Hypo
2471,GO_Biological_Process_2018,protein ADP-ribosylation (GO:0006471),2/19,0.5654273707568428,0.8919577146220279,0,0,1.089080806860732,0.6209649341298267,PARP3;TNKS2,Hypo
2472,GO_Biological_Process_2018,negative regulation of phosphate metabolic process (GO:0045936),2/19,0.5654273707568428,0.8919577146220279,0,0,1.089080806860732,0.6209649341298267,CDKN1C;INHBA,Hypo
2473,GO_Biological_Process_2018,endoplasmic reticulum mannose trimming (GO:1904380),2/19,0.5654273707568428,0.8919577146220279,0,0,1.089080806860732,0.6209649341298267,UGGT2;UGGT1,Hypo
2474,GO_Biological_Process_2018,acetylcholine receptor signaling pathway (GO:0095500),2/19,0.5654273707568428,0.8919577146220279,0,0,1.089080806860732,0.6209649341298267,GRK2;CHRM4,Hypo
2475,GO_Biological_Process_2018,morphogenesis of an epithelium (GO:0002009),2/19,0.5654273707568428,0.8919577146220279,0,0,1.089080806860732,0.6209649341298267,KDF1;FGFR2,Hypo
2476,GO_Biological_Process_2018,negative regulation of response to biotic stimulus (GO:0002832),2/19,0.5654273707568428,0.8919577146220279,0,0,1.089080806860732,0.6209649341298267,NFKBIL1;TRIB1,Hypo
2477,GO_Biological_Process_2018,cyclic nucleotide biosynthetic process (GO:0009190),2/19,0.5654273707568428,0.8919577146220279,0,0,1.089080806860732,0.6209649341298267,ADCY9;ADCY3,Hypo
2478,GO_Biological_Process_2018,excitatory postsynaptic potential (GO:0060079),2/19,0.5654273707568428,0.8919577146220279,0,0,1.089080806860732,0.6209649341298267,LRRK2;GRIN2B,Hypo
2479,GO_Biological_Process_2018,nucleosome disassembly (GO:0006337),2/19,0.5654273707568428,0.8919577146220279,0,0,1.089080806860732,0.6209649341298267,SMARCC2;SMARCA4,Hypo
2480,GO_Biological_Process_2018,chromatin disassembly (GO:0031498),2/19,0.5654273707568428,0.8919577146220279,0,0,1.089080806860732,0.6209649341298267,SMARCC2;SMARCA4,Hypo
2481,GO_Biological_Process_2018,histone deubiquitination (GO:0016578),2/19,0.5654273707568428,0.8919577146220279,0,0,1.089080806860732,0.6209649341298267,TRRAP;USP51,Hypo
2482,GO_Biological_Process_2018,fatty-acyl-CoA metabolic process (GO:0035337),2/19,0.5654273707568428,0.8919577146220279,0,0,1.089080806860732,0.6209649341298267,FASN;HSD17B4,Hypo
2483,GO_Biological_Process_2018,macromolecule biosynthetic process (GO:0009059),2/19,0.5654273707568428,0.8919577146220279,0,0,1.089080806860732,0.6209649341298267,COL5A1;GALNT2,Hypo
2484,GO_Biological_Process_2018,negative regulation of protein localization to cell periphery (GO:1904376),2/19,0.5654273707568428,0.8919577146220279,0,0,1.089080806860732,0.6209649341298267,TMEM59;TMBIM1,Hypo
2485,GO_Biological_Process_2018,positive regulation of immunoglobulin production (GO:0002639),2/19,0.5654273707568428,0.8919577146220279,0,0,1.089080806860732,0.6209649341298267,PAXIP1;TNFRSF4,Hypo
2486,GO_Biological_Process_2018,negative regulation of calcium ion transport (GO:0051926),2/19,0.5654273707568428,0.8919577146220279,0,0,1.089080806860732,0.6209649341298267,EPO;ATP1A2,Hypo
2487,GO_Biological_Process_2018,positive regulation of adherens junction organization (GO:1903393),2/19,0.5654273707568428,0.8919577146220279,0,0,1.089080806860732,0.6209649341298267,ABL1;PPM1F,Hypo
2488,GO_Biological_Process_2018,mitochondrial calcium ion homeostasis (GO:0051560),2/19,0.5654273707568428,0.8919577146220279,0,0,1.089080806860732,0.6209649341298267,SLC8A3;RAP1GDS1,Hypo
2489,GO_Biological_Process_2018,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),2/19,0.5654273707568428,0.8919577146220279,0,0,1.089080806860732,0.6209649341298267,CDKN1C;TGFB1I1,Hypo
2490,GO_Biological_Process_2018,activin receptor signaling pathway (GO:0032924),2/19,0.5654273707568428,0.8919577146220279,0,0,1.089080806860732,0.6209649341298267,SMAD3;INHBA,Hypo
2491,GO_Biological_Process_2018,regulation of protein kinase A signaling (GO:0010738),2/19,0.5654273707568428,0.8919577146220279,0,0,1.089080806860732,0.6209649341298267,LRRK2;AKAP6,Hypo
2492,GO_Biological_Process_2018,negative regulation of protein localization to plasma membrane (GO:1903077),2/19,0.5654273707568428,0.8919577146220279,0,0,1.089080806860732,0.6209649341298267,TMEM59;TMBIM1,Hypo
2493,GO_Biological_Process_2018,positive regulation of heart contraction (GO:0045823),2/19,0.5654273707568428,0.8919577146220279,0,0,1.089080806860732,0.6209649341298267,RYR2;KCNQ1,Hypo
2494,GO_Biological_Process_2018,NADP metabolic process (GO:0006739),2/19,0.5654273707568428,0.8919577146220279,0,0,1.089080806860732,0.6209649341298267,PGM2;DERA,Hypo
2495,GO_Biological_Process_2018,positive regulation of activated T cell proliferation (GO:0042104),2/19,0.5654273707568428,0.8919577146220279,0,0,1.089080806860732,0.6209649341298267,HMGB1;IL12RB1,Hypo
2496,GO_Biological_Process_2018,production of small RNA involved in gene silencing by RNA (GO:0070918),2/19,0.5654273707568428,0.8919577146220279,0,0,1.089080806860732,0.6209649341298267,AGO2;DROSHA,Hypo
2497,GO_Biological_Process_2018,positive regulation of protein ubiquitination (GO:0031398),8/83,0.5679594030632742,0.8954277011044977,0,0,0.9872983178853416,0.5585199269432964,PAXIP1;PEF1;SMURF1;LRRK2;UBE2D1;PIN1;INAVA;SMAD7,Hypo
2498,GO_Biological_Process_2018,receptor-mediated endocytosis (GO:0006898),18/188,0.5688083368829979,0.8954277011044977,0,0,0.979905005480453,0.5528739117370487,SCARB1;LRP1;HIP1R;AP2A1;SORL1;IGF2R;DNM1;RAB31;GRK2;CTTN;AP2S1;AP1S1;CD9;ACKR3;PIP5K1C;LDLRAP1;LDLR;RAMP1,Hypo
2499,GO_Biological_Process_2018,establishment of protein localization to organelle (GO:0072594),6/62,0.5703638624322358,0.8954277011044977,0,0,0.9917328042328042,0.5568388952536587,RYR2;IPO9;NUP188;NUP133;TSC2;HK1,Hypo
2500,GO_Biological_Process_2018,negative regulation of DNA biosynthetic process (GO:2000279),3/30,0.5708724682517277,0.8954277011044977,0,0,1.0285339268390117,0.5765852604770758,STN1;SRC;FAM129B,Hypo
2501,GO_Biological_Process_2018,positive regulation of phospholipase C activity (GO:0010863),3/30,0.5708724682517277,0.8954277011044977,0,0,1.0285339268390117,0.5765852604770758,PDGFRA;KIT;ABL2,Hypo
2502,GO_Biological_Process_2018,artery morphogenesis (GO:0048844),3/30,0.5708724682517277,0.8954277011044977,0,0,1.0285339268390117,0.5765852604770758,LRP1;NF1;SMAD7,Hypo
2503,GO_Biological_Process_2018,positive regulation of B cell proliferation (GO:0030890),3/30,0.5708724682517277,0.8954277011044977,0,0,1.0285339268390117,0.5765852604770758,NFATC2;IRS2;TNFRSF4,Hypo
2504,GO_Biological_Process_2018,regulation of protein polymerization (GO:0032271),3/30,0.5708724682517277,0.8954277011044977,0,0,1.0285339268390117,0.5765852604770758,PLEKHG2;ABL1;MAPT,Hypo
2505,GO_Biological_Process_2018,regulation of sodium ion transmembrane transport (GO:1902305),3/30,0.5708724682517277,0.8954277011044977,0,0,1.0285339268390117,0.5765852604770758,NEDD4L;SCN1B;SNTA1,Hypo
2506,GO_Biological_Process_2018,replication fork processing (GO:0031297),3/30,0.5708724682517277,0.8954277011044977,0,0,1.0285339268390117,0.5765852604770758,RAD51;BHLHE40;SETMAR,Hypo
2507,GO_Biological_Process_2018,epithelium development (GO:0060429),11/115,0.5729485691969578,0.8954277011044977,0,0,0.9789245050977904,0.5452211299887715,RARG;BDH2;MTHFD1;DVL1;CDHR2;RARA;IFT122;TPP1;RHCG;PKD1;FGFR2,Hypo
2508,GO_Biological_Process_2018,regulation of phagocytosis (GO:0050764),4/41,0.5762769993027531,0.8954277011044977,0,0,1.0006944251548568,0.5515495764279483,TUB;SCARB1;DOCK2;SYT7,Hypo
2509,GO_Biological_Process_2018,spliceosomal complex assembly (GO:0000245),4/41,0.5762769993027531,0.8954277011044977,0,0,1.0006944251548568,0.5515495764279483,SRPK2;SART3;SNRNP200;SRPK1,Hypo
2510,GO_Biological_Process_2018,positive regulation of cell division (GO:0051781),4/41,0.5762769993027531,0.8954277011044977,0,0,1.0006944251548568,0.5515495764279483,PRKCE;FGF1;FGFR2;CIT,Hypo
2511,GO_Biological_Process_2018,telomere organization (GO:0032200),4/41,0.5762769993027531,0.8954277011044977,0,0,1.0006944251548568,0.5515495764279483,PARP3;XRCC6;STN1;DOT1L,Hypo
2512,GO_Biological_Process_2018,B cell differentiation (GO:0030183),5/52,0.5814775850272945,0.8954277011044977,0,0,0.9846852267133402,0.5338794470831704,TPD52;HDAC5;NFAM1;KIT;BLNK,Hypo
2513,GO_Biological_Process_2018,positive regulation of proteolysis (GO:0045862),5/52,0.5814775850272945,0.8954277011044977,0,0,0.9846852267133402,0.5338794470831704,CYFIP2;TNIP1;FURIN;BTRC;GPLD1,Hypo
2514,GO_Biological_Process_2018,transmembrane transport (GO:0055085),36/378,0.5853574922311142,0.8954277011044977,0,0,0.9738766980146292,0.521542642805892,RYR1;MRS2;RYR2;SCARB1;ATP8A1;SLC44A2;NEDD4L;ABCB8;ATP1A2;TCIRG1;ADD3;RYR3;SLC22A15;CALHM2;SLC22A17;LRRC8D;ATP6V1E1;ASIC2;ATP6V0A1;ASIC1;ABCC4;ATP8B2;KCNJ11;TSC22D3;ATP11C;ERLIN2;ATP2B1;TPCN1;SLC22A23;CLCN6;CLCN5;P2RX4;ATP13A2;SGK1;ABCG1;KCNK3,Hypo
2515,GO_Biological_Process_2018,regulation of viral genome replication (GO:0045069),6/63,0.5864391096899673,0.8954277011044977,0,0,0.9742798353909464,0.5199599330882723,SRPK2;RNASEL;TNIP1;ADARB1;FKBP6;SRPK1,Hypo
2516,GO_Biological_Process_2018,regulation of proteolysis (GO:0030162),6/63,0.5864391096899673,0.8954277011044977,0,0,0.9742798353909464,0.5199599330882723,CYFIP2;CDK5;BTBD3;KLHL11;BTRC;F2,Hypo
2517,GO_Biological_Process_2018,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",6/63,0.5864391096899673,0.8954277011044977,0,0,0.9742798353909464,0.5199599330882723,EDC4;TNKS1BP1;SAMD4B;WDR61;DCP1A;DCPS,Hypo
2518,GO_Biological_Process_2018,positive regulation of defense response (GO:0031349),7/74,0.5911677175175023,0.8954277011044977,0,0,0.9669690661463656,0.5082926232762027,IL33;TNIP1;POLR3B;NLRP10;PDE2A;POLR3G;EREG,Hypo
2519,GO_Biological_Process_2018,alpha-amino acid metabolic process (GO:1901605),3/31,0.593694736719161,0.8954277011044977,0,0,0.9917455425930002,0.5170862113924358,SLC6A8;MTHFD1;KYAT3,Hypo
2520,GO_Biological_Process_2018,regulation of protein export from nucleus (GO:0046825),3/31,0.593694736719161,0.8954277011044977,0,0,0.9917455425930002,0.5170862113924358,BAG3;ZC3H3;RAPGEF3,Hypo
2521,GO_Biological_Process_2018,gene silencing by miRNA (GO:0035195),3/31,0.593694736719161,0.8954277011044977,0,0,0.9917455425930002,0.5170862113924358,TNRC6C;AGO2;LIMD1,Hypo
2522,GO_Biological_Process_2018,proton transport (GO:0015992),3/31,0.593694736719161,0.8954277011044977,0,0,0.9917455425930002,0.5170862113924358,TCIRG1;ATP6V1E1;SLC9A1,Hypo
2523,GO_Biological_Process_2018,regulation of protein tyrosine kinase activity (GO:0061097),3/31,0.593694736719161,0.8954277011044977,0,0,0.9917455425930002,0.5170862113924358,DLG3;DOK7;SRCIN1,Hypo
2524,GO_Biological_Process_2018,vacuolar acidification (GO:0007035),2/20,0.5939397801564141,0.8954277011044977,0,0,1.028519279032626,0.5358352432376566,TCIRG1;ATP6V0A1,Hypo
2525,GO_Biological_Process_2018,negative regulation of innate immune response (GO:0045824),2/20,0.5939397801564141,0.8954277011044977,0,0,1.028519279032626,0.5358352432376566,TYRO3;TRAFD1,Hypo
2526,GO_Biological_Process_2018,"regulation of DNA-templated transcription, elongation (GO:0032784)",2/20,0.5939397801564141,0.8954277011044977,0,0,1.028519279032626,0.5358352432376566,ELL;ERCC6,Hypo
2527,GO_Biological_Process_2018,purine nucleotide metabolic process (GO:0006163),2/20,0.5939397801564141,0.8954277011044977,0,0,1.028519279032626,0.5358352432376566,MTHFD1;PPAT,Hypo
2528,GO_Biological_Process_2018,positive regulation of gene silencing by miRNA (GO:2000637),2/20,0.5939397801564141,0.8954277011044977,0,0,1.028519279032626,0.5358352432376566,AGO2;LIMD1,Hypo
2529,GO_Biological_Process_2018,glial cell development (GO:0021782),2/20,0.5939397801564141,0.8954277011044977,0,0,1.028519279032626,0.5358352432376566,EIF2B5;NF1,Hypo
2530,GO_Biological_Process_2018,striated muscle cell development (GO:0055002),2/20,0.5939397801564141,0.8954277011044977,0,0,1.028519279032626,0.5358352432376566,TMOD2;LMOD1,Hypo
2531,GO_Biological_Process_2018,negative regulation of telomere maintenance via telomerase (GO:0032211),2/20,0.5939397801564141,0.8954277011044977,0,0,1.028519279032626,0.5358352432376566,STN1;SRC,Hypo
2532,GO_Biological_Process_2018,growth hormone receptor signaling pathway (GO:0060396),2/20,0.5939397801564141,0.8954277011044977,0,0,1.028519279032626,0.5358352432376566,PXN;PIK3R1,Hypo
2533,GO_Biological_Process_2018,regulation of toll-like receptor signaling pathway (GO:0034121),2/20,0.5939397801564141,0.8954277011044977,0,0,1.028519279032626,0.5358352432376566,NFKBIL1;TYRO3,Hypo
2534,GO_Biological_Process_2018,inactivation of MAPK activity (GO:0000188),2/20,0.5939397801564141,0.8954277011044977,0,0,1.028519279032626,0.5358352432376566,RGS3;DUSP1,Hypo
2535,GO_Biological_Process_2018,inositol phosphate-mediated signaling (GO:0048016),2/20,0.5939397801564141,0.8954277011044977,0,0,1.028519279032626,0.5358352432376566,ADGRB2;NFATC2,Hypo
2536,GO_Biological_Process_2018,immune response-activating cell surface receptor signaling pathway (GO:0002429),2/20,0.5939397801564141,0.8954277011044977,0,0,1.028519279032626,0.5358352432376566,GPLD1;BCAR1,Hypo
2537,GO_Biological_Process_2018,mitochondrial RNA metabolic process (GO:0000959),2/20,0.5939397801564141,0.8954277011044977,0,0,1.028519279032626,0.5358352432376566,FOXO3;TEFM,Hypo
2538,GO_Biological_Process_2018,"wound healing, spreading of cells (GO:0044319)",2/20,0.5939397801564141,0.8954277011044977,0,0,1.028519279032626,0.5358352432376566,COL5A1;FLNA,Hypo
2539,GO_Biological_Process_2018,regulation of lipoprotein lipase activity (GO:0051004),2/20,0.5939397801564141,0.8954277011044977,0,0,1.028519279032626,0.5358352432376566,SORT1;FURIN,Hypo
2540,GO_Biological_Process_2018,embryonic digestive tract development (GO:0048566),2/20,0.5939397801564141,0.8954277011044977,0,0,1.028519279032626,0.5358352432376566,PDGFRA;FGFR2,Hypo
2541,GO_Biological_Process_2018,error-prone translesion synthesis (GO:0042276),2/20,0.5939397801564141,0.8954277011044977,0,0,1.028519279032626,0.5358352432376566,NEXMIF;REV1,Hypo
2542,GO_Biological_Process_2018,Arp2/3 complex-mediated actin nucleation (GO:0034314),2/20,0.5939397801564141,0.8954277011044977,0,0,1.028519279032626,0.5358352432376566,ARPC3;ARPC1B,Hypo
2543,GO_Biological_Process_2018,regulation of signal transduction by p53 class mediator (GO:1901796),13/138,0.5944020349426068,0.8954277011044977,0,0,0.9624161073825503,0.5006482450971974,PRKAG1;CHD5;PRKAG2;MAPK14;PRKAB1;BOP1;CDK5;KAT6A;SMYD2;PIN1;RBBP7;RFFL;TAF4,Hypo
2544,GO_Biological_Process_2018,response to cytokine (GO:0034097),13/138,0.5944020349426068,0.8954277011044977,0,0,0.9624161073825503,0.5006482450971974,SMAD3;SRC;TRAFD1;LIFR;PRKCA;AKAP6;PTPN11;DDOST;TBK1;MAPKAPK2;TIMP2;TIMP3;PTPN5,Hypo
2545,GO_Biological_Process_2018,cellular response to radiation (GO:0071478),4/42,0.5958300608281334,0.8954277011044977,0,0,0.974306269270298,0.5044955771552722,RAD51;TNKS1BP1;INTS7;MAPK14,Hypo
2546,GO_Biological_Process_2018,regulation of telomerase activity (GO:0051972),4/42,0.5958300608281334,0.8954277011044977,0,0,0.974306269270298,0.5044955771552722,SRC;MAP3K4;SMG6;WRAP53,Hypo
2547,GO_Biological_Process_2018,translesion synthesis (GO:0019985),4/42,0.5958300608281334,0.8954277011044977,0,0,0.974306269270298,0.5044955771552722,NPLOC4;USP10;NEXMIF;REV1,Hypo
2548,GO_Biological_Process_2018,regulation of interleukin-6 production (GO:0032675),4/42,0.5958300608281334,0.8954277011044977,0,0,0.974306269270298,0.5044955771552722,AFAP1L2;MAPKAPK2;ARHGEF2;INAVA,Hypo
2549,GO_Biological_Process_2018,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),5/53,0.5988385037480671,0.8954277011044977,0,0,0.9641173950299914,0.4943640430820418,PDGFRA;SEMA4D;UNC5B;KIT;PDGFA,Hypo
2550,GO_Biological_Process_2018,positive regulation of cell adhesion (GO:0045785),6/64,0.602197576846754,0.8954277011044977,0,0,0.957428693060877,0.4855788103712675,EPB41L4B;PRKCA;PRKD2;STX3;PPM1F;SMAD7,Hypo
2551,GO_Biological_Process_2018,secretory granule organization (GO:0033363),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,ABCA1,Hypo
2552,GO_Biological_Process_2018,alanine transport (GO:0032328),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,SLC6A17,Hypo
2553,GO_Biological_Process_2018,negative regulation of cytokine production involved in inflammatory response (GO:1900016),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,F2,Hypo
2554,GO_Biological_Process_2018,negative regulation of phagocytosis (GO:0050765),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,HMGB1,Hypo
2555,GO_Biological_Process_2018,regulation of protein acetylation (GO:1901983),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,RAPGEF3,Hypo
2556,GO_Biological_Process_2018,ATF6-mediated unfolded protein response (GO:0036500),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,DDIT3,Hypo
2557,GO_Biological_Process_2018,regulation of interleukin-6 biosynthetic process (GO:0045408),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,EREG,Hypo
2558,GO_Biological_Process_2018,regulation of amyloid precursor protein biosynthetic process (GO:0042984),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,SOAT1,Hypo
2559,GO_Biological_Process_2018,cellular response to interleukin-4 (GO:0071353),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,TCF7,Hypo
2560,GO_Biological_Process_2018,negative regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902894),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,PPARD,Hypo
2561,GO_Biological_Process_2018,regulation of interleukin-1 secretion (GO:0050704),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,HMGB1,Hypo
2562,GO_Biological_Process_2018,negative regulation of T cell apoptotic process (GO:0070233),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,TSC22D3,Hypo
2563,GO_Biological_Process_2018,short-chain fatty acid metabolic process (GO:0046459),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,ALDH5A1,Hypo
2564,GO_Biological_Process_2018,positive regulation of coagulation (GO:0050820),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,F2,Hypo
2565,GO_Biological_Process_2018,regulation of microtubule-based movement (GO:0060632),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,HAP1,Hypo
2566,GO_Biological_Process_2018,sphingomyelin metabolic process (GO:0006684),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,SMPD4,Hypo
2567,GO_Biological_Process_2018,embryonic forelimb morphogenesis (GO:0035115),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,CACNA1C,Hypo
2568,GO_Biological_Process_2018,mitochondrial respiratory chain complex III assembly (GO:0034551),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,UQCC2,Hypo
2569,GO_Biological_Process_2018,regulation of leukocyte mediated cytotoxicity (GO:0001910),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,PIK3R6,Hypo
2570,GO_Biological_Process_2018,positive regulation of immunoglobulin secretion (GO:0051024),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,TNFRSF4,Hypo
2571,GO_Biological_Process_2018,small nucleolar ribonucleoprotein complex assembly (GO:0000491),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,NUFIP1,Hypo
2572,GO_Biological_Process_2018,peptidyl-arginine omega-N-methylation (GO:0035247),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,PRMT8,Hypo
2573,GO_Biological_Process_2018,regulation of integrin activation (GO:0033623),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,SRC,Hypo
2574,GO_Biological_Process_2018,positive regulation of leukocyte apoptotic process (GO:2000108),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,RAPGEF2,Hypo
2575,GO_Biological_Process_2018,ATP synthesis coupled electron transport (GO:0042773),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,NDUFA12,Hypo
2576,GO_Biological_Process_2018,regulation of endoplasmic reticulum unfolded protein response (GO:1900101),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,PIK3R1,Hypo
2577,GO_Biological_Process_2018,negative regulation of gluconeogenesis (GO:0045721),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,SOGA1,Hypo
2578,GO_Biological_Process_2018,semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,PLXND1,Hypo
2579,GO_Biological_Process_2018,establishment of viral latency (GO:0019043),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,XRCC6,Hypo
2580,GO_Biological_Process_2018,regulation of sensory perception of pain (GO:0051930),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,MGLL,Hypo
2581,GO_Biological_Process_2018,endosome to pigment granule transport (GO:0043485),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,BLOC1S5,Hypo
2582,GO_Biological_Process_2018,L-ascorbic acid metabolic process (GO:0019852),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,SLC2A1,Hypo
2583,GO_Biological_Process_2018,epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,CCDC40,Hypo
2584,GO_Biological_Process_2018,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,BOP1,Hypo
2585,GO_Biological_Process_2018,regulation of skeletal muscle cell differentiation (GO:2001014),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,UQCC2,Hypo
2586,GO_Biological_Process_2018,respiratory chain complex III assembly (GO:0017062),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,UQCC2,Hypo
2587,GO_Biological_Process_2018,negative regulation of fibrinolysis (GO:0051918),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,F2,Hypo
2588,GO_Biological_Process_2018,mitochondrial calcium uptake (GO:0036444),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,SLC25A23,Hypo
2589,GO_Biological_Process_2018,positive regulation of astrocyte differentiation (GO:0048711),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,BIN1,Hypo
2590,GO_Biological_Process_2018,interleukin-1 secretion (GO:0050701),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,ABCA1,Hypo
2591,GO_Biological_Process_2018,positive regulation of natural killer cell mediated immune response to tumor cell (GO:0002857),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,CADM3,Hypo
2592,GO_Biological_Process_2018,negative regulation of histone methylation (GO:0031061),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,H2AFY,Hypo
2593,GO_Biological_Process_2018,regulation of striated muscle tissue development (GO:0016202),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,MEGF10,Hypo
2594,GO_Biological_Process_2018,glycine transport (GO:0015816),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,SLC6A17,Hypo
2595,GO_Biological_Process_2018,peptidyl-arginine methylation (GO:0018216),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,PRMT8,Hypo
2596,GO_Biological_Process_2018,mitotic DNA replication checkpoint (GO:0033314),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,CLSPN,Hypo
2597,GO_Biological_Process_2018,oogenesis (GO:0048477),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,KMT2D,Hypo
2598,GO_Biological_Process_2018,interleukin-23-mediated signaling pathway (GO:0038155),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,IL12RB1,Hypo
2599,GO_Biological_Process_2018,mitochondrial protein processing (GO:0034982),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,MIPEP,Hypo
2600,GO_Biological_Process_2018,positive regulation of ribosome biogenesis (GO:0090070),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,BUD23,Hypo
2601,GO_Biological_Process_2018,intestinal lipid absorption (GO:0098856),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,LDLR,Hypo
2602,GO_Biological_Process_2018,positive regulation of hemostasis (GO:1900048),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,F2,Hypo
2603,GO_Biological_Process_2018,negative regulation of heterotypic cell-cell adhesion (GO:0034115),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,MBP,Hypo
2604,GO_Biological_Process_2018,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,MBP,Hypo
2605,GO_Biological_Process_2018,regulation of bile acid biosynthetic process (GO:0070857),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,NR1D1,Hypo
2606,GO_Biological_Process_2018,positive regulation of rRNA processing (GO:2000234),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,BUD23,Hypo
2607,GO_Biological_Process_2018,regulation of methylation-dependent chromatin silencing (GO:0090308),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,TET1,Hypo
2608,GO_Biological_Process_2018,regulation of leukocyte activation (GO:0002694),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,MYO18A,Hypo
2609,GO_Biological_Process_2018,negative regulation of interferon-beta production (GO:0032688),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,PTPRS,Hypo
2610,GO_Biological_Process_2018,response to interleukin-4 (GO:0070670),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,TCF7,Hypo
2611,GO_Biological_Process_2018,granulocyte activation (GO:0036230),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,PREX1,Hypo
2612,GO_Biological_Process_2018,regulation of hair cycle (GO:0042634),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,PER1,Hypo
2613,GO_Biological_Process_2018,potassium ion import across plasma membrane (GO:1990573),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,ATP1A2,Hypo
2614,GO_Biological_Process_2018,hexose catabolic process (GO:0019320),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,PGM2,Hypo
2615,GO_Biological_Process_2018,mRNA methylation (GO:0080009),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,TRMT61A,Hypo
2616,GO_Biological_Process_2018,regulation of oxidative phosphorylation (GO:0002082),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,UQCC2,Hypo
2617,GO_Biological_Process_2018,negative regulation of chromatin silencing (GO:0031936),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,TET1,Hypo
2618,GO_Biological_Process_2018,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,CALM3,Hypo
2619,GO_Biological_Process_2018,endosome to melanosome transport (GO:0035646),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,BLOC1S5,Hypo
2620,GO_Biological_Process_2018,dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,DNM1,Hypo
2621,GO_Biological_Process_2018,proline transport (GO:0015824),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,SLC6A17,Hypo
2622,GO_Biological_Process_2018,mast cell mediated immunity (GO:0002448),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,KIT,Hypo
2623,GO_Biological_Process_2018,positive regulation of protein homooligomerization (GO:0032464),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,HRK,Hypo
2624,GO_Biological_Process_2018,positive regulation of vascular endothelial cell proliferation (GO:1905564),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,HMGB1,Hypo
2625,GO_Biological_Process_2018,negative regulation of microtubule polymerization (GO:0031115),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,CLIP3,Hypo
2626,GO_Biological_Process_2018,detection of mechanical stimulus involved in sensory perception (GO:0050974),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,KIT,Hypo
2627,GO_Biological_Process_2018,lipoprotein biosynthetic process (GO:0042158),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,ALOX12B,Hypo
2628,GO_Biological_Process_2018,sphingosine metabolic process (GO:0006670),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,SGPP2,Hypo
2629,GO_Biological_Process_2018,histone phosphorylation (GO:0016572),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,BAZ1B,Hypo
2630,GO_Biological_Process_2018,Golgi inheritance (GO:0048313),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,GOLGA2,Hypo
2631,GO_Biological_Process_2018,negative regulation of peptidyl-lysine acetylation (GO:2000757),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,KLF15,Hypo
2632,GO_Biological_Process_2018,vitamin transmembrane transport (GO:0035461),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,SCARB1,Hypo
2633,GO_Biological_Process_2018,negative regulation of interleukin-17 production (GO:0032700),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,FOXP3,Hypo
2634,GO_Biological_Process_2018,regulation of immunoglobulin secretion (GO:0051023),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,TNFRSF4,Hypo
2635,GO_Biological_Process_2018,negative regulation of NIK/NF-kappaB signaling (GO:1901223),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,HDAC7,Hypo
2636,GO_Biological_Process_2018,small RNA loading onto RISC (GO:0070922),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,AGO2,Hypo
2637,GO_Biological_Process_2018,negative regulation of leukocyte chemotaxis (GO:0002689),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,PADI2,Hypo
2638,GO_Biological_Process_2018,dynamin family protein polymerization involved in membrane fission (GO:0003373),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,DNM1,Hypo
2639,GO_Biological_Process_2018,megakaryocyte differentiation (GO:0030219),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,KIT,Hypo
2640,GO_Biological_Process_2018,response to UV-C (GO:0010225),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,MAP3K4,Hypo
2641,GO_Biological_Process_2018,positive regulation of protein sumoylation (GO:0033235),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,PIAS4,Hypo
2642,GO_Biological_Process_2018,neuronal ion channel clustering (GO:0045161),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,SPTBN4,Hypo
2643,GO_Biological_Process_2018,microtubule anchoring at centrosome (GO:0034454),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,BBS4,Hypo
2644,GO_Biological_Process_2018,regulation of muscle system process (GO:0090257),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,PPP1R12B,Hypo
2645,GO_Biological_Process_2018,regulation of interferon-gamma secretion (GO:1902713),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,RASGRP1,Hypo
2646,GO_Biological_Process_2018,regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,UBQLN2,Hypo
2647,GO_Biological_Process_2018,positive regulation of mitochondrial translation (GO:0070131),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,UQCC2,Hypo
2648,GO_Biological_Process_2018,mature B cell differentiation involved in immune response (GO:0002313),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,PTK2B,Hypo
2649,GO_Biological_Process_2018,positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002860),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,CADM3,Hypo
2650,GO_Biological_Process_2018,ionotropic glutamate receptor signaling pathway (GO:0035235),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,PTK2B,Hypo
2651,GO_Biological_Process_2018,interleukin-1 beta production (GO:0032611),1/9,0.6028622146050083,0.8954277011044977,0,0,1.1571318624935865,0.5855857968817147,ABCA1,Hypo
2652,GO_Biological_Process_2018,C-terminal protein lipidation (GO:0006501),7/75,0.6056879724600442,0.8992856854580152,0,0,0.9526959522872454,0.4776725307125758,NTNG2;NRN1L;NEGR1;NTM;RTN4RL2;CNTN3;GPLD1,Hypo
2653,GO_Biological_Process_2018,negative regulation of cell motility (GO:2000146),9/97,0.6127031310511522,0.9022721263291158,0,0,0.9464310805114514,0.4636326880226943,KANK1;STK24;ZMYND8;NF1;PIN1;ADARB1;LDLRAD4;RNF41;SMAD7,Hypo
2654,GO_Biological_Process_2018,eye development (GO:0001654),4/43,0.6148340313108083,0.9022721263291158,0,0,0.94927135214905,0.4617283531756073,FBN2;COL5A1;CACNA1C;SIPA1L3,Hypo
2655,GO_Biological_Process_2018,substantia nigra development (GO:0021762),4/43,0.6148340313108083,0.9022721263291158,0,0,0.94927135214905,0.4617283531756073,PADI2;MBP;CALM3;NDRG2,Hypo
2656,GO_Biological_Process_2018,regulation of interferon-gamma production (GO:0032649),4/43,0.6148340313108083,0.9022721263291158,0,0,0.94927135214905,0.4617283531756073,RARA;HMGB1;IL12RB1;FOXP3,Hypo
2657,GO_Biological_Process_2018,response to lipid (GO:0033993),13/140,0.6156674059945241,0.9022721263291158,0,0,0.9471542567246208,0.4594156440802505,RARG;TNFRSF9;WNT9B;NR1D1;RXRA;MAPKAPK2;RARA;TNFRSF25;TRIB1;TNFRSF4;ABCG1;PCK2;PPARD,Hypo
2658,GO_Biological_Process_2018,ATP biosynthetic process (GO:0006754),3/32,0.6157122945773951,0.9022721263291158,0,0,0.9574942882949896,0.4643612509236122,PRKAG2;TCIRG1;ATP6V0A1,Hypo
2659,GO_Biological_Process_2018,negative regulation of receptor activity (GO:2000272),3/32,0.6157122945773951,0.9022721263291158,0,0,0.9574942882949896,0.4643612509236122,ZFYVE28;CALM3;EPHB2,Hypo
2660,GO_Biological_Process_2018,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),3/32,0.6157122945773951,0.9022721263291158,0,0,0.9574942882949896,0.4643612509236122,ARFGEF2;ARHGEF2;RASGRP1,Hypo
2661,GO_Biological_Process_2018,positive regulation of TOR signaling (GO:0032008),3/32,0.6157122945773951,0.9022721263291158,0,0,0.9574942882949896,0.4643612509236122,RPTOR;RRAGC;LARS,Hypo
2662,GO_Biological_Process_2018,activation of adenylate cyclase activity (GO:0007190),3/32,0.6157122945773951,0.9022721263291158,0,0,0.9574942882949896,0.4643612509236122,ADCY9;ADCY3;CAP2,Hypo
2663,GO_Biological_Process_2018,endodermal cell differentiation (GO:0035987),3/32,0.6157122945773951,0.9022721263291158,0,0,0.9574942882949896,0.4643612509236122,LAMB3;COL4A2;INHBA,Hypo
2664,GO_Biological_Process_2018,purine ribonucleoside triphosphate metabolic process (GO:0009205),3/32,0.6157122945773951,0.9022721263291158,0,0,0.9574942882949896,0.4643612509236122,LRRK2;RAB23;ATP1A2,Hypo
2665,GO_Biological_Process_2018,negative regulation of fat cell differentiation (GO:0045599),3/32,0.6157122945773951,0.9022721263291158,0,0,0.9574942882949896,0.4643612509236122,TRIO;SMAD3;RORA,Hypo
2666,GO_Biological_Process_2018,positive regulation of telomere maintenance via telomerase (GO:0032212),3/32,0.6157122945773951,0.9022721263291158,0,0,0.9574942882949896,0.4643612509236122,TNKS2;MAP3K4;CCT5,Hypo
2667,GO_Biological_Process_2018,positive regulation of T cell differentiation (GO:0045582),3/32,0.6157122945773951,0.9022721263291158,0,0,0.9574942882949896,0.4643612509236122,BCL6;ZMIZ1;IL12RB1,Hypo
2668,GO_Biological_Process_2018,regulation of erythrocyte differentiation (GO:0045646),3/32,0.6157122945773951,0.9022721263291158,0,0,0.9574942882949896,0.4643612509236122,INHBA;FOXO3;MAPK14,Hypo
2669,GO_Biological_Process_2018,positive regulation of telomere maintenance (GO:0032206),3/32,0.6157122945773951,0.9022721263291158,0,0,0.9574942882949896,0.4643612509236122,TNKS2;ERCC1;MAP3K4,Hypo
2670,GO_Biological_Process_2018,regulation of nitric oxide biosynthetic process (GO:0045428),3/32,0.6157122945773951,0.9022721263291158,0,0,0.9574942882949896,0.4643612509236122,SMAD3;P2RX4;NOS1AP,Hypo
2671,GO_Biological_Process_2018,positive regulation of myeloid leukocyte differentiation (GO:0002763),3/32,0.6157122945773951,0.9022721263291158,0,0,0.9574942882949896,0.4643612509236122,IL34;ACIN1;PRKCA,Hypo
2672,GO_Biological_Process_2018,positive regulation of calcium ion transport into cytosol (GO:0010524),3/32,0.6157122945773951,0.9022721263291158,0,0,0.9574942882949896,0.4643612509236122,P2RX4;AKAP6;F2,Hypo
2673,GO_Biological_Process_2018,phosphatidylcholine biosynthetic process (GO:0006656),3/32,0.6157122945773951,0.9022721263291158,0,0,0.9574942882949896,0.4643612509236122,SLC44A2;CHPT1;LPIN1,Hypo
2674,GO_Biological_Process_2018,RNA modification (GO:0009451),5/54,0.6157856134970939,0.9022721263291158,0,0,0.9443890666806568,0.4578930887953236,WDR4;MEPCE;BCDIN3D;TRMT61A;TARBP1,Hypo
2675,GO_Biological_Process_2018,positive regulation of immune response (GO:0050778),5/54,0.6157856134970939,0.9022721263291158,0,0,0.9443890666806568,0.4578930887953236,POLR3B;POLR3G;EIF2AK4;IL12RB1;EREG,Hypo
2676,GO_Biological_Process_2018,membrane fusion (GO:0061025),5/54,0.6157856134970939,0.9022721263291158,0,0,0.9443890666806568,0.4578930887953236,NSF;NAPA;RIMS1;VASH2;DNM1,Hypo
2677,GO_Biological_Process_2018,monocarboxylic acid metabolic process (GO:0032787),10/108,0.6161503796443648,0.9022721263291158,0,0,0.9442457395329266,0.4572644288495047,PER2;GNPAT;ACOT7;PDHA1;ALDH5A1;GPAM;FASN;HOGA1;ACACB;PCK2,Hypo
2678,GO_Biological_Process_2018,negative regulation of blood vessel morphogenesis (GO:2000181),6/65,0.6176246427338867,0.9022721263291158,0,0,0.9411487758945386,0.4535154831240728,COL4A2;ADGRB1;DAB2IP;VASH1;GTF2I;FAM129B,Hypo
2679,GO_Biological_Process_2018,positive regulation of apoptotic signaling pathway (GO:2001235),7/76,0.6199317787777743,0.9022721263291158,0,0,0.938836551873317,0.4489007928697534,HRK;TRAF7;WWOX;HIP1R;DAB2IP;G0S2;BOK,Hypo
2680,GO_Biological_Process_2018,mRNA transcription (GO:0009299),2/21,0.6210266421647117,0.9022721263291158,0,0,0.9743326488706364,0.4641538499381947,DDIT3;EREG,Hypo
2681,GO_Biological_Process_2018,cellular response to hexose stimulus (GO:0071331),2/21,0.6210266421647117,0.9022721263291158,0,0,0.9743326488706364,0.4641538499381947,SLC2A5;PCK2,Hypo
2682,GO_Biological_Process_2018,ventricular cardiac muscle tissue development (GO:0003229),2/21,0.6210266421647117,0.9022721263291158,0,0,0.9743326488706364,0.4641538499381947,FGFR2;SMAD7,Hypo
2683,GO_Biological_Process_2018,positive regulation of translational initiation (GO:0045948),2/21,0.6210266421647117,0.9022721263291158,0,0,0.9743326488706364,0.4641538499381947,EIF2B5;MTOR,Hypo
2684,GO_Biological_Process_2018,positive regulation of histone acetylation (GO:0035066),2/21,0.6210266421647117,0.9022721263291158,0,0,0.9743326488706364,0.4641538499381947,PAXIP1;FOXP3,Hypo
2685,GO_Biological_Process_2018,negative regulation of cytokine biosynthetic process (GO:0042036),2/21,0.6210266421647117,0.9022721263291158,0,0,0.9743326488706364,0.4641538499381947,INHBA;FOXP3,Hypo
2686,GO_Biological_Process_2018,negative regulation of G-protein coupled receptor protein signaling pathway (GO:0045744),2/21,0.6210266421647117,0.9022721263291158,0,0,0.9743326488706364,0.4641538499381947,GRK2;MGRN1,Hypo
2687,GO_Biological_Process_2018,regulation of macrophage activation (GO:0043030),2/21,0.6210266421647117,0.9022721263291158,0,0,0.9743326488706364,0.4641538499381947,IL33;MYO18A,Hypo
2688,GO_Biological_Process_2018,negative regulation of protein tyrosine kinase activity (GO:0061099),2/21,0.6210266421647117,0.9022721263291158,0,0,0.9743326488706364,0.4641538499381947,ZFYVE28;SRCIN1,Hypo
2689,GO_Biological_Process_2018,non-motile cilium assembly (GO:1905515),2/21,0.6210266421647117,0.9022721263291158,0,0,0.9743326488706364,0.4641538499381947,CCDC13;BBS4,Hypo
2690,GO_Biological_Process_2018,positive regulation of BMP signaling pathway (GO:0030513),2/21,0.6210266421647117,0.9022721263291158,0,0,0.9743326488706364,0.4641538499381947,NUMA1;UBE2O,Hypo
2691,GO_Biological_Process_2018,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",2/21,0.6210266421647117,0.9022721263291158,0,0,0.9743326488706364,0.4641538499381947,ERCC1;ERCC2,Hypo
2692,GO_Biological_Process_2018,positive regulation of defense response to virus by host (GO:0002230),2/21,0.6210266421647117,0.9022721263291158,0,0,0.9743326488706364,0.4641538499381947,EIF2AK4;IL12RB1,Hypo
2693,GO_Biological_Process_2018,cellular response to misfolded protein (GO:0071218),2/21,0.6210266421647117,0.9022721263291158,0,0,0.9743326488706364,0.4641538499381947,UGGT2;UGGT1,Hypo
2694,GO_Biological_Process_2018,protein-DNA complex disassembly (GO:0032986),2/21,0.6210266421647117,0.9022721263291158,0,0,0.9743326488706364,0.4641538499381947,SMARCC2;SMARCA4,Hypo
2695,GO_Biological_Process_2018,mitochondrial calcium ion transmembrane transport (GO:0006851),2/21,0.6210266421647117,0.9022721263291158,0,0,0.9743326488706364,0.4641538499381947,SLC8A3;SLC25A23,Hypo
2696,GO_Biological_Process_2018,glutamate metabolic process (GO:0006536),2/21,0.6210266421647117,0.9022721263291158,0,0,0.9743326488706364,0.4641538499381947,ALDH5A1;GAD1,Hypo
2697,GO_Biological_Process_2018,regulation of ruffle assembly (GO:1900027),2/21,0.6210266421647117,0.9022721263291158,0,0,0.9743326488706364,0.4641538499381947,KANK1;PLEKHM1,Hypo
2698,GO_Biological_Process_2018,calcium ion homeostasis (GO:0055074),8/87,0.6224951764288922,0.9022721263291158,0,0,0.937099949158508,0.4442035550609275,SLC8A3;RYR2;RMDN3;ATP13A2;FAM20A;ATP2B1;SLC8A2;CHERP,Hypo
2699,GO_Biological_Process_2018,positive regulation of cellular component biogenesis (GO:0044089),8/87,0.6224951764288922,0.9022721263291158,0,0,0.937099949158508,0.4442035550609275,SMAD3;ERCC1;CLSTN1;STX18;PRKCA;ATP13A2;EPHB2;EPHB1,Hypo
2700,GO_Biological_Process_2018,proteasomal protein catabolic process (GO:0010498),22/237,0.6286815741637171,0.9022721263291158,0,0,0.9465647013413104,0.4393294457527489,NHLRC3;ANAPC7;SMURF1;NEDD4L;UBE2D1;KLHL11;UBE4B;AGAP3;NR1D1;PPP2R5C;FBXO44;RNF41;RMND5B;TRIM9;SPSB1;UBXN11;DDIT3;BTBD3;KCTD13;RBCK1;BTRC;RFFL,Hypo
2701,GO_Biological_Process_2018,macromolecular complex assembly (GO:0065003),11/120,0.6307787638903485,0.9022721263291158,0,0,0.9337594806743283,0.4302764525657896,RIMS1;KMT2A;SLC2A1;USH1C;REPS2;PTK2B;FANCC;TEAD1;LLGL1;WASF3;PEX14,Hypo
2702,GO_Biological_Process_2018,positive regulation of DNA biosynthetic process (GO:2000573),5/55,0.632303717381029,0.9022721263291158,0,0,0.9254498714652956,0.424212741711278,TNKS2;PRKD2;MAP3K4;CCT5;WRAP53,Hypo
2703,GO_Biological_Process_2018,Notch signaling pathway (GO:0007219),5/55,0.632303717381029,0.9022721263291158,0,0,0.9254498714652956,0.424212741711278,PLXND1;WWC1;DTX1;MAML3;DLGAP5,Hypo
2704,GO_Biological_Process_2018,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),15/163,0.6323791092026284,0.9022721263291158,0,0,0.9376702283679028,0.4297025802311187,PRKCB;SLC44A2;PLEKHG5;PELI2;CXXC5;S100B;LITAF;INAVA;TBK1;TRIM5;FLNA;PIM2;RBCK1;MAP3K14;BRD4,Hypo
2705,GO_Biological_Process_2018,sphingolipid biosynthetic process (GO:0030148),6/66,0.6327075299105133,0.9022721263291158,0,0,0.9254115226337448,0.4236043497932221,SMPD4;ST8SIA1;PRKD2;ALOX12B;ALOXE3;SGPP2,Hypo
2706,GO_Biological_Process_2018,amide biosynthetic process (GO:0043604),4/44,0.6332712479262477,0.9022721263291158,0,0,0.9254881808838644,0.4228152327033952,SMPD4;FURIN;ALOX12B;ALOXE3,Hypo
2707,GO_Biological_Process_2018,hexose biosynthetic process (GO:0019319),4/44,0.6332712479262477,0.9022721263291158,0,0,0.9254881808838644,0.4228152327033952,PER2;CHST15;ENO1;PCK2,Hypo
2708,GO_Biological_Process_2018,positive regulation of interleukin-8 production (GO:0032757),4/44,0.6332712479262477,0.9022721263291158,0,0,0.9254881808838644,0.4228152327033952,AFAP1L2;NLRP10;DDIT3;PRKD2,Hypo
2709,GO_Biological_Process_2018,negative regulation of type I interferon production (GO:0032480),4/44,0.6332712479262477,0.9022721263291158,0,0,0.9254881808838644,0.4228152327033952,PTPRS;TBK1;NPLOC4;PIN1,Hypo
2710,GO_Biological_Process_2018,negative regulation of immune response (GO:0050777),4/44,0.6332712479262477,0.9022721263291158,0,0,0.9254881808838644,0.4228152327033952,NLRP10;TYRO3;TRAFD1;FOXP3,Hypo
2711,GO_Biological_Process_2018,ERAD pathway (GO:0036503),7/77,0.6338883553234632,0.9022721263291158,0,0,0.9253731343283582,0.4218613584606806,NPLOC4;UBE4B;ERLIN2;UGGT2;UGGT1;RNF121;UBQLN2,Hypo
2712,GO_Biological_Process_2018,negative regulation of translation (GO:0017148),8/88,0.6355368403013065,0.9022721263291158,0,0,0.9253347064881564,0.4194405455011541,TNRC6C;UNK;AGO2;SAMD4B;EIF2AK4;LIMD1;CPEB3;TOB1,Hypo
2713,GO_Biological_Process_2018,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",8/88,0.6355368403013065,0.9022721263291158,0,0,0.9253347064881564,0.4194405455011541,TIAM1;DAAM1;SMURF1;DVL1;PRICKLE2;DVL2;AP2S1;AP2A1,Hypo
2714,GO_Biological_Process_2018,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),8/88,0.6355368403013065,0.9022721263291158,0,0,0.9253347064881564,0.4194405455011541,RNF144B;RNF114;LRRK2;DVL1;RNF19B;TRIB1;CBFA2T3;SMAD7,Hypo
2715,GO_Biological_Process_2018,negative regulation of mitochondrion organization (GO:0010823),3/33,0.6369077211547264,0.9022721263291158,0,0,0.9255264509501796,0.4175332093338229,LRRK2;MAPT;SLC25A5,Hypo
2716,GO_Biological_Process_2018,positive regulation of cell-matrix adhesion (GO:0001954),3/33,0.6369077211547264,0.9022721263291158,0,0,0.9255264509501796,0.4175332093338229,ABL1;PTK2B;PPM1F,Hypo
2717,GO_Biological_Process_2018,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),3/33,0.6369077211547264,0.9022721263291158,0,0,0.9255264509501796,0.4175332093338229,NACC2;DDIT3;BOK,Hypo
2718,GO_Biological_Process_2018,mRNA stabilization (GO:0048255),3/33,0.6369077211547264,0.9022721263291158,0,0,0.9255264509501796,0.4175332093338229,MAPKAPK2;AXIN2;MAPK14,Hypo
2719,GO_Biological_Process_2018,regulation of DNA recombination (GO:0000018),3/33,0.6369077211547264,0.9022721263291158,0,0,0.9255264509501796,0.4175332093338229,RAD51;FIGN;USP51,Hypo
2720,GO_Biological_Process_2018,intracellular pH reduction (GO:0051452),3/33,0.6369077211547264,0.9022721263291158,0,0,0.9255264509501796,0.4175332093338229,TCIRG1;ATP6V1E1;ATP6V0A1,Hypo
2721,GO_Biological_Process_2018,positive regulation of calcium ion transport (GO:0051928),3/33,0.6369077211547264,0.9022721263291158,0,0,0.9255264509501796,0.4175332093338229,P2RX4;CAMK2A;CACNA1D,Hypo
2722,GO_Biological_Process_2018,negative regulation of cytokine production (GO:0001818),10/110,0.639603448548318,0.9022721263291158,0,0,0.9252577319587628,0.413504070529373,TWSG1;TBK1;NPLOC4;RARA;PIN1;HMGB1;F2;FOXP3;CMKLR1;HDAC7,Hypo
2723,GO_Biological_Process_2018,organelle assembly (GO:0070925),35/376,0.6403491154534933,0.9022721263291158,0,0,0.94915890140349,0.4230797577690808,UNC119B;FBF1;CEP164;LMOD1;ASAP1;LIMD1;RPGR;GOLGA2;SEPT8;SEPT9;ATXN2;ABLIM1;SH3PXD2A;RAB23;FLNA;PCNT;BBS4;DYNC1H1;ABCC4;SEPT11;DBNL;TMOD2;HPS1;HPS4;IFT122;VPS37B;DYNLL2;RILPL2;TTLL3;RILPL1;ULK1;MAPT;DZIP1;LSM14A;CHMP5,Hypo
2724,GO_Biological_Process_2018,regulation of response to stress (GO:0080134),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,H2AFY,Hypo
2725,GO_Biological_Process_2018,thyroid gland development (GO:0030878),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,THRA,Hypo
2726,GO_Biological_Process_2018,dorsal/ventral axis specification (GO:0009950),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,LRP4,Hypo
2727,GO_Biological_Process_2018,positive regulation of steroid metabolic process (GO:0045940),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,LDLRAP1,Hypo
2728,GO_Biological_Process_2018,mitotic nuclear envelope reassembly (GO:0007084),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,LMNA,Hypo
2729,GO_Biological_Process_2018,glycine metabolic process (GO:0006544),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,TDH,Hypo
2730,GO_Biological_Process_2018,nerve growth factor signaling pathway (GO:0038180),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,RAPGEF2,Hypo
2731,GO_Biological_Process_2018,I-kappaB phosphorylation (GO:0007252),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,DAB2IP,Hypo
2732,GO_Biological_Process_2018,glutamine metabolic process (GO:0006541),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,ALDH5A1,Hypo
2733,GO_Biological_Process_2018,regulation of protein exit from endoplasmic reticulum (GO:0070861),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,SORL1,Hypo
2734,GO_Biological_Process_2018,creatine metabolic process (GO:0006600),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,SLC6A8,Hypo
2735,GO_Biological_Process_2018,mitotic G1 DNA damage checkpoint (GO:0031571),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,FBXO31,Hypo
2736,GO_Biological_Process_2018,nuclear pore complex assembly (GO:0051292),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,AHCTF1,Hypo
2737,GO_Biological_Process_2018,negative regulation of gene silencing by miRNA (GO:0060965),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,NCOR2,Hypo
2738,GO_Biological_Process_2018,positive regulation of fertilization (GO:1905516),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,LHFPL2,Hypo
2739,GO_Biological_Process_2018,regulation of granulocyte differentiation (GO:0030852),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,RARA,Hypo
2740,GO_Biological_Process_2018,glycoprotein catabolic process (GO:0006516),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,NEU4,Hypo
2741,GO_Biological_Process_2018,negative regulation of reproductive process (GO:2000242),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,DUSP1,Hypo
2742,GO_Biological_Process_2018,regulation of histone phosphorylation (GO:0033127),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,H2AFY,Hypo
2743,GO_Biological_Process_2018,regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002858),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,CADM3,Hypo
2744,GO_Biological_Process_2018,G1 DNA damage checkpoint (GO:0044783),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,FBXO31,Hypo
2745,GO_Biological_Process_2018,nucleoside metabolic process (GO:0009116),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,MACROD1,Hypo
2746,GO_Biological_Process_2018,motor neuron axon guidance (GO:0008045),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,SLIT1,Hypo
2747,GO_Biological_Process_2018,mitochondrial respiratory chain complex III biogenesis (GO:0097033),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,UQCC2,Hypo
2748,GO_Biological_Process_2018,regulation of fatty acid beta-oxidation (GO:0031998),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,IRS2,Hypo
2749,GO_Biological_Process_2018,positive regulation of T cell receptor signaling pathway (GO:0050862),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,PRKD2,Hypo
2750,GO_Biological_Process_2018,cardiovascular system development (GO:0072358),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,FLT4,Hypo
2751,GO_Biological_Process_2018,IRES-dependent viral translational initiation (GO:0075522),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,EIF3F,Hypo
2752,GO_Biological_Process_2018,complement receptor mediated signaling pathway (GO:0002430),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,GPLD1,Hypo
2753,GO_Biological_Process_2018,protein deneddylation (GO:0000338),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,COPS4,Hypo
2754,GO_Biological_Process_2018,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,SORL1,Hypo
2755,GO_Biological_Process_2018,regulation of gene expression by genetic imprinting (GO:0006349),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,DNMT3A,Hypo
2756,GO_Biological_Process_2018,negative regulation by host of viral process (GO:0044793),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,EIF2AK4,Hypo
2757,GO_Biological_Process_2018,neuron projection fasciculation (GO:0106030),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,EPHB2,Hypo
2758,GO_Biological_Process_2018,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,BAG3,Hypo
2759,GO_Biological_Process_2018,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,GPLD1,Hypo
2760,GO_Biological_Process_2018,coenzyme A metabolic process (GO:0015936),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,ACOT7,Hypo
2761,GO_Biological_Process_2018,ESCRT complex disassembly (GO:1904896),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,CHMP5,Hypo
2762,GO_Biological_Process_2018,cilium movement involved in cell motility (GO:0060294),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,CFAP46,Hypo
2763,GO_Biological_Process_2018,UV protection (GO:0009650),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,ERCC2,Hypo
2764,GO_Biological_Process_2018,regulation of mRNA 3'-end processing (GO:0031440),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,AHCYL1,Hypo
2765,GO_Biological_Process_2018,mitotic G1/S transition checkpoint (GO:0044819),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,FBXO31,Hypo
2766,GO_Biological_Process_2018,positive regulation of lipid localization (GO:1905954),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,LRP1,Hypo
2767,GO_Biological_Process_2018,chaperone-mediated protein transport (GO:0072321),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,CLIP3,Hypo
2768,GO_Biological_Process_2018,T cell homeostasis (GO:0043029),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,FOXP3,Hypo
2769,GO_Biological_Process_2018,very-low-density lipoprotein particle assembly (GO:0034379),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,SOAT1,Hypo
2770,GO_Biological_Process_2018,positive regulation of execution phase of apoptosis (GO:1900119),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,BOK,Hypo
2771,GO_Biological_Process_2018,dicarboxylic acid biosynthetic process (GO:0043650),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,MTHFD1,Hypo
2772,GO_Biological_Process_2018,negative regulation of homotypic cell-cell adhesion (GO:0034111),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,CD9,Hypo
2773,GO_Biological_Process_2018,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,WNT9B,Hypo
2774,GO_Biological_Process_2018,response to histamine (GO:0034776),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,DIAPH1,Hypo
2775,GO_Biological_Process_2018,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,CELF4,Hypo
2776,GO_Biological_Process_2018,sequestering of actin monomers (GO:0042989),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,TWF2,Hypo
2777,GO_Biological_Process_2018,regulation of dendritic cell apoptotic process (GO:2000668),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,RAPGEF2,Hypo
2778,GO_Biological_Process_2018,regulation of plasminogen activation (GO:0010755),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,ENO1,Hypo
2779,GO_Biological_Process_2018,forelimb morphogenesis (GO:0035136),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,CACNA1C,Hypo
2780,GO_Biological_Process_2018,positive regulation of nuclease activity (GO:0032075),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,DAB2IP,Hypo
2781,GO_Biological_Process_2018,smooth muscle cell differentiation (GO:0051145),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,TMEM204,Hypo
2782,GO_Biological_Process_2018,protein prenylation (GO:0018342),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,FNTB,Hypo
2783,GO_Biological_Process_2018,negative regulation of glucose transport (GO:0010829),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,PRKCB,Hypo
2784,GO_Biological_Process_2018,protein deglycosylation (GO:0006517),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,ENGASE,Hypo
2785,GO_Biological_Process_2018,peptidyl-serine dephosphorylation (GO:0070262),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,PPP2R2C,Hypo
2786,GO_Biological_Process_2018,amino sugar metabolic process (GO:0006040),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,ST6GAL1,Hypo
2787,GO_Biological_Process_2018,regulation of myeloid leukocyte differentiation (GO:0002761),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,MTOR,Hypo
2788,GO_Biological_Process_2018,regulation of coagulation (GO:0050818),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,F2,Hypo
2789,GO_Biological_Process_2018,adenylate cyclase-inhibiting dopamine receptor signaling pathway (GO:0007195),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,FLNA,Hypo
2790,GO_Biological_Process_2018,negative regulation of cytosolic calcium ion concentration (GO:0051481),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,SMAD3,Hypo
2791,GO_Biological_Process_2018,regulation of actin filament length (GO:0030832),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,SSH1,Hypo
2792,GO_Biological_Process_2018,"energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988)",1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,ATP1A2,Hypo
2793,GO_Biological_Process_2018,regulation of cytoplasmic translational elongation (GO:1900247),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,CPEB3,Hypo
2794,GO_Biological_Process_2018,presynaptic membrane assembly (GO:0097105),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,LRP4,Hypo
2795,GO_Biological_Process_2018,N-acetylneuraminate metabolic process (GO:0006054),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,ST6GAL1,Hypo
2796,GO_Biological_Process_2018,regulation of triglyceride catabolic process (GO:0010896),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,GPLD1,Hypo
2797,GO_Biological_Process_2018,ESCRT III complex disassembly (GO:1904903),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,CHMP5,Hypo
2798,GO_Biological_Process_2018,"regulation of DNA-templated transcription, initiation (GO:2000142)",1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,THRA,Hypo
2799,GO_Biological_Process_2018,regulation of transforming growth factor beta production (GO:0071634),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,SMAD3,Hypo
2800,GO_Biological_Process_2018,positive regulation of cardiac muscle cell differentiation (GO:2000727),1/10,0.6416004635308081,0.9022721263291158,0,0,1.02850464625734,0.4564395626787057,AKAP6,Hypo
2801,GO_Biological_Process_2018,acylglycerol homeostasis (GO:0055090),2/22,0.6466947601095914,0.9052347761448758,0,0,0.925564681724846,0.4034359415511988,SCARB1;RORA,Hypo
2802,GO_Biological_Process_2018,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),2/22,0.6466947601095914,0.9052347761448758,0,0,0.925564681724846,0.4034359415511988,CLIP3;ZDHHC7,Hypo
2803,GO_Biological_Process_2018,peptidyl-L-cysteine S-palmitoylation (GO:0018230),2/22,0.6466947601095914,0.9052347761448758,0,0,0.925564681724846,0.4034359415511988,CLIP3;ZDHHC7,Hypo
2804,GO_Biological_Process_2018,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",2/22,0.6466947601095914,0.9052347761448758,0,0,0.925564681724846,0.4034359415511988,ERCC1;ERCC2,Hypo
2805,GO_Biological_Process_2018,nuclear transport (GO:0051169),2/22,0.6466947601095914,0.9052347761448758,0,0,0.925564681724846,0.4034359415511988,RGS14;ANP32A,Hypo
2806,GO_Biological_Process_2018,negative regulation of response to endoplasmic reticulum stress (GO:1903573),2/22,0.6466947601095914,0.9052347761448758,0,0,0.925564681724846,0.4034359415511988,LRRK2;CREB3L1,Hypo
2807,GO_Biological_Process_2018,"DNA catabolic process, endonucleolytic (GO:0000737)",2/22,0.6466947601095914,0.9052347761448758,0,0,0.925564681724846,0.4034359415511988,SETMAR;HMGB1,Hypo
2808,GO_Biological_Process_2018,negative regulation of sprouting angiogenesis (GO:1903671),2/22,0.6466947601095914,0.9052347761448758,0,0,0.925564681724846,0.4034359415511988,HDAC5;ITGB1BP1,Hypo
2809,GO_Biological_Process_2018,beta-catenin destruction complex disassembly (GO:1904886),2/22,0.6466947601095914,0.9052347761448758,0,0,0.925564681724846,0.4034359415511988,DVL1;DVL2,Hypo
2810,GO_Biological_Process_2018,negative regulation of nervous system development (GO:0051961),2/22,0.6466947601095914,0.9052347761448758,0,0,0.925564681724846,0.4034359415511988,SLIT1;SORL1,Hypo
2811,GO_Biological_Process_2018,positive regulation of RNA splicing (GO:0033120),2/22,0.6466947601095914,0.9052347761448758,0,0,0.925564681724846,0.4034359415511988,CELF4;PIK3R1,Hypo
2812,GO_Biological_Process_2018,protein homotrimerization (GO:0070207),2/22,0.6466947601095914,0.9052347761448758,0,0,0.925564681724846,0.4034359415511988,CLYBL;ASIC1,Hypo
2813,GO_Biological_Process_2018,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),2/22,0.6466947601095914,0.9052347761448758,0,0,0.925564681724846,0.4034359415511988,SMURF1;DAB2IP,Hypo
2814,GO_Biological_Process_2018,extracellular matrix disassembly (GO:0022617),7/78,0.6475482140918543,0.90610742994949,0,0,0.9122889679818488,0.3964461424632756,FBN2;SCUBE1;LAMB3;OPTC;TIMP2;HTRA1;FURIN,Hypo
2815,GO_Biological_Process_2018,regulation of establishment of planar polarity (GO:0090175),8/89,0.6483236979797761,0.9063057572968132,0,0,0.913859963636826,0.3960350816376792,TIAM1;DAAM1;SMURF1;DVL1;PRICKLE2;DVL2;AP2S1;AP2A1,Hypo
2816,GO_Biological_Process_2018,protein import (GO:0017038),5/56,0.6483802041285655,0.9063057572968132,0,0,0.9072533897877916,0.3930929522975901,IPO9;NUP188;NUP133;LAMP2;TSC2,Hypo
2817,GO_Biological_Process_2018,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),5/56,0.6483802041285655,0.9063057572968132,0,0,0.9072533897877916,0.3930929522975901,CLIP3;MADD;OTULIN;RBCK1;RFFL,Hypo
2818,GO_Biological_Process_2018,metal ion homeostasis (GO:0055065),4/45,0.6511280780652824,0.9089327628927713,0,0,0.9028651643145414,0.3873733197045393,SLC7A8;ANK3;FAM20A;LETMD1,Hypo
2819,GO_Biological_Process_2018,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),3/34,0.6572704671759071,0.9089327628927713,0,0,0.8956210547243899,0.3758560409564123,TNKS2;MAP3K4;CCT5,Hypo
2820,GO_Biological_Process_2018,ventricular cardiac muscle tissue morphogenesis (GO:0055010),3/34,0.6572704671759071,0.9089327628927713,0,0,0.8956210547243899,0.3758560409564123,RYR2;FGFR2;SMAD7,Hypo
2821,GO_Biological_Process_2018,regulation of double-strand break repair (GO:2000779),3/34,0.6572704671759071,0.9089327628927713,0,0,0.8956210547243899,0.3758560409564123,RAD51;FIGN;USP51,Hypo
2822,GO_Biological_Process_2018,regulation of interleukin-8 production (GO:0032677),3/34,0.6572704671759071,0.9089327628927713,0,0,0.8956210547243899,0.3758560409564123,AFAP1L2;DDIT3;PRKD2,Hypo
2823,GO_Biological_Process_2018,regulation of inflammatory response (GO:0050727),15/166,0.6605814297229328,0.9089327628927713,0,0,0.918887006519842,0.3810026015210126,IL33;SEMA7A;PDE2A;RORA;MAPK14;PER1;SBNO2;BCL6;TNIP1;NLRP10;OTULIN;TYRO3;MGLL;PPARD;BRD4,Hypo
2824,GO_Biological_Process_2018,protein processing (GO:0016485),9/101,0.6613585418344086,0.9089327628927713,0,0,0.905080303743028,0.3742137446874171,RHBDF1;RHBDF2;ECE1;CPXM1;FURIN;PCSK7;F2;SPPL3;SEC11C,Hypo
2825,GO_Biological_Process_2018,regulation of endopeptidase activity (GO:0052548),6/68,0.6617984913751628,0.9089327628927713,0,0,0.8954599761051374,0.3696406514038379,SERPIND1;TIMP2;TIMP3;SPOCK1;FURIN;ATP13A2,Hypo
2826,GO_Biological_Process_2018,cholesterol metabolic process (GO:0008203),6/68,0.6617984913751628,0.9089327628927713,0,0,0.8954599761051374,0.3696406514038379,ABCA1;RXRA;SOAT1;LDLRAP1;ABCG1;PPARD,Hypo
2827,GO_Biological_Process_2018,monocarboxylic acid biosynthetic process (GO:0072330),6/68,0.6617984913751628,0.9089327628927713,0,0,0.8954599761051374,0.3696406514038379,PER2;OSBPL2;HSD17B4;CSPG4;MLYCD;HOGA1,Hypo
2828,GO_Biological_Process_2018,viral process (GO:0016032),20/220,0.6631428355304092,0.9089327628927713,0,0,0.9248704663212436,0.3799043003742498,CTBP2;NUP188;NUP133;NEDD4L;AP2A1;FURIN;EIF2AK4;VPS37B;RXRA;GRK2;MVB12B;AP1S2;AP2S1;ELMO1;PI4KA;AP1S1;FYN;EIF3F;DOCK2;CHMP5,Hypo
2829,GO_Biological_Process_2018,IRE1-mediated unfolded protein response (GO:0036498),5/57,0.6640049123778654,0.9089327628927713,0,0,0.8897567727901918,0.3643249077151798,LMNA;PPP2R5B;TPP1;PDIA5;ARFGAP1,Hypo
2830,GO_Biological_Process_2018,regulation of Rho protein signal transduction (GO:0035023),5/57,0.6640049123778654,0.9089327628927713,0,0,0.8897567727901918,0.3643249077151798,ABCA1;KANK1;KCTD13;ABL1;ARHGEF2,Hypo
2831,GO_Biological_Process_2018,RNA secondary structure unwinding (GO:0010501),4/46,0.6683946223920793,0.9089327628927713,0,0,0.8813194342485196,0.3550629135411246,DDX27;DDX24;AGO2;DDX54,Hypo
2832,GO_Biological_Process_2018,regulation of DNA metabolic process (GO:0051052),4/46,0.6683946223920793,0.9089327628927713,0,0,0.8813194342485196,0.3550629135411246,UPF1;ZBTB38;SMG5;SMG6,Hypo
2833,GO_Biological_Process_2018,nucleocytoplasmic transport (GO:0006913),4/46,0.6683946223920793,0.9089327628927713,0,0,0.8813194342485196,0.3550629135411246,ATXN1;RGS14;ANP32A;HTATIP2,Hypo
2834,GO_Biological_Process_2018,regulation of G1/S transition of mitotic cell cycle (GO:2000045),4/46,0.6683946223920793,0.9089327628927713,0,0,0.8813194342485196,0.3550629135411246,RPTOR;RBL1;JADE1;MYO16,Hypo
2835,GO_Biological_Process_2018,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),4/46,0.6683946223920793,0.9089327628927713,0,0,0.8813194342485196,0.3550629135411246,PER2;USP4;ADGRB1;SMAD7,Hypo
2836,GO_Biological_Process_2018,positive regulation of cell cycle G1/S phase transition (GO:1902808),2/23,0.670963157079587,0.9089327628927713,0,0,0.8814412828786545,0.3517312559146098,RPTOR;STXBP4,Hypo
2837,GO_Biological_Process_2018,cellular amino acid catabolic process (GO:0009063),2/23,0.670963157079587,0.9089327628927713,0,0,0.8814412828786545,0.3517312559146098,ALDH5A1;ABAT,Hypo
2838,GO_Biological_Process_2018,vitamin transport (GO:0051180),2/23,0.670963157079587,0.9089327628927713,0,0,0.8814412828786545,0.3517312559146098,SCARB1;SLC35F3,Hypo
2839,GO_Biological_Process_2018,metanephros development (GO:0001656),2/23,0.670963157079587,0.9089327628927713,0,0,0.8814412828786545,0.3517312559146098,NF1;PKD1,Hypo
2840,GO_Biological_Process_2018,peroxisome organization (GO:0007031),2/23,0.670963157079587,0.9089327628927713,0,0,0.8814412828786545,0.3517312559146098,PEX1;PEX14,Hypo
2841,GO_Biological_Process_2018,positive regulation of ATP metabolic process (GO:1903580),2/23,0.670963157079587,0.9089327628927713,0,0,0.8814412828786545,0.3517312559146098,PFKFB3;ENO1,Hypo
2842,GO_Biological_Process_2018,apoptotic nuclear changes (GO:0030262),2/23,0.670963157079587,0.9089327628927713,0,0,0.8814412828786545,0.3517312559146098,ACIN1;HMGB1,Hypo
2843,GO_Biological_Process_2018,response to alkaloid (GO:0043279),2/23,0.670963157079587,0.9089327628927713,0,0,0.8814412828786545,0.3517312559146098,RYR1;RYR2,Hypo
2844,GO_Biological_Process_2018,regulation of monooxygenase activity (GO:0032768),2/23,0.670963157079587,0.9089327628927713,0,0,0.8814412828786545,0.3517312559146098,POR;NOS1AP,Hypo
2845,GO_Biological_Process_2018,viral budding (GO:0046755),2/23,0.670963157079587,0.9089327628927713,0,0,0.8814412828786545,0.3517312559146098,VPS37B;CHMP5,Hypo
2846,GO_Biological_Process_2018,NAD metabolic process (GO:0019674),2/23,0.670963157079587,0.9089327628927713,0,0,0.8814412828786545,0.3517312559146098,QPRT;NMNAT3,Hypo
2847,GO_Biological_Process_2018,regulation of ion homeostasis (GO:2000021),2/23,0.670963157079587,0.9089327628927713,0,0,0.8814412828786545,0.3517312559146098,WNK2;NEDD4L,Hypo
2848,GO_Biological_Process_2018,mitotic G2/M transition checkpoint (GO:0044818),2/23,0.670963157079587,0.9089327628927713,0,0,0.8814412828786545,0.3517312559146098,FOXN3;CLSPN,Hypo
2849,GO_Biological_Process_2018,neuronal action potential (GO:0019228),2/23,0.670963157079587,0.9089327628927713,0,0,0.8814412828786545,0.3517312559146098,CACNA1I;ANK3,Hypo
2850,GO_Biological_Process_2018,cell-cell adhesion mediated by cadherin (GO:0044331),2/23,0.670963157079587,0.9089327628927713,0,0,0.8814412828786545,0.3517312559146098,CDH22;CDHR2,Hypo
2851,GO_Biological_Process_2018,cellular response to lipopolysaccharide (GO:0071222),8/91,0.6731049191244963,0.9089327628927713,0,0,0.8917399774173935,0.3529988939396363,UPF1;SBNO2;TNIP1;PRKCE;NFKBIL1;DAB2IP;NR1D1;MAPK14,Hypo
2852,GO_Biological_Process_2018,phagocytosis (GO:0006909),12/135,0.6748980130556467,0.9089327628927713,0,0,0.9024641949205868,0.3548432280619726,LRP1;ADGRB1;ADORA1;ELMO1;TYRO3;RARA;MYH9;PIP5K1C;HMGB1;DOCK1;SYT7;CORO1C,Hypo
2853,GO_Biological_Process_2018,negative regulation of angiogenesis (GO:0016525),6/69,0.6757896298459207,0.9089327628927713,0,0,0.8811973349010386,0.3453178396035959,COL4A2;ADGRB1;DAB2IP;VASH1;GTF2I;FAM129B,Hypo
2854,GO_Biological_Process_2018,positive regulation of posttranscriptional gene silencing (GO:0060148),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,LIMD1,Hypo
2855,GO_Biological_Process_2018,formation of extrachromosomal circular DNA (GO:0001325),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,ERCC1,Hypo
2856,GO_Biological_Process_2018,L-phenylalanine catabolic process (GO:0006559),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,HGD,Hypo
2857,GO_Biological_Process_2018,positive regulation of cell cycle phase transition (GO:1901989),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,STXBP4,Hypo
2858,GO_Biological_Process_2018,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,CALM3,Hypo
2859,GO_Biological_Process_2018,mononuclear cell differentiation (GO:1903131),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,MYH9,Hypo
2860,GO_Biological_Process_2018,intracellular protein transmembrane transport (GO:0065002),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,PEX14,Hypo
2861,GO_Biological_Process_2018,positive regulation by host of viral process (GO:0044794),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,PPIB,Hypo
2862,GO_Biological_Process_2018,import across plasma membrane (GO:0098739),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,ATP1A2,Hypo
2863,GO_Biological_Process_2018,regulation of leukocyte cell-cell adhesion (GO:1903037),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,PAG1,Hypo
2864,GO_Biological_Process_2018,interleukin-2-mediated signaling pathway (GO:0038110),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,PTK2B,Hypo
2865,GO_Biological_Process_2018,immune response-regulating cell surface receptor signaling pathway (GO:0002768),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,KIT,Hypo
2866,GO_Biological_Process_2018,negative regulation of leukocyte cell-cell adhesion (GO:1903038),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,PAG1,Hypo
2867,GO_Biological_Process_2018,positive regulation of cytolysis (GO:0045919),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,GPLD1,Hypo
2868,GO_Biological_Process_2018,modulation by host of viral process (GO:0044788),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,PPIB,Hypo
2869,GO_Biological_Process_2018,myosin filament assembly (GO:0031034),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,MYBPC1,Hypo
2870,GO_Biological_Process_2018,regulation of actin filament depolymerization (GO:0030834),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,PDXP,Hypo
2871,GO_Biological_Process_2018,biotin metabolic process (GO:0006768),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,ACACB,Hypo
2872,GO_Biological_Process_2018,positive regulation of histone deacetylation (GO:0031065),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,PRKD2,Hypo
2873,GO_Biological_Process_2018,purine nucleobase metabolic process (GO:0006144),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,MTHFD1,Hypo
2874,GO_Biological_Process_2018,regulation of hemopoiesis (GO:1903706),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,PRKCB,Hypo
2875,GO_Biological_Process_2018,rRNA base methylation (GO:0070475),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,BUD23,Hypo
2876,GO_Biological_Process_2018,regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901407),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,BRD4,Hypo
2877,GO_Biological_Process_2018,monocyte differentiation (GO:0030224),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,MYH9,Hypo
2878,GO_Biological_Process_2018,T cell proliferation (GO:0042098),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,TNFRSF4,Hypo
2879,GO_Biological_Process_2018,positive regulation of chromosome segregation (GO:0051984),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,NUMA1,Hypo
2880,GO_Biological_Process_2018,positive regulation of actin filament depolymerization (GO:0030836),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,PDXP,Hypo
2881,GO_Biological_Process_2018,sphingolipid catabolic process (GO:0030149),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,SMPD4,Hypo
2882,GO_Biological_Process_2018,negative regulation of cellular senescence (GO:2000773),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,RBL1,Hypo
2883,GO_Biological_Process_2018,transcytosis (GO:0045056),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,LRP1,Hypo
2884,GO_Biological_Process_2018,cellular response to interleukin-2 (GO:0071352),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,PTK2B,Hypo
2885,GO_Biological_Process_2018,response to sterol (GO:0036314),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,RORA,Hypo
2886,GO_Biological_Process_2018,negative regulation of nucleocytoplasmic transport (GO:0046823),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,CABP1,Hypo
2887,GO_Biological_Process_2018,histone mRNA catabolic process (GO:0071044),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,UPF1,Hypo
2888,GO_Biological_Process_2018,negative regulation of receptor binding (GO:1900121),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,PTPRF,Hypo
2889,GO_Biological_Process_2018,positive regulation of fatty acid biosynthetic process (GO:0045723),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,MID1IP1,Hypo
2890,GO_Biological_Process_2018,regulation of cholesterol esterification (GO:0010872),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,ABCG1,Hypo
2891,GO_Biological_Process_2018,cell part morphogenesis (GO:0032990),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,PACSIN2,Hypo
2892,GO_Biological_Process_2018,t-circle formation (GO:0090656),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,ERCC1,Hypo
2893,GO_Biological_Process_2018,photoreceptor cell development (GO:0042461),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,MAPRE2,Hypo
2894,GO_Biological_Process_2018,inhibition of cysteine-type endopeptidase activity involved in apoptotic process (GO:1990001),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,BIRC6,Hypo
2895,GO_Biological_Process_2018,magnesium ion transport (GO:0015693),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,MRS2,Hypo
2896,GO_Biological_Process_2018,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,CALM3,Hypo
2897,GO_Biological_Process_2018,epithelial cell-cell adhesion (GO:0090136),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,KIT,Hypo
2898,GO_Biological_Process_2018,oxidative phosphorylation (GO:0006119),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,TEFM,Hypo
2899,GO_Biological_Process_2018,icosanoid secretion (GO:0032309),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,ABCC4,Hypo
2900,GO_Biological_Process_2018,L-serine metabolic process (GO:0006563),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,SERINC5,Hypo
2901,GO_Biological_Process_2018,protein O-linked mannosylation (GO:0035269),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,DPM3,Hypo
2902,GO_Biological_Process_2018,erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,HGD,Hypo
2903,GO_Biological_Process_2018,telomere maintenance via telomere trimming (GO:0090737),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,ERCC1,Hypo
2904,GO_Biological_Process_2018,regulation of receptor biosynthetic process (GO:0010869),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,NR1D1,Hypo
2905,GO_Biological_Process_2018,presynaptic membrane organization (GO:0097090),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,LRP4,Hypo
2906,GO_Biological_Process_2018,protein carboxylation (GO:0018214),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,F2,Hypo
2907,GO_Biological_Process_2018,midbrain dopaminergic neuron differentiation (GO:1904948),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,WNT9B,Hypo
2908,GO_Biological_Process_2018,regulation of mRNA polyadenylation (GO:1900363),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,CPEB3,Hypo
2909,GO_Biological_Process_2018,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,PPP1R16B,Hypo
2910,GO_Biological_Process_2018,peptidyl-glutamic acid carboxylation (GO:0017187),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,F2,Hypo
2911,GO_Biological_Process_2018,L-phenylalanine metabolic process (GO:0006558),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,HGD,Hypo
2912,GO_Biological_Process_2018,regulation of stem cell population maintenance (GO:2000036),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,WNT9B,Hypo
2913,GO_Biological_Process_2018,microtubule anchoring at microtubule organizing center (GO:0072393),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,BBS4,Hypo
2914,GO_Biological_Process_2018,regulation of histone deacetylation (GO:0031063),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,FOXP3,Hypo
2915,GO_Biological_Process_2018,carnitine metabolic process (GO:0009437),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,ACADL,Hypo
2916,GO_Biological_Process_2018,regulation of trophoblast cell migration (GO:1901163),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,AGO2,Hypo
2917,GO_Biological_Process_2018,negative regulation of protein localization to nucleus (GO:1900181),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,CABP1,Hypo
2918,GO_Biological_Process_2018,regulation of inclusion body assembly (GO:0090083),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,DNAJB2,Hypo
2919,GO_Biological_Process_2018,positive regulation of superoxide anion generation (GO:0032930),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,MAPT,Hypo
2920,GO_Biological_Process_2018,UV-damage excision repair (GO:0070914),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,ERCC1,Hypo
2921,GO_Biological_Process_2018,negative regulation of bone mineralization (GO:0030502),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,PTK2B,Hypo
2922,GO_Biological_Process_2018,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,DAB2IP,Hypo
2923,GO_Biological_Process_2018,positive regulation of receptor biosynthetic process (GO:0010870),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,SCAP,Hypo
2924,GO_Biological_Process_2018,low-density lipoprotein particle remodeling (GO:0034374),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,ABCG1,Hypo
2925,GO_Biological_Process_2018,regulation of non-canonical Wnt signaling pathway (GO:2000050),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,TIAM1,Hypo
2926,GO_Biological_Process_2018,somite development (GO:0061053),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,MTHFD1,Hypo
2927,GO_Biological_Process_2018,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,MAD1L1,Hypo
2928,GO_Biological_Process_2018,internal protein amino acid acetylation (GO:0006475),1/11,0.676561777270634,0.9089327628927713,0,0,0.9256028732683428,0.3616622144314591,MAPT,Hypo
2929,GO_Biological_Process_2018,anatomical structure homeostasis (GO:0060249),3/35,0.6767960887444777,0.9089327628927713,0,0,0.8675847457627118,0.3386922876527123,PARP3;XRCC6;STN1,Hypo
2930,GO_Biological_Process_2018,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),3/35,0.6767960887444777,0.9089327628927713,0,0,0.8675847457627118,0.3386922876527123,RAD51;BHLHE40;SETMAR,Hypo
2931,GO_Biological_Process_2018,positive regulation of osteoblast differentiation (GO:0045669),3/35,0.6767960887444777,0.9089327628927713,0,0,0.8675847457627118,0.3386922876527123,FBN2;TMEM119;RUNX2,Hypo
2932,GO_Biological_Process_2018,sulfur compound catabolic process (GO:0044273),3/35,0.6767960887444777,0.9089327628927713,0,0,0.8675847457627118,0.3386922876527123,CSPG4;MLYCD;GNS,Hypo
2933,GO_Biological_Process_2018,ubiquitin-dependent ERAD pathway (GO:0030433),5/58,0.6791699898564608,0.9118100170567824,0,0,0.8729204054906146,0.3377187893310228,NPLOC4;UBE4B;ERLIN2;RNF121;UBQLN2,Hypo
2934,GO_Biological_Process_2018,protein import into nucleus (GO:0006606),9/103,0.6842986168972485,0.9181898014672256,0,0,0.8857246210003618,0.3360092736260394,RERE;OPRD1;IPO9;NUP188;BCL6;NUP133;TRPS1;TSC2;TNPO1,Hypo
2935,GO_Biological_Process_2018,fatty acid biosynthetic process (GO:0006633),4/47,0.6850644184737106,0.9181898014672256,0,0,0.8607758311623127,0.3255819193173114,ACOT7;ABHD2;TECR;MLYCD,Hypo
2936,GO_Biological_Process_2018,cellular response to heat (GO:0034605),4/47,0.6850644184737106,0.9181898014672256,0,0,0.8607758311623127,0.3255819193173114,BAG3;RBBP7;MAPT;FGF1,Hypo
2937,GO_Biological_Process_2018,response to glucose (GO:0009749),4/47,0.6850644184737106,0.9181898014672256,0,0,0.8607758311623127,0.3255819193173114,EIF2B5;IRS2;GPLD1;PCK2,Hypo
2938,GO_Biological_Process_2018,positive regulation of cellular metabolic process (GO:0031325),8/92,0.685087541638024,0.9181898014672256,0,0,0.8810749840615958,0.3332301810404748,NSF;FASN;ECE1;INHBA;F2;MAPK14;ACACB;RNF41,Hypo
2939,GO_Biological_Process_2018,sensory perception of light stimulus (GO:0050953),7/81,0.6866711648084456,0.9199992238709072,0,0,0.8751582256471603,0.3289717627786773,ABLIM1;USH1G;OPA3;GRM8;USH1C;USH2A;RPGR,Hypo
2940,GO_Biological_Process_2018,ubiquitin-dependent protein catabolic process (GO:0006511),31/341,0.6871640928052309,0.9203466037265572,0,0,0.9244398124022928,0.3468333266469102,TGFB1I1;UBR4;NEDD4L;UBE2D1;RNF19B;KLHL11;AGAP3;UBE3B;FBXO21;RMND5B;TRIM9;BTBD3;MVB12B;BTRC;RFFL;AREL1;NHLRC3;ANAPC7;SMURF1;KLHL3;UBE4B;PPP2R5C;FBXO10;TRPC4AP;RNF144B;SPSB1;NPLOC4;UBXN11;DDIT3;KCTD13;RBCK1,Hypo
2941,GO_Biological_Process_2018,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),2/24,0.6938606308665171,0.92191250603386,0,0,0.8413291021093896,0.3074924590906396,DDIT3;DAB2IP,Hypo
2942,GO_Biological_Process_2018,neuromuscular synaptic transmission (GO:0007274),2/24,0.6938606308665171,0.92191250603386,0,0,0.8413291021093896,0.3074924590906396,KIF1B;TSPOAP1,Hypo
2943,GO_Biological_Process_2018,negative regulation of T cell proliferation (GO:0042130),2/24,0.6938606308665171,0.92191250603386,0,0,0.8413291021093896,0.3074924590906396,PRKAR1A;FOXP3,Hypo
2944,GO_Biological_Process_2018,cGMP biosynthetic process (GO:0006182),2/24,0.6938606308665171,0.92191250603386,0,0,0.8413291021093896,0.3074924590906396,ADCY9;ADCY3,Hypo
2945,GO_Biological_Process_2018,regulation of cellular senescence (GO:2000772),2/24,0.6938606308665171,0.92191250603386,0,0,0.8413291021093896,0.3074924590906396,RBL1;VASH1,Hypo
2946,GO_Biological_Process_2018,positive regulation of immune effector process (GO:0002699),2/24,0.6938606308665171,0.92191250603386,0,0,0.8413291021093896,0.3074924590906396,MYO18A;IL12RB1,Hypo
2947,GO_Biological_Process_2018,regulation of actin filament bundle assembly (GO:0032231),2/24,0.6938606308665171,0.92191250603386,0,0,0.8413291021093896,0.3074924590906396,SHANK3;SLC9A1,Hypo
2948,GO_Biological_Process_2018,renal system development (GO:0072001),5/59,0.6938697497643748,0.92191250603386,0,0,0.8567076073502808,0.3131018001395459,IFT140;LRP4;ITGA6;PKD1;SULF2,Hypo
2949,GO_Biological_Process_2018,dicarboxylic acid metabolic process (GO:0043648),5/59,0.6938697497643748,0.92191250603386,0,0,0.8567076073502808,0.3131018001395459,ALDH5A1;MTHFD1;GPT2;IDH2;HOGA1,Hypo
2950,GO_Biological_Process_2018,mRNA transport (GO:0051028),9/104,0.695403779123426,0.92191250603386,0,0,0.8763523956723338,0.3183460716447437,UPF1;NUP188;NUP133;KIF5C;ZC3H11A;SYMPK;SRSF4;SMG5;SMG6,Hypo
2951,GO_Biological_Process_2018,heart looping (GO:0001947),3/36,0.6954855250472434,0.92191250603386,0,0,0.8412476070411355,0.3054949296702237,ZIC3;BBS4;CCDC40,Hypo
2952,GO_Biological_Process_2018,histone deacetylation (GO:0016575),3/36,0.6954855250472434,0.92191250603386,0,0,0.8412476070411355,0.3054949296702237,PER2;HDAC5;PER1,Hypo
2953,GO_Biological_Process_2018,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",3/36,0.6954855250472434,0.92191250603386,0,0,0.8412476070411355,0.3054949296702237,TNRC6C;CAMK2A;AGO2,Hypo
2954,GO_Biological_Process_2018,acylglycerol metabolic process (GO:0006639),3/36,0.6954855250472434,0.92191250603386,0,0,0.8412476070411355,0.3054949296702237,ABHD2;DGKZ;MGLL,Hypo
2955,GO_Biological_Process_2018,regulation of ubiquitin protein ligase activity (GO:1904666),3/36,0.6954855250472434,0.92191250603386,0,0,0.8412476070411355,0.3054949296702237,GOLGA2;ANAPC7;UBE2D1,Hypo
2956,GO_Biological_Process_2018,negative regulation of blood coagulation (GO:0030195),3/36,0.6954855250472434,0.92191250603386,0,0,0.8412476070411355,0.3054949296702237,PDGFRA;PDGFA;F2,Hypo
2957,GO_Biological_Process_2018,negative regulation of NF-kappaB transcription factor activity (GO:0032088),7/82,0.6990737072367942,0.92191250603386,0,0,0.8634414136215475,0.3091112451945583,NLRP10;NFKBIL1;OTULIN;DAB2IP;RBCK1;FOXP3;CMKLR1,Hypo
2958,GO_Biological_Process_2018,positive regulation of protein secretion (GO:0050714),7/82,0.6990737072367942,0.92191250603386,0,0,0.8634414136215475,0.3091112451945583,CADM1;TGFB3;MYO18A;IRS2;ATP13A2;TNFRSF4;MYH10,Hypo
2959,GO_Biological_Process_2018,C-terminal protein amino acid modification (GO:0018410),7/82,0.6990737072367942,0.92191250603386,0,0,0.8634414136215475,0.3091112451945583,NTNG2;NRN1L;NEGR1;NTM;RTN4RL2;CNTN3;GPLD1,Hypo
2960,GO_Biological_Process_2018,protein K48-linked ubiquitination (GO:0070936),4/48,0.7011341490093187,0.92191250603386,0,0,0.841166028216388,0.2986610808091949,UBE2D1;NEDD4L;KLHL3;RFFL,Hypo
2961,GO_Biological_Process_2018,regulation of cell cycle arrest (GO:0071156),4/48,0.7011341490093187,0.92191250603386,0,0,0.841166028216388,0.2986610808091949,CDK5;BIN1;DAB2IP;SETMAR,Hypo
2962,GO_Biological_Process_2018,recombinational repair (GO:0000725),6/71,0.7026326839234996,0.92191250603386,0,0,0.853988603988604,0.3013905306365808,RAD51;AP5Z1;NSMCE2;RECQL;PALB2;FAN1,Hypo
2963,GO_Biological_Process_2018,organelle membrane fusion (GO:0090174),6/71,0.7026326839234996,0.92191250603386,0,0,0.853988603988604,0.3013905306365808,SYT12;STX8;STX3;SYT13;STX1A;SYT7,Hypo
2964,GO_Biological_Process_2018,vesicle organization (GO:0016050),11/127,0.704328880314211,0.92191250603386,0,0,0.8770695879497075,0.3074215493335335,ARFGEF2;SYT12;SORT1;STX8;AKTIP;VPS11;STX3;SYT13;STX1A;SYT7;DNM1,Hypo
2965,GO_Biological_Process_2018,mRNA export from nucleus (GO:0006406),9/105,0.7062606988028833,0.92191250603386,0,0,0.8671754250386399,0.3015783328340027,UPF1;NUP188;NUP133;ZC3H11A;ZC3H3;SYMPK;SRSF4;SMG5;SMG6,Hypo
2966,GO_Biological_Process_2018,RNA processing (GO:0006396),17/193,0.7063281878706286,0.92191250603386,0,0,0.8931536001504962,0.3105274406622379,SRPK2;MBNL1;SF3B2;NUFIP1;PABPC4;DDX54;TSEN54;SRPK1;PPP1R9B;DHX30;ATXN1;SON;RRAGC;DHX34;HNRNPF;DROSHA;SRSF4,Hypo
2967,GO_Biological_Process_2018,muscle organ development (GO:0007517),5/60,0.7081005257933295,0.92191250603386,0,0,0.8410843655059593,0.2903164258030473,SGCE;SPEG;COL6A3;CHD2;MEF2D,Hypo
2968,GO_Biological_Process_2018,regulation of systemic arterial blood pressure (GO:0003073),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,SLC2A5,Hypo
2969,GO_Biological_Process_2018,axonal fasciculation (GO:0007413),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,EPHB2,Hypo
2970,GO_Biological_Process_2018,fatty acid elongation (GO:0030497),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,TECR,Hypo
2971,GO_Biological_Process_2018,viral RNA genome replication (GO:0039694),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,PI4KA,Hypo
2972,GO_Biological_Process_2018,regulation of rRNA processing (GO:2000232),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,BUD23,Hypo
2973,GO_Biological_Process_2018,nucleoside catabolic process (GO:0009164),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,DERA,Hypo
2974,GO_Biological_Process_2018,cell wall macromolecule catabolic process (GO:0016998),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,LYZL4,Hypo
2975,GO_Biological_Process_2018,nonribosomal peptide biosynthetic process (GO:0019184),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,BDH2,Hypo
2976,GO_Biological_Process_2018,regulation of interleukin-2 biosynthetic process (GO:0045076),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,FOXP3,Hypo
2977,GO_Biological_Process_2018,"alternative mRNA splicing, via spliceosome (GO:0000380)",1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,CELF4,Hypo
2978,GO_Biological_Process_2018,cellular glucan metabolic process (GO:0006073),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,PRKAG2,Hypo
2979,GO_Biological_Process_2018,positive regulation of ruffle assembly (GO:1900029),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,PLEKHM1,Hypo
2980,GO_Biological_Process_2018,tRNA 5'-leader removal (GO:0001682),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,POP5,Hypo
2981,GO_Biological_Process_2018,positive regulation of pseudopodium assembly (GO:0031274),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,CDC42EP1,Hypo
2982,GO_Biological_Process_2018,activation of cysteine-type endopeptidase activity (GO:0097202),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,CYFIP2,Hypo
2983,GO_Biological_Process_2018,regulation of mononuclear cell migration (GO:0071675),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,CMKLR1,Hypo
2984,GO_Biological_Process_2018,regulation of pseudopodium assembly (GO:0031272),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,CDC42EP1,Hypo
2985,GO_Biological_Process_2018,negative regulation of vascular smooth muscle cell proliferation (GO:1904706),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,TGFB3,Hypo
2986,GO_Biological_Process_2018,"regulation of protein import into nucleus, translocation (GO:0033158)",1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,PDE2A,Hypo
2987,GO_Biological_Process_2018,negative regulation of ATP metabolic process (GO:1903579),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,CBFA2T3,Hypo
2988,GO_Biological_Process_2018,regulation of angiotensin levels in blood (GO:0002002),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,ECE1,Hypo
2989,GO_Biological_Process_2018,protein hydroxylation (GO:0018126),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,P3H1,Hypo
2990,GO_Biological_Process_2018,regulation of blood vessel size (GO:0050880),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,ITGB1BP1,Hypo
2991,GO_Biological_Process_2018,establishment of protein localization to mitochondrial membrane (GO:0090151),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,SAMM50,Hypo
2992,GO_Biological_Process_2018,PERK-mediated unfolded protein response (GO:0036499),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,DDIT3,Hypo
2993,GO_Biological_Process_2018,regulation of vascular endothelial cell proliferation (GO:1905562),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,HMGB1,Hypo
2994,GO_Biological_Process_2018,regulation of hormone secretion (GO:0046883),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,SCG5,Hypo
2995,GO_Biological_Process_2018,plasma membrane tubulation (GO:0097320),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,PACSIN2,Hypo
2996,GO_Biological_Process_2018,endosome transport via multivesicular body sorting pathway (GO:0032509),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,SORT1,Hypo
2997,GO_Biological_Process_2018,positive regulation of stem cell differentiation (GO:2000738),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,SOX5,Hypo
2998,GO_Biological_Process_2018,positive regulation of mRNA metabolic process (GO:1903313),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,UPF1,Hypo
2999,GO_Biological_Process_2018,dermatan sulfate biosynthetic process (GO:0030208),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,CSPG4,Hypo
3000,GO_Biological_Process_2018,negative regulation of interleukin-12 production (GO:0032695),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,CMKLR1,Hypo
3001,GO_Biological_Process_2018,negative regulation of androgen receptor signaling pathway (GO:0060766),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,SMARCA4,Hypo
3002,GO_Biological_Process_2018,keratan sulfate catabolic process (GO:0042340),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,GNS,Hypo
3003,GO_Biological_Process_2018,regulation of sister chromatid cohesion (GO:0007063),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,AXIN2,Hypo
3004,GO_Biological_Process_2018,protein kinase C-activating G-protein coupled receptor signaling pathway (GO:0007205),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,DGKH,Hypo
3005,GO_Biological_Process_2018,positive regulation of T cell cytokine production (GO:0002726),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,PRKCZ,Hypo
3006,GO_Biological_Process_2018,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,RASGRP1,Hypo
3007,GO_Biological_Process_2018,positive regulation of protein depolymerization (GO:1901881),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,PDXP,Hypo
3008,GO_Biological_Process_2018,positive regulation of lyase activity (GO:0051349),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,NF1,Hypo
3009,GO_Biological_Process_2018,regulation of vasculogenesis (GO:2001212),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,RAPGEF2,Hypo
3010,GO_Biological_Process_2018,signal transduction involved in G2 DNA damage checkpoint (GO:0072425),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,BABAM2,Hypo
3011,GO_Biological_Process_2018,regulation of IRE1-mediated unfolded protein response (GO:1903894),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,DAB2IP,Hypo
3012,GO_Biological_Process_2018,iron ion transport (GO:0006826),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,SLC25A28,Hypo
3013,GO_Biological_Process_2018,modification-dependent macromolecule catabolic process (GO:0043632),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,UBL4A,Hypo
3014,GO_Biological_Process_2018,cellular modified amino acid catabolic process (GO:0042219),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,HOGA1,Hypo
3015,GO_Biological_Process_2018,cell differentiation in hindbrain (GO:0021533),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,FAIM2,Hypo
3016,GO_Biological_Process_2018,entry of bacterium into host cell (GO:0035635),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,SRC,Hypo
3017,GO_Biological_Process_2018,endochondral bone morphogenesis (GO:0060350),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,COL13A1,Hypo
3018,GO_Biological_Process_2018,epithelial structure maintenance (GO:0010669),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,MUC2,Hypo
3019,GO_Biological_Process_2018,positive regulation of skeletal muscle tissue development (GO:0048643),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,FAM129B,Hypo
3020,GO_Biological_Process_2018,histone arginine methylation (GO:0034969),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,PRMT8,Hypo
3021,GO_Biological_Process_2018,regulation of actomyosin structure organization (GO:0110020),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,SLC9A1,Hypo
3022,GO_Biological_Process_2018,skeletal muscle fiber development (GO:0048741),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,RYR1,Hypo
3023,GO_Biological_Process_2018,pre-mRNA cleavage required for polyadenylation (GO:0098789),1/12,0.7081142316698874,0.92191250603386,0,0,0.8414105135500723,0.290412716020708,CSTF2,Hypo
3024,GO_Biological_Process_2018,cellular response to fibroblast growth factor stimulus (GO:0044344),8/94,0.7082140334137482,0.92191250603386,0,0,0.8604890666538931,0.2968764069074617,KL;NR4A1;DSTYK;HNRNPF;ITGB1BP1;PTPN11;FGF1;FGFR2,Hypo
3025,GO_Biological_Process_2018,positive regulation of sequence-specific DNA binding transcription factor activity (GO:0051091),19/215,0.7082272767855954,0.92191250603386,0,0,0.8962946131326689,0.3092128797067364,OPRD1;HDAC5;PRKCH;CRTC3;PRKCB;CRTC1;NFAM1;BUD31;CAMK2A;PRKCZ;SMARCA4;TRIM5;DDIT3;KIT;DVL2;PRKD2;RBCK1;ARHGEF2;CARD11,Hypo
3026,GO_Biological_Process_2018,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),26/291,0.7102260462000357,0.9242089183950912,0,0,0.9069352371239164,0.3103278300698926,NEDD4L;UBE2D1;KLHL11;UBR2;AGAP3;RMND5B;TRIM9;BTBD3;BTRC;RFFL;UBQLN2;NHLRC3;ANAPC7;SMURF1;FBXL18;UBE4B;ERLIN2;PPP2R5C;FBXO31;SPSB1;NPLOC4;UBXN11;DDIT3;KCTD13;RBCK1;RNF121,Hypo
3027,GO_Biological_Process_2018,sodium-independent organic anion transport (GO:0043252),3/37,0.7133444234160256,0.9261462303907056,0,0,0.8164597117737696,0.275792671394546,SLC22A23;SLC22A17;SLCO2B1,Hypo
3028,GO_Biological_Process_2018,response to steroid hormone (GO:0048545),3/37,0.7133444234160256,0.9261462303907056,0,0,0.8164597117737696,0.275792671394546,TGFB3;ABHD2;ATP1A2,Hypo
3029,GO_Biological_Process_2018,organophosphate ester transport (GO:0015748),2/25,0.7154236688282665,0.9261462303907056,0,0,0.8047049370591911,0.2694798854193097,SCARB1;LDLR,Hypo
3030,GO_Biological_Process_2018,regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000058),2/25,0.7154236688282665,0.9261462303907056,0,0,0.8047049370591911,0.2694798854193097,SMURF1;PTK2B,Hypo
3031,GO_Biological_Process_2018,positive regulation of nuclear division (GO:0051785),2/25,0.7154236688282665,0.9261462303907056,0,0,0.8047049370591911,0.2694798854193097,TGFA;EREG,Hypo
3032,GO_Biological_Process_2018,female gamete generation (GO:0007292),2/25,0.7154236688282665,0.9261462303907056,0,0,0.8047049370591911,0.2694798854193097,KMT2D;TOB2,Hypo
3033,GO_Biological_Process_2018,peptide hormone secretion (GO:0030072),2/25,0.7154236688282665,0.9261462303907056,0,0,0.8047049370591911,0.2694798854193097,CAMK2G;CDK16,Hypo
3034,GO_Biological_Process_2018,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),2/25,0.7154236688282665,0.9261462303907056,0,0,0.8047049370591911,0.2694798854193097,SULT4A1;PAPSS1,Hypo
3035,GO_Biological_Process_2018,regulation of vascular smooth muscle cell proliferation (GO:1904705),2/25,0.7154236688282665,0.9261462303907056,0,0,0.8047049370591911,0.2694798854193097,TGFB3;MEF2D,Hypo
3036,GO_Biological_Process_2018,positive regulation of calcium ion transmembrane transport (GO:1904427),2/25,0.7154236688282665,0.9261462303907056,0,0,0.8047049370591911,0.2694798854193097,AKAP6;F2,Hypo
3037,GO_Biological_Process_2018,L-amino acid transport (GO:0015807),2/25,0.7154236688282665,0.9261462303907056,0,0,0.8047049370591911,0.2694798854193097,SLC7A5;SLC6A17,Hypo
3038,GO_Biological_Process_2018,positive regulation of interleukin-12 production (GO:0032735),2/25,0.7154236688282665,0.9261462303907056,0,0,0.8047049370591911,0.2694798854193097,HMGB1;MAPK14,Hypo
3039,GO_Biological_Process_2018,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),2/25,0.7154236688282665,0.9261462303907056,0,0,0.8047049370591911,0.2694798854193097,AKAP6;CALM3,Hypo
3040,GO_Biological_Process_2018,misfolded or incompletely synthesized protein catabolic process (GO:0006515),2/25,0.7154236688282665,0.9261462303907056,0,0,0.8047049370591911,0.2694798854193097,UGGT2;UGGT1,Hypo
3041,GO_Biological_Process_2018,lipid biosynthetic process (GO:0008610),6/72,0.715476765442731,0.9261462303907056,0,0,0.8410026187803965,0.2815728520359669,AGPAT5;SREBF1;GNPAT;GPAM;MLYCD;AGPAT4,Hypo
3042,GO_Biological_Process_2018,glycoprotein biosynthetic process (GO:0009101),6/72,0.715476765442731,0.9261462303907056,0,0,0.8410026187803965,0.2815728520359669,GOLGA2;TNIP1;B3GALT1;POMGNT1;DDOST;ST3GAL2,Hypo
3043,GO_Biological_Process_2018,organic hydroxy compound biosynthetic process (GO:1901617),4/49,0.7166033576082633,0.9269952793494086,0,0,0.8224277720680598,0.2740598999507757,PER2;OSBPL2;PRKAG2;HSD17B4,Hypo
3044,GO_Biological_Process_2018,positive regulation of response to DNA damage stimulus (GO:2001022),4/49,0.7166033576082633,0.9269952793494086,0,0,0.8224277720680598,0.2740598999507757,BABAM2;EYA1;EYA2;NACC2,Hypo
3045,GO_Biological_Process_2018,protein modification process (GO:0036211),7/84,0.7228974278592297,0.9314376252138962,0,0,0.8409207879099799,0.2728686517071542,UBL4A;CSNK1G3;MSRA;RPN1;ABL1;ABL2;ST3GAL6,Hypo
3046,GO_Biological_Process_2018,cellular response to molecule of bacterial origin (GO:0071219),7/84,0.7228974278592297,0.9314376252138962,0,0,0.8409207879099799,0.2728686517071542,UPF1;SBNO2;TNIP1;NFKBIL1;DAB2IP;NR1D1;MAPK14,Hypo
3047,GO_Biological_Process_2018,viral life cycle (GO:0019058),9/107,0.7272187328699874,0.9314376252138962,0,0,0.8493833391161719,0.2705523560083243,GRK2;NUP188;CTBP2;NUP133;MVB12B;NEDD4L;FURIN;VPS37B;CHMP5,Hypo
3048,GO_Biological_Process_2018,positive regulation of epithelial cell proliferation (GO:0050679),9/107,0.7272187328699874,0.9314376252138962,0,0,0.8493833391161719,0.2705523560083243,PPP1R16B;NR4A1;STXBP4;FLT4;VASH2;TGFA;PRKCA;PRKD2;FGFR2,Hypo
3049,GO_Biological_Process_2018,negative regulation of response to external stimulus (GO:0032102),9/107,0.7272187328699874,0.9314376252138962,0,0,0.8493833391161719,0.2705523560083243,PTPRS;NLRP10;NFKBIL1;OTULIN;TYRO3;RORA;TRIB1;AJAP1;PPARD,Hypo
3050,GO_Biological_Process_2018,nucleic acid phosphodiester bond hydrolysis (GO:0090305),6/73,0.7279329000411491,0.9314376252138962,0,0,0.8284042749216879,0.2630567996419515,EDC4;ERCC1;ERCC2;SETMAR;DCP1A;FAN1,Hypo
3051,GO_Biological_Process_2018,regulation of cell death (GO:0010941),8/96,0.7302014312827146,0.9314376252138962,0,0,0.8408388727647224,0.2643890445278039,TBK1;LRP1;RILPL1;LRRK2;AXIN2;PDE8A;EPHB1;CRYAB,Hypo
3052,GO_Biological_Process_2018,positive regulation of innate immune response (GO:0045089),3/38,0.7303825117398003,0.9314376252138962,0,0,0.7930882676645389,0.2491779390009246,POLR3B;POLR3G;EREG,Hypo
3053,GO_Biological_Process_2018,regulation of ossification (GO:0030278),3/38,0.7303825117398003,0.9314376252138962,0,0,0.7930882676645389,0.2491779390009246,ZBTB16;LRP4;FGFR2,Hypo
3054,GO_Biological_Process_2018,chemical homeostasis (GO:0048878),3/38,0.7303825117398003,0.9314376252138962,0,0,0.7930882676645389,0.2491779390009246,NEDD4L;IRS2;KLHL3,Hypo
3055,GO_Biological_Process_2018,regulation of type I interferon production (GO:0032479),7/85,0.7343142539801771,0.9314376252138962,0,0,0.8300935640101877,0.2563480028054573,XRCC6;TBK1;NPLOC4;POLR3B;POLR3G;PIN1;DTX4,Hypo
3056,GO_Biological_Process_2018,cellular amide metabolic process (GO:0043603),5/62,0.7351496939011429,0.9314376252138962,0,0,0.8114824335904027,0.2496778364711897,MIPEP;CERK;FASN;CPXM1;ACACB,Hypo
3057,GO_Biological_Process_2018,stress-activated MAPK cascade (GO:0051403),5/62,0.7351496939011429,0.9314376252138962,0,0,0.8114824335904027,0.2496778364711897,CCM2;BTRC;TRIB1;MAPK14;MAP3K11,Hypo
3058,GO_Biological_Process_2018,second-messenger-mediated signaling (GO:0019932),5/62,0.7351496939011429,0.9314376252138962,0,0,0.8114824335904027,0.2496778364711897,RYR2;LRRK2;PPP1R9A;PPP1R9B;CAMKK2,Hypo
3059,GO_Biological_Process_2018,bile acid biosynthetic process (GO:0006699),2/26,0.7356946763071037,0.9314376252138962,0,0,0.7711327857631759,0.2366915653516635,OSBPL2;HSD17B4,Hypo
3060,GO_Biological_Process_2018,response to ketone (GO:1901654),2/26,0.7356946763071037,0.9314376252138962,0,0,0.7711327857631759,0.2366915653516635,TGFB3;ABHD2,Hypo
3061,GO_Biological_Process_2018,internal peptidyl-lysine acetylation (GO:0018393),2/26,0.7356946763071037,0.9314376252138962,0,0,0.7711327857631759,0.2366915653516635,TRRAP;KAT6A,Hypo
3062,GO_Biological_Process_2018,regulation of viral entry into host cell (GO:0046596),2/26,0.7356946763071037,0.9314376252138962,0,0,0.7711327857631759,0.2366915653516635,TRIM5;TRIM11,Hypo
3063,GO_Biological_Process_2018,strand displacement (GO:0000732),2/26,0.7356946763071037,0.9314376252138962,0,0,0.7711327857631759,0.2366915653516635,RAD51;PALB2,Hypo
3064,GO_Biological_Process_2018,GPI anchor metabolic process (GO:0006505),2/26,0.7356946763071037,0.9314376252138962,0,0,0.7711327857631759,0.2366915653516635,DPM3;GPLD1,Hypo
3065,GO_Biological_Process_2018,regulation of rhodopsin mediated signaling pathway (GO:0022400),2/26,0.7356946763071037,0.9314376252138962,0,0,0.7711327857631759,0.2366915653516635,FNTB;NMT1,Hypo
3066,GO_Biological_Process_2018,snRNA 3'-end processing (GO:0034472),2/26,0.7356946763071037,0.9314376252138962,0,0,0.7711327857631759,0.2366915653516635,INTS1;INTS7,Hypo
3067,GO_Biological_Process_2018,RNA biosynthetic process (GO:0032774),2/26,0.7356946763071037,0.9314376252138962,0,0,0.7711327857631759,0.2366915653516635,TCF4;TAF4,Hypo
3068,GO_Biological_Process_2018,monovalent inorganic cation homeostasis (GO:0055067),2/26,0.7356946763071037,0.9314376252138962,0,0,0.7711327857631759,0.2366915653516635,PDK2;SLC9A1,Hypo
3069,GO_Biological_Process_2018,snRNA processing (GO:0016180),2/26,0.7356946763071037,0.9314376252138962,0,0,0.7711327857631759,0.2366915653516635,INTS1;INTS7,Hypo
3070,GO_Biological_Process_2018,dermatan sulfate metabolic process (GO:0030205),1/13,0.7365900488807531,0.9314376252138962,0,0,0.7712502137848469,0.2357895342254445,CSPG4,Hypo
3071,GO_Biological_Process_2018,signal transduction involved in DNA damage checkpoint (GO:0072422),1/13,0.7365900488807531,0.9314376252138962,0,0,0.7712502137848469,0.2357895342254445,BABAM2,Hypo
3072,GO_Biological_Process_2018,mitochondrial genome maintenance (GO:0000002),1/13,0.7365900488807531,0.9314376252138962,0,0,0.7712502137848469,0.2357895342254445,SLC25A4,Hypo
3073,GO_Biological_Process_2018,positive regulation of cardiac muscle cell proliferation (GO:0060045),1/13,0.7365900488807531,0.9314376252138962,0,0,0.7712502137848469,0.2357895342254445,FGFR2,Hypo
3074,GO_Biological_Process_2018,embryonic appendage morphogenesis (GO:0035113),1/13,0.7365900488807531,0.9314376252138962,0,0,0.7712502137848469,0.2357895342254445,MBNL1,Hypo
3075,GO_Biological_Process_2018,very long-chain fatty acid biosynthetic process (GO:0042761),1/13,0.7365900488807531,0.9314376252138962,0,0,0.7712502137848469,0.2357895342254445,TECR,Hypo
3076,GO_Biological_Process_2018,muscle cell development (GO:0055001),1/13,0.7365900488807531,0.9314376252138962,0,0,0.7712502137848469,0.2357895342254445,MEGF10,Hypo
3077,GO_Biological_Process_2018,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),1/13,0.7365900488807531,0.9314376252138962,0,0,0.7712502137848469,0.2357895342254445,ZFYVE28,Hypo
3078,GO_Biological_Process_2018,positive regulation of T cell mediated cytotoxicity (GO:0001916),1/13,0.7365900488807531,0.9314376252138962,0,0,0.7712502137848469,0.2357895342254445,IL12RB1,Hypo
3079,GO_Biological_Process_2018,tricarboxylic acid metabolic process (GO:0072350),1/13,0.7365900488807531,0.9314376252138962,0,0,0.7712502137848469,0.2357895342254445,IDH2,Hypo
3080,GO_Biological_Process_2018,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),1/13,0.7365900488807531,0.9314376252138962,0,0,0.7712502137848469,0.2357895342254445,NCOR2,Hypo
3081,GO_Biological_Process_2018,pathway-restricted SMAD protein phosphorylation (GO:0060389),1/13,0.7365900488807531,0.9314376252138962,0,0,0.7712502137848469,0.2357895342254445,SMAD7,Hypo
3082,GO_Biological_Process_2018,alpha-linolenic acid metabolic process (GO:0036109),1/13,0.7365900488807531,0.9314376252138962,0,0,0.7712502137848469,0.2357895342254445,HSD17B4,Hypo
3083,GO_Biological_Process_2018,cellular potassium ion homeostasis (GO:0030007),1/13,0.7365900488807531,0.9314376252138962,0,0,0.7712502137848469,0.2357895342254445,ATP1A2,Hypo
3084,GO_Biological_Process_2018,regulation of cAMP metabolic process (GO:0030814),1/13,0.7365900488807531,0.9314376252138962,0,0,0.7712502137848469,0.2357895342254445,RAMP1,Hypo
3085,GO_Biological_Process_2018,phosphate ion transport (GO:0006817),1/13,0.7365900488807531,0.9314376252138962,0,0,0.7712502137848469,0.2357895342254445,SLC37A1,Hypo
3086,GO_Biological_Process_2018,tetrahydrofolate metabolic process (GO:0046653),1/13,0.7365900488807531,0.9314376252138962,0,0,0.7712502137848469,0.2357895342254445,MTHFD1,Hypo
3087,GO_Biological_Process_2018,regulation of execution phase of apoptosis (GO:1900117),1/13,0.7365900488807531,0.9314376252138962,0,0,0.7712502137848469,0.2357895342254445,BOK,Hypo
3088,GO_Biological_Process_2018,mRNA modification (GO:0016556),1/13,0.7365900488807531,0.9314376252138962,0,0,0.7712502137848469,0.2357895342254445,TRMT61A,Hypo
3089,GO_Biological_Process_2018,establishment of chromosome localization (GO:0051303),1/13,0.7365900488807531,0.9314376252138962,0,0,0.7712502137848469,0.2357895342254445,TRAPPC12,Hypo
3090,GO_Biological_Process_2018,protein localization to endoplasmic reticulum (GO:0070972),1/13,0.7365900488807531,0.9314376252138962,0,0,0.7712502137848469,0.2357895342254445,RYR2,Hypo
3091,GO_Biological_Process_2018,motile cilium assembly (GO:0044458),1/13,0.7365900488807531,0.9314376252138962,0,0,0.7712502137848469,0.2357895342254445,CCDC40,Hypo
3092,GO_Biological_Process_2018,positive regulation of lamellipodium assembly (GO:0010592),1/13,0.7365900488807531,0.9314376252138962,0,0,0.7712502137848469,0.2357895342254445,TWF2,Hypo
3093,GO_Biological_Process_2018,negative regulation of hormone secretion (GO:0046888),1/13,0.7365900488807531,0.9314376252138962,0,0,0.7712502137848469,0.2357895342254445,RAB11FIP5,Hypo
3094,GO_Biological_Process_2018,positive regulation of ERAD pathway (GO:1904294),1/13,0.7365900488807531,0.9314376252138962,0,0,0.7712502137848469,0.2357895342254445,UBQLN2,Hypo
3095,GO_Biological_Process_2018,regulation of fibrinolysis (GO:0051917),1/13,0.7365900488807531,0.9314376252138962,0,0,0.7712502137848469,0.2357895342254445,F2,Hypo
3096,GO_Biological_Process_2018,nucleotide metabolic process (GO:0009117),1/13,0.7365900488807531,0.9314376252138962,0,0,0.7712502137848469,0.2357895342254445,PDE8A,Hypo
3097,GO_Biological_Process_2018,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),1/13,0.7365900488807531,0.9314376252138962,0,0,0.7712502137848469,0.2357895342254445,PLXND1,Hypo
3098,GO_Biological_Process_2018,chondroitin sulfate catabolic process (GO:0030207),1/13,0.7365900488807531,0.9314376252138962,0,0,0.7712502137848469,0.2357895342254445,CSPG4,Hypo
3099,GO_Biological_Process_2018,negative regulation of blood pressure (GO:0045776),1/13,0.7365900488807531,0.9314376252138962,0,0,0.7712502137848469,0.2357895342254445,RNLS,Hypo
3100,GO_Biological_Process_2018,regulation of cytolysis (GO:0042268),1/13,0.7365900488807531,0.9314376252138962,0,0,0.7712502137848469,0.2357895342254445,GPLD1,Hypo
3101,GO_Biological_Process_2018,regulation of retinoic acid receptor signaling pathway (GO:0048385),1/13,0.7365900488807531,0.9314376252138962,0,0,0.7712502137848469,0.2357895342254445,CTBP2,Hypo
3102,GO_Biological_Process_2018,regulation of leukocyte migration (GO:0002685),1/13,0.7365900488807531,0.9314376252138962,0,0,0.7712502137848469,0.2357895342254445,STK10,Hypo
3103,GO_Biological_Process_2018,high-density lipoprotein particle assembly (GO:0034380),1/13,0.7365900488807531,0.9314376252138962,0,0,0.7712502137848469,0.2357895342254445,ABCA1,Hypo
3104,GO_Biological_Process_2018,negative regulation of interleukin-10 production (GO:0032693),1/13,0.7365900488807531,0.9314376252138962,0,0,0.7712502137848469,0.2357895342254445,FOXP3,Hypo
3105,GO_Biological_Process_2018,ribonucleoprotein complex disassembly (GO:0032988),1/13,0.7365900488807531,0.9314376252138962,0,0,0.7712502137848469,0.2357895342254445,KLC1,Hypo
3106,GO_Biological_Process_2018,modulation by virus of host process (GO:0019054),1/13,0.7365900488807531,0.9314376252138962,0,0,0.7712502137848469,0.2357895342254445,EIF2AK4,Hypo
3107,GO_Biological_Process_2018,regulation of interleukin-1 beta production (GO:0032651),1/13,0.7365900488807531,0.9314376252138962,0,0,0.7712502137848469,0.2357895342254445,INAVA,Hypo
3108,GO_Biological_Process_2018,regulation of lymphocyte activation (GO:0051249),1/13,0.7365900488807531,0.9314376252138962,0,0,0.7712502137848469,0.2357895342254445,PAG1,Hypo
3109,GO_Biological_Process_2018,regulation of superoxide anion generation (GO:0032928),1/13,0.7365900488807531,0.9314376252138962,0,0,0.7712502137848469,0.2357895342254445,MAPT,Hypo
3110,GO_Biological_Process_2018,synaptic vesicle cycle (GO:0099504),1/13,0.7365900488807531,0.9314376252138962,0,0,0.7712502137848469,0.2357895342254445,SYT7,Hypo
3111,GO_Biological_Process_2018,striated muscle myosin thick filament assembly (GO:0071688),1/13,0.7365900488807531,0.9314376252138962,0,0,0.7712502137848469,0.2357895342254445,MYBPC1,Hypo
3112,GO_Biological_Process_2018,mRNA cleavage involved in mRNA processing (GO:0098787),1/13,0.7365900488807531,0.9314376252138962,0,0,0.7712502137848469,0.2357895342254445,CSTF2,Hypo
3113,GO_Biological_Process_2018,regulation of axon guidance (GO:1902667),1/13,0.7365900488807531,0.9314376252138962,0,0,0.7712502137848469,0.2357895342254445,ZSWIM8,Hypo
3114,GO_Biological_Process_2018,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),1/13,0.7365900488807531,0.9314376252138962,0,0,0.7712502137848469,0.2357895342254445,RASGRP1,Hypo
3115,GO_Biological_Process_2018,"regulation of gene expression, epigenetic (GO:0040029)",6/74,0.740000403456809,0.934849772038605,0,0,0.8161764705882353,0.245754446915518,HDAC5;H2AFY;DNMT3A;RBBP7;ERCC6;BAZ1B,Hypo
3116,GO_Biological_Process_2018,glucose homeostasis (GO:0042593),6/74,0.740000403456809,0.934849772038605,0,0,0.8161764705882353,0.245754446915518,HK3;HKDC1;CRY2;PIK3R1;PDK2;HK1,Hypo
3117,GO_Biological_Process_2018,mRNA 3'-end processing (GO:0031124),6/74,0.740000403456809,0.934849772038605,0,0,0.8161764705882353,0.245754446915518,AHCYL1;ZC3H3;ZC3H11A;CSTF2;SYMPK;SRSF4,Hypo
3118,GO_Biological_Process_2018,cellular response to DNA damage stimulus (GO:0006974),29/329,0.7443703849333725,0.9400689151178436,0,0,0.8931979871594655,0.2636868182442898,TRRAP;STXBP4;USP10;DOT1L;BABAM2;MACROD1;ABL1;APBB1;CLSPN;BOK;UPF1;PARP3;CCDC13;ZBTB38;RECQL;NFATC2;FANCC;BAZ1B;MAPK14;MTOR;FBXO31;RAD51;BCL6;FANCD2;DDIT3;ERCC1;MAPKAPK2;INTS7;FAN1,Hypo
3119,GO_Biological_Process_2018,response to organonitrogen compound (GO:0010243),4/51,0.7457510410501892,0.9409767215008902,0,0,0.7873433775775732,0.2309777771478058,RRAGC;QRFPR;INAVA;MTOR,Hypo
3120,GO_Biological_Process_2018,skeletal muscle tissue development (GO:0007519),3/39,0.7466130204305393,0.9409767215008902,0,0,0.771015237116932,0.2252970309100421,RYR1;IGSF8;LEMD2,Hypo
3121,GO_Biological_Process_2018,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),3/39,0.7466130204305393,0.9409767215008902,0,0,0.771015237116932,0.2252970309100421,IMPDH1;PPAT;PRKAG2,Hypo
3122,GO_Biological_Process_2018,positive regulation of phagocytosis (GO:0050766),3/39,0.7466130204305393,0.9409767215008902,0,0,0.771015237116932,0.2252970309100421,TUB;MYO18A;DOCK2,Hypo
3123,GO_Biological_Process_2018,purine ribonucleoside monophosphate metabolic process (GO:0009167),3/39,0.7466130204305393,0.9409767215008902,0,0,0.771015237116932,0.2252970309100421,IMPDH1;PPAT;ATP1A2,Hypo
3124,GO_Biological_Process_2018,mitotic DNA damage checkpoint (GO:0044773),3/39,0.7466130204305393,0.9409767215008902,0,0,0.771015237116932,0.2252970309100421,CLSPN;FOXN3;FBXO31,Hypo
3125,GO_Biological_Process_2018,kidney development (GO:0001822),5/63,0.7479695574380939,0.9409767215008902,0,0,0.7974470348373371,0.2315730371448107,ZBTB16;NF1;LRP4;PKD1;SULF2,Hypo
3126,GO_Biological_Process_2018,cellular response to hypoxia (GO:0071456),11/132,0.7508708641095208,0.9409767215008902,0,0,0.8405926203760139,0.2408479374287941,OPRD1;EGLN1;SLC8A3;EPO;EPAS1;HP1BP3;LMNA;UBE2D1;RORA;LIMD1;MTOR,Hypo
3127,GO_Biological_Process_2018,mitotic cell cycle phase transition (GO:0044772),19/221,0.7515024074426571,0.9409767215008902,0,0,0.8693797396311356,0.2483651571421296,DYNC1I2;DYNC1H1;CTDP1;ODF2;CEP164;CAMK2A;USH1C;INHBA;CCNB2;MELK;FGFR1OP;PIM2;BTRC;PCNT;PPP1R12B;CDK14;NINL;CLASP1;CLASP2,Hypo
3128,GO_Biological_Process_2018,negative regulation of cellular amide metabolic process (GO:0034249),6/75,0.7516797324055353,0.9409767215008902,0,0,0.8043030953658973,0.2295842435760663,BIN1;SAMD4B;HAP1;CPEB3;TOB1;SORL1,Hypo
3129,GO_Biological_Process_2018,regulation of defense response (GO:0031347),6/75,0.7516797324055353,0.9409767215008902,0,0,0.8043030953658973,0.2295842435760663,SEMA7A;SBNO2;BCL6;NLRP10;MGLL;BRD4,Hypo
3130,GO_Biological_Process_2018,purine ribonucleotide biosynthetic process (GO:0009152),6/75,0.7516797324055353,0.9409767215008902,0,0,0.8043030953658973,0.2295842435760663,ACOT7;ADCY9;IMPDH1;PRKAG2;ADCY3;PAPSS1,Hypo
3131,GO_Biological_Process_2018,ATP synthesis coupled proton transport (GO:0015986),2/27,0.7547204767248727,0.9409767215008902,0,0,0.7402464065708418,0.2083111333013103,TCIRG1;ATP6V0A1,Hypo
3132,GO_Biological_Process_2018,peptidyl-glutamic acid modification (GO:0018200),2/27,0.7547204767248727,0.9409767215008902,0,0,0.7402464065708418,0.2083111333013103,TTLL3;F2,Hypo
3133,GO_Biological_Process_2018,modulation by host of viral transcription (GO:0043921),2/27,0.7547204767248727,0.9409767215008902,0,0,0.7402464065708418,0.2083111333013103,CTDP1;SMARCA4,Hypo
3134,GO_Biological_Process_2018,regulation of protein localization to nucleus (GO:1900180),2/27,0.7547204767248727,0.9409767215008902,0,0,0.7402464065708418,0.2083111333013103,PIN1;F2,Hypo
3135,GO_Biological_Process_2018,negative regulation of myeloid leukocyte differentiation (GO:0002762),2/27,0.7547204767248727,0.9409767215008902,0,0,0.7402464065708418,0.2083111333013103,RARA;INHBA,Hypo
3136,GO_Biological_Process_2018,purine ribonucleoside triphosphate biosynthetic process (GO:0009206),2/27,0.7547204767248727,0.9409767215008902,0,0,0.7402464065708418,0.2083111333013103,IMPDH1;PRKAG2,Hypo
3137,GO_Biological_Process_2018,phosphatidylserine metabolic process (GO:0006658),2/27,0.7547204767248727,0.9409767215008902,0,0,0.7402464065708418,0.2083111333013103,PLA2G5;SERINC5,Hypo
3138,GO_Biological_Process_2018,regulation of blood vessel diameter (GO:0097746),2/27,0.7547204767248727,0.9409767215008902,0,0,0.7402464065708418,0.2083111333013103,PER2;ECE1,Hypo
3139,GO_Biological_Process_2018,cellular response to glucose stimulus (GO:0071333),2/27,0.7547204767248727,0.9409767215008902,0,0,0.7402464065708418,0.2083111333013103,PCK2;RAB11FIP5,Hypo
3140,GO_Biological_Process_2018,negative regulation of smooth muscle cell proliferation (GO:0048662),2/27,0.7547204767248727,0.9409767215008902,0,0,0.7402464065708418,0.2083111333013103,TGFB3;TRIB1,Hypo
3141,GO_Biological_Process_2018,leukocyte cell-cell adhesion (GO:0007159),2/27,0.7547204767248727,0.9409767215008902,0,0,0.7402464065708418,0.2083111333013103,SEMA4D;TNIP1,Hypo
3142,GO_Biological_Process_2018,response to lipopolysaccharide (GO:0032496),13/155,0.7555447260478296,0.9409767215008902,0,0,0.8463937990358257,0.2372579767588711,SCARB1;UPF1;NFKBIL1;TNFRSF9;DAB2IP;NR1D1;MAPK14;SBNO2;TNIP1;MAPKAPK2;TNFRSF25;TRIB1;TNFRSF4,Hypo
3143,GO_Biological_Process_2018,positive regulation of gene expression (GO:0010628),70/771,0.7563281173812642,0.9409767215008902,0,0,0.92150271648405,0.2573572595485818,CDKN1C;EPO;TGFB1I1;PRKAG1;RORA;MYRFL;MED16;RIMS1;EPB41L4B;ZIC3;CREB3L2;PIM2;BUD23;EPHB2;BTRC;TEAD1;NCOA1;SMARCC2;ATMIN;H2AFY;EBF3;ANK3;BAZ1B;PRKAB1;FOXP3;RUNX2;OLFM1;MED24;ELF4;DDIT3;KAT6A;NOS1AP;RARA;PPARD;KDM3A;KMT2A;ALOX12B;PIK3R1;FOXO3;PPM1F;CAMKK2;FAM129B;RAI1;PRDM16;DVL1;DVL2;HIVEP3;PCBD2;APBB1;ATF7IP;SRPK2;XRCC6;AFAP1L2;SMAD3;TGFB3;ZBTB16;NTRK3;NFATC2;ESRRG;FOXN3;INHBA;NR1D1;MAPK14;MTOR;SMARCA4;ERCC2;TCF4;ERCC6;TAF4;CPEB3,Hypo
3144,GO_Biological_Process_2018,positive regulation of mitotic cell cycle (GO:0045931),4/52,0.7594404789125945,0.9409767215008902,0,0,0.7708975676601576,0.2121304498537699,USP2;TGFA;PRKCA;EREG,Hypo
3145,GO_Biological_Process_2018,triglyceride metabolic process (GO:0006641),4/52,0.7594404789125945,0.9409767215008902,0,0,0.7708975676601576,0.2121304498537699,GNPAT;GPAM;FABP12;LPIN1,Hypo
3146,GO_Biological_Process_2018,cellular response to organic substance (GO:0071310),11/133,0.7595528034825111,0.9409767215008902,0,0,0.8336560167062623,0.2292766089326653,NCOA1;TBK1;SMAD3;TWF2;AKAP6;PTPN11;QRFPR;MAPK14;DCPS;PTPN5;RAMP1,Hypo
3147,GO_Biological_Process_2018,"nucleotide-excision repair, DNA incision (GO:0033683)",3/40,0.7620521504921004,0.9409767215008902,0,0,0.7501353433556823,0.2038419932457613,ERCC1;ERCC2;FAN1,Hypo
3148,GO_Biological_Process_2018,sensory organ development (GO:0007423),3/40,0.7620521504921004,0.9409767215008902,0,0,0.7501353433556823,0.2038419932457613,SOX3;ECE1;SIPA1L3,Hypo
3149,GO_Biological_Process_2018,tRNA aminoacylation (GO:0043039),3/40,0.7620521504921004,0.9409767215008902,0,0,0.7501353433556823,0.2038419932457613,YARS;LARS;MARS,Hypo
3150,GO_Biological_Process_2018,response to peptide hormone (GO:0043434),3/40,0.7620521504921004,0.9409767215008902,0,0,0.7501353433556823,0.2038419932457613,EIF2B5;SRC;SORT1,Hypo
3151,GO_Biological_Process_2018,determination of heart left/right asymmetry (GO:0061371),3/40,0.7620521504921004,0.9409767215008902,0,0,0.7501353433556823,0.2038419932457613,ZIC3;BBS4;CCDC40,Hypo
3152,GO_Biological_Process_2018,negative regulation of transport (GO:0051051),3/40,0.7620521504921004,0.9409767215008902,0,0,0.7501353433556823,0.2038419932457613,PRKCB;CRYAB;CTTNBP2NL,Hypo
3153,GO_Biological_Process_2018,branching involved in blood vessel morphogenesis (GO:0001569),1/14,0.7622890881719574,0.9409767215008902,0,0,0.7118838062911947,0.193226204690295,COL4A1,Hypo
3154,GO_Biological_Process_2018,positive regulation of neural precursor cell proliferation (GO:2000179),1/14,0.7622890881719574,0.9409767215008902,0,0,0.7118838062911947,0.193226204690295,DISP3,Hypo
3155,GO_Biological_Process_2018,regulation of Golgi organization (GO:1903358),1/14,0.7622890881719574,0.9409767215008902,0,0,0.7118838062911947,0.193226204690295,STX18,Hypo
3156,GO_Biological_Process_2018,regulation of lipase activity (GO:0060191),1/14,0.7622890881719574,0.9409767215008902,0,0,0.7118838062911947,0.193226204690295,FURIN,Hypo
3157,GO_Biological_Process_2018,modified amino acid transport (GO:0072337),1/14,0.7622890881719574,0.9409767215008902,0,0,0.7118838062911947,0.193226204690295,SLC6A8,Hypo
3158,GO_Biological_Process_2018,cardiac left ventricle morphogenesis (GO:0003214),1/14,0.7622890881719574,0.9409767215008902,0,0,0.7118838062911947,0.193226204690295,RYR2,Hypo
3159,GO_Biological_Process_2018,regulation of lymphocyte differentiation (GO:0045619),1/14,0.7622890881719574,0.9409767215008902,0,0,0.7118838062911947,0.193226204690295,ABL1,Hypo
3160,GO_Biological_Process_2018,positive regulation of mitochondrial fission (GO:0090141),1/14,0.7622890881719574,0.9409767215008902,0,0,0.7118838062911947,0.193226204690295,DDHD1,Hypo
3161,GO_Biological_Process_2018,hydrogen peroxide catabolic process (GO:0042744),1/14,0.7622890881719574,0.9409767215008902,0,0,0.7118838062911947,0.193226204690295,PXDN,Hypo
3162,GO_Biological_Process_2018,negative regulation of biomineral tissue development (GO:0070168),1/14,0.7622890881719574,0.9409767215008902,0,0,0.7118838062911947,0.193226204690295,PTK2B,Hypo
3163,GO_Biological_Process_2018,amyloid-beta metabolic process (GO:0050435),1/14,0.7622890881719574,0.9409767215008902,0,0,0.7118838062911947,0.193226204690295,IDE,Hypo
3164,GO_Biological_Process_2018,regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle (GO:0031657),1/14,0.7622890881719574,0.9409767215008902,0,0,0.7118838062911947,0.193226204690295,PKD1,Hypo
3165,GO_Biological_Process_2018,response to ethanol (GO:0045471),1/14,0.7622890881719574,0.9409767215008902,0,0,0.7118838062911947,0.193226204690295,GRIN2B,Hypo
3166,GO_Biological_Process_2018,quinone biosynthetic process (GO:1901663),1/14,0.7622890881719574,0.9409767215008902,0,0,0.7118838062911947,0.193226204690295,COQ8A,Hypo
3167,GO_Biological_Process_2018,neutrophil activation (GO:0042119),1/14,0.7622890881719574,0.9409767215008902,0,0,0.7118838062911947,0.193226204690295,PREX1,Hypo
3168,GO_Biological_Process_2018,regulation of fatty acid metabolic process (GO:0019217),1/14,0.7622890881719574,0.9409767215008902,0,0,0.7118838062911947,0.193226204690295,PRKAG2,Hypo
3169,GO_Biological_Process_2018,Golgi to vacuole transport (GO:0006896),1/14,0.7622890881719574,0.9409767215008902,0,0,0.7118838062911947,0.193226204690295,VTI1A,Hypo
3170,GO_Biological_Process_2018,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),1/14,0.7622890881719574,0.9409767215008902,0,0,0.7118838062911947,0.193226204690295,ALG13,Hypo
3171,GO_Biological_Process_2018,epiboly involved in wound healing (GO:0090505),1/14,0.7622890881719574,0.9409767215008902,0,0,0.7118838062911947,0.193226204690295,FLNA,Hypo
3172,GO_Biological_Process_2018,positive regulation of vascular smooth muscle cell proliferation (GO:1904707),1/14,0.7622890881719574,0.9409767215008902,0,0,0.7118838062911947,0.193226204690295,MEF2D,Hypo
3173,GO_Biological_Process_2018,regulation of histone modification (GO:0031056),1/14,0.7622890881719574,0.9409767215008902,0,0,0.7118838062911947,0.193226204690295,PRDM10,Hypo
3174,GO_Biological_Process_2018,positive regulation of purine nucleotide metabolic process (GO:1900544),1/14,0.7622890881719574,0.9409767215008902,0,0,0.7118838062911947,0.193226204690295,RAMP1,Hypo
3175,GO_Biological_Process_2018,interleukin-6-mediated signaling pathway (GO:0070102),1/14,0.7622890881719574,0.9409767215008902,0,0,0.7118838062911947,0.193226204690295,PTPN11,Hypo
3176,GO_Biological_Process_2018,histone H4-K16 acetylation (GO:0043984),1/14,0.7622890881719574,0.9409767215008902,0,0,0.7118838062911947,0.193226204690295,KMT2A,Hypo
3177,GO_Biological_Process_2018,regulation of protein modification by small protein conjugation or removal (GO:1903320),1/14,0.7622890881719574,0.9409767215008902,0,0,0.7118838062911947,0.193226204690295,DNAJB2,Hypo
3178,GO_Biological_Process_2018,regulation of interferon-gamma biosynthetic process (GO:0045072),1/14,0.7622890881719574,0.9409767215008902,0,0,0.7118838062911947,0.193226204690295,INHBA,Hypo
3179,GO_Biological_Process_2018,regulation of mRNA catabolic process (GO:0061013),1/14,0.7622890881719574,0.9409767215008902,0,0,0.7118838062911947,0.193226204690295,UPF1,Hypo
3180,GO_Biological_Process_2018,regulation of adaptive immune response (GO:0002819),1/14,0.7622890881719574,0.9409767215008902,0,0,0.7118838062911947,0.193226204690295,EIF2AK4,Hypo
3181,GO_Biological_Process_2018,estrogen metabolic process (GO:0008210),1/14,0.7622890881719574,0.9409767215008902,0,0,0.7118838062911947,0.193226204690295,HSD17B4,Hypo
3182,GO_Biological_Process_2018,positive regulation of smooth muscle contraction (GO:0045987),1/14,0.7622890881719574,0.9409767215008902,0,0,0.7118838062911947,0.193226204690295,CTTN,Hypo
3183,GO_Biological_Process_2018,positive regulation of interleukin-8 secretion (GO:2000484),1/14,0.7622890881719574,0.9409767215008902,0,0,0.7118838062911947,0.193226204690295,NLRP10,Hypo
3184,GO_Biological_Process_2018,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),1/14,0.7622890881719574,0.9409767215008902,0,0,0.7118838062911947,0.193226204690295,DUSP1,Hypo
3185,GO_Biological_Process_2018,ubiquinone metabolic process (GO:0006743),1/14,0.7622890881719574,0.9409767215008902,0,0,0.7118838062911947,0.193226204690295,COQ8A,Hypo
3186,GO_Biological_Process_2018,positive regulation of myoblast differentiation (GO:0045663),1/14,0.7622890881719574,0.9409767215008902,0,0,0.7118838062911947,0.193226204690295,MAPK14,Hypo
3187,GO_Biological_Process_2018,establishment of mitotic spindle orientation (GO:0000132),1/14,0.7622890881719574,0.9409767215008902,0,0,0.7118838062911947,0.193226204690295,NUMA1,Hypo
3188,GO_Biological_Process_2018,regulation of activin receptor signaling pathway (GO:0032925),1/14,0.7622890881719574,0.9409767215008902,0,0,0.7118838062911947,0.193226204690295,SMAD7,Hypo
3189,GO_Biological_Process_2018,myotube cell development (GO:0014904),1/14,0.7622890881719574,0.9409767215008902,0,0,0.7118838062911947,0.193226204690295,RYR1,Hypo
3190,GO_Biological_Process_2018,pore complex assembly (GO:0046931),1/14,0.7622890881719574,0.9409767215008902,0,0,0.7118838062911947,0.193226204690295,AHCTF1,Hypo
3191,GO_Biological_Process_2018,double-strand break repair via homologous recombination (GO:0000724),6/76,0.762972401129493,0.9415251528975792,0,0,0.7927689594356261,0.2144704977651719,RAD51;AP5Z1;NSMCE2;RECQL;PALB2;FAN1,Hypo
3192,GO_Biological_Process_2018,regulation of protein targeting to mitochondrion (GO:1903214),7/88,0.7665775165670367,0.9456776817280168,0,0,0.7992159254811511,0.2124471419249497,SH3GLB1;SREBF1;MYBPC1;LRRK2;VPS11;HPS4;WBP11,Hypo
3193,GO_Biological_Process_2018,adenylate cyclase-modulating G-protein coupled receptor signaling pathway (GO:0007188),11/134,0.7680243518905066,0.9471659117397324,0,0,0.8268322033400839,0.218228996930589,ABCA1;ADGRD1;ADCY9;PSAP;GRM8;GNAS;ADCY3;CACNA1D;GPR37L1;GPR101;RAMP1,Hypo
3194,GO_Biological_Process_2018,protein deubiquitination (GO:0016579),22/257,0.7706323738825812,0.9491823389671904,0,0,0.8650348724287101,0.2253795042868837,USP46;IL33;SMAD3;USP27X;TRRAP;USP4;USP10;USP2;UBE2D1;FOXK1;AXIN2;JOSD1;SMAD7;BABAM2;STAMBPL1;TNKS2;TNIP1;OTULIN;USP51;CLSPN;EIF3F;NFRKB,Hypo
3195,GO_Biological_Process_2018,cellular response to metal ion (GO:0071248),8/100,0.770713005229101,0.9491823389671904,0,0,0.8041015537545336,0.2094195748454006,RYR1;ITPKB;LRRK2;ATP13A2;ANK3;GPLD1;RYR3;KCNH1,Hypo
3196,GO_Biological_Process_2018,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),8/100,0.770713005229101,0.9491823389671904,0,0,0.8041015537545336,0.2094195748454006,UPF1;NUP188;NUP133;ZC3H11A;SYMPK;SRSF4;SMG5;SMG6,Hypo
3197,GO_Biological_Process_2018,negative regulation of cell adhesion (GO:0007162),5/65,0.7722146238357939,0.9491823389671904,0,0,0.7707797772065125,0.199240989992977,PLXND1;DSCAM;SEMA4D;SPOCK1;ITGB1BP1,Hypo
3198,GO_Biological_Process_2018,cellular response to alcohol (GO:0097306),2/28,0.7725510481667461,0.9491823389671904,0,0,0.7117359027009951,0.1836685675174616,RAD51;GPLD1,Hypo
3199,GO_Biological_Process_2018,regulation of NIK/NF-kappaB signaling (GO:1901222),2/28,0.7725510481667461,0.9491823389671904,0,0,0.7117359027009951,0.1836685675174616,SASH1;HDAC7,Hypo
3200,GO_Biological_Process_2018,triglyceride homeostasis (GO:0070328),2/28,0.7725510481667461,0.9491823389671904,0,0,0.7117359027009951,0.1836685675174616,SCARB1;RORA,Hypo
3201,GO_Biological_Process_2018,dopamine receptor signaling pathway (GO:0007212),2/28,0.7725510481667461,0.9491823389671904,0,0,0.7117359027009951,0.1836685675174616,GNAS;FLNA,Hypo
3202,GO_Biological_Process_2018,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),2/28,0.7725510481667461,0.9491823389671904,0,0,0.7117359027009951,0.1836685675174616,OTULIN;INAVA,Hypo
3203,GO_Biological_Process_2018,protein export from nucleus (GO:0006611),2/28,0.7725510481667461,0.9491823389671904,0,0,0.7117359027009951,0.1836685675174616,SMURF1;PKD1,Hypo
3204,GO_Biological_Process_2018,regulation of actin polymerization or depolymerization (GO:0008064),2/28,0.7725510481667461,0.9491823389671904,0,0,0.7117359027009951,0.1836685675174616,PLEKHG2;SSH1,Hypo
3205,GO_Biological_Process_2018,cellular response to hydrogen peroxide (GO:0070301),2/28,0.7725510481667461,0.9491823389671904,0,0,0.7117359027009951,0.1836685675174616,PLEKHA1;ABL1,Hypo
3206,GO_Biological_Process_2018,positive regulation of cellular process (GO:0048522),46/519,0.7755168694843552,0.9493751418856572,0,0,0.897789454048004,0.2282410119575839,KMT2D;RYR2;KMT2A;NUMA1;LRP1;TENM4;EPO;FLT4;DOT1L;PDGFA;TGFA;IRS2;AKAP6;TCIRG1;MST1R;FGF1;ACACB;RPTOR;NACC2;LMNA;VPS11;FLNA;PTK2B;STX3;SRPK2;PDGFRA;NTRK3;IL34;GLP2R;TET1;LIFR;AXIN2;SORL1;EREG;TIAM1;P2RX4;FASN;KCNQ1;NOS1AP;RARA;FGFR1OP;ITGB1BP1;SLC25A5;HDGFL2;GPLD1;FGFR2,Hypo
3207,GO_Biological_Process_2018,mitochondrial transport (GO:0006839),11/135,0.7762855506175914,0.9493751418856572,0,0,0.8201184514798117,0.2076825721291776,MRS2;SLC25A27;SLC25A29;SLC25A17;SLC25A28;SAMM50;PITRM1;SLC25A43;SLC25A5;SLC25A23;SLC25A4,Hypo
3208,GO_Biological_Process_2018,negative regulation of cellular protein metabolic process (GO:0032269),7/89,0.7766723428092704,0.9493751418856572,0,0,0.7894254547280419,0.1995167944121035,RIC1;CDK5;DAB2IP;SAMD4B;F2;CPEB3;TOB1,Hypo
3209,GO_Biological_Process_2018,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),3/41,0.7767185895491622,0.9493751418856572,0,0,0.7303543913713405,0.1845438805833959,PCDHGB4;CDH22;PCDHGC3,Hypo
3210,GO_Biological_Process_2018,gluconeogenesis (GO:0006094),3/41,0.7767185895491622,0.9493751418856572,0,0,0.7303543913713405,0.1845438805833959,PER2;ENO1;PCK2,Hypo
3211,GO_Biological_Process_2018,peptide transport (GO:0015833),3/41,0.7767185895491622,0.9493751418856572,0,0,0.7303543913713405,0.1845438805833959,MYH9;ITGB1BP1;RAMP1,Hypo
3212,GO_Biological_Process_2018,DNA duplex unwinding (GO:0032508),3/41,0.7767185895491622,0.9493751418856572,0,0,0.7303543913713405,0.1845438805833959,RAD51;ERCC2;RECQL,Hypo
3213,GO_Biological_Process_2018,positive regulation of receptor-mediated endocytosis (GO:0048260),3/41,0.7767185895491622,0.9493751418856572,0,0,0.7303543913713405,0.1845438805833959,HIP1;HIP1R;LDLRAP1,Hypo
3214,GO_Biological_Process_2018,intrinsic apoptotic signaling pathway (GO:0097193),8/101,0.7801198298268998,0.9493751418856572,0,0,0.7954110051714782,0.1975067115428559,STK24;DDIT3;ABL1;DAB2IP;PDK2;PPM1F;PDK1;BOK,Hypo
3215,GO_Biological_Process_2018,negative regulation of epithelial cell proliferation (GO:0050680),5/66,0.7836496165289728,0.9493751418856572,0,0,0.7581019006279236,0.1848201460640875,CDKN1C;DAB2IP;NF1;VASH1;EREG,Hypo
3216,GO_Biological_Process_2018,JNK cascade (GO:0007254),5/66,0.7836496165289728,0.9493751418856572,0,0,0.7581019006279236,0.1848201460640875,DBNL;DAB2IP;TRIB1;MAP4K5;MAP3K11,Hypo
3217,GO_Biological_Process_2018,negative regulation of inflammatory response (GO:0050728),6/78,0.7844086092206625,0.9493751418856572,0,0,0.770661865569273,0.1871361287070816,NLRP10;OTULIN;TYRO3;RORA;F2;PPARD,Hypo
3218,GO_Biological_Process_2018,intracellular transport of virus (GO:0075733),4/54,0.785092027089928,0.9493751418856572,0,0,0.7399794450154162,0.1790412353531343,NUP188;NUP133;MVB12B;VPS37B,Hypo
3219,GO_Biological_Process_2018,negative regulation of cellular component organization (GO:0051129),4/54,0.785092027089928,0.9493751418856572,0,0,0.7399794450154162,0.1790412353531343,DNAJB2;ULK1;PRKCZ;RAPGEF3,Hypo
3220,GO_Biological_Process_2018,transport of virus (GO:0046794),4/54,0.785092027089928,0.9493751418856572,0,0,0.7399794450154162,0.1790412353531343,NUP188;NUP133;MVB12B;VPS37B,Hypo
3221,GO_Biological_Process_2018,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),1/15,0.7854819973103216,0.9493751418856572,0,0,0.6609983141537785,0.1596031592868082,RNLS,Hypo
3222,GO_Biological_Process_2018,ubiquinone biosynthetic process (GO:0006744),1/15,0.7854819973103216,0.9493751418856572,0,0,0.6609983141537785,0.1596031592868082,COQ8A,Hypo
3223,GO_Biological_Process_2018,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),1/15,0.7854819973103216,0.9493751418856572,0,0,0.6609983141537785,0.1596031592868082,HSD17B4,Hypo
3224,GO_Biological_Process_2018,apoptotic DNA fragmentation (GO:0006309),1/15,0.7854819973103216,0.9493751418856572,0,0,0.6609983141537785,0.1596031592868082,HMGB1,Hypo
3225,GO_Biological_Process_2018,vitamin D metabolic process (GO:0042359),1/15,0.7854819973103216,0.9493751418856572,0,0,0.6609983141537785,0.1596031592868082,PIAS4,Hypo
3226,GO_Biological_Process_2018,histone H4-K8 acetylation (GO:0043982),1/15,0.7854819973103216,0.9493751418856572,0,0,0.6609983141537785,0.1596031592868082,JADE1,Hypo
3227,GO_Biological_Process_2018,phosphatidylethanolamine biosynthetic process (GO:0006646),1/15,0.7854819973103216,0.9493751418856572,0,0,0.6609983141537785,0.1596031592868082,LPIN1,Hypo
3228,GO_Biological_Process_2018,epithelial cilium movement (GO:0003351),1/15,0.7854819973103216,0.9493751418856572,0,0,0.6609983141537785,0.1596031592868082,CCDC40,Hypo
3229,GO_Biological_Process_2018,positive regulation of glycolytic process (GO:0045821),1/15,0.7854819973103216,0.9493751418856572,0,0,0.6609983141537785,0.1596031592868082,PFKFB3,Hypo
3230,GO_Biological_Process_2018,positive regulation of coenzyme metabolic process (GO:0051197),1/15,0.7854819973103216,0.9493751418856572,0,0,0.6609983141537785,0.1596031592868082,PFKFB3,Hypo
3231,GO_Biological_Process_2018,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),1/15,0.7854819973103216,0.9493751418856572,0,0,0.6609983141537785,0.1596031592868082,CCT5,Hypo
3232,GO_Biological_Process_2018,negative regulation of cell aging (GO:0090344),1/15,0.7854819973103216,0.9493751418856572,0,0,0.6609983141537785,0.1596031592868082,RBL1,Hypo
3233,GO_Biological_Process_2018,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),1/15,0.7854819973103216,0.9493751418856572,0,0,0.6609983141537785,0.1596031592868082,CSPG4,Hypo
3234,GO_Biological_Process_2018,negative regulation of lipid catabolic process (GO:0050995),1/15,0.7854819973103216,0.9493751418856572,0,0,0.6609983141537785,0.1596031592868082,GPLD1,Hypo
3235,GO_Biological_Process_2018,cellular response to virus (GO:0098586),1/15,0.7854819973103216,0.9493751418856572,0,0,0.6609983141537785,0.1596031592868082,MAPK14,Hypo
3236,GO_Biological_Process_2018,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),1/15,0.7854819973103216,0.9493751418856572,0,0,0.6609983141537785,0.1596031592868082,ACADL,Hypo
3237,GO_Biological_Process_2018,response to cholesterol (GO:0070723),1/15,0.7854819973103216,0.9493751418856572,0,0,0.6609983141537785,0.1596031592868082,GPLD1,Hypo
3238,GO_Biological_Process_2018,regulation of exit from mitosis (GO:0007096),1/15,0.7854819973103216,0.9493751418856572,0,0,0.6609983141537785,0.1596031592868082,PPP1R9B,Hypo
3239,GO_Biological_Process_2018,negative regulation of muscle cell differentiation (GO:0051148),1/15,0.7854819973103216,0.9493751418856572,0,0,0.6609983141537785,0.1596031592868082,EREG,Hypo
3240,GO_Biological_Process_2018,positive regulation of viral release from host cell (GO:1902188),1/15,0.7854819973103216,0.9493751418856572,0,0,0.6609983141537785,0.1596031592868082,VPS37B,Hypo
3241,GO_Biological_Process_2018,regulation of mitochondrial translation (GO:0070129),1/15,0.7854819973103216,0.9493751418856572,0,0,0.6609983141537785,0.1596031592868082,UQCC2,Hypo
3242,GO_Biological_Process_2018,negative regulation of signal transduction by p53 class mediator (GO:1901797),1/15,0.7854819973103216,0.9493751418856572,0,0,0.6609983141537785,0.1596031592868082,RFFL,Hypo
3243,GO_Biological_Process_2018,cofactor transport (GO:0051181),1/15,0.7854819973103216,0.9493751418856572,0,0,0.6609983141537785,0.1596031592868082,SLC25A29,Hypo
3244,GO_Biological_Process_2018,negative regulation of RNA metabolic process (GO:0051253),1/15,0.7854819973103216,0.9493751418856572,0,0,0.6609983141537785,0.1596031592868082,NCOR2,Hypo
3245,GO_Biological_Process_2018,positive regulation of double-strand break repair (GO:2000781),1/15,0.7854819973103216,0.9493751418856572,0,0,0.6609983141537785,0.1596031592868082,SETMAR,Hypo
3246,GO_Biological_Process_2018,positive regulation of exosomal secretion (GO:1903543),1/15,0.7854819973103216,0.9493751418856572,0,0,0.6609983141537785,0.1596031592868082,ATP13A2,Hypo
3247,GO_Biological_Process_2018,regulation of protein complex disassembly (GO:0043244),1/15,0.7854819973103216,0.9493751418856572,0,0,0.6609983141537785,0.1596031592868082,UPF1,Hypo
3248,GO_Biological_Process_2018,regulation of RNA export from nucleus (GO:0046831),1/15,0.7854819973103216,0.9493751418856572,0,0,0.6609983141537785,0.1596031592868082,ZC3H3,Hypo
3249,GO_Biological_Process_2018,toll-like receptor 4 signaling pathway (GO:0034142),1/15,0.7854819973103216,0.9493751418856572,0,0,0.6609983141537785,0.1596031592868082,PRKCE,Hypo
3250,GO_Biological_Process_2018,regulation of T cell mediated cytotoxicity (GO:0001914),1/15,0.7854819973103216,0.9493751418856572,0,0,0.6609983141537785,0.1596031592868082,IL12RB1,Hypo
3251,GO_Biological_Process_2018,regulation of fertilization (GO:0080154),1/15,0.7854819973103216,0.9493751418856572,0,0,0.6609983141537785,0.1596031592868082,LHFPL2,Hypo
3252,GO_Biological_Process_2018,negative regulation of anoikis (GO:2000811),1/15,0.7854819973103216,0.9493751418856572,0,0,0.6609983141537785,0.1596031592868082,SRC,Hypo
3253,GO_Biological_Process_2018,inhibition of cysteine-type endopeptidase activity (GO:0097340),1/15,0.7854819973103216,0.9493751418856572,0,0,0.6609983141537785,0.1596031592868082,BIRC6,Hypo
3254,GO_Biological_Process_2018,base conversion or substitution editing (GO:0016553),1/15,0.7854819973103216,0.9493751418856572,0,0,0.6609983141537785,0.1596031592868082,ADARB1,Hypo
3255,GO_Biological_Process_2018,histone H4-K5 acetylation (GO:0043981),1/15,0.7854819973103216,0.9493751418856572,0,0,0.6609983141537785,0.1596031592868082,JADE1,Hypo
3256,GO_Biological_Process_2018,atrioventricular valve morphogenesis (GO:0003181),1/15,0.7854819973103216,0.9493751418856572,0,0,0.6609983141537785,0.1596031592868082,OLFM1,Hypo
3257,GO_Biological_Process_2018,regulation of B cell differentiation (GO:0045577),1/15,0.7854819973103216,0.9493751418856572,0,0,0.6609983141537785,0.1596031592868082,INHBA,Hypo
3258,GO_Biological_Process_2018,"phototransduction, visible light (GO:0007603)",1/15,0.7854819973103216,0.9493751418856572,0,0,0.6609983141537785,0.1596031592868082,MAPRE2,Hypo
3259,GO_Biological_Process_2018,regulation of cytokine-mediated signaling pathway (GO:0001959),7/90,0.7864406067609586,0.9502421932611704,0,0,0.7798708989328389,0.1873546836754554,CLIP3;RNASEL;MADD;OTULIN;LIFR;PTPN11;RBCK1,Hypo
3260,GO_Biological_Process_2018,collagen fibril organization (GO:0030199),2/29,0.7892384638587597,0.9509973414315248,0,0,0.6853372880066925,0.1622102678511601,COL5A1;NF1,Hypo
3261,GO_Biological_Process_2018,superoxide metabolic process (GO:0006801),2/29,0.7892384638587597,0.9509973414315248,0,0,0.6853372880066925,0.1622102678511601,PREX1;SH3PXD2A,Hypo
3262,GO_Biological_Process_2018,regulation of vasoconstriction (GO:0019229),2/29,0.7892384638587597,0.9509973414315248,0,0,0.6853372880066925,0.1622102678511601,PER2;ECE1,Hypo
3263,GO_Biological_Process_2018,negative regulation of Notch signaling pathway (GO:0045746),2/29,0.7892384638587597,0.9509973414315248,0,0,0.6853372880066925,0.1622102678511601,FAM129B;DLK2,Hypo
3264,GO_Biological_Process_2018,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),2/29,0.7892384638587597,0.9509973414315248,0,0,0.6853372880066925,0.1622102678511601,CREB3L1;DDIT3,Hypo
3265,GO_Biological_Process_2018,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),2/29,0.7892384638587597,0.9509973414315248,0,0,0.6853372880066925,0.1622102678511601,TNKS1BP1;SAMD4B,Hypo
3266,GO_Biological_Process_2018,regulation of cellular biosynthetic process (GO:0031326),2/29,0.7892384638587597,0.9509973414315248,0,0,0.6853372880066925,0.1622102678511601,NOS1AP;PRKAG2,Hypo
3267,GO_Biological_Process_2018,carbohydrate derivative biosynthetic process (GO:1901137),2/29,0.7892384638587597,0.9509973414315248,0,0,0.6853372880066925,0.1622102678511601,TNIP1;ST3GAL2,Hypo
3268,GO_Biological_Process_2018,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),2/29,0.7892384638587597,0.9509973414315248,0,0,0.6853372880066925,0.1622102678511601,TBK1;UBE2D1,Hypo
3269,GO_Biological_Process_2018,glycolipid biosynthetic process (GO:0009247),3/42,0.7906330712288586,0.9516060602923212,0,0,0.7115878471810675,0.1671671410206237,DPM3;ST8SIA1;ST3GAL2,Hypo
3270,GO_Biological_Process_2018,regulation of protein modification process (GO:0031399),3/42,0.7906330712288586,0.9516060602923212,0,0,0.7115878471810675,0.1671671410206237,PPP1R16B;CCDC88C;CORO1C,Hypo
3271,GO_Biological_Process_2018,regulation of cytosolic calcium ion concentration (GO:0051480),11/137,0.7921786888868189,0.9516060602923212,0,0,0.8070106502288039,0.1880078955002886,RYR1;PDGFRA;RYR2;SMAD3;ABL1;ABL2;CACNA1C;HMGB1;ATP2B1;F2;SPPL3,Hypo
3272,GO_Biological_Process_2018,protein modification by small protein removal (GO:0070646),22/261,0.7941185129095465,0.9516060602923212,0,0,0.8503663258042674,0.1960286294048313,USP46;IL33;SMAD3;USP27X;TRRAP;USP4;USP10;USP2;UBE2D1;FOXK1;AXIN2;JOSD1;SMAD7;COPS4;BABAM2;STAMBPL1;TNKS2;TNIP1;USP51;CLSPN;EIF3F;NFRKB,Hypo
3273,GO_Biological_Process_2018,cell-cell junction assembly (GO:0007043),6/79,0.7945597316705111,0.9516060602923212,0,0,0.7600625739895146,0.1747893968815123,TJP1;CNTNAP1;FBF1;CDH22;CD9;PRKCA,Hypo
3274,GO_Biological_Process_2018,positive regulation of cellular protein metabolic process (GO:0032270),7/91,0.7958852351992726,0.9516060602923212,0,0,0.7705438325613313,0.1759153730477858,CYFIP2;UQCC2;VPS11;INHBA;BTRC;CPEB3;MTOR,Hypo
3275,GO_Biological_Process_2018,regulation of B cell proliferation (GO:0030888),3/43,0.8038179784187263,0.9516060602923212,0,0,0.6937596302003082,0.1515049141815043,NFATC2;IRS2;TNFRSF4,Hypo
3276,GO_Biological_Process_2018,development of primary male sexual characteristics (GO:0046546),3/43,0.8038179784187263,0.9516060602923212,0,0,0.6937596302003082,0.1515049141815043,KIT;INHBA;LHFPL2,Hypo
3277,GO_Biological_Process_2018,response to hydrogen peroxide (GO:0042542),3/43,0.8038179784187263,0.9516060602923212,0,0,0.6937596302003082,0.1515049141815043,PLEKHA1;STK24;ABL1,Hypo
3278,GO_Biological_Process_2018,protein transmembrane import into intracellular organelle (GO:0044743),3/43,0.8038179784187263,0.9516060602923212,0,0,0.6937596302003082,0.1515049141815043,SAMM50;PEX1;PEX14,Hypo
3279,GO_Biological_Process_2018,protein lipidation (GO:0006497),10/127,0.803918193279859,0.9516060602923212,0,0,0.7900696096572385,0.1724388269074137,NTNG2;DPM3;NRN1L;NEGR1;NTM;ZDHHC7;CNTN3;RTN4RL2;ALOX12B;GPLD1,Hypo
3280,GO_Biological_Process_2018,nucleic acid metabolic process (GO:0090304),6/80,0.8043392052540629,0.9516060602923212,0,0,0.7497497497497497,0.1632461632324524,ATXN2;DDX24;HNRNPF;ERI3;DDX54;SETMAR,Hypo
3281,GO_Biological_Process_2018,negative regulation of defense response (GO:0031348),6/80,0.8043392052540629,0.9516060602923212,0,0,0.7497497497497497,0.1632461632324524,NLRP10;OTULIN;TYRO3;TRAFD1;RORA;PPARD,Hypo
3282,GO_Biological_Process_2018,RNA transport (GO:0050658),6/80,0.8043392052540629,0.9516060602923212,0,0,0.7497497497497497,0.1632461632324524,ATXN2;NUP188;NUP133;KIF5C;ZC3H11A;SRSF4,Hypo
3283,GO_Biological_Process_2018,regulation of defense response to virus by host (GO:0050691),2/30,0.8048360089308861,0.9516060602923212,0,0,0.6608242886476973,0.1434760138962487,EIF2AK4;IL12RB1,Hypo
3284,GO_Biological_Process_2018,cyclic purine nucleotide metabolic process (GO:0052652),2/30,0.8048360089308861,0.9516060602923212,0,0,0.6608242886476973,0.1434760138962487,ADCY9;ADCY3,Hypo
3285,GO_Biological_Process_2018,multivesicular body assembly (GO:0036258),2/30,0.8048360089308861,0.9516060602923212,0,0,0.6608242886476973,0.1434760138962487,VPS37B;CHMP5,Hypo
3286,GO_Biological_Process_2018,protein palmitoylation (GO:0018345),2/30,0.8048360089308861,0.9516060602923212,0,0,0.6608242886476973,0.1434760138962487,CLIP3;ZDHHC7,Hypo
3287,GO_Biological_Process_2018,regulation of cell adhesion mediated by integrin (GO:0033628),2/30,0.8048360089308861,0.9516060602923212,0,0,0.6608242886476973,0.1434760138962487,PTPN11;ITGB1BP1,Hypo
3288,GO_Biological_Process_2018,'de novo' posttranslational protein folding (GO:0051084),2/30,0.8048360089308861,0.9516060602923212,0,0,0.6608242886476973,0.1434760138962487,UGGT2;UGGT1,Hypo
3289,GO_Biological_Process_2018,MyD88-independent toll-like receptor signaling pathway (GO:0002756),2/30,0.8048360089308861,0.9516060602923212,0,0,0.6608242886476973,0.1434760138962487,TBK1;UBE2D1,Hypo
3290,GO_Biological_Process_2018,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),2/30,0.8048360089308861,0.9516060602923212,0,0,0.6608242886476973,0.1434760138962487,KMT2D;GPAM,Hypo
3291,GO_Biological_Process_2018,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),2/30,0.8048360089308861,0.9516060602923212,0,0,0.6608242886476973,0.1434760138962487,NMT1;DYNLL2,Hypo
3292,GO_Biological_Process_2018,ATP-dependent chromatin remodeling (GO:0043044),2/30,0.8048360089308861,0.9516060602923212,0,0,0.6608242886476973,0.1434760138962487,SMARCC2;SMARCA4,Hypo
3293,GO_Biological_Process_2018,nuclear envelope organization (GO:0006998),2/30,0.8048360089308861,0.9516060602923212,0,0,0.6608242886476973,0.1434760138962487,SUN1;LEMD2,Hypo
3294,GO_Biological_Process_2018,CENP-A containing nucleosome assembly (GO:0034080),2/30,0.8048360089308861,0.9516060602923212,0,0,0.6608242886476973,0.1434760138962487,CENPI;RBBP7,Hypo
3295,GO_Biological_Process_2018,CENP-A containing chromatin organization (GO:0061641),2/30,0.8048360089308861,0.9516060602923212,0,0,0.6608242886476973,0.1434760138962487,CENPI;RBBP7,Hypo
3296,GO_Biological_Process_2018,bile acid metabolic process (GO:0008206),2/30,0.8048360089308861,0.9516060602923212,0,0,0.6608242886476973,0.1434760138962487,OSBPL2;HSD17B4,Hypo
3297,GO_Biological_Process_2018,ribosomal large subunit assembly (GO:0000027),2/30,0.8048360089308861,0.9516060602923212,0,0,0.6608242886476973,0.1434760138962487,DHX30;BOP1,Hypo
3298,GO_Biological_Process_2018,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),2/30,0.8048360089308861,0.9516060602923212,0,0,0.6608242886476973,0.1434760138962487,NMT1;DYNLL2,Hypo
3299,GO_Biological_Process_2018,negative regulation of endothelial cell proliferation (GO:0001937),2/30,0.8048360089308861,0.9516060602923212,0,0,0.6608242886476973,0.1434760138962487,NF1;VASH1,Hypo
3300,GO_Biological_Process_2018,nuclear export (GO:0051168),7/92,0.8050097387915165,0.9516060602923212,0,0,0.7614362265750356,0.1651562056990381,ATXN1;NUP188;NUP133;SMURF1;ZC3H11A;SRSF4;PKD1,Hypo
3301,GO_Biological_Process_2018,protein localization to microtubule organizing center (GO:1905508),1/16,0.8064130564244143,0.9516060602923212,0,0,0.6168975543013511,0.1327311785860344,BBS4,Hypo
3302,GO_Biological_Process_2018,regulation of systemic arterial blood pressure by hormone (GO:0001990),1/16,0.8064130564244143,0.9516060602923212,0,0,0.6168975543013511,0.1327311785860344,ECE1,Hypo
3303,GO_Biological_Process_2018,protein transport along microtubule (GO:0098840),1/16,0.8064130564244143,0.9516060602923212,0,0,0.6168975543013511,0.1327311785860344,RPGR,Hypo
3304,GO_Biological_Process_2018,embryonic digit morphogenesis (GO:0042733),1/16,0.8064130564244143,0.9516060602923212,0,0,0.6168975543013511,0.1327311785860344,ECE1,Hypo
3305,GO_Biological_Process_2018,regulation of cell cycle phase transition (GO:1901987),1/16,0.8064130564244143,0.9516060602923212,0,0,0.6168975543013511,0.1327311785860344,ERCC2,Hypo
3306,GO_Biological_Process_2018,regulation of exosomal secretion (GO:1903541),1/16,0.8064130564244143,0.9516060602923212,0,0,0.6168975543013511,0.1327311785860344,ATP13A2,Hypo
3307,GO_Biological_Process_2018,sympathetic nervous system development (GO:0048485),1/16,0.8064130564244143,0.9516060602923212,0,0,0.6168975543013511,0.1327311785860344,NF1,Hypo
3308,GO_Biological_Process_2018,neuromuscular process (GO:0050905),1/16,0.8064130564244143,0.9516060602923212,0,0,0.6168975543013511,0.1327311785860344,TPP1,Hypo
3309,GO_Biological_Process_2018,protein deacylation (GO:0035601),1/16,0.8064130564244143,0.9516060602923212,0,0,0.6168975543013511,0.1327311785860344,HDAC5,Hypo
3310,GO_Biological_Process_2018,positive regulation of lymphocyte differentiation (GO:0045621),1/16,0.8064130564244143,0.9516060602923212,0,0,0.6168975543013511,0.1327311785860344,ZMIZ1,Hypo
3311,GO_Biological_Process_2018,positive regulation of macrophage derived foam cell differentiation (GO:0010744),1/16,0.8064130564244143,0.9516060602923212,0,0,0.6168975543013511,0.1327311785860344,PRKCH,Hypo
3312,GO_Biological_Process_2018,negative regulation of DNA replication (GO:0008156),1/16,0.8064130564244143,0.9516060602923212,0,0,0.6168975543013511,0.1327311785860344,TGFB3,Hypo
3313,GO_Biological_Process_2018,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),1/16,0.8064130564244143,0.9516060602923212,0,0,0.6168975543013511,0.1327311785860344,BRD4,Hypo
3314,GO_Biological_Process_2018,regulation of protein homodimerization activity (GO:0043496),1/16,0.8064130564244143,0.9516060602923212,0,0,0.6168975543013511,0.1327311785860344,TRAF4,Hypo
3315,GO_Biological_Process_2018,mRNA transcription from RNA polymerase II promoter (GO:0042789),1/16,0.8064130564244143,0.9516060602923212,0,0,0.6168975543013511,0.1327311785860344,DDIT3,Hypo
3316,GO_Biological_Process_2018,cardiac epithelial to mesenchymal transition (GO:0060317),1/16,0.8064130564244143,0.9516060602923212,0,0,0.6168975543013511,0.1327311785860344,OLFM1,Hypo
3317,GO_Biological_Process_2018,odontogenesis of dentin-containing tooth (GO:0042475),1/16,0.8064130564244143,0.9516060602923212,0,0,0.6168975543013511,0.1327311785860344,ANKRD11,Hypo
3318,GO_Biological_Process_2018,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),1/16,0.8064130564244143,0.9516060602923212,0,0,0.6168975543013511,0.1327311785860344,RPTOR,Hypo
3319,GO_Biological_Process_2018,aorta morphogenesis (GO:0035909),1/16,0.8064130564244143,0.9516060602923212,0,0,0.6168975543013511,0.1327311785860344,LRP1,Hypo
3320,GO_Biological_Process_2018,detection of visible light (GO:0009584),1/16,0.8064130564244143,0.9516060602923212,0,0,0.6168975543013511,0.1327311785860344,MAPRE2,Hypo
3321,GO_Biological_Process_2018,positive regulation of leukocyte activation (GO:0002696),1/16,0.8064130564244143,0.9516060602923212,0,0,0.6168975543013511,0.1327311785860344,IL33,Hypo
3322,GO_Biological_Process_2018,endoplasmic reticulum to cytosol transport (GO:1903513),1/16,0.8064130564244143,0.9516060602923212,0,0,0.6168975543013511,0.1327311785860344,NPLOC4,Hypo
3323,GO_Biological_Process_2018,ruffle organization (GO:0031529),1/16,0.8064130564244143,0.9516060602923212,0,0,0.6168975543013511,0.1327311785860344,PLEKHA1,Hypo
3324,GO_Biological_Process_2018,neurotransmitter transport (GO:0006836),1/16,0.8064130564244143,0.9516060602923212,0,0,0.6168975543013511,0.1327311785860344,SYNJ1,Hypo
3325,GO_Biological_Process_2018,positive regulation of positive chemotaxis (GO:0050927),1/16,0.8064130564244143,0.9516060602923212,0,0,0.6168975543013511,0.1327311785860344,NTRK3,Hypo
3326,GO_Biological_Process_2018,mesenchyme development (GO:0060485),1/16,0.8064130564244143,0.9516060602923212,0,0,0.6168975543013511,0.1327311785860344,FGFR2,Hypo
3327,GO_Biological_Process_2018,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",1/16,0.8064130564244143,0.9516060602923212,0,0,0.6168975543013511,0.1327311785860344,PAXIP1,Hypo
3328,GO_Biological_Process_2018,positive regulation of epithelial cell apoptotic process (GO:1904037),1/16,0.8064130564244143,0.9516060602923212,0,0,0.6168975543013511,0.1327311785860344,PIAS4,Hypo
3329,GO_Biological_Process_2018,lipopolysaccharide-mediated signaling pathway (GO:0031663),1/16,0.8064130564244143,0.9516060602923212,0,0,0.6168975543013511,0.1327311785860344,PRKCE,Hypo
3330,GO_Biological_Process_2018,C21-steroid hormone biosynthetic process (GO:0006700),1/16,0.8064130564244143,0.9516060602923212,0,0,0.6168975543013511,0.1327311785860344,TSPOAP1,Hypo
3331,GO_Biological_Process_2018,dendritic cell chemotaxis (GO:0002407),1/16,0.8064130564244143,0.9516060602923212,0,0,0.6168975543013511,0.1327311785860344,HMGB1,Hypo
3332,GO_Biological_Process_2018,DNA strand elongation involved in DNA replication (GO:0006271),1/16,0.8064130564244143,0.9516060602923212,0,0,0.6168975543013511,0.1327311785860344,PARP3,Hypo
3333,GO_Biological_Process_2018,fibrinolysis (GO:0042730),1/16,0.8064130564244143,0.9516060602923212,0,0,0.6168975543013511,0.1327311785860344,F2,Hypo
3334,GO_Biological_Process_2018,phosphatidylinositol acyl-chain remodeling (GO:0036149),1/16,0.8064130564244143,0.9516060602923212,0,0,0.6168975543013511,0.1327311785860344,PLA2G5,Hypo
3335,GO_Biological_Process_2018,hyaluronan catabolic process (GO:0030214),1/16,0.8064130564244143,0.9516060602923212,0,0,0.6168975543013511,0.1327311785860344,SLC9A1,Hypo
3336,GO_Biological_Process_2018,histone H2A acetylation (GO:0043968),1/16,0.8064130564244143,0.9516060602923212,0,0,0.6168975543013511,0.1327311785860344,TRRAP,Hypo
3337,GO_Biological_Process_2018,positive regulation of mRNA processing (GO:0050685),1/16,0.8064130564244143,0.9516060602923212,0,0,0.6168975543013511,0.1327311785860344,CELF4,Hypo
3338,GO_Biological_Process_2018,chromosome organization (GO:0051276),4/56,0.8085134814434972,0.9535133543131544,0,0,0.7114396394971935,0.1512221338669659,COPS4;NUP133;DOT1L;AXIN2,Hypo
3339,GO_Biological_Process_2018,organonitrogen compound catabolic process (GO:1901565),4/56,0.8085134814434972,0.9535133543131544,0,0,0.7114396394971935,0.1512221338669659,TPP1;IDE;CTSD;MTOR,Hypo
3340,GO_Biological_Process_2018,positive regulation of mitochondrion organization (GO:0010822),10/128,0.8115340666059997,0.9558563709548168,0,0,0.7833304211078106,0.1635820404465015,SH3GLB1;HRK;MYBPC1;VPS11;HPS4;HIP1R;DDHD1;WBP11;BOK;CAMKK2,Hypo
3341,GO_Biological_Process_2018,negative regulation of programmed cell death (GO:0043069),35/408,0.8122313397245913,0.9558563709548168,0,0,0.8661617398973813,0.1801357248309098,AVEN;TNFAIP8;SRC;FLT4;FAIM2;MST1R;PIK3R1;FAM129B;BABAM2;DSTYK;BAG3;MYO18A;FLNA;PTK2B;PIM2;EPHB2;EPHB1;DCPS;HTATIP2;MAP4K4;PDGFRA;AREL1;SEMA4D;NTRK3;LMTK2;RNF144B;SON;PAX7;KIT;TYRO3;BIRC6;ARHGEF2;CRYAB;SLC25A4;FGFR2,Hypo
3342,GO_Biological_Process_2018,negative regulation of cell death (GO:0060548),6/81,0.8137526348065445,0.9558563709548168,0,0,0.7397119341563786,0.1524537771908451,CDK5;LRRK2;ATP13A2;PDE8A;DCPS;SORL1,Hypo
3343,GO_Biological_Process_2018,BMP signaling pathway (GO:0030509),6/81,0.8137526348065445,0.9558563709548168,0,0,0.7397119341563786,0.1524537771908451,TGFB3;SMURF1;UBE2D1;TOB1;RUNX2;SMAD7,Hypo
3344,GO_Biological_Process_2018,positive regulation of Wnt signaling pathway (GO:0030177),11/140,0.8144598064189891,0.9558563709548168,0,0,0.7881110298203742,0.1617441840433372,KANK1;SCEL;TNKS2;WNK2;LRRK2;DVL1;PIN1;AXIN2;FGFR2;SMARCA4;SULF2,Hypo
3345,GO_Biological_Process_2018,regulation of smooth muscle cell proliferation (GO:0048660),3/44,0.8162969866323622,0.9558563709548168,0,0,0.6768010823405615,0.1373750776733326,XRCC6;TRIB1;EREG,Hypo
3346,GO_Biological_Process_2018,carboxylic acid biosynthetic process (GO:0046394),3/44,0.8162969866323622,0.9558563709548168,0,0,0.6768010823405615,0.1373750776733326,GPT2;ASPG;NAT8L,Hypo
3347,GO_Biological_Process_2018,positive regulation of viral process (GO:0048524),3/44,0.8162969866323622,0.9558563709548168,0,0,0.6768010823405615,0.1373750776733326,CTDP1;MVB12B;PPIB,Hypo
3348,GO_Biological_Process_2018,positive regulation of ubiquitin-protein transferase activity (GO:0051443),2/31,0.8193974498201267,0.9558563709548168,0,0,0.6380018409686328,0.1270810513642028,GOLGA2;PIN1,Hypo
3349,GO_Biological_Process_2018,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),2/31,0.8193974498201267,0.9558563709548168,0,0,0.6380018409686328,0.1270810513642028,NFKBIL1;RARA,Hypo
3350,GO_Biological_Process_2018,zinc ion homeostasis (GO:0055069),2/31,0.8193974498201267,0.9558563709548168,0,0,0.6380018409686328,0.1270810513642028,TMC8;ATP13A2,Hypo
3351,GO_Biological_Process_2018,multivesicular body organization (GO:0036257),2/31,0.8193974498201267,0.9558563709548168,0,0,0.6380018409686328,0.1270810513642028,VPS37B;CHMP5,Hypo
3352,GO_Biological_Process_2018,cofactor biosynthetic process (GO:0051188),2/31,0.8193974498201267,0.9558563709548168,0,0,0.6380018409686328,0.1270810513642028,BDH2;MOCOS,Hypo
3353,GO_Biological_Process_2018,positive regulation of interleukin-1 beta production (GO:0032731),2/31,0.8193974498201267,0.9558563709548168,0,0,0.6380018409686328,0.1270810513642028,PANX1;INAVA,Hypo
3354,GO_Biological_Process_2018,positive regulation of insulin secretion (GO:0032024),2/31,0.8193974498201267,0.9558563709548168,0,0,0.6380018409686328,0.1270810513642028,IRS2;GPLD1,Hypo
3355,GO_Biological_Process_2018,regulation of cytokine secretion (GO:0050707),2/31,0.8193974498201267,0.9558563709548168,0,0,0.6380018409686328,0.1270810513642028,CADM1;FOXP3,Hypo
3356,GO_Biological_Process_2018,sarcomere organization (GO:0045214),2/31,0.8193974498201267,0.9558563709548168,0,0,0.6380018409686328,0.1270810513642028,MYBPC1;OBSCN,Hypo
3357,GO_Biological_Process_2018,protein destabilization (GO:0031648),2/31,0.8193974498201267,0.9558563709548168,0,0,0.6380018409686328,0.1270810513642028,CCDC88C;BTRC,Hypo
3358,GO_Biological_Process_2018,positive regulation of cell cycle (GO:0045787),6/82,0.8228062205068368,0.9558563709548168,0,0,0.7299382716049383,0.1423631904056823,SRPK2;USP2;RARA;SETMAR;PRKCA;FGFR2,Hypo
3359,GO_Biological_Process_2018,Rab protein signal transduction (GO:0032482),5/70,0.8249688442868858,0.9558563709548168,0,0,0.7112912794146727,0.1368593117119016,RAB31;RAB5C;RAB15;RAB23;RAB6B,Hypo
3360,GO_Biological_Process_2018,neuropeptide signaling pathway (GO:0007218),5/70,0.8249688442868858,0.9558563709548168,0,0,0.7112912794146727,0.1368593117119016,OPRD1;SORT1;RAPGEF2;AGRP;SORCS3,Hypo
3361,GO_Biological_Process_2018,snRNA transcription (GO:0009301),5/70,0.8249688442868858,0.9558563709548168,0,0,0.7112912794146727,0.1368593117119016,ELL;INTS1;INTS7;POU2F2;GTF2E1,Hypo
3362,GO_Biological_Process_2018,interferon-gamma-mediated signaling pathway (GO:0060333),5/70,0.8249688442868858,0.9558563709548168,0,0,0.7112912794146727,0.1368593117119016,CAMK2B;TRIM5;IRF2;CAMK2A;CAMK2G,Hypo
3363,GO_Biological_Process_2018,snRNA transcription from RNA polymerase II promoter (GO:0042795),5/70,0.8249688442868858,0.9558563709548168,0,0,0.7112912794146727,0.1368593117119016,ELL;INTS1;INTS7;POU2F2;GTF2E1,Hypo
3364,GO_Biological_Process_2018,negative regulation of developmental process (GO:0051093),5/70,0.8249688442868858,0.9558563709548168,0,0,0.7112912794146727,0.1368593117119016,KANK1;DDIT3;WNT9B;MAPT;RAPGEF3,Hypo
3365,GO_Biological_Process_2018,regulation of protein sumoylation (GO:0033233),1/17,0.8253027462851821,0.9558563709548168,0,0,0.5783093894304772,0.111038291292205,PIAS4,Hypo
3366,GO_Biological_Process_2018,cardiac myofibril assembly (GO:0055003),1/17,0.8253027462851821,0.9558563709548168,0,0,0.5783093894304772,0.111038291292205,PDGFRA,Hypo
3367,GO_Biological_Process_2018,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),1/17,0.8253027462851821,0.9558563709548168,0,0,0.5783093894304772,0.111038291292205,PAXIP1,Hypo
3368,GO_Biological_Process_2018,ureteric bud development (GO:0001657),1/17,0.8253027462851821,0.9558563709548168,0,0,0.5783093894304772,0.111038291292205,FGFR2,Hypo
3369,GO_Biological_Process_2018,RNA stabilization (GO:0043489),1/17,0.8253027462851821,0.9558563709548168,0,0,0.5783093894304772,0.111038291292205,AXIN2,Hypo
3370,GO_Biological_Process_2018,positive regulation of monocyte chemotaxis (GO:0090026),1/17,0.8253027462851821,0.9558563709548168,0,0,0.5783093894304772,0.111038291292205,HMGB1,Hypo
3371,GO_Biological_Process_2018,histone H2A ubiquitination (GO:0033522),1/17,0.8253027462851821,0.9558563709548168,0,0,0.5783093894304772,0.111038291292205,UBR2,Hypo
3372,GO_Biological_Process_2018,negative regulation of B cell activation (GO:0050869),1/17,0.8253027462851821,0.9558563709548168,0,0,0.5783093894304772,0.111038291292205,INHBA,Hypo
3373,GO_Biological_Process_2018,positive regulation of striated muscle cell differentiation (GO:0051155),1/17,0.8253027462851821,0.9558563709548168,0,0,0.5783093894304772,0.111038291292205,MAPK14,Hypo
3374,GO_Biological_Process_2018,negative regulation of cell development (GO:0010721),1/17,0.8253027462851821,0.9558563709548168,0,0,0.5783093894304772,0.111038291292205,SORL1,Hypo
3375,GO_Biological_Process_2018,regulation of myelination (GO:0031641),1/17,0.8253027462851821,0.9558563709548168,0,0,0.5783093894304772,0.111038291292205,TENM4,Hypo
3376,GO_Biological_Process_2018,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),1/17,0.8253027462851821,0.9558563709548168,0,0,0.5783093894304772,0.111038291292205,RFFL,Hypo
3377,GO_Biological_Process_2018,spindle assembly checkpoint (GO:0071173),1/17,0.8253027462851821,0.9558563709548168,0,0,0.5783093894304772,0.111038291292205,MAD1L1,Hypo
3378,GO_Biological_Process_2018,maturation of 5.8S rRNA (GO:0000460),1/17,0.8253027462851821,0.9558563709548168,0,0,0.5783093894304772,0.111038291292205,PDCD11,Hypo
3379,GO_Biological_Process_2018,DNA replication checkpoint (GO:0000076),1/17,0.8253027462851821,0.9558563709548168,0,0,0.5783093894304772,0.111038291292205,CLSPN,Hypo
3380,GO_Biological_Process_2018,positive regulation of signal transduction by p53 class mediator (GO:1901798),1/17,0.8253027462851821,0.9558563709548168,0,0,0.5783093894304772,0.111038291292205,CHD5,Hypo
3381,GO_Biological_Process_2018,positive regulation of macrophage activation (GO:0043032),1/17,0.8253027462851821,0.9558563709548168,0,0,0.5783093894304772,0.111038291292205,IL33,Hypo
3382,GO_Biological_Process_2018,regulation of transcription from RNA polymerase I promoter (GO:0006356),1/17,0.8253027462851821,0.9558563709548168,0,0,0.5783093894304772,0.111038291292205,FLNA,Hypo
3383,GO_Biological_Process_2018,virion assembly (GO:0019068),1/17,0.8253027462851821,0.9558563709548168,0,0,0.5783093894304772,0.111038291292205,CHMP5,Hypo
3384,GO_Biological_Process_2018,heterocycle biosynthetic process (GO:0018130),1/17,0.8253027462851821,0.9558563709548168,0,0,0.5783093894304772,0.111038291292205,MOCOS,Hypo
3385,GO_Biological_Process_2018,defense response to fungus (GO:0050832),1/17,0.8253027462851821,0.9558563709548168,0,0,0.5783093894304772,0.111038291292205,NLRP10,Hypo
3386,GO_Biological_Process_2018,serine family amino acid metabolic process (GO:0009069),1/17,0.8253027462851821,0.9558563709548168,0,0,0.5783093894304772,0.111038291292205,MTHFD1,Hypo
3387,GO_Biological_Process_2018,regulation of T cell migration (GO:2000404),1/17,0.8253027462851821,0.9558563709548168,0,0,0.5783093894304772,0.111038291292205,LRCH1,Hypo
3388,GO_Biological_Process_2018,positive chemotaxis (GO:0050918),1/17,0.8253027462851821,0.9558563709548168,0,0,0.5783093894304772,0.111038291292205,TSC2,Hypo
3389,GO_Biological_Process_2018,purine-containing compound metabolic process (GO:0072521),1/17,0.8253027462851821,0.9558563709548168,0,0,0.5783093894304772,0.111038291292205,MACROD1,Hypo
3390,GO_Biological_Process_2018,cellular response to inorganic substance (GO:0071241),1/17,0.8253027462851821,0.9558563709548168,0,0,0.5783093894304772,0.111038291292205,MTR,Hypo
3391,GO_Biological_Process_2018,cellular response to glucocorticoid stimulus (GO:0071385),1/17,0.8253027462851821,0.9558563709548168,0,0,0.5783093894304772,0.111038291292205,PCK2,Hypo
3392,GO_Biological_Process_2018,viral entry into host cell (GO:0046718),1/17,0.8253027462851821,0.9558563709548168,0,0,0.5783093894304772,0.111038291292205,GRK2,Hypo
3393,GO_Biological_Process_2018,mitotic spindle assembly checkpoint (GO:0007094),1/17,0.8253027462851821,0.9558563709548168,0,0,0.5783093894304772,0.111038291292205,MAD1L1,Hypo
3394,GO_Biological_Process_2018,mitotic spindle checkpoint (GO:0071174),1/17,0.8253027462851821,0.9558563709548168,0,0,0.5783093894304772,0.111038291292205,MAD1L1,Hypo
3395,GO_Biological_Process_2018,positive regulation of cell cycle G2/M phase transition (GO:1902751),1/17,0.8253027462851821,0.9558563709548168,0,0,0.5783093894304772,0.111038291292205,BRD4,Hypo
3396,GO_Biological_Process_2018,DNA catabolic process (GO:0006308),1/17,0.8253027462851821,0.9558563709548168,0,0,0.5783093894304772,0.111038291292205,SETMAR,Hypo
3397,GO_Biological_Process_2018,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),1/17,0.8253027462851821,0.9558563709548168,0,0,0.5783093894304772,0.111038291292205,IGFBP6,Hypo
3398,GO_Biological_Process_2018,positive regulation of lymphocyte migration (GO:2000403),1/17,0.8253027462851821,0.9558563709548168,0,0,0.5783093894304772,0.111038291292205,PTK2B,Hypo
3399,GO_Biological_Process_2018,preassembly of GPI anchor in ER membrane (GO:0016254),1/17,0.8253027462851821,0.9558563709548168,0,0,0.5783093894304772,0.111038291292205,PIGQ,Hypo
3400,GO_Biological_Process_2018,regulation of transposition (GO:0010528),1/17,0.8253027462851821,0.9558563709548168,0,0,0.5783093894304772,0.111038291292205,UBR2,Hypo
3401,GO_Biological_Process_2018,protein complex subunit organization (GO:0071822),3/45,0.82809474475752,0.9588081127571636,0,0,0.6606500843788979,0.1246169092953915,NUP133;COL5A1;NF1,Hypo
3402,GO_Biological_Process_2018,tRNA modification (GO:0006400),4/58,0.8298086257095707,0.9605101900293856,0,0,0.6850138936469872,0.1277963127060565,WDR4;TRMT13;TRMT61A;TARBP1,Hypo
3403,GO_Biological_Process_2018,transcription elongation from RNA polymerase II promoter (GO:0006368),7/95,0.8305053189080808,0.961034210099568,0,0,0.735355354887007,0.136570891776645,CTDP1;ELL;ERCC2;MLLT1;WDR61;TAF4;GTF2E1,Hypo
3404,GO_Biological_Process_2018,negative regulation of endopeptidase activity (GO:0010951),6/83,0.8315066902994834,0.9616336965057896,0,0,0.7204184704184704,0.1329286871712331,SERPIND1;BIN1;TIMP2;TIMP3;SPOCK1;SORL1,Hypo
3405,GO_Biological_Process_2018,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),2/32,0.8329764337338802,0.9616336965057896,0,0,0.6167008898015058,0.112702043240315,ATP1A2;CALM3,Hypo
3406,GO_Biological_Process_2018,protein trimerization (GO:0070206),2/32,0.8329764337338802,0.9616336965057896,0,0,0.6167008898015058,0.112702043240315,CLYBL;ASIC1,Hypo
3407,GO_Biological_Process_2018,GPI anchor biosynthetic process (GO:0006506),2/32,0.8329764337338802,0.9616336965057896,0,0,0.6167008898015058,0.112702043240315,DPM3;PIGQ,Hypo
3408,GO_Biological_Process_2018,regulation of cell-cell adhesion (GO:0022407),2/32,0.8329764337338802,0.9616336965057896,0,0,0.6167008898015058,0.112702043240315,SRC;SMAD7,Hypo
3409,GO_Biological_Process_2018,vasculogenesis (GO:0001570),2/32,0.8329764337338802,0.9616336965057896,0,0,0.6167008898015058,0.112702043240315,FLT4;CCM2,Hypo
3410,GO_Biological_Process_2018,global genome nucleotide-excision repair (GO:0070911),2/32,0.8329764337338802,0.9616336965057896,0,0,0.6167008898015058,0.112702043240315,ERCC1;ERCC2,Hypo
3411,GO_Biological_Process_2018,chromatin remodeling at centromere (GO:0031055),2/32,0.8329764337338802,0.9616336965057896,0,0,0.6167008898015058,0.112702043240315,CENPI;RBBP7,Hypo
3412,GO_Biological_Process_2018,phosphatidylcholine metabolic process (GO:0046470),5/71,0.8342367196346919,0.9619609012415256,0,0,0.7004751889070655,0.1269527786087836,SLC44A2;CHPT1;PLA2G5;LPIN1;GPLD1,Hypo
3413,GO_Biological_Process_2018,defense response to Gram-negative bacterium (GO:0050829),5/71,0.8342367196346919,0.9619609012415256,0,0,0.7004751889070655,0.1269527786087836,NLRP10;ADGRB1;DROSHA;F2;LYZL4,Hypo
3414,GO_Biological_Process_2018,positive regulation of growth (GO:0045927),5/71,0.8342367196346919,0.9619609012415256,0,0,0.7004751889070655,0.1269527786087836,RPTOR;FGFR1OP;AKAP6;HDGFL2;PPM1F,Hypo
3415,GO_Biological_Process_2018,nuclear import (GO:0051170),5/71,0.8342367196346919,0.9619609012415256,0,0,0.7004751889070655,0.1269527786087836,IPO9;NUP188;NUP133;TSC2;HTATIP2,Hypo
3416,GO_Biological_Process_2018,protein localization to nucleus (GO:0034504),7/96,0.8383943761226912,0.9638081077318597,0,0,0.727052455660481,0.1281551176788015,IPO9;NUP188;NUP133;LMNA;DVL1;TSC2;BBS4,Hypo
3417,GO_Biological_Process_2018,maturation of SSU-rRNA (GO:0030490),3/46,0.8392365925592539,0.9638081077318597,0,0,0.6452502956247537,0.1130882565619725,NOB1;PDCD11;UTP4,Hypo
3418,GO_Biological_Process_2018,regulation of telomerase RNA localization to Cajal body (GO:1904872),1/18,0.8423500653539966,0.9638081077318597,0,0,0.544261008662059,0.0933731990719074,CCT5,Hypo
3419,GO_Biological_Process_2018,regulation of viral process (GO:0050792),1/18,0.8423500653539966,0.9638081077318597,0,0,0.544261008662059,0.0933731990719074,MVB12B,Hypo
3420,GO_Biological_Process_2018,protein localization to centrosome (GO:0071539),1/18,0.8423500653539966,0.9638081077318597,0,0,0.544261008662059,0.0933731990719074,BBS4,Hypo
3421,GO_Biological_Process_2018,nuclear envelope reassembly (GO:0031468),1/18,0.8423500653539966,0.9638081077318597,0,0,0.544261008662059,0.0933731990719074,LMNA,Hypo
3422,GO_Biological_Process_2018,regulation of keratinocyte proliferation (GO:0010837),1/18,0.8423500653539966,0.9638081077318597,0,0,0.544261008662059,0.0933731990719074,STXBP4,Hypo
3423,GO_Biological_Process_2018,anterior/posterior axis specification (GO:0009948),1/18,0.8423500653539966,0.9638081077318597,0,0,0.544261008662059,0.0933731990719074,DDIT3,Hypo
3424,GO_Biological_Process_2018,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),1/18,0.8423500653539966,0.9638081077318597,0,0,0.544261008662059,0.0933731990719074,MVB12B,Hypo
3425,GO_Biological_Process_2018,outer dynein arm assembly (GO:0036158),1/18,0.8423500653539966,0.9638081077318597,0,0,0.544261008662059,0.0933731990719074,DNAAF5,Hypo
3426,GO_Biological_Process_2018,regulation of cardiac muscle cell proliferation (GO:0060043),1/18,0.8423500653539966,0.9638081077318597,0,0,0.544261008662059,0.0933731990719074,FGFR2,Hypo
3427,GO_Biological_Process_2018,"retrograde protein transport, ER to cytosol (GO:0030970)",1/18,0.8423500653539966,0.9638081077318597,0,0,0.544261008662059,0.0933731990719074,NPLOC4,Hypo
3428,GO_Biological_Process_2018,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),1/18,0.8423500653539966,0.9638081077318597,0,0,0.544261008662059,0.0933731990719074,ALG13,Hypo
3429,GO_Biological_Process_2018,phosphatidylglycerol acyl-chain remodeling (GO:0036148),1/18,0.8423500653539966,0.9638081077318597,0,0,0.544261008662059,0.0933731990719074,PLA2G5,Hypo
3430,GO_Biological_Process_2018,regulation of epithelial cell differentiation (GO:0030856),1/18,0.8423500653539966,0.9638081077318597,0,0,0.544261008662059,0.0933731990719074,AJAP1,Hypo
3431,GO_Biological_Process_2018,positive regulation of carbohydrate metabolic process (GO:0045913),1/18,0.8423500653539966,0.9638081077318597,0,0,0.544261008662059,0.0933731990719074,PFKFB3,Hypo
3432,GO_Biological_Process_2018,piRNA metabolic process (GO:0034587),1/18,0.8423500653539966,0.9638081077318597,0,0,0.544261008662059,0.0933731990719074,FKBP6,Hypo
3433,GO_Biological_Process_2018,positive regulation of morphogenesis of an epithelium (GO:1905332),1/18,0.8423500653539966,0.9638081077318597,0,0,0.544261008662059,0.0933731990719074,MTOR,Hypo
3434,GO_Biological_Process_2018,negative regulation of calcium-mediated signaling (GO:0050849),1/18,0.8423500653539966,0.9638081077318597,0,0,0.544261008662059,0.0933731990719074,CALM3,Hypo
3435,GO_Biological_Process_2018,membrane protein ectodomain proteolysis (GO:0006509),1/18,0.8423500653539966,0.9638081077318597,0,0,0.544261008662059,0.0933731990719074,MYH9,Hypo
3436,GO_Biological_Process_2018,release of cytochrome c from mitochondria (GO:0001836),1/18,0.8423500653539966,0.9638081077318597,0,0,0.544261008662059,0.0933731990719074,BOK,Hypo
3437,GO_Biological_Process_2018,calcium-mediated signaling using intracellular calcium source (GO:0035584),1/18,0.8423500653539966,0.9638081077318597,0,0,0.544261008662059,0.0933731990719074,RYR2,Hypo
3438,GO_Biological_Process_2018,positive regulation of lipid catabolic process (GO:0050996),1/18,0.8423500653539966,0.9638081077318597,0,0,0.544261008662059,0.0933731990719074,IRS2,Hypo
3439,GO_Biological_Process_2018,endoplasmic reticulum calcium ion homeostasis (GO:0032469),1/18,0.8423500653539966,0.9638081077318597,0,0,0.544261008662059,0.0933731990719074,RAP1GDS1,Hypo
3440,GO_Biological_Process_2018,response to metal ion (GO:0010038),5/72,0.8430993871230467,0.9638081077318597,0,0,0.6899819667728198,0.1177595196420053,AHCYL1;PEF1;NEDD4L;CALM3;MAPT,Hypo
3441,GO_Biological_Process_2018,RNA metabolic process (GO:0016070),15/191,0.844399825775025,0.9638081077318597,0,0,0.787262156448203,0.1331489945712496,FTO;PARP3;NUFIP1;DDX27;DDX24;PABPC4;DDX54;SND1;DHX30;ATXN2;ATXN1;DHX34;HNRNPF;AGO2;DROSHA,Hypo
3442,GO_Biological_Process_2018,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),8/109,0.8453205448860049,0.9638081077318597,0,0,0.7320818590612923,0.1230185820697444,SMAD3;HIP1;HIP1R;HMGB1;MAPT;GRAMD4;PPM1F;BOK,Hypo
3443,GO_Biological_Process_2018,axonemal dynein complex assembly (GO:0070286),2/33,0.8456260016048,0.9638081077318597,0,0,0.5967741935483871,0.1000659602790533,DNAAF5;CCDC40,Hypo
3444,GO_Biological_Process_2018,positive regulation of cell-cell adhesion (GO:0022409),2/33,0.8456260016048,0.9638081077318597,0,0,0.5967741935483871,0.1000659602790533,ANK3;SMAD7,Hypo
3445,GO_Biological_Process_2018,protein acetylation (GO:0006473),2/33,0.8456260016048,0.9638081077318597,0,0,0.5967741935483871,0.1000659602790533,KAT6A;MAPT,Hypo
3446,GO_Biological_Process_2018,"chemical synaptic transmission, postsynaptic (GO:0099565)",2/33,0.8456260016048,0.9638081077318597,0,0,0.5967741935483871,0.1000659602790533,LRRK2;GRIN2B,Hypo
3447,GO_Biological_Process_2018,entry into host cell (GO:0030260),2/33,0.8456260016048,0.9638081077318597,0,0,0.5967741935483871,0.1000659602790533,GRK2;SRC,Hypo
3448,GO_Biological_Process_2018,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),2/33,0.8456260016048,0.9638081077318597,0,0,0.5967741935483871,0.1000659602790533,NUP188;NUP133,Hypo
3449,GO_Biological_Process_2018,tRNA export from nucleus (GO:0006409),2/33,0.8456260016048,0.9638081077318597,0,0,0.5967741935483871,0.1000659602790533,NUP188;NUP133,Hypo
3450,GO_Biological_Process_2018,regulation of postsynaptic membrane potential (GO:0060078),2/33,0.8456260016048,0.9638081077318597,0,0,0.5967741935483871,0.1000659602790533,LRRK2;GRIN2B,Hypo
3451,GO_Biological_Process_2018,carboxylic acid metabolic process (GO:0019752),2/33,0.8456260016048,0.9638081077318597,0,0,0.5967741935483871,0.1000659602790533,ST6GAL1;SLC2A1,Hypo
3452,GO_Biological_Process_2018,positive regulation of nucleocytoplasmic transport (GO:0046824),2/33,0.8456260016048,0.9638081077318597,0,0,0.5967741935483871,0.1000659602790533,BAG3;RAPGEF3,Hypo
3453,GO_Biological_Process_2018,negative regulation of multi-organism process (GO:0043901),2/33,0.8456260016048,0.9638081077318597,0,0,0.5967741935483871,0.1000659602790533,NFKBIL1;TRIB1,Hypo
3454,GO_Biological_Process_2018,regulation of interleukin-12 production (GO:0032655),2/33,0.8456260016048,0.9638081077318597,0,0,0.5967741935483871,0.1000659602790533,HMGB1;CMKLR1,Hypo
3455,GO_Biological_Process_2018,stem cell differentiation (GO:0048863),2/33,0.8456260016048,0.9638081077318597,0,0,0.5967741935483871,0.1000659602790533,KIT;FGFR2,Hypo
3456,GO_Biological_Process_2018,positive regulation of cytosolic calcium ion concentration (GO:0007204),10/133,0.8463076209640539,0.9643059644134824,0,0,0.7512781828849217,0.1253675688849764,PDGFRA;RYR2;CACNB3;P2RX4;ABL1;ABL2;CACNA1C;HMGB1;SPPL3;GRM1,Hypo
3457,GO_Biological_Process_2018,nucleosome assembly (GO:0006334),4/60,0.849094663867975,0.9647677547606428,0,0,0.6604757010717957,0.1080436523478457,SART3;H2AFY;UBN1;CABIN1,Hypo
3458,GO_Biological_Process_2018,positive regulation of tumor necrosis factor production (GO:0032760),3/47,0.8497483104261164,0.9647677547606428,0,0,0.630550497268525,0.1026631288539149,ARFGEF2;ARHGEF2;RASGRP1,Hypo
3459,GO_Biological_Process_2018,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),3/47,0.8497483104261164,0.9647677547606428,0,0,0.630550497268525,0.1026631288539149,TWSG1;TGFB3;INHBA,Hypo
3460,GO_Biological_Process_2018,"mRNA splicing, via spliceosome (GO:0000398)",21/261,0.8514652399163133,0.9647677547606428,0,0,0.8078667703473302,0.129902231451383,SRPK2;ZCCHC8;SPEN;SF3B2;BUD31;CSTF2;PRCC;CELF4;PRPF40B;CWC25;CWC27;WBP11;SRPK1;CHERP;SART3;HNRNPF;SYMPK;SRSF4;SNRNP200;DCPS;CTNNBL1,Hypo
3461,GO_Biological_Process_2018,B cell activation (GO:0042113),5/73,0.8515674953756524,0.9647677547606428,0,0,0.6797973688189929,0.1092274725212496,TPD52;HDAC5;PRKCB;NFAM1;BLNK,Hypo
3462,GO_Biological_Process_2018,lymphocyte differentiation (GO:0030098),5/73,0.8515674953756524,0.9647677547606428,0,0,0.6797973688189929,0.1092274725212496,TPD52;HDAC5;NFAM1;KIT;BLNK,Hypo
3463,GO_Biological_Process_2018,apoptotic mitochondrial changes (GO:0008637),2/34,0.8573981959105047,0.9647677547606428,0,0,0.5780929158110883,0.0889412304994502,CAMK2A;BOK,Hypo
3464,GO_Biological_Process_2018,positive regulation of muscle cell differentiation (GO:0051149),2/34,0.8573981959105047,0.9647677547606428,0,0,0.5780929158110883,0.0889412304994502,ABL1;MAPK14,Hypo
3465,GO_Biological_Process_2018,positive regulation of DNA binding (GO:0043388),2/34,0.8573981959105047,0.9647677547606428,0,0,0.5780929158110883,0.0889412304994502,HMGB1;FAM129B,Hypo
3466,GO_Biological_Process_2018,positive regulation of cytokinesis (GO:0032467),2/34,0.8573981959105047,0.9647677547606428,0,0,0.5780929158110883,0.0889412304994502,PRKCE;CIT,Hypo
3467,GO_Biological_Process_2018,negative regulation of T cell activation (GO:0050868),2/34,0.8573981959105047,0.9647677547606428,0,0,0.5780929158110883,0.0889412304994502,FOXP3;PAG1,Hypo
3468,GO_Biological_Process_2018,negative regulation of cellular metabolic process (GO:0031324),2/34,0.8573981959105047,0.9647677547606428,0,0,0.5780929158110883,0.0889412304994502,ATXN2;NR1D1,Hypo
3469,GO_Biological_Process_2018,positive regulation of chromosome organization (GO:2001252),1/19,0.8577346222827548,0.9647677547606428,0,0,0.5139957813123539,0.0788780626409463,NUMA1,Hypo
3470,GO_Biological_Process_2018,negative regulation of lymphocyte activation (GO:0051250),1/19,0.8577346222827548,0.9647677547606428,0,0,0.5139957813123539,0.0788780626409463,PAG1,Hypo
3471,GO_Biological_Process_2018,error-free translesion synthesis (GO:0070987),1/19,0.8577346222827548,0.9647677547606428,0,0,0.5139957813123539,0.0788780626409463,NPLOC4,Hypo
3472,GO_Biological_Process_2018,regulation of sprouting angiogenesis (GO:1903670),1/19,0.8577346222827548,0.9647677547606428,0,0,0.5139957813123539,0.0788780626409463,FGF1,Hypo
3473,GO_Biological_Process_2018,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),1/19,0.8577346222827548,0.9647677547606428,0,0,0.5139957813123539,0.0788780626409463,ALAD,Hypo
3474,GO_Biological_Process_2018,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",1/19,0.8577346222827548,0.9647677547606428,0,0,0.5139957813123539,0.0788780626409463,PDCD11,Hypo
3475,GO_Biological_Process_2018,sulfur compound transport (GO:0072348),1/19,0.8577346222827548,0.9647677547606428,0,0,0.5139957813123539,0.0788780626409463,SLC35F3,Hypo
3476,GO_Biological_Process_2018,positive regulation of mononuclear cell migration (GO:0071677),1/19,0.8577346222827548,0.9647677547606428,0,0,0.5139957813123539,0.0788780626409463,HMGB1,Hypo
3477,GO_Biological_Process_2018,purine ribonucleoside bisphosphate metabolic process (GO:0034035),1/19,0.8577346222827548,0.9647677547606428,0,0,0.5139957813123539,0.0788780626409463,SULT4A1,Hypo
3478,GO_Biological_Process_2018,cellular response to zinc ion (GO:0071294),1/19,0.8577346222827548,0.9647677547606428,0,0,0.5139957813123539,0.0788780626409463,ATP13A2,Hypo
3479,GO_Biological_Process_2018,positive regulation of toll-like receptor signaling pathway (GO:0034123),1/19,0.8577346222827548,0.9647677547606428,0,0,0.5139957813123539,0.0788780626409463,HMGB1,Hypo
3480,GO_Biological_Process_2018,positive regulation of lipid storage (GO:0010884),1/19,0.8577346222827548,0.9647677547606428,0,0,0.5139957813123539,0.0788780626409463,SCARB1,Hypo
3481,GO_Biological_Process_2018,leukotriene metabolic process (GO:0006691),1/19,0.8577346222827548,0.9647677547606428,0,0,0.5139957813123539,0.0788780626409463,MAPKAPK2,Hypo
3482,GO_Biological_Process_2018,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),1/19,0.8577346222827548,0.9647677547606428,0,0,0.5139957813123539,0.0788780626409463,BOK,Hypo
3483,GO_Biological_Process_2018,gamma-aminobutyric acid signaling pathway (GO:0007214),1/19,0.8577346222827548,0.9647677547606428,0,0,0.5139957813123539,0.0788780626409463,GABBR2,Hypo
3484,GO_Biological_Process_2018,positive regulation of interferon-alpha production (GO:0032727),1/19,0.8577346222827548,0.9647677547606428,0,0,0.5139957813123539,0.0788780626409463,TBK1,Hypo
3485,GO_Biological_Process_2018,cellular polysaccharide biosynthetic process (GO:0033692),1/19,0.8577346222827548,0.9647677547606428,0,0,0.5139957813123539,0.0788780626409463,NDST1,Hypo
3486,GO_Biological_Process_2018,folic acid metabolic process (GO:0046655),1/19,0.8577346222827548,0.9647677547606428,0,0,0.5139957813123539,0.0788780626409463,MTHFD1,Hypo
3487,GO_Biological_Process_2018,striated muscle cell differentiation (GO:0051146),1/19,0.8577346222827548,0.9647677547606428,0,0,0.5139957813123539,0.0788780626409463,SORT1,Hypo
3488,GO_Biological_Process_2018,nucleotide-sugar biosynthetic process (GO:0009226),1/19,0.8577346222827548,0.9647677547606428,0,0,0.5139957813123539,0.0788780626409463,PMM1,Hypo
3489,GO_Biological_Process_2018,positive regulation of blood coagulation (GO:0030194),1/19,0.8577346222827548,0.9647677547606428,0,0,0.5139957813123539,0.0788780626409463,F2,Hypo
3490,GO_Biological_Process_2018,DNA double-strand break processing (GO:0000729),1/19,0.8577346222827548,0.9647677547606428,0,0,0.5139957813123539,0.0788780626409463,SETMAR,Hypo
3491,GO_Biological_Process_2018,aspartate family amino acid catabolic process (GO:0009068),1/19,0.8577346222827548,0.9647677547606428,0,0,0.5139957813123539,0.0788780626409463,ASPG,Hypo
3492,GO_Biological_Process_2018,drug transport (GO:0015893),1/19,0.8577346222827548,0.9647677547606428,0,0,0.5139957813123539,0.0788780626409463,PDZK1,Hypo
3493,GO_Biological_Process_2018,telomere capping (GO:0016233),1/19,0.8577346222827548,0.9647677547606428,0,0,0.5139957813123539,0.0788780626409463,STN1,Hypo
3494,GO_Biological_Process_2018,positive regulation of epithelial cell differentiation (GO:0030858),1/19,0.8577346222827548,0.9647677547606428,0,0,0.5139957813123539,0.0788780626409463,KDF1,Hypo
3495,GO_Biological_Process_2018,positive regulation of transcription regulatory region DNA binding (GO:2000679),1/19,0.8577346222827548,0.9647677547606428,0,0,0.5139957813123539,0.0788780626409463,FAM129B,Hypo
3496,GO_Biological_Process_2018,mitochondrial membrane organization (GO:0007006),1/19,0.8577346222827548,0.9647677547606428,0,0,0.5139957813123539,0.0788780626409463,SLC25A4,Hypo
3497,GO_Biological_Process_2018,histone methylation (GO:0016571),1/19,0.8577346222827548,0.9647677547606428,0,0,0.5139957813123539,0.0788780626409463,PRMT8,Hypo
3498,GO_Biological_Process_2018,positive regulation of STAT cascade (GO:1904894),1/19,0.8577346222827548,0.9647677547606428,0,0,0.5139957813123539,0.0788780626409463,KIT,Hypo
3499,GO_Biological_Process_2018,protein exit from endoplasmic reticulum (GO:0032527),1/19,0.8577346222827548,0.9647677547606428,0,0,0.5139957813123539,0.0788780626409463,NPLOC4,Hypo
3500,GO_Biological_Process_2018,negative regulation of transposition (GO:0010529),1/19,0.8577346222827548,0.9647677547606428,0,0,0.5139957813123539,0.0788780626409463,UBR2,Hypo
3501,GO_Biological_Process_2018,regulation of heterotypic cell-cell adhesion (GO:0034114),1/19,0.8577346222827548,0.9647677547606428,0,0,0.5139957813123539,0.0788780626409463,MBP,Hypo
3502,GO_Biological_Process_2018,RNA 3'-end processing (GO:0031123),4/61,0.8580233571950159,0.9648170151273672,0,0,0.6488523466940733,0.0993548388518539,ZC3H11A;CSTF2;SYMPK;SRSF4,Hypo
3503,GO_Biological_Process_2018,cellular calcium ion homeostasis (GO:0006874),9/123,0.858516222758507,0.9650957195906849,0,0,0.7295208655332303,0.1112881907793765,RYR1;SLC8A3;RYR2;RMDN3;ATP13A2;ATP2B1;F2;SLC8A2;CHERP,Hypo
3504,GO_Biological_Process_2018,pattern recognition receptor signaling pathway (GO:0002221),3/48,0.8596558997621326,0.96582561014348,0,0,0.6165040232836843,0.0932296411532253,MAPKAPK2;HMGB1;INAVA,Hypo
3505,GO_Biological_Process_2018,cellular response to mechanical stimulus (GO:0071260),3/48,0.8596558997621326,0.96582561014348,0,0,0.6165040232836843,0.0932296411532253,PDE2A;MAP3K14;SLC9A1,Hypo
3506,GO_Biological_Process_2018,organic substance transport (GO:0071702),6/87,0.8629269111821736,0.9689478629266196,0,0,0.6846898338667886,0.1009405925572378,SLC22A23;ABCA1;SLC22A15;SLC22A17;PSAP;RHCG,Hypo
3507,GO_Biological_Process_2018,cellular response to BMP stimulus (GO:0071773),6/87,0.8629269111821736,0.9689478629266196,0,0,0.6846898338667886,0.1009405925572378,TGFB3;SMURF1;UBE2D1;TOB1;RUNX2;SMAD7,Hypo
3508,GO_Biological_Process_2018,organic anion transport (GO:0015711),9/124,0.8646837289912848,0.9690390535699652,0,0,0.7231368859619649,0.1051379349578433,SLC22A23;SCARB1;SLC22A15;SLC25A17;SLC22A17;SLCO2B1;SLC4A1;SLC25A4;LDLR,Hypo
3509,GO_Biological_Process_2018,diterpenoid metabolic process (GO:0016101),4/62,0.8664973848674139,0.9690390535699652,0,0,0.6376297976397207,0.0913699192754301,LRP1;SDC3;GPC4;GPC6,Hypo
3510,GO_Biological_Process_2018,negative regulation of peptidase activity (GO:0010466),4/62,0.8664973848674139,0.9690390535699652,0,0,0.6376297976397207,0.0913699192754301,SERPIND1;TIMP2;TIMP3;SPOCK1,Hypo
3511,GO_Biological_Process_2018,regulation of translational initiation (GO:0006446),4/62,0.8664973848674139,0.9690390535699652,0,0,0.6376297976397207,0.0913699192754301,EIF2B5;AGO2;EIF2AK4;EIF4G3,Hypo
3512,GO_Biological_Process_2018,positive regulation of type I interferon production (GO:0032481),4/62,0.8664973848674139,0.9690390535699652,0,0,0.6376297976397207,0.0913699192754301,XRCC6;TBK1;POLR3B;POLR3G,Hypo
3513,GO_Biological_Process_2018,positive regulation of RNA metabolic process (GO:0051254),2/35,0.8683437515436369,0.9690390535699652,0,0,0.5605438367245349,0.079130636867338,PIK3R1;BUD23,Hypo
3514,GO_Biological_Process_2018,regulation of cyclin-dependent protein kinase activity (GO:1904029),2/35,0.8683437515436369,0.9690390535699652,0,0,0.5605438367245349,0.079130636867338,CDKN1C;BCCIP,Hypo
3515,GO_Biological_Process_2018,tRNA transport (GO:0051031),2/35,0.8683437515436369,0.9690390535699652,0,0,0.5605438367245349,0.079130636867338,NUP188;NUP133,Hypo
3516,GO_Biological_Process_2018,membrane protein proteolysis (GO:0033619),2/35,0.8683437515436369,0.9690390535699652,0,0,0.5605438367245349,0.079130636867338,MYH9;SPPL3,Hypo
3517,GO_Biological_Process_2018,positive regulation of telomerase activity (GO:0051973),2/35,0.8683437515436369,0.9690390535699652,0,0,0.5605438367245349,0.079130636867338,MAP3K4;WRAP53,Hypo
3518,GO_Biological_Process_2018,negative regulation of tumor necrosis factor production (GO:0032720),2/35,0.8683437515436369,0.9690390535699652,0,0,0.5605438367245349,0.079130636867338,NFKBIL1;RARA,Hypo
3519,GO_Biological_Process_2018,flagellated sperm motility (GO:0030317),2/35,0.8683437515436369,0.9690390535699652,0,0,0.5605438367245349,0.079130636867338,ADCY3;CCDC40,Hypo
3520,GO_Biological_Process_2018,regulation of reactive oxygen species metabolic process (GO:2000377),3/49,0.8689853920877859,0.9690390535699652,0,0,0.603068265559054,0.0846882516835364,F2;MAPK14;RNF41,Hypo
3521,GO_Biological_Process_2018,regulation of megakaryocyte differentiation (GO:0045652),3/49,0.8689853920877859,0.9690390535699652,0,0,0.603068265559054,0.0846882516835364,TNRC6C;KMT2D;KMT2A,Hypo
3522,GO_Biological_Process_2018,lipid homeostasis (GO:0055088),3/49,0.8689853920877859,0.9690390535699652,0,0,0.603068265559054,0.0846882516835364,ABCA1;IRS2;ABCG1,Hypo
3523,GO_Biological_Process_2018,T cell activation (GO:0042110),6/88,0.8699768526967923,0.9690390535699652,0,0,0.6763023185787413,0.0942012530312665,KIT;FYN;EIF2AK4;TNFRSF4;FOXP3;DDOST,Hypo
3524,GO_Biological_Process_2018,positive regulation of protein complex assembly (GO:0031334),6/88,0.8699768526967923,0.9690390535699652,0,0,0.6763023185787413,0.0942012530312665,SH3GLB1;SRC;ERCC1;ERCC2;ASAP1;IDE,Hypo
3525,GO_Biological_Process_2018,muscle contraction (GO:0006936),10/137,0.8703365528993978,0.9690390535699652,0,0,0.7274535270720026,0.1010253266078723,RYR1;MYBPC1;SLC6A8;KCNJ12;TMOD2;PXN;LMOD1;SORBS1;CRYAB;SNTA1,Hypo
3526,GO_Biological_Process_2018,hydrogen peroxide metabolic process (GO:0042743),1/20,0.8716185241935481,0.9690390535699652,0,0,0.4869163673678809,0.0669039756140387,PXDN,Hypo
3527,GO_Biological_Process_2018,regulation of epidermal cell differentiation (GO:0045604),1/20,0.8716185241935481,0.9690390535699652,0,0,0.4869163673678809,0.0669039756140387,KDF1,Hypo
3528,GO_Biological_Process_2018,viral budding via host ESCRT complex (GO:0039702),1/20,0.8716185241935481,0.9690390535699652,0,0,0.4869163673678809,0.0669039756140387,VPS37B,Hypo
3529,GO_Biological_Process_2018,phosphatidylethanolamine metabolic process (GO:0046337),1/20,0.8716185241935481,0.9690390535699652,0,0,0.4869163673678809,0.0669039756140387,LPIN1,Hypo
3530,GO_Biological_Process_2018,androgen metabolic process (GO:0008209),1/20,0.8716185241935481,0.9690390535699652,0,0,0.4869163673678809,0.0669039756140387,HSD17B4,Hypo
3531,GO_Biological_Process_2018,regulation of anoikis (GO:2000209),1/20,0.8716185241935481,0.9690390535699652,0,0,0.4869163673678809,0.0669039756140387,SRC,Hypo
3532,GO_Biological_Process_2018,regulation of cell development (GO:0060284),1/20,0.8716185241935481,0.9690390535699652,0,0,0.4869163673678809,0.0669039756140387,PER2,Hypo
3533,GO_Biological_Process_2018,regulation of response to cytokine stimulus (GO:0060759),1/20,0.8716185241935481,0.9690390535699652,0,0,0.4869163673678809,0.0669039756140387,LIFR,Hypo
3534,GO_Biological_Process_2018,branching involved in ureteric bud morphogenesis (GO:0001658),1/20,0.8716185241935481,0.9690390535699652,0,0,0.4869163673678809,0.0669039756140387,FGF1,Hypo
3535,GO_Biological_Process_2018,aromatic amino acid family catabolic process (GO:0009074),1/20,0.8716185241935481,0.9690390535699652,0,0,0.4869163673678809,0.0669039756140387,HGD,Hypo
3536,GO_Biological_Process_2018,covalent chromatin modification (GO:0016569),1/20,0.8716185241935481,0.9690390535699652,0,0,0.4869163673678809,0.0669039756140387,PRDM10,Hypo
3537,GO_Biological_Process_2018,dorsal/ventral pattern formation (GO:0009953),1/20,0.8716185241935481,0.9690390535699652,0,0,0.4869163673678809,0.0669039756140387,DSCAML1,Hypo
3538,GO_Biological_Process_2018,dopaminergic neuron differentiation (GO:0071542),1/20,0.8716185241935481,0.9690390535699652,0,0,0.4869163673678809,0.0669039756140387,WNT9B,Hypo
3539,GO_Biological_Process_2018,positive regulation of interleukin-2 production (GO:0032743),1/20,0.8716185241935481,0.9690390535699652,0,0,0.4869163673678809,0.0669039756140387,PRKD2,Hypo
3540,GO_Biological_Process_2018,proteoglycan metabolic process (GO:0006029),1/20,0.8716185241935481,0.9690390535699652,0,0,0.4869163673678809,0.0669039756140387,SULF2,Hypo
3541,GO_Biological_Process_2018,regulation of cholesterol transport (GO:0032374),1/20,0.8716185241935481,0.9690390535699652,0,0,0.4869163673678809,0.0669039756140387,LRP1,Hypo
3542,GO_Biological_Process_2018,mitochondrial respiratory chain complex IV assembly (GO:0033617),1/20,0.8716185241935481,0.9690390535699652,0,0,0.4869163673678809,0.0669039756140387,CHCHD5,Hypo
3543,GO_Biological_Process_2018,cellular divalent inorganic cation homeostasis (GO:0072503),7/101,0.8735307801901596,0.9708910110522118,0,0,0.6881878209831255,0.0930511912699121,SLC8A3;RYR2;RMDN3;ATP13A2;ATP2B1;SLC8A2;CHERP,Hypo
3544,GO_Biological_Process_2018,iron ion homeostasis (GO:0055072),4/63,0.8745331516302965,0.971385910882959,0,0,0.6267876739770412,0.0840303371489195,BDH2;SLC25A28;SLC22A17;ATP13A2,Hypo
3545,GO_Biological_Process_2018,response to interleukin-1 (GO:0070555),5/76,0.8747158735470566,0.971385910882959,0,0,0.6509649154567508,0.0871356647255703,UPF1;SRC;USP10;DAB2IP;PRKCA,Hypo
3546,GO_Biological_Process_2018,nucleic acid-templated transcription (GO:0097659),5/76,0.8747158735470566,0.971385910882959,0,0,0.6509649154567508,0.0871356647255703,NCOA1;GTF3C1;RRAGC;DTX1;BAZ1B,Hypo
3547,GO_Biological_Process_2018,blood circulation (GO:0008015),3/50,0.8777626825102375,0.9722666923168164,0,0,0.5902042422056847,0.0769502478369271,RCAN1;EPO;ITGB1BP1,Hypo
3548,GO_Biological_Process_2018,histone exchange (GO:0043486),2/36,0.8785118558767198,0.9722666923168164,0,0,0.5440270564077787,0.0704655809700458,CENPI;RBBP7,Hypo
3549,GO_Biological_Process_2018,lymphocyte proliferation (GO:0046651),2/36,0.8785118558767198,0.9722666923168164,0,0,0.5440270564077787,0.0704655809700458,ELF4;TNFRSF4,Hypo
3550,GO_Biological_Process_2018,mRNA catabolic process (GO:0006402),2/36,0.8785118558767198,0.9722666923168164,0,0,0.5440270564077787,0.0704655809700458,UPF1;DHX34,Hypo
3551,GO_Biological_Process_2018,zymogen activation (GO:0031638),2/36,0.8785118558767198,0.9722666923168164,0,0,0.5440270564077787,0.0704655809700458,CYFIP2;FURIN,Hypo
3552,GO_Biological_Process_2018,centromere complex assembly (GO:0034508),2/36,0.8785118558767198,0.9722666923168164,0,0,0.5440270564077787,0.0704655809700458,CENPI;RBBP7,Hypo
3553,GO_Biological_Process_2018,cardiac muscle tissue morphogenesis (GO:0055008),2/36,0.8785118558767198,0.9722666923168164,0,0,0.5440270564077787,0.0704655809700458,FGFR2;SMAD7,Hypo
3554,GO_Biological_Process_2018,regulation of cysteine-type endopeptidase activity (GO:2000116),2/36,0.8785118558767198,0.9722666923168164,0,0,0.5440270564077787,0.0704655809700458,FYN;GRIN2B,Hypo
3555,GO_Biological_Process_2018,protein acylation (GO:0043543),2/36,0.8785118558767198,0.9722666923168164,0,0,0.5440270564077787,0.0704655809700458,KAT6A;ZDHHC7,Hypo
3556,GO_Biological_Process_2018,regulation of nitric-oxide synthase activity (GO:0050999),2/36,0.8785118558767198,0.9722666923168164,0,0,0.5440270564077787,0.0704655809700458,SCARB1;NOS1AP,Hypo
3557,GO_Biological_Process_2018,"regulation of transcription, DNA-templated (GO:0006355)",143/1598,0.8797346988960647,0.9722666923168164,0,0,0.9025933892061608,0.1156537095966825,EPO;ZMYND8;MYRFL;RORA;ENO1;ZFP30;CREB3L2;PIM2;BTRC;TNFRSF4;GTF2I;PIAS4;SMARCC2;PRKCB;ZBTB38;ESX1;EBF3;RFX1;FOXP3;RUNX2;EREG;DKK3;PRKAR1A;DDIT3;KAT6A;ERF;ERG;ABCG1;KMT2D;KMT2A;CTBP2;TSHZ3;EPAS1;TSHZ1;TCF7;TGFA;FOXO3;GTF2E1;RAI1;SBNO1;SBNO2;ATXN1;NACC2;HLTF;PRDM16;DVL1;DVL2;HIVEP1;ABL1;HIVEP3;AFAP1L2;XRCC6;SMAD3;TGFB3;ZBTB16;NFATC2;ESRRG;NR1D1;FOXN3;INHBA;MED13L;SMARCA4;SP2;BCL6;CDK5;BHLHE40;TCF4;BRWD1;CDKN1C;TENM1;THRA;TGFB1I1;HP1BP3;BHLHE41;HMGB3;TCF20;HMGB1;MED16;LIMD1;CHD2;LITAF;ZMYM1;BCL7A;ZIC3;TEAD1;HTATIP2;NCOA1;BRD3;SREBF1;ZHX2;PRMT8;KLF13;ATMIN;NUP133;BUD31;TSC22D3;TFEB;CBFA2T3;ETV5;MED24;ELF4;KIT;CRY2;IRF2;RARA;PPARD;HDAC5;KDM3A;RGS14;CIPC;FOXK1;TRAK1;PPM1F;FAM129B;CAMKK2;UBN1;PAK6;ASCC2;APBB2;APBB1;PCBD2;MTA3;BRD4;ATF7IP;SPEN;KDM4A;UTP4;KCNIP3;DAB2IP;GRHL1;MAPK14;PEX14;TARBP1;GATAD2A;PER2;PER1;NR6A1;TEF;ERCC2;FOSB;POLR3G;ERCC6;TAF4,Hypo
3558,GO_Biological_Process_2018,water-soluble vitamin metabolic process (GO:0006767),5/77,0.8817182864775738,0.9722666923168164,0,0,0.6418880319908598,0.0808025838539231,MTHFD1;FASN;SLC2A1;MTR;ACACB,Hypo
3559,GO_Biological_Process_2018,inorganic anion transmembrane transport (GO:0098661),4/64,0.882147136834573,0.9722666923168164,0,0,0.6163069544364509,0.0772826826756046,CLIC6;CLCN6;CLCN5;SLC37A1,Hypo
3560,GO_Biological_Process_2018,positive regulation of JAK-STAT cascade (GO:0046427),4/64,0.882147136834573,0.9722666923168164,0,0,0.6163069544364509,0.0772826826756046,EPO;KIT;PTK2B;F2,Hypo
3561,GO_Biological_Process_2018,hyaluronan metabolic process (GO:0030212),1/21,0.8841480812081329,0.9722666923168164,0,0,0.4625448948178553,0.0569534848647535,SLC9A1,Hypo
3562,GO_Biological_Process_2018,positive regulation of cellular component movement (GO:0051272),1/21,0.8841480812081329,0.9722666923168164,0,0,0.4625448948178553,0.0569534848647535,NTN1,Hypo
3563,GO_Biological_Process_2018,cortical actin cytoskeleton organization (GO:0030866),1/21,0.8841480812081329,0.9722666923168164,0,0,0.4625448948178553,0.0569534848647535,LLGL1,Hypo
3564,GO_Biological_Process_2018,energy reserve metabolic process (GO:0006112),1/21,0.8841480812081329,0.9722666923168164,0,0,0.4625448948178553,0.0569534848647535,PRKAG2,Hypo
3565,GO_Biological_Process_2018,mesoderm development (GO:0007498),1/21,0.8841480812081329,0.9722666923168164,0,0,0.4625448948178553,0.0569534848647535,MEST,Hypo
3566,GO_Biological_Process_2018,positive regulation of T cell mediated immunity (GO:0002711),1/21,0.8841480812081329,0.9722666923168164,0,0,0.4625448948178553,0.0569534848647535,IL12RB1,Hypo
3567,GO_Biological_Process_2018,mitochondrial fission (GO:0000266),1/21,0.8841480812081329,0.9722666923168164,0,0,0.4625448948178553,0.0569534848647535,DNM1,Hypo
3568,GO_Biological_Process_2018,ventricular septum morphogenesis (GO:0060412),1/21,0.8841480812081329,0.9722666923168164,0,0,0.4625448948178553,0.0569534848647535,SMAD7,Hypo
3569,GO_Biological_Process_2018,negative regulation of viral process (GO:0048525),1/21,0.8841480812081329,0.9722666923168164,0,0,0.4625448948178553,0.0569534848647535,TRIM11,Hypo
3570,GO_Biological_Process_2018,limb morphogenesis (GO:0035108),1/21,0.8841480812081329,0.9722666923168164,0,0,0.4625448948178553,0.0569534848647535,MBNL1,Hypo
3571,GO_Biological_Process_2018,meiosis I (GO:0007127),1/21,0.8841480812081329,0.9722666923168164,0,0,0.4625448948178553,0.0569534848647535,MEI1,Hypo
3572,GO_Biological_Process_2018,mitochondrial respiratory chain complex IV biogenesis (GO:0097034),1/21,0.8841480812081329,0.9722666923168164,0,0,0.4625448948178553,0.0569534848647535,CHCHD5,Hypo
3573,GO_Biological_Process_2018,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),1/21,0.8841480812081329,0.9722666923168164,0,0,0.4625448948178553,0.0569534848647535,CDKN1C,Hypo
3574,GO_Biological_Process_2018,lipid catabolic process (GO:0016042),1/21,0.8841480812081329,0.9722666923168164,0,0,0.4625448948178553,0.0569534848647535,ACADL,Hypo
3575,GO_Biological_Process_2018,phosphatidylserine acyl-chain remodeling (GO:0036150),1/21,0.8841480812081329,0.9722666923168164,0,0,0.4625448948178553,0.0569534848647535,PLA2G5,Hypo
3576,GO_Biological_Process_2018,negative regulation of cell cycle arrest (GO:0071157),1/21,0.8841480812081329,0.9722666923168164,0,0,0.4625448948178553,0.0569534848647535,SETMAR,Hypo
3577,GO_Biological_Process_2018,cobalamin metabolic process (GO:0009235),1/21,0.8841480812081329,0.9722666923168164,0,0,0.4625448948178553,0.0569534848647535,MTR,Hypo
3578,GO_Biological_Process_2018,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),1/21,0.8841480812081329,0.9722666923168164,0,0,0.4625448948178553,0.0569534848647535,RUNX2,Hypo
3579,GO_Biological_Process_2018,regulation of interleukin-17 production (GO:0032660),1/21,0.8841480812081329,0.9722666923168164,0,0,0.4625448948178553,0.0569534848647535,FOXP3,Hypo
3580,GO_Biological_Process_2018,histone ubiquitination (GO:0016574),1/21,0.8841480812081329,0.9722666923168164,0,0,0.4625448948178553,0.0569534848647535,UBR2,Hypo
3581,GO_Biological_Process_2018,tetrapyrrole metabolic process (GO:0033013),1/21,0.8841480812081329,0.9722666923168164,0,0,0.4625448948178553,0.0569534848647535,MTR,Hypo
3582,GO_Biological_Process_2018,positive regulation of NF-kappaB transcription factor activity (GO:0051092),9/128,0.8872149460518061,0.97472802676897,0,0,0.6986739054199732,0.0836089066581947,PRKCH;PRKCB;TRIM5;CAMK2A;PRKD2;RBCK1;ARHGEF2;PRKCZ;CARD11,Hypo
3583,GO_Biological_Process_2018,protein monoubiquitination (GO:0006513),2/37,0.8879499683871466,0.97472802676897,0,0,0.5284540921091229,0.0628014206188625,MGRN1;UBE2O,Hypo
3584,GO_Biological_Process_2018,spliceosomal snRNP assembly (GO:0000387),2/37,0.8879499683871466,0.97472802676897,0,0,0.5284540921091229,0.0628014206188625,SART3;USP4,Hypo
3585,GO_Biological_Process_2018,positive regulation of smooth muscle cell proliferation (GO:0048661),2/37,0.8879499683871466,0.97472802676897,0,0,0.5284540921091229,0.0628014206188625,MEF2D;EREG,Hypo
3586,GO_Biological_Process_2018,protein K63-linked ubiquitination (GO:0070534),2/37,0.8879499683871466,0.97472802676897,0,0,0.5284540921091229,0.0628014206188625,TRIM5;UBE2O,Hypo
3587,GO_Biological_Process_2018,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",2/37,0.8879499683871466,0.97472802676897,0,0,0.5284540921091229,0.0628014206188625,ERCC1;ERCC2,Hypo
3588,GO_Biological_Process_2018,fibroblast growth factor receptor signaling pathway (GO:0008543),5/78,0.8883833169456486,0.97472802676897,0,0,0.6330598302637602,0.0749238754457162,KL;HNRNPF;PTPN11;FGF1;FGFR2,Hypo
3589,GO_Biological_Process_2018,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),5/78,0.8883833169456486,0.97472802676897,0,0,0.6330598302637602,0.0749238754457162,EGLN1;EPO;EPAS1;UBE2D1;LIMD1,Hypo
3590,GO_Biological_Process_2018,regulation of JAK-STAT cascade (GO:0046425),4/65,0.8893558081258384,0.97472802676897,0,0,0.6061698650447324,0.0710781990101441,KIT;DOT1L;LRRC4;RTN4RL2,Hypo
3591,GO_Biological_Process_2018,DNA synthesis involved in DNA repair (GO:0000731),4/65,0.8893558081258384,0.97472802676897,0,0,0.6061698650447324,0.0710781990101441,RAD51;USP10;REV1;PALB2,Hypo
3592,GO_Biological_Process_2018,negative regulation of apoptotic signaling pathway (GO:2001234),4/65,0.8893558081258384,0.97472802676897,0,0,0.6061698650447324,0.0710781990101441,SRC;ITGA6;BIRC6;SLC25A5,Hypo
3593,GO_Biological_Process_2018,chromatin assembly (GO:0031497),4/65,0.8893558081258384,0.97472802676897,0,0,0.6061698650447324,0.0710781990101441,SART3;H2AFY;TNRC18;BAHCC1,Hypo
3594,GO_Biological_Process_2018,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),5/79,0.8947227324661103,0.9778759649360756,0,0,0.6244702285833391,0.0694669455029124,HIP1;SMAD3;HIP1R;MAPT;BOK,Hypo
3595,GO_Biological_Process_2018,triglyceride catabolic process (GO:0019433),1/22,0.8954553453984322,0.9778759649360756,0,0,0.4404945148916416,0.0486406924620587,FABP12,Hypo
3596,GO_Biological_Process_2018,rRNA modification (GO:0000154),1/22,0.8954553453984322,0.9778759649360756,0,0,0.4404945148916416,0.0486406924620587,BUD23,Hypo
3597,GO_Biological_Process_2018,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",1/22,0.8954553453984322,0.9778759649360756,0,0,0.4404945148916416,0.0486406924620587,ERCC2,Hypo
3598,GO_Biological_Process_2018,phosphatidylglycerol metabolic process (GO:0046471),1/22,0.8954553453984322,0.9778759649360756,0,0,0.4404945148916416,0.0486406924620587,PLA2G5,Hypo
3599,GO_Biological_Process_2018,STAT cascade (GO:0097696),1/22,0.8954553453984322,0.9778759649360756,0,0,0.4404945148916416,0.0486406924620587,PKD1,Hypo
3600,GO_Biological_Process_2018,C21-steroid hormone metabolic process (GO:0008207),1/22,0.8954553453984322,0.9778759649360756,0,0,0.4404945148916416,0.0486406924620587,TSPOAP1,Hypo
3601,GO_Biological_Process_2018,maturation of LSU-rRNA (GO:0000470),1/22,0.8954553453984322,0.9778759649360756,0,0,0.4404945148916416,0.0486406924620587,BOP1,Hypo
3602,GO_Biological_Process_2018,regulation of monocyte chemotaxis (GO:0090025),1/22,0.8954553453984322,0.9778759649360756,0,0,0.4404945148916416,0.0486406924620587,HMGB1,Hypo
3603,GO_Biological_Process_2018,regulation of calcium ion import (GO:0090279),1/22,0.8954553453984322,0.9778759649360756,0,0,0.4404945148916416,0.0486406924620587,FYN,Hypo
3604,GO_Biological_Process_2018,lymphocyte activation involved in immune response (GO:0002285),1/22,0.8954553453984322,0.9778759649360756,0,0,0.4404945148916416,0.0486406924620587,EIF2AK4,Hypo
3605,GO_Biological_Process_2018,outflow tract septum morphogenesis (GO:0003148),1/22,0.8954553453984322,0.9778759649360756,0,0,0.4404945148916416,0.0486406924620587,FGFR2,Hypo
3606,GO_Biological_Process_2018,hematopoietic progenitor cell differentiation (GO:0002244),1/22,0.8954553453984322,0.9778759649360756,0,0,0.4404945148916416,0.0486406924620587,INHBA,Hypo
3607,GO_Biological_Process_2018,purine ribonucleotide metabolic process (GO:0009150),4/66,0.896175544252016,0.9783912053239164,0,0,0.5963597785366177,0.06537234185355,LRRK2;RAB23;ATP1A2;SULT4A1,Hypo
3608,GO_Biological_Process_2018,cellular response to hormone stimulus (GO:0032870),5/80,0.900748285130158,0.982653543121286,0,0,0.6161096829477292,0.0644015959353353,NCOA1;SRC;ATP1A2;QRFPR;RAMP1,Hypo
3609,GO_Biological_Process_2018,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),6/93,0.900828114803494,0.982653543121286,0,0,0.6372569887895558,0.0665556368241766,EGLN1;EPO;EPAS1;BAG3;UBE2D1;LIMD1,Hypo
3610,GO_Biological_Process_2018,proteolysis involved in cellular protein catabolic process (GO:0051603),6/93,0.900828114803494,0.982653543121286,0,0,0.6372569887895558,0.0665556368241766,UBL4A;IDE;CTSF;NR1D1;FBXO44;RNF41,Hypo
3611,GO_Biological_Process_2018,response to endoplasmic reticulum stress (GO:0034976),7/106,0.90209396479605,0.9834896560563634,0,0,0.6532489069802503,0.067308540132039,EIF2B5;CREB3L1;DDIT3;CREB3L2;DAB2IP;PIK3R1;PDIA5,Hypo
3612,GO_Biological_Process_2018,RNA splicing (GO:0008380),7/106,0.90209396479605,0.9834896560563634,0,0,0.6532489069802503,0.067308540132039,SRPK2;MBNL1;SF3B2;RRAGC;SRSF4;SRPK1;PPP1R9B,Hypo
3613,GO_Biological_Process_2018,epidermal cell differentiation (GO:0009913),4/67,0.9026225681939162,0.9835215203639932,0,0,0.586861123346221,0.0601243847465606,SCEL;ERCC2;USH2A;EREG,Hypo
3614,GO_Biological_Process_2018,regulation of gene silencing by miRNA (GO:0060964),4/67,0.9026225681939162,0.9835215203639932,0,0,0.586861123346221,0.0601243847465606,NUP188;NUP133;AGO2;LIMD1,Hypo
3615,GO_Biological_Process_2018,RNA export from nucleus (GO:0006405),8/119,0.9040951080892886,0.9835656926219816,0,0,0.6657574154999489,0.0671221393533381,UPF1;NUP188;NUP133;ZC3H11A;SYMPK;SRSF4;SMG5;SMG6,Hypo
3616,GO_Biological_Process_2018,DNA biosynthetic process (GO:0071897),2/39,0.904816672156284,0.9835656926219816,0,0,0.4998335090737554,0.0499948110929367,RAD51;PALB2,Hypo
3617,GO_Biological_Process_2018,regulation of type I interferon-mediated signaling pathway (GO:0060338),2/39,0.904816672156284,0.9835656926219816,0,0,0.4998335090737554,0.0499948110929367,RNASEL;PTPN11,Hypo
3618,GO_Biological_Process_2018,protein K48-linked deubiquitination (GO:0071108),1/23,0.9056594991469732,0.9835656926219816,0,0,0.4204487149587201,0.0416630503867705,USP27X,Hypo
3619,GO_Biological_Process_2018,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",1/23,0.9056594991469732,0.9835656926219816,0,0,0.4204487149587201,0.0416630503867705,COPS4,Hypo
3620,GO_Biological_Process_2018,regulation of smooth muscle contraction (GO:0006940),1/23,0.9056594991469732,0.9835656926219816,0,0,0.4204487149587201,0.0416630503867705,CTTN,Hypo
3621,GO_Biological_Process_2018,regulation of interleukin-8 secretion (GO:2000482),1/23,0.9056594991469732,0.9835656926219816,0,0,0.4204487149587201,0.0416630503867705,NLRP10,Hypo
3622,GO_Biological_Process_2018,folic acid-containing compound metabolic process (GO:0006760),1/23,0.9056594991469732,0.9835656926219816,0,0,0.4204487149587201,0.0416630503867705,MTHFD1,Hypo
3623,GO_Biological_Process_2018,rRNA methylation (GO:0031167),1/23,0.9056594991469732,0.9835656926219816,0,0,0.4204487149587201,0.0416630503867705,BUD23,Hypo
3624,GO_Biological_Process_2018,regulation of androgen receptor signaling pathway (GO:0060765),1/23,0.9056594991469732,0.9835656926219816,0,0,0.4204487149587201,0.0416630503867705,SMARCA4,Hypo
3625,GO_Biological_Process_2018,negative regulation of viral transcription (GO:0032897),1/23,0.9056594991469732,0.9835656926219816,0,0,0.4204487149587201,0.0416630503867705,TRIM11,Hypo
3626,GO_Biological_Process_2018,glutamine family amino acid metabolic process (GO:0009064),1/23,0.9056594991469732,0.9835656926219816,0,0,0.4204487149587201,0.0416630503867705,ALDH5A1,Hypo
3627,GO_Biological_Process_2018,negative regulation of cell cycle process (GO:0010948),5/81,0.9064716673492248,0.9839051798535676,0,0,0.6079691516709511,0.0596998374278755,RAD51;DAB2IP;SETMAR;RBBP7;E2F6,Hypo
3628,GO_Biological_Process_2018,positive regulation of protein targeting to mitochondrion (GO:1903955),5/81,0.9064716673492248,0.9839051798535676,0,0,0.6079691516709511,0.0596998374278755,SH3GLB1;MYBPC1;VPS11;HPS4;WBP11,Hypo
3629,GO_Biological_Process_2018,positive regulation of cell cycle process (GO:0090068),7/107,0.9070950848075432,0.984187388913,0,0,0.6466803911477097,0.0630565115504828,DYNC1H1;NUMA1;PRKCE;DAB2IP;TGFA;EREG;CIT,Hypo
3630,GO_Biological_Process_2018,organonitrogen compound biosynthetic process (GO:1901566),13/181,0.9072313808436412,0.984187388913,0,0,0.7143656120166187,0.0695490327565334,SLC44A2;GPT2;MOCOS;FURIN;INHBA;SGPP2;TNIP1;ASPG;PRKD2;CHPT1;NAT8L;LPIN1;ST3GAL2,Hypo
3631,GO_Biological_Process_2018,protein targeting to mitochondrion (GO:0006626),3/54,0.9078556004441344,0.9845933948649356,0,0,0.5437928638327442,0.052568425354647,MIPEP;SAMM50;PITRM1,Hypo
3632,GO_Biological_Process_2018,termination of RNA polymerase II transcription (GO:0006369),4/68,0.9087128876907876,0.9849807552597724,0,0,0.5776593011305241,0.0552970661471355,ZC3H11A;CSTF2;SYMPK;SRSF4,Hypo
3633,GO_Biological_Process_2018,protein sumoylation (GO:0016925),4/68,0.9087128876907876,0.9849807552597724,0,0,0.5776593011305241,0.0552970661471355,PIAS4;NUP188;NUP133;EYA1,Hypo
3634,GO_Biological_Process_2018,post-translational protein modification (GO:0043687),28/357,0.9091395976115428,0.9851721801903348,0,0,0.784687935882392,0.0747467235603586,CUL9;EPAS1;KLHL11;FBXO21;FBXO44;FBXO41;ARSI;RBBP7;BTRC;WSB2;SERPIND1;FBXW8;ZBTB16;TMEM132A;KLHL2;FBXL18;KLHL3;FBXL16;FBXO10;SGPP2;FBXO31;COPS4;SPSB1;GAN;MGAT4A;SPARCL1;VWA1;ASB2,Hypo
3635,GO_Biological_Process_2018,DNA repair (GO:0006281),22/288,0.909774257407599,0.9855887788582322,0,0,0.7628927089508002,0.0721382030879414,FTO;UPF1;PARP3;EYA1;TRRAP;DOT1L;RECQL;FANCC;HMGB1;FANCE;PALB2;MTOR;BABAM2;RAD51;FANCD2;ERCC1;ERCC2;ABL1;TNKS1BP1;ASCC2;ERCC6;FAN1,Hypo
3636,GO_Biological_Process_2018,"DNA-templated transcription, elongation (GO:0006354)",7/108,0.911875809807982,0.9867298482524688,0,0,0.6402419449356156,0.0590632616236695,CTDP1;ELL;ERCC2;WDR61;MLLT1;TAF4;GTF2E1,Hypo
3637,GO_Biological_Process_2018,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",5/82,0.9119044727155512,0.9867298482524688,0,0,0.6000400627649985,0.0553357181237802,PAXIP1;USP10;PCBP4;PLAGL1;TNKS1BP1,Hypo
3638,GO_Biological_Process_2018,positive regulation of Ras protein signal transduction (GO:0046579),2/40,0.912330567995809,0.9867298482524688,0,0,0.486652977412731,0.0446518169463929,EPO;RASGRP1,Hypo
3639,GO_Biological_Process_2018,negative regulation of cytokine-mediated signaling pathway (GO:0001960),2/40,0.912330567995809,0.9867298482524688,0,0,0.486652977412731,0.0446518169463929,PADI2;RFFL,Hypo
3640,GO_Biological_Process_2018,regulation of viral transcription (GO:0046782),2/40,0.912330567995809,0.9867298482524688,0,0,0.486652977412731,0.0446518169463929,CTDP1;TRIM11,Hypo
3641,GO_Biological_Process_2018,regulation of ATPase activity (GO:0043462),2/40,0.912330567995809,0.9867298482524688,0,0,0.486652977412731,0.0446518169463929,DNAJB2;VMA21,Hypo
3642,GO_Biological_Process_2018,regulation of gene silencing by RNA (GO:0060966),3/55,0.9142467443004104,0.9873056116197492,0,0,0.533305677373474,0.0478134047879954,NUP188;NUP133;AGO2,Hypo
3643,GO_Biological_Process_2018,regulation of posttranscriptional gene silencing (GO:0060147),3/55,0.9142467443004104,0.9873056116197492,0,0,0.533305677373474,0.0478134047879954,NUP188;NUP133;AGO2,Hypo
3644,GO_Biological_Process_2018,negative regulation of endothelial cell apoptotic process (GO:2000352),1/24,0.9148681092693792,0.9873056116197492,0,0,0.4021460280634439,0.0357810904229528,PAK4,Hypo
3645,GO_Biological_Process_2018,mRNA splice site selection (GO:0006376),1/24,0.9148681092693792,0.9873056116197492,0,0,0.4021460280634439,0.0357810904229528,SFSWAP,Hypo
3646,GO_Biological_Process_2018,mammary gland development (GO:0030879),1/24,0.9148681092693792,0.9873056116197492,0,0,0.4021460280634439,0.0357810904229528,TGFB3,Hypo
3647,GO_Biological_Process_2018,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),1/24,0.9148681092693792,0.9873056116197492,0,0,0.4021460280634439,0.0357810904229528,ACKR3,Hypo
3648,GO_Biological_Process_2018,regulation of cell cycle G1/S phase transition (GO:1902806),1/24,0.9148681092693792,0.9873056116197492,0,0,0.4021460280634439,0.0357810904229528,STXBP4,Hypo
3649,GO_Biological_Process_2018,histone mRNA metabolic process (GO:0008334),1/24,0.9148681092693792,0.9873056116197492,0,0,0.4021460280634439,0.0357810904229528,UPF1,Hypo
3650,GO_Biological_Process_2018,negative regulation of apoptotic process (GO:0043066),39/485,0.9163601519389444,0.988644929741852,0,0,0.8055275922028005,0.0703594621206963,AVEN;TNFAIP8;SRC;FLT4;AGAP2;FAIM2;MST1R;PIK3R1;FAM129B;BABAM2;DSTYK;BAG3;MYO18A;FLNA;PTK2B;PIM2;EPHB2;EPHB1;HTATIP2;MAP4K4;PDGFRA;PRKCH;AREL1;SEMA4D;UNC5B;TGFB3;NTRK3;LMTK2;PRKCA;RNF144B;SON;PAX7;KIT;ERCC2;TYRO3;BIRC6;CRYAB;RETREG1;FGFR2,Hypo
3651,GO_Biological_Process_2018,regulation of mitotic cell cycle phase transition (GO:1901990),13/184,0.918158834617021,0.9903142523429478,0,0,0.7017151379567487,0.0599158634588861,DYNC1I2;DYNC1H1;ANAPC7;ODF2;CEP164;UBE2D1;PPP1R9B;ERCC2;FGFR1OP;BTRC;PCNT;NINL;CLASP1,Hypo
3652,GO_Biological_Process_2018,positive regulation of viral transcription (GO:0050434),2/41,0.9192850023602288,0.9905745462364548,0,0,0.4741483704522719,0.039903891798083,CTDP1;SMARCA4,Hypo
3653,GO_Biological_Process_2018,negative regulation of STAT cascade (GO:1904893),2/41,0.9192850023602288,0.9905745462364548,0,0,0.4741483704522719,0.039903891798083,LRRC4;RTN4RL2,Hypo
3654,GO_Biological_Process_2018,regulation of protein localization (GO:0032880),2/41,0.9192850023602288,0.9905745462364548,0,0,0.4741483704522719,0.039903891798083,TRIM5;DVL1,Hypo
3655,GO_Biological_Process_2018,autophagosome organization (GO:1905037),3/56,0.9202316248523892,0.9905745462364548,0,0,0.5232142337994593,0.0434947335834298,RAB23;ULK1;ATP13A2,Hypo
3656,GO_Biological_Process_2018,ATP metabolic process (GO:0046034),3/56,0.9202316248523892,0.9905745462364548,0,0,0.5232142337994593,0.0434947335834298,PRKAG2;ATP1A2;TEFM,Hypo
3657,GO_Biological_Process_2018,cellular defense response (GO:0006968),3/56,0.9202316248523892,0.9905745462364548,0,0,0.5232142337994593,0.0434947335834298,RAB23;PTK2B;TCIRG1,Hypo
3658,GO_Biological_Process_2018,mitochondrial respiratory chain complex assembly (GO:0033108),6/97,0.9207677731551628,0.9905745462364548,0,0,0.6091100257766925,0.050280461691942,CHCHD5;SAMM50;SDHAF2;NDUFA12;NDUFB11;UQCC2,Hypo
3659,GO_Biological_Process_2018,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),7/110,0.9208047329379498,0.9905745462364548,0,0,0.6277401076305783,0.051793129806462,SH3GLB1;MYBPC1;VPS11;HPS4;NMT1;WBP11;DYNLL2,Hypo
3660,GO_Biological_Process_2018,heterotypic cell-cell adhesion (GO:0034113),1/25,0.9231782582467696,0.9905745462364548,0,0,0.3853685650761074,0.0308036400515286,CTNNA3,Hypo
3661,GO_Biological_Process_2018,regulation of centrosome duplication (GO:0010824),1/25,0.9231782582467696,0.9905745462364548,0,0,0.3853685650761074,0.0308036400515286,CHMP5,Hypo
3662,GO_Biological_Process_2018,respiratory chain complex IV assembly (GO:0008535),1/25,0.9231782582467696,0.9905745462364548,0,0,0.3853685650761074,0.0308036400515286,CHCHD5,Hypo
3663,GO_Biological_Process_2018,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",1/25,0.9231782582467696,0.9905745462364548,0,0,0.3853685650761074,0.0308036400515286,SMYD2,Hypo
3664,GO_Biological_Process_2018,"RNA splicing, via transesterification reactions (GO:0000375)",1/25,0.9231782582467696,0.9905745462364548,0,0,0.3853685650761074,0.0308036400515286,SRSF4,Hypo
3665,GO_Biological_Process_2018,response to alcohol (GO:0097305),1/25,0.9231782582467696,0.9905745462364548,0,0,0.3853685650761074,0.0308036400515286,GRIN2B,Hypo
3666,GO_Biological_Process_2018,positive regulation of interleukin-1 beta secretion (GO:0050718),1/25,0.9231782582467696,0.9905745462364548,0,0,0.3853685650761074,0.0308036400515286,PANX1,Hypo
3667,GO_Biological_Process_2018,ncRNA 3'-end processing (GO:0043628),1/25,0.9231782582467696,0.9905745462364548,0,0,0.3853685650761074,0.0308036400515286,INTS7,Hypo
3668,GO_Biological_Process_2018,regulation of protein import into nucleus (GO:0042306),1/25,0.9231782582467696,0.9905745462364548,0,0,0.3853685650761074,0.0308036400515286,CABP1,Hypo
3669,GO_Biological_Process_2018,potassium ion homeostasis (GO:0055075),1/25,0.9231782582467696,0.9905745462364548,0,0,0.3853685650761074,0.0308036400515286,ATP1A2,Hypo
3670,GO_Biological_Process_2018,prostaglandin metabolic process (GO:0006693),1/25,0.9231782582467696,0.9905745462364548,0,0,0.3853685650761074,0.0308036400515286,ABHD16A,Hypo
3671,GO_Biological_Process_2018,response to UV (GO:0009411),6/98,0.9251683575898966,0.9915316154945044,0,0,0.6024557165861514,0.0468587344261121,ERCC2;REV1;UBE4B;EIF2AK4;ERCC6;MAP3K4,Hypo
3672,GO_Biological_Process_2018,response to molecule of bacterial origin (GO:0002237),6/98,0.9251683575898966,0.9915316154945044,0,0,0.6024557165861514,0.0468587344261121,TNFRSF9;MAPKAPK2;TNFRSF25;TRIB1;TNFRSF4;INAVA,Hypo
3673,GO_Biological_Process_2018,protein modification by small protein conjugation (GO:0032446),31/398,0.9255123944048912,0.9915316154945044,0,0,0.7783529966362476,0.0602505580209017,CUL9;NUP188;EPAS1;NEDD4L;UBE2D1;WDR61;UBR2;KLHDC7A;UBE3B;PDZD4;HLTF;BTRC;PIAS4;UBL4A;AREL1;FBXW8;NUP133;EYA1;SMURF1;KLHL2;KLHL3;FBXO10;TRPC4AP;PJA1;TRAF7;GAN;OTULIN;KCTD13;BIRC6;ASB2;PDZRN4,Hypo
3674,GO_Biological_Process_2018,negative regulation of macromolecule metabolic process (GO:0010605),8/124,0.925570899546523,0.9915316154945044,0,0,0.6368834120529848,0.0492594565472055,OPRD1;OLFM1;KDM4A;ATXN2;RBL1;DIP2A;MAPT;LDLR,Hypo
3675,GO_Biological_Process_2018,determination of left/right symmetry (GO:0007368),2/42,0.9257175729815044,0.9915316154945044,0,0,0.4622689938398357,0.0356807350704669,ZIC3;CCDC40,Hypo
3676,GO_Biological_Process_2018,positive regulation of protein localization to nucleus (GO:1900182),2/42,0.9257175729815044,0.9915316154945044,0,0,0.4622689938398357,0.0356807350704669,F2;CCT5,Hypo
3677,GO_Biological_Process_2018,chloride transmembrane transport (GO:1902476),3/57,0.9258322624495524,0.9915316154945044,0,0,0.5134965473948525,0.0395711750761807,CLIC6;CLCN6;CLCN5,Hypo
3678,GO_Biological_Process_2018,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",17/236,0.9298033091864816,0.9921124572684842,0,0,0.7160587441859366,0.0521163383940419,ZCCHC8;SPEN;SF3B2;BUD31;CSTF2;PRCC;PRPF40B;CWC25;CWC27;WBP11;CHERP;SART3;HNRNPF;SYMPK;SRSF4;SNRNP200;CTNNBL1,Hypo
3679,GO_Biological_Process_2018,negative regulation of cell cycle (GO:0045786),4/72,0.9298170773033304,0.9921124572684842,0,0,0.5435584305664712,0.0395533355084617,NR4A1;SMAD3;DUSP1;INHBA,Hypo
3680,GO_Biological_Process_2018,T cell receptor signaling pathway (GO:0050852),11/163,0.930003875199458,0.9921124572684842,0,0,0.6679989685404848,0.0484743644934356,EIF2B5;UBE2D1;PRKD2;FYN;RBCK1;PIK3R1;BTRC;SPPL3;CARD11;PAG1;BCAR1,Hypo
3681,GO_Biological_Process_2018,response to growth factor (GO:0070848),1/26,0.9306775659374336,0.9921124572684842,0,0,0.3699332991277578,0.0265768933064728,TWF2,Hypo
3682,GO_Biological_Process_2018,negative regulation of catalytic activity (GO:0043086),1/26,0.9306775659374336,0.9921124572684842,0,0,0.3699332991277578,0.0265768933064728,TMBIM1,Hypo
3683,GO_Biological_Process_2018,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),1/26,0.9306775659374336,0.9921124572684842,0,0,0.3699332991277578,0.0265768933064728,BRD4,Hypo
3684,GO_Biological_Process_2018,fat-soluble vitamin metabolic process (GO:0006775),1/26,0.9306775659374336,0.9921124572684842,0,0,0.3699332991277578,0.0265768933064728,PIAS4,Hypo
3685,GO_Biological_Process_2018,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),1/26,0.9306775659374336,0.9921124572684842,0,0,0.3699332991277578,0.0265768933064728,PLA2G5,Hypo
3686,GO_Biological_Process_2018,T cell activation involved in immune response (GO:0002286),1/26,0.9306775659374336,0.9921124572684842,0,0,0.3699332991277578,0.0265768933064728,EIF2AK4,Hypo
3687,GO_Biological_Process_2018,positive regulation of release of cytochrome c from mitochondria (GO:0090200),1/26,0.9306775659374336,0.9921124572684842,0,0,0.3699332991277578,0.0265768933064728,HRK,Hypo
3688,GO_Biological_Process_2018,regulation of T cell receptor signaling pathway (GO:0050856),1/26,0.9306775659374336,0.9921124572684842,0,0,0.3699332991277578,0.0265768933064728,PRKD2,Hypo
3689,GO_Biological_Process_2018,autophagosome assembly (GO:0000045),3/58,0.9310698945348664,0.9921124572684842,0,0,0.5041322314049587,0.0360055927265691,SMURF1;RAB23;ULK1,Hypo
3690,GO_Biological_Process_2018,cardiac ventricle morphogenesis (GO:0003208),2/43,0.9316638688591324,0.9921124572684842,0,0,0.450969099013372,0.0319210292003777,FGFR2;SMAD7,Hypo
3691,GO_Biological_Process_2018,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),2/43,0.9316638688591324,0.9921124572684842,0,0,0.450969099013372,0.0319210292003777,PDK2;BOK,Hypo
3692,GO_Biological_Process_2018,response to unfolded protein (GO:0006986),2/43,0.9316638688591324,0.9921124572684842,0,0,0.450969099013372,0.0319210292003777,DNAJB2;DDIT3,Hypo
3693,GO_Biological_Process_2018,nucleobase-containing compound catabolic process (GO:0034655),2/43,0.9316638688591324,0.9921124572684842,0,0,0.450969099013372,0.0319210292003777,PABPC4;SND1,Hypo
3694,GO_Biological_Process_2018,branching morphogenesis of an epithelial tube (GO:0048754),2/43,0.9316638688591324,0.9921124572684842,0,0,0.450969099013372,0.0319210292003777,COL4A1;PKD1,Hypo
3695,GO_Biological_Process_2018,positive regulation of interferon-gamma production (GO:0032729),2/43,0.9316638688591324,0.9921124572684842,0,0,0.450969099013372,0.0319210292003777,IL12RB1;RASGRP1,Hypo
3696,GO_Biological_Process_2018,mitotic metaphase plate congression (GO:0007080),2/43,0.9316638688591324,0.9921124572684842,0,0,0.450969099013372,0.0319210292003777,MAD1L1;CHMP5,Hypo
3697,GO_Biological_Process_2018,male gonad development (GO:0008584),2/43,0.9316638688591324,0.9921124572684842,0,0,0.450969099013372,0.0319210292003777,KIT;INHBA,Hypo
3698,GO_Biological_Process_2018,RNA catabolic process (GO:0006401),2/43,0.9316638688591324,0.9921124572684842,0,0,0.450969099013372,0.0319210292003777,PABPC4;SND1,Hypo
3699,GO_Biological_Process_2018,positive regulation of canonical Wnt signaling pathway (GO:0090263),7/113,0.9327227857620852,0.992971635977528,0,0,0.6098719156332845,0.0424758979057066,SCEL;TNKS2;WNK2;LRRK2;PIN1;AXIN2;FGFR2,Hypo
3700,GO_Biological_Process_2018,transcription-coupled nucleotide-excision repair (GO:0006283),4/73,0.9343532672009458,0.9939015715648192,0,0,0.5356509823197343,0.0363710669366241,COPS4;ERCC1;ERCC2;ERCC6,Hypo
3701,GO_Biological_Process_2018,chloride transport (GO:0006821),4/73,0.9343532672009458,0.9939015715648192,0,0,0.5356509823197343,0.0363710669366241,CLIC6;CLCN6;CLCN5;SLC4A1,Hypo
3702,GO_Biological_Process_2018,positive regulation of inflammatory response (GO:0050729),4/73,0.9343532672009458,0.9939015715648192,0,0,0.5356509823197343,0.0363710669366241,IL33;TNIP1;NLRP10;PDE2A,Hypo
3703,GO_Biological_Process_2018,regulation of T cell activation (GO:0050863),2/44,0.937157504461622,0.9945047919675186,0,0,0.44020729441674,0.0285711774621628,ABL1;PAG1,Hypo
3704,GO_Biological_Process_2018,metaphase plate congression (GO:0051310),2/44,0.937157504461622,0.9945047919675186,0,0,0.44020729441674,0.0285711774621628,TRAPPC12;CHMP5,Hypo
3705,GO_Biological_Process_2018,inorganic anion transport (GO:0015698),2/44,0.937157504461622,0.9945047919675186,0,0,0.44020729441674,0.0285711774621628,CLCN6;SLC4A1,Hypo
3706,GO_Biological_Process_2018,ribosomal small subunit biogenesis (GO:0042274),2/44,0.937157504461622,0.9945047919675186,0,0,0.44020729441674,0.0285711774621628,NOB1;UTP4,Hypo
3707,GO_Biological_Process_2018,cristae formation (GO:0042407),1/27,0.9374451110879404,0.9945047919675186,0,0,0.3556853613292813,0.0229762325481433,SAMM50,Hypo
3708,GO_Biological_Process_2018,cargo loading into vesicle (GO:0035459),1/27,0.9374451110879404,0.9945047919675186,0,0,0.3556853613292813,0.0229762325481433,KIF13A,Hypo
3709,GO_Biological_Process_2018,muscle fiber development (GO:0048747),1/27,0.9374451110879404,0.9945047919675186,0,0,0.3556853613292813,0.0229762325481433,RYR1,Hypo
3710,GO_Biological_Process_2018,phosphatidylcholine acyl-chain remodeling (GO:0036151),1/27,0.9374451110879404,0.9945047919675186,0,0,0.3556853613292813,0.0229762325481433,PLA2G5,Hypo
3711,GO_Biological_Process_2018,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),1/27,0.9374451110879404,0.9945047919675186,0,0,0.3556853613292813,0.0229762325481433,GPAM,Hypo
3712,GO_Biological_Process_2018,cardiac muscle cell development (GO:0055013),1/27,0.9374451110879404,0.9945047919675186,0,0,0.3556853613292813,0.0229762325481433,PDGFRA,Hypo
3713,GO_Biological_Process_2018,spermatogenesis (GO:0007283),10/153,0.9378899273358808,0.9947087840000092,0,0,0.6454833825967846,0.0413901276909926,NR6A1;GPX4;KIT;TYRO3;TMEM119;PRKAG1;SPATA2;UBR2;FKBP6;CDK16,Hypo
3714,GO_Biological_Process_2018,regulation of mRNA stability (GO:0043488),8/128,0.9396235145839636,0.995887558185315,0,0,0.6155166495022314,0.0383319150775186,ANP32A;PCBP4;MAPKAPK2;SAMD4B;PRKCA;AXIN2;DCP1A;TNPO1,Hypo
3715,GO_Biological_Process_2018,membrane lipid biosynthetic process (GO:0046467),3/60,0.9405370535548676,0.995887558185315,0,0,0.4863893168977914,0.0298177241567396,PRKD2;SGPP2;ST3GAL2,Hypo
3716,GO_Biological_Process_2018,male gamete generation (GO:0048232),10/154,0.9408467123092652,0.995887558185315,0,0,0.6409650630011455,0.0390828776499905,NR6A1;GPX4;KIT;TYRO3;TMEM119;PRKAG1;SPATA2;UBR2;FKBP6;CDK16,Hypo
3717,GO_Biological_Process_2018,mitochondrial gene expression (GO:0140053),2/45,0.9422301656849136,0.995887558185315,0,0,0.4299460388711141,0.0255842387180486,FOXO3;TEFM,Hypo
3718,GO_Biological_Process_2018,retinoid metabolic process (GO:0001523),4/75,0.9426363826844594,0.995887558185315,0,0,0.5205043208893649,0.0307486194363934,LRP1;SDC3;GPC4;GPC6,Hypo
3719,GO_Biological_Process_2018,"synaptic transmission, cholinergic (GO:0007271)",1/28,0.9435522638100016,0.995887558185315,0,0,0.3424928263306919,0.0199000395251637,CHRM4,Hypo
3720,GO_Biological_Process_2018,negative regulation of response to DNA damage stimulus (GO:2001021),1/28,0.9435522638100016,0.995887558185315,0,0,0.3424928263306919,0.0199000395251637,ACKR3,Hypo
3721,GO_Biological_Process_2018,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway (GO:0051482),1/28,0.9435522638100016,0.995887558185315,0,0,0.3424928263306919,0.0199000395251637,GRM1,Hypo
3722,GO_Biological_Process_2018,organelle fission (GO:0048285),1/28,0.9435522638100016,0.995887558185315,0,0,0.3424928263306919,0.0199000395251637,DNM1,Hypo
3723,GO_Biological_Process_2018,protein K11-linked ubiquitination (GO:0070979),1/28,0.9435522638100016,0.995887558185315,0,0,0.3424928263306919,0.0199000395251637,ANAPC7,Hypo
3724,GO_Biological_Process_2018,negative regulation of JNK cascade (GO:0046329),1/28,0.9435522638100016,0.995887558185315,0,0,0.3424928263306919,0.0199000395251637,PER1,Hypo
3725,GO_Biological_Process_2018,ventricular septum development (GO:0003281),1/28,0.9435522638100016,0.995887558185315,0,0,0.3424928263306919,0.0199000395251637,SMAD7,Hypo
3726,GO_Biological_Process_2018,transcription elongation from RNA polymerase I promoter (GO:0006362),1/28,0.9435522638100016,0.995887558185315,0,0,0.3424928263306919,0.0199000395251637,ERCC2,Hypo
3727,GO_Biological_Process_2018,carboxylic acid catabolic process (GO:0046395),1/28,0.9435522638100016,0.995887558185315,0,0,0.3424928263306919,0.0199000395251637,SLC9A1,Hypo
3728,GO_Biological_Process_2018,RNA phosphodiester bond hydrolysis (GO:0090501),1/28,0.9435522638100016,0.995887558185315,0,0,0.3424928263306919,0.0199000395251637,NOB1,Hypo
3729,GO_Biological_Process_2018,negative regulation of proteasomal protein catabolic process (GO:1901799),1/28,0.9435522638100016,0.995887558185315,0,0,0.3424928263306919,0.0199000395251637,ALAD,Hypo
3730,GO_Biological_Process_2018,regulation of receptor internalization (GO:0002090),1/28,0.9435522638100016,0.995887558185315,0,0,0.3424928263306919,0.0199000395251637,ATXN2,Hypo
3731,GO_Biological_Process_2018,aerobic respiration (GO:0009060),1/28,0.9435522638100016,0.995887558185315,0,0,0.3424928263306919,0.0199000395251637,CHCHD5,Hypo
3732,GO_Biological_Process_2018,positive regulation of leukocyte chemotaxis (GO:0002690),3/61,0.9448049829981152,0.9965774506400892,0,0,0.4779767281228415,0.0271379604104582,PTK2B;HMGB1;CMKLR1,Hypo
3733,GO_Biological_Process_2018,regulation of cellular ketone metabolic process (GO:0010565),3/61,0.9448049829981152,0.9965774506400892,0,0,0.4779767281228415,0.0271379604104582,PRKAG2;OAZ1;PDK2,Hypo
3734,GO_Biological_Process_2018,DNA metabolic process (GO:0006259),23/314,0.9449649094035878,0.9965774506400892,0,0,0.7284028554257905,0.0412330537737269,UPF1;XRCC6;PARP3;STN1;TRRAP;DOT1L;RECQL;REV1;SETMAR;HMGB3;FANCC;HMGB1;AXIN2;PALB2;MTOR;RAD51;FANCD2;TOP1MT;ERCC1;ERI3;KCTD13;CLSPN;FAN1,Hypo
3735,GO_Biological_Process_2018,ribonucleoprotein complex assembly (GO:0022618),10/156,0.9463939853833264,0.9966304657676448,0,0,0.6321141081768112,0.0348271621899117,SRPK2;DYNC1H1;BOP1;ATXN2;SART3;MAPT;SNRNP200;LIMD1;LSM14A;SRPK1,Hypo
3736,GO_Biological_Process_2018,cellular response to interleukin-12 (GO:0071349),2/46,0.9469116666882073,0.9966304657676448,0,0,0.4201512040321075,0.022919024297768,HNRNPF;IL12RB1,Hypo
3737,GO_Biological_Process_2018,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",2/46,0.9469116666882073,0.9966304657676448,0,0,0.4201512040321075,0.022919024297768,NDUFB11;NDUFA12,Hypo
3738,GO_Biological_Process_2018,interleukin-12-mediated signaling pathway (GO:0035722),2/46,0.9469116666882073,0.9966304657676448,0,0,0.4201512040321075,0.022919024297768,HNRNPF;IL12RB1,Hypo
3739,GO_Biological_Process_2018,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",3/62,0.9487867050800094,0.9966304657676448,0,0,0.4698493118487373,0.0247005718325045,PCBP4;PLAGL1;TNKS1BP1,Hypo
3740,GO_Biological_Process_2018,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",1/29,0.9490634366830252,0.9966304657676448,0,0,0.3302426152605732,0.0172649639772316,ERCC2,Hypo
3741,GO_Biological_Process_2018,regulation of neutrophil chemotaxis (GO:0090022),1/29,0.9490634366830252,0.9966304657676448,0,0,0.3302426152605732,0.0172649639772316,JAM3,Hypo
3742,GO_Biological_Process_2018,negative regulation of lymphocyte proliferation (GO:0050672),1/29,0.9490634366830252,0.9966304657676448,0,0,0.3302426152605732,0.0172649639772316,FOXP3,Hypo
3743,GO_Biological_Process_2018,coenzyme biosynthetic process (GO:0009108),1/29,0.9490634366830252,0.9966304657676448,0,0,0.3302426152605732,0.0172649639772316,ACOT7,Hypo
3744,GO_Biological_Process_2018,negative regulation of epithelial cell apoptotic process (GO:1904036),1/29,0.9490634366830252,0.9966304657676448,0,0,0.3302426152605732,0.0172649639772316,PAK4,Hypo
3745,GO_Biological_Process_2018,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),1/29,0.9490634366830252,0.9966304657676448,0,0,0.3302426152605732,0.0172649639772316,TNIP1,Hypo
3746,GO_Biological_Process_2018,skeletal muscle organ development (GO:0060538),1/29,0.9490634366830252,0.9966304657676448,0,0,0.3302426152605732,0.0172649639772316,IGSF8,Hypo
3747,GO_Biological_Process_2018,striated muscle tissue development (GO:0014706),1/29,0.9490634366830252,0.9966304657676448,0,0,0.3302426152605732,0.0172649639772316,IGSF8,Hypo
3748,GO_Biological_Process_2018,regulation of myoblast differentiation (GO:0045661),1/29,0.9490634366830252,0.9966304657676448,0,0,0.3302426152605732,0.0172649639772316,MAPK14,Hypo
3749,GO_Biological_Process_2018,very long-chain fatty acid metabolic process (GO:0000038),1/29,0.9490634366830252,0.9966304657676448,0,0,0.3302426152605732,0.0172649639772316,TECR,Hypo
3750,GO_Biological_Process_2018,determination of bilateral symmetry (GO:0009855),1/29,0.9490634366830252,0.9966304657676448,0,0,0.3302426152605732,0.0172649639772316,ZIC3,Hypo
3751,GO_Biological_Process_2018,protein-DNA complex assembly (GO:0065004),5/91,0.9495491667423476,0.9968747781977896,0,0,0.5369761463502122,0.0277981641496383,SART3;RAD51;H2AFY;ERCC2;TCF4,Hypo
3752,GO_Biological_Process_2018,regulation of intrinsic apoptotic signaling pathway (GO:2001242),2/47,0.951230013291718,0.9978415505608724,0,0,0.4107916951859457,0.020539330487958,SRC;BOK,Hypo
3753,GO_Biological_Process_2018,postreplication repair (GO:0006301),2/47,0.951230013291718,0.9978415505608724,0,0,0.4107916951859457,0.020539330487958,USP10;REV1,Hypo
3754,GO_Biological_Process_2018,negative regulation of JAK-STAT cascade (GO:0046426),2/47,0.951230013291718,0.9978415505608724,0,0,0.4107916951859457,0.020539330487958,LRRC4;RTN4RL2,Hypo
3755,GO_Biological_Process_2018,signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431),3/63,0.95249936267438,0.998434334756915,0,0,0.4619928094504366,0.0224832686493301,PCBP4;PLAGL1;TNKS1BP1,Hypo
3756,GO_Biological_Process_2018,positive regulation of translation (GO:0045727),4/78,0.9532825982442642,0.998434334756915,0,0,0.4993194633482403,0.0238893824221626,EIF2B5;UQCC2;CPEB3;MTOR,Hypo
3757,GO_Biological_Process_2018,visual perception (GO:0007601),4/78,0.9532825982442642,0.998434334756915,0,0,0.4993194633482403,0.0238893824221626,ABLIM1;OPA3;GRM8;RPGR,Hypo
3758,GO_Biological_Process_2018,smoothened signaling pathway (GO:0007224),1/30,0.9540367624622976,0.998434334756915,0,0,0.3188372463332213,0.0150022722907705,DISP3,Hypo
3759,GO_Biological_Process_2018,regulation of leukocyte chemotaxis (GO:0002688),1/30,0.9540367624622976,0.998434334756915,0,0,0.3188372463332213,0.0150022722907705,PTK2B,Hypo
3760,GO_Biological_Process_2018,regulation of blood coagulation (GO:0030193),1/30,0.9540367624622976,0.998434334756915,0,0,0.3188372463332213,0.0150022722907705,F2,Hypo
3761,GO_Biological_Process_2018,negative regulation of stress-activated MAPK cascade (GO:0032873),1/30,0.9540367624622976,0.998434334756915,0,0,0.3188372463332213,0.0150022722907705,PER1,Hypo
3762,GO_Biological_Process_2018,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),1/30,0.9540367624622976,0.998434334756915,0,0,0.3188372463332213,0.0150022722907705,PKD1,Hypo
3763,GO_Biological_Process_2018,mRNA processing (GO:0006397),20/283,0.9540763737052624,0.998434334756915,0,0,0.7008412301266771,0.0329476356462519,ZCCHC8;SPEN;SF3B2;BUD31;CSTF2;PRCC;PRPF40B;CWC25;CWC27;WBP11;CHERP;SON;SART3;ZC3H11A;HNRNPF;ERCC2;SYMPK;SRSF4;SNRNP200;CTNNBL1,Hypo
3764,GO_Biological_Process_2018,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),2/48,0.9552114718867408,0.9993567032568051,0,0,0.4018391215070083,0.0184132837876578,ABL1;BOK,Hypo
3765,GO_Biological_Process_2018,steroid biosynthetic process (GO:0006694),4/79,0.9564057740879868,0.9999956484855184,0,0,0.4926344638574854,0.0219581989632179,OSBPL2;PRKAG2;HSD17B4;TSPOAP1,Hypo
3766,GO_Biological_Process_2018,nucleosome organization (GO:0034728),4/79,0.9564057740879868,0.9999956484855184,0,0,0.4926344638574854,0.0219581989632179,SART3;SMARCC2;H2AFY;SMARCA4,Hypo
3767,GO_Biological_Process_2018,negative regulation of cell-cell adhesion (GO:0022408),1/31,0.95852470637376,0.9999956484855184,0,0,0.3081922353343595,0.0130550048276056,MBP,Hypo
3768,GO_Biological_Process_2018,cellular zinc ion homeostasis (GO:0006882),1/31,0.95852470637376,0.9999956484855184,0,0,0.3081922353343595,0.0130550048276056,ATP13A2,Hypo
3769,GO_Biological_Process_2018,termination of RNA polymerase I transcription (GO:0006363),1/31,0.95852470637376,0.9999956484855184,0,0,0.3081922353343595,0.0130550048276056,ERCC2,Hypo
3770,GO_Biological_Process_2018,nucleotide-excision repair (GO:0006289),6/108,0.958612924736952,0.9999956484855184,0,0,0.5430888404744614,0.0229552299146856,COPS4;ERCC1;ERCC2;FANCC;ERCC6;FAN1,Hypo
3771,GO_Biological_Process_2018,glutathione metabolic process (GO:0006749),2/49,0.9588806426434012,0.9999956484855184,0,0,0.3932675084101533,0.0165127804465671,ALDH5A1;GDAP1L1,Hypo
3772,GO_Biological_Process_2018,establishment of protein localization to mitochondrion (GO:0072655),2/49,0.9588806426434012,0.9999956484855184,0,0,0.3932675084101533,0.0165127804465671,PITRM1;HK1,Hypo
3773,GO_Biological_Process_2018,gonad development (GO:0008406),2/49,0.9588806426434012,0.9999956484855184,0,0,0.3932675084101533,0.0165127804465671,KIT;INHBA,Hypo
3774,GO_Biological_Process_2018,regulation of G2/M transition of mitotic cell cycle (GO:0010389),9/149,0.9604606365261548,0.9999956484855184,0,0,0.5931773018326342,0.0239301247331337,DYNC1I2;DYNC1H1;ODF2;CEP164;FGFR1OP;PCNT;NINL;CLASP1;BRD4,Hypo
3775,GO_Biological_Process_2018,regulation of translation (GO:0006417),14/213,0.9605812945163006,0.9999956484855184,0,0,0.6486824618962581,0.0260878437366767,CYFIP2;UPF1;NUP188;NUP133;SAMD4B;EIF2AK4;FOXO3;TOB1;MTOR;ATXN2;TCOF1;AGO2;CPEB3;EIF4G3,Hypo
3776,GO_Biological_Process_2018,epidermis development (GO:0008544),4/81,0.9620812344581722,0.9999956484855184,0,0,0.4797853739272033,0.0185467698485001,SCEL;LAMB3;GRHL1;FGFR2,Hypo
3777,GO_Biological_Process_2018,heart morphogenesis (GO:0003007),2/50,0.9622605336209747,0.9999956484855184,0,0,0.3850530458590007,0.0148130060813481,RYR2;OLFM1,Hypo
3778,GO_Biological_Process_2018,7-methylguanosine RNA capping (GO:0009452),1/32,0.9625746178869976,0.9999956484855184,0,0,0.29823399923865,0.0113757454374121,ERCC2,Hypo
3779,GO_Biological_Process_2018,mismatch repair (GO:0006298),1/32,0.9625746178869976,0.9999956484855184,0,0,0.29823399923865,0.0113757454374121,ABL1,Hypo
3780,GO_Biological_Process_2018,protein deacetylation (GO:0006476),1/32,0.9625746178869976,0.9999956484855184,0,0,0.29823399923865,0.0113757454374121,HDAC5,Hypo
3781,GO_Biological_Process_2018,7-methylguanosine mRNA capping (GO:0006370),1/32,0.9625746178869976,0.9999956484855184,0,0,0.29823399923865,0.0113757454374121,ERCC2,Hypo
3782,GO_Biological_Process_2018,response to zinc ion (GO:0010043),1/32,0.9625746178869976,0.9999956484855184,0,0,0.29823399923865,0.0113757454374121,ATP13A2,Hypo
3783,GO_Biological_Process_2018,inflammatory response (GO:0006954),17/252,0.9634191832939552,0.9999956484855184,0,0,0.6667070257894795,0.0248459526557786,HDAC5;AFAP1L2;NFAM1;TNFRSF9;HMGB1;TBK1;SCUBE1;NLRP10;NFX1;KIT;MAPKAPK2;ADORA1;BLNK;TNFRSF25;NFRKB;TNFRSF4;MGLL,Hypo
3784,GO_Biological_Process_2018,mitotic sister chromatid segregation (GO:0000070),4/82,0.964654385141757,0.9999956484855184,0,0,0.4736079268453369,0.0170429668575018,NCAPD2;DLGAP5;NCAPH;CHMP5,Hypo
3785,GO_Biological_Process_2018,positive regulation of cell cycle arrest (GO:0071158),4/82,0.964654385141757,0.9999956484855184,0,0,0.4736079268453369,0.0170429668575018,PCBP4;PLAGL1;DAB2IP;TNKS1BP1,Hypo
3786,GO_Biological_Process_2018,positive regulation of ubiquitin protein ligase activity (GO:1904668),4/82,0.964654385141757,0.9999956484855184,0,0,0.4736079268453369,0.0170429668575018,GOLGA2;ANAPC7;UBE2D1;BTRC,Hypo
3787,GO_Biological_Process_2018,transcription initiation from RNA polymerase I promoter (GO:0006361),1/33,0.966229229986566,0.9999956484855184,0,0,0.2888981528989225,0.0099248576434009,ERCC2,Hypo
3788,GO_Biological_Process_2018,transcription from RNA polymerase I promoter (GO:0006360),1/33,0.966229229986566,0.9999956484855184,0,0,0.2888981528989225,0.0099248576434009,ERCC2,Hypo
3789,GO_Biological_Process_2018,proteolysis (GO:0006508),20/291,0.9665485747938511,0.9999956484855184,0,0,0.6798462803280882,0.023130901622818,MIPEP;RHBDF1;PEF1;HTRA3;TMPRSS4;RHBDF2;HTRA1;ECE1;FURIN;IDE;PCSK7;F2;SPPL3;PITRM1;CAPN5;FBXO3;TPP1;CPXM1;CTSF;CTSD,Hypo
3790,GO_Biological_Process_2018,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),3/68,0.967570804377388,0.9999956484855184,0,0,0.4263363754889178,0.0140548922781941,SRC;BIRC6;RFFL,Hypo
3791,GO_Biological_Process_2018,chemokine-mediated signaling pathway (GO:0070098),2/52,0.9682370114170968,0.9999956484855184,0,0,0.3696098562628336,0.0119304056070954,PTK2B;ACKR3,Hypo
3792,GO_Biological_Process_2018,regulation of DNA binding (GO:0051101),2/52,0.9682370114170968,0.9999956484855184,0,0,0.3696098562628336,0.0119304056070954,DOT1L;HMGB1,Hypo
3793,GO_Biological_Process_2018,mitochondrion organization (GO:0007005),10/167,0.9694568726192632,0.9999956484855184,0,0,0.587464705496093,0.0182227377332805,ALAS1;CLUH;SAMM50;PITRM1;LRRK2;IDH2;HAP1;TRAK1;SLC25A4;DNM1,Hypo
3794,GO_Biological_Process_2018,negative regulation of DNA binding (GO:0043392),1/34,0.969527108461826,0.9999956484855184,0,0,0.2801281154282694,0.008669080922742,PER2,Hypo
3795,GO_Biological_Process_2018,endoplasmic reticulum organization (GO:0007029),1/34,0.969527108461826,0.9999956484855184,0,0,0.2801281154282694,0.008669080922742,STX18,Hypo
3796,GO_Biological_Process_2018,positive regulation of chemokine production (GO:0032722),1/34,0.969527108461826,0.9999956484855184,0,0,0.2801281154282694,0.008669080922742,IL33,Hypo
3797,GO_Biological_Process_2018,regulation of interleukin-1 beta secretion (GO:0050706),1/34,0.969527108461826,0.9999956484855184,0,0,0.2801281154282694,0.008669080922742,PANX1,Hypo
3798,GO_Biological_Process_2018,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),2/53,0.9708723448709784,0.9999956484855184,0,0,0.3623424729234609,0.010710947501161,EPO;KIT,Hypo
3799,GO_Biological_Process_2018,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",1/35,0.9725030584709874,0.9999956484855184,0,0,0.2718739625147134,0.0075804057375669,PDCD11,Hypo
3800,GO_Biological_Process_2018,positive regulation of NIK/NF-kappaB signaling (GO:1901224),1/35,0.9725030584709874,0.9999956484855184,0,0,0.2718739625147134,0.0075804057375669,SASH1,Hypo
3801,GO_Biological_Process_2018,regulation of endothelial cell apoptotic process (GO:2000351),1/35,0.9725030584709874,0.9999956484855184,0,0,0.2718739625147134,0.0075804057375669,PAK4,Hypo
3802,GO_Biological_Process_2018,apical junction assembly (GO:0043297),1/35,0.9725030584709874,0.9999956484855184,0,0,0.2718739625147134,0.0075804057375669,FBF1,Hypo
3803,GO_Biological_Process_2018,toll-like receptor signaling pathway (GO:0002224),4/86,0.9734056182177436,0.9999956484855184,0,0,0.4504048329280826,0.0121403964666269,TNIP1;MAPKAPK2;UBE2D1;HMGB1,Hypo
3804,GO_Biological_Process_2018,positive regulation of lymphocyte proliferation (GO:0050671),3/71,0.974311614622122,0.9999956484855184,0,0,0.4074594398622315,0.01060376261352,NFATC2;IRS2;TNFRSF4,Hypo
3805,GO_Biological_Process_2018,cellular response to interferon-gamma (GO:0071346),6/116,0.9748629041145388,0.9999956484855184,0,0,0.5033670033670034,0.0128149331340523,CAMK2B;TRIM5;IRF2;CAMK2A;IL12RB1;CAMK2G,Hypo
3806,GO_Biological_Process_2018,natural killer cell activation (GO:0030101),1/36,0.9751884908474306,0.9999956484855184,0,0,0.2640914754819321,0.0066351669948333,ELF4,Hypo
3807,GO_Biological_Process_2018,inner mitochondrial membrane organization (GO:0007007),1/36,0.9751884908474306,0.9999956484855184,0,0,0.2640914754819321,0.0066351669948333,SAMM50,Hypo
3808,GO_Biological_Process_2018,spermatid development (GO:0007286),1/36,0.9751884908474306,0.9999956484855184,0,0,0.2640914754819321,0.0066351669948333,BBS4,Hypo
3809,GO_Biological_Process_2018,positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000060),4/87,0.9752514339890812,0.9999956484855184,0,0,0.4449535036342699,0.0111505170987958,ANAPC7;SMURF1;UBE2D1;BTRC,Hypo
3810,GO_Biological_Process_2018,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),3/72,0.9762461414997244,0.9999956484855184,0,0,0.4015318996896005,0.0096530397627959,FBXL18;BTRC;FBXO31,Hypo
3811,GO_Biological_Process_2018,DNA-dependent DNA replication (GO:0006261),2/56,0.977572150671796,0.9999956484855184,0,0,0.3421552969807589,0.0077611696479408,RAD51;NEXMIF,Hypo
3812,GO_Biological_Process_2018,cellular iron ion homeostasis (GO:0006879),2/56,0.977572150671796,0.9999956484855184,0,0,0.3421552969807589,0.0077611696479408,SLC22A17;ATP13A2,Hypo
3813,GO_Biological_Process_2018,epithelial to mesenchymal transition (GO:0001837),1/37,0.9776117532602484,0.9999956484855184,0,0,0.2567413488398609,0.0058133091419732,OLFM1,Hypo
3814,GO_Biological_Process_2018,regulation of osteoclast differentiation (GO:0045670),1/37,0.9776117532602484,0.9999956484855184,0,0,0.2567413488398609,0.0058133091419732,MTOR,Hypo
3815,GO_Biological_Process_2018,organic cyclic compound biosynthetic process (GO:1901362),1/37,0.9776117532602484,0.9999956484855184,0,0,0.2567413488398609,0.0058133091419732,MOCOS,Hypo
3816,GO_Biological_Process_2018,base-excision repair (GO:0006284),1/37,0.9776117532602484,0.9999956484855184,0,0,0.2567413488398609,0.0058133091419732,ERCC6,Hypo
3817,GO_Biological_Process_2018,positive regulation of macromolecule metabolic process (GO:0010604),18/276,0.9778209829397494,0.9999956484855184,0,0,0.6424960277336415,0.0144103312093943,SRPK2;NSF;SMAD3;NTRK3;PRKAG1;ALOX12B;ECE1;ANK3;INHBA;MAPK14;PRKAB1;PPM1F;MTOR;EPB41L4B;RIMS1;OLFM1;NOS1AP;EPHB2,Hypo
3818,GO_Biological_Process_2018,"phagocytosis, engulfment (GO:0006911)",5/104,0.9785973440385054,0.9999956484855184,0,0,0.4661265612422425,0.0100846547587898,MEGF10;ADGRB1;ELMO1;MYH9;DOCK1,Hypo
3819,GO_Biological_Process_2018,positive regulation of cell proliferation (GO:0008284),30/424,0.978824440039412,0.9999956484855184,0,0,0.7001903553299492,0.0149861590054049,KMT2D;EPO;FLT4;DOT1L;PDGFA;TGFA;IRS2;TCIRG1;MST1R;FGF1;NACC2;PTK2B;STX3;SRPK2;PDGFRA;PRKCH;NTRK3;IL34;GLP2R;TET1;LIFR;EREG;DISP3;TIAM1;RARA;TMEM119;FGFR1OP;ITGB1BP1;SLC25A5;FGFR2,Hypo
3820,GO_Biological_Process_2018,cellular respiration (GO:0045333),2/57,0.9794535793889242,0.9999956484855184,0,0,0.3359156244166511,0.0069737544427655,CHCHD5;ALDH5A1,Hypo
3821,GO_Biological_Process_2018,muscle filament sliding (GO:0030049),1/38,0.9797984281988774,0.9999956484855184,0,0,0.2497885263406043,0.0050977876542708,MYBPC1,Hypo
3822,GO_Biological_Process_2018,mitochondrion disassembly (GO:0061726),1/38,0.9797984281988774,0.9999956484855184,0,0,0.2497885263406043,0.0050977876542708,MARK2,Hypo
3823,GO_Biological_Process_2018,actin-myosin filament sliding (GO:0033275),1/38,0.9797984281988774,0.9999956484855184,0,0,0.2497885263406043,0.0050977876542708,MYBPC1,Hypo
3824,GO_Biological_Process_2018,retina homeostasis (GO:0001895),1/38,0.9797984281988774,0.9999956484855184,0,0,0.2497885263406043,0.0050977876542708,BBS4,Hypo
3825,GO_Biological_Process_2018,T cell differentiation (GO:0030217),1/38,0.9797984281988774,0.9999956484855184,0,0,0.2497885263406043,0.0050977876542708,KIT,Hypo
3826,GO_Biological_Process_2018,DNA replication (GO:0006260),6/120,0.980554443902942,0.9999956484855184,0,0,0.48559670781893,0.0095357150999082,UPF1;NEXMIF;TOP1MT;REV1;KCTD13;CLSPN,Hypo
3827,GO_Biological_Process_2018,"DNA-templated transcription, termination (GO:0006353)",5/106,0.98133189539942,0.9999956484855184,0,0,0.4568454274733386,0.0086090479112463,ZC3H11A;CSTF2;ERCC2;SYMPK;SRSF4,Hypo
3828,GO_Biological_Process_2018,positive regulation of peptide hormone secretion (GO:0090277),1/39,0.9817716034621266,0.9999956484855184,0,0,0.2432016418676244,0.0044740786338495,IRS2,Hypo
3829,GO_Biological_Process_2018,alpha-amino acid catabolic process (GO:1901606),1/39,0.9817716034621266,0.9999956484855184,0,0,0.2432016418676244,0.0044740786338495,HOGA1,Hypo
3830,GO_Biological_Process_2018,stimulatory C-type lectin receptor signaling pathway (GO:0002223),6/121,0.9817765063448884,0.9999956484855184,0,0,0.4813472893183038,0.0088527404574596,MUC2;SRC;UBE2D1;FYN;BTRC;CARD11,Hypo
3831,GO_Biological_Process_2018,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition (GO:0051437),3/76,0.9826835758876808,0.9999956484855184,0,0,0.3794457226080165,0.0066281984851045,ANAPC7;UBE2D1;BTRC,Hypo
3832,GO_Biological_Process_2018,keratinocyte differentiation (GO:0030216),2/59,0.9827680726114282,0.9999956484855184,0,0,0.3240930869267625,0.005633426552861,SCEL;EREG,Hypo
3833,GO_Biological_Process_2018,sterol biosynthetic process (GO:0016126),1/40,0.9835521144378002,0.9999956484855184,0,0,0.2369525463419768,0.0039297759492157,PRKAG2,Hypo
3834,GO_Biological_Process_2018,negative regulation of cytokine secretion (GO:0050710),1/40,0.9835521144378002,0.9999956484855184,0,0,0.2369525463419768,0.0039297759492157,FOXP3,Hypo
3835,GO_Biological_Process_2018,regulation of release of cytochrome c from mitochondria (GO:0090199),1/40,0.9835521144378002,0.9999956484855184,0,0,0.2369525463419768,0.0039297759492157,HRK,Hypo
3836,GO_Biological_Process_2018,positive regulation of cytokine biosynthetic process (GO:0042108),1/40,0.9835521144378002,0.9999956484855184,0,0,0.2369525463419768,0.0039297759492157,EREG,Hypo
3837,GO_Biological_Process_2018,JAK-STAT cascade (GO:0007259),1/40,0.9835521144378002,0.9999956484855184,0,0,0.2369525463419768,0.0039297759492157,PKD1,Hypo
3838,GO_Biological_Process_2018,autophagy of mitochondrion (GO:0000422),1/40,0.9835521144378002,0.9999956484855184,0,0,0.2369525463419768,0.0039297759492157,MARK2,Hypo
3839,GO_Biological_Process_2018,tumor necrosis factor-mediated signaling pathway (GO:0033209),6/123,0.9840085300215944,0.9999956484855184,0,0,0.4730663712145194,0.0076261673168284,TNFRSF9;PTK2B;TNFRSF25;FOXO3;TNFRSF4;MAP3K14,Hypo
3840,GO_Biological_Process_2018,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),4/93,0.9840285264325368,0.9999956484855184,0,0,0.4148180652909454,0.0066787334901994,SRC;HMGB1;GRAMD4;PPM1F,Hypo
3841,GO_Biological_Process_2018,cellular response to cytokine stimulus (GO:0071345),32/456,0.9841603507075496,0.9999956484855184,0,0,0.6935683790111555,0.0110738159465625,OPRD1;CNTFR;LAMA5;USP10;TCF7;LRRC4;RORA;AKAP6;PIK3R1;FOXO3;SBNO2;TBK1;SMPD4;ST3GAL6;FYN;STX3;IL12RB1;UPF1;SMAD3;IL34;PDE2A;DAB2IP;RTN4RL2;PTPN11;LIFR;EREG;LRCH1;BCL6;KIT;ARHGEF2;PTPN5;STX1A,Hypo
3842,GO_Biological_Process_2018,innate immune response activating cell surface receptor signaling pathway (GO:0002220),6/124,0.9850260204779376,0.9999956484855184,0,0,0.4690311780707261,0.0070763772411705,MUC2;SRC;UBE2D1;FYN;BTRC;CARD11,Hypo
3843,GO_Biological_Process_2018,mesenchymal cell differentiation (GO:0048762),1/41,0.9851587645007568,0.9999956484855184,0,0,0.2310159055926116,0.0034542580662124,FGFR2,Hypo
3844,GO_Biological_Process_2018,bicarbonate transport (GO:0015701),1/41,0.9851587645007568,0.9999956484855184,0,0,0.2310159055926116,0.0034542580662124,SLC4A1,Hypo
3845,GO_Biological_Process_2018,respiratory electron transport chain (GO:0022904),4/94,0.9851677894326668,0.9999956484855184,0,0,0.4101861368048418,0.0061295376628454,ALDH5A1;SDHAF2;NDUFA12;NDUFB11,Hypo
3846,GO_Biological_Process_2018,positive regulation of T cell proliferation (GO:0042102),2/61,0.9855605211043448,0.9999956484855184,0,0,0.31307207740229,0.0045535528132582,HMGB1;IL12RB1,Hypo
3847,GO_Biological_Process_2018,protein targeting to membrane (GO:0006612),2/61,0.9855605211043448,0.9999956484855184,0,0,0.31307207740229,0.0045535528132582,RAB3IP;ZDHHC7,Hypo
3848,GO_Biological_Process_2018,positive regulation of cellular amide metabolic process (GO:0034250),2/61,0.9855605211043448,0.9999956484855184,0,0,0.31307207740229,0.0045535528132582,CPEB3;MTOR,Hypo
3849,GO_Biological_Process_2018,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),2/61,0.9855605211043448,0.9999956484855184,0,0,0.31307207740229,0.0045535528132582,EPO;KIT,Hypo
3850,GO_Biological_Process_2018,"G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",6/125,0.9859825633699892,0.9999956484855184,0,0,0.4650638032990974,0.0065651237525442,OPRD1;HRH3;GNAS;CACNA1D;GPR101;HTR5A,Hypo
3851,GO_Biological_Process_2018,gene expression (GO:0010467),28/411,0.986143876280162,0.9999956484855184,0,0,0.6719990871128041,0.0093764139314299,GTF3C1;NUFIP1;NUP188;DTX1;SMG5;SMG6;DHX30;ATXN1;DHX34;TSPAN5;SYMPK;DROSHA;NCOA1;UPF1;NUP133;PABPC4;MRPL28;DDX54;BAZ1B;SORL1;TSPAN15;TSPAN14;RRAGC;TNIP1;ZC3H11A;HNRNPF;AGO2;SRSF4,Hypo
3852,GO_Biological_Process_2018,negative regulation of mitotic cell cycle phase transition (GO:1901991),3/79,0.9863776680092772,0.9999956484855184,0,0,0.3644067796610169,0.0049981914670091,RBL1;JADE1;MYO16,Hypo
3853,GO_Biological_Process_2018,anaphase-promoting complex-dependent catabolic process (GO:0031145),3/79,0.9863776680092772,0.9999956484855184,0,0,0.3644067796610169,0.0049981914670091,ANAPC7;UBE2D1;FBXO31,Hypo
3854,GO_Biological_Process_2018,carbohydrate homeostasis (GO:0033500),2/63,0.9879104364890348,0.9999956484855184,0,0,0.3027737570269633,0.0036827088642557,CRY2;PDK2,Hypo
3855,GO_Biological_Process_2018,mRNA metabolic process (GO:0016071),4/97,0.9881400551266882,0.9999956484855184,0,0,0.3968880195382864,0.0047352055061917,SF3B2;SON;SRSF4;EREG,Hypo
3856,GO_Biological_Process_2018,NADH dehydrogenase complex assembly (GO:0010257),2/64,0.9889410989741888,0.9999956484855184,0,0,0.2978737497516063,0.0033125066057992,NDUFA12;NDUFB11,Hypo
3857,GO_Biological_Process_2018,mitochondrial respiratory chain complex I biogenesis (GO:0097031),2/64,0.9889410989741888,0.9999956484855184,0,0,0.2978737497516063,0.0033125066057992,NDUFA12;NDUFB11,Hypo
3858,GO_Biological_Process_2018,mitochondrial respiratory chain complex I assembly (GO:0032981),2/64,0.9889410989741888,0.9999956484855184,0,0,0.2978737497516063,0.0033125066057992,NDUFA12;NDUFB11,Hypo
3859,GO_Biological_Process_2018,cellular response to type I interferon (GO:0071357),2/65,0.989885812403306,0.9999956484855184,0,0,0.2931292982627685,0.0029798596743947,RNASEL;IRF2,Hypo
3860,GO_Biological_Process_2018,type I interferon signaling pathway (GO:0060337),2/65,0.989885812403306,0.9999956484855184,0,0,0.2931292982627685,0.0029798596743947,RNASEL;IRF2,Hypo
3861,GO_Biological_Process_2018,defense response to Gram-positive bacterium (GO:0050830),2/65,0.989885812403306,0.9999956484855184,0,0,0.2931292982627685,0.0029798596743947,DROSHA;LYZL4,Hypo
3862,GO_Biological_Process_2018,peptidyl-lysine modification (GO:0018205),5/115,0.9900473250043416,0.9999956484855184,0,0,0.4192568357092778,0.0041936307377066,PIAS4;POP5;NUP188;NUP133;EYA1,Hypo
3863,GO_Biological_Process_2018,protein methylation (GO:0006479),1/46,0.9911233532338418,0.9999956484855184,0,0,0.2052904623453623,0.0018304270184036,PRMT8,Hypo
3864,GO_Biological_Process_2018,cellular response to UV (GO:0034644),2/67,0.991544659079506,0.9999956484855184,0,0,0.2840783446532933,0.0024121916357726,ERCC1;EIF2AK4,Hypo
3865,GO_Biological_Process_2018,mitochondrial ATP synthesis coupled electron transport (GO:0042775),3/85,0.991626245317104,0.9999956484855184,0,0,0.3376301251456274,0.0028391356138875,SDHAF2;NDUFA12;NDUFB11,Hypo
3866,GO_Biological_Process_2018,plasma membrane invagination (GO:0099024),4/103,0.992469125623386,0.9999956484855184,0,0,0.3727096245081857,0.0028174516645424,ELMO1;SPIRE1;MYH9;DOCK1,Hypo
3867,GO_Biological_Process_2018,negative regulation of cell cycle G2/M phase transition (GO:1902750),2/69,0.992936365678603,0.9999956484855184,0,0,0.2755677464831898,0.0019534170547534,BABAM2;H2AFY,Hypo
3868,GO_Biological_Process_2018,B cell receptor signaling pathway (GO:0050853),4/104,0.993023983725456,0.9999956484855184,0,0,0.36896197327852,0.0025829044333696,PLEKHA1;PRKCB;NFATC2;BCAR1,Hypo
3869,GO_Biological_Process_2018,regulation of stem cell differentiation (GO:2000736),3/88,0.9934548799825592,0.9999956484855184,0,0,0.3256593854799238,0.0021384857449313,PDGFRA;KMT2A;ABL1,Hypo
3870,GO_Biological_Process_2018,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),1/49,0.9934791534560408,0.9999956484855184,0,0,0.1924277407217376,0.0012589007929504,F2,Hypo
3871,GO_Biological_Process_2018,protein autoubiquitination (GO:0051865),1/49,0.9934791534560408,0.9999956484855184,0,0,0.1924277407217376,0.0012589007929504,RNF41,Hypo
3872,GO_Biological_Process_2018,G1/S transition of mitotic cell cycle (GO:0000082),4/105,0.993539439939592,0.9999956484855184,0,0,0.3652885329642933,0.0023676248597677,CAMK2A;PIM2;INHBA;BRD4,Hypo
3873,GO_Biological_Process_2018,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436),2/71,0.9941029003371804,0.9999956484855184,0,0,0.2675505163229473,0.0015824425698303,ANAPC7;UBE2D1,Hypo
3874,GO_Biological_Process_2018,regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439),2/72,0.9946130759620392,0.9999956484855184,0,0,0.2637136990319741,0.0014244458091098,ANAPC7;UBE2D1,Hypo
3875,GO_Biological_Process_2018,regulation of cellular amine metabolic process (GO:0033238),1/51,0.9946910938208112,0.9999956484855184,0,0,0.1847101077475628,0.000983220861481573,OAZ1,Hypo
3876,GO_Biological_Process_2018,regulation of cellular amino acid metabolic process (GO:0006521),1/51,0.9946910938208112,0.9999956484855184,0,0,0.1847101077475628,0.000983220861481573,OAZ1,Hypo
3877,GO_Biological_Process_2018,phospholipase C-activating G-protein coupled receptor signaling pathway (GO:0007200),3/91,0.9948938041459368,0.9999956484855184,0,0,0.3145048326096092,0.0016100373626076,OPRD1;CHRM4;GRM1,Hypo
3878,GO_Biological_Process_2018,ncRNA processing (GO:0034470),12/227,0.9950076819881132,0.9999956484855184,0,0,0.5136438908488732,0.0025706958661602,BOP1;SMAD3;DDX27;PDCD11;INTS1;UTP4;NOB1;AGO2;ADAT1;DROSHA;INTS7;RRP9,Hypo
3879,GO_Biological_Process_2018,cell cycle G1/S phase transition (GO:0044843),3/92,0.9953012249476142,0.9999956484855184,0,0,0.3109537577258011,0.0014645452445047,CAMK2A;PIM2;INHBA,Hypo
3880,GO_Biological_Process_2018,viral gene expression (GO:0019080),4/110,0.9956131461010592,0.9999956484855184,0,0,0.3479609843122806,0.0015298119903236,NUP188;NUP133;FURIN;EIF2AK4,Hypo
3881,GO_Biological_Process_2018,antigen receptor-mediated signaling pathway (GO:0050851),14/257,0.9956695804101212,0.9999956484855184,0,0,0.5299161650171751,0.0022997423683213,EIF2B5;PLEKHA1;PRKCB;NFATC2;UBE2D1;PIK3R1;SPPL3;PRKD2;FYN;RBCK1;BTRC;PAG1;CARD11;BCAR1,Hypo
3882,GO_Biological_Process_2018,neutrophil chemotaxis (GO:0030593),1/53,0.995677784141068,0.9999956484855184,0,0,0.1775861388483245,0.0007692292131367288,PIP5K1C,Hypo
3883,GO_Biological_Process_2018,positive regulation of response to stimulus (GO:0048584),1/54,0.996100059332988,0.9999956484855184,0,0,0.1742257761600046,0.0006807985913170293,GPLD1,Hypo
3884,GO_Biological_Process_2018,nuclear-transcribed mRNA catabolic process (GO:0000956),8/174,0.9961042915633874,0.9999956484855184,0,0,0.4438102564738873,0.0017323318855503,UPF1;DHX34;TNKS1BP1;SAMD4B;DCP1A;DCPS;SMG5;SMG6,Hypo
3885,GO_Biological_Process_2018,regulation of protein processing (GO:0070613),5/128,0.9961271060035788,0.9999956484855184,0,0,0.374673438251092,0.0014538877069103,TMEM59;LRRK2;SUSD4;F2;CPN2,Hypo
3886,GO_Biological_Process_2018,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",4/112,0.9962479369783672,0.9999956484855184,0,0,0.3414791975943055,0.0012836611675278,UPF1;DCP1A;SMG5;SMG6,Hypo
3887,GO_Biological_Process_2018,regulation of hematopoietic stem cell differentiation (GO:1902036),2/76,0.99625451461879,0.9999956484855184,0,0,0.2494034075142904,0.0009358905953018138,KMT2A;ABL1,Hypo
3888,GO_Biological_Process_2018,negative regulation of ubiquitin protein ligase activity (GO:1904667),2/77,0.996581007594132,0.9999956484855184,0,0,0.2460643394934976,0.0008427335802736529,ANAPC7;UBE2D1,Hypo
3889,GO_Biological_Process_2018,regulation of hematopoietic progenitor cell differentiation (GO:1901532),2/77,0.996581007594132,0.9999956484855184,0,0,0.2460643394934976,0.0008427335802736529,KMT2A;ABL1,Hypo
3890,GO_Biological_Process_2018,granulocyte chemotaxis (GO:0071621),1/56,0.9968248480239952,0.9999956484855184,0,0,0.1678716358039087,0.0005338659581455618,PIP5K1C,Hypo
3891,GO_Biological_Process_2018,ribosome assembly (GO:0042255),1/56,0.9968248480239952,0.9999956484855184,0,0,0.1678716358039087,0.0005338659581455618,BOP1,Hypo
3892,GO_Biological_Process_2018,response to tumor necrosis factor (GO:0034612),3/97,0.9969082367596273,0.9999956484855184,0,0,0.294331705078189,0.0009114136109279244,SMPD4;DAB2IP;ARHGEF2,Hypo
3893,GO_Biological_Process_2018,cellular response to tumor necrosis factor (GO:0071356),9/194,0.9972219494809867,0.9999956484855184,0,0,0.447763064455491,0.0012456394404758,SMPD4;TNFRSF9;DAB2IP;PTK2B;TNFRSF25;ARHGEF2;FOXO3;TNFRSF4;MAP3K14,Hypo
3894,GO_Biological_Process_2018,steroid metabolic process (GO:0008202),3/99,0.997388074401968,0.9999956484855184,0,0,0.2881676938880328,0.0007536572535527163,PIAS4;WWOX;HSD17B4,Hypo
3895,GO_Biological_Process_2018,NIK/NF-kappaB signaling (GO:0038061),2/80,0.9974014490054754,0.9999956484855184,0,0,0.2365608382035486,0.0006155154723555684,BTRC;MAP3K14,Hypo
3896,GO_Biological_Process_2018,neutrophil migration (GO:1990266),1/58,0.9974148938913128,0.9999956484855184,0,0,0.1619634000342055,0.0004192346916665063,PIP5K1C,Hypo
3897,GO_Biological_Process_2018,regulation of gene expression (GO:0010468),76/1037,0.9978070964028776,0.9999956484855184,0,0,0.7211693617796296,0.0015831914157939,ZC3H3;ZMYND8;HP1BP3;PRKAG1;HMGB3;RORA;TCF20;HMGB1;LIMD1;RIMS1;EPB41L4B;SART3;ZFP30;DIP2A;EPHB2;MBNL1;PRMT8;MBNL2;NUP133;H2AFY;TSC22D3;TFEB;ANK3;PRKAB1;FOXP3;OLFM1;RBL1;DDIT3;IRF2;NOS1AP;MAPT;ABCG1;OPRD1;KMT2D;HDAC5;KDM3A;AHNAK;TCF7;ALOX12B;TOB2;PRDM10;TOB1;PPM1F;SBNO1;SBNO2;NACC2;HLTF;HIVEP1;ABL1;PAK6;HIVEP3;ASCC2;APBB2;APBB1;MBNL3;SRPK2;KDM4A;SMAD3;PTCD2;UTP4;SORT1;NTRK3;AHNAK2;NFATC2;ESRRG;INHBA;MAPK14;MTOR;SRPK1;CLK1;PER1;SON;NR6A1;NLRP10;HNRNPF;BHLHE40,Hypo
3898,GO_Biological_Process_2018,positive regulation of B cell activation (GO:0050871),4/119,0.9978419922517529,0.9999956484855184,0,0,0.3205683900084901,0.0006925365881952221,PAXIP1;NFATC2;IRS2;TNFRSF4,Hypo
3899,GO_Biological_Process_2018,rRNA metabolic process (GO:0016072),9/200,0.9981131315702164,0.9999956484855184,0,0,0.4335515508549326,0.0008188274870261215,GTF3C1;BOP1;DDX27;PDCD11;UTP4;NOB1;MARS;MAPT;RRP9,Hypo
3900,GO_Biological_Process_2018,regulation of T cell proliferation (GO:0042129),1/62,0.998286258666787,0.9999956484855184,0,0,0.1513092043839211,0.0002595272825357162,FOXP3,Hypo
3901,GO_Biological_Process_2018,translational elongation (GO:0006414),3/105,0.9984311845570946,0.9999956484855184,0,0,0.2711260158917188,0.0004256806752879384,EEF2K;MRPL28;MRPL22,Hypo
3902,GO_Biological_Process_2018,ribosomal large subunit biogenesis (GO:0042273),1/63,0.9984535918241604,0.9999956484855184,0,0,0.148860457803009,0.00023037720354681624,BOP1,Hypo
3903,GO_Biological_Process_2018,mitochondrial translational elongation (GO:0070125),2/87,0.9986356510970628,0.9999956484855184,0,0,0.2169948061360067,0.00029625877184715106,MRPL28;MRPL22,Hypo
3904,GO_Biological_Process_2018,regulation of protein activation cascade (GO:2000257),3/108,0.9987865168247184,0.9999956484855184,0,0,0.2633355345219752,0.0003197472838313904,SUSD4;F2;CPN2,Hypo
3905,GO_Biological_Process_2018,cellular response to light stimulus (GO:0071482),1/66,0.9988636710914836,0.9999956484855184,0,0,0.1419662943521332,0.00016141213032060703,EIF2AK4,Hypo
3906,GO_Biological_Process_2018,mitochondrial translational termination (GO:0070126),2/89,0.9988660512555214,0.9999956484855184,0,0,0.2119828176260945,0.00024051404098204224,MRPL28;MRPL22,Hypo
3907,GO_Biological_Process_2018,regulation of complement activation (GO:0030449),3/109,0.9988863685262064,0.9999956484855184,0,0,0.2608367008750763,0.00029063782138118166,SUSD4;F2;CPN2,Hypo
3908,GO_Biological_Process_2018,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),1/67,0.9989745474735954,0.9999956484855184,0,0,0.1398075158978186,0.00014343952817702022,BCCIP,Hypo
3909,GO_Biological_Process_2018,response to interferon-gamma (GO:0034341),1/68,0.999074581148096,0.9999956484855184,0,0,0.1377131785913939,0.00012750137681651993,IL12RB1,Hypo
3910,GO_Biological_Process_2018,positive regulation of T cell activation (GO:0050870),1/68,0.999074581148096,0.9999956484855184,0,0,0.1377131785913939,0.00012750137681651993,ZMIZ1,Hypo
3911,GO_Biological_Process_2018,regulation of humoral immune response (GO:0002920),3/113,0.9992110303254536,0.9999956484855184,0,0,0.251295699677826,0.00019834293996478925,SUSD4;F2;CPN2,Hypo
3912,GO_Biological_Process_2018,cellular transition metal ion homeostasis (GO:0046916),2/93,0.9992174507121908,0.9999956484855184,0,0,0.2026197621680167,0.0001586220234543507,SLC22A17;ATP13A2,Hypo
3913,GO_Biological_Process_2018,Fc receptor signaling pathway (GO:0038093),7/183,0.9992688955746956,0.9999956484855184,0,0,0.3658763393066018,0.0002675916414214558,KIT;UBE2D1;NFATC2;PIK3R1;BTRC;CARD11;VAV2,Hypo
3914,GO_Biological_Process_2018,cellular response to interleukin-1 (GO:0071347),5/150,0.999272801297069,0.9999956484855184,0,0,0.3174363974824927,0.000230923310258284,UPF1;USP10;PELI2;DAB2IP;BTRC,Hypo
3915,GO_Biological_Process_2018,regulation of immune effector process (GO:0002697),3/114,0.9992763598775664,0.9999956484855184,0,0,0.2490178930856897,0.00018026456984758464,SUSD4;F2;CPN2,Hypo
3916,GO_Biological_Process_2018,interleukin-1-mediated signaling pathway (GO:0070498),2/95,0.999350174026568,0.9999956484855184,0,0,0.1982402684860126,0.0001288635494191573,PELI2;BTRC,Hypo
3917,GO_Biological_Process_2018,negative regulation of cysteine-type endopeptidase activity (GO:2000117),1/72,0.9993859894708368,0.9999956484855184,0,0,0.1299257835365192,7.980030072152859e-05,SRC,Hypo
3918,GO_Biological_Process_2018,translational termination (GO:0006415),2/96,0.9994078865991396,0.9999956484855184,0,0,0.1961204071824894,0.00011615991459075951,MRPL28;MRPL22,Hypo
3919,GO_Biological_Process_2018,protein targeting to ER (GO:0045047),2/97,0.9994604978210176,0.9999956484855184,0,0,0.1940451745379876,0.00010471604429188622,PMM1;SRP68,Hypo
3920,GO_Biological_Process_2018,regulation of cellular macromolecule biosynthetic process (GO:2000112),39/631,0.999551739191484,0.9999956484855184,0,0,0.6018339768339769,0.00026983906870697567,CYFIP2;KMT2D;KDM3A;ZMYND8;TCF7;HP1BP3;HMGB3;TCF20;RORA;HMGB1;FOXO3;LIMD1;SBNO1;ATXN2;SBNO2;TCOF1;ZFP30;HLTF;ABL1;HIVEP1;PAK6;ASCC2;HIVEP3;APBB2;APBB1;PRMT8;UTP4;NUP133;ZBTB38;TSC22D3;TFEB;NFATC2;ESRRG;FOXP3;NR6A1;DDIT3;BHLHE40;IRF2;ABCG1,Hypo
3921,GO_Biological_Process_2018,regulation of acute inflammatory response (GO:0002673),3/121,0.9996057962430182,0.9999956484855184,0,0,0.2341542398997153,9.232267925099264e-05,SUSD4;F2;CPN2,Hypo
3922,GO_Biological_Process_2018,cellular protein metabolic process (GO:0044267),27/484,0.9997073406507304,0.9999956484855184,0,0,0.5405155374705142,0.00015821007742481785,RPN1;DENND3;FURIN;SPPL3;ABL1;ABL2;ST3GAL6;IGFBP6;LMCD1;SEC11C;UBL4A;CSNK1G3;SERPIND1;PABPC4;TMEM132A;DAB2IP;MRPL28;F2;SORL1;SGPP2;MSRA;TNIP1;MGAT4A;AGO2;SPARCL1;MSRB3;VWA1,Hypo
3923,GO_Biological_Process_2018,cytokine-mediated signaling pathway (GO:0019221),38/633,0.9997665119602488,0.9999956484855184,0,0,0.5830403291023523,0.00013614883871927906,OPRD1;CAMK2B;CNTFR;LAMA5;RNASEL;EPO;PELI2;CAMK2A;LRRC4;IRS2;RORA;PIK3R1;FOXO3;TRIM5;PTK2B;FYN;STX3;IL12RB1;BTRC;TNFRSF4;CAMK2G;IL33;TNFRSF9;IL34;RTN4RL2;PTPN11;LIFR;EREG;SMARCA4;BCL6;HNRNPF;KIT;IRF2;ACKR3;TNFRSF25;BRWD1;MAP3K14;STX1A,Hypo
3924,GO_Biological_Process_2018,Fc-epsilon receptor signaling pathway (GO:0038095),6/182,0.9997683492586648,0.9999956484855184,0,0,0.3134469696969697,7.261863430456586e-05,UBE2D1;NFATC2;PIK3R1;BTRC;CARD11;VAV2,Hypo
3925,GO_Biological_Process_2018,mitochondrial translation (GO:0032543),2/107,0.9997873912570644,0.9999956484855184,0,0,0.1754669013395912,3.730976365214706e-05,MRPL28;MRPL22,Hypo
3926,GO_Biological_Process_2018,viral transcription (GO:0019083),2/113,0.9998780836047666,0.9999956484855184,0,0,0.1659267069944688,2.0230419224667e-05,NUP188;NUP133,Hypo
3927,GO_Biological_Process_2018,peptide biosynthetic process (GO:0043043),5/174,0.9998897704160536,0.9999956484855184,0,0,0.271991603413395,2.998317382793943e-05,TNIP1;PABPC4;AGO2;MRPL28;FURIN,Hypo
3928,GO_Biological_Process_2018,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),1/89,0.9998908689128164,0.9999956484855184,0,0,0.1047273660152059,1.1429634986690568e-05,SRP68,Hypo
3929,GO_Biological_Process_2018,cellular macromolecule biosynthetic process (GO:0034645),17/367,0.9999099319807664,0.9999956484855184,0,0,0.4447564851082699,4.0060139750856814e-05,NCOA1;GTF3C1;UPF1;PABPC4;REV1;MRPL28;DTX1;INHBA;BAZ1B;EEF2K;RRAGC;TNIP1;TOP1MT;AGO2;KCTD13;CLSPN;ST3GAL2,Hypo
3930,GO_Biological_Process_2018,cotranslational protein targeting to membrane (GO:0006613),1/93,0.99992665400047,0.9999956484855184,0,0,0.1001516942913868,7.345995525411973e-06,SRP68,Hypo
3931,GO_Biological_Process_2018,translation (GO:0006412),8/232,0.9999293340287008,0.9999956484855184,0,0,0.3278284537295866,2.3167134676005062e-05,YARS;EEF2K;TNIP1;LARS;PABPC4;MARS;AGO2;MRPL28,Hypo
3932,GO_Biological_Process_2018,regulation of nucleic acid-templated transcription (GO:1903506),34/607,0.9999297786014076,0.9999956484855184,0,0,0.54124721733396,3.800847110497378e-05,KMT2D;KDM3A;ZMYND8;TCF7;HP1BP3;HMGB3;TCF20;RORA;HMGB1;LIMD1;SBNO1;SBNO2;ZFP30;HLTF;ABL1;HIVEP1;PAK6;ASCC2;HIVEP3;APBB2;APBB1;PRMT8;UTP4;NUP133;TSC22D3;TFEB;NFATC2;ESRRG;FOXP3;NR6A1;DDIT3;BHLHE40;IRF2;ABCG1,Hypo
3933,GO_Biological_Process_2018,rRNA processing (GO:0006364),6/202,0.9999485358568516,0.9999956484855184,0,0,0.2811476442428823,1.446939493984628e-05,BOP1;DDX27;PDCD11;UTP4;NOB1;RRP9,Hypo
3934,GO_Biological_Process_2018,ribosome biogenesis (GO:0042254),7/226,0.9999671158858504,0.9999956484855184,0,0,0.2933302312246044,9.646063409077175e-06,SETD4;BOP1;DDX27;PDCD11;UTP4;NOB1;RRP9,Hypo
3935,GO_Biological_Process_2018,sensory perception of chemical stimulus (GO:0007606),3/327,0.9999952139909636,0.9999956484855184,0,0,0.0842987311913865,4.034554547213296e-07,GNAS;ADCY3;BBS4,Hypo
3936,GO_Biological_Process_2018,regulation of immune response (GO:0050776),3/251,0.9999955898592822,0.9999956484855184,0,0,0.1106044037974054,4.877820603535233e-07,NLRP10;BCL6;FOXP3,Hypo
3937,GO_Biological_Process_2018,defense response to bacterium (GO:0042742),4/241,0.9999955958441406,0.9999956484855184,0,0,0.1544919579706939,6.804081602474069e-07,NLRP10;ADGRB1;DROSHA;LYZL4,Hypo
3938,GO_Biological_Process_2018,sensory perception of smell (GO:0007608),2/241,0.9999956484855184,0.9999956484855184,0,0,0.076512333215915,3.329452504129991e-07,ADCY3;BBS4,Hypo
3939,GO_Molecular_Function_2018,Rho guanyl-nucleotide exchange factor activity (GO:0005089),21/59,7.110178088974336e-08,2.160164824723177e-05,0,0,5.1601866251944015,84.93230350903279,ARHGEF10;TRIO;ARHGEF12;PLEKHG2;PLEKHG5;ARHGEF16;ARHGEF10L;KALRN;FGD1;VAV2;PREX1;TIAM1;ABR;OBSCN;MCF2L;ARHGEF3;ARHGEF1;ARHGEF2;DOCK2;ARHGEF7;DOCK1,Hypo
3940,GO_Molecular_Function_2018,actin binding (GO:0003779),53/254,7.409935569527533e-08,2.160164824723177e-05,0,0,2.480997752408228,40.7326712777416,HIP1;ARPC1B;LRRK2;ESPN;PPP1R9A;ANTXR1;SYNE3;SYNE2;PPP1R9B;SYNE1;CAPZB;MYO18A;PLS1;MYBPC1;DBNL;MAP1S;ACTN1;PRKCE;PAWR;SHROOM3;SPTB;BIN1;MAP1A;MYH9;MAPT;SPTBN4;SPTBN5;FLII;TWF2;CORO1C;ABLIM1;TMEM201;ABLIM2;MOBP;COBLL1;ABL1;FLNA;ABL2;MYH10;CAP2;MYO10;MICAL3;HIP1R;KLHL2;SORBS1;CORO2B;MYO19;MYO16;SSH1;MYO1E;MLPH;ARPC3;CORO7,Hypo
3941,GO_Molecular_Function_2018,GTPase regulator activity (GO:0030695),56/275,7.687419305064688e-08,2.160164824723177e-05,0,0,2.4073522250027724,39.435066959365045,GPSM1;RTKN;LRRK2;ARHGAP6;ARHGAP44;PREX1;RIMS1;RGS3;TBC1D30;TBC1D22A;ADPRHL1;TSC2;AXIN2;ARFGAP1;BCR;TBC1D1;ACAP2;RASA3;RASA2;RAPGEF2;CDC42EP1;ITGB1BP1;RIN2;LLGL1;TBC1D9B;RGS14;RAP1GDS1;AGAP2;AGAP1;RASAL1;ARHGAP17;ASAP1;AGAP3;ASAP2;KALRN;RAP1GAP;INPP5B;ABR;ARHGAP21;LARS;TBC1D14;SH3BP4;RALGDS;TBC1D15;TBC1D16;RAP1GAP2;GIT2;TNK2;DAB2IP;MTSS1L;ARHGAP26;SGSM1;ARHGAP31;SGSM3;SGSM2;NF1,Hypo
3942,GO_Molecular_Function_2018,actin filament binding (GO:0051015),33/127,1.1287914329652613e-07,2.378927944974288e-05,0,0,3.288316185529251,52.60302341857217,HIP1;ARPC1B;TWF2;ESPN;PPP1R9A;ANTXR1;SYNE3;CORO1C;PPP1R9B;SYNE1;ABLIM1;TMEM201;ABLIM2;CAPZB;MYO18A;ABL2;FLNA;MYH10;PLS1;MYBPC1;DBNL;MYO10;MAP1S;ACTN1;HIP1R;SHROOM3;CORO2B;SPTB;MYO16;MYO1E;BIN1;ARPC3;MYH9,Hypo
3943,GO_Molecular_Function_2018,protein kinase activity (GO:0004672),84/513,1.4239711396811435e-06,0.0002400815341502408,0,0,1.8490170065732767,24.891579755191582,PRAG1;MAST4;LRRK2;FLT4;PRKAG1;FGF1;STK10;DSTYK;TBK1;RASSF2;EEF2K;PIM2;EPHB2;EPHB1;MAP3K4;STK32C;PDK2;PDK1;CSNK1G3;PDGFRA;PRKCH;KSR1;PRKCB;PRKCE;LMTK2;PRKCA;NRG2;BAZ1B;PRKAB1;CIT;EREG;BCR;MELK;MAPKAPK2;KIT;TYRO3;SIK3;PRKD2;ULK1;SGK1;CAMK2B;NIM1K;SRC;PELI2;CAMK2A;STK39;MST1R;STK4;PRKCZ;CAMKK2;GRK2;ABL1;ABL2;PAK6;PTK2B;FYN;MAP4K5;MARK3;CAMK2G;MARK2;MAP4K4;PAK4;SRPK2;CDK18;TNK2;NTRK3;ERLIN2;EIF2AK4;CDC42BPB;CDC42BPA;MAPK14;MTOR;SRPK1;CLK1;SBK1;STK24;CDK5;WNK2;ERCC2;FGFR1OP;MAP3K14;MAP3K11;FGFR2;CDK16,Hypo
3944,GO_Molecular_Function_2018,GTPase activator activity (GO:0005096),48/249,3.256719869994526e-06,0.0004575691417342309,0,0,2.241034574760268,28.31500133336837,TBC1D9B;RGS14;LRRK2;RAP1GDS1;AGAP2;AGAP1;RASAL1;ARHGAP17;ASAP1;AGAP3;ASAP2;KALRN;ARHGAP6;RAP1GAP;INPP5B;ARHGAP44;PREX1;ABR;ARHGAP21;RGS3;LARS;TBC1D30;TBC1D14;TBC1D22A;TBC1D15;TBC1D16;RAP1GAP2;GIT2;ADPRHL1;DAB2IP;MTSS1L;TSC2;AXIN2;ARHGAP26;ARFGAP1;BCR;SGSM1;TBC1D1;ACAP2;ARHGAP31;RASA3;SGSM3;SGSM2;RASA2;NF1;RAPGEF2;CDC42EP1;LLGL1,Hypo
3945,GO_Molecular_Function_2018,small GTPase binding (GO:0031267),19/63,5.175224321995917e-06,0.0006232448719203655,0,0,4.026575961583729,49.009984204778064,ABCA1;GIT2;AGAP2;TSC2;AGAP1;ASAP1;AGAP3;ASAP2;SORL1;ARFGAP1;RAP1GAP;FGD1;ACAP2;RILPL2;RILPL1;SH3BP4;FLNA;RAB11FIP4;RAPGEF4,Hypo
3946,GO_Molecular_Function_2018,Rab guanyl-nucleotide exchange factor activity (GO:0017112),16/51,1.6325764067486175e-05,0.0015710431252153,0,0,4.258236076229871,46.937540183298616,TRAPPC3;ANKRD27;RIC1;TRAPPC10;DENND2A;RAB3IP;DENND3;TRAPPC9;ST5;MADD;TRAPPC12;RAB3GAP2;RIN3;SBF1;RIN1;RIN2,Hypo
3947,GO_Molecular_Function_2018,ankyrin binding (GO:0030506),9/18,1.677270240443423e-05,0.0015710431252153,0,0,9.294693456980935,102.20219854243632,SPTBN4;OBSCN;KCNJ11;KCNQ2;SLC4A1;CACNA1D;RHCG;SPTB;PLEC,Hypo
3948,GO_Molecular_Function_2018,Ras GTPase binding (GO:0017016),35/184,8.766310333481804e-05,0.0060952429207001,0,0,2.195787407783833,20.51306673929201,TBC1D9B;LRRK2;RAP1GAP;RIMS1;RIMS3;RUSC2;MOBP;TBC1D30;TBC1D14;SH3BP4;FLNA;TBC1D22A;TBC1D15;RAB11FIP4;TBC1D16;RAB11FIP5;NSF;ANKRD27;YIPF1;RIC1;ADPRHL1;ARHGEF16;HPS4;RNF41;SGSM1;TBC1D1;MLPH;SGSM3;SGSM2;RAB3GAP2;ULK1;RIN3;ARHGEF2;LLGL1;RAPGEF4,Hypo
3949,GO_Molecular_Function_2018,protein serine/threonine kinase activity (GO:0004674),59/368,9.22932044925117e-05,0.0060952429207001,0,0,1.791348561316678,16.642595540418636,MAST4;LRRK2;PRKAG1;STK10;DSTYK;TBK1;PIM2;MAP3K4;STK32C;CSNK1G3;CDKL4;PRKCH;PRKCB;PRKCE;LMTK2;PRKCA;CIT;MELK;MAPKAPK2;SIK3;ULK1;PRKD2;SGK1;CAMK2B;NIM1K;PELI2;CAMK2A;STK39;STK4;PRKCZ;CAMKK2;CCNB2;GRK2;PAK6;PTK2B;MAP4K5;MARK3;CAMK2G;MARK2;MAP4K4;PAK4;SRPK2;CDK18;EIF2AK4;CDC42BPB;MAPK14;CDC42BPA;MTOR;SRPK1;CLK1;SBK1;STK24;CDK5;WNK2;ERCC2;CDK14;MAP3K14;MAP3K11;CDK16,Hypo
3950,GO_Molecular_Function_2018,cadherin binding (GO:0045296),52/313,9.380258416084115e-05,0.0060952429207001,0,0,1.8673174828111057,17.31809642758163,PTPRT;LAD1;DOCK9;ENO1;GOLGA2;SEPT9;CAPZB;EFHD2;TNKS1BP1;MB21D2;SH3GLB1;DBNL;ARHGEF16;ANK3;SND1;PKM;CTTN;CDC42EP1;MYH9;ITGA6;CHMP5;PLEC;AHNAK;SRC;TWF2;ASAP1;FAM129B;CCNB2;KLC2;EPB41L1;BAG3;COBLL1;CDH22;PACSIN2;FLNA;PAK6;CTNNA3;MARK2;SPTBN2;PAK4;DAB2IP;BAIAP2;TJP1;PPFIBP1;EHD4;P2RX4;STK24;FASN;GLOD4;PI4KA;PFKP;TJP2,Hypo
3951,GO_Molecular_Function_2018,GTPase binding (GO:0051020),19/76,9.399544243072588e-05,0.0060952429207001,0,0,3.105989987916451,28.79955996199796,ABCA1;GIT2;AGAP2;TSC2;AGAP1;ASAP1;ENO1;AGAP3;ASAP2;ARFGAP1;FGD1;GOLGA4;ACAP2;RRAGC;RILPL2;RILPL1;GNB2;FLNA;ULK1,Hypo
3952,GO_Molecular_Function_2018,Rab GTPase binding (GO:0017137),27/130,0.00012018388986061525,0.0072367870823213,0,0,2.446465625615316,22.082991566477247,TBC1D9B;RIMS1;RIMS3;RUSC2;MOBP;TBC1D30;TBC1D14;TBC1D22A;TBC1D15;RAB11FIP4;TBC1D16;RAB11FIP5;NSF;ANKRD27;YIPF1;RIC1;ADPRHL1;HPS4;SGSM1;TBC1D1;MLPH;SGSM3;SGSM2;RAB3GAP2;ULK1;RIN3;LLGL1,Hypo
3953,GO_Molecular_Function_2018,voltage-gated calcium channel activity (GO:0005245),12/37,0.00012946604111970794,0.0072759915109275,0,0,4.464396284829721,39.965686007091286,RYR1;CACNB1;CACNA1I;CACNB3;CACNB4;NCS1;CACNA1D;CACNA1C;CACNG2;CACNA1E;CACNG4;TPCN1,Hypo
3954,GO_Molecular_Function_2018,phospholipid-translocating ATPase activity (GO:0004012),8/20,0.0003461634498889943,0.0182384867660263,0,0,6.1922416752488845,49.3434938920557,ABCA1;ATP8A2;ATP8B2;ATP8A1;ATP11C;ATP11A;ATP9B;ATP9A,Hypo
3955,GO_Molecular_Function_2018,high voltage-gated calcium channel activity (GO:0008331),6/12,0.000468857801848058,0.0232498309975242,0,0,9.281893004115226,71.14766863298068,CACNB1;CACNB3;CACNB4;CACNA1D;CACNA1C;CACNA1E,Hypo
3956,GO_Molecular_Function_2018,calcium channel activity (GO:0005262),20/93,0.0005454730212511706,0.0255463198285964,0,0,2.5519199375399246,19.174762024151057,RYR1;RYR2;PDE2A;CACNA1D;CACNA1C;PKD1;TRPC4AP;CACNA1E;TPCN1;PANX1;CACNB1;CACNA1I;FAM155A;CACNB3;LOXHD1;CACNB4;P2RX4;NCS1;CACNG2;CACNG4,Hypo
3957,GO_Molecular_Function_2018,cAMP-dependent protein kinase inhibitor activity (GO:0004862),5/9,0.0007890266370848249,0.0350078660559214,0,0,11.597686375321336,82.86211135616232,PRKAR1B;PRKAR1A;PPP1R1B;PRKAG2;PKIG,Hypo
3958,GO_Molecular_Function_2018,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",41/254,0.000884489022433955,0.0372812122955912,0,0,1.7985401495756448,12.644637340795615,DGKG;PRAG1;SRC;LRRK2;PRKAG1;STK4;PRKCZ;PAPSS1;HK1;HK3;RASSF2;TBK1;GRK2;EEF2K;ABL1;ABL2;MAP4K5;PDK2;PDK1;PAK4;PDGFRA;CSNK1G3;KSR1;PRKCA;CDC42BPB;PRKAB1;DGKZ;MTOR;SRPK1;PKM;STK24;CDK5;MAPKAPK2;ERCC2;PI4KA;PRKD2;FAM20A;MAP3K14;DGKI;MAP3K11;DGKH,Hypo
3959,GO_Molecular_Function_2018,kinase activity (GO:0016301),44/280,0.0010328306497557,0.0414607732259083,0,0,1.7425258327849609,11.980652796132835,DGKG;PRAG1;TRRAP;SRC;LRRK2;CAMK2A;PRKAG1;STK39;STK4;PRKCZ;PAPSS1;RASSF2;TBK1;GRK2;EEF2K;ABL1;ABL2;MAP4K5;PDK2;PDK1;MAP4K4;PAK4;PDGFRA;CSNK1G3;KSR1;PRKCA;CDC42BPB;PRKAB1;DGKZ;MTOR;SRPK1;BCR;STK24;CDK5;MAPKAPK2;ERCC2;PI4KA;ULK1;PRKD2;COQ8A;MAP3K14;DGKI;MAP3K11;DGKH,Hypo
3960,GO_Molecular_Function_2018,voltage-gated cation channel activity (GO:0022843),20/100,0.0014202966233573,0.0437187133108277,0,0,2.327720207253886,15.262604277814305,RYR1;KCNH6;KCNJ11;KCND3;CACNA1D;CACNA1C;KCNA6;CACNA1E;TPCN1;CACNB1;CACNA1I;CACNB3;KCNU1;CACNB4;KCNQ1;KCNQ2;NCS1;CACNG2;CACNG4;KCNH1,Hypo
3961,GO_Molecular_Function_2018,protein kinase C activity (GO:0004697),5/10,0.0014514408114429,0.0437187133108277,0,0,9.277634961439588,60.63118657379572,PRKCH;PRKCB;PRKCE;PRKCA;PRKCZ,Hypo
3962,GO_Molecular_Function_2018,clathrin adaptor activity (GO:0035615),5/10,0.0014514408114429,0.0437187133108277,0,0,9.277634961439588,60.63118657379572,HIP1;HIP1R;AP2S1;AP2A1;LDLRAP1,Hypo
3963,GO_Molecular_Function_2018,G-protein activated inward rectifier potassium channel activity (GO:0015467),5/10,0.0014514408114429,0.0437187133108277,0,0,9.277634961439588,60.63118657379572,KCNJ4;KCNJ6;KCNJ10;KCNJ12;KCNJ9,Hypo
3964,GO_Molecular_Function_2018,inositol trisphosphate phosphatase activity (GO:0046030),5/10,0.0014514408114429,0.0437187133108277,0,0,9.277634961439588,60.63118657379572,INPP4A;INPP5B;SYNJ1;INPP1;INPP5E,Hypo
3965,GO_Molecular_Function_2018,endocytic adaptor activity (GO:0098748),5/10,0.0014514408114429,0.0437187133108277,0,0,9.277634961439588,60.63118657379572,HIP1;HIP1R;AP2S1;AP2A1;LDLRAP1,Hypo
3966,GO_Molecular_Function_2018,spectrin binding (GO:0030507),7/19,0.001452104356706,0.0437187133108277,0,0,5.41542288557214,35.38838863873118,SPTBN4;SPTBN5;MYO10;USH1G;USH1C;ANK3;ANK1,Hypo
3967,GO_Molecular_Function_2018,ligand-gated cation channel activity (GO:0099094),14/60,0.0015678320795956,0.0455752566585907,0,0,2.830309019044197,18.278309581297894,KCNJ4;KCNK6;KCNJ6;KCNJ10;KCNJ11;KCNJ12;KCNJ9;GRIK5;GRIK4;GRIN2B;P2RX4;PTK2B;ASIC2;ASIC1,Hypo
3968,GO_Molecular_Function_2018,protein tyrosine kinase activity (GO:0004713),26/147,0.002012256878705,0.0556818705385381,0,0,2.0023453205271387,12.431557641813155,SRC;FLT4;MST1R;FGF1;CAMKK2;ABL1;ABL2;PTK2B;FYN;EPHB2;EPHB1;PDGFRA;TNK2;NTRK3;LMTK2;ERLIN2;NRG2;BAZ1B;EREG;BCR;CLK1;MELK;KIT;TYRO3;FGFR1OP;FGFR2,Hypo
3969,GO_Molecular_Function_2018,glutamate receptor binding (GO:0035254),7/20,0.0020476132701004,0.0556818705385381,0,0,4.998574765430144,30.94657837113109,NSF;HIP1;DLG3;CAMK2A;GNAS;SHANK3;SHANK2,Hypo
3970,GO_Molecular_Function_2018,microtubule binding (GO:0008017),32/195,0.0023508514264307,0.0613764405017323,0,0,1.830843734206772,11.08205630874874,NUMA1;RGS14;LRRK2;GOLGA2;KIF5C;KIF13A;KIF1C;KIF1B;KIF21B;MAP4;KIF3C;MAP9;CLASP1;CLASP2;DST;MAP1S;MTUS2;CFAP157;CCSAP;PEX14;DNM1;CLIP3;CLIP2;CLIP1;KIF26A;MAP1A;CCDC88C;TUBGCP6;MAPT;ARHGEF2;FGF13;MAPRE2,Hypo
3971,GO_Molecular_Function_2018,acylglycerol lipase activity (GO:0047372),5/11,0.0024480472370525,0.0613764405017323,0,0,7.730934018851757,46.481967255041226,DAGLA;ABHD16A;ABHD2;DAGLB;MGLL,Hypo
3972,GO_Molecular_Function_2018,cAMP-dependent protein kinase regulator activity (GO:0008603),4/7,0.0024754436264043,0.0613764405017323,0,0,12.365193559438165,74.20767700199245,PRKAR1B;PRKAR1A;PRKAG1;PRKAG2,Hypo
3973,GO_Molecular_Function_2018,syntaxin binding (GO:0019905),16/77,0.0027307035501441,0.0657170970180881,0,0,2.43972400698459,14.402168980377422,NSF;NAPA;ABCA1;TMED9;STXBP4;LRRK2;STX8;STXBP1;SYT13;SYT7;GOLGA2;SYT12;SNPH;VPS11;ABL1;LLGL1,Hypo
3974,GO_Molecular_Function_2018,inward rectifier potassium channel activity (GO:0005242),7/21,0.0028156106722884,0.0657170970180881,0,0,4.641276376737005,27.25624875055068,KCNJ4;KCNK6;KCNJ6;KCNJ10;KCNJ11;KCNJ12;KCNJ9,Hypo
3975,GO_Molecular_Function_2018,DNA polymerase binding (GO:0070182),6/16,0.0028843802961675,0.0657170970180881,0,0,5.567901234567901,32.56356527230561,RAD51;FANCD2;HMGB1;SMG5;SMARCA4;SMG6,Hypo
3976,GO_Molecular_Function_2018,phosphatidylinositol bisphosphate kinase activity (GO:0052813),15/71,0.0030894521074467,0.0675858250720002,0,0,2.490863787375415,14.396598658126678,PDGFRA;KL;SRC;PDGFA;IRS2;PTPN11;NRG2;PIK3R1;FGF1;PIK3R6;EREG;KIT;FYN;PIP5K1C;FGFR2,Hypo
3977,GO_Molecular_Function_2018,motor activity (GO:0003774),17/85,0.0031267463556441,0.0675858250720002,0,0,2.325659596482152,13.413851785264171,DYNC1I2;DNAH2;DNAH17;MYO10;KLC1;MYO1E;KIF5C;KIF26A;KIF13A;KIF1C;MYH9;PIN1;KIF1B;KIF21B;KIF3C;MYH10;BBS4,Hypo
3978,GO_Molecular_Function_2018,cAMP binding (GO:0030552),5/12,0.0038617595609397,0.0794015441432243,0,0,6.62614763128902,36.81906631416492,PDE10A;PDE2A;RAPGEF2;PDE4A;RAPGEF4,Hypo
3979,GO_Molecular_Function_2018,microtubule plus-end binding (GO:0051010),5/12,0.0038617595609397,0.0794015441432243,0,0,6.62614763128902,36.81906631416492,CLIP1;DST;NUMA1;CLASP1;CLASP2,Hypo
3980,GO_Molecular_Function_2018,"phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity (GO:0004439)",4/8,0.004569540394457,0.0875482398301649,0,0,9.273381294964029,49.96815593463664,INPP5B;SYNJ1;INPP5E;SYNJ2,Hypo
3981,GO_Molecular_Function_2018,GDP-dissociation inhibitor activity (GO:0005092),4/8,0.004569540394457,0.0875482398301649,0,0,9.273381294964029,49.96815593463664,GPSM1;RGS14;SH3BP4;ITGB1BP1,Hypo
3982,GO_Molecular_Function_2018,"phosphatidylinositol-4,5-bisphosphate phosphatase activity (GO:0106019)",4/8,0.004569540394457,0.0875482398301649,0,0,9.273381294964029,49.96815593463664,INPP5B;SYNJ1;INPP5E;SYNJ2,Hypo
3983,GO_Molecular_Function_2018,protein phosphatase regulator activity (GO:0019888),11/47,0.0047095600864166,0.0882257589522051,0,0,2.8387198441350066,15.210317320703814,PPP1R16B;RCAN1;PPP4R1;PPP2R2C;RCAN2;PPP1R1B;LMTK2;CALM3;PPP2R5C;CABIN1;PPP1R9B,Hypo
3984,GO_Molecular_Function_2018,ADP binding (GO:0043531),7/23,0.0049910635544099,0.0914666647036436,0,0,4.060666495110653,21.52196388928272,PRKAG1;MYO18A;PRKAG2;MYH9;COQ8A;MYH10;ABCG1,Hypo
3985,GO_Molecular_Function_2018,"phosphatidylinositol-4,5-bisphosphate 3-kinase activity (GO:0046934)",14/68,0.0053327814093535,0.0956496750656396,0,0,2.40993265993266,12.61330398100418,PDGFRA;KL;SRC;PDGFA;IRS2;PTPN11;NRG2;PIK3R1;FGF1;PIK3R6;EREG;KIT;FYN;FGFR2,Hypo
3986,GO_Molecular_Function_2018,hexose transmembrane transporter activity (GO:0015149),5/13,0.0057759823726574,0.0973830628030047,0,0,5.797557840616967,29.880885185415917,SLC2A13;SLC2A12;SLC2A1;SLC2A2;SLC2A5,Hypo
3987,GO_Molecular_Function_2018,ionotropic glutamate receptor binding (GO:0035255),5/13,0.0057759823726574,0.0973830628030047,0,0,5.797557840616967,29.880885185415917,NSF;DLG3;GNAS;SHANK3;SHANK2,Hypo
3988,GO_Molecular_Function_2018,phosphatidylinositol phosphate 5-phosphatase activity (GO:0034595),5/13,0.0057759823726574,0.0973830628030047,0,0,5.797557840616967,29.880885185415917,FIG4;INPP5B;SYNJ1;INPP5E;SYNJ2,Hypo
3989,GO_Molecular_Function_2018,phosphoprotein phosphatase activity (GO:0004721),23/136,0.0062226407247729,0.1028565908035991,0,0,1.894599795178897,9.623735056855171,PTPRT;CCDC155;DUSP5;MTMR3;PTPRS;CTDP1;EYA1;DUSP1;EYA2;CTDSPL;PPM1H;PDXP;PTPN11;PTPRF;PPM1F;SSH1;DUSP14;DUSP7;PPP4R1;PPP2R2C;SBF1;PTPN5;DLGAP5,Hypo
3990,GO_Molecular_Function_2018,calcium ion transmembrane transporter activity (GO:0015085),15/77,0.0068510606600241,0.1110662333923146,0,0,2.2490622655663914,11.207868484508548,RYR1;RYR2;PDE2A;CACNA1D;ATP2B1;PKD1;TRPC4AP;CACNA1E;PANX1;CACNB3;LOXHD1;CACNB4;ATP13A2;CACNG2;CACNG4,Hypo
3991,GO_Molecular_Function_2018,neuropilin binding (GO:0038191),6/19,0.0075729466565791,0.1143162548846505,0,0,4.282288698955366,20.911156693277977,SEMA4A;SEMA7A;SEMA4D;PXN;SEMA4C;ABL1,Hypo
3992,GO_Molecular_Function_2018,"RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding (GO:0001133)",6/19,0.0075729466565791,0.1143162548846505,0,0,4.282288698955366,20.911156693277977,RARG;THRA;RARA;RORA;NR1D1;PPARD,Hypo
3993,GO_Molecular_Function_2018,ATP transmembrane transporter activity (GO:0005347),4/9,0.0075939623648166,0.1143162548846505,0,0,7.4182939362795475,36.20425487995991,SLC25A17;SLC25A5;SLC25A23;SLC25A4,Hypo
3994,GO_Molecular_Function_2018,neurotrophin binding (GO:0043121),4/9,0.0075939623648166,0.1143162548846505,0,0,7.4182939362795475,36.20425487995991,SORT1;NTRK3;FURIN;HAP1,Hypo
3995,GO_Molecular_Function_2018,ligand-dependent nuclear receptor transcription coactivator activity (GO:0030374),13/65,0.0091210208824399,0.1325693207568432,0,0,2.3229220443985543,10.911167967766303,NCOA1;RARG;THRA;PRKCB;ACTN1;BUD31;RORA;NR1D1;MED16;MED24;ZMIZ2;RARA;PPARD,Hypo
3996,GO_Molecular_Function_2018,mitogen-activated protein kinase kinase binding (GO:0031434),13/65,0.0091210208824399,0.1325693207568432,0,0,2.3229220443985543,10.911167967766303,PDGFRA;FLT4;NTRK3;DAB2IP;LMTK2;MST1R;KIT;TYRO3;PIN1;EPHB2;TRIB1;EPHB1;FGFR2,Hypo
3997,GO_Molecular_Function_2018,glutamate receptor activity (GO:0008066),6/20,0.0099409523436163,0.1396703804278092,0,0,3.976190476190476,18.334581899180566,GRM2;GRID1;GRIK5;GRM8;GRIK4;GRM1,Hypo
3998,GO_Molecular_Function_2018,ligand-gated calcium channel activity (GO:0099604),6/20,0.0099409523436163,0.1396703804278092,0,0,3.976190476190476,18.334581899180566,RYR1;RYR2;P2RX4;RASA3;GRIN2B;RYR3,Hypo
3999,GO_Molecular_Function_2018,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",5/15,0.0114261414120394,0.1564098036333378,0,0,4.637532133676093,20.738354761240785,PDE10A;PDE2A;PDE4C;PDE4A;PDE8A,Hypo
4000,GO_Molecular_Function_2018,diacylglycerol kinase activity (GO:0004143),4/10,0.0116889888836302,0.1564098036333378,0,0,6.181569030489894,27.502468234562105,DGKG;DGKZ;DGKI;DGKH,Hypo
4001,GO_Molecular_Function_2018,ADP transmembrane transporter activity (GO:0015217),4/10,0.0116889888836302,0.1564098036333378,0,0,6.181569030489894,27.502468234562105,SLC25A17;SLC25A5;SLC25A23;SLC25A4,Hypo
4002,GO_Molecular_Function_2018,sialyltransferase activity (GO:0008373),6/21,0.0127910951158726,0.1660899916033138,0,0,3.710905349794239,16.1758588493424,ST6GAL1;ST8SIA1;ST3GAL6;ST6GALNAC3;ST3GAL2;ST3GAL3,Hypo
4003,GO_Molecular_Function_2018,calmodulin-dependent protein kinase activity (GO:0004683),7/27,0.0128064643584998,0.1660899916033138,0,0,3.247812660833762,14.15333492647131,CAMK2B;EEF2K;CAMK2A;MAPKAPK2;PTK2B;CAMK2G;CAMKK2,Hypo
4004,GO_Molecular_Function_2018,transmembrane receptor protein tyrosine kinase activity (GO:0004714),12/61,0.0136225493202243,0.1739971072265018,0,0,2.2747204144815822,9.772264460366983,PDGFRA;FLT4;NTRK3;KIT;TYRO3;CRIM1;LMTK2;MST1R;EPHB2;EPHB1;IGF2R;FGFR2,Hypo
4005,GO_Molecular_Function_2018,adenyl ribonucleotide binding (GO:0032559),39/279,0.0138486267663223,0.174244662149399,0,0,1.5144557823129252,6.481218323338868,RYR1;NIM1K;TWF2;PRKAG1;PRKAG2;ATP1A2;IDE;STK4;ABL1;MYO18A;PDE4A;MAP4K5;MYH10;PDK2;MARK2;MAP4K4;ABCA1;SRPK2;KCNJ11;PDE2A;LMTK2;PEX1;CDC42BPB;SYN3;CDC42BPA;SRPK1;RAD51;PDE10A;P2RX4;WNK2;SIK3;RAPGEF2;MYH9;COQ8A;ERCC6;CARS2;PFKM;ABCG1;RAPGEF4,Hypo
4006,GO_Molecular_Function_2018,phosphatidylinositol 3-kinase activity (GO:0035004),14/76,0.0143089252944728,0.1773885885770674,0,0,2.098040522527326,8.91010910928915,PDGFRA;KL;SRC;PDGFA;IRS2;PTPN11;NRG2;PIK3R1;FGF1;PIK3R6;EREG;KIT;FYN;FGFR2,Hypo
4007,GO_Molecular_Function_2018,histone methyltransferase activity (H3-K36 specific) (GO:0046975),3/6,0.01476319482203,0.1803677280430629,0,0,9.269131997945555,39.07511999036861,SMYD2;SETMAR;ASH1L,Hypo
4008,GO_Molecular_Function_2018,protein tyrosine phosphatase activity (GO:0004725),12/62,0.0154362316557715,0.1826924234982063,0,0,2.2291021671826625,9.297669461615728,PTPRT;PTPRE;PTPRB;PTPRS;MTMR3;EYA1;DUSP1;EYA2;PTPN11;PTPN5;PTPRF;DUSP7,Hypo
4009,GO_Molecular_Function_2018,histone-lysine N-methyltransferase activity (GO:0018024),9/41,0.0154772673381234,0.1826924234982063,0,0,2.6107998454404946,10.882813574516463,KMT2D;KMT2A;SETD1B;DOT1L;PRDM16;SMYD2;SETMAR;KMT5B;ASH1L,Hypo
4010,GO_Molecular_Function_2018,kinesin binding (GO:0019894),7/28,0.0156719723171551,0.1826924234982063,0,0,3.0929833590667357,12.85407190336615,ARHGEF10;SPTBN5;KLC2;CROCC;CLSTN1;KIF1B;MAPK8IP1,Hypo
4011,GO_Molecular_Function_2018,phospholipid transporter activity (GO:0005548),10/48,0.0158203403503784,0.1826924234982063,0,0,2.443298969072165,10.131038518532494,ABCA1;ATP8A2;ATP8A1;ATP8B2;PITPNM2;ATP11C;ATP11A;ATP9B;ATP9A;ABCG1,Hypo
4012,GO_Molecular_Function_2018,platelet-derived growth factor binding (GO:0048407),4/11,0.0169695399592344,0.1907376291417946,0,0,5.298194097782998,21.597215675599703,PDGFRA;COL5A1;COL4A1;PDGFA,Hypo
4013,GO_Molecular_Function_2018,calcium-dependent protein serine/threonine kinase activity (GO:0009931),4/11,0.0169695399592344,0.1907376291417946,0,0,5.298194097782998,21.597215675599703,PRKCB;MAPKAPK2;CAMK2A;PRKCA,Hypo
4014,GO_Molecular_Function_2018,MAP kinase kinase kinase activity (GO:0004709),14/78,0.0177664167809385,0.1938849651123895,0,0,2.0322507747933884,8.190875586614027,PDGFRA;FLT4;NTRK3;LMTK2;MST1R;STK4;KIT;TYRO3;EPHB2;EPHB1;MAP3K14;MAP3K4;MAP3K11;FGFR2,Hypo
4015,GO_Molecular_Function_2018,"ATPase activity, coupled to movement of substances (GO:0043492)",11/56,0.0179395341385129,0.1938849651123895,0,0,2.2698412698412698,9.126460632272108,ABCA1;ABCC4;ATP8A2;ATP8A1;ATP8B2;ATP11C;ABCB8;ATP11A;ATP9B;ABCG1;ATP9A,Hypo
4016,GO_Molecular_Function_2018,amino acid transmembrane transporter activity (GO:0015171),11/56,0.0179395341385129,0.1938849651123895,0,0,2.2698412698412698,9.126460632272108,SLC7A5;SLC6A19;SLC25A29;SLC6A18;SLC6A17;SLC7A8;SLC43A2;SLC38A10;SLC16A10;SLC7A1;SLC38A4,Hypo
4017,GO_Molecular_Function_2018,WW domain binding (GO:0050699),7/29,0.0189641807383663,0.2023646121828206,0,0,2.952229448369438,11.706189961022307,ENAH;TRAF4;TNK2;PMEPA1;RAPGEF2;WBP11;LITAF,Hypo
4018,GO_Molecular_Function_2018,phosphatase binding (GO:0019902),17/102,0.0194738377209622,0.2040267353753531,0,0,1.858768753233316,7.321101576242087,PPP1R26;SPTBN4;MTMR3;SMAD3;ANAPC7;ELL;FLT4;TSC2;NFATC2;PIK3R1;MAPK14;TRPC4AP;PPP1R3F;SH3RF2;DLG3;CRY2;PPP1R12B,Hypo
4019,GO_Molecular_Function_2018,carboxylic acid transmembrane transporter activity (GO:0046943),12/64,0.0196039923670268,0.2040267353753531,0,0,2.1431293165039293,8.42683170983435,SLC7A5;SLC6A19;SLC25A29;SLC6A18;SLC6A17;SLC7A8;SLC43A2;SLC38A10;SLC16A10;EMB;SLC7A1;SLC38A4,Hypo
4020,GO_Molecular_Function_2018,protein homodimerization activity (GO:0042803),81/664,0.0203602471342094,0.2093132723675435,0,0,1.298450754248931,5.056389206099411,TENM1;TENM2;HIP1;TENM4;LRRK2;FLT4;QPRT;BHLHE41;ABAT;SLC4A1;ECE1;ENO1;IDE;SPPL3;SYNE1;TRIM9;STK10;TRIM5;IMPA2;TBC1D22A;PDK2;BOK;SH3GLB1;TPD52;PDGFRA;ZHX2;PRMT8;ACOT7;ZBTB38;ACTN1;ACSL6;SETMAR;MTUS2;TSC2;HOGA1;FOXP3;CLIP1;ALDH5A1;DDIT3;KIT;MYH9;MAPT;CRYAB;DSCAML1;MGLL;ABCG1;CAMK2B;CTBP2;KMT2A;CAMK2A;PDGFA;HSD17B4;STK4;RASGRP1;RAP1GAP;PAPSS1;NACC2;PSAP;CDH22;FLNA;DROSHA;CAMK2G;RAB11FIP4;CADM3;SMAD3;CADM1;ZBTB16;PDE2A;DAB2IP;HPS4;HIP1R;GRHL1;S100B;P2RX4;NR6A1;BHLHE40;FGFR1OP;CRYL1;TCF4;MAP3K11;FGFR2,Hypo
4021,GO_Molecular_Function_2018,RNA polymerase II regulatory region DNA binding (GO:0001012),29/201,0.0208345645467715,0.2116088905172094,0,0,1.569137924772708,6.074355590076529,RARG;HLF;THRA;ZMYND8;RORA;ENO1;MNT;RXRA;CREB3L1;PLAGL1;TRPS1;CREB3L2;MXI1;E4F1;MEF2D;E2F6;SREBF1;H2AFY;ESX1;NR1D1;ETV5;GATAD2A;NR4A1;RBL1;TEF;NFX1;IRF2;RARA;PPARD,Hypo
4022,GO_Molecular_Function_2018,protein serine/threonine kinase inhibitor activity (GO:0030291),7/30,0.0227113685806427,0.2197209114961874,0,0,2.823715008167558,10.687449740961414,RPTOR;H2AFY;PRKAR1B;PRKAR1A;PPP1R1B;PRKAG2;PKIG,Hypo
4023,GO_Molecular_Function_2018,transcription corepressor binding (GO:0001222),4/12,0.0235234436525698,0.2197209114961874,0,0,4.635662898252827,17.382612892412695,PER2;PER1;RORA;NR1D1,Hypo
4024,GO_Molecular_Function_2018,SH3/SH2 adaptor activity (GO:0005070),10/51,0.0236962563886782,0.2197209114961874,0,0,2.2641438270052805,8.47341835210454,SHF;SHE;CNTNAP1;SRC;BLNK;PTPN11;SORBS1;ARHGAP6;TOB1;PAG1,Hypo
4025,GO_Molecular_Function_2018,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),3/7,0.0239790318596076,0.2197209114961874,0,0,6.951463790446842,25.932960526804987,DUSP5;DUSP1;DUSP7,Hypo
4026,GO_Molecular_Function_2018,cAMP response element binding (GO:0035497),3/7,0.0239790318596076,0.2197209114961874,0,0,6.951463790446842,25.932960526804987,CREB3L1;CREB3L2;E4F1,Hypo
4027,GO_Molecular_Function_2018,"inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity (GO:0052659)",3/7,0.0239790318596076,0.2197209114961874,0,0,6.951463790446842,25.932960526804987,INPP5B;SYNJ1;ITPK1,Hypo
4028,GO_Molecular_Function_2018,phosphofructokinase activity (GO:0008443),3/7,0.0239790318596076,0.2197209114961874,0,0,6.951463790446842,25.932960526804987,PFKFB3;PFKM;PFKP,Hypo
4029,GO_Molecular_Function_2018,"beta-galactoside (CMP) alpha-2,3-sialyltransferase activity (GO:0003836)",3/7,0.0239790318596076,0.2197209114961874,0,0,6.951463790446842,25.932960526804987,ST3GAL6;ST3GAL2;ST3GAL3,Hypo
4030,GO_Molecular_Function_2018,phosphatidylinositol phosphate 4-phosphatase activity (GO:0034596),3/7,0.0239790318596076,0.2197209114961874,0,0,6.951463790446842,25.932960526804987,INPP4A;SYNJ1;SYNJ2,Hypo
4031,GO_Molecular_Function_2018,lysine-acetylated histone binding (GO:0070577),5/18,0.0254978114206907,0.2286665428472581,0,0,3.566739173422978,13.086946182884311,BRD3;KMT2A;ZMYND8;SMARCA4;BRD4,Hypo
4032,GO_Molecular_Function_2018,acetylation-dependent protein binding (GO:0140033),5/18,0.0254978114206907,0.2286665428472581,0,0,3.566739173422978,13.086946182884311,BRD3;KMT2A;ZMYND8;SMARCA4;BRD4,Hypo
4033,GO_Molecular_Function_2018,cation channel activity (GO:0005261),22/146,0.0260927454570169,0.2315387833712134,0,0,1.649595101057422,6.014585324754126,RYR1;KCNK6;RYR2;KCNK13;PDE2A;CACNA1D;CACNA1C;TRPC4AP;CACNA1E;PKD1;TPCN1;PANX1;CACNA1I;CACNB3;LOXHD1;KCNU1;CACNB4;CALHM2;P2RX4;CACNG2;CACNG4;KCNK3,Hypo
4034,GO_Molecular_Function_2018,transcription regulatory region sequence-specific DNA binding (GO:0000976),39/292,0.0269322108490948,0.2341247630136257,0,0,1.4355892554650318,5.188840144893494,RARG;KDM3A;HLF;KMT2A;THRA;ZMYND8;RORA;ENO1;CHD2;MNT;RXRA;CREB3L1;PLAGL1;TRPS1;CREB3L2;MXI1;TNRC18;E4F1;TEAD1;MEF2D;BAHCC1;E2F6;SREBF1;SMAD3;H2AFY;ESX1;NR1D1;ETV5;GATAD2A;PER2;PER1;NR4A1;TEF;NFX1;DDIT3;IRF2;CRY2;RARA;PPARD,Hypo
4035,GO_Molecular_Function_2018,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors (GO:0016706)",7/31,0.0269396227904171,0.2341247630136257,0,0,2.705910104649168,9.779584243572046,FTO;EGLN1;KDM4A;KDM4B;TET3;TET1;P4HTM,Hypo
4036,GO_Molecular_Function_2018,microtubule motor activity (GO:0003777),11/60,0.0289097386651603,0.2486827519870429,0,0,2.0840850006841314,7.385115179696791,DYNC1I2;DNAH2;DNAH17;KIF5C;KIF26A;KIF13A;KIF1C;KIF1B;KIF21B;KIF3C;BBS4,Hypo
4037,GO_Molecular_Function_2018,protein kinase A catalytic subunit binding (GO:0034236),4/13,0.0314112178837128,0.264796566759699,0,0,4.120360854173804,14.258880361210256,RYR2;PRKAR1B;PRKAR1A;KCNQ1,Hypo
4038,GO_Molecular_Function_2018,guanylate kinase activity (GO:0004385),4/13,0.0314112178837128,0.264796566759699,0,0,4.120360854173804,14.258880361210256,MPP3;DLG3;CARD11;TJP2,Hypo
4039,GO_Molecular_Function_2018,R-SMAD binding (GO:0070412),5/19,0.0318995583422903,0.2662507691341657,0,0,3.311788468600808,11.40965147457454,SMAD3;SMURF1;PMEPA1;DROSHA;LDLRAD4,Hypo
4040,GO_Molecular_Function_2018,protein phosphatase binding (GO:0019903),15/92,0.0322780172317085,0.2667683188855912,0,0,1.8094231350045304,6.212417049030502,MTMR3;ANAPC7;FLT4;DAB2IP;PIK3R1;MAPK14;SMG5;STRN4;PPP1R9B;CTTNBP2NL;SLC9A1;PPP1R3F;SH3RF2;KCNQ1;MAPT,Hypo
4041,GO_Molecular_Function_2018,voltage-gated potassium channel activity (GO:0005249),14/85,0.034963944443458,0.2828727481853099,0,0,1.831175066930509,6.140731884217902,KCNJ4;KCNK6;KCNJ6;KCNJ10;KCNH6;KCNJ11;KCND3;KCNJ12;KCNJ9;KCNA6;KCNU1;KCNQ1;KCNQ2;KCNH1,Hypo
4042,GO_Molecular_Function_2018,protein-lysine N-methyltransferase activity (GO:0016279),9/47,0.0356131045773531,0.2828727481853099,0,0,2.1978361669242656,7.329875052727957,SETD4;KMT2D;KMT2A;SETD1B;DOT1L;PRDM16;SMYD2;KMT5B;ASH1L,Hypo
4043,GO_Molecular_Function_2018,tau protein binding (GO:0048156),3/8,0.0356247497586754,0.2828727481853099,0,0,5.560862865947612,18.543890947660675,BIN1;FYN;S100B,Hypo
4044,GO_Molecular_Function_2018,cAMP response element binding protein binding (GO:0008140),3/8,0.0356247497586754,0.2828727481853099,0,0,5.560862865947612,18.543890947660675,CRTC3;CRTC1;DDIT3,Hypo
4045,GO_Molecular_Function_2018,PDZ domain binding (GO:0030165),11/62,0.0359043701729871,0.2828727481853099,0,0,2.0021337054677466,6.660891134855661,NSF;KCNJ4;PLEKHA1;CADM1;ARHGEF16;CCDC88C;CRIM1;RAPGEF2;PDZK1;ATP2B1;CIT,Hypo
4046,GO_Molecular_Function_2018,tubulin binding (GO:0015631),34/255,0.0375745575714307,0.2900149473756122,0,0,1.4315882447406456,4.697653919630819,NUMA1;RGS14;LRRK2;GOLGA2;KIF5C;KIF13A;KIF1C;KIF1B;KIF21B;MAP4;KIF3C;MAP9;BBS4;CCT5;CLASP1;RAB11FIP5;CLASP2;MAP1S;MTUS2;CFAP157;CCSAP;PEX14;DNM1;CLIP3;CLIP2;CLIP1;KIF26A;MAP1A;CCDC88C;TUBGCP6;MAPT;ARHGEF2;FGF13;MAPRE2,Hypo
4047,GO_Molecular_Function_2018,SH3 domain binding (GO:0017124),10/55,0.0381338989295434,0.2900149473756122,0,0,2.0624284077892323,6.737235175224907,CNTNAP1;AFAP1L2;LANCL1;ELMO1;ABL1;DAB2IP;MAPT;ESPN;SHANK3;REPS1,Hypo
4048,GO_Molecular_Function_2018,protein kinase activator activity (GO:0030295),10/55,0.0381338989295434,0.2900149473756122,0,0,2.0624284077892323,6.737235175224907,RPTOR;AFAP1L2;MADD;PRKAG2;CALM3;FAM20A;ERCC6;STK4;FGF13;MARK2,Hypo
4049,GO_Molecular_Function_2018,magnesium ion binding (GO:0000287),19/127,0.0391180110639021,0.2900149473756122,0,0,1.634626081285843,5.298104737978451,SRPK2;NIM1K;CERK;EYA2;IDH2;PDXP;CDC42BPB;STK4;CDC42BPA;NUDT3;CLYBL;SRPK1;RRAGC;SIK3;ABL1;ABL2;XXYLT1;MARK2;FAN1,Hypo
4050,GO_Molecular_Function_2018,protein phosphatase 2A binding (GO:0051721),5/20,0.0392191032038194,0.2900149473756122,0,0,3.0908311910882604,10.009939080219082,DAB2IP;MAPT;SMG5;STRN4;CTTNBP2NL,Hypo
4051,GO_Molecular_Function_2018,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",5/20,0.0392191032038194,0.2900149473756122,0,0,3.0908311910882604,10.009939080219082,PDE10A;PDE2A;PDE4C;PDE4A;PDE8A,Hypo
4052,GO_Molecular_Function_2018,glucose transmembrane transporter activity (GO:0005355),5/20,0.0392191032038194,0.2900149473756122,0,0,3.0908311910882604,10.009939080219082,SLC2A13;SLC2A12;SLC2A1;SLC2A2;SLC2A5,Hypo
4053,GO_Molecular_Function_2018,ATP-dependent microtubule motor activity (GO:1990939),9/48,0.0401806697799853,0.292002626073514,0,0,2.141362501486149,6.883129778409804,DYNC1I2;DYNC1H1;DNAH2;DNAH17;KIF5C;KIF1C;KIF1B;WDR78;DYNLL2,Hypo
4054,GO_Molecular_Function_2018,histone methyltransferase activity (GO:0042054),9/48,0.0401806697799853,0.292002626073514,0,0,2.141362501486149,6.883129778409804,KMT2D;PRMT8;KMT2A;SETD1B;DOT1L;PRDM16;SMYD2;KMT5B;ASH1L,Hypo
4055,GO_Molecular_Function_2018,Rac guanyl-nucleotide exchange factor activity (GO:0030676),4/14,0.040666956770098,0.2930106372409631,0,0,3.7081192189105856,11.874656234757868,TIAM1;PREX1;ARHGEF2;DOCK2,Hypo
4056,GO_Molecular_Function_2018,protein phosphorylated amino acid binding (GO:0045309),7/34,0.0427321787344198,0.3027161905303857,0,0,2.40485312899106,7.58202826118495,ABL1;ABL2;PIN1;PIK3R1;LDLRAP1;PTPN5;VAV2,Hypo
4057,GO_Molecular_Function_2018,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),7/34,0.0427321787344198,0.3027161905303857,0,0,2.40485312899106,7.58202826118495,DUSP5;CCDC155;DUSP1;SBF1;DUSP14;SSH1;DUSP7,Hypo
4058,GO_Molecular_Function_2018,sequence-specific double-stranded DNA binding (GO:1990837),17/112,0.0436285086328248,0.3064902731455945,0,0,1.66218313502328,5.206031503790007,RARG;KDM3A;KMT2A;THRA;H2AFY;RORA;NR1D1;PER2;PER1;DDIT3;CRY2;RARA;TNRC18;MAPT;BAHCC1;MEF2D;PPARD,Hypo
4059,GO_Molecular_Function_2018,Rho GTPase binding (GO:0017048),12/72,0.0448432788317051,0.3124205293812187,0,0,1.8565531475748196,5.763820668108697,ARHGAP44;RTKN;LRRK2;ARHGEF16;KCTD13;CDC42EP1;FLNA;PAK6;MTSS1L;ARHGAP17;ARHGEF2;PAK4,Hypo
4060,GO_Molecular_Function_2018,cyclic nucleotide binding (GO:0030551),5/21,0.0474778651458389,0.3218973786179196,0,0,2.8974935732647813,8.83008753849075,PDE10A;PDE2A;RAPGEF2;PDE4A;RAPGEF4,Hypo
4061,GO_Molecular_Function_2018,manganese ion binding (GO:0030145),7/35,0.0490911853905116,0.3218973786179196,0,0,2.318836850231601,6.989149997127673,B4GALT1;GALNT2;ABL1;ABL2;ATP13A2;XXYLT1;PCK2,Hypo
4062,GO_Molecular_Function_2018,RNA 7-methylguanosine cap binding (GO:0000340),3/9,0.0496401651486708,0.3218973786179196,0,0,4.633795582948125,13.91507957644256,CYFIP2;AGO2;DCPS,Hypo
4063,GO_Molecular_Function_2018,GABA receptor binding (GO:0050811),3/9,0.0496401651486708,0.3218973786179196,0,0,4.633795582948125,13.91507957644256,ARFGEF2;JAKMIP1;TRAK1,Hypo
4064,GO_Molecular_Function_2018,actin-dependent ATPase activity (GO:0030898),3/9,0.0496401651486708,0.3218973786179196,0,0,4.633795582948125,13.91507957644256,MYO10;MYH9;MYH10,Hypo
4065,GO_Molecular_Function_2018,D-glucose transmembrane transporter activity (GO:0055056),3/9,0.0496401651486708,0.3218973786179196,0,0,4.633795582948125,13.91507957644256,SLC2A12;SLC2A1;SLC2A2,Hypo
4066,GO_Molecular_Function_2018,inositol tetrakisphosphate phosphatase activity (GO:0052743),3/9,0.0496401651486708,0.3218973786179196,0,0,4.633795582948125,13.91507957644256,INPP5B;SYNJ1;ITPK1,Hypo
4067,GO_Molecular_Function_2018,MAP kinase phosphatase activity (GO:0033549),3/9,0.0496401651486708,0.3218973786179196,0,0,4.633795582948125,13.91507957644256,DUSP5;DUSP1;DUSP7,Hypo
4068,GO_Molecular_Function_2018,UDP-xylosyltransferase activity (GO:0035252),3/9,0.0496401651486708,0.3218973786179196,0,0,4.633795582948125,13.91507957644256,XYLT2;XYLT1;XXYLT1,Hypo
4069,GO_Molecular_Function_2018,intracellular ligand-gated ion channel activity (GO:0005217),4/15,0.0512999936646151,0.3227305571587356,0,0,3.3708306082406803,10.011584831692312,RYR1;RYR2;RASA3;RYR3,Hypo
4070,GO_Molecular_Function_2018,lipoprotein particle receptor activity (GO:0030228),4/15,0.0512999936646151,0.3227305571587356,0,0,3.3708306082406803,10.011584831692312,SCARB1;LRP1;SORL1;LDLR,Hypo
4071,GO_Molecular_Function_2018,syntaxin-1 binding (GO:0017075),4/15,0.0512999936646151,0.3227305571587356,0,0,3.3708306082406803,10.011584831692312,NSF;SNPH;STXBP1;LRRK2,Hypo
4072,GO_Molecular_Function_2018,"phosphatidylinositol-3,5-bisphosphate phosphatase activity (GO:0106018)",4/15,0.0512999936646151,0.3227305571587356,0,0,3.3708306082406803,10.011584831692312,FIG4;MTMR3;SYNJ1;SYNJ2,Hypo
4073,GO_Molecular_Function_2018,non-membrane spanning protein tyrosine kinase activity (GO:0004715),8/43,0.0534950723591033,0.3340470073979564,0,0,2.1203472120052966,6.208728051986669,CLK1;MELK;SRC;TNK2;ABL1;ABL2;PTK2B;FYN,Hypo
4074,GO_Molecular_Function_2018,ATP binding (GO:0005524),33/255,0.0565767909412181,0.3488092878726824,0,0,1.382424678199326,3.970539931121626,RYR1;NIM1K;TWF2;PRKAG1;PRKAG2;ATP1A2;IDE;STK4;ABL1;MYO18A;MAP4K5;MYH10;PDK2;MARK2;MAP4K4;ABCA1;SRPK2;KCNJ11;LMTK2;PEX1;CDC42BPB;SYN3;CDC42BPA;SRPK1;RAD51;P2RX4;WNK2;SIK3;MYH9;ERCC6;CARS2;PFKM;ABCG1,Hypo
4075,GO_Molecular_Function_2018,NAD binding (GO:0051287),5/22,0.0566866814217763,0.3488092878726824,0,0,2.7269015575381825,7.826796457420239,ALDH5A1;BDH2;ALDH2;RNLS;CRYL1,Hypo
4076,GO_Molecular_Function_2018,phosphotyrosine residue binding (GO:0001784),6/29,0.0574596714803828,0.3510036453475558,0,0,2.4190821256038646,6.910524035563994,ABL1;ABL2;PIK3R1;LDLRAP1;PTPN5;VAV2,Hypo
4077,GO_Molecular_Function_2018,"transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding (GO:0001227)",22/159,0.0589293476394679,0.357391655108428,0,0,1.491981403519399,4.224420092652712,TSHZ3;TSHZ1;ZBTB16;ESX1;BHLHE41;ENO1;NR1D1;FOXO3;MNT;RBL1;SP2;NFX1;NACC2;TRPS1;BHLHE40;MXI1;ERF;HIVEP1;E4F1;MAFK;E2F6;PPARD,Hypo
4078,GO_Molecular_Function_2018,transcription corepressor activity (GO:0003714),27/203,0.0599853206214929,0.3586356403114793,0,0,1.425914763863282,4.01203277956385,RERE;CTBP2;ZMYND8;BHLHE41;LIMD1;TOB2;TOB1;SOX3;MNT;MXI1;E4F1;LMCD1;E2F6;ZHX2;KCNIP3;PAWR;DDX54;NR1D1;CBFA2T3;CDYL2;PEX14;SMARCA4;NCOR2;DDIT3;BHLHE40;RARA;ERF,Hypo
4079,GO_Molecular_Function_2018,ATPase activity (GO:0016887),27/203,0.0599853206214929,0.3586356403114793,0,0,1.425914763863282,4.01203277956385,DYNC1I2;DNAH2;FIGN;ATP1A2;KIF5C;KIF13A;KIF1C;KIF1B;KIF21B;KIF3C;MYH10;ABCA1;NSF;DYNC1H1;TOR3A;DNAH17;PEX1;WDR78;DYNLL2;MYO19;MYO1E;KATNAL1;NLRP10;KIF26A;MYH9;ACIN1;ATP13A2,Hypo
4080,GO_Molecular_Function_2018,ionotropic glutamate receptor activity (GO:0004970),4/16,0.0632970811540337,0.3728717703216933,0,0,3.0897567660157588,8.527469326836092,GRIK5;GRIK4;PTK2B;GRIN2B,Hypo
4081,GO_Molecular_Function_2018,histone methyltransferase activity (H3-K4 specific) (GO:0042800),4/16,0.0632970811540337,0.3728717703216933,0,0,3.0897567660157588,8.527469326836092,KMT2D;KMT2A;SETD1B;SETMAR,Hypo
4082,GO_Molecular_Function_2018,death receptor binding (GO:0005123),3/10,0.0659049748255424,0.3728717703216933,0,0,3.9716046665199207,10.800943115654707,TMBIM1;MADD;DAB2IP,Hypo
4083,GO_Molecular_Function_2018,adenylate cyclase binding (GO:0008179),3/10,0.0659049748255424,0.3728717703216933,0,0,3.9716046665199207,10.800943115654707,AKAP6;CALM3;CAP2,Hypo
4084,GO_Molecular_Function_2018,vinculin binding (GO:0017166),3/10,0.0659049748255424,0.3728717703216933,0,0,3.9716046665199207,10.800943115654707,ACTN1;PXN;RTCB,Hypo
4085,GO_Molecular_Function_2018,cyclic-nucleotide phosphodiesterase activity (GO:0004112),3/10,0.0659049748255424,0.3728717703216933,0,0,3.9716046665199207,10.800943115654707,PDE10A;PDE2A;PDE8A,Hypo
4086,GO_Molecular_Function_2018,I-SMAD binding (GO:0070411),3/10,0.0659049748255424,0.3728717703216933,0,0,3.9716046665199207,10.800943115654707,SMURF1;TGFB1I1;SMAD7,Hypo
4087,GO_Molecular_Function_2018,mitogen-activated protein kinase kinase kinase binding (GO:0031435),3/10,0.0659049748255424,0.3728717703216933,0,0,3.9716046665199207,10.800943115654707,DAB2IP;MAP3K11;SASH1,Hypo
4088,GO_Molecular_Function_2018,endoribonuclease activity (GO:0004521),5/23,0.0668461292412567,0.3731873307972148,0,0,2.57526421022565,6.967021623369182,RNASEL;NOB1;ZC3H3;AGO2;SMG6,Hypo
4089,GO_Molecular_Function_2018,calcium-release channel activity (GO:0015278),5/23,0.0668461292412567,0.3731873307972148,0,0,2.57526421022565,6.967021623369182,RYR1;RYR2;RASA3;RYR3;TPCN1,Hypo
4090,GO_Molecular_Function_2018,peptidyl-prolyl cis-trans isomerase activity (GO:0003755),7/38,0.0716080799120771,0.3971421800386908,0,0,2.094084637989142,5.5211533311279615,FKBP8;PIN1;CWC27;PPIB;FKBP6;NKTR;FKBP5,Hypo
4091,GO_Molecular_Function_2018,ubiquitin-protein transferase activity (GO:0004842),50/417,0.073103483572382,0.4027858604674385,0,0,1.2679621396816292,3.3168358617221103,UBE2D1;RNF19B;KLHDC7A;UBE3B;FBXO21;TMEM189;TRIM9;RNF114;TRIM5;FBXO3;BTRC;UNKL;AREL1;ZER1;NHLRC3;FBXW8;AKTIP;UBE2QL1;FBXO10;RNF41;PJA1;TRAF7;RNF144B;GAN;KCTD13;BIRC6;RBCK1;PDZRN4;RNF121;MGRN1;PELI2;UBR4;NEDD4L;UBR2;DTX4;FBXO44;FBXO41;RMND5B;PDZD4;HLTF;RFFL;SMURF1;FBXL18;KLHL2;KLHL3;FBXL16;FBXO31;SPSB1;UBE2O;ASB2,Hypo
4092,GO_Molecular_Function_2018,myosin binding (GO:0017022),8/46,0.0745544573429056,0.4081130359744771,0,0,1.952626158599382,5.069457726471593,MLPH;MOBP;LMTK2;HAP1;TRAK1;RAB6B;USH2A;STX1A,Hypo
4093,GO_Molecular_Function_2018,"ATP-dependent microtubule motor activity, plus-end-directed (GO:0008574)",6/31,0.0755564722000848,0.4109297165462676,0,0,2.2253086419753085,5.747693894329304,DYNC1I2;KIF5C;KIF1C;KIF1B;WDR78;DYNLL2,Hypo
4094,GO_Molecular_Function_2018,transmembrane receptor protein kinase activity (GO:0019199),10/62,0.0760756185083226,0.4111009384776664,0,0,1.784099920697859,4.595890374591429,PDGFRA;FLT4;NTRK3;KIT;TYRO3;LMTK2;MST1R;EPHB2;EPHB1;FGFR2,Hypo
4095,GO_Molecular_Function_2018,antiporter activity (GO:0015297),4/17,0.0766248843928964,0.4114317040968896,0,0,2.8519250533639022,7.326120312742382,SLC7A5;CLCN6;CLCN5;SLC7A8,Hypo
4096,GO_Molecular_Function_2018,kinase activator activity (GO:0019209),5/24,0.0779470268020286,0.4158819214817095,0,0,2.4395886889460154,6.225161463812914,RPTOR;MADD;PRKAG2;FGF13;MARK2,Hypo
4097,GO_Molecular_Function_2018,receptor tyrosine kinase binding (GO:0030971),7/39,0.0802744112306399,0.4256058406756571,0,0,2.028531909418425,5.116574906785523,SHC2;ARHGEF16;PITPNM2;LRP4;ELMO2;TOB1;RNF41,Hypo
4098,GO_Molecular_Function_2018,protein phosphatase 1 binding (GO:0008157),3/11,0.0842557805693756,0.4330952623169735,0,0,3.4749614791987677,8.596700600976762,SH3RF2;KCNQ1;PPP1R9B,Hypo
4099,GO_Molecular_Function_2018,potassium:proton antiporter activity (GO:0015386),3/11,0.0842557805693756,0.4330952623169735,0,0,3.4749614791987677,8.596700600976762,SLC9A6;SLC9A8;SLC9A1,Hypo
4100,GO_Molecular_Function_2018,dynactin binding (GO:0034452),3/11,0.0842557805693756,0.4330952623169735,0,0,3.4749614791987677,8.596700600976762,SPTBN5;MAPT;BBS4,Hypo
4101,GO_Molecular_Function_2018,MAP kinase kinase kinase kinase activity (GO:0008349),3/11,0.0842557805693756,0.4330952623169735,0,0,3.4749614791987677,8.596700600976762,STK24;MAP4K5;MAP4K4,Hypo
4102,GO_Molecular_Function_2018,nitric-oxide synthase binding (GO:0050998),3/11,0.0842557805693756,0.4330952623169735,0,0,3.4749614791987677,8.596700600976762,NOS1AP;DNM1;SNTA1,Hypo
4103,GO_Molecular_Function_2018,transcription cofactor binding (GO:0001221),5/25,0.0899710757530414,0.4497608613332933,0,0,2.3174807197943443,5.581112435233727,PER2;PER1;RORA;NR1D1;TEAD1,Hypo
4104,GO_Molecular_Function_2018,actin monomer binding (GO:0003785),5/25,0.0899710757530414,0.4497608613332933,0,0,2.3174807197943443,5.581112435233727,COBLL1;PRKCE;TWF2;ABL1;ABL2,Hypo
4105,GO_Molecular_Function_2018,epidermal growth factor receptor binding (GO:0005154),5/25,0.0899710757530414,0.4497608613332933,0,0,2.3174807197943443,5.581112435233727,ATXN2;HIP1;TNK2;TGFA;EREG,Hypo
4106,GO_Molecular_Function_2018,protein kinase A regulatory subunit binding (GO:0034237),4/18,0.0912326302348673,0.4497608613332933,0,0,2.648069299662311,6.340385286129587,ARFGEF2;RYR2;KCNQ1;AKAP6,Hypo
4107,GO_Molecular_Function_2018,semaphorin receptor binding (GO:0030215),4/18,0.0912326302348673,0.4497608613332933,0,0,2.648069299662311,6.340385286129587,SEMA4A;SEMA7A;SEMA4D;SEMA4C,Hypo
4108,GO_Molecular_Function_2018,phosphatase inhibitor activity (GO:0019212),4/18,0.0912326302348673,0.4497608613332933,0,0,2.648069299662311,6.340385286129587,PPP1R1B;LMTK2;CABIN1;PPP1R9B,Hypo
4109,GO_Molecular_Function_2018,microfilament motor activity (GO:0000146),4/18,0.0912326302348673,0.4497608613332933,0,0,2.648069299662311,6.340385286129587,MYO1E;MYO10;MYH9;MYH10,Hypo
4110,GO_Molecular_Function_2018,protein kinase regulator activity (GO:0019887),15/107,0.0961451227730145,0.4563615338928204,0,0,1.51314459049545,3.5436280710499224,CDKN1C;LRRC4;PRKAG1;PRKAG2;RTN4RL2;MAPK8IP1;RPTOR;CNKSR2;PRKAR1B;PRKAR1A;MADD;PPP1R1B;TRIB1;FGF13;MARK2,Hypo
4111,GO_Molecular_Function_2018,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),6/33,0.0965174996761127,0.4563615338928204,0,0,2.0602423411065387,4.816910344171122,CCNB2;CDK18;CDKL4;CDK5;CDK14;CDK16,Hypo
4112,GO_Molecular_Function_2018,tumor necrosis factor receptor superfamily binding (GO:0032813),5/26,0.1028916104005052,0.4563615338928204,0,0,2.2070020810380706,5.018897462942009,BABAM2;TRAF4;MADD;TMBIM1;DAB2IP,Hypo
4113,GO_Molecular_Function_2018,RNA polymerase II basal transcription factor binding (GO:0001091),3/12,0.1044999081723734,0.4563615338928204,0,0,3.088683444615648,6.976004945409247,CTDP1;TCF4;GTF2E1,Hypo
4114,GO_Molecular_Function_2018,metalloendopeptidase inhibitor activity (GO:0008191),3/12,0.1044999081723734,0.4563615338928204,0,0,3.088683444615648,6.976004945409247,TIMP2;TIMP3;SPOCK1,Hypo
4115,GO_Molecular_Function_2018,"phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity (GO:0052629)",3/12,0.1044999081723734,0.4563615338928204,0,0,3.088683444615648,6.976004945409247,MTMR3;SYNJ1;SYNJ2,Hypo
4116,GO_Molecular_Function_2018,basic amino acid transmembrane transporter activity (GO:0015174),3/12,0.1044999081723734,0.4563615338928204,0,0,3.088683444615648,6.976004945409247,SLC25A29;SLC7A1;SLC15A4,Hypo
4117,GO_Molecular_Function_2018,protein kinase binding (GO:0019901),57/495,0.1049773648126529,0.4563615338928204,0,0,1.2107620722344037,2.72907045442216,RYR2;FLT4;PRKAG1;PRKAG2;AP2A1;PKD1;GOLGA2;RPTOR;TRIM5;EPHB2;EPHB1;CEP68;NSF;PDGFRA;H2AFY;PRKCB;LMTK2;SRCIN1;DNM1;PRKAR1B;PRKAR1A;KCNQ1;MAPKAPK2;RHOJ;KIT;DOK7;TYRO3;RARA;PRKD2;MAPT;TRIB1;ARHGEF7;LLGL1;HDAC5;SHC2;CTBP2;TWF2;MST1R;FOXO3;HDAC7;DVL1;ABL1;TBC1D14;RFFL;BCL2L14;SASH1;SMAD3;NTRK3;DAB2IP;TNIP1;PIN1;FGFR1OP;CSPG4;CALM3;MAP3K11;BCAR1;FGFR2,Hypo
4118,GO_Molecular_Function_2018,leak channel activity (GO:0022840),4/19,0.1070547923493893,0.4563615338928204,0,0,2.471394313120932,5.522119282414287,PANX1;KCNK6;KCNK13;KCNK3,Hypo
4119,GO_Molecular_Function_2018,ephrin receptor binding (GO:0046875),4/19,0.1070547923493893,0.4563615338928204,0,0,2.471394313120932,5.522119282414287,SRC;ABL1;FYN;ANKS1B,Hypo
4120,GO_Molecular_Function_2018,insulin receptor binding (GO:0005158),4/19,0.1070547923493893,0.4563615338928204,0,0,2.471394313120932,5.522119282414287,IRS2;PTPN11;SORBS1;PIK3R1,Hypo
4121,GO_Molecular_Function_2018,cyclin-dependent protein kinase activity (GO:0097472),6/34,0.10804293104658,0.4563615338928204,0,0,1.9865520282186948,4.420528457498535,CCNB2;CDK18;CDKL4;CDK5;CDK14;CDK16,Hypo
4122,GO_Molecular_Function_2018,alpha-sialidase activity (GO:0016997),2/6,0.1093535348118027,0.4563615338928204,0,0,4.631930184804928,10.251245252658242,NEU4;NEU1,Hypo
4123,GO_Molecular_Function_2018,nerve growth factor binding (GO:0048406),2/6,0.1093535348118027,0.4563615338928204,0,0,4.631930184804928,10.251245252658242,SORT1;FURIN,Hypo
4124,GO_Molecular_Function_2018,ubiquitin-dependent protein binding (GO:0140036),2/6,0.1093535348118027,0.4563615338928204,0,0,4.631930184804928,10.251245252658242,IDE;FAN1,Hypo
4125,GO_Molecular_Function_2018,palmitoyl-CoA hydrolase activity (GO:0016290),2/6,0.1093535348118027,0.4563615338928204,0,0,4.631930184804928,10.251245252658242,GNPAT;ACOT7,Hypo
4126,GO_Molecular_Function_2018,calcium:sodium antiporter activity (GO:0005432),2/6,0.1093535348118027,0.4563615338928204,0,0,4.631930184804928,10.251245252658242,SLC8A3;SLC8A2,Hypo
4127,GO_Molecular_Function_2018,ADP-ribosylation factor binding (GO:0030306),2/6,0.1093535348118027,0.4563615338928204,0,0,4.631930184804928,10.251245252658242,SORL1;RAB11FIP4,Hypo
4128,GO_Molecular_Function_2018,clathrin heavy chain binding (GO:0032050),2/6,0.1093535348118027,0.4563615338928204,0,0,4.631930184804928,10.251245252658242,LRP1;LDLR,Hypo
4129,GO_Molecular_Function_2018,1-phosphatidylinositol-4-phosphate 5-kinase activity (GO:0016308),2/6,0.1093535348118027,0.4563615338928204,0,0,4.631930184804928,10.251245252658242,PIP4K2A;PIP5K1C,Hypo
4130,GO_Molecular_Function_2018,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),2/6,0.1093535348118027,0.4563615338928204,0,0,4.631930184804928,10.251245252658242,PIK3R1;PIK3R6,Hypo
4131,GO_Molecular_Function_2018,exo-alpha-sialidase activity (GO:0004308),2/6,0.1093535348118027,0.4563615338928204,0,0,4.631930184804928,10.251245252658242,NEU4;NEU1,Hypo
4132,GO_Molecular_Function_2018,"coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway (GO:1904929)",2/6,0.1093535348118027,0.4563615338928204,0,0,4.631930184804928,10.251245252658242,GPC4;GPC6,Hypo
4133,GO_Molecular_Function_2018,rRNA (guanine) methyltransferase activity (GO:0016435),2/6,0.1093535348118027,0.4563615338928204,0,0,4.631930184804928,10.251245252658242,BUD23;TARBP1,Hypo
4134,GO_Molecular_Function_2018,sodium channel inhibitor activity (GO:0019871),2/6,0.1093535348118027,0.4563615338928204,0,0,4.631930184804928,10.251245252658242,NEDD4L;SCN1B,Hypo
4135,GO_Molecular_Function_2018,phosphatidylinositol phosphate phosphatase activity (GO:0052866),2/6,0.1093535348118027,0.4563615338928204,0,0,4.631930184804928,10.251245252658242,SYNJ1;SYNJ2,Hypo
4136,GO_Molecular_Function_2018,inositol trisphosphate kinase activity (GO:0051766),2/6,0.1093535348118027,0.4563615338928204,0,0,4.631930184804928,10.251245252658242,ITPKB;ITPK1,Hypo
4137,GO_Molecular_Function_2018,purine nucleobase transmembrane transporter activity (GO:0005345),2/6,0.1093535348118027,0.4563615338928204,0,0,4.631930184804928,10.251245252658242,SLC25A5;SLC25A4,Hypo
4138,GO_Molecular_Function_2018,arginine transmembrane transporter activity (GO:0015181),2/6,0.1093535348118027,0.4563615338928204,0,0,4.631930184804928,10.251245252658242,SLC25A29;SLC7A1,Hypo
4139,GO_Molecular_Function_2018,clathrin light chain binding (GO:0032051),2/6,0.1093535348118027,0.4563615338928204,0,0,4.631930184804928,10.251245252658242,HIP1;HIP1R,Hypo
4140,GO_Molecular_Function_2018,L-lysine transmembrane transporter activity (GO:0015189),2/6,0.1093535348118027,0.4563615338928204,0,0,4.631930184804928,10.251245252658242,SLC25A29;SLC7A1,Hypo
4141,GO_Molecular_Function_2018,transcription coactivator activity (GO:0003713),35/291,0.113257084904066,0.4690270773208588,0,0,1.270377774151436,2.7670034230039477,RARG;THRA;TGFB1I1;WWC1;JADE1;DTX1;TCF20;RORA;MED16;FAM129B;MNT;RXRA;ZMIZ2;PRDM16;E4F1;HTATIP2;BCL9L;NCOA1;WWOX;SMARCC2;PRKCB;ACTN1;BUD31;NR1D1;ZFX;ARID1B;SMARCA4;PER2;MED24;KAT6A;RARA;MAML3;LPIN1;TAF4;PPARD,Hypo
4142,GO_Molecular_Function_2018,RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977),53/460,0.1135012144406348,0.4690270773208588,0,0,1.2111182922991042,2.635322846956129,RARG;THRA;ZMYND8;BHLHE41;RORA;ENO1;LITAF;SOX3;ZIC3;CREB3L1;TRPS1;CREB3L2;SREBF1;SMARCC2;H2AFY;ESX1;TFEB;RFX1;ETV5;NFX1;ELF4;DDIT3;IRF2;RARA;ERG;PPARD;AKNA;HLF;PRDM10;MNT;RXRA;PLAGL1;NACC2;MXI1;E4F1;MEF2D;E2F6;SMAD3;ZBTB16;NFATC2;NR1D1;GRHL1;GATAD2A;SMARCA4;PER1;NR4A1;NR6A1;SP2;TEF;NFIC;FOSB;TCF4;SSBP3,Hypo
4143,GO_Molecular_Function_2018,beta-tubulin binding (GO:0048487),5/27,0.1166744222975604,0.4797879902285046,0,0,2.1065669548960035,4.5256809062865,MAP1S;FGF13;BBS4;CCT5;PEX14,Hypo
4144,GO_Molecular_Function_2018,Rac GTPase binding (GO:0048365),7/43,0.1206508363973854,0.493731335354349,0,0,1.8027391776748445,3.812531160494864,ARHGAP44;FLNA;PAK6;MTSS1L;ARHGAP17;ARHGEF2;PAK4,Hypo
4145,GO_Molecular_Function_2018,mitogen-activated protein kinase binding (GO:0051019),4/20,0.1240137230748912,0.5050413939716587,0,0,2.316803699897225,4.836010436207122,TNIP1;MAPKAPK2;ABL1;MAPK14,Hypo
4146,GO_Molecular_Function_2018,histone demethylase activity (H3-K9 specific) (GO:0032454),3/13,0.1264265280686868,0.505106934416602,0,0,2.7796610169491527,5.748600119218783,KDM4A;KDM4B;KDM3A,Hypo
4147,GO_Molecular_Function_2018,organic acid:sodium symporter activity (GO:0005343),3/13,0.1264265280686868,0.505106934416602,0,0,2.7796610169491527,5.748600119218783,SLC13A3;SLC6A8;SLC10A3,Hypo
4148,GO_Molecular_Function_2018,sodium:proton antiporter activity (GO:0015385),3/13,0.1264265280686868,0.505106934416602,0,0,2.7796610169491527,5.748600119218783,SLC9A6;SLC9A8;SLC9A1,Hypo
4149,GO_Molecular_Function_2018,low-density lipoprotein receptor activity (GO:0005041),3/13,0.1264265280686868,0.505106934416602,0,0,2.7796610169491527,5.748600119218783,LRP1;SORL1;LDLR,Hypo
4150,GO_Molecular_Function_2018,phosphatidylinositol bisphosphate binding (GO:1902936),12/87,0.1382220681481917,0.5329221627747271,0,0,1.4840041279669762,2.93668641619961,AMER2;HIP1;PLEKHA1;KCNQ1;TWF2;HIP1R;ATP13A2;MAPT;LDLRAP1;SYT7;KCNH1;SLC9A1,Hypo
4151,GO_Molecular_Function_2018,ubiquitin-like protein ligase activity (GO:0061659),23/186,0.1399651926894725,0.5329221627747271,0,0,1.3097729711143868,2.5754871584576478,PIAS4;AREL1;NHLRC3;SMURF1;AKTIP;PELI2;RNF19B;NEDD4L;UBR2;UBE3B;RNF41;PJA1;PDZD4;TMEM189;RNF144B;RNF114;HLTF;UBE2O;BTRC;RFFL;ASB2;PDZRN4;RNF121,Hypo
4152,GO_Molecular_Function_2018,scavenger receptor activity (GO:0005044),4/21,0.1420221674171334,0.5329221627747271,0,0,2.1804002176410133,4.255644366120813,SCARB1;LRP1;MEGF10;ACKR3,Hypo
4153,GO_Molecular_Function_2018,primary miRNA binding (GO:0070878),2/7,0.1435033581848909,0.5329221627747271,0,0,3.705338809034908,7.193533062663419,SMAD3;DROSHA,Hypo
4154,GO_Molecular_Function_2018,DEAD/H-box RNA helicase binding (GO:0017151),2/7,0.1435033581848909,0.5329221627747271,0,0,3.705338809034908,7.193533062663419,SMAD3;DROSHA,Hypo
4155,GO_Molecular_Function_2018,AT DNA binding (GO:0003680),2/7,0.1435033581848909,0.5329221627747271,0,0,3.705338809034908,7.193533062663419,KMT2A;MAPT,Hypo
4156,GO_Molecular_Function_2018,aldehyde-lyase activity (GO:0016832),2/7,0.1435033581848909,0.5329221627747271,0,0,3.705338809034908,7.193533062663419,HOGA1;DERA,Hypo
4157,GO_Molecular_Function_2018,N-acetylglucosamine 6-O-sulfotransferase activity (GO:0001517),2/7,0.1435033581848909,0.5329221627747271,0,0,3.705338809034908,7.193533062663419,CHST1;CHST2,Hypo
4158,GO_Molecular_Function_2018,m7G(5')pppN diphosphatase activity (GO:0050072),2/7,0.1435033581848909,0.5329221627747271,0,0,3.705338809034908,7.193533062663419,DCPS;NUDT3,Hypo
4159,GO_Molecular_Function_2018,histone threonine kinase activity (GO:0035184),2/7,0.1435033581848909,0.5329221627747271,0,0,3.705338809034908,7.193533062663419,PRKCB;PRKCA,Hypo
4160,GO_Molecular_Function_2018,AP-2 adaptor complex binding (GO:0035612),2/7,0.1435033581848909,0.5329221627747271,0,0,3.705338809034908,7.193533062663419,HIP1;LDLRAP1,Hypo
4161,GO_Molecular_Function_2018,calcium-dependent protein serine/threonine phosphatase activity (GO:0004723),2/7,0.1435033581848909,0.5329221627747271,0,0,3.705338809034908,7.193533062663419,CAMK2G;PPM1F,Hypo
4162,GO_Molecular_Function_2018,vascular endothelial growth factor-activated receptor activity (GO:0005021),2/7,0.1435033581848909,0.5329221627747271,0,0,3.705338809034908,7.193533062663419,PDGFRA;FLT4,Hypo
4163,GO_Molecular_Function_2018,cation:sugar symporter activity (GO:0005402),2/7,0.1435033581848909,0.5329221627747271,0,0,3.705338809034908,7.193533062663419,SLC2A13;SLC2A12,Hypo
4164,GO_Molecular_Function_2018,NMDA glutamate receptor activity (GO:0004972),2/7,0.1435033581848909,0.5329221627747271,0,0,3.705338809034908,7.193533062663419,PTK2B;GRIN2B,Hypo
4165,GO_Molecular_Function_2018,single-stranded DNA endodeoxyribonuclease activity (GO:0000014),2/7,0.1435033581848909,0.5329221627747271,0,0,3.705338809034908,7.193533062663419,ERCC1;SETMAR,Hypo
4166,GO_Molecular_Function_2018,transcription regulatory region DNA binding (GO:0044212),43/374,0.144555868023295,0.534476301507183,0,0,1.2070603294904922,2.3345623666099007,KMT2D;HDAC5;RARG;KDM3A;KMT2A;THRA;TCF7;BHLHE41;TCF20;RORA;FOXO3;RAI1;RXRA;CREB3L1;CREB3L2;HIVEP1;TNRC18;HIVEP3;E4F1;TEAD1;MEF2D;BAHCC1;SREBF1;XRCC6;SMAD3;H2AFY;TFEB;NR1D1;GRHL1;FOXP3;KLF15;ETV5;SMAD7;PER2;PER1;RBL1;DDIT3;AGO2;BHLHE40;CRY2;RARA;TCF4;PPARD,Hypo
4167,GO_Molecular_Function_2018,cation transmembrane transporter activity (GO:0008324),13/97,0.1483777628932356,0.535146088705361,0,0,1.4354426334292103,2.738815652316924,ATP8A1;CACNA1D;CACNA1C;ATP2B1;CACNA1E;SLC7A1;TPCN1;CACNA1I;CALHM2;SLC7A8;ATP13A2;RHCG;SLC15A4,Hypo
4168,GO_Molecular_Function_2018,outward rectifier potassium channel activity (GO:0015271),3/14,0.149815512377776,0.535146088705361,0,0,2.52682448522202,4.796798927549129,KCNU1;KCND3;KCNQ1,Hypo
4169,GO_Molecular_Function_2018,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),3/14,0.149815512377776,0.535146088705361,0,0,2.52682448522202,4.796798927549129,MTMR3;SYNJ1;SYNJ2,Hypo
4170,GO_Molecular_Function_2018,vitamin D receptor binding (GO:0042809),3/14,0.149815512377776,0.535146088705361,0,0,2.52682448522202,4.796798927549129,MED24;RXRA;MED16,Hypo
4171,GO_Molecular_Function_2018,titin binding (GO:0031432),3/14,0.149815512377776,0.535146088705361,0,0,2.52682448522202,4.796798927549129,MYBPC1;OBSCN;CALM3,Hypo
4172,GO_Molecular_Function_2018,O-methyltransferase activity (GO:0008171),3/14,0.149815512377776,0.535146088705361,0,0,2.52682448522202,4.796798927549129,MEPCE;BCDIN3D;TARBP1,Hypo
4173,GO_Molecular_Function_2018,phosphatidylinositol-3-phosphatase activity (GO:0004438),3/14,0.149815512377776,0.535146088705361,0,0,2.52682448522202,4.796798927549129,MTMR3;SYNJ1;SYNJ2,Hypo
4174,GO_Molecular_Function_2018,monovalent cation:proton antiporter activity (GO:0005451),3/14,0.149815512377776,0.535146088705361,0,0,2.52682448522202,4.796798927549129,SLC9A6;SLC9A8;SLC9A1,Hypo
4175,GO_Molecular_Function_2018,bHLH transcription factor binding (GO:0043425),4/22,0.1609856146846818,0.5726197180556405,0,0,2.0591526778577136,3.76091936833438,SMAD3;BHLHE40;BHLHE41;TCF4,Hypo
4176,GO_Molecular_Function_2018,potassium channel activity (GO:0005267),13/100,0.1742180078380427,0.5953834312605684,0,0,1.385713183676618,2.421461517165967,KCNK6;KCNH6;KCNJ11;KCND3;GRIK5;KCNK13;GRIK4;KCNA6;KCNU1;KCNQ1;KCNQ2;KCNK3;KCNH1,Hypo
4177,GO_Molecular_Function_2018,adrenergic receptor binding (GO:0031690),3/15,0.1744443999262634,0.5953834312605684,0,0,2.316127375449409,4.044303994255914,GRK2;GNAS;RAPGEF2,Hypo
4178,GO_Molecular_Function_2018,FK506 binding (GO:0005528),3/15,0.1744443999262634,0.5953834312605684,0,0,2.316127375449409,4.044303994255914,FKBP8;FKBP6;FKBP5,Hypo
4179,GO_Molecular_Function_2018,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),3/15,0.1744443999262634,0.5953834312605684,0,0,2.316127375449409,4.044303994255914,PTPRE;PTPRB;PTPRF,Hypo
4180,GO_Molecular_Function_2018,transmembrane receptor protein phosphatase activity (GO:0019198),3/15,0.1744443999262634,0.5953834312605684,0,0,2.316127375449409,4.044303994255914,PTPRE;PTPRB;PTPRF,Hypo
4181,GO_Molecular_Function_2018,ubiquitin protein ligase activity (GO:0061630),23/192,0.1762253755134576,0.5953834312605684,0,0,1.2628484046391515,2.192294172580565,AREL1;NHLRC3;SMURF1;AKTIP;PELI2;RNF19B;NEDD4L;UBE4B;UBR2;UBE3B;RNF41;PJA1;PDZD4;TMEM189;RNF144B;RNF114;HLTF;UBE2O;BTRC;RFFL;ASB2;PDZRN4;RNF121,Hypo
4182,GO_Molecular_Function_2018,aryl hydrocarbon receptor binding (GO:0017162),2/8,0.1794629092694294,0.5953834312605684,0,0,3.087611225188227,5.303857577682986,NCOA1;TAF4,Hypo
4183,GO_Molecular_Function_2018,calcium-dependent protein kinase activity (GO:0010857),2/8,0.1794629092694294,0.5953834312605684,0,0,3.087611225188227,5.303857577682986,CAMK2A;MAPKAPK2,Hypo
4184,GO_Molecular_Function_2018,3-hydroxyacyl-CoA dehydrogenase activity (GO:0003857),2/8,0.1794629092694294,0.5953834312605684,0,0,3.087611225188227,5.303857577682986,HADHA;HSD17B4,Hypo
4185,GO_Molecular_Function_2018,ligand-gated sodium channel activity (GO:0015280),2/8,0.1794629092694294,0.5953834312605684,0,0,3.087611225188227,5.303857577682986,ASIC2;ASIC1,Hypo
4186,GO_Molecular_Function_2018,type I transforming growth factor beta receptor binding (GO:0034713),2/8,0.1794629092694294,0.5953834312605684,0,0,3.087611225188227,5.303857577682986,TGFB3;SMAD7,Hypo
4187,GO_Molecular_Function_2018,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),2/8,0.1794629092694294,0.5953834312605684,0,0,3.087611225188227,5.303857577682986,KCND3;KCNQ1,Hypo
4188,GO_Molecular_Function_2018,phosphatidylinositol 3-kinase regulator activity (GO:0035014),2/8,0.1794629092694294,0.5953834312605684,0,0,3.087611225188227,5.303857577682986,PIK3R1;PIK3R6,Hypo
4189,GO_Molecular_Function_2018,coreceptor activity involved in Wnt signaling pathway (GO:0071936),2/8,0.1794629092694294,0.5953834312605684,0,0,3.087611225188227,5.303857577682986,GPC4;GPC6,Hypo
4190,GO_Molecular_Function_2018,CTD phosphatase activity (GO:0008420),2/8,0.1794629092694294,0.5953834312605684,0,0,3.087611225188227,5.303857577682986,CTDP1;CTDSPL,Hypo
4191,GO_Molecular_Function_2018,protein phosphatase inhibitor activity (GO:0004864),4/23,0.1808044583661986,0.5953834312605684,0,0,1.950668036998972,3.3363039556827068,PPP1R1B;LMTK2;CABIN1;PPP1R9B,Hypo
4192,GO_Molecular_Function_2018,disordered domain specific binding (GO:0097718),4/23,0.1808044583661986,0.5953834312605684,0,0,1.950668036998972,3.3363039556827068,NUMA1;FKBP8;FYN;CALM3,Hypo
4193,GO_Molecular_Function_2018,lipoprotein particle binding (GO:0071813),4/23,0.1808044583661986,0.5953834312605684,0,0,1.950668036998972,3.3363039556827068,SCARB1;MAPT;SORL1;LDLR,Hypo
4194,GO_Molecular_Function_2018,nucleotide kinase activity (GO:0019201),4/23,0.1808044583661986,0.5953834312605684,0,0,1.950668036998972,3.3363039556827068,MPP3;DLG3;CARD11;TJP2,Hypo
4195,GO_Molecular_Function_2018,protein tyrosine kinase binding (GO:1990782),7/48,0.1829544699540765,0.5966628568515638,0,0,1.5824535857298871,2.687825828571507,SHC2;ARHGEF16;PITPNM2;LRP4;ELMO2;TOB1;RNF41,Hypo
4196,GO_Molecular_Function_2018,sterol binding (GO:0032934),7/48,0.1829544699540765,0.5966628568515638,0,0,1.5824535857298871,2.687825828571507,ABCA1;SOAT1;OSBPL2;RORA;ERLIN2;ABCG1;OSBP2,Hypo
4197,GO_Molecular_Function_2018,growth factor receptor binding (GO:0070851),12/92,0.1833163462924733,0.5966628568515638,0,0,1.3908668730650156,2.359663997441732,PDGFRA;KL;ATXN2;HIP1;SRC;TNK2;TGFA;PDGFA;FYN;FGF1;IL12RB1;EREG,Hypo
4198,GO_Molecular_Function_2018,sodium channel activity (GO:0005272),6/40,0.1903235685937134,0.6147232502854423,0,0,1.635439360929557,2.7132424112815507,CACNA1I;GRIK5;GRIK4;ASIC2;SCN1B;ASIC1,Hypo
4199,GO_Molecular_Function_2018,protein kinase C binding (GO:0005080),6/40,0.1903235685937134,0.6147232502854423,0,0,1.635439360929557,2.7132424112815507,HDAC5;PRKCB;TWF2;ABL1;PRKD2;HDAC7,Hypo
4200,GO_Molecular_Function_2018,amyloid-beta binding (GO:0001540),7/49,0.1967855151717732,0.6262991231894531,0,0,1.544690341396466,2.5111117950205726,CLSTN1;APBB2;APBB1;LDLRAP1;EPHB2;CRYAB;SORL1,Hypo
4201,GO_Molecular_Function_2018,ribonuclease activity (GO:0004540),7/49,0.1967855151717732,0.6262991231894531,0,0,1.544690341396466,2.5111117950205726,RNASEL;NOB1;ZC3H3;AGO2;DCPS;SMG5;SMG6,Hypo
4202,GO_Molecular_Function_2018,telomeric DNA binding (GO:0042162),5/32,0.1969085309617945,0.6262991231894531,0,0,1.7159859087879654,2.7885045024854715,UPF1;XRCC6;STN1;SMG5;SMG6,Hypo
4203,GO_Molecular_Function_2018,potassium ion leak channel activity (GO:0022841),3/16,0.2000937866677156,0.6262991231894531,0,0,2.137845205641816,3.439726852966764,KCNK6;KCNK13;KCNK3,Hypo
4204,GO_Molecular_Function_2018,sulfuric ester hydrolase activity (GO:0008484),3/16,0.2000937866677156,0.6262991231894531,0,0,2.137845205641816,3.439726852966764,ARSI;GNS;SULF2,Hypo
4205,GO_Molecular_Function_2018,potassium ion antiporter activity (GO:0022821),3/16,0.2000937866677156,0.6262991231894531,0,0,2.137845205641816,3.439726852966764,SLC9A6;SLC9A8;SLC9A1,Hypo
4206,GO_Molecular_Function_2018,four-way junction DNA binding (GO:0000400),3/16,0.2000937866677156,0.6262991231894531,0,0,2.137845205641816,3.439726852966764,RAD51;HMGB3;HMGB1,Hypo
4207,GO_Molecular_Function_2018,phosphatidic acid binding (GO:0070300),3/16,0.2000937866677156,0.6262991231894531,0,0,2.137845205641816,3.439726852966764,PACSIN2;RAPGEF2;ATP13A2,Hypo
4208,GO_Molecular_Function_2018,neutral amino acid transmembrane transporter activity (GO:0015175),4/24,0.2013759480123944,0.6262991231894531,0,0,1.8530318602261049,2.969635003934776,SLC7A5;SLC6A19;SLC43A2;SLC7A8,Hypo
4209,GO_Molecular_Function_2018,ATPase coupled ion transmembrane transporter activity (GO:0042625),4/24,0.2013759480123944,0.6262991231894531,0,0,1.8530318602261049,2.969635003934776,ABCC4;ATP8A1;ATP13A2;ATP2B1,Hypo
4210,GO_Molecular_Function_2018,protein kinase inhibitor activity (GO:0004860),9/67,0.20267015534133,0.6262991231894531,0,0,1.438362735170282,2.2958793176845385,CDKN1C;RPTOR;H2AFY;PPP1R1B;LRRC4;FGFR1OP;RTN4RL2;TRIB1;MAPK8IP1,Hypo
4211,GO_Molecular_Function_2018,"ATPase activity, coupled (GO:0042623)",12/94,0.2030890685765425,0.6262991231894531,0,0,1.3567922676130786,2.1628769828905225,MYO1E;RAD51;KATNAL1;MYO10;ERCC2;MYH9;FIGN;PEX1;ERCC6;SNRNP200;MYH10;SMARCA4,Hypo
4212,GO_Molecular_Function_2018,thiol-dependent ubiquitin-specific protease activity (GO:0004843),10/76,0.203565788557426,0.6262991231894531,0,0,1.4045610746641677,2.235732621231735,USP46;USP27X;STAMBPL1;USP4;USP10;USP2;OTULIN;USP51;EIF3F;JOSD1,Hypo
4213,GO_Molecular_Function_2018,aminoacyl-tRNA ligase activity (GO:0004812),6/41,0.2059212219000364,0.6312421456790208,0,0,1.5886243386243386,2.510442041209024,YARS;LRRC47;LARS;MARS;NARS2;CARS2,Hypo
4214,GO_Molecular_Function_2018,acetylglucosaminyltransferase activity (GO:0008375),7/50,0.2110115370091371,0.6360835370637196,0,0,1.5086835270320411,2.347273903987812,NDST1;PIGQ;MGAT4A;B3GALT1;MGAT3;ALG13;POMGNT1,Hypo
4215,GO_Molecular_Function_2018,phosphatase activity (GO:0016791),13/104,0.2118248976008124,0.6360835370637196,0,0,1.3245077070580429,2.055629736580849,DUSP5;PTPRS;CTDP1;CTDSPL;PPM1H;PDXP;PTPN11;HDHD2;SGPP2;SSH1;PPP4R1;LPIN1;DLGAP5,Hypo
4216,GO_Molecular_Function_2018,histone kinase activity (GO:0035173),2/9,0.2165551306492141,0.6360835370637196,0,0,2.6463772367263125,4.048719312960691,MELK;BAZ1B,Hypo
4217,GO_Molecular_Function_2018,RAGE receptor binding (GO:0050786),2/9,0.2165551306492141,0.6360835370637196,0,0,2.6463772367263125,4.048719312960691,HMGB1;S100B,Hypo
4218,GO_Molecular_Function_2018,UDP-glucosyltransferase activity (GO:0035251),2/9,0.2165551306492141,0.6360835370637196,0,0,2.6463772367263125,4.048719312960691,UGGT2;UGGT1,Hypo
4219,GO_Molecular_Function_2018,cytoskeletal adaptor activity (GO:0008093),2/9,0.2165551306492141,0.6360835370637196,0,0,2.6463772367263125,4.048719312960691,BIN3;ANK1,Hypo
4220,GO_Molecular_Function_2018,histone demethylase activity (H3-K36 specific) (GO:0051864),2/9,0.2165551306492141,0.6360835370637196,0,0,2.6463772367263125,4.048719312960691,KDM4A;KDM4B,Hypo
4221,GO_Molecular_Function_2018,dolichyl-diphosphooligosaccharide-protein glycotransferase activity (GO:0004579),2/9,0.2165551306492141,0.6360835370637196,0,0,2.6463772367263125,4.048719312960691,RPN1;DDOST,Hypo
4222,GO_Molecular_Function_2018,adenine nucleotide transmembrane transporter activity (GO:0000295),2/9,0.2165551306492141,0.6360835370637196,0,0,2.6463772367263125,4.048719312960691,SLC25A17;SLC25A23,Hypo
4223,GO_Molecular_Function_2018,cytidylyltransferase activity (GO:0070567),2/9,0.2165551306492141,0.6360835370637196,0,0,2.6463772367263125,4.048719312960691,CMAS;TAMM41,Hypo
4224,GO_Molecular_Function_2018,glucocorticoid receptor binding (GO:0035259),2/9,0.2165551306492141,0.6360835370637196,0,0,2.6463772367263125,4.048719312960691,NR4A1;SMAD3,Hypo
4225,GO_Molecular_Function_2018,chloride channel inhibitor activity (GO:0019869),2/9,0.2165551306492141,0.6360835370637196,0,0,2.6463772367263125,4.048719312960691,STX8;STX1A,Hypo
4226,GO_Molecular_Function_2018,lipoprotein particle receptor binding (GO:0070325),4/25,0.2225959257493098,0.6473994582513813,0,0,1.7646943669554152,2.651271775748792,LRP1;LANCL1;AP2A1;LDLRAP1,Hypo
4227,GO_Molecular_Function_2018,phosphatidylinositol kinase activity (GO:0052742),7/51,0.2256030153113237,0.6473994582513813,0,0,1.4743133860478173,2.195220777376542,KL;PI4KA;IRS2;PTPN11;PIK3R1;FGF1;FGFR2,Hypo
4228,GO_Molecular_Function_2018,GTP-Rho binding (GO:0017049),3/17,0.2265514118436032,0.6473994582513813,0,0,1.985031917235307,2.947342391459043,RTKN;KCTD13;CDC42EP1,Hypo
4229,GO_Molecular_Function_2018,Notch binding (GO:0005112),3/17,0.2265514118436032,0.6473994582513813,0,0,1.985031917235307,2.947342391459043,NCOR2;MEGF10;DTX1,Hypo
4230,GO_Molecular_Function_2018,low-density lipoprotein particle binding (GO:0030169),3/17,0.2265514118436032,0.6473994582513813,0,0,1.985031917235307,2.947342391459043,SCARB1;SORL1;LDLR,Hypo
4231,GO_Molecular_Function_2018,"ATP-dependent microtubule motor activity, minus-end-directed (GO:0008569)",3/17,0.2265514118436032,0.6473994582513813,0,0,1.985031917235307,2.947342391459043,DYNC1H1;DNAH2;DNAH17,Hypo
4232,GO_Molecular_Function_2018,RNA cap binding (GO:0000339),3/17,0.2265514118436032,0.6473994582513813,0,0,1.985031917235307,2.947342391459043,CYFIP2;AGO2;DCPS,Hypo
4233,GO_Molecular_Function_2018,ligand-dependent nuclear receptor binding (GO:0016922),3/17,0.2265514118436032,0.6473994582513813,0,0,1.985031917235307,2.947342391459043,NCOA1;NCOR2;RXRA,Hypo
4234,GO_Molecular_Function_2018,RNA polymerase core enzyme binding (GO:0043175),5/34,0.2332480157580569,0.6642840448785202,0,0,1.5974647637620778,2.3253542898578567,TCOF1;AGO2;SMYD2;GTF2E1;BRD4,Hypo
4235,GO_Molecular_Function_2018,lipase activity (GO:0016298),6/43,0.2383827141888662,0.6698554268707142,0,0,1.502585919252586,2.1545246733737327,DAGLA;ABHD16A;ABHD2;DDHD1;DAGLB;MGLL,Hypo
4236,GO_Molecular_Function_2018,1-phosphatidylinositol-3-kinase activity (GO:0016303),6/43,0.2383827141888662,0.6698554268707142,0,0,1.502585919252586,2.1545246733737327,KL;IRS2;PTPN11;PIK3R1;FGF1;FGFR2,Hypo
4237,GO_Molecular_Function_2018,cholesterol binding (GO:0015485),6/43,0.2383827141888662,0.6698554268707142,0,0,1.502585919252586,2.1545246733737327,ABCA1;SOAT1;OSBPL2;ERLIN2;ABCG1;OSBP2,Hypo
4238,GO_Molecular_Function_2018,potassium channel regulator activity (GO:0015459),6/43,0.2383827141888662,0.6698554268707142,0,0,1.502585919252586,2.1545246733737327,KCNIP3;NEDD4L;FLNA;KCNAB1;KCNAB2;SGK1,Hypo
4239,GO_Molecular_Function_2018,collagen binding (GO:0005518),7/52,0.2405293473228288,0.6736419926682549,0,0,1.4414708068851148,2.0539707377524232,MRC2;P3H1;SPARCL1;PDGFA;PPIB;ANTXR1;USH2A,Hypo
4240,GO_Molecular_Function_2018,SH2 domain binding (GO:0042169),4/26,0.2443603475598385,0.6760425819386489,0,0,1.684387554891152,2.373489552124641,AFAP1L2;SRC;ABL1;PAG1,Hypo
4241,GO_Molecular_Function_2018,RNA polymerase II core binding (GO:0000993),4/26,0.2443603475598385,0.6760425819386489,0,0,1.684387554891152,2.373489552124641,AGO2;SMYD2;GTF2E1;BRD4,Hypo
4242,GO_Molecular_Function_2018,"transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding (GO:0000982)",31/280,0.2531656094061578,0.6760425819386489,0,0,1.1548664695258366,1.586453259803775,AKNA;HLF;TSHZ3;TSHZ1;BHLHE41;ENO1;LITAF;ZIC3;CREB3L1;NACC2;CAMTA1;TEAD1;MEF2D;TFEB;EBF3;NR1D1;GRHL1;KLF15;NR4A1;RBL1;SP2;TEF;NFX1;ELF4;DDIT3;NFIC;BHLHE40;FOSB;TCF4;ERG;SSBP3,Hypo
4243,GO_Molecular_Function_2018,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),3/18,0.2536151692777526,0.6760425819386489,0,0,1.852593733949666,2.541642338723844,AGPAT5;LCLAT1;AGPAT4,Hypo
4244,GO_Molecular_Function_2018,SUMO transferase activity (GO:0019789),3/18,0.2536151692777526,0.6760425819386489,0,0,1.852593733949666,2.541642338723844,PIAS4;NSMCE2;HDAC7,Hypo
4245,GO_Molecular_Function_2018,tau-protein kinase activity (GO:0050321),2/10,0.2542176731607968,0.6760425819386489,0,0,2.315451745379877,3.1711602757918778,CDK5;MARK2,Hypo
4246,GO_Molecular_Function_2018,"oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor (GO:0016671)",2/10,0.2542176731607968,0.6760425819386489,0,0,2.315451745379877,3.1711602757918778,MSRA;MSRB3,Hypo
4247,GO_Molecular_Function_2018,oligosaccharyl transferase activity (GO:0004576),2/10,0.2542176731607968,0.6760425819386489,0,0,2.315451745379877,3.1711602757918778,RPN1;DDOST,Hypo
4248,GO_Molecular_Function_2018,long-chain fatty acid-CoA ligase activity (GO:0004467),2/10,0.2542176731607968,0.6760425819386489,0,0,2.315451745379877,3.1711602757918778,ACSL6;ACSL4,Hypo
4249,GO_Molecular_Function_2018,activin binding (GO:0048185),2/10,0.2542176731607968,0.6760425819386489,0,0,2.315451745379877,3.1711602757918778,SMURF1;SMAD7,Hypo
4250,GO_Molecular_Function_2018,cGMP binding (GO:0030553),2/10,0.2542176731607968,0.6760425819386489,0,0,2.315451745379877,3.1711602757918778,PDE10A;PDE2A,Hypo
4251,GO_Molecular_Function_2018,Tat protein binding (GO:0030957),2/10,0.2542176731607968,0.6760425819386489,0,0,2.315451745379877,3.1711602757918778,CTDP1;SMARCA4,Hypo
4252,GO_Molecular_Function_2018,leucine zipper domain binding (GO:0043522),2/10,0.2542176731607968,0.6760425819386489,0,0,2.315451745379877,3.1711602757918778,DDIT3;PAWR,Hypo
4253,GO_Molecular_Function_2018,sugar:proton symporter activity (GO:0005351),2/10,0.2542176731607968,0.6760425819386489,0,0,2.315451745379877,3.1711602757918778,SLC2A13;SLC2A12,Hypo
4254,GO_Molecular_Function_2018,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",2/10,0.2542176731607968,0.6760425819386489,0,0,2.315451745379877,3.1711602757918778,PADI2;AGMAT,Hypo
4255,GO_Molecular_Function_2018,microtubule minus-end binding (GO:0051011),2/10,0.2542176731607968,0.6760425819386489,0,0,2.315451745379877,3.1711602757918778,NUMA1;TUBGCP6,Hypo
4256,GO_Molecular_Function_2018,basal RNA polymerase II transcription machinery binding (GO:0001099),4/27,0.2665665950323643,0.7066529547556072,0,0,1.611063943875955,2.130037871628523,AGO2;SMYD2;GTF2E1;BRD4,Hypo
4257,GO_Molecular_Function_2018,phosphatidylinositol binding (GO:0035091),12/100,0.2674268824340258,0.7067111658052784,0,0,1.2638615254714325,1.6669184502805965,ZFYVE28;TUB;SCARB1;MYO1E;HIP1;NUMA1;SH3PXD2A;PLEKHA1;MCF2L;HIP1R;WDFY3;MAPT,Hypo
4258,GO_Molecular_Function_2018,cadherin binding involved in cell-cell adhesion (GO:0098641),3/19,0.281095239074885,0.738203384860212,0,0,1.7367103235747303,2.2039926216031454,CDC42EP1;BAIAP2;PAK4,Hypo
4259,GO_Molecular_Function_2018,RNA methyltransferase activity (GO:0008173),3/19,0.281095239074885,0.738203384860212,0,0,1.7367103235747303,2.2039926216031454,MEPCE;BCDIN3D;TRMT13,Hypo
4260,GO_Molecular_Function_2018,thiol-dependent ubiquitinyl hydrolase activity (GO:0036459),11/92,0.2836306976021253,0.742548689685067,0,0,1.2585015822079602,1.5858155022906788,USP46;USP27X;STAMBPL1;TRRAP;USP4;USP10;USP2;OTULIN;USP51;EIF3F;JOSD1,Hypo
4261,GO_Molecular_Function_2018,gap junction channel activity (GO:0005243),2/11,0.2919869817492074,0.7504421512639691,0,0,2.058065252110427,2.53357312139422,PANX1;PANX2,Hypo
4262,GO_Molecular_Function_2018,microtubule-severing ATPase activity (GO:0008568),2/11,0.2919869817492074,0.7504421512639691,0,0,2.058065252110427,2.53357312139422,KATNAL1;FIGN,Hypo
4263,GO_Molecular_Function_2018,Lys63-specific deubiquitinase activity (GO:0061578),2/11,0.2919869817492074,0.7504421512639691,0,0,2.058065252110427,2.53357312139422,USP27X;STAMBPL1,Hypo
4264,GO_Molecular_Function_2018,"intramolecular transferase activity, phosphotransferases (GO:0016868)",2/11,0.2919869817492074,0.7504421512639691,0,0,2.058065252110427,2.53357312139422,PMM1;PGM2,Hypo
4265,GO_Molecular_Function_2018,"3',5'-cyclic-GMP phosphodiesterase activity (GO:0047555)",2/11,0.2919869817492074,0.7504421512639691,0,0,2.058065252110427,2.53357312139422,PDE10A;PDE2A,Hypo
4266,GO_Molecular_Function_2018,tumor necrosis factor receptor binding (GO:0005164),2/11,0.2919869817492074,0.7504421512639691,0,0,2.058065252110427,2.53357312139422,BABAM2;TRAF4,Hypo
4267,GO_Molecular_Function_2018,"transcriptional repressor activity, RNA polymerase II transcription factor binding (GO:0001191)",6/47,0.3071636043212891,0.7794355382177727,0,0,1.3556910569105691,1.600223506265796,RERE;SPEN;SOX3;ZMYND8;BHLHE40;BHLHE41,Hypo
4268,GO_Molecular_Function_2018,integrin binding (GO:0005178),11/94,0.3080607535386894,0.7794355382177727,0,0,1.2280395434238245,1.4459653085684363,LAMA5;SEMA7A;DST;COL5A1;SRC;ACTN1;PRKCA;ITGB1BP1;HMGB1;FGF1;JAM3,Hypo
4269,GO_Molecular_Function_2018,organic cation transmembrane transporter activity (GO:0015101),3/20,0.3088155038727592,0.7794355382177727,0,0,1.634460255596846,1.9205091965850865,SLC25A17;SLC7A8;SLC44A2,Hypo
4270,GO_Molecular_Function_2018,ubiquitin conjugating enzyme activity (GO:0061631),3/20,0.3088155038727592,0.7794355382177727,0,0,1.634460255596846,1.9205091965850865,UBE2D1;UBE2QL1;UBE2O,Hypo
4271,GO_Molecular_Function_2018,lysophosphatidic acid acyltransferase activity (GO:0042171),3/20,0.3088155038727592,0.7794355382177727,0,0,1.634460255596846,1.9205091965850865,AGPAT5;LCLAT1;AGPAT4,Hypo
4272,GO_Molecular_Function_2018,low-density lipoprotein particle receptor binding (GO:0050750),3/20,0.3088155038727592,0.7794355382177727,0,0,1.634460255596846,1.9205091965850865,LANCL1;AP2A1;LDLRAP1,Hypo
4273,GO_Molecular_Function_2018,alpha-actinin binding (GO:0051393),4/29,0.3119077044235571,0.7825541512769604,0,0,1.4820143884892083,1.7266178312428324,MYBPC1;RARA;CACNA1D;CACNA1C,Hypo
4274,GO_Molecular_Function_2018,delayed rectifier potassium channel activity (GO:0005251),4/29,0.3119077044235571,0.7825541512769604,0,0,1.4820143884892083,1.7266178312428324,KCNQ1;KCNQ2;KCNA6;KCNH1,Hypo
4275,GO_Molecular_Function_2018,secondary active transmembrane transporter activity (GO:0015291),8/66,0.3131318676138402,0.7832942563752741,0,0,1.2778862885755886,1.4837932242563363,SLC22A23;SLC7A5;CLCN6;CLCN5;SLC7A8;SLC22A17;SLCO2B1;SLC4A1,Hypo
4276,GO_Molecular_Function_2018,kinase binding (GO:0019900),44/418,0.3176602286061218,0.7904343447507814,0,0,1.0910437627306957,1.2511794535473195,SHC2;MIDN;CTBP2;SRC;WWC1;WWC2;PRKAG1;PRKAG2;AP2A1;FOXO3;PKD1;HDAC7;GOLGA2;RPTOR;TRIM5;DVL1;FLNA;TBC1D14;RFFL;PDE8A;BCL2L14;TNS2;SASH1;CEP68;NSF;SMAD3;H2AFY;DAB2IP;SRCIN1;DNM1;TIAM1;PER1;DLG3;RHOJ;DOK7;FGFR1OP;CSPG4;CALM3;MAPT;ARHGEF7;PFKM;BCAR1;STX1A;LLGL1,Hypo
4277,GO_Molecular_Function_2018,steroid hormone receptor binding (GO:0035258),9/76,0.3211608383675562,0.7904343447507814,0,0,1.244526978707698,1.4135502040648709,NCOA1;NR4A1;KDM3A;SMAD3;PRKCB;TGFB1I1;DDX54;PADI2;SMARCA4,Hypo
4278,GO_Molecular_Function_2018,acetylgalactosaminyltransferase activity (GO:0008376),6/48,0.3249077636880599,0.7904343447507814,0,0,1.3233392122281011,1.4877163910179312,GALNT13;CHPF;GALNT2;B3GALT1;B4GALNT1;GALNT9,Hypo
4279,GO_Molecular_Function_2018,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),2/12,0.3294843918808396,0.7904343447507814,0,0,1.8521560574948663,2.0563123579627134,KCND3;KCNQ1,Hypo
4280,GO_Molecular_Function_2018,Ral GTPase binding (GO:0017160),2/12,0.3294843918808396,0.7904343447507814,0,0,1.8521560574948663,2.0563123579627134,FLNA;RNF41,Hypo
4281,GO_Molecular_Function_2018,wide pore channel activity (GO:0022829),2/12,0.3294843918808396,0.7904343447507814,0,0,1.8521560574948663,2.0563123579627134,PANX1;PANX2,Hypo
4282,GO_Molecular_Function_2018,protein tyrosine kinase activator activity (GO:0030296),2/12,0.3294843918808396,0.7904343447507814,0,0,1.8521560574948663,2.0563123579627134,AFAP1L2;ERCC6,Hypo
4283,GO_Molecular_Function_2018,potassium ion binding (GO:0030955),2/12,0.3294843918808396,0.7904343447507814,0,0,1.8521560574948663,2.0563123579627134,KCNJ11;ATP1A2,Hypo
4284,GO_Molecular_Function_2018,tRNA (guanine) methyltransferase activity (GO:0016423),2/12,0.3294843918808396,0.7904343447507814,0,0,1.8521560574948663,2.0563123579627134,WDR4;TARBP1,Hypo
4285,GO_Molecular_Function_2018,voltage-gated chloride channel activity (GO:0005247),2/12,0.3294843918808396,0.7904343447507814,0,0,1.8521560574948663,2.0563123579627134,CLCN6;CLCN5,Hypo
4286,GO_Molecular_Function_2018,arylsulfatase activity (GO:0004065),2/12,0.3294843918808396,0.7904343447507814,0,0,1.8521560574948663,2.0563123579627134,ARSI;SULF2,Hypo
4287,GO_Molecular_Function_2018,calcium:cation antiporter activity (GO:0015368),2/12,0.3294843918808396,0.7904343447507814,0,0,1.8521560574948663,2.0563123579627134,SLC8A3;SLC8A2,Hypo
4288,GO_Molecular_Function_2018,fibroblast growth factor receptor binding (GO:0005104),2/12,0.3294843918808396,0.7904343447507814,0,0,1.8521560574948663,2.0563123579627134,KL;FGF1,Hypo
4289,GO_Molecular_Function_2018,sulfotransferase activity (GO:0008146),5/39,0.3303817757032654,0.7904343447507814,0,0,1.3621654317253893,1.5086069295984068,CHST11;CHST15;CHST1;SULT4A1;CHST2,Hypo
4290,GO_Molecular_Function_2018,anion:anion antiporter activity (GO:0015301),3/21,0.3366143888084585,0.7904343447507814,0,0,1.5435713062831706,1.6806670658728051,SLC4A1;SLC25A5;SLC25A4,Hypo
4291,GO_Molecular_Function_2018,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),3/21,0.3366143888084585,0.7904343447507814,0,0,1.5435713062831706,1.6806670658728051,GRID1;GRIK5;GRIK4,Hypo
4292,GO_Molecular_Function_2018,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",3/21,0.3366143888084585,0.7904343447507814,0,0,1.5435713062831706,1.6806670658728051,HGD;ALOX12B;ALOXE3,Hypo
4293,GO_Molecular_Function_2018,protein binding involved in cell-cell adhesion (GO:0098632),3/21,0.3366143888084585,0.7904343447507814,0,0,1.5435713062831706,1.6806670658728051,CDC42EP1;BAIAP2;PAK4,Hypo
4294,GO_Molecular_Function_2018,polypeptide N-acetylgalactosaminyltransferase activity (GO:0004653),3/21,0.3366143888084585,0.7904343447507814,0,0,1.5435713062831706,1.6806670658728051,GALNT13;GALNT2;GALNT9,Hypo
4295,GO_Molecular_Function_2018,solute:proton symporter activity (GO:0015295),3/21,0.3366143888084585,0.7904343447507814,0,0,1.5435713062831706,1.6806670658728051,SLC2A13;SLC2A12;SLC15A4,Hypo
4296,GO_Molecular_Function_2018,ubiquitin-like protein conjugating enzyme activity (GO:0061650),3/21,0.3366143888084585,0.7904343447507814,0,0,1.5435713062831706,1.6806670658728051,UBE2D1;UBE2QL1;UBE2O,Hypo
4297,GO_Molecular_Function_2018,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",3/21,0.3366143888084585,0.7904343447507814,0,0,1.5435713062831706,1.6806670658728051,HIP1;HIP1R;ATP13A2,Hypo
4298,GO_Molecular_Function_2018,metal ion binding (GO:0046872),46/442,0.3418224799892778,0.8004343073082255,0,0,1.07705733808675,1.1561819994560103,RYR1;RYR2;NIM1K;LRP1;CERK;PDXP;EFCAB6;STK4;RASGRP1;NUDT3;CLYBL;RYR3;CAMKK2;SCUBE1;NCS1;CDH22;ABL1;SLIT1;MAN1C1;PCDHA4;ABL2;SPOCK1;XXYLT1;PCDHA7;MARK2;TPD52;SRPK2;RPH3AL;EYA2;IDH2;CDC42BPB;SYT13;CDC42BPA;S100B;SYT7;SRPK1;CLIP1;MELK;SYT12;RRAGC;PITPNM2;SIK3;SPARCL1;RAPGEF2;CALM3;FAN1,Hypo
4299,GO_Molecular_Function_2018,regulatory region DNA binding (GO:0000975),24/224,0.3440796698712599,0.8034879825525543,0,0,1.1121495327102804,1.1865323733206203,KMT2D;HDAC5;XRCC6;SMAD3;KMT2A;THRA;H2AFY;TCF7;TFEB;TCF20;NR1D1;GRHL1;KLF15;ETV5;SMAD7;RAI1;RXRA;CREB3L1;DDIT3;CREB3L2;HIVEP1;HIVEP3;TEAD1;MEF2D,Hypo
4300,GO_Molecular_Function_2018,"transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding (GO:0001077)",19/175,0.3457144097377974,0.8050752690855337,0,0,1.1286366835305208,1.1987727066368818,AKNA;HLF;TFEB;EBF3;GRHL1;LITAF;KLF15;NR4A1;TEF;ZIC3;ELF4;CREB3L1;DDIT3;NFIC;CAMTA1;TCF4;ERG;MEF2D;SSBP3,Hypo
4301,GO_Molecular_Function_2018,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",10/88,0.3542780798677128,0.8214855543083442,0,0,1.1876817340734869,1.2324254317882102,ABCC4;HADHA;BDH2;CTBP2;IMPDH1;GPD1;HSD17B4;CRYL1;KCNAB1;KCNAB2,Hypo
4302,GO_Molecular_Function_2018,O-acyltransferase activity (GO:0008374),4/31,0.3578644838276814,0.8214855543083442,0,0,1.3720832857523504,1.4099540207393382,GNPAT;GPAM;SOAT1;LCLAT1,Hypo
4303,GO_Molecular_Function_2018,actinin binding (GO:0042805),3/22,0.3643452418386853,0.8214855543083442,0,0,1.4622496147919877,1.4763652868386326,RARA;CACNA1D;CACNA1C,Hypo
4304,GO_Molecular_Function_2018,monocarboxylic acid binding (GO:0033293),3/22,0.3643452418386853,0.8214855543083442,0,0,1.4622496147919877,1.4763652868386326,RXRA;PSAP;RARA,Hypo
4305,GO_Molecular_Function_2018,"ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism (GO:0015662)",3/22,0.3643452418386853,0.8214855543083442,0,0,1.4622496147919877,1.4763652868386326,ABCC4;ATP13A2;ATP2B1,Hypo
4306,GO_Molecular_Function_2018,telomerase RNA binding (GO:0070034),3/22,0.3643452418386853,0.8214855543083442,0,0,1.4622496147919877,1.4763652868386326,SMG5;SMG6;WRAP53,Hypo
4307,GO_Molecular_Function_2018,platelet-derived growth factor receptor binding (GO:0005161),2/13,0.3664039957531879,0.8214855543083442,0,0,1.6836848982639536,1.690451191461817,PDGFRA;PDGFA,Hypo
4308,GO_Molecular_Function_2018,insulin-like growth factor I binding (GO:0031994),2/13,0.3664039957531879,0.8214855543083442,0,0,1.6836848982639536,1.690451191461817,ITGA6;IGFBP6,Hypo
4309,GO_Molecular_Function_2018,tRNA-specific ribonuclease activity (GO:0004549),2/13,0.3664039957531879,0.8214855543083442,0,0,1.6836848982639536,1.690451191461817,POP5;TSEN54,Hypo
4310,GO_Molecular_Function_2018,ubiquitin-ubiquitin ligase activity (GO:0034450),2/13,0.3664039957531879,0.8214855543083442,0,0,1.6836848982639536,1.690451191461817,PELI2;UBE4B,Hypo
4311,GO_Molecular_Function_2018,GTPase inhibitor activity (GO:0005095),2/13,0.3664039957531879,0.8214855543083442,0,0,1.6836848982639536,1.690451191461817,RTKN;TNK2,Hypo
4312,GO_Molecular_Function_2018,tRNA methyltransferase activity (GO:0008175),2/13,0.3664039957531879,0.8214855543083442,0,0,1.6836848982639536,1.690451191461817,TRMT13;TARBP1,Hypo
4313,GO_Molecular_Function_2018,RNA stem-loop binding (GO:0035613),2/13,0.3664039957531879,0.8214855543083442,0,0,1.6836848982639536,1.690451191461817,CPEB3;MYH10,Hypo
4314,GO_Molecular_Function_2018,carbohydrate kinase activity (GO:0019200),2/13,0.3664039957531879,0.8214855543083442,0,0,1.6836848982639536,1.690451191461817,HK3;HK1,Hypo
4315,GO_Molecular_Function_2018,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",7/60,0.3681447344586929,0.823198968564133,0,0,1.2233465075403722,1.2224646190339008,AMER2;KCNQ1;TWF2;HIP1R;LDLRAP1;SYT7;SLC9A1,Hypo
4316,GO_Molecular_Function_2018,sodium ion transmembrane transporter activity (GO:0015081),8/71,0.3889501030559102,0.8553190174195333,0,0,1.1761398002386674,1.1106337688776573,SLC8A3;SLC9A6;SLC9A8;TRAPPC10;SLC4A1;ATP1A2;SLC8A2;SLC9A1,Hypo
4317,GO_Molecular_Function_2018,androgen receptor binding (GO:0050681),5/42,0.3905227909558448,0.8553190174195333,0,0,1.2515111512540815,1.176757073452504,NCOA1;KDM3A;PRKCB;TGFB1I1;SMARCA4,Hypo
4318,GO_Molecular_Function_2018,anion transmembrane transporter activity (GO:0008509),7/62,0.4011502168431203,0.8553190174195333,0,0,1.1787301735834932,1.076674909173018,SLC22A23;ABCA1;ABCC4;SLC22A15;SLC22A17;SLCO2B1;SLC4A1,Hypo
4319,GO_Molecular_Function_2018,insulin-like growth factor binding (GO:0005520),2/14,0.4025020658147796,0.8553190174195333,0,0,1.5432922655715264,1.404480919411767,ITGA6;IGFBP6,Hypo
4320,GO_Molecular_Function_2018,protein serine/threonine/tyrosine kinase activity (GO:0004712),2/14,0.4025020658147796,0.8553190174195333,0,0,1.5432922655715264,1.404480919411767,TNK2;SGK1,Hypo
4321,GO_Molecular_Function_2018,5'-nucleotidase activity (GO:0008253),2/14,0.4025020658147796,0.8553190174195333,0,0,1.5432922655715264,1.404480919411767,NT5DC1;NT5DC2,Hypo
4322,GO_Molecular_Function_2018,retinoic acid binding (GO:0001972),2/14,0.4025020658147796,0.8553190174195333,0,0,1.5432922655715264,1.404480919411767,RXRA;RARA,Hypo
4323,GO_Molecular_Function_2018,calcium-transporting ATPase activity (GO:0005388),2/14,0.4025020658147796,0.8553190174195333,0,0,1.5432922655715264,1.404480919411767,ATP13A2;ATP2B1,Hypo
4324,GO_Molecular_Function_2018,1-phosphatidylinositol binding (GO:0005545),2/14,0.4025020658147796,0.8553190174195333,0,0,1.5432922655715264,1.404480919411767,SCARB1;WDFY3,Hypo
4325,GO_Molecular_Function_2018,transcription coactivator binding (GO:0001223),2/14,0.4025020658147796,0.8553190174195333,0,0,1.5432922655715264,1.404480919411767,RORA;TEAD1,Hypo
4326,GO_Molecular_Function_2018,LRR domain binding (GO:0030275),2/14,0.4025020658147796,0.8553190174195333,0,0,1.5432922655715264,1.404480919411767,DDIT3;PAWR,Hypo
4327,GO_Molecular_Function_2018,tropomyosin binding (GO:0005523),2/14,0.4025020658147796,0.8553190174195333,0,0,1.5432922655715264,1.404480919411767,TMOD2;LMOD1,Hypo
4328,GO_Molecular_Function_2018,phosphoric diester hydrolase activity (GO:0008081),4/33,0.4037578593194345,0.8553190174195333,0,0,1.2773150937378177,1.1584480729787574,SMPD4;PDE2A;ENPP6;GPLD1,Hypo
4329,GO_Molecular_Function_2018,ion channel inhibitor activity (GO:0008200),4/33,0.4037578593194345,0.8553190174195333,0,0,1.2773150937378177,1.1584480729787574,STX8;NEDD4L;SCN1B;STX1A,Hypo
4330,GO_Molecular_Function_2018,anion:cation symporter activity (GO:0015296),5/43,0.4105412161008536,0.8553190174195333,0,0,1.218508997429306,1.0848129114052931,SLC13A3;SLC6A8;SLC10A3;SLC4A1;SLC6A1,Hypo
4331,GO_Molecular_Function_2018,ATPase binding (GO:0051117),7/63,0.4176489210332264,0.8553190174195333,0,0,1.1576170869788986,1.0107318024393728,ABCA1;NUFIP1;TCIRG1;ATP6V1E1;ANK1;SNTA1;ATP6V0A1,Hypo
4332,GO_Molecular_Function_2018,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",3/24,0.4190906864479796,0.8553190174195333,0,0,1.3228410008071023,1.150432417434982,POP5;AGO2;DROSHA,Hypo
4333,GO_Molecular_Function_2018,death receptor activity (GO:0005035),3/24,0.4190906864479796,0.8553190174195333,0,0,1.3228410008071023,1.150432417434982,TNFRSF9;TNFRSF25;TNFRSF4,Hypo
4334,GO_Molecular_Function_2018,tumor necrosis factor-activated receptor activity (GO:0005031),3/24,0.4190906864479796,0.8553190174195333,0,0,1.3228410008071023,1.150432417434982,TNFRSF9;TNFRSF25;TNFRSF4,Hypo
4335,GO_Molecular_Function_2018,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",3/24,0.4190906864479796,0.8553190174195333,0,0,1.3228410008071023,1.150432417434982,HIP1;PLEKHA1;HIP1R,Hypo
4336,GO_Molecular_Function_2018,DNA secondary structure binding (GO:0000217),3/24,0.4190906864479796,0.8553190174195333,0,0,1.3228410008071023,1.150432417434982,RAD51;HMGB3;HMGB1,Hypo
4337,GO_Molecular_Function_2018,mannosyltransferase activity (GO:0000030),3/24,0.4190906864479796,0.8553190174195333,0,0,1.3228410008071023,1.150432417434982,DPM3;DPY19L3;DPY19L4,Hypo
4338,GO_Molecular_Function_2018,core promoter sequence-specific DNA binding (GO:0001046),8/73,0.4195845665365773,0.8553190174195333,0,0,1.1398241305553356,0.9899260694524532,SOX3;H2AFY;KMT2A;RORA;NR1D1;CHD2;PRDM10;SMARCA4,Hypo
4339,GO_Molecular_Function_2018,ion channel activity (GO:0005216),10/93,0.4218263699379814,0.8553190174195333,0,0,1.115824121227177,0.9631364169230624,CACNA1I;CALHM2;DLG3;GRIK5;GRIK4;CACNA1D;CACNA1C;CACNA1E;KCNK3;TPCN1,Hypo
4340,GO_Molecular_Function_2018,E-box binding (GO:0070888),4/34,0.4264924975366813,0.8553190174195333,0,0,1.2346694073312778,1.0521365031591683,PER1;BHLHE40;BHLHE41;TCF4,Hypo
4341,GO_Molecular_Function_2018,"transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding (GO:0003705)",7/64,0.4341071627963012,0.8553190174195333,0,0,1.1372448104306057,0.9489896902688952,NFIX;ZBTB16;BHLHE40;BHLHE41;HIVEP1;RFX1;MEF2D,Hypo
4342,GO_Molecular_Function_2018,RNA polymerase II transcription cofactor activity (GO:0001104),9/84,0.4352544702487261,0.8553190174195333,0,0,1.1112828438948996,0.9243922180308858,RERE;NCOA1;SOX3;WWOX;MED24;ZMYND8;JADE1;MED13L;SMARCA4,Hypo
4343,GO_Molecular_Function_2018,phosphatidylinositol phosphate kinase activity (GO:0016307),2/15,0.4375878478519471,0.8553190174195333,0,0,1.4244984994471648,1.177316383434859,PIP4K2A;PIP5K1C,Hypo
4344,GO_Molecular_Function_2018,insulin-like growth factor receptor binding (GO:0005159),2/15,0.4375878478519471,0.8553190174195333,0,0,1.4244984994471648,1.177316383434859,GNAS;PIK3R1,Hypo
4345,GO_Molecular_Function_2018,metal ion transmembrane transporter activity (GO:0046873),3/25,0.4458854164257624,0.8553190174195333,0,0,1.2626418265863566,1.0198273105696067,MRS2;TRAPPC10;ATP2B1,Hypo
4346,GO_Molecular_Function_2018,ATP-dependent helicase activity (GO:0008026),9/85,0.4495565649303226,0.8553190174195333,0,0,1.0965996908809892,0.876724427296696,UPF1;DHX30;DDX27;DDX24;DHX34;RECQL;DDX54;CHD2;SNRNP200,Hypo
4347,GO_Molecular_Function_2018,bile acid:sodium symporter activity (GO:0008508),1/6,0.4596831205219083,0.8553190174195333,0,0,1.8517188301693177,1.439189011887332,SLC10A3,Hypo
4348,GO_Molecular_Function_2018,vascular endothelial growth factor receptor 2 binding (GO:0043184),1/6,0.4596831205219083,0.8553190174195333,0,0,1.8517188301693177,1.439189011887332,DAB2IP,Hypo
4349,GO_Molecular_Function_2018,protein phosphatase 2B binding (GO:0030346),1/6,0.4596831205219083,0.8553190174195333,0,0,1.8517188301693177,1.439189011887332,SLC9A1,Hypo
4350,GO_Molecular_Function_2018,long-chain fatty acid binding (GO:0036041),1/6,0.4596831205219083,0.8553190174195333,0,0,1.8517188301693177,1.439189011887332,PPARD,Hypo
4351,GO_Molecular_Function_2018,O-acetyltransferase activity (GO:0016413),1/6,0.4596831205219083,0.8553190174195333,0,0,1.8517188301693177,1.439189011887332,GNPAT,Hypo
4352,GO_Molecular_Function_2018,beta-glucosidase activity (GO:0008422),1/6,0.4596831205219083,0.8553190174195333,0,0,1.8517188301693177,1.439189011887332,KL,Hypo
4353,GO_Molecular_Function_2018,G-protein coupled neurotransmitter receptor activity (GO:0099528),1/6,0.4596831205219083,0.8553190174195333,0,0,1.8517188301693177,1.439189011887332,CHRM4,Hypo
4354,GO_Molecular_Function_2018,"alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity (GO:0001665)",1/6,0.4596831205219083,0.8553190174195333,0,0,1.8517188301693177,1.439189011887332,ST6GALNAC3,Hypo
4355,GO_Molecular_Function_2018,cAMP-dependent protein kinase activity (GO:0004691),1/6,0.4596831205219083,0.8553190174195333,0,0,1.8517188301693177,1.439189011887332,PRKAG1,Hypo
4356,GO_Molecular_Function_2018,"alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity (GO:0003828)",1/6,0.4596831205219083,0.8553190174195333,0,0,1.8517188301693177,1.439189011887332,ST8SIA1,Hypo
4357,GO_Molecular_Function_2018,5'-3' DNA helicase activity (GO:0043139),1/6,0.4596831205219083,0.8553190174195333,0,0,1.8517188301693177,1.439189011887332,ERCC2,Hypo
4358,GO_Molecular_Function_2018,G-protein coupled acetylcholine receptor activity (GO:0016907),1/6,0.4596831205219083,0.8553190174195333,0,0,1.8517188301693177,1.439189011887332,CHRM4,Hypo
4359,GO_Molecular_Function_2018,NADPH-hemoprotein reductase activity (GO:0003958),1/6,0.4596831205219083,0.8553190174195333,0,0,1.8517188301693177,1.439189011887332,POR,Hypo
4360,GO_Molecular_Function_2018,neurotrophin TRKA receptor binding (GO:0005168),1/6,0.4596831205219083,0.8553190174195333,0,0,1.8517188301693177,1.439189011887332,PIK3R1,Hypo
4361,GO_Molecular_Function_2018,chondroitin sulfotransferase activity (GO:0034481),1/6,0.4596831205219083,0.8553190174195333,0,0,1.8517188301693177,1.439189011887332,CHST11,Hypo
4362,GO_Molecular_Function_2018,acyl-CoA oxidase activity (GO:0003997),1/6,0.4596831205219083,0.8553190174195333,0,0,1.8517188301693177,1.439189011887332,ACADL,Hypo
4363,GO_Molecular_Function_2018,solute:proton antiporter activity (GO:0015299),1/6,0.4596831205219083,0.8553190174195333,0,0,1.8517188301693177,1.439189011887332,SLC9A1,Hypo
4364,GO_Molecular_Function_2018,iron ion transmembrane transporter activity (GO:0005381),1/6,0.4596831205219083,0.8553190174195333,0,0,1.8517188301693177,1.439189011887332,SLC25A28,Hypo
4365,GO_Molecular_Function_2018,peptidyl-proline 4-dioxygenase activity (GO:0031545),1/6,0.4596831205219083,0.8553190174195333,0,0,1.8517188301693177,1.439189011887332,EGLN1,Hypo
4366,GO_Molecular_Function_2018,RNA polymerase I core binding (GO:0001042),1/6,0.4596831205219083,0.8553190174195333,0,0,1.8517188301693177,1.439189011887332,TCOF1,Hypo
4367,GO_Molecular_Function_2018,phosphatidylethanolamine binding (GO:0008429),1/6,0.4596831205219083,0.8553190174195333,0,0,1.8517188301693177,1.439189011887332,NF1,Hypo
4368,GO_Molecular_Function_2018,xylosyltransferase activity (GO:0042285),1/6,0.4596831205219083,0.8553190174195333,0,0,1.8517188301693177,1.439189011887332,XXYLT1,Hypo
4369,GO_Molecular_Function_2018,U4 snRNA binding (GO:0030621),1/6,0.4596831205219083,0.8553190174195333,0,0,1.8517188301693177,1.439189011887332,SART3,Hypo
4370,GO_Molecular_Function_2018,phosphoserine residue binding (GO:0050815),1/6,0.4596831205219083,0.8553190174195333,0,0,1.8517188301693177,1.439189011887332,PIN1,Hypo
4371,GO_Molecular_Function_2018,interleukin-1 binding (GO:0019966),1/6,0.4596831205219083,0.8553190174195333,0,0,1.8517188301693177,1.439189011887332,PXDN,Hypo
4372,GO_Molecular_Function_2018,G-protein coupled glutamate receptor binding (GO:0035256),1/6,0.4596831205219083,0.8553190174195333,0,0,1.8517188301693177,1.439189011887332,FYN,Hypo
4373,GO_Molecular_Function_2018,L-ornithine transmembrane transporter activity (GO:0000064),1/6,0.4596831205219083,0.8553190174195333,0,0,1.8517188301693177,1.439189011887332,SLC7A1,Hypo
4374,GO_Molecular_Function_2018,"endoribonuclease activity, producing 3'-phosphomonoesters (GO:0016892)",1/6,0.4596831205219083,0.8553190174195333,0,0,1.8517188301693177,1.439189011887332,TSEN54,Hypo
4375,GO_Molecular_Function_2018,T cell receptor binding (GO:0042608),1/6,0.4596831205219083,0.8553190174195333,0,0,1.8517188301693177,1.439189011887332,DOCK2,Hypo
4376,GO_Molecular_Function_2018,DNA ligase (ATP) activity (GO:0003910),1/6,0.4596831205219083,0.8553190174195333,0,0,1.8517188301693177,1.439189011887332,PARP3,Hypo
4377,GO_Molecular_Function_2018,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",1/6,0.4596831205219083,0.8553190174195333,0,0,1.8517188301693177,1.439189011887332,DPYSL2,Hypo
4378,GO_Molecular_Function_2018,azole transmembrane transporter activity (GO:1901474),1/6,0.4596831205219083,0.8553190174195333,0,0,1.8517188301693177,1.439189011887332,SLC15A4,Hypo
4379,GO_Molecular_Function_2018,"aspartic endopeptidase activity, intramembrane cleaving (GO:0042500)",1/6,0.4596831205219083,0.8553190174195333,0,0,1.8517188301693177,1.439189011887332,SPPL3,Hypo
4380,GO_Molecular_Function_2018,1-phosphatidylinositol 4-kinase activity (GO:0004430),1/6,0.4596831205219083,0.8553190174195333,0,0,1.8517188301693177,1.439189011887332,PI4KA,Hypo
4381,GO_Molecular_Function_2018,mechanically-gated ion channel activity (GO:0008381),1/6,0.4596831205219083,0.8553190174195333,0,0,1.8517188301693177,1.439189011887332,FAM155A,Hypo
4382,GO_Molecular_Function_2018,exoribonuclease activity (GO:0004532),1/6,0.4596831205219083,0.8553190174195333,0,0,1.8517188301693177,1.439189011887332,DCPS,Hypo
4383,GO_Molecular_Function_2018,U3 snoRNA binding (GO:0034511),1/6,0.4596831205219083,0.8553190174195333,0,0,1.8517188301693177,1.439189011887332,RRP9,Hypo
4384,GO_Molecular_Function_2018,acetyl-CoA C-acyltransferase activity (GO:0003988),1/6,0.4596831205219083,0.8553190174195333,0,0,1.8517188301693177,1.439189011887332,HADHA,Hypo
4385,GO_Molecular_Function_2018,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),1/6,0.4596831205219083,0.8553190174195333,0,0,1.8517188301693177,1.439189011887332,ALDH2,Hypo
4386,GO_Molecular_Function_2018,LBD domain binding (GO:0050693),1/6,0.4596831205219083,0.8553190174195333,0,0,1.8517188301693177,1.439189011887332,RXRA,Hypo
4387,GO_Molecular_Function_2018,very long-chain fatty acid-CoA ligase activity (GO:0031957),1/6,0.4596831205219083,0.8553190174195333,0,0,1.8517188301693177,1.439189011887332,ACSL4,Hypo
4388,GO_Molecular_Function_2018,beta-galactosidase activity (GO:0004565),1/6,0.4596831205219083,0.8553190174195333,0,0,1.8517188301693177,1.439189011887332,PSAP,Hypo
4389,GO_Molecular_Function_2018,"transferase activity, transferring acyl groups other than amino-acyl groups (GO:0016747)",6/56,0.4683234253028115,0.8553190174195333,0,0,1.1111111111111112,0.8428846022702755,SOAT1;KAT6A;FASN;NMT1;ZDHHC7;LCLAT1,Hypo
4390,GO_Molecular_Function_2018,RNA polymerase III activity (GO:0001056),2/16,0.47151555614137,0.8553190174195333,0,0,1.3226752713405692,0.9943914811539832,POLR3B;POLR1D,Hypo
4391,GO_Molecular_Function_2018,alkali metal ion binding (GO:0031420),2/16,0.47151555614137,0.8553190174195333,0,0,1.3226752713405692,0.9943914811539832,KCNJ11;ATP1A2,Hypo
4392,GO_Molecular_Function_2018,acid-thiol ligase activity (GO:0016878),2/16,0.47151555614137,0.8553190174195333,0,0,1.3226752713405692,0.9943914811539832,ACSL4;AACS,Hypo
4393,GO_Molecular_Function_2018,nucleotidyltransferase activity (GO:0016779),2/16,0.47151555614137,0.8553190174195333,0,0,1.3226752713405692,0.9943914811539832,REV1;PAPSS1,Hypo
4394,GO_Molecular_Function_2018,nucleotidase activity (GO:0008252),2/16,0.47151555614137,0.8553190174195333,0,0,1.3226752713405692,0.9943914811539832,NT5DC1;NT5DC2,Hypo
4395,GO_Molecular_Function_2018,bile acid transmembrane transporter activity (GO:0015125),2/16,0.47151555614137,0.8553190174195333,0,0,1.3226752713405692,0.9943914811539832,SLCO2B1;SLC10A3,Hypo
4396,GO_Molecular_Function_2018,poly(U) RNA binding (GO:0008266),2/16,0.47151555614137,0.8553190174195333,0,0,1.3226752713405692,0.9943914811539832,ATXN1;PABPC4,Hypo
4397,GO_Molecular_Function_2018,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",2/16,0.47151555614137,0.8553190174195333,0,0,1.3226752713405692,0.9943914811539832,TCIRG1;ATP6V0A1,Hypo
4398,GO_Molecular_Function_2018,calcium channel regulator activity (GO:0005246),3/26,0.4721712837686765,0.8553190174195333,0,0,1.2076773631674147,0.906257360595516,GRM2;NRXN2;SGK1,Hypo
4399,GO_Molecular_Function_2018,RNA polymerase II transcription corepressor activity (GO:0001106),3/26,0.4721712837686765,0.8553190174195333,0,0,1.2076773631674147,0.906257360595516,RERE;SOX3;ZMYND8,Hypo
4400,GO_Molecular_Function_2018,carboxy-lyase activity (GO:0016831),3/26,0.4721712837686765,0.8553190174195333,0,0,1.2076773631674147,0.906257360595516,GAD1;MLYCD;PCK2,Hypo
4401,GO_Molecular_Function_2018,"transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding (GO:0001078)",10/97,0.4757867653527853,0.8553190174195333,0,0,1.0642848678753407,0.7905353646067957,RBL1;TSHZ3;SP2;NFX1;TSHZ1;NACC2;BHLHE40;BHLHE41;ENO1;NR1D1,Hypo
4402,GO_Molecular_Function_2018,nucleoside-triphosphatase activity (GO:0017111),42/424,0.480946651531419,0.8553190174195333,0,0,1.018110573281965,0.7452558468072037,ARF3;RAB5C;LRRK2;FIGN;ATP1A2;KLC1;RAP1GAP;SEPT8;SEPT9;KIF5C;RAB23;KIF13A;KIF1C;KIF1B;KIF21B;KIF3C;RAB6B;MYH10;ABCA1;NSF;UPF1;TOR3A;SEPT11;MYO10;RECQL;MYO19;DNM1;ARL4D;MYO1E;RAB31;RRAGC;KATNAL1;NLRP10;RAB15;KIF26A;GNB2;RHOJ;GNAS;PIN1;MYH9;ACIN1;ATP13A2,Hypo
4403,GO_Molecular_Function_2018,RNA helicase activity (GO:0003724),7/67,0.4829756833709215,0.8553190174195333,0,0,1.0802024360953852,0.7861594200691003,UPF1;DHX30;DDX27;DDX24;DHX34;DDX54;SNRNP200,Hypo
4404,GO_Molecular_Function_2018,ATP-dependent RNA helicase activity (GO:0004004),7/67,0.4829756833709215,0.8553190174195333,0,0,1.0802024360953852,0.7861594200691003,UPF1;DHX30;DDX27;DDX24;DHX34;DDX54;SNRNP200,Hypo
4405,GO_Molecular_Function_2018,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),5/47,0.4891941504791496,0.8553190174195333,0,0,1.1022156934753335,0.7880796274175543,PRMT8;MEPCE;DNMT3A;SMYD2;TARBP1,Hypo
4406,GO_Molecular_Function_2018,RNA polymerase II activating transcription factor binding (GO:0001102),5/47,0.4891941504791496,0.8553190174195333,0,0,1.1022156934753335,0.7880796274175543,SMAD3;RBL1;BHLHE40;BHLHE41;MEF2D,Hypo
4407,GO_Molecular_Function_2018,frizzled binding (GO:0005109),4/37,0.4930844627796626,0.8553190174195333,0,0,1.1222398704413092,0.7935075269133864,WNT5B;DVL1;DVL2;WNT9B,Hypo
4408,GO_Molecular_Function_2018,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),3/27,0.4978718575851876,0.8553190174195333,0,0,1.1572932717000513,0.8071108507355711,SOX3;H2AFY;PRDM10,Hypo
4409,GO_Molecular_Function_2018,RNA-dependent ATPase activity (GO:0008186),7/68,0.4990148760653812,0.8553190174195333,0,0,1.0624351391713,0.738519246647245,UPF1;DHX30;DDX27;DDX24;DHX34;DDX54;SNRNP200,Hypo
4410,GO_Molecular_Function_2018,activating transcription factor binding (GO:0033613),7/68,0.4990148760653812,0.8553190174195333,0,0,1.0624351391713,0.738519246647245,RBL1;SMAD3;PRDM16;BHLHE40;BHLHE41;MEF2D;HDAC7,Hypo
4411,GO_Molecular_Function_2018,double-stranded DNA binding (GO:0003690),10/99,0.5024088027031651,0.8553190174195333,0,0,1.0402525194022936,0.7160486078785996,XRCC6;HLF;RXRA;RAD51;H2AFY;BHLHE40;SETMAR;HMGB3;HMGB1;MAPT,Hypo
4412,GO_Molecular_Function_2018,chemokine binding (GO:0019956),2/17,0.5041774256696413,0.8553190174195333,0,0,1.234428473648186,0.8453699949866341,ACKR3;HMGB1,Hypo
4413,GO_Molecular_Function_2018,ephrin receptor activity (GO:0005003),2/17,0.5041774256696413,0.8553190174195333,0,0,1.234428473648186,0.8453699949866341,EPHB2;EPHB1,Hypo
4414,GO_Molecular_Function_2018,"DNA binding, bending (GO:0008301)",2/17,0.5041774256696413,0.8553190174195333,0,0,1.234428473648186,0.8453699949866341,HMGB3;HMGB1,Hypo
4415,GO_Molecular_Function_2018,receptor antagonist activity (GO:0048019),2/17,0.5041774256696413,0.8553190174195333,0,0,1.234428473648186,0.8453699949866341,PXDN;DKK3,Hypo
4416,GO_Molecular_Function_2018,transmembrane-ephrin receptor activity (GO:0005005),2/17,0.5041774256696413,0.8553190174195333,0,0,1.234428473648186,0.8453699949866341,EPHB2;EPHB1,Hypo
4417,GO_Molecular_Function_2018,acyl-CoA hydrolase activity (GO:0047617),2/17,0.5041774256696413,0.8553190174195333,0,0,1.234428473648186,0.8453699949866341,GNPAT;ACOT7,Hypo
4418,GO_Molecular_Function_2018,cholesterol transporter activity (GO:0017127),2/17,0.5041774256696413,0.8553190174195333,0,0,1.234428473648186,0.8453699949866341,ABCA1;ABCG1,Hypo
4419,GO_Molecular_Function_2018,DNA ligase activity (GO:0003909),1/7,0.512379719806482,0.8553190174195333,0,0,1.543013511202326,1.0317966070672226,PARP3,Hypo
4420,GO_Molecular_Function_2018,extracellular ATP-gated cation channel activity (GO:0004931),1/7,0.512379719806482,0.8553190174195333,0,0,1.543013511202326,1.0317966070672226,P2RX4,Hypo
4421,GO_Molecular_Function_2018,insulin-like growth factor II binding (GO:0031995),1/7,0.512379719806482,0.8553190174195333,0,0,1.543013511202326,1.0317966070672226,IGFBP6,Hypo
4422,GO_Molecular_Function_2018,"beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity (GO:0003831)",1/7,0.512379719806482,0.8553190174195333,0,0,1.543013511202326,1.0317966070672226,B4GALT1,Hypo
4423,GO_Molecular_Function_2018,ATP-gated ion channel activity (GO:0035381),1/7,0.512379719806482,0.8553190174195333,0,0,1.543013511202326,1.0317966070672226,P2RX4,Hypo
4424,GO_Molecular_Function_2018,choline transmembrane transporter activity (GO:0015220),1/7,0.512379719806482,0.8553190174195333,0,0,1.543013511202326,1.0317966070672226,SLC44A2,Hypo
4425,GO_Molecular_Function_2018,opioid receptor activity (GO:0004985),1/7,0.512379719806482,0.8553190174195333,0,0,1.543013511202326,1.0317966070672226,OPRD1,Hypo
4426,GO_Molecular_Function_2018,flap endonuclease activity (GO:0048256),1/7,0.512379719806482,0.8553190174195333,0,0,1.543013511202326,1.0317966070672226,FAN1,Hypo
4427,GO_Molecular_Function_2018,NAADP-sensitive calcium-release channel activity (GO:0072345),1/7,0.512379719806482,0.8553190174195333,0,0,1.543013511202326,1.0317966070672226,TPCN1,Hypo
4428,GO_Molecular_Function_2018,histone serine kinase activity (GO:0035174),1/7,0.512379719806482,0.8553190174195333,0,0,1.543013511202326,1.0317966070672226,MELK,Hypo
4429,GO_Molecular_Function_2018,ATP-dependent 3'-5' DNA helicase activity (GO:0043140),1/7,0.512379719806482,0.8553190174195333,0,0,1.543013511202326,1.0317966070672226,RECQL,Hypo
4430,GO_Molecular_Function_2018,nucleotide receptor activity (GO:0016502),1/7,0.512379719806482,0.8553190174195333,0,0,1.543013511202326,1.0317966070672226,P2RX4,Hypo
4431,GO_Molecular_Function_2018,peptidyl-proline dioxygenase activity (GO:0031543),1/7,0.512379719806482,0.8553190174195333,0,0,1.543013511202326,1.0317966070672226,EGLN1,Hypo
4432,GO_Molecular_Function_2018,poly(G) binding (GO:0034046),1/7,0.512379719806482,0.8553190174195333,0,0,1.543013511202326,1.0317966070672226,ATXN1,Hypo
4433,GO_Molecular_Function_2018,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",1/7,0.512379719806482,0.8553190174195333,0,0,1.543013511202326,1.0317966070672226,FAN1,Hypo
4434,GO_Molecular_Function_2018,bubble DNA binding (GO:0000405),1/7,0.512379719806482,0.8553190174195333,0,0,1.543013511202326,1.0317966070672226,HMGB1,Hypo
4435,GO_Molecular_Function_2018,C4-dicarboxylate transmembrane transporter activity (GO:0015556),1/7,0.512379719806482,0.8553190174195333,0,0,1.543013511202326,1.0317966070672226,SLC13A3,Hypo
4436,GO_Molecular_Function_2018,myosin heavy chain binding (GO:0032036),1/7,0.512379719806482,0.8553190174195333,0,0,1.543013511202326,1.0317966070672226,SPTBN5,Hypo
4437,GO_Molecular_Function_2018,CDP-alcohol phosphatidyltransferase activity (GO:0017169),1/7,0.512379719806482,0.8553190174195333,0,0,1.543013511202326,1.0317966070672226,CHPT1,Hypo
4438,GO_Molecular_Function_2018,leucine binding (GO:0070728),1/7,0.512379719806482,0.8553190174195333,0,0,1.543013511202326,1.0317966070672226,UBR2,Hypo
4439,GO_Molecular_Function_2018,type II transforming growth factor beta receptor binding (GO:0005114),1/7,0.512379719806482,0.8553190174195333,0,0,1.543013511202326,1.0317966070672226,TGFB3,Hypo
4440,GO_Molecular_Function_2018,phosphatidylinositol 3-kinase regulatory subunit binding (GO:0036312),1/7,0.512379719806482,0.8553190174195333,0,0,1.543013511202326,1.0317966070672226,DAB2IP,Hypo
4441,GO_Molecular_Function_2018,NEDD8-specific protease activity (GO:0019784),1/7,0.512379719806482,0.8553190174195333,0,0,1.543013511202326,1.0317966070672226,COPS4,Hypo
4442,GO_Molecular_Function_2018,quaternary ammonium group transmembrane transporter activity (GO:0015651),1/7,0.512379719806482,0.8553190174195333,0,0,1.543013511202326,1.0317966070672226,SLC25A29,Hypo
4443,GO_Molecular_Function_2018,annealing helicase activity (GO:0036310),1/7,0.512379719806482,0.8553190174195333,0,0,1.543013511202326,1.0317966070672226,RECQL,Hypo
4444,GO_Molecular_Function_2018,potassium ion transmembrane transporter activity (GO:0015079),4/38,0.5145664997754792,0.8561212304388186,0,0,1.0891723595913183,0.7236793145529342,KCNK6;KCNU1;KCNK13;KCNK3,Hypo
4445,GO_Molecular_Function_2018,growth factor activity (GO:0008083),7/69,0.5148914161713891,0.8561212304388186,0,0,1.0452409808576697,0.693830171777366,GRN;TGFA;PDGFA;INHBA;FGF1;F2;EREG,Hypo
4446,GO_Molecular_Function_2018,protein heterodimerization activity (GO:0046982),26/265,0.5171671932299471,0.8582124879780421,0,0,1.00706773719326,0.6640494542166392,TENM1;TENM2;HIP1;TENM4;EPAS1;PEF1;BHLHE41;PDGFA;RXRA;SCUBE1;TCOF1;BUD23;TEAD1;BOK;TPD52;GABBR2;ZHX2;PRMT8;NR4A1;RRAGC;DDIT3;BHLHE40;RARA;RAB3GAP2;TCF4;ABCG1,Hypo
4447,GO_Molecular_Function_2018,kinase inhibitor activity (GO:0019210),6/59,0.52041243781038,0.8593057509703432,0,0,1.0480433263452131,0.6845123443846025,CDKN1C;PPP1R1B;LRRC4;RTN4RL2;TRIB1;MAPK8IP1,Hypo
4448,GO_Molecular_Function_2018,double-stranded RNA binding (GO:0003725),6/59,0.52041243781038,0.8593057509703432,0,0,1.0480433263452131,0.6845123443846025,DHX30;MBNL1;ACTN1;AGO2;DROSHA;ADARB2,Hypo
4449,GO_Molecular_Function_2018,acylglycerol O-acyltransferase activity (GO:0016411),3/28,0.5229227167826643,0.8593057509703432,0,0,1.110939907550077,0.7202463326944146,AGPAT5;LCLAT1;AGPAT4,Hypo
4450,GO_Molecular_Function_2018,sterol transporter activity (GO:0015248),3/28,0.5229227167826643,0.8593057509703432,0,0,1.110939907550077,0.7202463326944146,ABCA1;OSBPL2;ABCG1,Hypo
4451,GO_Molecular_Function_2018,inorganic anion exchanger activity (GO:0005452),3/28,0.5229227167826643,0.8593057509703432,0,0,1.110939907550077,0.7202463326944146,SLC22A23;SLC22A17;SLC4A1,Hypo
4452,GO_Molecular_Function_2018,L-amino acid transmembrane transporter activity (GO:0015179),5/49,0.5271053736892358,0.8619444367956934,0,0,1.0519981304043,0.6736520527674852,SLC7A5;SLC7A8;SLC43A2;SLC7A1;SLC15A4,Hypo
4453,GO_Molecular_Function_2018,organic anion transmembrane transporter activity (GO:0008514),7/70,0.5305848573999832,0.8619444367956934,0,0,1.0285926688397096,0.6518967057751874,SLC22A23;SLC22A15;SLC25A17;SLC22A17;SLCO2B1;SLC4A1;SLC25A23,Hypo
4454,GO_Molecular_Function_2018,fatty acid ligase activity (GO:0015645),2/18,0.5354976898191676,0.8619444367956934,0,0,1.157212525667351,0.7227471543191993,ACSL6;ACSL4,Hypo
4455,GO_Molecular_Function_2018,NAD+ ADP-ribosyltransferase activity (GO:0003950),2/18,0.5354976898191676,0.8619444367956934,0,0,1.157212525667351,0.7227471543191993,PARP3;TNKS2,Hypo
4456,GO_Molecular_Function_2018,voltage-gated anion channel activity (GO:0008308),2/18,0.5354976898191676,0.8619444367956934,0,0,1.157212525667351,0.7227471543191993,CLCN6;CLCN5,Hypo
4457,GO_Molecular_Function_2018,RNA polymerase II transcription coactivator activity (GO:0001105),4/39,0.5356161712298375,0.8619444367956934,0,0,1.0579944207898988,0.6605455630014396,NCOA1;WWOX;JADE1;SMARCA4,Hypo
4458,GO_Molecular_Function_2018,phosphatidylinositol phosphate binding (GO:1901981),8/81,0.5394233780350159,0.8619444367956934,0,0,1.0144604489087652,0.6261803059734548,ZFYVE28;CYTH3;HIP1;MYO10;HIP1R;DAB2IP;MAPT;KCNH1,Hypo
4459,GO_Molecular_Function_2018,cation-transporting ATPase activity (GO:0019829),3/29,0.547270588724001,0.8619444367956934,0,0,1.068152186796255,0.6438948717844778,ATP8A1;ATP13A2;ATP2B1,Hypo
4460,GO_Molecular_Function_2018,nucleosomal DNA binding (GO:0031492),3/29,0.547270588724001,0.8619444367956934,0,0,1.068152186796255,0.6438948717844778,SMARCC2;H2AFY;SMARCA4,Hypo
4461,GO_Molecular_Function_2018,ubiquitin conjugating enzyme binding (GO:0031624),3/29,0.547270588724001,0.8619444367956934,0,0,1.068152186796255,0.6438948717844778,RNF144B;RNF114;RNF19B,Hypo
4462,GO_Molecular_Function_2018,protein serine/threonine phosphatase activity (GO:0004722),6/61,0.5539883567848178,0.8619444367956934,0,0,1.0098204264870931,0.596411666979097,MTMR3;CTDP1;PPP2R2C;CTDSPL;CAMK2G;PPM1F,Hypo
4463,GO_Molecular_Function_2018,histone deacetylase activity (GO:0004407),4/40,0.5561968352747146,0.8619444367956934,0,0,1.028548589699669,0.6033805726987415,HDAC5;NACC2;RBBP7;MTA3,Hypo
4464,GO_Molecular_Function_2018,protein kinase B binding (GO:0043422),1/8,0.5599392338305909,0.8619444367956934,0,0,1.3225097119401892,0.7669591057947374,RARA,Hypo
4465,GO_Molecular_Function_2018,rRNA methyltransferase activity (GO:0008649),1/8,0.5599392338305909,0.8619444367956934,0,0,1.3225097119401892,0.7669591057947374,BUD23,Hypo
4466,GO_Molecular_Function_2018,ether hydrolase activity (GO:0016803),1/8,0.5599392338305909,0.8619444367956934,0,0,1.3225097119401892,0.7669591057947374,TMEM86A,Hypo
4467,GO_Molecular_Function_2018,"mannosyl-oligosaccharide 1,2-alpha-mannosidase activity (GO:0004571)",1/8,0.5599392338305909,0.8619444367956934,0,0,1.3225097119401892,0.7669591057947374,MAN1C1,Hypo
4468,GO_Molecular_Function_2018,cyclic nucleotide-dependent protein kinase activity (GO:0004690),1/8,0.5599392338305909,0.8619444367956934,0,0,1.3225097119401892,0.7669591057947374,PRKAG1,Hypo
4469,GO_Molecular_Function_2018,neurotrophin TRK receptor binding (GO:0005167),1/8,0.5599392338305909,0.8619444367956934,0,0,1.3225097119401892,0.7669591057947374,PIK3R1,Hypo
4470,GO_Molecular_Function_2018,purinergic receptor activity (GO:0035586),1/8,0.5599392338305909,0.8619444367956934,0,0,1.3225097119401892,0.7669591057947374,P2RX4,Hypo
4471,GO_Molecular_Function_2018,phosphatidylinositol transporter activity (GO:0008526),1/8,0.5599392338305909,0.8619444367956934,0,0,1.3225097119401892,0.7669591057947374,PITPNM2,Hypo
4472,GO_Molecular_Function_2018,protein phosphatase activator activity (GO:0072542),1/8,0.5599392338305909,0.8619444367956934,0,0,1.3225097119401892,0.7669591057947374,CALM3,Hypo
4473,GO_Molecular_Function_2018,galactosidase activity (GO:0015925),1/8,0.5599392338305909,0.8619444367956934,0,0,1.3225097119401892,0.7669591057947374,PSAP,Hypo
4474,GO_Molecular_Function_2018,RNA polymerase I regulatory region sequence-specific DNA binding (GO:0001163),1/8,0.5599392338305909,0.8619444367956934,0,0,1.3225097119401892,0.7669591057947374,SMARCA4,Hypo
4475,GO_Molecular_Function_2018,sodium:bicarbonate symporter activity (GO:0008510),1/8,0.5599392338305909,0.8619444367956934,0,0,1.3225097119401892,0.7669591057947374,SLC4A1,Hypo
4476,GO_Molecular_Function_2018,activin receptor binding (GO:0070697),1/8,0.5599392338305909,0.8619444367956934,0,0,1.3225097119401892,0.7669591057947374,INHBA,Hypo
4477,GO_Molecular_Function_2018,phosphatidylcholine transporter activity (GO:0008525),1/8,0.5599392338305909,0.8619444367956934,0,0,1.3225097119401892,0.7669591057947374,ABCA1,Hypo
4478,GO_Molecular_Function_2018,epinephrine binding (GO:0051379),1/8,0.5599392338305909,0.8619444367956934,0,0,1.3225097119401892,0.7669591057947374,RNLS,Hypo
4479,GO_Molecular_Function_2018,protein-arginine omega-N asymmetric methyltransferase activity (GO:0035242),1/8,0.5599392338305909,0.8619444367956934,0,0,1.3225097119401892,0.7669591057947374,PRMT8,Hypo
4480,GO_Molecular_Function_2018,RNA polymerase I CORE element sequence-specific DNA binding (GO:0001164),1/8,0.5599392338305909,0.8619444367956934,0,0,1.3225097119401892,0.7669591057947374,SMARCA4,Hypo
4481,GO_Molecular_Function_2018,acetylcholine receptor regulator activity (GO:0030548),1/8,0.5599392338305909,0.8619444367956934,0,0,1.3225097119401892,0.7669591057947374,CDK5,Hypo
4482,GO_Molecular_Function_2018,NAD+ binding (GO:0070403),1/8,0.5599392338305909,0.8619444367956934,0,0,1.3225097119401892,0.7669591057947374,CRYL1,Hypo
4483,GO_Molecular_Function_2018,enoyl-CoA hydratase activity (GO:0004300),1/8,0.5599392338305909,0.8619444367956934,0,0,1.3225097119401892,0.7669591057947374,HADHA,Hypo
4484,GO_Molecular_Function_2018,signal recognition particle binding (GO:0005047),1/8,0.5599392338305909,0.8619444367956934,0,0,1.3225097119401892,0.7669591057947374,SRP68,Hypo
4485,GO_Molecular_Function_2018,glucosidase activity (GO:0015926),1/8,0.5599392338305909,0.8619444367956934,0,0,1.3225097119401892,0.7669591057947374,KL,Hypo
4486,GO_Molecular_Function_2018,RNA binding (GO:0003723),134/1387,0.5603877961610795,0.8619444367956934,0,0,0.9891669684387426,0.5728525489158418,DMGDH;RTCB;BCCIP;MSI2;ADARB1;ENO1;ADARB2;RRP9;RIMS1;PEG10;MBNL1;MBNL2;RBFOX3;ACTN1;FNDC3B;ALG13;WBP11;SND1;ZC3H11A;SRSF4;FLYWCH2;SNRNP200;PPIB;ZCCHC8;ANP32A;PEF1;STXBP1;MEPCE;RPN1;CSTF2;TWF2;DHX30;ATXN2;PDCD11;DHX34;PCBP4;HLTF;ERI3;MAP4;MYH10;MARK2;YARS;SRPK2;XRCC6;SMAD3;MRPL28;HELZ;EIF2AK4;PRRC2B;MRPL22;PRRC2A;CHERP;SRPK1;DIAPH1;SON;FASN;HNRNPF;AGO2;KYAT3;UBE2O;CPEB3;DCP1A;LSM14A;EIF4G3;WRAP53;ZC3H3;CELF4;CELF5;HMGB3;TCF20;HMGB1;CHD2;SMG5;RPGR;SMG6;DUSP14;SYNE1;ELAVL3;EEF2K;SART3;CSRP1;MYO18A;KIF1C;BUD23;RRP12;TNPO1;RBM33;LRRC47;ZCCHC24;UPF1;CLUH;PABPC4;PRPF40B;DDX54;DNM1;PCDHGA9;PKM;NFX1;MYH9;ARHGEF1;MAPT;SLC25A5;PLEC;RNASEL;SF3B2;GRN;DDX27;NUFIP1;LRP1;DDX24;AHNAK;USP10;JAKMIP1;UNK;TCOF1;FAM120A;FLNA;DROSHA;MBNL3;TEFM;SPEN;DYNC1H1;PTCD2;UTP4;AHNAK2;ADAT1;SAMD4B;PDAP1;SRP68;BICC1;SCAF4;BOP1;ACIN1;R3HDM2,Hypo
4487,GO_Molecular_Function_2018,transforming growth factor beta binding (GO:0050431),2/19,0.5654273707568428,0.8619444367956934,0,0,1.089080806860732,0.6209649341298267,TWSG1;TGFB3,Hypo
4488,GO_Molecular_Function_2018,gamma-tubulin binding (GO:0043015),2/19,0.5654273707568428,0.8619444367956934,0,0,1.089080806860732,0.6209649341298267,TUBGCP6;RAB11FIP5,Hypo
4489,GO_Molecular_Function_2018,dynein complex binding (GO:0070840),2/19,0.5654273707568428,0.8619444367956934,0,0,1.089080806860732,0.6209649341298267,ATMIN;NUMA1,Hypo
4490,GO_Molecular_Function_2018,FAD binding (GO:0071949),2/19,0.5654273707568428,0.8619444367956934,0,0,1.089080806860732,0.6209649341298267,CRY2;MICAL3,Hypo
4491,GO_Molecular_Function_2018,RNA polymerase binding (GO:0070063),2/19,0.5654273707568428,0.8619444367956934,0,0,1.089080806860732,0.6209649341298267,BIN1;PPIB,Hypo
4492,GO_Molecular_Function_2018,purine ribonucleoside triphosphate binding (GO:0035639),38/396,0.5668909276177624,0.8626156172956204,0,0,0.98217666721208,0.5574720450269807,RYR1;NIM1K;LRRK2;PRKAG1;TWF2;PRKAG2;ATP1A2;IDE;STK4;ABL1;MYO18A;MAP4K5;MYH10;PDK2;MARK2;MAP4K4;ABCA1;SRPK2;KCNJ11;LMTK2;CDC42BPB;PEX1;CDC42BPA;SYN3;SRPK1;RAB31;RAD51;P2RX4;RRAGC;WNK2;RHOJ;SIK3;SCG5;MYH9;ERCC6;PFKM;CARS2;ABCG1,Hypo
4493,GO_Molecular_Function_2018,Hsp90 protein binding (GO:0051879),3/30,0.5708724682517277,0.8671089923174891,0,0,1.0285339268390117,0.5765852604770758,UNC45B;MAPT;FKBP6,Hypo
4494,GO_Molecular_Function_2018,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",4/41,0.5762769993027531,0.8702274775890788,0,0,1.0006944251548568,0.5515495764279483,MPP3;DLG3;CARD11;TJP2,Hypo
4495,GO_Molecular_Function_2018,RNA polymerase II core promoter proximal region sequence-specific DNA binding (GO:0000978),25/262,0.576376363181666,0.8702274775890788,0,0,0.9761082799057482,0.5378302188265205,AKNA;BHLHE41;LITAF;ZIC3;NACC2;MEF2D;SMARCC2;SMAD3;TFEB;NFATC2;RFX1;NR1D1;GRHL1;SMARCA4;PER1;NR4A1;NR6A1;SP2;ELF4;DDIT3;NFIC;FOSB;TCF4;ERG;SSBP3,Hypo
4496,GO_Molecular_Function_2018,endonuclease activity (GO:0004519),7/73,0.5763831225424839,0.8702274775890788,0,0,0.9816746986072772,0.5408857721250071,RNASEL;RAD51;NOB1;ZC3H3;AGO2;SETMAR;SMG6,Hypo
4497,GO_Molecular_Function_2018,ubiquitin-like protein-specific protease activity (GO:0019783),7/74,0.5911677175175023,0.8702274775890788,0,0,0.9669690661463656,0.5082926232762027,USP46;COPS4;TRRAP;USP4;USP10;USP2;JOSD1,Hypo
4498,GO_Molecular_Function_2018,phosphatidylinositol-3-phosphate binding (GO:0032266),3/31,0.593694736719161,0.8702274775890788,0,0,0.9917455425930002,0.5170862113924358,ZFYVE28;HIP1;DAB2IP,Hypo
4499,GO_Molecular_Function_2018,protein serine/threonine kinase activator activity (GO:0043539),3/31,0.593694736719161,0.8702274775890788,0,0,0.9917455425930002,0.5170862113924358,CALM3;FAM20A;STK4,Hypo
4500,GO_Molecular_Function_2018,ligand-gated channel activity (GO:0022834),3/31,0.593694736719161,0.8702274775890788,0,0,0.9917455425930002,0.5170862113924358,DLG3;GRIK5;GRIK4,Hypo
4501,GO_Molecular_Function_2018,"transcription factor activity, RNA polymerase II core promoter sequence-specific (GO:0000983)",2/20,0.5939397801564141,0.8702274775890788,0,0,1.028519279032626,0.5358352432376566,SMAD3;TAF4,Hypo
4502,GO_Molecular_Function_2018,poly-pyrimidine tract binding (GO:0008187),2/20,0.5939397801564141,0.8702274775890788,0,0,1.028519279032626,0.5358352432376566,ATXN1;PABPC4,Hypo
4503,GO_Molecular_Function_2018,poly-purine tract binding (GO:0070717),2/20,0.5939397801564141,0.8702274775890788,0,0,1.028519279032626,0.5358352432376566,ATXN1;PABPC4,Hypo
4504,GO_Molecular_Function_2018,aldo-keto reductase (NADP) activity (GO:0004033),2/20,0.5939397801564141,0.8702274775890788,0,0,1.028519279032626,0.5358352432376566,KCNAB1;KCNAB2,Hypo
4505,GO_Molecular_Function_2018,histone deacetylase binding (GO:0042826),8/85,0.5956812385599567,0.8702274775890788,0,0,0.9615472066553424,0.4981291358107405,NCOR2;HDAC5;SP2;NACC2;BHLHE41;FOXP3;MEF2D;SMG5,Hypo
4506,GO_Molecular_Function_2018,protein deacetylase activity (GO:0033558),4/42,0.5958300608281334,0.8702274775890788,0,0,0.974306269270298,0.5044955771552722,HDAC5;NACC2;RBBP7;MTA3,Hypo
4507,GO_Molecular_Function_2018,"hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances (GO:0016820)",4/42,0.5958300608281334,0.8702274775890788,0,0,0.974306269270298,0.5044955771552722,ABCA1;ABCC4;ABCB8;ABCG1,Hypo
4508,GO_Molecular_Function_2018,"transferase activity, transferring pentosyl groups (GO:0016763)",4/42,0.5958300608281334,0.8702274775890788,0,0,0.974306269270298,0.5044955771552722,PARP3;TNKS2;PPAT;QPRT,Hypo
4509,GO_Molecular_Function_2018,repressing transcription factor binding (GO:0070491),5/53,0.5988385037480671,0.8702274775890788,0,0,0.9641173950299914,0.4943640430820418,HDAC5;ZMYND8;HMGB1;BBS4;HDAC7,Hypo
4510,GO_Molecular_Function_2018,double-stranded telomeric DNA binding (GO:0003691),1/9,0.6028622146050083,0.8702274775890788,0,0,1.1571318624935865,0.5855857968817147,XRCC6,Hypo
4511,GO_Molecular_Function_2018,armadillo repeat domain binding (GO:0070016),1/9,0.6028622146050083,0.8702274775890788,0,0,1.1571318624935865,0.5855857968817147,STRN4,Hypo
4512,GO_Molecular_Function_2018,"transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly (GO:0001075)",1/9,0.6028622146050083,0.8702274775890788,0,0,1.1571318624935865,0.5855857968817147,TAF4,Hypo
4513,GO_Molecular_Function_2018,superoxide-generating NADPH oxidase activator activity (GO:0016176),1/9,0.6028622146050083,0.8702274775890788,0,0,1.1571318624935865,0.5855857968817147,SH3PXD2A,Hypo
4514,GO_Molecular_Function_2018,siRNA binding (GO:0035197),1/9,0.6028622146050083,0.8702274775890788,0,0,1.1571318624935865,0.5855857968817147,AGO2,Hypo
4515,GO_Molecular_Function_2018,"hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides (GO:0016818)",1/9,0.6028622146050083,0.8702274775890788,0,0,1.1571318624935865,0.5855857968817147,NUDT3,Hypo
4516,GO_Molecular_Function_2018,histone-arginine N-methyltransferase activity (GO:0008469),1/9,0.6028622146050083,0.8702274775890788,0,0,1.1571318624935865,0.5855857968817147,PRMT8,Hypo
4517,GO_Molecular_Function_2018,phosphatase activator activity (GO:0019211),1/9,0.6028622146050083,0.8702274775890788,0,0,1.1571318624935865,0.5855857968817147,CALM3,Hypo
4518,GO_Molecular_Function_2018,retinoid X receptor binding (GO:0046965),1/9,0.6028622146050083,0.8702274775890788,0,0,1.1571318624935865,0.5855857968817147,RARG,Hypo
4519,GO_Molecular_Function_2018,peptide disulfide oxidoreductase activity (GO:0015037),1/9,0.6028622146050083,0.8702274775890788,0,0,1.1571318624935865,0.5855857968817147,PDIA5,Hypo
4520,GO_Molecular_Function_2018,vascular endothelial growth factor receptor binding (GO:0005172),1/9,0.6028622146050083,0.8702274775890788,0,0,1.1571318624935865,0.5855857968817147,DAB2IP,Hypo
4521,GO_Molecular_Function_2018,ribonuclease P activity (GO:0004526),1/9,0.6028622146050083,0.8702274775890788,0,0,1.1571318624935865,0.5855857968817147,POP5,Hypo
4522,GO_Molecular_Function_2018,complement component C1q binding (GO:0001849),1/9,0.6028622146050083,0.8702274775890788,0,0,1.1571318624935865,0.5855857968817147,MEGF10,Hypo
4523,GO_Molecular_Function_2018,core promoter binding (GO:0001047),9/97,0.6127031310511522,0.8769270675793165,0,0,0.9464310805114514,0.4636326880226943,HDAC5;KMT2A;H2AFY;AGO2;RORA;NR1D1;FOXO3;CHD2;FOXP3,Hypo
4524,GO_Molecular_Function_2018,monocarboxylic acid transmembrane transporter activity (GO:0008028),3/32,0.6157122945773951,0.8769270675793165,0,0,0.9574942882949896,0.4643612509236122,SLCO2B1;SLC16A10;EMB,Hypo
4525,GO_Molecular_Function_2018,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",3/32,0.6157122945773951,0.8769270675793165,0,0,0.9574942882949896,0.4643612509236122,CYTH3;MYO10;HIP1R,Hypo
4526,GO_Molecular_Function_2018,estrogen receptor binding (GO:0030331),3/32,0.6157122945773951,0.8769270675793165,0,0,0.9574942882949896,0.4643612509236122,NCOA1;DDX54;PADI2,Hypo
4527,GO_Molecular_Function_2018,core promoter proximal region sequence-specific DNA binding (GO:0000987),26/278,0.6189227129579274,0.8769270675793165,0,0,0.9544187044187044,0.4579061117431909,AKNA;BHLHE41;LITAF;ZIC3;NACC2;TEAD1;MEF2D;SMARCC2;SMAD3;TFEB;NFATC2;RFX1;NR1D1;GRHL1;SMARCA4;PER1;NR4A1;NR6A1;SP2;ELF4;DDIT3;NFIC;FOSB;TCF4;ERG;SSBP3,Hypo
4528,GO_Molecular_Function_2018,lysine N-methyltransferase activity (GO:0016278),2/21,0.6210266421647117,0.8769270675793165,0,0,0.9743326488706364,0.4641538499381947,SETD4;SMYD2,Hypo
4529,GO_Molecular_Function_2018,adenylyltransferase activity (GO:0070566),2/21,0.6210266421647117,0.8769270675793165,0,0,0.9743326488706364,0.4641538499381947,ABL1;NMNAT3,Hypo
4530,GO_Molecular_Function_2018,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),2/21,0.6210266421647117,0.8769270675793165,0,0,0.9743326488706364,0.4641538499381947,PEF1;CAPN5,Hypo
4531,GO_Molecular_Function_2018,AU-rich element binding (GO:0017091),2/21,0.6210266421647117,0.8769270675793165,0,0,0.9743326488706364,0.4641538499381947,CPEB3;ELAVL3,Hypo
4532,GO_Molecular_Function_2018,chemokine receptor activity (GO:0004950),2/21,0.6210266421647117,0.8769270675793165,0,0,0.9743326488706364,0.4641538499381947,ACKR3;CMKLR1,Hypo
4533,GO_Molecular_Function_2018,hydrogen-exporting ATPase activity (GO:0036442),2/21,0.6210266421647117,0.8769270675793165,0,0,0.9743326488706364,0.4641538499381947,TCIRG1;ATP6V0A1,Hypo
4534,GO_Molecular_Function_2018,aspartic-type endopeptidase activity (GO:0004190),2/21,0.6210266421647117,0.8769270675793165,0,0,0.9743326488706364,0.4641538499381947,SPPL3;CTSD,Hypo
4535,GO_Molecular_Function_2018,voltage-gated ion channel activity (GO:0005244),2/21,0.6210266421647117,0.8769270675793165,0,0,0.9743326488706364,0.4641538499381947,PTK2B;GRIN2B,Hypo
4536,GO_Molecular_Function_2018,single-stranded DNA binding (GO:0003697),8/87,0.6224951764288922,0.8775308256347093,0,0,0.937099949158508,0.4442035550609275,STN1;RAD51;ERCC1;CRY2;SETMAR;HMGB1;MAPT;WBP11,Hypo
4537,GO_Molecular_Function_2018,transforming growth factor beta receptor binding (GO:0005160),4/44,0.6332712479262477,0.8824774434228827,0,0,0.9254881808838644,0.4228152327033952,SMAD3;TGFB3;INHBA;SMAD7,Hypo
4538,GO_Molecular_Function_2018,transmitter-gated ion channel activity (GO:0022824),3/33,0.6369077211547264,0.8824774434228827,0,0,0.9255264509501796,0.4175332093338229,GRID1;GRIK5;GRIK4,Hypo
4539,GO_Molecular_Function_2018,sodium-independent organic anion transmembrane transporter activity (GO:0015347),3/33,0.6369077211547264,0.8824774434228827,0,0,0.9255264509501796,0.4175332093338229,SLC22A23;SLC22A17;SLCO2B1,Hypo
4540,GO_Molecular_Function_2018,Lys48-specific deubiquitinase activity (GO:1990380),1/10,0.6416004635308081,0.8824774434228827,0,0,1.02850464625734,0.4564395626787057,USP27X,Hypo
4541,GO_Molecular_Function_2018,protein serine/threonine phosphatase inhibitor activity (GO:0004865),1/10,0.6416004635308081,0.8824774434228827,0,0,1.02850464625734,0.4564395626787057,PPP1R1B,Hypo
4542,GO_Molecular_Function_2018,NADPH binding (GO:0070402),1/10,0.6416004635308081,0.8824774434228827,0,0,1.02850464625734,0.4564395626787057,KCNAB1,Hypo
4543,GO_Molecular_Function_2018,galactosyltransferase activity (GO:0008378),1/10,0.6416004635308081,0.8824774434228827,0,0,1.02850464625734,0.4564395626787057,B4GALT1,Hypo
4544,GO_Molecular_Function_2018,volume-sensitive anion channel activity (GO:0005225),1/10,0.6416004635308081,0.8824774434228827,0,0,1.02850464625734,0.4564395626787057,LRRC8D,Hypo
4545,GO_Molecular_Function_2018,fatty acid synthase activity (GO:0004312),1/10,0.6416004635308081,0.8824774434228827,0,0,1.02850464625734,0.4564395626787057,FASN,Hypo
4546,GO_Molecular_Function_2018,co-SMAD binding (GO:0070410),1/10,0.6416004635308081,0.8824774434228827,0,0,1.02850464625734,0.4564395626787057,SMAD3,Hypo
4547,GO_Molecular_Function_2018,magnesium ion transmembrane transporter activity (GO:0015095),1/10,0.6416004635308081,0.8824774434228827,0,0,1.02850464625734,0.4564395626787057,MRS2,Hypo
4548,GO_Molecular_Function_2018,mannosyl-oligosaccharide mannosidase activity (GO:0015924),1/10,0.6416004635308081,0.8824774434228827,0,0,1.02850464625734,0.4564395626787057,MAN1C1,Hypo
4549,GO_Molecular_Function_2018,RNA polymerase II transcription factor binding (GO:0001085),11/121,0.6418479308403638,0.8824774434228827,0,0,0.925219185146983,0.4102457684024008,RERE;SPEN;HDAC5;SMAD3;RBL1;TRPS1;BHLHE40;BHLHE41;TEAD1;MEF2D;BBS4,Hypo
4550,GO_Molecular_Function_2018,Wnt-activated receptor activity (GO:0042813),2/22,0.6466947601095914,0.8824774434228827,0,0,0.925564681724846,0.4034359415511988,FRZB;LRP4,Hypo
4551,GO_Molecular_Function_2018,mRNA 5'-UTR binding (GO:0048027),2/22,0.6466947601095914,0.8824774434228827,0,0,0.925564681724846,0.4034359415511988,MYH10;CCT5,Hypo
4552,GO_Molecular_Function_2018,fibroblast growth factor binding (GO:0017134),2/22,0.6466947601095914,0.8824774434228827,0,0,0.925564681724846,0.4034359415511988,KL;FGFR2,Hypo
4553,GO_Molecular_Function_2018,core promoter proximal region DNA binding (GO:0001159),2/22,0.6466947601095914,0.8824774434228827,0,0,0.925564681724846,0.4034359415511988,SMAD3;TEAD1,Hypo
4554,GO_Molecular_Function_2018,histone acetyltransferase binding (GO:0035035),2/22,0.6466947601095914,0.8824774434228827,0,0,0.925564681724846,0.4034359415511988,EPAS1;FOXP3,Hypo
4555,GO_Molecular_Function_2018,methyltransferase activity (GO:0008168),6/67,0.647435241499678,0.8824774434228827,0,0,0.9101902448896984,0.3956929246177444,PRMT8;DNMT3A;MEPCE;BCDIN3D;BUD23;TARBP1,Hypo
4556,GO_Molecular_Function_2018,"translation factor activity, RNA binding (GO:0008135)",6/67,0.647435241499678,0.8824774434228827,0,0,0.9101902448896984,0.3956929246177444,EIF2B5;EEF2K;AGO2;EIF3F;CPEB3;EIF4G3,Hypo
4557,GO_Molecular_Function_2018,nuclear hormone receptor binding (GO:0035257),5/56,0.6483802041285655,0.8824774434228827,0,0,0.9072533897877916,0.3930929522975901,NCOA1;MED24;RXRA;BUD31;MED16,Hypo
4558,GO_Molecular_Function_2018,hydro-lyase activity (GO:0016836),4/45,0.6511280780652824,0.8824774434228827,0,0,0.9028651643145414,0.3873733197045393,ALAD;HADHA;HSD17B4;ENO1,Hypo
4559,GO_Molecular_Function_2018,"ATPase activity, coupled to transmembrane movement of substances (GO:0042626)",4/45,0.6511280780652824,0.8824774434228827,0,0,0.9028651643145414,0.3873733197045393,ABCA1;ABCC4;ABCB8;ABCG1,Hypo
4560,GO_Molecular_Function_2018,P-P-bond-hydrolysis-driven transmembrane transporter activity (GO:0015405),4/45,0.6511280780652824,0.8824774434228827,0,0,0.9028651643145414,0.3873733197045393,ABCA1;ABCC4;ABCB8;ABCG1,Hypo
4561,GO_Molecular_Function_2018,helicase activity (GO:0004386),3/34,0.6572704671759071,0.8886901912953189,0,0,0.8956210547243899,0.3758560409564123,UPF1;DDX24;RECQL,Hypo
4562,GO_Molecular_Function_2018,"transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding (GO:0001228)",26/284,0.6626325547055051,0.8886901912953189,0,0,0.9319086528388854,0.3835127092563355,AKNA;HLF;RORA;LITAF;ZIC3;CREB3L1;PLAGL1;TRPS1;CREB3L2;CAMTA1;MEF2D;TFEB;EBF3;GRHL1;KLF15;ETV5;NR4A1;TEF;ELF4;DDIT3;NFIC;IRF2;TCF4;ERG;LHX4;SSBP3,Hypo
4563,GO_Molecular_Function_2018,calcium ion binding (GO:0005509),26/284,0.6626325547055051,0.8886901912953189,0,0,0.9319086528388854,0.3835127092563355,RYR1;RYR2;LRP1;EFCAB6;RASGRP1;RYR3;CAMKK2;SCUBE1;NCS1;CDH22;SLIT1;MAN1C1;PCDHA4;SPOCK1;PCDHA7;TPD52;RPH3AL;SYT13;S100B;SYT7;MELK;SYT12;PITPNM2;SPARCL1;RAPGEF2;CALM3,Hypo
4564,GO_Molecular_Function_2018,ATPase activator activity (GO:0001671),2/23,0.670963157079587,0.8886901912953189,0,0,0.8814412828786545,0.3517312559146098,DNAJB2;NCAPH,Hypo
4565,GO_Molecular_Function_2018,voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1905030),2/23,0.670963157079587,0.8886901912953189,0,0,0.8814412828786545,0.3517312559146098,CACNA1I;SCN1B,Hypo
4566,GO_Molecular_Function_2018,voltage-gated sodium channel activity (GO:0005248),2/23,0.670963157079587,0.8886901912953189,0,0,0.8814412828786545,0.3517312559146098,CACNA1I;SCN1B,Hypo
4567,GO_Molecular_Function_2018,semaphorin receptor activity (GO:0017154),1/11,0.676561777270634,0.8886901912953189,0,0,0.9256028732683428,0.3616622144314591,PLXND1,Hypo
4568,GO_Molecular_Function_2018,U6 snRNA binding (GO:0017070),1/11,0.676561777270634,0.8886901912953189,0,0,0.9256028732683428,0.3616622144314591,SART3,Hypo
4569,GO_Molecular_Function_2018,sodium:potassium-exchanging ATPase activity (GO:0005391),1/11,0.676561777270634,0.8886901912953189,0,0,0.9256028732683428,0.3616622144314591,ATP1A2,Hypo
4570,GO_Molecular_Function_2018,potassium-transporting ATPase activity (GO:0008556),1/11,0.676561777270634,0.8886901912953189,0,0,0.9256028732683428,0.3616622144314591,ATP1A2,Hypo
4571,GO_Molecular_Function_2018,aryl sulfotransferase activity (GO:0004062),1/11,0.676561777270634,0.8886901912953189,0,0,0.9256028732683428,0.3616622144314591,SULT4A1,Hypo
4572,GO_Molecular_Function_2018,prenyltransferase activity (GO:0004659),1/11,0.676561777270634,0.8886901912953189,0,0,0.9256028732683428,0.3616622144314591,FNTB,Hypo
4573,GO_Molecular_Function_2018,thioesterase binding (GO:0031996),1/11,0.676561777270634,0.8886901912953189,0,0,0.9256028732683428,0.3616622144314591,TRAF4,Hypo
4574,GO_Molecular_Function_2018,nucleotide diphosphatase activity (GO:0004551),1/11,0.676561777270634,0.8886901912953189,0,0,0.9256028732683428,0.3616622144314591,NUDT3,Hypo
4575,GO_Molecular_Function_2018,mRNA 3'-UTR AU-rich region binding (GO:0035925),1/11,0.676561777270634,0.8886901912953189,0,0,0.9256028732683428,0.3616622144314591,CPEB3,Hypo
4576,GO_Molecular_Function_2018,adenyl nucleotide binding (GO:0030554),1/11,0.676561777270634,0.8886901912953189,0,0,0.9256028732683428,0.3616622144314591,BAG3,Hypo
4577,GO_Molecular_Function_2018,adenyl-nucleotide exchange factor activity (GO:0000774),1/11,0.676561777270634,0.8886901912953189,0,0,0.9256028732683428,0.3616622144314591,BAG3,Hypo
4578,GO_Molecular_Function_2018,ubiquitin-like protein conjugating enzyme binding (GO:0044390),3/35,0.6767960887444777,0.8886901912953189,0,0,0.8675847457627118,0.3386922876527123,RNF144B;RNF114;RNF19B,Hypo
4579,GO_Molecular_Function_2018,ion transmembrane transporter activity (GO:0015075),3/35,0.6767960887444777,0.8886901912953189,0,0,0.8675847457627118,0.3386922876527123,ABCA1;SLC4A1;KCNK3,Hypo
4580,GO_Molecular_Function_2018,endodeoxyribonuclease activity (GO:0004520),3/35,0.6767960887444777,0.8886901912953189,0,0,0.8675847457627118,0.3386922876527123,RAD51;ERCC1;SETMAR,Hypo
4581,GO_Molecular_Function_2018,calcium-dependent phospholipid binding (GO:0005544),4/47,0.6850644184737106,0.8981482189320964,0,0,0.8607758311623127,0.3255819193173114,RPH3AL;SYT12;SYT13;SYT7,Hypo
4582,GO_Molecular_Function_2018,UDP-galactosyltransferase activity (GO:0035250),2/24,0.6938606308665171,0.9047751506401638,0,0,0.8413291021093896,0.3074924590906396,B4GALT1;B3GALT1,Hypo
4583,GO_Molecular_Function_2018,ammonium transmembrane transporter activity (GO:0008519),2/24,0.6938606308665171,0.9047751506401638,0,0,0.8413291021093896,0.3074924590906396,SLC44A2;RHCG,Hypo
4584,GO_Molecular_Function_2018,retinoid binding (GO:0005501),2/24,0.6938606308665171,0.9047751506401638,0,0,0.8413291021093896,0.3074924590906396,RXRA;RARA,Hypo
4585,GO_Molecular_Function_2018,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),3/36,0.6954855250472434,0.9047751506401638,0,0,0.8412476070411355,0.3054949296702237,GRID1;GRIK5;GRIK4,Hypo
4586,GO_Molecular_Function_2018,translation initiation factor activity (GO:0003743),3/36,0.6954855250472434,0.9047751506401638,0,0,0.8412476070411355,0.3054949296702237,EIF2B5;AGO2;EIF3F,Hypo
4587,GO_Molecular_Function_2018,flavin adenine dinucleotide binding (GO:0050660),4/48,0.7011341490093187,0.9058274617567756,0,0,0.841166028216388,0.2986610808091949,POR;ACADL;CRY2;MICAL3,Hypo
4588,GO_Molecular_Function_2018,single-stranded telomeric DNA binding (GO:0043047),1/12,0.7081142316698874,0.9058274617567756,0,0,0.8414105135500723,0.290412716020708,STN1,Hypo
4589,GO_Molecular_Function_2018,BMP receptor binding (GO:0070700),1/12,0.7081142316698874,0.9058274617567756,0,0,0.8414105135500723,0.290412716020708,TGFB3,Hypo
4590,GO_Molecular_Function_2018,sodium:amino acid symporter activity (GO:0005283),1/12,0.7081142316698874,0.9058274617567756,0,0,0.8414105135500723,0.290412716020708,SLC6A1,Hypo
4591,GO_Molecular_Function_2018,RNA polymerase I activity (GO:0001054),1/12,0.7081142316698874,0.9058274617567756,0,0,0.8414105135500723,0.290412716020708,POLR1D,Hypo
4592,GO_Molecular_Function_2018,ATPase-coupled anion transmembrane transporter activity (GO:0043225),1/12,0.7081142316698874,0.9058274617567756,0,0,0.8414105135500723,0.290412716020708,ABCC4,Hypo
4593,GO_Molecular_Function_2018,protein-arginine N-methyltransferase activity (GO:0016274),1/12,0.7081142316698874,0.9058274617567756,0,0,0.8414105135500723,0.290412716020708,PRMT8,Hypo
4594,GO_Molecular_Function_2018,sodium ion binding (GO:0031402),1/12,0.7081142316698874,0.9058274617567756,0,0,0.8414105135500723,0.290412716020708,ATP1A2,Hypo
4595,GO_Molecular_Function_2018,annealing activity (GO:0097617),1/12,0.7081142316698874,0.9058274617567756,0,0,0.8414105135500723,0.290412716020708,RECQL,Hypo
4596,GO_Molecular_Function_2018,"UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity (GO:0008499)",1/12,0.7081142316698874,0.9058274617567756,0,0,0.8414105135500723,0.290412716020708,B3GALT1,Hypo
4597,GO_Molecular_Function_2018,single-stranded DNA-dependent ATPase activity (GO:0043142),1/12,0.7081142316698874,0.9058274617567756,0,0,0.8414105135500723,0.290412716020708,RAD51,Hypo
4598,GO_Molecular_Function_2018,zinc ion binding (GO:0008270),27/302,0.7116896196097124,0.9083537850425032,0,0,0.907530846688413,0.3086633929135035,KMT2A;MYCBP2;ECE1;IDE;LIMD1;LITAF;RASGRP1;ALAD;RXRA;CSRP1;FNTB;TIMP2;PIAS4;KDM4A;SMAD3;LANCL1;BAZ1B;S100B;GRIN2B;TRAF7;CLIP1;P2RX4;KAT6A;MSRB3;ATP13A2;ARHGEF2;SHANK3,Hypo
4599,GO_Molecular_Function_2018,transition metal ion binding (GO:0046914),36/399,0.7140466922843621,0.9083537850425032,0,0,0.916448612658359,0.3086662377061006,KDM3A;B4GALT1;KMT2A;MYCBP2;ECE1;IDE;LIMD1;LITAF;RASGRP1;ALAD;RXRA;CSRP1;FNTB;TIMP2;ABL1;ABL2;XXYLT1;PCK2;PIAS4;KDM4A;SMAD3;GALNT2;LANCL1;TET1;BAZ1B;S100B;GRIN2B;TRAF7;CLIP1;P2RX4;KAT6A;TET3;MSRB3;ATP13A2;ARHGEF2;SHANK3,Hypo
4600,GO_Molecular_Function_2018,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",2/25,0.7154236688282665,0.9083537850425032,0,0,0.8047049370591911,0.2694798854193097,ALDH5A1;ALDH2,Hypo
4601,GO_Molecular_Function_2018,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",2/25,0.7154236688282665,0.9083537850425032,0,0,0.8047049370591911,0.2694798854193097,TCIRG1;ATP6V0A1,Hypo
4602,GO_Molecular_Function_2018,DNA-dependent ATPase activity (GO:0008094),6/72,0.715476765442731,0.9083537850425032,0,0,0.8410026187803965,0.2815728520359669,RAD51;ERCC2;RECQL;ERCC6;CHD2;SMARCA4,Hypo
4603,GO_Molecular_Function_2018,"transcriptional activator activity, RNA polymerase II transcription factor binding (GO:0001190)",4/50,0.7314741721802362,0.9254029973270862,0,0,0.8045042227087895,0.2515631343009611,NCOA1;WWOX;JADE1;SMARCA4,Hypo
4604,GO_Molecular_Function_2018,thyroid hormone receptor binding (GO:0046966),2/26,0.7356946763071037,0.9254029973270862,0,0,0.7711327857631759,0.2366915653516635,MED24;MED16,Hypo
4605,GO_Molecular_Function_2018,enhancer binding (GO:0035326),2/26,0.7356946763071037,0.9254029973270862,0,0,0.7711327857631759,0.2366915653516635,RAI1;SMAD3,Hypo
4606,GO_Molecular_Function_2018,glycine binding (GO:0016594),1/13,0.7365900488807531,0.9254029973270862,0,0,0.7712502137848469,0.2357895342254445,GRIN2B,Hypo
4607,GO_Molecular_Function_2018,phosphatidate phosphatase activity (GO:0008195),1/13,0.7365900488807531,0.9254029973270862,0,0,0.7712502137848469,0.2357895342254445,LPIN1,Hypo
4608,GO_Molecular_Function_2018,"oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor (GO:0016653)",1/13,0.7365900488807531,0.9254029973270862,0,0,0.7712502137848469,0.2357895342254445,POR,Hypo
4609,GO_Molecular_Function_2018,3'-5' DNA helicase activity (GO:0043138),1/13,0.7365900488807531,0.9254029973270862,0,0,0.7712502137848469,0.2357895342254445,RECQL,Hypo
4610,GO_Molecular_Function_2018,sequence-specific DNA binding (GO:0043565),35/394,0.7451405690236994,0.9347522316770516,0,0,0.9006523778700626,0.2649560737173188,HLF;KMT2A;EPAS1;TCF7;RORA;MYRFL;FOXO3;CXXC5;SMG5;SMG6;RXRA;ZIC3;PRDM16;HIVEP1;CAMTA1;HIVEP3;TEAD1;MEF2D;UPF1;XRCC6;STN1;SMAD3;ZBTB38;ESX1;FOXN3;GRHL1;POU2F2;FOXP3;NR4A1;NR6A1;BCL6;ERF;MAFK;LHX4;MAPT,Hypo
4611,GO_Molecular_Function_2018,signal sequence binding (GO:0005048),3/39,0.7466130204305393,0.9352076912673768,0,0,0.771015237116932,0.2252970309100421,BABAM2;CABP1;TNPO1,Hypo
4612,GO_Molecular_Function_2018,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",6/75,0.7516797324055353,0.9353853003332752,0,0,0.8043030953658973,0.2295842435760663,NDST1;HDAC5;NACC2;ASPG;RBBP7;MTA3,Hypo
4613,GO_Molecular_Function_2018,hormone receptor binding (GO:0051427),3/40,0.7620521504921004,0.9353853003332752,0,0,0.7501353433556823,0.2038419932457613,NCOA1;SRC;BUD31,Hypo
4614,GO_Molecular_Function_2018,DNA helicase activity (GO:0003678),3/40,0.7620521504921004,0.9353853003332752,0,0,0.7501353433556823,0.2038419932457613,ERCC2;RECQL;CHD2,Hypo
4615,GO_Molecular_Function_2018,MAP kinase activity (GO:0004707),1/14,0.7622890881719574,0.9353853003332752,0,0,0.7118838062911947,0.193226204690295,MAPK14,Hypo
4616,GO_Molecular_Function_2018,lipoprotein transporter activity (GO:0042954),1/14,0.7622890881719574,0.9353853003332752,0,0,0.7118838062911947,0.193226204690295,LRP1,Hypo
4617,GO_Molecular_Function_2018,peptide transmembrane transporter activity (GO:1904680),1/14,0.7622890881719574,0.9353853003332752,0,0,0.7118838062911947,0.193226204690295,SLC15A4,Hypo
4618,GO_Molecular_Function_2018,"beta-1,3-galactosyltransferase activity (GO:0048531)",1/14,0.7622890881719574,0.9353853003332752,0,0,0.7118838062911947,0.193226204690295,B3GALT1,Hypo
4619,GO_Molecular_Function_2018,CARD domain binding (GO:0050700),1/14,0.7622890881719574,0.9353853003332752,0,0,0.7118838062911947,0.193226204690295,CARD11,Hypo
4620,GO_Molecular_Function_2018,acid-amino acid ligase activity (GO:0016881),1/14,0.7622890881719574,0.9353853003332752,0,0,0.7118838062911947,0.193226204690295,TTLL3,Hypo
4621,GO_Molecular_Function_2018,aldehyde dehydrogenase (NAD) activity (GO:0004029),1/14,0.7622890881719574,0.9353853003332752,0,0,0.7118838062911947,0.193226204690295,ALDH2,Hypo
4622,GO_Molecular_Function_2018,heparan sulfate sulfotransferase activity (GO:0034483),1/14,0.7622890881719574,0.9353853003332752,0,0,0.7118838062911947,0.193226204690295,NDST1,Hypo
4623,GO_Molecular_Function_2018,poly(A) binding (GO:0008143),1/14,0.7622890881719574,0.9353853003332752,0,0,0.7118838062911947,0.193226204690295,PABPC4,Hypo
4624,GO_Molecular_Function_2018,transaminase activity (GO:0008483),1/14,0.7622890881719574,0.9353853003332752,0,0,0.7118838062911947,0.193226204690295,ABAT,Hypo
4625,GO_Molecular_Function_2018,nucleoside kinase activity (GO:0019206),1/14,0.7622890881719574,0.9353853003332752,0,0,0.7118838062911947,0.193226204690295,DGUOK,Hypo
4626,GO_Molecular_Function_2018,cysteine-type peptidase activity (GO:0008234),5/65,0.7722146238357939,0.9411279387349234,0,0,0.7707797772065125,0.199240989992977,USP10;USP2;OTULIN;CTSF;CTSD,Hypo
4627,GO_Molecular_Function_2018,ATP-dependent DNA helicase activity (GO:0004003),2/28,0.7725510481667461,0.9411279387349234,0,0,0.7117359027009951,0.1836685675174616,RECQL;CHD2,Hypo
4628,GO_Molecular_Function_2018,metallocarboxypeptidase activity (GO:0004181),2/28,0.7725510481667461,0.9411279387349234,0,0,0.7117359027009951,0.1836685675174616,CPXM1;CPN2,Hypo
4629,GO_Molecular_Function_2018,channel activity (GO:0015267),2/28,0.7725510481667461,0.9411279387349234,0,0,0.7117359027009951,0.1836685675174616,PANX1;PANX2,Hypo
4630,GO_Molecular_Function_2018,nuclear localization sequence binding (GO:0008139),2/28,0.7725510481667461,0.9411279387349234,0,0,0.7117359027009951,0.1836685675174616,CABP1;TNPO1,Hypo
4631,GO_Molecular_Function_2018,protein methyltransferase activity (GO:0008276),3/41,0.7767185895491622,0.9445953262947236,0,0,0.7303543913713405,0.1845438805833959,SETD4;DOT1L;SMYD2,Hypo
4632,GO_Molecular_Function_2018,iron ion binding (GO:0005506),4/54,0.785092027089928,0.9445953262947236,0,0,0.7399794450154162,0.1790412353531343,FTO;KDM3A;TET3;TET1,Hypo
4633,GO_Molecular_Function_2018,acyl-CoA dehydrogenase activity (GO:0003995),1/15,0.7854819973103216,0.9445953262947236,0,0,0.6609983141537785,0.1596031592868082,ACADL,Hypo
4634,GO_Molecular_Function_2018,"oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor (GO:0016641)",1/15,0.7854819973103216,0.9445953262947236,0,0,0.6609983141537785,0.1596031592868082,RNLS,Hypo
4635,GO_Molecular_Function_2018,purinergic nucleotide receptor activity (GO:0001614),1/15,0.7854819973103216,0.9445953262947236,0,0,0.6609983141537785,0.1596031592868082,P2RX4,Hypo
4636,GO_Molecular_Function_2018,RNA polymerase II carboxy-terminal domain kinase activity (GO:0008353),1/15,0.7854819973103216,0.9445953262947236,0,0,0.6609983141537785,0.1596031592868082,ERCC2,Hypo
4637,GO_Molecular_Function_2018,myosin V binding (GO:0031489),1/15,0.7854819973103216,0.9445953262947236,0,0,0.6609983141537785,0.1596031592868082,RAB6B,Hypo
4638,GO_Molecular_Function_2018,5'-3' exonuclease activity (GO:0008409),1/15,0.7854819973103216,0.9445953262947236,0,0,0.6609983141537785,0.1596031592868082,FAN1,Hypo
4639,GO_Molecular_Function_2018,G-protein coupled chemoattractant receptor activity (GO:0001637),1/15,0.7854819973103216,0.9445953262947236,0,0,0.6609983141537785,0.1596031592868082,CMKLR1,Hypo
4640,GO_Molecular_Function_2018,ubiquitin protein ligase binding (GO:0031625),24/284,0.7986759762832317,0.951922995610151,0,0,0.8526240115025162,0.1916698368894185,UBL4A;PIAS4;KDM4A;SMAD3;TNK2;AKTIP;USP2;KLHL11;DTX1;ERLIN2;AXIN2;SMG5;SMAD7;TMEM189;PER1;NPLOC4;TRAF4;PRKAR1A;BTBD3;HLTF;UBE2O;TRIB1;SLC25A5;RFFL,Hypo
4641,GO_Molecular_Function_2018,protein transporter activity (GO:0008565),6/80,0.8043392052540629,0.951922995610151,0,0,0.7497497497497497,0.1632461632324524,IPO9;LRP1;AP2S1;ITGB1BP1;TNPO1;RAMP1,Hypo
4642,GO_Molecular_Function_2018,pre-mRNA binding (GO:0036002),2/30,0.8048360089308861,0.951922995610151,0,0,0.6608242886476973,0.1434760138962487,CELF4;CELF5,Hypo
4643,GO_Molecular_Function_2018,5'-3' RNA polymerase activity (GO:0034062),2/30,0.8048360089308861,0.951922995610151,0,0,0.6608242886476973,0.1434760138962487,POLR3B;POLR1D,Hypo
4644,GO_Molecular_Function_2018,snoRNA binding (GO:0030515),2/30,0.8048360089308861,0.951922995610151,0,0,0.6608242886476973,0.1434760138962487,NUFIP1;RRP9,Hypo
4645,GO_Molecular_Function_2018,retinoic acid receptor binding (GO:0042974),1/16,0.8064130564244143,0.951922995610151,0,0,0.6168975543013511,0.1327311785860344,RARG,Hypo
4646,GO_Molecular_Function_2018,muscle alpha-actinin binding (GO:0051371),1/16,0.8064130564244143,0.951922995610151,0,0,0.6168975543013511,0.1327311785860344,MYBPC1,Hypo
4647,GO_Molecular_Function_2018,peptidoglycan binding (GO:0042834),1/16,0.8064130564244143,0.951922995610151,0,0,0.6168975543013511,0.1327311785860344,HK1,Hypo
4648,GO_Molecular_Function_2018,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),1/16,0.8064130564244143,0.951922995610151,0,0,0.6168975543013511,0.1327311785860344,TGFB3,Hypo
4649,GO_Molecular_Function_2018,MHC class II protein complex binding (GO:0023026),1/16,0.8064130564244143,0.951922995610151,0,0,0.6168975543013511,0.1327311785860344,PKM,Hypo
4650,GO_Molecular_Function_2018,adrenergic receptor activity (GO:0004935),1/16,0.8064130564244143,0.951922995610151,0,0,0.6168975543013511,0.1327311785860344,GPR101,Hypo
4651,GO_Molecular_Function_2018,ubiquitin-specific protease binding (GO:1990381),1/16,0.8064130564244143,0.951922995610151,0,0,0.6168975543013511,0.1327311785860344,SART3,Hypo
4652,GO_Molecular_Function_2018,DNA binding (GO:0003677),80/893,0.807896451110207,0.951922995610151,0,0,0.9070255408436436,0.1934879430068797,RERE;RARG;HP1BP3;HMGB3;RORA;TCF20;MYRFL;HMGB1;CHD2;SOX3;ZMYM1;ZIC3;TEAD1;GTF2I;SREBF1;H2AFY;MAP1S;ESX1;DNMT3A;RECQL;SETMAR;TET1;WBP11;FOXP3;ETV5;TRAF4;DDIT3;KAT6A;IRF2;CRY2;ERF;ERG;MAPT;FAN1;PPARD;GTF3C1;KMT2D;NUFIP1;HLF;EPAS1;TCF7;MLLT1;FOXO3;CXXC5;RXRA;PLAGL1;HLTF;MXI1;PRDM16;HIVEP1;ABL1;CAMTA1;E4F1;HIVEP3;MEF2D;E2F6;XRCC6;STN1;SMAD3;ZBTB16;KCNIP3;NFATC2;FOXN3;GRHL1;POU2F2;PALB2;RCAN1;NR4A1;RAD51;NR6A1;BCL6;IMPDH1;ERCC1;BHLHE40;FOSB;TCF4;MAFK;ERCC6;LHX4;TAF4,Hypo
4653,GO_Molecular_Function_2018,G-protein coupled amine receptor activity (GO:0008227),4/56,0.8085134814434972,0.951922995610151,0,0,0.7114396394971935,0.1512221338669659,HRH3;CHRM4;HTR5A;GPR101,Hypo
4654,GO_Molecular_Function_2018,phosphoric ester hydrolase activity (GO:0042578),4/56,0.8085134814434972,0.951922995610151,0,0,0.7114396394971935,0.1512221338669659,DUSP5;PDXP;ENPP6;HDHD2,Hypo
4655,GO_Molecular_Function_2018,cysteine-type endopeptidase activity (GO:0004197),6/81,0.8137526348065445,0.9567551898771506,0,0,0.7397119341563786,0.1524537771908451,PEF1;USP10;CAPN5;USP2;CTSF;CTSD,Hypo
4656,GO_Molecular_Function_2018,phospholipase activity (GO:0004620),5/69,0.8152855531195621,0.9572224530359204,0,0,0.7224453727506427,0.1475355220634479,SMPD4;PLA2G5;DDHD1;MGLL;GPLD1,Hypo
4657,GO_Molecular_Function_2018,organic acid transmembrane transporter activity (GO:0005342),1/17,0.8253027462851821,0.9596278829219428,0,0,0.5783093894304772,0.111038291292205,SLC10A3,Hypo
4658,GO_Molecular_Function_2018,monovalent inorganic cation transmembrane transporter activity (GO:0015077),1/17,0.8253027462851821,0.9596278829219428,0,0,0.5783093894304772,0.111038291292205,TRAPPC10,Hypo
4659,GO_Molecular_Function_2018,CXCR chemokine receptor binding (GO:0045236),1/17,0.8253027462851821,0.9596278829219428,0,0,0.5783093894304772,0.111038291292205,YARS,Hypo
4660,GO_Molecular_Function_2018,CoA hydrolase activity (GO:0016289),1/17,0.8253027462851821,0.9596278829219428,0,0,0.5783093894304772,0.111038291292205,ACOT7,Hypo
4661,GO_Molecular_Function_2018,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",1/17,0.8253027462851821,0.9596278829219428,0,0,0.5783093894304772,0.111038291292205,BDH2,Hypo
4662,GO_Molecular_Function_2018,G-protein beta/gamma-subunit complex binding (GO:0031683),1/17,0.8253027462851821,0.9596278829219428,0,0,0.5783093894304772,0.111038291292205,GNAS,Hypo
4663,GO_Molecular_Function_2018,aspartic-type peptidase activity (GO:0070001),1/17,0.8253027462851821,0.9596278829219428,0,0,0.5783093894304772,0.111038291292205,CTSD,Hypo
4664,GO_Molecular_Function_2018,GTPase activity (GO:0003924),18/222,0.8265628232451567,0.9597692286441696,0,0,0.8150347095359883,0.15524728449041,ARF3;SEPT11;RAB5C;LRRK2;RAP1GAP;DNM1;SEPT8;SEPT9;ARL4D;RAB31;RRAGC;NLRP10;RAB15;GNB2;RAB23;RHOJ;GNAS;RAB6B,Hypo
4665,GO_Molecular_Function_2018,single-stranded RNA binding (GO:0003727),3/45,0.82809474475752,0.9602254055441394,0,0,0.6606500843788979,0.1246169092953915,HNRNPF;AGO2;ADARB2,Hypo
4666,GO_Molecular_Function_2018,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",2/32,0.8329764337338802,0.9645592495022816,0,0,0.6167008898015058,0.112702043240315,NEU1;ENGASE,Hypo
4667,GO_Molecular_Function_2018,damaged DNA binding (GO:0003684),3/46,0.8392365925592539,0.967440197674958,0,0,0.6452502956247537,0.1130882565619725,ERCC1;CRY2;HMGB1,Hypo
4668,GO_Molecular_Function_2018,nuclease activity (GO:0004518),4/59,0.839695071455972,0.967440197674958,0,0,0.6725217228814351,0.1175006168607219,SETMAR;SMG5;SND1;SMG6,Hypo
4669,GO_Molecular_Function_2018,ion antiporter activity (GO:0099516),1/18,0.8423500653539966,0.967440197674958,0,0,0.544261008662059,0.0933731990719074,SLC4A1,Hypo
4670,GO_Molecular_Function_2018,calcium-activated potassium channel activity (GO:0015269),1/18,0.8423500653539966,0.967440197674958,0,0,0.544261008662059,0.0933731990719074,KCNU1,Hypo
4671,GO_Molecular_Function_2018,"transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding (GO:0001205)",1/18,0.8423500653539966,0.967440197674958,0,0,0.544261008662059,0.0933731990719074,MEF2D,Hypo
4672,GO_Molecular_Function_2018,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",1/18,0.8423500653539966,0.967440197674958,0,0,0.544261008662059,0.0933731990719074,MTHFD1,Hypo
4673,GO_Molecular_Function_2018,glucuronosyltransferase activity (GO:0015020),2/33,0.8456260016048,0.9698812508201992,0,0,0.5967741935483871,0.1000659602790533,CHPF;B3GAT2,Hypo
4674,GO_Molecular_Function_2018,carboxylic acid binding (GO:0031406),2/34,0.8573981959105047,0.9782537953979368,0,0,0.5780929158110883,0.0889412304994502,PSAP;ERCC2,Hypo
4675,GO_Molecular_Function_2018,MHC protein complex binding (GO:0023023),1/19,0.8577346222827548,0.9782537953979368,0,0,0.5139957813123539,0.0788780626409463,PKM,Hypo
4676,GO_Molecular_Function_2018,neuropeptide binding (GO:0042923),1/19,0.8577346222827548,0.9782537953979368,0,0,0.5139957813123539,0.0788780626409463,OPRD1,Hypo
4677,GO_Molecular_Function_2018,lysophospholipase activity (GO:0004622),1/19,0.8577346222827548,0.9782537953979368,0,0,0.5139957813123539,0.0788780626409463,MGLL,Hypo
4678,GO_Molecular_Function_2018,inorganic anion transmembrane transporter activity (GO:0015103),3/48,0.8596558997621326,0.9782537953979368,0,0,0.6165040232836843,0.0932296411532253,SLC22A23;SLC22A17;SLC4A1,Hypo
4679,GO_Molecular_Function_2018,ubiquitin-like protein ligase binding (GO:0044389),24/297,0.8601545317431548,0.9782537953979368,0,0,0.8114294843266806,0.1222363485392942,UBL4A;PIAS4;KDM4A;SMAD3;TNK2;AKTIP;USP2;KLHL11;DTX1;ERLIN2;AXIN2;SMG5;SMAD7;TMEM189;PER1;NPLOC4;TRAF4;PRKAR1A;BTBD3;HLTF;UBE2O;TRIB1;SLC25A5;RFFL,Hypo
4680,GO_Molecular_Function_2018,ubiquitin binding (GO:0043130),4/62,0.8664973848674139,0.9782537953979368,0,0,0.6376297976397207,0.0913699192754301,SMAD3;NPLOC4;UBXN11;RBCK1,Hypo
4681,GO_Molecular_Function_2018,"intramolecular oxidoreductase activity, transposing S-S bonds (GO:0016864)",1/20,0.8716185241935481,0.9782537953979368,0,0,0.4869163673678809,0.0669039756140387,PDIA5,Hypo
4682,GO_Molecular_Function_2018,protein disulfide isomerase activity (GO:0003756),1/20,0.8716185241935481,0.9782537953979368,0,0,0.4869163673678809,0.0669039756140387,PDIA5,Hypo
4683,GO_Molecular_Function_2018,methyl-CpG binding (GO:0008327),1/20,0.8716185241935481,0.9782537953979368,0,0,0.4869163673678809,0.0669039756140387,ZBTB38,Hypo
4684,GO_Molecular_Function_2018,proteasome binding (GO:0070628),1/20,0.8716185241935481,0.9782537953979368,0,0,0.4869163673678809,0.0669039756140387,UBL4A,Hypo
4685,GO_Molecular_Function_2018,DNA-directed DNA polymerase activity (GO:0003887),1/20,0.8716185241935481,0.9782537953979368,0,0,0.4869163673678809,0.0669039756140387,NEXMIF,Hypo
4686,GO_Molecular_Function_2018,ferrous iron binding (GO:0008198),1/20,0.8716185241935481,0.9782537953979368,0,0,0.4869163673678809,0.0669039756140387,FTO,Hypo
4687,GO_Molecular_Function_2018,UDP-glycosyltransferase activity (GO:0008194),4/63,0.8745331516302965,0.9782537953979368,0,0,0.6267876739770412,0.0840303371489195,B4GALT1;B3GALT1;XXYLT1;POMGNT1,Hypo
4688,GO_Molecular_Function_2018,exonuclease activity (GO:0004527),2/36,0.8785118558767198,0.9782537953979368,0,0,0.5440270564077787,0.0704655809700458,DCPS;FAN1,Hypo
4689,GO_Molecular_Function_2018,peptidase inhibitor activity (GO:0030414),2/36,0.8785118558767198,0.9782537953979368,0,0,0.5440270564077787,0.0704655809700458,SERPIND1;SGPP2,Hypo
4690,GO_Molecular_Function_2018,snRNA binding (GO:0017069),2/36,0.8785118558767198,0.9782537953979368,0,0,0.5440270564077787,0.0704655809700458,SART3;MEPCE,Hypo
4691,GO_Molecular_Function_2018,endopeptidase regulator activity (GO:0061135),2/36,0.8785118558767198,0.9782537953979368,0,0,0.5440270564077787,0.0704655809700458,SERPIND1;SGPP2,Hypo
4692,GO_Molecular_Function_2018,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),2/36,0.8785118558767198,0.9782537953979368,0,0,0.5440270564077787,0.0704655809700458,POLR3B;POLR1D,Hypo
4693,GO_Molecular_Function_2018,TBP-class protein binding (GO:0017025),1/21,0.8841480812081329,0.9782537953979368,0,0,0.4625448948178553,0.0569534848647535,THRA,Hypo
4694,GO_Molecular_Function_2018,N-methyltransferase activity (GO:0008170),1/21,0.8841480812081329,0.9782537953979368,0,0,0.4625448948178553,0.0569534848647535,SMYD2,Hypo
4695,GO_Molecular_Function_2018,DNA polymerase activity (GO:0034061),1/21,0.8841480812081329,0.9782537953979368,0,0,0.4625448948178553,0.0569534848647535,NEXMIF,Hypo
4696,GO_Molecular_Function_2018,GABA receptor activity (GO:0016917),1/21,0.8841480812081329,0.9782537953979368,0,0,0.4625448948178553,0.0569534848647535,GABBR2,Hypo
4697,GO_Molecular_Function_2018,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",1/21,0.8841480812081329,0.9782537953979368,0,0,0.4625448948178553,0.0569534848647535,HSD17B4,Hypo
4698,GO_Molecular_Function_2018,cysteine-type endopeptidase inhibitor activity (GO:0004869),3/51,0.8860133887648659,0.9782537953979368,0,0,0.5778762198253724,0.0699364391617406,TNFAIP8;SPOCK1;BIRC6,Hypo
4699,GO_Molecular_Function_2018,hydrogen ion transmembrane transporter activity (GO:0015078),3/51,0.8860133887648659,0.9782537953979368,0,0,0.5778762198253724,0.0699364391617406,TCIRG1;SLC9A1;ATP6V0A1,Hypo
4700,GO_Molecular_Function_2018,GDP binding (GO:0019003),3/51,0.8860133887648659,0.9782537953979368,0,0,0.5778762198253724,0.0699364391617406,RAB31;RAB5C;RRAGC,Hypo
4701,GO_Molecular_Function_2018,metalloendopeptidase activity (GO:0004222),4/65,0.8893558081258384,0.9782537953979368,0,0,0.6061698650447324,0.0710781990101441,MIPEP;PITRM1;ECE1;IDE,Hypo
4702,GO_Molecular_Function_2018,RNA polymerase II distal enhancer sequence-specific DNA binding (GO:0000980),3/52,0.8937627291931091,0.9782537953979368,0,0,0.5660513820320116,0.0635760284937541,SMARCC2;ZBTB16;SMARCA4,Hypo
4703,GO_Molecular_Function_2018,bicarbonate transmembrane transporter activity (GO:0015106),1/22,0.8954553453984322,0.9782537953979368,0,0,0.4404945148916416,0.0486406924620587,SLC4A1,Hypo
4704,GO_Molecular_Function_2018,N-acetyltransferase activity (GO:0008080),1/22,0.8954553453984322,0.9782537953979368,0,0,0.4404945148916416,0.0486406924620587,NAT8L,Hypo
4705,GO_Molecular_Function_2018,phosphatidylinositol-4-phosphate binding (GO:0070273),1/22,0.8954553453984322,0.9782537953979368,0,0,0.4404945148916416,0.0486406924620587,DAB2IP,Hypo
4706,GO_Molecular_Function_2018,ATPase regulator activity (GO:0060590),2/38,0.8967036894057253,0.9782537953979368,0,0,0.5137462924937257,0.0560136589154878,DNAJB2;BAG3,Hypo
4707,GO_Molecular_Function_2018,tRNA binding (GO:0000049),2/38,0.8967036894057253,0.9782537953979368,0,0,0.5137462924937257,0.0560136589154878,YARS;EIF2AK4,Hypo
4708,GO_Molecular_Function_2018,divalent inorganic cation transmembrane transporter activity (GO:0072509),2/38,0.8967036894057253,0.9782537953979368,0,0,0.5137462924937257,0.0560136589154878,MRS2;ATP2B1,Hypo
4709,GO_Molecular_Function_2018,ribosome binding (GO:0043022),2/38,0.8967036894057253,0.9782537953979368,0,0,0.5137462924937257,0.0560136589154878,SRP68;CPEB3,Hypo
4710,GO_Molecular_Function_2018,protease binding (GO:0002020),8/118,0.8992198729440998,0.9782537953979368,0,0,0.6718472053178541,0.0713687829644421,SART3;BIN1;TIMP2;TIMP3;FURIN;RFFL;NFRKB;LDLR,Hypo
4711,GO_Molecular_Function_2018,amino acid binding (GO:0016597),2/39,0.904816672156284,0.9782537953979368,0,0,0.4998335090737554,0.0499948110929367,UBR2;GRIN2B,Hypo
4712,GO_Molecular_Function_2018,carboxypeptidase activity (GO:0004180),2/39,0.904816672156284,0.9782537953979368,0,0,0.4998335090737554,0.0499948110929367,CPXM1;CPN2,Hypo
4713,GO_Molecular_Function_2018,acetylcholine receptor activity (GO:0015464),1/23,0.9056594991469732,0.9782537953979368,0,0,0.4204487149587201,0.0416630503867705,CHRM4,Hypo
4714,GO_Molecular_Function_2018,calcium activated cation channel activity (GO:0005227),1/23,0.9056594991469732,0.9782537953979368,0,0,0.4204487149587201,0.0416630503867705,KCNU1,Hypo
4715,GO_Molecular_Function_2018,ligand-gated ion channel activity (GO:0015276),4/68,0.9087128876907876,0.9782537953979368,0,0,0.5776593011305241,0.0552970661471355,P2RX4;DLG3;GRIK5;GRIK4,Hypo
4716,GO_Molecular_Function_2018,G-protein coupled receptor binding (GO:0001664),9/133,0.9109256462736792,0.9782537953979368,0,0,0.670314603380366,0.0625363324543931,ARHGEF12;WNT5B;USP4;PSAP;DVL1;DVL2;GNAS;WNT9B;FLNA,Hypo
4717,GO_Molecular_Function_2018,methylated histone binding (GO:0035064),3/55,0.9142467443004104,0.9782537953979368,0,0,0.533305677373474,0.0478134047879954,KDM4A;ZMYND8;CHD5,Hypo
4718,GO_Molecular_Function_2018,protein-cysteine S-palmitoyltransferase activity (GO:0019706),1/24,0.9148681092693792,0.9782537953979368,0,0,0.4021460280634439,0.0357810904229528,ZDHHC7,Hypo
4719,GO_Molecular_Function_2018,NF-kappaB binding (GO:0051059),1/24,0.9148681092693792,0.9782537953979368,0,0,0.4021460280634439,0.0357810904229528,FOXP3,Hypo
4720,GO_Molecular_Function_2018,protein-cysteine S-acyltransferase activity (GO:0019707),1/24,0.9148681092693792,0.9782537953979368,0,0,0.4021460280634439,0.0357810904229528,ZDHHC7,Hypo
4721,GO_Molecular_Function_2018,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),1/24,0.9148681092693792,0.9782537953979368,0,0,0.4021460280634439,0.0357810904229528,TNFAIP8,Hypo
4722,GO_Molecular_Function_2018,G-protein coupled serotonin receptor activity (GO:0004993),1/24,0.9148681092693792,0.9782537953979368,0,0,0.4021460280634439,0.0357810904229528,HTR5A,Hypo
4723,GO_Molecular_Function_2018,acetyltransferase activity (GO:0016407),1/24,0.9148681092693792,0.9782537953979368,0,0,0.4021460280634439,0.0357810904229528,KAT6A,Hypo
4724,GO_Molecular_Function_2018,phosphatidylinositol phospholipase C activity (GO:0004435),1/24,0.9148681092693792,0.9782537953979368,0,0,0.4021460280634439,0.0357810904229528,PLCH2,Hypo
4725,GO_Molecular_Function_2018,disulfide oxidoreductase activity (GO:0015036),1/24,0.9148681092693792,0.9782537953979368,0,0,0.4021460280634439,0.0357810904229528,PDIA5,Hypo
4726,GO_Molecular_Function_2018,miRNA binding (GO:0035198),1/24,0.9148681092693792,0.9782537953979368,0,0,0.4021460280634439,0.0357810904229528,AGO2,Hypo
4727,GO_Molecular_Function_2018,copper ion binding (GO:0005507),2/41,0.9192850023602288,0.9782537953979368,0,0,0.4741483704522719,0.039903891798083,P2RX4;ATP13A2,Hypo
4728,GO_Molecular_Function_2018,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",2/41,0.9192850023602288,0.9782537953979368,0,0,0.4741483704522719,0.039903891798083,POR;MICAL3,Hypo
4729,GO_Molecular_Function_2018,pyrophosphatase activity (GO:0016462),2/41,0.9192850023602288,0.9782537953979368,0,0,0.4741483704522719,0.039903891798083,DCPS;NUDT3,Hypo
4730,GO_Molecular_Function_2018,serine-type endopeptidase inhibitor activity (GO:0004867),3/56,0.9202316248523892,0.9782537953979368,0,0,0.5232142337994593,0.0434947335834298,SERPIND1;SPOCK1;FURIN,Hypo
4731,GO_Molecular_Function_2018,chloride transmembrane transporter activity (GO:0015108),3/56,0.9202316248523892,0.9782537953979368,0,0,0.5232142337994593,0.0434947335834298,CLIC6;CLCN5;SLC4A1,Hypo
4732,GO_Molecular_Function_2018,N-acyltransferase activity (GO:0016410),1/25,0.9231782582467696,0.980150216249404,0,0,0.3853685650761074,0.0308036400515286,NMT1,Hypo
4733,GO_Molecular_Function_2018,endopeptidase inhibitor activity (GO:0004866),7/111,0.9249671348772652,0.9808142071717416,0,0,0.62166950393919,0.0484884010361516,SERPIND1;TIMP2;TIMP3;SPOCK1;BIRC6;FURIN;SGPP2,Hypo
4734,GO_Molecular_Function_2018,heme binding (GO:0020037),4/72,0.9298170773033304,0.9829181948347432,0,0,0.5435584305664712,0.0395533355084617,PGRMC1;SRC;PXDN;NR1D1,Hypo
4735,GO_Molecular_Function_2018,alpha-tubulin binding (GO:0043014),1/26,0.9306775659374336,0.9829181948347432,0,0,0.3699332991277578,0.0265768933064728,BBS4,Hypo
4736,GO_Molecular_Function_2018,neuropeptide hormone activity (GO:0005184),1/26,0.9306775659374336,0.9829181948347432,0,0,0.3699332991277578,0.0265768933064728,AGRP,Hypo
4737,GO_Molecular_Function_2018,polyubiquitin modification-dependent protein binding (GO:0031593),2/43,0.9316638688591324,0.9829181948347432,0,0,0.450969099013372,0.0319210292003777,BABAM2;TNIP1,Hypo
4738,GO_Molecular_Function_2018,"transferase activity, transferring hexosyl groups (GO:0016758)",6/100,0.9333288931193396,0.9829181948347432,0,0,0.589571841344891,0.0406790591015554,B4GALT1;DPY19L3;DPY19L4;B3GALT1;POMGNT1;DDOST,Hypo
4739,GO_Molecular_Function_2018,cytokine receptor activity (GO:0004896),4/73,0.9343532672009458,0.9829181948347432,0,0,0.5356509823197343,0.0363710669366241,CNTFR;LIFR;IL12RB1;CMKLR1,Hypo
4740,GO_Molecular_Function_2018,substrate-specific channel activity (GO:0022838),1/27,0.9374451110879404,0.9829181948347432,0,0,0.3556853613292813,0.0229762325481433,KCNK3,Hypo
4741,GO_Molecular_Function_2018,phospholipase C activity (GO:0004629),1/27,0.9374451110879404,0.9829181948347432,0,0,0.3556853613292813,0.0229762325481433,PLCH2,Hypo
4742,GO_Molecular_Function_2018,Hsp70 protein binding (GO:0030544),1/27,0.9374451110879404,0.9829181948347432,0,0,0.3556853613292813,0.0229762325481433,DNAJB2,Hypo
4743,GO_Molecular_Function_2018,mRNA binding (GO:0003729),12/179,0.940568097527096,0.9832970378610014,0,0,0.6630577853580765,0.040626364212147,CLUH;UNK;RBFOX3;PCBP4;CSTF2;AGO2;SAMD4B;ADARB1;CPEB3;DCP1A;MYH10;CCT5,Hypo
4744,GO_Molecular_Function_2018,dicarboxylic acid transmembrane transporter activity (GO:0005310),1/28,0.9435522638100016,0.9832970378610014,0,0,0.3424928263306919,0.0199000395251637,SLC13A3,Hypo
4745,GO_Molecular_Function_2018,palmitoyltransferase activity (GO:0016409),1/28,0.9435522638100016,0.9832970378610014,0,0,0.3424928263306919,0.0199000395251637,ZDHHC7,Hypo
4746,GO_Molecular_Function_2018,RNA polymerase II repressing transcription factor binding (GO:0001103),1/28,0.9435522638100016,0.9832970378610014,0,0,0.3424928263306919,0.0199000395251637,BBS4,Hypo
4747,GO_Molecular_Function_2018,carboxylic ester hydrolase activity (GO:0052689),6/103,0.9440925518553256,0.9832970378610014,0,0,0.5712422044037164,0.0328641783462574,DAGLA;ABHD16A;ABHD2;PLA2G5;DAGLB;MGLL,Hypo
4748,GO_Molecular_Function_2018,chloride channel activity (GO:0005254),3/61,0.9448049829981152,0.9832970378610014,0,0,0.4779767281228415,0.0271379604104582,CLIC6;CLCN6;CLCN5,Hypo
4749,GO_Molecular_Function_2018,excitatory extracellular ligand-gated ion channel activity (GO:0005231),1/29,0.9490634366830252,0.9839727472753712,0,0,0.3302426152605732,0.0172649639772316,P2RX4,Hypo
4750,GO_Molecular_Function_2018,mRNA 3'-UTR binding (GO:0003730),3/63,0.95249936267438,0.9839727472753712,0,0,0.4619928094504366,0.0224832686493301,PCBP4;CPEB3;CCT5,Hypo
4751,GO_Molecular_Function_2018,nucleobase-containing compound kinase activity (GO:0019205),1/30,0.9540367624622976,0.9839727472753712,0,0,0.3188372463332213,0.0150022722907705,DGUOK,Hypo
4752,GO_Molecular_Function_2018,phospholipase A2 activity (GO:0004623),1/30,0.9540367624622976,0.9839727472753712,0,0,0.3188372463332213,0.0150022722907705,PLA2G5,Hypo
4753,GO_Molecular_Function_2018,glutathione transferase activity (GO:0004364),1/30,0.9540367624622976,0.9839727472753712,0,0,0.3188372463332213,0.0150022722907705,GDAP1L1,Hypo
4754,GO_Molecular_Function_2018,NADP binding (GO:0050661),1/30,0.9540367624622976,0.9839727472753712,0,0,0.3188372463332213,0.0150022722907705,KCNAB1,Hypo
4755,GO_Molecular_Function_2018,deoxyribonuclease activity (GO:0004536),1/30,0.9540367624622976,0.9839727472753712,0,0,0.3188372463332213,0.0150022722907705,RAD51,Hypo
4756,GO_Molecular_Function_2018,enhancer sequence-specific DNA binding (GO:0001158),3/64,0.955959288278208,0.9839727472753712,0,0,0.4543938972947031,0.0204658794689111,SMARCC2;ZBTB16;SMARCA4,Hypo
4757,GO_Molecular_Function_2018,G-protein coupled peptide receptor activity (GO:0008528),3/64,0.955959288278208,0.9839727472753712,0,0,0.4543938972947031,0.0204658794689111,OPRD1;GPR37L1;SORCS3,Hypo
4758,GO_Molecular_Function_2018,serotonin receptor activity (GO:0099589),1/31,0.95852470637376,0.9854101554549752,0,0,0.3081922353343595,0.0130550048276056,HTR5A,Hypo
4759,GO_Molecular_Function_2018,anion channel activity (GO:0005253),3/66,0.9621823064269358,0.9864247271264618,0,0,0.4399197789028297,0.0169594963315189,CLIC6;CLCN5;LRRC8D,Hypo
4760,GO_Molecular_Function_2018,transition metal ion transmembrane transporter activity (GO:0046915),1/32,0.9625746178869976,0.9864247271264618,0,0,0.29823399923865,0.0113757454374121,SLC25A28,Hypo
4761,GO_Molecular_Function_2018,cytokine receptor binding (GO:0005126),8/137,0.9630220052492028,0.9864247271264618,0,0,0.5722862229460558,0.0215631821624481,SMAD3;EPO;TGFB3;IL34;PXDN;LIFR;INHBA;IL12RB1,Hypo
4762,GO_Molecular_Function_2018,methylation-dependent protein binding (GO:0140034),2/52,0.9682370114170968,0.990562864835695,0,0,0.3696098562628336,0.0119304056070954,KDM4A;ZMYND8,Hypo
4763,GO_Molecular_Function_2018,neuropeptide receptor activity (GO:0008188),1/35,0.9725030584709874,0.9933275597008192,0,0,0.2718739625147134,0.0075804057375669,SORCS3,Hypo
4764,GO_Molecular_Function_2018,metalloexopeptidase activity (GO:0008235),2/54,0.973296043075773,0.9933275597008192,0,0,0.3553546043279103,0.0096183777557887,CPXM1;CPN2,Hypo
4765,GO_Molecular_Function_2018,peptide-lysine-N-acetyltransferase activity (GO:0061733),1/39,0.9817716034621266,0.999755170950906,0,0,0.2432016418676244,0.0044740786338495,KAT6A,Hypo
4766,GO_Molecular_Function_2018,histone acetyltransferase activity (GO:0004402),1/41,0.9851587645007568,0.999755170950906,0,0,0.2310159055926116,0.0034542580662124,KAT6A,Hypo
4767,GO_Molecular_Function_2018,NADH dehydrogenase (ubiquinone) activity (GO:0008137),1/43,0.9879167016478696,0.999755170950906,0,0,0.2199907156295047,0.0026744040004293,NDUFA12,Hypo
4768,GO_Molecular_Function_2018,NADH dehydrogenase (quinone) activity (GO:0050136),1/43,0.9879167016478696,0.999755170950906,0,0,0.2199907156295047,0.0026744040004293,NDUFA12,Hypo
4769,GO_Molecular_Function_2018,G-protein coupled receptor activity (GO:0004930),16/267,0.9897399898545848,0.999755170950906,0,0,0.5866585364848774,0.0060502135106771,OPRD1;GABBR2;LANCL1;GLP2R;GPR83;GPR37L1;HTR5A;GRM1;GRM2;ADGRD1;ADGRB2;FRZB;ADGRB1;GRM8;QRFPR;CMKLR1,Hypo
4770,GO_Molecular_Function_2018,exopeptidase activity (GO:0008238),1/45,0.9901622543115812,0.999755170950906,0,0,0.2099678156630439,0.0020758375790547,TPP1,Hypo
4771,GO_Molecular_Function_2018,metallopeptidase activity (GO:0008237),4/102,0.9918720293577984,0.999755170950906,0,0,0.3765337584160077,0.0030729607884985,MIPEP;PITRM1;ECE1;IDE,Hypo
4772,GO_Molecular_Function_2018,guanyl ribonucleotide binding (GO:0032561),8/170,0.994953512936506,0.999755170950906,0,0,0.4548702495836035,0.0023013084881702,RAB31;RAB5C;PDE10A;RRAGC;LRRK2;PDE2A;RHOJ;SCG5,Hypo
4773,GO_Molecular_Function_2018,"peptidase activity, acting on L-amino acid peptides (GO:0070011)",9/185,0.9950994018157788,0.999755170950906,0,0,0.4708971476745819,0.0023133507492287,PITRM1;HTRA3;OTULIN;PREP;TRAPPC12;HTRA1;TPP1;ECE1;FURIN,Hypo
4774,GO_Molecular_Function_2018,hormone activity (GO:0005179),2/83,0.998027149995597,0.999755170950906,0,0,0.2277612999721144,0.0004497827045869181,AGRP;INHBA,Hypo
4775,GO_Molecular_Function_2018,serine-type peptidase activity (GO:0008236),10/220,0.9986458188552793,0.999755170950906,0,0,0.4378988708885616,0.0005933962680132052,RHBDF1;HTRA3;TMPRSS4;RHBDF2;PREP;HTRA1;TPP1;FURIN;F2;CTSD,Hypo
4776,GO_Molecular_Function_2018,purine ribonucleoside binding (GO:0032550),6/159,0.99870473290365,0.999755170950906,0,0,0.3610304203986121,0.0004679339395053989,RAB31;RAB5C;RRAGC;LRRK2;RHOJ;SCG5,Hypo
4777,GO_Molecular_Function_2018,GTP binding (GO:0005525),5/147,0.9990823556005,0.999755170950906,0,0,0.3241971106846736,0.0002976342450482414,RAB31;RRAGC;LRRK2;RHOJ;SCG5,Hypo
4778,GO_Molecular_Function_2018,cytokine activity (GO:0005125),5/155,0.9995077145204978,0.999755170950906,0,0,0.3067694944301628,0.00015105535189174476,IL33;EPO;TGFB3;INHBA;HMGB1,Hypo
4779,GO_Molecular_Function_2018,endopeptidase activity (GO:0004175),18/354,0.9995718030113692,0.999755170950906,0,0,0.4911823425022182,0.00021036784258136445,MIPEP;RHBDF1;USP10;HTRA3;TMPRSS4;USP2;RHBDF2;PREP;HTRA1;ECE1;FURIN;IDE;F2;PITRM1;TRAPPC12;TPP1;CTSF;CTSD,Hypo
4780,GO_Molecular_Function_2018,serine-type endopeptidase activity (GO:0004252),7/196,0.9997149933495136,0.999755170950906,0,0,0.3404624387640342,9.704788959258584e-05,RHBDF1;TMPRSS4;RHBDF2;HTRA1;FURIN;F2;CTSD,Hypo
4781,GO_Molecular_Function_2018,immunoglobulin receptor binding (GO:0034987),1/81,0.999755170950906,0.999755170950906,0,0,0.1152514109799897,2.8220348078440715e-05,FLNA,Hypo
